data_2k4n_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2k4n _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 14.7 m120 . . . . . 0 C--O 1.232 0.166 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.6 m -63.93 -28.01 69.53 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.239 0.542 . . . . 0.0 110.36 178.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -62.71 -33.1 74.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.192 178.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 88.7 t -66.9 -39.42 83.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.164 177.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.459 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 64.0 mt -63.43 -39.9 87.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.422 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.461 ' HZ3' ' CD ' ' A' ' 19' ' ' GLU . 96.8 mttt -64.2 -40.24 95.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.755 179.213 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -68.1 -36.85 80.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.7 177.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -62.14 -43.52 98.65 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.255 176.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' A' ' 6' ' ' ILE . 94.0 mt -65.26 -32.4 74.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.662 177.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -62.92 -47.35 83.64 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.36 177.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -64.02 -52.37 59.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.16 -178.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 40.1 pt -67.5 -27.46 38.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.243 -177.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.62 58.21 1.45 Allowed Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.503 178.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.437 ' HG2' HG21 ' A' ' 30' ' ' VAL . 8.4 tp10 -136.36 148.22 47.75 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -95.92 139.93 31.42 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.682 -179.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.444 ' HB3' HD12 ' A' ' 10' ' ' LEU . 52.6 p90 -112.34 142.39 44.91 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.863 0.363 . . . . 0.0 110.49 176.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 62.1 mt -101.65 96.59 4.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 176.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.461 ' CD ' ' HZ3' ' A' ' 7' ' ' LYS . 39.9 tt0 -97.28 121.88 39.67 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.374 0.607 . . . . 0.0 110.813 -178.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 96.3 mt -109.22 34.01 3.98 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.334 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 69.8 101.12 0.06 Allowed 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.268 -177.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 7.7 m120 68.74 3.64 4.01 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.019 -177.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -129.32 113.9 15.55 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 110.406 -0.22 . . . . 0.0 110.406 172.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.403 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 67.6 mt -105.95 102.65 14.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 175.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 42.7 m-70 -87.81 120.99 29.68 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 59.9 mt -117.89 172.14 7.59 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.483 0.659 . . . . 0.0 111.634 -175.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -80.19 136.17 53.73 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.402 176.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.822 ' HG2' ' HG2' ' A' ' 92' ' ' GLU . 88.2 Cg_exo -49.01 -43.81 34.66 Favored 'Trans proline' 0 N--CA 1.474 0.367 0 C-N-CA 123.536 2.824 . . . . 0.0 114.073 -175.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -67.71 -36.66 81.02 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.784 0.326 . . . . 0.0 110.988 -179.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.437 HG21 ' HG2' ' A' ' 15' ' ' GLU . 41.2 t -68.96 -43.86 81.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.087 0.47 . . . . 0.0 109.881 176.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -55.87 -45.62 78.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.082 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 78.4 t80 -57.7 -39.45 77.2 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.28 -178.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -76.78 -42.29 41.31 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.032 -178.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 89.4 t -65.6 -37.16 79.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.791 0.329 . . . . 0.0 110.516 178.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 26.1 t90 -54.19 -53.92 46.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.665 177.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.514 ' HA ' ' HB3' ' A' ' 40' ' ' GLU . 65.9 mttm -71.88 -26.46 62.35 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 121.158 -0.217 . . . . 0.0 111.246 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 77.1 t80 -63.36 -38.59 91.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.733 0.301 . . . . 0.0 110.975 179.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 29.0 m -88.39 10.42 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.827 0.346 . . . . 0.0 111.755 -177.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 99.86 8.18 51.83 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.934 176.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.514 ' HB3' ' HA ' ' A' ' 36' ' ' LYS . 19.1 pt-20 40.69 81.36 0.25 Allowed Pre-proline 0 N--CA 1.473 0.708 0 C-N-CA 124.335 1.054 . . . . 0.0 113.315 178.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -88.08 -168.68 0.39 Allowed 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.008 2.472 . . . . 0.0 111.842 175.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -75.85 136.4 40.17 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.008 0.432 . . . . 0.0 110.717 179.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 97.2 mt -97.08 146.66 24.81 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.71 -179.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 61.1 tttm -111.5 118.39 35.62 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.62 -179.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 37.2 p -105.19 141.94 35.84 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.178 -176.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 21.2 p90 -130.05 151.37 50.67 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.77 0.319 . . . . 0.0 110.273 177.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.508 HG22 ' HG3' ' A' ' 74' ' ' LYS . 42.5 t -107.23 129.86 60.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.632 177.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 6.4 tt -125.92 111.88 28.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 121.239 0.542 . . . . 0.0 110.543 177.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.573 ' HA ' ' HA ' ' A' ' 72' ' ' LYS . 1.6 mp0 . . . . . 0 C--N 1.324 -0.509 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.021 177.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.573 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 20.5 pttp . . . . . 0 N--CA 1.453 -0.296 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 13.9 tt -105.79 137.12 37.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 121.276 0.56 . . . . 0.0 110.945 -175.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.576 ' O ' ' HB3' ' A' ' 90' ' ' TYR . 28.7 tttm -95.52 125.82 40.38 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.07 178.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -125.03 158.66 33.17 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.701 0.286 . . . . 0.0 110.281 178.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 11.1 p -121.94 146.75 26.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.617 -175.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.401 ' CE1' ' HD2' ' A' ' 85' ' ' ARG . 48.7 p90 -152.67 164.53 37.55 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.81 0.338 . . . . 0.0 110.393 175.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -132.54 147.9 52.37 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 170.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.529 ' HG2' ' HG2' ' A' ' 85' ' ' ARG . 45.3 mt-10 -104.27 132.14 50.84 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.947 0.403 . . . . 0.0 110.91 -176.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 49.5 p -85.14 -175.65 5.83 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.164 -179.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 7.9 mp -66.86 -20.79 65.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.388 177.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.412 ' HB2' HG23 ' A' ' 84' ' ' VAL . 9.3 m-20 -92.08 6.58 45.92 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.287 -178.331 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 64.94 23.15 12.56 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.957 -177.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.412 HG23 ' HB2' ' A' ' 82' ' ' ASP . 79.3 t -87.87 126.51 41.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 176.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.529 ' HG2' ' HG2' ' A' ' 79' ' ' GLU . 31.1 mtm180 -96.74 111.09 23.4 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.446 -175.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 24' ' ' ILE . 59.7 t -83.43 103.33 10.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 175.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.4 t -99.21 144.08 12.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.002 -172.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.487 HG21 ' HA ' ' A' ' 28' ' ' PRO . 51.5 m -151.39 148.94 28.72 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.735 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -57.56 112.44 1.43 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.055 178.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.576 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 70.9 t80 -71.96 -30.12 64.97 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.09 0.471 . . . . 0.0 110.25 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.3 p -60.95 -47.28 87.15 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.574 175.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.822 ' HG2' ' HG2' ' A' ' 28' ' ' PRO . 15.1 tp10 -72.17 -36.03 69.17 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.147 178.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.448 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 58.3 t80 -60.49 -52.59 64.54 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.068 -179.158 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.537 ' NE2' ' HH ' ' A' ' 90' ' ' TYR . 47.8 mt-30 -64.84 -31.71 73.07 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.777 0.322 . . . . 0.0 110.876 177.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.442 ' HB3' ' O ' ' A' ' 92' ' ' GLU . 76.8 tttt -59.42 -41.71 90.14 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.504 175.291 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.432 HG13 ' O ' ' A' ' 92' ' ' GLU . 73.1 mt -72.2 -37.11 58.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.499 176.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 93' ' ' PHE . 86.5 mt -59.14 -48.96 79.7 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.62 177.016 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -65.3 -29.4 70.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.788 178.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 65.7 tttm -68.58 -52.05 35.92 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.795 -178.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 56.8 mtt180 -82.64 -10.36 58.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.224 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.576 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.021 -179.549 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 . . . . . 0 C--O 1.233 0.222 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.2 m -60.06 -37.13 78.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.0 0.429 . . . . 0.0 111.241 -176.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -64.51 -35.99 82.74 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.577 -178.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 77.5 t -64.36 -40.57 89.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.347 177.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.54 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 65.9 mt -62.49 -46.4 96.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.216 177.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.405 ' O ' ' HG3' ' A' ' 11' ' ' GLU . 98.9 mttt -56.4 -49.23 75.11 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.622 178.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -57.92 -45.79 85.99 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.274 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 93.0 t80 -58.76 -40.67 84.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.352 178.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.54 ' HG ' ' O ' ' A' ' 6' ' ' ILE . 77.0 mt -66.48 -43.41 85.48 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.891 179.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.405 ' HG3' ' O ' ' A' ' 7' ' ' LYS . 52.4 mt-10 -62.46 -34.62 77.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.923 0.392 . . . . 0.0 110.624 178.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -66.16 -50.52 63.64 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.353 178.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 38.4 pt -75.98 -6.65 9.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.66 -177.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.73 24.19 39.58 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.614 175.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -89.91 154.16 20.07 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.837 0.351 . . . . 0.0 110.503 -177.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -103.36 122.87 45.72 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.136 177.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.501 ' HB3' HD12 ' A' ' 10' ' ' LEU . 39.8 p90 -115.25 133.24 56.22 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.029 176.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.531 ' HB ' ' HB2' ' A' ' 25' ' ' HIS . 44.0 mt -106.95 91.91 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 176.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.678 ' HA ' ' O ' ' A' ' 23' ' ' GLU . 1.0 OUTLIER -98.12 106.84 19.2 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.626 -179.081 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 97.0 mt -125.54 122.4 36.44 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.858 -178.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.47 ' O ' ' HB2' ' A' ' 22' ' ' ASN . 36.6 mt-10 58.43 36.64 25.51 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 123.577 0.548 . . . . 0.0 111.173 175.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.47 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 0.9 OUTLIER 73.92 25.71 1.87 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.08 -179.833 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.678 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 55.8 mt-10 -115.07 113.73 24.43 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.17 171.317 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.478 HG23 ' HG ' ' A' ' 26' ' ' LEU . 60.2 mt -91.55 101.62 12.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 177.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.531 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 12.3 m170 -87.29 121.95 30.41 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.201 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.478 ' HG ' HG23 ' A' ' 24' ' ' ILE . 63.6 mt -130.03 -174.83 3.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.243 0.544 . . . . 0.0 111.955 -175.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -92.02 144.7 29.59 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.091 177.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.478 ' HA ' HG23 ' A' ' 88' ' ' THR . 78.0 Cg_exo -50.19 -46.8 26.8 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 123.479 2.786 . . . . 0.0 113.911 -176.112 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -67.39 -36.52 81.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.791 0.329 . . . . 0.0 110.837 -177.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 48.4 t -68.46 -41.56 83.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.09 179.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -56.01 -42.07 75.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.373 177.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 79.7 t80 -60.78 -44.99 96.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.351 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -68.64 -42.37 78.12 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.177 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 93.5 t -64.9 -36.99 79.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.814 0.34 . . . . 0.0 110.16 177.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.511 ' CD1' ' HD2' ' A' ' 41' ' ' PRO . 27.6 t90 -52.8 -50.88 62.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.563 176.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -70.71 -34.84 72.36 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.322 178.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -57.97 -43.59 86.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.731 0.3 . . . . 0.0 111.29 179.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.509 HG23 ' HD3' ' A' ' 41' ' ' PRO . 27.6 m -82.35 14.43 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -175.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 101.89 1.96 52.19 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.743 175.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 57.22 70.45 1.35 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.19 0.519 . . . . 0.0 110.869 179.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.511 ' HD2' ' CD1' ' A' ' 35' ' ' TRP . 87.4 Cg_endo -88.28 -162.74 0.14 Allowed 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.967 2.445 . . . . 0.0 112.215 -179.153 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -88.11 145.12 26.11 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.247 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 96.0 mt -93.7 157.24 16.26 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.573 -175.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -125.3 148.3 48.76 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.184 176.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.6 p -141.15 153.13 45.22 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.797 0.332 . . . . 0.0 111.557 -175.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 16.8 p90 -145.04 148.86 34.17 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.839 176.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.414 ' HA ' ' HA ' ' A' ' 74' ' ' LYS . 45.7 t -102.03 122.28 54.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 17.5 tt -109.61 150.32 12.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.394 -178.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 . . . . . 0 C--N 1.327 -0.403 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.359 -175.186 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 51.3 mttm . . . . . 0 N--CA 1.451 -0.415 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 61.5 mt -98.63 125.6 51.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.238 0.542 . . . . 0.0 110.814 -176.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.502 ' O ' ' HB3' ' A' ' 90' ' ' TYR . 86.8 tttt -87.48 122.89 31.79 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.71 177.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -113.01 161.49 16.99 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.425 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.481 ' HB ' ' CD1' ' A' ' 90' ' ' TYR . 13.1 p -118.11 145.39 24.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.521 -0.308 . . . . 0.0 110.962 -175.392 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.404 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 38.8 p90 -154.94 159.55 40.5 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.909 178.313 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -133.4 152.29 51.9 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 170.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.536 ' HG2' ' HG2' ' A' ' 85' ' ' ARG . 24.9 mt-10 -104.61 138.82 40.37 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.987 0.423 . . . . 0.0 110.93 -173.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 73.0 p -97.54 -169.28 1.81 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.848 -175.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -69.9 -28.28 65.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.039 -179.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -95.71 19.5 11.14 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.086 -172.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 65.8 17.1 10.75 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.529 -179.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 85.2 t -88.34 137.9 20.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.108 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.536 ' HG2' ' HG2' ' A' ' 79' ' ' GLU . 90.5 mtt180 -107.84 113.87 27.41 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.453 -177.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 53.2 t -83.54 102.67 9.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 177.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' A' ' 25' ' ' HIS . 32.5 t -100.38 136.29 32.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.778 -174.098 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.478 HG23 ' HA ' ' A' ' 28' ' ' PRO . 52.3 m -146.98 157.62 43.68 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.07 178.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -67.11 122.88 18.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.337 0.589 . . . . 0.0 111.617 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.502 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 49.2 t80 -78.38 -20.1 51.97 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.691 -178.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.536 ' O ' ' HG3' ' A' ' 95' ' ' LYS . 4.1 m -62.22 -61.1 2.7 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.867 0.365 . . . . 0.0 110.253 179.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -71.17 -29.28 64.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.125 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.511 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 62.9 t80 -58.24 -45.18 88.24 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.875 0.369 . . . . 0.0 110.07 176.225 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.448 ' NE2' HD13 ' A' ' 97' ' ' LEU . 20.7 mm-40 -61.67 -40.38 94.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.049 176.138 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.536 ' HG3' ' O ' ' A' ' 91' ' ' SER . 90.3 mttt -65.18 -40.75 94.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.832 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.447 HD11 ' HB2' ' A' ' 28' ' ' PRO . 66.6 mt -71.5 -31.12 41.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.239 -179.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.511 ' HG ' ' O ' ' A' ' 93' ' ' PHE . 53.8 mt -61.7 -42.44 98.94 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.939 0.4 . . . . 0.0 110.419 175.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -73.94 -20.74 60.28 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.17 0.509 . . . . 0.0 110.521 177.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -74.38 -42.74 58.79 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.205 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 67.2 mtt180 -98.75 -4.12 34.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.843 0.354 . . . . 0.0 111.443 -177.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.455 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.588 177.915 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . 0.448 HD21 HD23 ' A' ' 81' ' ' LEU . 0.8 OUTLIER . . . . . 0 C--O 1.234 0.279 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 64.8 p -58.76 -31.2 68.15 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.953 0.406 . . . . 0.0 110.409 176.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.585 ' HA ' ' HD2' ' A' ' 7' ' ' LYS . 35.5 tt0 -62.32 -38.39 89.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.8 178.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 93.0 t -65.55 -45.8 91.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.041 0.448 . . . . 0.0 110.046 178.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 59.6 mt -59.62 -41.72 85.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.657 174.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.585 ' HD2' ' HA ' ' A' ' 4' ' ' GLU . 62.9 mttm -50.9 -57.79 7.62 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.811 0.339 . . . . 0.0 110.614 175.109 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -56.39 -43.17 78.99 Favored 'General case' 0 C--O 1.223 -0.323 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.963 -179.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.464 ' O ' HG12 ' A' ' 13' ' ' ILE . 70.1 t80 -60.81 -48.96 79.44 Favored 'General case' 0 C--N 1.328 -0.358 0 O-C-N 123.123 0.265 . . . . 0.0 110.935 -178.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 96.7 mt -62.48 -47.85 82.2 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.986 0.422 . . . . 0.0 111.085 -178.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -73.73 -21.74 60.12 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.013 -177.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -75.61 -38.53 58.92 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.858 0.361 . . . . 0.0 110.7 177.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.464 HG12 ' O ' ' A' ' 9' ' ' PHE . 32.1 pt -87.33 -4.82 9.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.875 0.369 . . . . 0.0 110.711 177.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 74.53 43.14 31.03 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.104 -0.569 . . . . 0.0 112.655 175.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 46.7 mm-40 -109.94 151.12 27.5 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.395 0.617 . . . . 0.0 111.742 -179.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -89.26 150.89 22.41 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.006 -178.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 33.0 p90 -145.54 143.3 29.86 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.906 0.384 . . . . 0.0 111.091 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.536 ' HB ' ' HB2' ' A' ' 25' ' ' HIS . 48.9 mm -97.82 92.76 3.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 174.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.4 ' HG3' HG12 ' A' ' 24' ' ' ILE . 33.8 tt0 -91.52 109.49 20.79 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.875 -175.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 69.7 mt -105.04 -170.79 1.81 Allowed 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 175.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -79.69 109.67 14.3 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.089 -0.644 . . . . 0.0 110.258 178.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 60.0 m-80 70.27 18.51 6.81 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 114.946 -1.025 . . . . 0.0 111.41 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.478 ' HG2' ' HB2' ' A' ' 85' ' ' ARG . 37.7 mt-10 -144.55 131.43 20.27 Favored 'General case' 0 C--O 1.222 -0.36 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.07 177.132 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.4 HG12 ' HG3' ' A' ' 19' ' ' GLU . 76.2 mt -125.91 107.84 18.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 173.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.536 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 19.6 m-70 -92.08 127.24 37.48 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 -178.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 87.2 mt -118.34 169.34 9.81 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.453 -174.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 84.9 mttt -70.42 140.43 87.42 Favored Pre-proline 0 C--N 1.327 -0.4 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 173.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -47.6 -48.42 15.66 Favored 'Trans proline' 0 CA--C 1.531 0.342 0 C-N-CA 123.15 2.567 . . . . 0.0 113.592 -176.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -73.81 -31.09 63.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.788 0.327 . . . . 0.0 111.051 -175.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.425 ' O ' HG22 ' A' ' 34' ' ' VAL . 56.3 t -73.23 -41.44 58.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 178.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -56.53 -39.63 73.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.265 176.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.552 ' HA ' ' HE1' ' A' ' 93' ' ' PHE . 47.2 t80 -53.97 -44.36 70.71 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.513 178.146 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -76.6 -36.26 57.61 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.291 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.425 HG22 ' O ' ' A' ' 30' ' ' VAL . 76.8 t -67.13 -40.02 84.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.006 0.432 . . . . 0.0 110.475 178.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.597 ' CD1' ' HD2' ' A' ' 41' ' ' PRO . 27.8 t90 -56.68 -45.76 81.53 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.259 176.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 25.0 mttm -71.67 -34.75 69.96 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.243 178.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 90.6 t80 -58.26 -43.26 87.79 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.143 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.461 HG23 ' HD3' ' A' ' 41' ' ' PRO . 35.8 m -81.49 13.74 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -177.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 103.75 -0.37 45.53 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.971 174.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 59.99 70.11 1.1 Allowed Pre-proline 0 CA--C 1.536 0.427 0 CA-C-O 121.147 0.498 . . . . 0.0 110.457 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.597 ' HD2' ' CD1' ' A' ' 35' ' ' TRP . 66.2 Cg_endo -92.68 -162.47 0.1 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 123.282 2.655 . . . . 0.0 113.259 -177.089 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -58.06 144.75 38.86 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.176 -179.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 68.5 mt -105.29 112.01 24.96 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.066 173.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 60.6 mttm -107.72 140.5 40.68 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.5 p -127.87 157.37 40.67 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.706 0.289 . . . . 0.0 111.756 -174.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 38.7 p90 -138.55 136.73 36.35 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 172.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 58.3 t -98.96 122.03 50.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.312 -179.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 13.0 tt -104.3 128.88 57.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.191 0.519 . . . . 0.0 110.415 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 . . . . . 0 C--N 1.323 -0.56 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.506 -179.749 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 58.2 mttm . . . . . 0 N--CA 1.449 -0.486 0 CA-C-O 121.156 0.503 . . . . 0.0 110.204 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 71.2 mt -93.77 134.64 30.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.066 -177.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -116.1 107.76 15.33 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.415 0.626 . . . . 0.0 110.961 -174.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 35.9 mmtp -96.4 149.15 22.04 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.982 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.477 ' HB ' ' HB2' ' A' ' 90' ' ' TYR . 9.7 p -114.07 142.84 25.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.539 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 37.5 p90 -151.36 159.03 44.48 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.152 0.501 . . . . 0.0 111.212 -177.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -132.27 147.84 52.42 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 168.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -102.21 137.78 40.02 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.944 0.402 . . . . 0.0 111.02 -174.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 82.8 p -91.48 -175.35 4.19 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.855 178.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.448 HD23 HD21 ' A' ' 2' ' ' ASN . 66.3 tp -60.92 -31.21 70.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.181 0.515 . . . . 0.0 110.356 176.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.503 ' HB2' HG22 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -79.84 -2.03 41.64 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.648 -178.142 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 59.3 m-80 70.87 23.11 4.48 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.346 0.658 . . . . 0.0 110.568 -176.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.503 HG22 ' HB2' ' A' ' 82' ' ' ASP . 70.7 t -86.24 126.49 40.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.438 178.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.478 ' HB2' ' HG2' ' A' ' 23' ' ' GLU . 63.4 mtt85 -86.03 110.02 19.21 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.666 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.539 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 49.1 t -82.66 109.05 16.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 171.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.441 HG22 ' HB3' ' A' ' 77' ' ' TYR . 9.6 t -116.79 147.59 20.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.22 0.533 . . . . 0.0 112.418 -167.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 6.0 t -155.76 -176.66 6.07 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 169.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -84.59 128.26 34.5 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 117.971 0.351 . . . . 0.0 110.561 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.477 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 11.2 t80 -77.46 -22.17 51.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.523 -174.066 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.3 -47.1 52.54 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.919 -0.401 . . . . 0.0 109.919 178.309 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.409 ' O ' ' HB3' ' A' ' 95' ' ' LYS . 54.8 mm-40 -70.21 -29.65 66.54 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.707 176.15 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.552 ' HE1' ' HA ' ' A' ' 32' ' ' TYR . 43.0 t80 -69.08 -47.65 64.68 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.662 0.267 . . . . 0.0 110.473 178.032 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.554 ' O ' ' HG3' ' A' ' 98' ' ' LYS . 43.1 mt-30 -60.95 -34.58 74.97 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.275 175.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.409 ' HB3' ' O ' ' A' ' 92' ' ' GLU . 42.4 tttt -52.98 -47.09 68.46 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.018 176.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.632 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 78.8 mt -68.94 -37.47 77.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.763 178.317 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 83.3 mt -65.34 -32.16 73.67 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.67 178.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.554 ' HG3' ' O ' ' A' ' 94' ' ' GLN . 96.8 mttt -65.35 -38.78 91.12 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 174.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.632 ' HE3' ' HA ' ' A' ' 96' ' ' ILE . 9.1 mtmp? -69.21 -33.24 73.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.716 178.246 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.54 ' HD3' ' OH ' ' A' ' 32' ' ' TYR . 13.0 ttp180 -71.16 -38.6 72.19 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.969 0.414 . . . . 0.0 110.365 175.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.52 0 C-N-CA 120.937 -0.649 . . . . 0.0 111.742 -178.283 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 13.0 m120 . . . . . 0 CA--C 1.522 -0.135 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.553 ' OG ' ' HB3' ' A' ' 82' ' ' ASP . 3.3 m -65.32 -35.06 79.85 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.797 0.332 . . . . 0.0 110.915 -177.246 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.447 ' O ' ' HG2' ' A' ' 8' ' ' GLU . 34.2 tt0 -58.51 -41.53 85.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.503 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 94.0 t -55.64 -45.2 78.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.825 177.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.507 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 64.4 mt -63.0 -43.59 99.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.554 -179.155 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.433 ' HE2' ' OE1' ' A' ' 19' ' ' GLU . 92.5 mttt -61.36 -46.62 89.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.784 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.447 ' HG2' ' O ' ' A' ' 4' ' ' GLU . 52.5 mm-40 -60.58 -48.01 83.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.271 177.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -59.69 -38.18 80.84 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.349 -178.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.507 ' HG ' ' O ' ' A' ' 6' ' ' ILE . 93.5 mt -65.26 -37.9 88.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.842 0.353 . . . . 0.0 110.488 178.267 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -69.97 -34.01 72.82 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.188 176.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -59.74 -43.61 94.17 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.052 175.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 35.1 pt -85.67 -7.51 10.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.841 0.353 . . . . 0.0 111.33 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 81.38 26.58 51.16 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 121.026 -0.606 . . . . 0.0 113.211 174.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -106.64 143.54 34.59 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.875 0.369 . . . . 0.0 110.408 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -102.29 147.92 26.08 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.885 -179.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 13.0 p90 -120.52 154.39 35.38 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.981 0.42 . . . . 0.0 111.672 -174.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 51.6 mt -101.51 96.84 5.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 174.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.433 ' OE1' ' HE2' ' A' ' 7' ' ' LYS . 61.1 tt0 -108.51 137.42 46.5 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.495 0.664 . . . . 0.0 112.02 -173.227 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 89.7 mt -116.73 -173.56 2.41 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 170.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -61.7 103.5 0.34 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.817 0.342 . . . . 0.0 110.831 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.446 ' HA ' HG21 ' A' ' 84' ' ' VAL . 4.2 m-20 66.94 23.0 9.98 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.725 178.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -134.81 113.95 12.12 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.681 0.277 . . . . 0.0 111.209 176.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.401 ' HB ' HG21 ' A' ' 86' ' ' VAL . 66.0 mt -103.33 109.68 27.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 175.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -92.55 120.31 32.88 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 64.8 mt -124.75 155.47 39.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.241 0.543 . . . . 0.0 111.691 -176.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -65.96 136.47 95.61 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.491 176.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -56.2 -33.46 90.72 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.319 2.013 . . . . 0.0 111.588 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -62.09 -43.91 97.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.956 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 45.9 t -81.36 -34.33 13.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.187 0.517 . . . . 0.0 110.244 179.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -55.64 -39.08 70.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.712 -176.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -58.46 -38.37 77.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.764 0.316 . . . . 0.0 111.113 -178.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -79.67 -34.53 40.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.838 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 95.9 t -64.53 -42.82 96.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.012 0.434 . . . . 0.0 110.024 176.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.503 ' CD1' ' HD2' ' A' ' 41' ' ' PRO . 29.6 t90 -57.6 -41.1 80.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.423 177.184 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -69.09 -43.61 74.19 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.884 176.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -60.92 -41.0 95.3 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.956 -178.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.488 HG21 ' HD3' ' A' ' 41' ' ' PRO . 35.1 m -76.9 4.42 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 112.308 0.485 . . . . 0.0 112.308 -175.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 105.82 -0.48 39.04 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.543 -0.837 . . . . 0.0 113.089 175.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 59.49 75.12 0.52 Allowed Pre-proline 0 CA--C 1.535 0.382 0 CA-C-O 120.987 0.422 . . . . 0.0 111.228 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.503 ' HD2' ' CD1' ' A' ' 35' ' ' TRP . 90.6 Cg_endo -91.58 -176.68 0.87 Allowed 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.791 2.327 . . . . 0.0 112.109 176.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 57.8 mm-40 -72.29 135.82 46.09 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.014 0.435 . . . . 0.0 110.765 178.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.453 ' HB3' ' CG2' ' A' ' 76' ' ' VAL . 95.2 mt -98.44 138.02 36.27 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.48 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -117.23 138.58 51.62 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.951 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 16.2 p -105.2 147.52 27.92 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 120.79 0.328 . . . . 0.0 111.443 -176.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.482 ' CE2' ' HB ' ' A' ' 48' ' ' ILE . 10.0 p90 -129.1 156.1 44.4 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 175.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 33.1 t -103.28 105.11 17.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.028 0.442 . . . . 0.0 110.945 -176.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.608 HG21 ' HB ' ' A' ' 73' ' ' ILE . 5.8 tt -95.83 101.33 12.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 121.672 0.749 . . . . 0.0 109.443 175.113 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 . . . . . 0 C--N 1.318 -0.802 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.913 -177.576 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 57.0 mttm . . . . . 0 N--CA 1.454 -0.262 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.608 ' HB ' HG21 ' A' ' 48' ' ' ILE . 58.8 mt -91.03 129.44 41.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.301 -178.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -103.32 111.46 23.87 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.237 -178.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.405 ' HB3' ' O ' ' A' ' 88' ' ' THR . 65.6 mttm -114.96 167.15 11.05 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.235 -0.439 . . . . 0.0 109.832 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.453 ' CG2' ' HB3' ' A' ' 43' ' ' LEU . 14.4 p -123.48 147.98 27.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 120.794 0.331 . . . . 0.0 111.241 -172.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 51.6 p90 -145.66 163.81 33.72 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.137 178.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.444 ' HB3' HD22 ' A' ' 43' ' ' LEU . 43.1 p90 -128.14 155.42 44.47 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 169.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -102.22 137.07 40.97 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.323 -175.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.414 ' C ' ' H ' ' A' ' 82' ' ' ASP . 69.8 p -90.31 169.08 11.41 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 175.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.3 mp -82.91 18.95 1.47 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.344 0.592 . . . . 0.0 109.638 174.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.553 ' HB3' ' OG ' ' A' ' 3' ' ' SER . 38.9 t70 -126.59 10.55 7.23 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.853 -177.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 66.3 t30 74.14 19.49 2.93 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 115.188 -0.915 . . . . 0.0 112.112 173.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.446 HG21 ' HA ' ' A' ' 22' ' ' ASN . 82.7 t -109.7 137.16 43.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 120.931 0.396 . . . . 0.0 110.413 177.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 84.0 mtt-85 -102.19 126.84 49.28 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.46 -178.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.401 HG21 ' HB ' ' A' ' 24' ' ' ILE . 61.0 t -98.67 113.93 34.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 174.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.8 t -111.02 147.13 15.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.146 -170.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.405 ' O ' ' HB3' ' A' ' 75' ' ' LYS . 4.9 t -152.74 -178.67 7.03 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.233 -0.439 . . . . 0.0 109.854 176.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -86.39 122.05 29.81 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.969 0.414 . . . . 0.0 110.885 -178.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 17.1 t80 -73.65 -23.87 59.91 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.28 -176.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 27.0 m -71.99 -52.34 17.52 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.848 0.356 . . . . 0.0 110.582 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.413 ' O ' ' HB3' ' A' ' 95' ' ' LYS . 10.0 mm-40 -71.26 -27.75 63.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.467 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.43 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 69.1 t80 -65.92 -42.82 89.65 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 175.267 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -63.3 -35.3 79.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.674 175.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.509 ' HZ1' ' HB2' ' A' ' 95' ' ' LYS . 3.7 ttmp? -56.49 -44.59 80.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.279 175.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 76.2 mt -69.27 -40.09 79.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.908 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.43 ' HG ' ' O ' ' A' ' 93' ' ' PHE . 99.5 mt -58.73 -50.95 72.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.412 177.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.589 ' HB3' ' HZ1' ' A' ' 98' ' ' LYS . 9.6 mtpm? -70.25 -25.43 63.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.198 -178.291 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -59.57 -53.3 59.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.569 174.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 39.8 ttt85 -77.41 -38.01 50.64 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.985 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.559 0 C-N-CA 120.738 -0.744 . . . . 0.0 111.643 -176.632 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 . . . . . 0 C--O 1.233 0.228 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.488 ' O ' ' HG3' ' A' ' 7' ' ' LYS . 89.3 p -62.95 -32.93 74.35 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.73 0.3 . . . . 0.0 111.118 -177.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.457 ' HA ' ' HD2' ' A' ' 7' ' ' LYS . 9.3 tp10 -56.81 -36.36 69.84 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.997 -178.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 66.5 t -64.38 -42.04 94.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.479 178.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.5 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 63.9 mt -63.95 -41.43 92.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.339 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.488 ' HG3' ' O ' ' A' ' 3' ' ' SER . 88.6 mttt -57.16 -52.45 65.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.426 178.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -69.27 -28.1 66.01 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.365 -178.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -64.92 -44.56 89.13 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.125 0.488 . . . . 0.0 109.892 175.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.5 ' HG ' ' O ' ' A' ' 6' ' ' ILE . 51.9 mt -64.52 -42.7 95.62 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.283 177.386 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -63.49 -38.0 89.47 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.504 178.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -62.82 -50.32 71.45 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.097 179.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 37.9 pt -78.44 -7.0 9.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.763 0.316 . . . . 0.0 111.382 -178.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 76.07 36.41 40.94 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 121.119 -0.562 . . . . 0.0 112.619 177.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -95.69 157.48 15.88 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 179.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -73.68 122.99 23.2 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.187 0.518 . . . . 0.0 111.093 -177.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 93.2 t80 -105.64 120.01 40.58 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.987 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 15.3 tt -131.34 121.39 48.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.314 0.578 . . . . 0.0 110.576 175.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -108.38 108.27 19.17 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.046 178.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 24.7 tp -93.39 75.46 4.51 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 59.3 71.5 0.58 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.537 -177.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 12.5 m120 68.38 11.64 8.43 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.172 -0.922 . . . . 0.0 112.004 178.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 79.3 mt-10 -115.13 113.99 24.72 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 174.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 40.7 mt -86.77 109.35 18.94 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 177.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.44 ' HA ' ' O ' ' A' ' 87' ' ' VAL . 24.8 m-70 -95.98 111.13 23.22 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -178.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.425 HD21 HD11 ' A' ' 10' ' ' LEU . 67.4 mt -113.32 163.3 15.01 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.44 0.638 . . . . 0.0 112.679 -170.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 33.7 tttp -62.63 129.61 92.94 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 114.46 -1.245 . . . . 0.0 109.681 173.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -51.12 -41.28 58.03 Favored 'Trans proline' 0 N--CA 1.473 0.308 0 C-N-CA 122.884 2.389 . . . . 0.0 112.518 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -53.78 -54.92 31.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.168 175.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 50.9 t -69.5 -41.12 80.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.712 -177.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -53.87 -42.01 68.15 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.476 179.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -59.18 -42.69 91.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.555 -179.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -78.26 -37.17 45.72 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.088 -178.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 95.8 t -62.43 -36.87 77.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.083 0.468 . . . . 0.0 109.86 175.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.419 ' CD1' ' HD2' ' A' ' 41' ' ' PRO . 35.3 t90 -55.78 -44.09 77.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.701 176.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.532 ' HA ' ' CG ' ' A' ' 40' ' ' GLU . 67.3 mttm -73.02 -31.67 64.61 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.656 -0.247 . . . . 0.0 111.325 179.23 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 83.8 t80 -67.23 -40.65 86.37 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.951 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.492 HG22 ' HD3' ' A' ' 41' ' ' PRO . 35.0 m -79.04 4.12 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -177.086 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 102.64 4.11 49.35 Favored Glycine 0 C--N 1.33 0.231 0 C-N-CA 120.767 -0.73 . . . . 0.0 113.241 174.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.532 ' CG ' ' HA ' ' A' ' 36' ' ' LYS . 54.0 mt-10 57.59 78.29 0.37 Allowed Pre-proline 0 C--O 1.236 0.347 0 C-N-CA 122.925 0.49 . . . . 0.0 111.95 -179.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.492 ' HD3' HG22 ' A' ' 38' ' ' VAL . 4.9 Cg_exo -77.89 175.3 11.36 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.738 2.292 . . . . 0.0 110.659 173.163 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -81.46 133.72 35.44 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.18 0.514 . . . . 0.0 110.12 178.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 89.7 mt -73.17 120.94 19.48 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.774 -172.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -96.53 118.4 32.95 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.197 176.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 24.2 p -109.47 143.12 39.52 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.052 -176.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 17.9 p90 -126.27 133.53 51.41 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.728 177.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.41 HG21 ' HB2' ' A' ' 74' ' ' LYS . 60.5 t -93.63 125.95 46.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.717 -179.01 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.511 HD13 ' HE3' ' A' ' 75' ' ' LYS . 13.7 pt -125.7 131.0 72.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.576 174.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 . . . . . 0 C--N 1.315 -0.919 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.136 -179.211 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 60.9 mttm . . . . . 0 N--CA 1.452 -0.348 0 N-CA-C 110.328 -0.249 . . . . 0.0 110.328 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 15.1 tt -109.89 129.81 64.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.546 0.688 . . . . 0.0 110.66 178.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.476 ' O ' ' HB3' ' A' ' 90' ' ' TYR . 36.4 ttpt -108.86 115.71 30.59 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.075 -177.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.511 ' HE3' HD13 ' A' ' 48' ' ' ILE . 81.4 mttt -104.13 167.01 10.04 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.35 -0.386 . . . . 0.0 109.975 -179.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 14.6 p -122.51 146.79 27.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 120.925 0.393 . . . . 0.0 111.303 -173.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.437 ' HB3' HG22 ' A' ' 87' ' ' VAL . 48.1 p90 -149.85 164.82 34.34 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.132 175.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -134.23 149.25 50.96 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 169.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.55 ' HG2' ' HG2' ' A' ' 85' ' ' ARG . 41.6 mt-10 -102.5 138.21 39.72 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.681 -176.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 38.4 p -83.25 178.55 8.03 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.123 175.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.8 mp -62.73 -27.01 68.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.194 0.521 . . . . 0.0 110.726 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -99.98 15.04 28.48 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.715 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 10.0 m120 64.1 34.59 11.06 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 171.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 58.6 t -90.69 129.56 41.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 169.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.55 ' HG2' ' HG2' ' A' ' 79' ' ' GLU . 41.7 mtm-85 -98.88 114.91 27.73 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.976 0.417 . . . . 0.0 111.389 -172.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 45.6 t -89.7 113.09 25.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 174.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 25' ' ' HIS . 19.3 t -113.28 148.2 16.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.937 -171.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 6.2 t -152.13 171.52 17.78 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.065 174.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -73.02 111.71 8.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.188 0.518 . . . . 0.0 110.368 177.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.476 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 15.3 t80 -72.14 -20.94 61.53 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.595 -177.099 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.4 m -62.64 -58.22 8.29 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-O 121.184 0.516 . . . . 0.0 110.068 178.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -67.53 -35.28 78.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.406 178.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -59.78 -46.77 88.17 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.48 179.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.448 ' O ' ' HG3' ' A' ' 98' ' ' LYS . 69.5 mt-30 -58.61 -40.02 82.11 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.612 0.244 . . . . 0.0 110.906 176.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -63.22 -39.82 95.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.528 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 80.1 mt -63.58 -42.27 95.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.743 177.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -57.84 -43.31 85.78 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.681 176.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.448 ' HG3' ' O ' ' A' ' 94' ' ' GLN . 94.0 mttt -70.05 -41.83 73.67 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.693 178.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 60.5 tttm -60.3 -48.68 80.69 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.649 -178.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 62.4 ttt180 -78.38 -30.48 47.91 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.041 0.448 . . . . 0.0 110.523 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.674 0 C-N-CA 120.681 -0.771 . . . . 0.0 111.869 -179.871 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 . . . . . 0 C--O 1.234 0.286 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 36.6 p -61.28 -27.9 68.8 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.931 -177.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -57.59 -45.59 85.09 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.98 0.419 . . . . 0.0 110.38 178.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.1 t -62.85 -39.31 84.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.261 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 58.9 mt -62.45 -45.75 98.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.181 177.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 49.3 mttm -57.07 -48.73 77.86 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.091 177.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -59.45 -47.34 85.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.927 179.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -63.62 -47.71 80.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.354 -177.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.418 HD12 HD21 ' A' ' 26' ' ' LEU . 95.5 mt -62.31 -46.98 86.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.195 -177.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -79.01 -6.1 55.54 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.734 0.302 . . . . 0.0 111.497 -177.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -82.42 -45.97 14.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.126 0.489 . . . . 0.0 109.792 173.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 34.9 pt -77.48 -12.21 13.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.941 179.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.46 28.48 10.45 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.771 -0.728 . . . . 0.0 113.06 174.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.511 ' OE2' HG21 ' A' ' 30' ' ' VAL . 3.9 tp10 -88.05 137.23 32.51 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.153 0.501 . . . . 0.0 111.058 -179.037 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -104.3 110.54 22.8 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.301 175.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.402 ' CD1' ' HB2' ' A' ' 19' ' ' GLU . 27.1 p90 -102.79 154.73 18.89 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.152 -177.022 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 58.1 mt -97.34 102.06 12.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 175.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.402 ' HB2' ' CD1' ' A' ' 17' ' ' TYR . 35.9 tt0 -105.84 116.71 32.41 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.491 0.662 . . . . 0.0 111.822 -172.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -94.24 -168.17 1.81 Allowed 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 172.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -68.21 99.79 0.95 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.003 0.43 . . . . 0.0 110.304 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 62.53 32.86 16.35 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.498 -178.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.413 ' HG2' ' HB2' ' A' ' 85' ' ' ARG . 23.2 mt-10 -138.56 113.77 9.44 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.097 174.228 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.512 ' HB ' HG22 ' A' ' 86' ' ' VAL . 64.3 mt -99.8 104.5 16.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 178.127 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 31.1 m-70 -90.85 112.12 23.82 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.981 0.419 . . . . 0.0 110.032 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.418 HD21 HD12 ' A' ' 10' ' ' LEU . 56.5 mt -101.37 -175.62 2.91 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.525 -0.762 . . . . 0.0 111.524 -176.067 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.424 ' HZ2' ' CD ' ' A' ' 15' ' ' GLU . 61.2 mttp -95.35 144.16 27.34 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.389 176.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.499 ' HA ' HG23 ' A' ' 88' ' ' THR . 5.9 Cg_exo -41.59 -49.79 5.06 Favored 'Trans proline' 0 CA--C 1.534 0.486 0 C-N-CA 124.033 3.155 . . . . 0.0 114.391 -175.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -72.33 -40.69 67.22 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.845 0.355 . . . . 0.0 111.142 -175.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.511 HG21 ' OE2' ' A' ' 15' ' ' GLU . 58.3 t -67.01 -40.5 85.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.636 -178.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -59.19 -40.33 85.35 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.453 177.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.605 ' HA ' ' HE1' ' A' ' 93' ' ' PHE . 20.6 t80 -61.12 -33.12 72.88 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.024 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -80.11 -43.59 21.45 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.889 -179.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.441 ' O ' HG11 ' A' ' 38' ' ' VAL . 59.5 t -65.58 -33.11 61.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.848 0.356 . . . . 0.0 110.507 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.464 ' O ' HG22 ' A' ' 38' ' ' VAL . 27.6 t90 -53.05 -40.05 63.68 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.09 176.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 78.2 mttt -70.15 -36.97 75.11 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.271 0.558 . . . . 0.0 110.292 178.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 23.0 t80 -73.07 -30.57 63.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.548 -174.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.475 HG21 ' HD3' ' A' ' 41' ' ' PRO . 18.4 m -75.27 -2.17 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-O 120.916 0.389 . . . . 0.0 111.335 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 116.84 -9.45 16.17 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.883 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.406 ' N ' ' HD3' ' A' ' 41' ' ' PRO . 33.4 tt0 58.85 64.73 3.18 Favored Pre-proline 0 CA--C 1.538 0.487 0 CA-C-O 121.044 0.45 . . . . 0.0 111.131 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.475 ' HD3' HG21 ' A' ' 38' ' ' VAL . 92.3 Cg_endo -98.06 -173.24 0.17 Allowed 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 123.331 2.687 . . . . 0.0 112.193 179.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -79.25 116.51 19.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.073 0.463 . . . . 0.0 109.814 176.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.6 mt -75.24 156.72 35.43 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.2 -176.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 57.5 tttm -109.96 129.31 55.68 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.817 -177.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.0 p -109.17 149.52 29.25 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.617 -175.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.52 ' OH ' ' HD2' ' A' ' 75' ' ' LYS . 28.2 p90 -134.85 159.85 40.09 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 176.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 50.6 t -111.98 120.37 62.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 120.948 0.404 . . . . 0.0 110.911 -177.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 8.4 tt -110.48 115.5 49.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.262 0.553 . . . . 0.0 109.561 174.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.46 ' HG2' ' HG2' ' A' ' 72' ' ' LYS . 43.4 mt-10 . . . . . 0 C--N 1.321 -0.643 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.265 -177.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.46 ' HG2' ' HG2' ' A' ' 49' ' ' GLU . 43.8 mttp . . . . . 0 N--CA 1.452 -0.325 0 CA-C-O 120.93 0.395 . . . . 0.0 110.059 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 51.4 mm -92.03 110.26 22.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.27 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 41.0 ttpt -93.63 115.02 27.48 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.051 177.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.52 ' HD2' ' OH ' ' A' ' 46' ' ' TYR . 62.4 mttm -102.62 166.3 10.59 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 177.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 12.6 p -122.35 144.18 32.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.347 -176.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.437 ' HB3' HG22 ' A' ' 87' ' ' VAL . 36.8 p90 -149.8 165.94 30.98 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.02 0.438 . . . . 0.0 111.412 179.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.466 ' CE2' HG13 ' A' ' 38' ' ' VAL . 50.1 p90 -124.36 134.59 53.1 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.196 166.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.444 ' OE1' ' HD2' ' A' ' 85' ' ' ARG . 34.5 tt0 -103.87 118.11 35.93 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.164 -176.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 72.7 p -79.07 179.64 7.23 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.549 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 7.7 mp -66.6 -14.22 62.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.029 0.443 . . . . 0.0 110.658 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.468 ' HB2' HG22 ' A' ' 84' ' ' VAL . 1.9 m-20 -85.54 -1.73 57.41 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.621 -178.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 55.3 m-80 70.35 18.39 6.75 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 123.766 0.666 . . . . 0.0 110.423 -175.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.468 HG22 ' HB2' ' A' ' 82' ' ' ASP . 93.1 t -87.97 123.55 40.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.041 177.373 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.444 ' HD2' ' OE1' ' A' ' 79' ' ' GLU . 0.2 OUTLIER -100.01 108.87 21.17 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.905 -178.964 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.512 HG22 ' HB ' ' A' ' 24' ' ' ILE . 59.6 t -82.92 106.17 13.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 174.138 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.437 HG22 ' HB3' ' A' ' 77' ' ' TYR . 41.4 t -107.0 142.58 19.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.798 -169.131 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.499 HG23 ' HA ' ' A' ' 28' ' ' PRO . 96.0 m -152.07 153.81 34.69 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.309 174.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -64.41 119.02 9.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.288 0.566 . . . . 0.0 111.922 -178.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 83.2 t80 -63.18 -37.48 87.4 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.806 -179.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.6 m -60.2 -45.41 93.26 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.751 178.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.424 ' HA ' ' HB3' ' A' ' 95' ' ' LYS . 22.0 mm-40 -77.93 -30.67 50.64 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.112 -179.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.605 ' HE1' ' HA ' ' A' ' 32' ' ' TYR . 75.7 t80 -61.03 -50.61 72.63 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.966 0.413 . . . . 0.0 110.405 177.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.638 ' HG2' HD11 ' A' ' 97' ' ' LEU . 45.4 mt-30 -77.31 -17.17 58.53 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.991 179.391 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.424 ' HB3' ' HA ' ' A' ' 92' ' ' GLU . 0.8 OUTLIER -69.35 -32.42 71.48 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 173.298 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.423 HD12 ' HB2' ' A' ' 28' ' ' PRO . 56.1 mt -79.03 -33.68 16.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.268 174.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.638 HD11 ' HG2' ' A' ' 94' ' ' GLN . 90.5 mt -59.94 -41.71 92.39 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 171.004 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 7.3 tmtt? -64.36 -40.36 95.69 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.805 176.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 56.7 tttm -62.11 -43.69 98.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.845 178.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 78.2 ttt180 -71.56 -45.44 62.29 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.967 0.413 . . . . 0.0 110.64 177.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.42 0 C-N-CA 120.846 -0.692 . . . . 0.0 111.811 -177.329 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 . . . . . 0 N--CA 1.453 -0.28 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.479 ' O ' ' HG3' ' A' ' 7' ' ' LYS . 19.1 p -56.67 -33.02 65.97 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.947 0.404 . . . . 0.0 110.803 177.074 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -51.59 -51.52 54.84 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.801 178.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.9 t -61.38 -48.65 87.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.928 -177.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.441 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 60.4 mt -54.4 -43.12 61.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.02 177.004 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.479 ' HG3' ' O ' ' A' ' 3' ' ' SER . 98.9 mttt -56.88 -49.24 76.13 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.163 178.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -61.01 -41.24 96.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.073 0.463 . . . . 0.0 110.529 -179.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.48 ' O ' HG13 ' A' ' 13' ' ' ILE . 74.5 t80 -62.22 -48.0 81.94 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.705 178.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.462 HD11 ' HB3' ' A' ' 17' ' ' TYR . 87.9 mt -69.45 -33.34 72.78 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.379 -177.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -65.66 -41.32 92.66 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.894 0.378 . . . . 0.0 110.137 176.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -64.05 -37.82 88.83 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.523 177.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.48 HG13 ' O ' ' A' ' 9' ' ' PHE . 59.6 mt -66.68 -41.05 87.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 121.432 0.634 . . . . 0.0 109.756 173.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.01 23.26 25.61 Favored Glycine 0 N--CA 1.446 -0.657 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.791 -179.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 47.8 mm-40 -98.02 158.92 15.26 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.152 0.501 . . . . 0.0 111.322 -178.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -77.72 114.36 16.49 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.981 -177.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.462 ' HB3' HD11 ' A' ' 10' ' ' LEU . 39.3 p90 -111.13 112.15 23.75 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 170.244 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.526 ' HB ' ' HB2' ' A' ' 25' ' ' HIS . 51.6 mt -84.91 95.17 4.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.473 -175.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -76.05 114.03 14.24 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.095 176.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.521 ' HB2' ' HB2' ' A' ' 23' ' ' GLU . 93.6 mt -114.84 169.22 9.24 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 172.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.441 ' O ' ' HB2' ' A' ' 22' ' ' ASN . 40.6 mt-10 -64.39 107.35 1.32 Allowed 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.474 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.441 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 88.2 m-20 80.48 2.95 1.84 Allowed 'General case' 0 N--CA 1.47 0.575 0 O-C-N 124.593 1.183 . . . . 0.0 112.031 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.521 ' HB2' ' HB2' ' A' ' 20' ' ' LEU . 54.6 mt-10 -134.3 150.98 51.01 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.442 0.639 . . . . 0.0 112.424 -177.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 59.1 mt -130.95 109.78 17.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 166.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.526 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 11.7 m170 -89.96 125.09 35.25 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.106 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.4 HD23 HD11 ' A' ' 10' ' ' LEU . 39.8 mt -120.81 175.29 6.11 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.236 0.541 . . . . 0.0 111.388 -177.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.406 ' HB2' HG21 ' A' ' 30' ' ' VAL . 87.2 mttt -93.54 153.66 41.27 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.481 178.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_exo -48.45 -53.08 7.35 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 123.143 2.562 . . . . 0.0 113.571 -176.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -72.02 -37.13 69.83 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.851 0.357 . . . . 0.0 110.88 -176.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.459 ' O ' HG21 ' A' ' 34' ' ' VAL . 47.4 t -63.69 -40.46 89.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.28 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -61.92 -39.22 91.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.431 177.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.41 ' HA ' ' HE1' ' A' ' 93' ' ' PHE . 66.3 t80 -60.63 -43.31 97.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.596 179.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -64.62 -44.56 90.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.062 178.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.459 HG21 ' O ' ' A' ' 30' ' ' VAL . 91.2 t -65.74 -40.95 89.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.99 -179.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.418 ' CD1' ' HD2' ' A' ' 41' ' ' PRO . 28.1 t90 -55.04 -48.09 73.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.623 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 62.9 mttm -72.4 -31.02 65.18 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.266 179.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -63.0 -43.71 98.03 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.231 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.475 HG21 ' HD3' ' A' ' 41' ' ' PRO . 34.9 m -80.54 -5.87 8.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -177.011 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 108.53 12.56 20.98 Favored Glycine 0 C--N 1.331 0.263 0 C-N-CA 120.575 -0.822 . . . . 0.0 113.728 174.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 55.25 78.39 0.39 Allowed Pre-proline 0 N--CA 1.466 0.359 0 C-N-CA 122.838 0.455 . . . . 0.0 111.856 178.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.475 ' HD3' HG21 ' A' ' 38' ' ' VAL . 95.1 Cg_endo -91.64 179.42 1.5 Allowed 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.852 2.368 . . . . 0.0 112.031 175.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -62.75 122.98 17.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.898 176.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 81.3 mt -92.2 132.16 36.87 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.669 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -97.57 137.62 36.21 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 31.6 p -122.41 135.48 54.7 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 120.825 0.345 . . . . 0.0 110.773 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.476 ' CE1' ' HB2' ' A' ' 75' ' ' LYS . 17.3 p90 -122.92 136.6 54.92 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.977 0.418 . . . . 0.0 110.294 179.127 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 50.3 t -96.89 105.0 16.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.981 178.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.451 HG23 ' HB ' ' A' ' 73' ' ' ILE . 8.4 tt -100.8 112.15 32.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 121.153 0.502 . . . . 0.0 110.189 178.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 . . . . . 0 C--N 1.322 -0.617 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 178.034 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 58.6 mttp . . . . . 0 N--CA 1.456 -0.152 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.451 ' HB ' HG23 ' A' ' 48' ' ' ILE . 55.1 mt -98.54 108.98 23.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.681 -178.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 57.4 tttp -87.12 103.03 15.01 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 176.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.476 ' HB2' ' CE1' ' A' ' 46' ' ' TYR . 97.5 mttt -104.91 163.73 12.31 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.337 178.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.9 p -116.84 141.11 36.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.946 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.464 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 33.8 p90 -149.01 152.4 36.22 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.612 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -131.28 144.43 51.28 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 170.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -102.03 130.4 48.57 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.305 -175.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 32.9 p -76.13 178.99 5.95 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.152 174.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 8.2 mp -70.46 -23.96 62.8 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.71 0.29 . . . . 0.0 110.822 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -90.06 8.92 30.22 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.337 0.589 . . . . 0.0 109.608 175.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 13.5 m120 65.77 30.39 10.16 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 114.711 -1.131 . . . . 0.0 112.906 171.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 43.3 t -87.89 127.28 41.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 171.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 34.2 mtt180 -93.25 108.38 20.02 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.214 -172.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.464 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 57.4 t -82.27 110.89 17.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 174.565 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 39.8 t -113.26 137.24 46.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.436 -171.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 59.1 m -148.27 154.74 40.44 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 174.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -66.61 126.27 28.4 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.95 0.405 . . . . 0.0 110.688 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -75.59 -26.19 57.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.68 -174.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.468 ' O ' ' HG3' ' A' ' 95' ' ' LYS . 28.1 t -69.74 -43.67 71.8 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -64.31 -39.16 93.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.102 0.477 . . . . 0.0 110.21 176.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.41 ' HE1' ' HA ' ' A' ' 32' ' ' TYR . 59.6 t80 -64.24 -42.32 96.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.372 178.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 26.3 mm-40 -60.58 -37.91 82.88 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.235 176.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.468 ' HG3' ' O ' ' A' ' 91' ' ' SER . 99.3 mttt -55.55 -49.68 72.03 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.862 0.363 . . . . 0.0 110.282 176.399 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 66.9 mt -64.05 -40.8 90.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.047 -178.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 97.4 mt -58.71 -46.65 86.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.1 0.476 . . . . 0.0 110.713 177.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.503 ' HB3' ' HZ3' ' A' ' 98' ' ' LYS . 9.0 mtpm? -73.65 -34.51 64.99 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.064 -179.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -64.39 -44.84 90.05 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.996 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.418 HH11 ' HD3' ' A' ' 100' ' ' ARG . 52.1 mtt180 -84.99 -18.65 33.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.795 0.331 . . . . 0.0 111.194 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.417 0 C-N-CA 120.834 -0.698 . . . . 0.0 111.773 -179.047 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 18.0 m120 . . . . . 0 CA--C 1.517 -0.311 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 35.3 p -64.08 -29.96 71.06 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.15 0.5 . . . . 0.0 110.146 175.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -64.75 -38.1 89.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.012 176.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 95.9 t -62.64 -41.66 93.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.879 175.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 73.8 mt -62.42 -43.72 98.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.36 176.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 53.5 mttp -52.27 -53.71 40.54 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.744 175.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -70.63 -25.81 63.19 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.915 -175.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -67.46 -43.51 80.89 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.353 0.596 . . . . 0.0 109.905 174.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.479 HD12 ' HB3' ' A' ' 17' ' ' TYR . 69.8 mt -72.29 -34.31 68.06 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.392 178.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -64.0 -32.31 73.81 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.385 177.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -63.74 -58.88 5.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.614 179.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.8 pt -76.89 -17.36 14.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.797 -176.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 79.42 46.9 7.74 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.806 -179.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -97.78 169.18 9.85 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.929 0.395 . . . . 0.0 110.985 -178.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -96.94 137.25 36.33 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.112 -177.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.479 ' HB3' HD12 ' A' ' 10' ' ' LEU . 24.6 p90 -133.32 115.89 15.46 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.224 0.535 . . . . 0.0 110.223 173.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.435 ' HB ' ' HB2' ' A' ' 25' ' ' HIS . 57.4 mt -85.48 92.11 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 175.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.5 ' HG3' HG12 ' A' ' 24' ' ' ILE . 33.2 tt0 -103.51 104.46 14.53 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.247 -171.034 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 85.5 mt -79.61 -174.32 4.23 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 173.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -69.47 100.44 1.4 Allowed 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.042 0.448 . . . . 0.0 109.875 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 71.17 29.42 2.87 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.517 -177.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.563 ' HA ' ' O ' ' A' ' 85' ' ' ARG . 5.1 mt-10 -144.61 113.51 6.81 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 177.04 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.5 HG12 ' HG3' ' A' ' 19' ' ' GLU . 51.2 mt -101.2 108.21 22.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 110.175 -0.306 . . . . 0.0 110.175 179.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.532 ' HA ' ' O ' ' A' ' 87' ' ' VAL . 24.4 m-70 -96.18 119.12 34.1 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.77 0.319 . . . . 0.0 110.263 178.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 98.3 mt -116.33 173.58 6.52 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.166 -176.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -73.8 147.1 86.24 Favored Pre-proline 0 C--N 1.329 -0.318 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 172.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.441 ' HA ' HG23 ' A' ' 88' ' ' THR . 82.5 Cg_exo -47.07 -51.28 9.61 Favored 'Trans proline' 0 CA--C 1.53 0.284 0 C-N-CA 123.137 2.558 . . . . 0.0 113.606 -178.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -71.22 -34.33 70.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.748 0.309 . . . . 0.0 111.196 -177.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.442 ' O ' HG22 ' A' ' 34' ' ' VAL . 58.1 t -67.41 -45.96 84.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.939 0.399 . . . . 0.0 110.187 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -61.15 -38.58 86.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.079 175.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.525 ' HA ' ' HE1' ' A' ' 93' ' ' PHE . 19.1 t80 -56.74 -38.56 72.56 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.274 178.053 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.419 ' CD ' ' HZ1' ' A' ' 36' ' ' LYS . 68.8 mm-40 -76.17 -36.68 58.59 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 121.139 -0.224 . . . . 0.0 111.182 177.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.442 HG22 ' O ' ' A' ' 30' ' ' VAL . 77.3 t -66.17 -33.12 61.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.093 0.473 . . . . 0.0 110.225 177.232 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.533 ' CZ2' ' HG3' ' A' ' 40' ' ' GLU . 45.9 t90 -56.98 -40.01 75.72 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.797 176.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.419 ' HZ1' ' CD ' ' A' ' 33' ' ' GLU . 80.8 mttt -70.42 -42.67 71.29 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.195 0.522 . . . . 0.0 109.679 175.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -58.64 -38.9 79.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.086 -176.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.465 HG23 ' HD3' ' A' ' 41' ' ' PRO . 34.6 m -82.53 3.89 2.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.958 -178.138 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 100.57 14.68 31.66 Favored Glycine 0 C--N 1.329 0.193 0 C-N-CA 120.665 -0.779 . . . . 0.0 114.489 170.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.533 ' HG3' ' CZ2' ' A' ' 35' ' ' TRP . 35.7 tt0 57.09 72.78 0.88 Allowed Pre-proline 0 N--CA 1.468 0.456 0 CA-C-O 120.965 0.412 . . . . 0.0 111.359 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.465 ' HD3' HG23 ' A' ' 38' ' ' VAL . 78.4 Cg_endo -98.26 173.15 0.56 Allowed 'Trans proline' 0 N--CA 1.449 -1.1 0 C-N-CA 123.091 2.527 . . . . 0.0 112.135 175.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -75.02 146.58 41.47 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 173.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 82.3 mt -112.34 153.85 26.62 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.913 0.387 . . . . 0.0 111.426 -173.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.501 ' HE3' ' OE1' ' A' ' 79' ' ' GLU . 64.4 mttm -101.46 145.43 28.98 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.6 178.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 24.4 p -127.83 138.58 52.76 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.906 0.384 . . . . 0.0 111.278 -178.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -134.28 146.79 50.36 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.862 179.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 41.3 t -107.93 116.0 50.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 120.739 0.304 . . . . 0.0 110.659 -179.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 10.2 pt -107.12 139.92 27.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.377 175.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 . . . . . 0 C--N 1.323 -0.565 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.238 -177.518 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 63.0 mttm . . . . . 0 N--CA 1.452 -0.326 0 CA-C-O 121.227 0.536 . . . . 0.0 110.927 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 69.2 mt -102.96 109.23 26.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.075 177.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.509 ' O ' ' HB3' ' A' ' 90' ' ' TYR . 82.8 tttt -88.88 127.79 35.65 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.78 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 72.5 mttt -124.59 165.25 18.19 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.657 0.265 . . . . 0.0 110.58 179.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 8.4 p -125.91 141.86 44.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.839 -173.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 14.0 p90 -155.34 168.36 27.34 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.83 0.348 . . . . 0.0 111.014 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -135.09 157.61 46.49 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.435 -0.579 . . . . 0.0 109.435 171.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.501 ' OE1' ' HE3' ' A' ' 44' ' ' LYS . 39.3 mt-10 -106.49 132.59 52.32 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.378 -176.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 69.7 p -84.66 166.97 16.64 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 175.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -67.7 -21.36 65.33 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.911 0.386 . . . . 0.0 110.496 178.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -90.81 16.9 8.44 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.103 178.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 66.6 t30 70.33 20.72 6.02 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 115.604 -0.725 . . . . 0.0 112.269 170.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 96.0 t -99.68 133.36 42.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.228 0.537 . . . . 0.0 110.208 176.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.563 ' O ' ' HA ' ' A' ' 23' ' ' GLU . 66.3 mtm180 -101.99 115.4 30.46 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.429 -176.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 43.1 t -91.84 108.57 20.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 177.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.532 ' O ' ' HA ' ' A' ' 25' ' ' HIS . 16.8 t -111.89 143.16 22.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.527 -170.146 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.441 HG23 ' HA ' ' A' ' 28' ' ' PRO . 91.4 m -150.66 154.46 37.51 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.887 176.277 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.63 120.44 13.45 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.827 0.822 . . . . 0.0 111.972 -177.377 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.509 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 82.4 t80 -65.65 -38.39 89.22 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.343 -1.298 . . . . 0.0 111.774 -173.193 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.495 ' O ' ' HG3' ' A' ' 95' ' ' LYS . 42.9 t -54.73 -56.62 17.25 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.634 -177.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 20.5 tp10 -71.39 -34.55 70.5 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.777 -175.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.525 ' HE1' ' HA ' ' A' ' 32' ' ' TYR . 83.8 t80 -64.01 -42.58 97.11 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.777 178.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 53.4 mm-40 -65.73 -31.63 72.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.304 178.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.538 ' O ' ' HG3' ' A' ' 99' ' ' LYS . 91.3 mttt -59.53 -44.76 93.11 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 174.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 65.1 mt -56.04 -50.06 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.772 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 87.5 mt -63.82 -36.4 83.77 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.597 179.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 59.1 tttm -66.57 -41.96 87.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.653 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.538 ' HG3' ' O ' ' A' ' 95' ' ' LYS . 90.9 mttt -64.29 -37.17 86.53 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.755 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 33.1 mtp180 -67.43 -32.52 73.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.351 176.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.469 0 C-N-CA 120.375 -0.917 . . . . 0.0 110.858 -175.119 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 13.7 m120 . . . . . 0 CA--C 1.516 -0.361 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.8 m -62.88 -34.34 77.18 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.307 0.575 . . . . 0.0 110.166 178.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -67.7 -35.38 78.69 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.899 176.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 89.8 t -64.59 -34.76 71.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.066 0.46 . . . . 0.0 110.131 178.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 74.7 mt -63.54 -44.82 98.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.91 -0.587 . . . . 0.0 109.948 174.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -59.84 -46.41 89.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.407 177.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -51.07 -49.59 60.34 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.173 176.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -62.4 -43.58 98.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.011 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.472 HD11 ' HB3' ' A' ' 17' ' ' TYR . 96.7 mt -69.61 -35.94 75.73 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.58 -177.227 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -70.24 -33.39 71.57 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 121.071 -0.252 . . . . 0.0 110.607 176.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -62.8 -53.77 49.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.584 178.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 30.1 pt -72.42 -24.49 22.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.121 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.54 47.43 4.59 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.022 178.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -111.37 -179.8 3.82 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.125 0.488 . . . . 0.0 111.387 -178.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -122.03 130.84 53.63 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.009 -173.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.472 ' HB3' HD11 ' A' ' 10' ' ' LEU . 51.5 p90 -123.04 144.56 49.2 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.565 177.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.541 ' HB ' ' HB2' ' A' ' 25' ' ' HIS . 75.5 mt -90.08 99.72 9.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 177.06 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.437 ' HB2' ' CE1' ' A' ' 17' ' ' TYR . 37.8 tt0 -92.56 106.98 18.86 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.089 -175.019 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 70.5 mt -112.58 166.31 11.45 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 172.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -60.39 106.03 0.49 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.043 0.449 . . . . 0.0 110.723 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 68.78 14.88 8.99 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 114.87 -1.059 . . . . 0.0 112.187 -179.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -138.46 113.71 9.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.873 0.368 . . . . 0.0 111.153 178.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.471 ' HB ' HG21 ' A' ' 86' ' ' VAL . 66.5 mt -105.28 104.76 17.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 174.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.541 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 20.0 m-70 -91.65 115.79 28.34 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -179.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 73.4 mt -105.16 153.76 21.11 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.953 -177.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.5 mtmm -77.22 133.76 68.08 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 173.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.442 ' HB2' HD13 ' A' ' 96' ' ' ILE . 7.0 Cg_endo -48.52 -43.97 31.62 Favored 'Trans proline' 0 CA--C 1.529 0.257 0 C-N-CA 123.685 2.923 . . . . 0.0 113.145 -175.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -57.4 -34.54 68.98 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 121.104 0.478 . . . . 0.0 111.504 -178.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 47.1 t -94.43 -32.17 4.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.733 -176.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.488 ' HE1' ' HE1' ' A' ' 78' ' ' PHE . 81.8 t80 -56.72 -35.23 68.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.187 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -58.98 -33.72 71.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.366 -178.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -77.94 -44.37 27.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.819 0.343 . . . . 0.0 110.594 179.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 46.3 t -63.67 -36.52 76.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.76 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.412 ' CD1' ' HD2' ' A' ' 41' ' ' PRO . 27.2 t90 -55.25 -45.38 76.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.941 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 74.8 mttt -78.2 -33.17 50.14 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.969 -0.293 . . . . 0.0 111.082 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 91.1 t80 -58.11 -37.37 74.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.879 178.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.415 HG22 ' HD3' ' A' ' 41' ' ' PRO . 33.6 m -89.73 7.83 3.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.757 -177.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 99.7 15.57 31.28 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.718 -0.753 . . . . 0.0 113.967 172.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 54.54 67.7 3.17 Favored Pre-proline 0 N--CA 1.469 0.52 0 C-N-CA 122.693 0.397 . . . . 0.0 111.424 179.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.415 ' HD3' HG22 ' A' ' 38' ' ' VAL . 5.7 Cg_exo -78.05 162.86 28.68 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 122.884 2.39 . . . . 0.0 111.958 -179.307 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -69.24 139.01 54.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.628 176.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.547 ' HB3' ' CG2' ' A' ' 76' ' ' VAL . 94.8 mt -111.05 134.29 52.77 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.216 -173.287 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -104.59 139.05 40.02 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.269 -0.423 . . . . 0.0 109.918 177.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 19.4 p -106.33 140.97 38.42 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.186 -178.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 6.5 p90 -124.84 153.71 42.15 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 175.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 66.5 t -111.91 113.51 44.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-O 121.024 0.44 . . . . 0.0 111.183 -174.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.43 HG22 ' HB ' ' A' ' 73' ' ' ILE . 8.2 tt -104.69 105.51 18.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 173.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.508 ' HB2' ' HG2' ' A' ' 72' ' ' LYS . 39.1 tt0 . . . . . 0 C--N 1.322 -0.619 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.606 -178.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.508 ' HG2' ' HB2' ' A' ' 49' ' ' GLU . 60.5 mttp . . . . . 0 C--O 1.234 0.274 0 CA-C-O 120.793 0.33 . . . . 0.0 110.934 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.43 ' HB ' HG22 ' A' ' 48' ' ' ILE . 60.9 mt -95.17 110.58 24.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.934 177.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -90.02 115.4 27.27 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.464 -178.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -118.22 167.11 11.82 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.299 178.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.547 ' CG2' ' HB3' ' A' ' 43' ' ' LEU . 12.0 p -126.19 150.09 31.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.636 -0.256 . . . . 0.0 110.616 -174.204 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -155.09 164.68 38.53 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.798 0.332 . . . . 0.0 110.77 179.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.488 ' HE1' ' HE1' ' A' ' 31' ' ' PHE . 50.7 p90 -134.69 152.67 51.94 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 170.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.529 ' HG2' ' HG2' ' A' ' 85' ' ' ARG . 33.7 mt-10 -102.31 127.07 49.46 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.162 -175.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 81.1 p -83.97 174.88 9.97 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.742 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.9 mp -71.2 -12.08 61.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.113 0.482 . . . . 0.0 110.613 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -92.22 4.76 52.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.491 -179.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 66.8 t30 70.88 21.26 5.13 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.728 0.775 . . . . 0.0 109.884 -178.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 99.2 t -100.05 136.46 31.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.643 178.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.529 ' HG2' ' HG2' ' A' ' 79' ' ' GLU . 69.0 mtt180 -107.5 119.22 38.8 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.148 0.499 . . . . 0.0 111.243 -176.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.471 HG21 ' HB ' ' A' ' 24' ' ' ILE . 87.1 t -89.63 111.06 22.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.675 177.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 25' ' ' HIS . 40.9 t -105.62 140.42 23.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.18 -173.233 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 58.9 m -147.91 152.45 37.58 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 176.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -67.87 126.92 30.96 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.782 0.325 . . . . 0.0 110.724 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -77.97 -30.23 50.14 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.045 -174.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 9.4 t -71.96 -40.63 68.52 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 -179.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.417 ' O ' HG13 ' A' ' 96' ' ' ILE . 35.8 mt-10 -69.49 -37.55 77.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.635 176.122 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -61.75 -47.22 86.18 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.931 0.396 . . . . 0.0 110.479 177.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 68.4 mm-40 -65.65 -31.33 72.28 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.016 178.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 57.9 tptt -66.19 -36.13 82.27 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 176.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.443 ' HA ' ' HG3' ' A' ' 99' ' ' LYS . 64.7 mt -67.12 -38.8 81.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.054 0.454 . . . . 0.0 110.501 176.013 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 73.1 mt -63.13 -25.97 68.6 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.166 176.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -79.37 -26.68 41.98 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.064 176.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.443 ' HG3' ' HA ' ' A' ' 96' ' ' ILE . 33.5 mttp -61.92 -51.62 67.38 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-O 121.239 0.542 . . . . 0.0 109.875 175.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -86.19 -30.03 22.75 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.035 -173.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.658 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.266 -175.655 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 . . . . . 0 CA--C 1.519 -0.249 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.7 p -63.83 -28.29 69.75 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.089 0.471 . . . . 0.0 110.102 175.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -62.33 -43.47 98.75 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.031 175.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 99.5 t -61.26 -39.63 83.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.033 176.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.541 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 63.5 mt -63.44 -41.48 92.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.3 177.386 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -54.95 -49.56 71.08 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.768 177.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -60.3 -36.9 78.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.898 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.454 ' O ' HG12 ' A' ' 13' ' ' ILE . 90.5 t80 -67.95 -44.43 76.78 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.299 177.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.541 ' HG ' ' O ' ' A' ' 6' ' ' ILE . 86.2 mt -66.73 -43.37 84.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.261 -178.467 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -65.57 -30.07 70.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.954 0.406 . . . . 0.0 110.938 179.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -75.23 -47.3 28.81 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.26 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.454 HG12 ' O ' ' A' ' 9' ' ' PHE . 40.3 pt -77.85 -37.92 24.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 121.041 -0.264 . . . . 0.0 111.504 -178.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 114.36 75.76 0.67 Allowed Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.904 178.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.514 ' HG2' HD23 ' A' ' 26' ' ' LEU . 3.8 tp10 -132.83 133.59 43.55 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 174.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -102.09 106.9 17.84 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 176.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.499 ' HB3' HD22 ' A' ' 26' ' ' LEU . 11.0 p90 -111.08 153.02 26.26 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.199 0.524 . . . . 0.0 112.241 -171.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.509 ' HB ' ' HB2' ' A' ' 25' ' ' HIS . 64.5 mt -89.35 107.18 17.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.355 174.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -94.29 97.74 10.44 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.38 0.61 . . . . 0.0 110.789 -179.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 91.9 mt -101.4 162.04 13.19 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 171.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -64.66 116.32 6.11 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 119.954 -0.699 . . . . 0.0 109.931 -178.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.428 ' O ' ' HG2' ' A' ' 85' ' ' ARG . 72.5 m-20 75.65 7.32 3.87 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 114.977 -1.011 . . . . 0.0 111.765 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -140.03 113.83 8.77 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-O 121.083 0.468 . . . . 0.0 112.191 -179.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 70.8 mt -109.4 116.36 51.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 173.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.509 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 23.6 m-70 -98.44 121.77 40.79 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.644 0.259 . . . . 0.0 111.073 -177.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.514 HD23 ' HG2' ' A' ' 15' ' ' GLU . 91.8 mt -117.25 161.81 18.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.633 -179.191 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 34.1 mttp -72.63 144.98 86.75 Favored Pre-proline 0 C--N 1.328 -0.356 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 172.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_exo -52.01 -33.75 54.05 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.25 1.966 . . . . 0.0 111.391 174.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -53.28 -57.31 10.98 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.168 175.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 45.1 t -79.57 -36.35 17.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.048 -175.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -55.21 -38.85 68.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.411 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.605 ' HA ' ' HE1' ' A' ' 93' ' ' PHE . 23.8 t80 -55.56 -44.82 77.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.426 177.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -78.89 -32.52 45.87 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.176 -177.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 84.7 t -65.22 -38.59 83.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 175.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 29.6 t90 -57.89 -42.33 84.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.117 176.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -63.02 -47.09 84.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.643 174.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 88.9 t80 -59.06 -43.88 91.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.044 -177.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.493 HG21 ' HD3' ' A' ' 41' ' ' PRO . 34.1 m -75.23 -8.46 11.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -175.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 108.21 5.02 32.93 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.442 -0.885 . . . . 0.0 113.107 175.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 57.02 76.03 0.52 Allowed Pre-proline 0 C--N 1.329 -0.307 0 C-N-CA 122.862 0.465 . . . . 0.0 112.014 178.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.493 ' HD3' HG21 ' A' ' 38' ' ' VAL . 57.7 Cg_endo -93.5 -172.63 0.33 Allowed 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 123.218 2.612 . . . . 0.0 111.22 175.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -72.02 148.15 46.15 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.085 0.469 . . . . 0.0 110.557 176.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 83.7 mt -111.95 132.76 54.56 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.225 -179.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -96.37 140.23 31.33 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 177.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 43.7 p -119.87 140.77 50.32 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 120.695 0.283 . . . . 0.0 110.527 178.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -122.68 141.8 51.36 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 177.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 48.2 t -97.37 108.57 21.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.786 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 10.1 tt -113.17 137.64 45.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.207 -179.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 . . . . . 0 N--CA 1.446 -0.629 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.26 177.097 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 51.8 mttm . . . . . 0 C--O 1.236 0.364 0 CA-C-O 120.813 0.34 . . . . 0.0 110.304 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.565 HG23 ' HG3' ' A' ' 75' ' ' LYS . 44.3 mm -97.46 120.23 46.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.174 0.511 . . . . 0.0 110.55 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.525 ' O ' ' HB3' ' A' ' 90' ' ' TYR . 57.2 tttp -85.58 101.87 13.06 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.283 178.312 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.565 ' HG3' HG23 ' A' ' 73' ' ' ILE . 74.6 mttt -102.43 154.96 18.58 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.171 -177.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 14.9 p -116.84 147.79 19.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.639 0.256 . . . . 0.0 111.258 -172.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.47 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 50.6 p90 -153.79 154.04 33.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.935 178.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -123.76 149.54 45.49 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 171.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -102.77 135.71 43.92 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.709 -174.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 59.7 p -89.85 -176.3 4.89 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.617 179.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.519 HD12 ' O ' ' A' ' 81' ' ' LEU . 2.1 tm? -63.89 -24.64 67.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.28 0.562 . . . . 0.0 109.803 178.047 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.422 ' O ' ' HB2' ' A' ' 83' ' ' ASN . 0.8 OUTLIER -81.75 1.33 34.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.841 -177.237 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.422 ' HB2' ' O ' ' A' ' 82' ' ' ASP . 47.1 m-80 71.46 6.62 5.8 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 123.572 0.545 . . . . 0.0 110.776 -176.114 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 85.1 t -83.55 132.54 31.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.731 178.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.428 ' HG2' ' O ' ' A' ' 22' ' ' ASN . 40.9 ptt180 -101.4 131.35 47.54 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.398 0.618 . . . . 0.0 111.109 -177.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 59.5 t -94.17 111.26 24.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.384 177.092 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.45 HG22 ' HB3' ' A' ' 77' ' ' TYR . 16.1 t -104.92 142.91 17.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.285 -171.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 8.1 t -151.42 -173.21 4.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.646 175.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -84.83 119.51 25.4 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.899 0.381 . . . . 0.0 110.56 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.525 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 76.3 t80 -70.28 -40.85 74.08 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.484 -176.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.584 ' O ' ' HG3' ' A' ' 95' ' ' LYS . 18.0 m -58.75 -56.94 15.72 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.36 -174.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.466 ' O ' HG13 ' A' ' 96' ' ' ILE . 33.1 mt-10 -75.29 -27.35 59.32 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 -176.268 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.605 ' HE1' ' HA ' ' A' ' 32' ' ' TYR . 65.7 t80 -61.78 -47.86 83.24 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 175.174 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 81.5 mm-40 -65.33 -28.84 69.58 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.946 178.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.584 ' HG3' ' O ' ' A' ' 91' ' ' SER . 65.9 mttm -68.49 -25.01 64.76 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.495 176.185 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.466 HG13 ' O ' ' A' ' 92' ' ' GLU . 77.0 mt -72.93 -39.4 58.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 174.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -63.11 -39.43 94.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.167 0.508 . . . . 0.0 109.822 173.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 62.6 mmtt -65.19 -37.34 87.04 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.114 174.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -63.11 -47.63 82.02 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.69 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 55.2 ttt180 -72.15 -34.31 68.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.747 177.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.73 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.871 -178.291 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 13.0 m120 . . . . . 0 CA--C 1.516 -0.333 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.424 ' O ' ' HG3' ' A' ' 7' ' ' LYS . 7.1 m -61.97 -36.03 80.25 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.861 0.363 . . . . 0.0 110.282 179.542 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -62.44 -42.5 99.5 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.152 175.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 67.3 t -60.06 -42.21 89.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.696 178.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.463 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 67.3 mt -62.18 -42.13 94.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.396 178.53 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.424 ' HG3' ' O ' ' A' ' 3' ' ' SER . 95.5 mttt -57.43 -51.23 70.26 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.839 178.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -60.28 -48.18 82.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.475 178.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.488 ' CE2' HD11 ' A' ' 13' ' ' ILE . 72.5 t80 -55.41 -41.73 73.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.99 -178.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.467 HD12 ' HB3' ' A' ' 17' ' ' TYR . 93.0 mt -64.64 -42.67 95.3 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.094 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -70.81 -34.45 71.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.776 0.322 . . . . 0.0 110.606 178.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -60.49 -37.46 81.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.568 175.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.488 HD11 ' CE2' ' A' ' 9' ' ' PHE . 64.2 mt -74.19 -41.87 51.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.157 0.503 . . . . 0.0 109.949 174.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 109.17 24.5 5.95 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.485 -175.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 82.5 mm-40 -102.3 -179.73 4.07 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.74 0.305 . . . . 0.0 110.584 -179.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -128.13 173.27 10.24 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 -179.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.467 ' HB3' HD12 ' A' ' 10' ' ' LEU . 30.0 p90 -158.51 141.32 14.57 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.765 0.317 . . . . 0.0 110.371 -178.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.523 ' HB ' ' HB2' ' A' ' 25' ' ' HIS . 69.7 mt -97.76 103.22 14.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 120.937 0.399 . . . . 0.0 110.2 179.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -89.49 118.21 28.97 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.55 -179.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 83.4 mt -116.07 -166.4 1.14 Allowed 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 175.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -67.15 101.79 0.94 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.888 0.375 . . . . 0.0 111.067 -179.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 48.6 m-80 64.88 15.98 10.22 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.601 177.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -132.44 128.25 37.08 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.301 -179.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.42 ' HB ' HG21 ' A' ' 86' ' ' VAL . 65.1 mt -109.55 106.65 21.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 172.208 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.523 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 20.4 m170 -87.41 115.49 24.86 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -178.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.18 161.01 13.93 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.391 -173.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -74.63 131.25 80.08 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.139 174.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.452 ' HA ' HG23 ' A' ' 88' ' ' THR . 89.8 Cg_exo -43.01 -50.23 6.41 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 123.825 3.017 . . . . 0.0 114.29 -174.07 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -75.15 -33.01 61.47 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.703 0.287 . . . . 0.0 111.655 -175.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.424 ' O ' HG23 ' A' ' 34' ' ' VAL . 21.8 t -74.12 -35.49 41.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.842 0.353 . . . . 0.0 110.305 -178.271 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -54.93 -38.49 67.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.877 179.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 73.8 t80 -59.14 -42.22 90.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.154 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -78.03 -31.16 50.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.985 -178.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 30' ' ' VAL . 92.8 t -65.38 -38.66 83.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.013 0.435 . . . . 0.0 109.838 175.25 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 26.9 t90 -57.34 -44.87 84.64 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.785 176.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.505 ' HZ3' ' HB3' ' A' ' 36' ' ' LYS . 8.3 mtpm? -80.02 -0.09 33.95 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.78 0.324 . . . . 0.0 111.24 -179.191 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -96.19 -39.58 9.61 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.012 0.434 . . . . 0.0 110.619 175.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 29.3 m -82.13 19.66 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.055 -0.52 . . . . 0.0 112.303 -173.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 91.02 19.48 42.79 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.97 176.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 37.17 65.82 2.33 Favored Pre-proline 0 N--CA 1.473 0.722 0 C-N-CA 123.884 0.874 . . . . 0.0 112.941 179.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -83.11 175.51 8.36 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 122.482 2.122 . . . . 0.0 111.953 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -71.55 110.4 6.11 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.844 175.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.493 ' HB3' ' CG2' ' A' ' 76' ' ' VAL . 81.0 mt -73.7 129.14 37.33 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.795 -178.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 25.6 tptp -92.54 121.98 34.52 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.959 -178.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 41.7 p -103.24 156.19 17.9 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.805 -178.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 30.6 p90 -132.83 146.5 51.88 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 173.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 57.9 t -99.28 116.55 42.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.45 -179.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.646 HG21 ' HB ' ' A' ' 73' ' ' ILE . 6.2 tt -102.95 101.29 11.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 174.189 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 . . . . . 0 C--N 1.319 -0.722 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.172 -175.963 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 67.3 mttm . . . . . 0 N--CA 1.454 -0.236 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.646 ' HB ' HG21 ' A' ' 48' ' ' ILE . 57.9 mt -91.1 132.96 34.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.598 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -117.7 126.75 53.06 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 120.885 0.374 . . . . 0.0 110.81 -174.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -123.07 159.01 29.37 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.22 176.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.493 ' CG2' ' HB3' ' A' ' 43' ' ' LEU . 9.9 p -122.71 145.36 29.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.638 -175.364 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -152.51 165.29 35.57 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.964 0.412 . . . . 0.0 110.365 178.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -137.69 144.97 42.05 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 169.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.542 ' HG2' ' HG3' ' A' ' 85' ' ' ARG . 43.7 mt-10 -101.93 122.51 44.16 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.183 -177.462 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 49.6 p -73.17 178.25 4.55 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.044 -178.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 8.0 mp -64.06 -24.3 67.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.06 0.457 . . . . 0.0 109.851 176.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -83.26 -2.19 55.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.982 179.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 15.5 m120 71.03 24.57 3.92 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.35 178.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 62.0 t -90.33 134.71 28.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.779 176.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.542 ' HG3' ' HG2' ' A' ' 79' ' ' GLU . 4.3 mpt_? -92.3 110.3 21.69 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.035 -176.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.42 HG21 ' HB ' ' A' ' 24' ' ' ILE . 49.4 t -89.22 103.36 13.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 173.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.8 t -107.09 141.41 22.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.683 -170.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.452 HG23 ' HA ' ' A' ' 28' ' ' PRO . 73.0 m -149.56 153.73 37.59 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.583 175.308 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -64.43 127.96 33.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.931 0.396 . . . . 0.0 111.047 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -80.69 -26.68 37.37 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.034 -174.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 47.3 t -62.94 -44.15 96.85 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.434 ' O ' ' HB3' ' A' ' 95' ' ' LYS . 39.8 mt-10 -80.05 -20.2 45.8 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.068 177.294 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -70.38 -49.53 48.14 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.406 173.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.448 ' HA ' HD12 ' A' ' 97' ' ' LEU . 19.6 pt20 -68.05 -22.6 64.94 Favored 'General case' 0 C--N 1.334 -0.074 0 CA-C-O 121.034 0.445 . . . . 0.0 110.05 177.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.434 ' HB3' ' O ' ' A' ' 92' ' ' GLU . 86.7 tttt -61.43 -45.05 95.91 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.726 173.284 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.428 HG13 ' O ' ' A' ' 92' ' ' GLU . 66.3 mt -68.49 -34.93 68.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.166 176.079 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.448 HD12 ' HA ' ' A' ' 94' ' ' GLN . 75.7 mt -60.83 -41.65 96.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.641 176.196 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.428 ' HG2' ' O ' ' A' ' 94' ' ' GLN . 34.4 mmtp -67.25 -38.77 85.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.177 0.513 . . . . 0.0 110.225 176.301 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -60.92 -50.22 74.3 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.31 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 73.9 mtp85 -95.44 1.17 53.99 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.641 -174.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.229 -0.203 0 C-N-CA 121.171 -0.538 . . . . 0.0 113.191 175.248 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 15.8 m120 . . . . . 0 C--O 1.234 0.287 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.5 p -57.48 -32.37 66.92 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.068 0.461 . . . . 0.0 111.078 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.469 ' HA ' ' HD2' ' A' ' 7' ' ' LYS . 35.3 tt0 -61.0 -42.3 98.18 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.697 178.071 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.3 t -68.01 -35.21 71.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.373 179.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.497 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 59.7 mt -62.73 -39.77 86.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.138 176.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.469 ' HD2' ' HA ' ' A' ' 4' ' ' GLU . 61.8 mttm -56.78 -44.66 82.07 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.488 176.097 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -57.67 -44.1 85.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.022 178.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -66.9 -43.54 83.13 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.878 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.501 HD11 ' HB3' ' A' ' 17' ' ' TYR . 87.3 mt -66.57 -40.03 88.76 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.371 -177.487 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -67.44 -39.46 85.4 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.922 0.391 . . . . 0.0 110.17 176.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -58.24 -51.04 71.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.183 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 33.7 pt -72.38 -26.26 24.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.405 -178.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.32 44.16 4.75 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.723 177.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -123.19 149.66 44.35 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.009 0.433 . . . . 0.0 110.813 178.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -93.99 131.96 38.93 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.294 -177.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.501 ' HB3' HD11 ' A' ' 10' ' ' LEU . 27.9 p90 -115.23 136.28 53.28 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.051 179.048 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 57.1 mt -87.45 97.81 6.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 120.848 0.356 . . . . 0.0 110.107 -179.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -91.12 106.63 18.65 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.352 0.596 . . . . 0.0 110.459 -179.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.494 ' HB2' ' HB2' ' A' ' 23' ' ' GLU . 88.1 mt -93.95 -164.84 1.22 Allowed 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.222 -0.899 . . . . 0.0 108.803 174.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -69.56 92.73 0.65 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.635 0.255 . . . . 0.0 110.52 179.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 10.0 m120 69.54 18.55 7.72 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.643 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.494 ' HB2' ' HB2' ' A' ' 20' ' ' LEU . 41.6 mt-10 -130.18 113.71 14.8 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.937 178.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 59.5 mt -96.04 102.55 13.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 173.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.494 ' HA ' ' O ' ' A' ' 87' ' ' VAL . 13.6 m-70 -90.35 117.74 29.31 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.016 0.436 . . . . 0.0 109.949 -179.076 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 70.6 mt -107.56 168.96 8.88 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.519 0.676 . . . . 0.0 111.562 -176.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -82.57 140.27 44.43 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 115.011 -0.995 . . . . 0.0 108.364 171.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.489 ' HA ' HG21 ' A' ' 88' ' ' THR . 3.2 Cg_endo -47.06 -43.69 24.53 Favored 'Trans proline' 0 CA--C 1.534 0.495 0 C-N-CA 123.195 2.597 . . . . 0.0 113.298 -176.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -61.15 -41.19 96.31 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.998 0.428 . . . . 0.0 111.197 179.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 47.9 t -73.82 -37.78 49.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.852 -178.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -60.62 -40.59 92.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.632 179.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 85.1 t80 -60.49 -39.69 88.6 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.576 178.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 38.2 mm-40 -59.6 -50.84 72.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.842 177.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 41.4 t -65.62 -40.33 87.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.996 -177.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.69 ' CD1' ' HD2' ' A' ' 41' ' ' PRO . 32.5 t90 -57.02 -44.62 83.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.708 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.422 ' HE2' ' HB3' ' A' ' 36' ' ' LYS . 51.1 mtpt -89.5 3.7 51.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.881 0.372 . . . . 0.0 111.108 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -83.6 -38.6 21.4 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -96.84 9.29 6.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.915 177.194 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 79.04 50.4 5.87 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.739 -0.744 . . . . 0.0 113.763 173.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 58.24 78.33 0.36 Allowed Pre-proline 0 N--CA 1.467 0.41 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 172.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.69 ' HD2' ' CD1' ' A' ' 35' ' ' TRP . 5.4 Cg_exo -78.76 173.73 13.22 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.374 2.049 . . . . 0.0 111.39 172.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -76.99 123.58 26.54 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.046 177.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.442 ' HB3' ' CG2' ' A' ' 76' ' ' VAL . 87.6 mt -94.36 132.03 39.41 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.809 -177.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -107.44 141.81 38.25 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.768 178.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 24.1 p -120.76 146.09 46.85 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.775 0.321 . . . . 0.0 111.487 -176.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 17.8 p90 -133.09 154.98 50.06 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 177.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.5 t -106.01 114.61 45.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.274 178.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 8.6 tt -110.53 118.03 56.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.267 0.556 . . . . 0.0 109.95 177.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.48 ' HG2' ' HG2' ' A' ' 72' ' ' LYS . 50.2 mt-10 . . . . . 0 C--N 1.322 -0.621 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.917 -178.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.48 ' HG2' ' HG2' ' A' ' 49' ' ' GLU . 61.5 mttm . . . . . 0 N--CA 1.453 -0.288 0 CA-C-O 120.749 0.309 . . . . 0.0 110.389 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 65.4 mt -97.77 118.91 45.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.131 0.491 . . . . 0.0 110.553 -178.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.409 ' O ' ' HB3' ' A' ' 90' ' ' TYR . 87.8 tttt -89.58 128.43 36.03 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.958 178.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.458 ' HG2' ' HA ' ' A' ' 89' ' ' ASP . 68.3 mttm -129.73 164.17 24.57 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 177.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.442 ' CG2' ' HB3' ' A' ' 43' ' ' LEU . 11.1 p -119.82 148.03 23.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.513 -174.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -154.79 162.35 41.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.058 0.456 . . . . 0.0 111.108 -179.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -132.45 142.21 49.15 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 168.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -102.16 132.43 48.07 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.633 -173.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 72.4 p -82.31 179.53 7.77 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.926 0.394 . . . . 0.0 109.994 176.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.9 mp -77.11 -6.45 52.87 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.85 0.357 . . . . 0.0 110.7 -178.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.506 ' HB2' HG23 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -97.89 8.85 44.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.203 -179.384 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 63.4 t30 67.14 28.42 8.22 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.865 0.84 . . . . 0.0 110.133 -176.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.506 HG23 ' HB2' ' A' ' 82' ' ' ASP . 59.2 t -98.72 113.72 34.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 175.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 85.6 mtt180 -94.69 110.51 22.35 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.567 -176.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 58.0 t -81.63 104.62 10.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.724 179.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.494 ' O ' ' HA ' ' A' ' 25' ' ' HIS . 41.4 t -103.53 140.97 20.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.236 -172.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.489 HG21 ' HA ' ' A' ' 28' ' ' PRO . 98.6 m -147.58 151.43 36.25 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.33 174.359 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.458 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 20.3 t70 -59.97 134.8 57.38 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.063 0.458 . . . . 0.0 111.563 -177.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.409 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 88.1 t80 -76.64 -41.04 47.29 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.62 -175.26 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 11.0 p -68.65 -37.57 79.78 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.911 -0.316 . . . . 0.0 111.058 -176.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 43.1 mm-40 -72.65 -31.75 65.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.594 0.235 . . . . 0.0 110.992 176.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -69.34 -49.77 52.56 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 121.078 -0.249 . . . . 0.0 111.078 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.431 ' HA ' HD11 ' A' ' 97' ' ' LEU . 11.0 pt20 -63.86 -28.66 70.0 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.146 0.498 . . . . 0.0 110.094 178.511 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 53.7 tttt -60.59 -45.55 93.55 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.414 173.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.511 ' HA ' ' HB3' ' A' ' 99' ' ' LYS . 21.7 mt -71.07 -33.1 50.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.458 -179.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.431 HD11 ' HA ' ' A' ' 94' ' ' GLN . 98.4 mt -56.62 -40.92 76.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.031 0.443 . . . . 0.0 110.197 175.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -81.06 -31.92 34.25 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.624 177.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.511 ' HB3' ' HA ' ' A' ' 96' ' ' ILE . 46.9 tttm -56.59 -46.69 80.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.11 178.404 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 68.6 mtp85 -95.03 -14.47 24.29 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.576 179.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.442 0 C-N-CA 120.673 -0.775 . . . . 0.0 111.779 -179.997 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 17.3 m120 . . . . . 0 C--O 1.234 0.239 0 CA-C-O 120.848 0.356 . . . . 0.0 110.642 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.0 t -67.78 -25.99 65.87 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 175.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.42 ' O ' ' HG3' ' A' ' 8' ' ' GLU . 35.5 tt0 -51.94 -45.77 64.47 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.012 175.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.3 t -61.01 -41.38 88.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.854 -178.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 56.6 mt -65.14 -41.91 92.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.284 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.485 ' HZ1' ' CD ' ' A' ' 19' ' ' GLU . 55.9 mttm -56.18 -44.44 79.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.24 177.496 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.42 ' HG3' ' O ' ' A' ' 4' ' ' GLU . 39.0 mt-10 -63.05 -41.65 99.53 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.595 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -66.02 -46.28 78.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.849 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 96.3 mt -68.16 -34.17 75.82 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.227 -177.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -67.15 -33.69 75.97 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.292 179.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -63.73 -55.06 26.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.844 178.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 19.6 pt -69.56 -39.55 78.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.688 -177.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 95.36 21.73 23.9 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.815 177.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -85.94 130.05 34.66 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 175.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -69.16 122.59 19.1 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.732 -176.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 43.8 p90 -112.95 133.91 54.7 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 171.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.529 ' HB ' ' HB2' ' A' ' 25' ' ' HIS . 57.8 mt -90.08 94.74 5.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 120.938 0.399 . . . . 0.0 110.081 -178.278 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.485 ' CD ' ' HZ1' ' A' ' 7' ' ' LYS . 36.5 tt0 -84.95 109.48 18.2 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.306 0.574 . . . . 0.0 110.598 179.433 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.4 mt -101.32 -161.86 0.89 Allowed 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.1 -0.954 . . . . 0.0 108.706 174.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -66.37 96.09 0.34 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.772 0.32 . . . . 0.0 110.61 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 65.25 20.14 11.84 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.65 179.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -134.24 114.22 12.82 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.801 0.334 . . . . 0.0 111.623 -178.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.444 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 54.3 mt -94.36 101.21 12.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 173.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.529 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 18.8 m-70 -84.87 107.07 16.84 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 177.605 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.9 mt -95.2 169.72 9.89 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.424 0.631 . . . . 0.0 111.752 -175.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -87.11 136.02 34.3 Favored Pre-proline 0 C--N 1.319 -0.728 0 CA-C-N 114.904 -1.044 . . . . 0.0 108.688 175.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.421 ' HA ' HG23 ' A' ' 88' ' ' THR . 82.9 Cg_exo -47.0 -43.53 24.46 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 123.305 2.67 . . . . 0.0 113.245 -177.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -56.86 -44.56 82.3 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.29 0.567 . . . . 0.0 110.86 178.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 17.1 t -76.68 -46.83 30.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.73 -175.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -56.4 -37.97 70.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.524 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.651 ' OH ' ' HD2' ' A' ' 100' ' ' ARG . 6.6 t80 -58.27 -32.14 68.12 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.701 178.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 50.7 mm-40 -95.21 -37.17 11.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.546 0.212 . . . . 0.0 111.555 179.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.492 ' O ' HG22 ' A' ' 38' ' ' VAL . 93.4 t -62.67 -35.86 72.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.69 0.281 . . . . 0.0 110.789 179.673 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.673 ' CD1' ' HD2' ' A' ' 41' ' ' PRO . 46.2 t90 -55.56 -36.94 67.36 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.665 176.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.441 ' HA ' ' OE2' ' A' ' 40' ' ' GLU . 93.1 mttt -74.85 -40.98 60.71 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.483 179.14 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -58.02 -41.62 83.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.657 -178.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.536 HG21 ' HD3' ' A' ' 41' ' ' PRO . 15.5 m -85.54 1.46 5.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.753 -178.434 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 90.89 41.07 5.42 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.97 -0.633 . . . . 0.0 114.289 169.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.441 ' OE2' ' HA ' ' A' ' 36' ' ' LYS . 21.3 mp0 51.25 67.18 4.48 Favored Pre-proline 0 N--CA 1.467 0.416 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 176.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.673 ' HD2' ' CD1' ' A' ' 35' ' ' TRP . 72.5 Cg_endo -77.41 -179.58 5.57 Favored 'Trans proline' 0 C--O 1.24 0.598 0 C-N-CA 122.461 2.108 . . . . 0.0 112.119 178.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -68.47 132.13 46.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.683 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.453 ' HB3' ' CG2' ' A' ' 76' ' ' VAL . 77.8 mt -106.31 107.73 18.88 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.212 178.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.523 ' HE2' ' HG3' ' A' ' 79' ' ' GLU . 31.1 mttm -88.51 118.11 27.92 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 -179.315 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 41.8 p -95.62 119.42 34.08 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.33 177.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 14.6 p90 -118.56 152.88 35.16 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 60.3 t -104.17 112.6 38.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.18 178.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.485 HG22 ' HB ' ' A' ' 73' ' ' ILE . 11.6 tt -102.09 123.9 55.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 176.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 . . . . . 0 C--N 1.319 -0.757 0 CA-C-O 121.154 0.502 . . . . 0.0 110.731 -176.169 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 65.0 mttm . . . . . 0 N--CA 1.455 -0.217 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.485 ' HB ' HG22 ' A' ' 48' ' ' ILE . 49.0 mt -91.25 128.9 42.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.647 -176.007 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -101.32 113.11 25.88 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.009 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -122.17 167.1 13.59 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.358 -179.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.453 ' CG2' ' HB3' ' A' ' 43' ' ' LEU . 14.8 p -126.31 147.39 31.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.819 -175.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 44.1 p90 -152.65 155.8 37.99 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.695 0.283 . . . . 0.0 110.782 175.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -124.71 157.73 34.93 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 171.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.525 ' HG2' ' HG2' ' A' ' 85' ' ' ARG . 29.4 mt-10 -109.07 146.34 34.16 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.908 0.385 . . . . 0.0 111.191 -174.524 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 32.5 p -102.6 179.46 4.29 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.995 175.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 11.2 mp -67.49 -18.16 64.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.066 0.46 . . . . 0.0 110.907 178.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -94.28 9.61 37.38 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.599 -177.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 14.7 t30 69.64 1.98 3.6 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.427 0.632 . . . . 0.0 110.808 -179.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 52.6 t -72.49 115.63 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 178.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.525 ' HG2' ' HG2' ' A' ' 79' ' ' GLU . 91.8 mtt180 -94.23 118.59 31.8 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.786 -176.572 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.444 ' HA ' ' O ' ' A' ' 24' ' ' ILE . 59.7 t -87.12 104.96 14.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 178.09 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 23.9 t -102.07 141.19 18.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.061 -173.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.421 HG23 ' HA ' ' A' ' 28' ' ' PRO . 97.9 m -150.99 150.02 30.27 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.363 175.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -64.88 125.83 26.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.943 0.401 . . . . 0.0 110.349 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -75.85 -25.28 56.07 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.512 -173.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 10.9 t -74.31 -44.72 51.44 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 -70.36 -29.95 66.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.806 176.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.526 ' HE1' ' HA ' ' A' ' 32' ' ' TYR . 72.4 t80 -65.34 -52.17 55.66 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.365 -0.38 . . . . 0.0 109.985 174.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -63.16 -27.87 69.67 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.004 177.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -58.44 -51.3 70.41 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.013 176.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.424 ' HA ' ' HB3' ' A' ' 99' ' ' LYS . 62.3 mt -72.99 -32.57 40.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.22 0.533 . . . . 0.0 110.436 179.372 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.406 ' HA ' HD22 ' A' ' 97' ' ' LEU . 0.2 OUTLIER -59.2 -50.2 74.95 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.509 -0.768 . . . . 0.0 110.033 176.853 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -65.96 -36.13 82.5 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.576 176.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.424 ' HB3' ' HA ' ' A' ' 96' ' ' ILE . 47.8 tttp -57.37 -42.39 82.01 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.29 -179.174 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.651 ' HD2' ' OH ' ' A' ' 32' ' ' TYR . 63.5 ttt180 -73.1 -40.59 64.86 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.079 0.466 . . . . 0.0 110.924 179.26 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.562 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.962 -176.984 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . 0.511 ' HB3' ' OD2' ' A' ' 82' ' ' ASP . 2.0 m-20 . . . . . 0 N--CA 1.455 -0.225 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.426 ' O ' ' HG3' ' A' ' 7' ' ' LYS . 14.8 p -62.27 -29.36 70.36 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.081 0.467 . . . . 0.0 110.374 178.465 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -57.08 -46.76 82.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.984 176.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.8 t -63.0 -38.9 83.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.266 -178.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.477 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 61.5 mt -63.58 -43.56 98.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.209 178.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.426 ' HG3' ' O ' ' A' ' 3' ' ' SER . 99.0 mttt -58.51 -45.13 89.45 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.817 178.255 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -57.43 -47.28 82.19 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.108 179.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -61.04 -46.05 92.27 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.768 178.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 6' ' ' ILE . 95.7 mt -64.69 -37.12 86.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.454 -177.398 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -74.5 -36.02 63.23 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.785 0.326 . . . . 0.0 110.842 177.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -67.88 -35.06 77.86 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.848 0.356 . . . . 0.0 110.861 -179.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 39.0 pt -82.34 -17.2 11.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.854 0.359 . . . . 0.0 110.576 175.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 77.09 48.45 8.35 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 121.119 -0.562 . . . . 0.0 113.045 174.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.03 158.55 26.56 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.871 0.367 . . . . 0.0 110.431 179.435 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -95.99 120.41 36.22 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.822 -178.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 42.1 p90 -116.25 145.92 42.76 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.09 179.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.464 ' HB ' ' HB2' ' A' ' 25' ' ' HIS . 51.1 mt -96.39 97.97 7.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 120.76 0.314 . . . . 0.0 110.859 -177.222 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 47.2 tt0 -90.58 125.51 35.65 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.072 0.463 . . . . 0.0 110.171 176.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.552 ' HB2' ' HB2' ' A' ' 23' ' ' GLU . 90.4 mt -120.39 -161.65 0.9 Allowed 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 174.447 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -78.67 101.16 7.36 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.796 0.331 . . . . 0.0 110.407 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 58.7 m-80 69.43 10.07 7.55 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.724 -178.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.552 ' HB2' ' HB2' ' A' ' 20' ' ' LEU . 46.9 mt-10 -123.48 132.98 54.08 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.71 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.504 ' HB ' HG21 ' A' ' 86' ' ' VAL . 69.5 mt -120.98 111.59 32.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 170.582 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.464 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 66.3 m-70 -100.97 127.17 47.58 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 110.132 -0.322 . . . . 0.0 110.132 -178.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 69.9 mt -118.01 177.08 4.92 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.413 -176.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 58.7 mttp -92.61 154.9 42.4 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.118 175.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.26 -48.52 21.58 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.795 2.33 . . . . 0.0 113.07 -174.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -64.08 -47.61 79.43 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.841 0.353 . . . . 0.0 110.773 -177.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 42.0 t -62.48 -45.86 97.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.775 -178.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -57.1 -44.76 83.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.842 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -59.48 -42.29 91.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.324 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -75.72 -44.37 42.32 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.91 -177.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 97.5 t -61.83 -36.52 74.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-O 120.744 0.307 . . . . 0.0 110.571 178.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 28.3 t90 -53.77 -53.83 46.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.816 177.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.46 ' HA ' ' CG ' ' A' ' 40' ' ' GLU . 65.4 mttm -71.38 -29.9 65.5 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.039 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 86.4 t80 -60.91 -42.09 97.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.458 179.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.485 HG21 ' HD3' ' A' ' 41' ' ' PRO . 30.3 m -86.29 -0.37 6.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 -176.276 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 109.36 11.01 22.72 Favored Glycine 0 C--N 1.329 0.187 0 C-N-CA 120.437 -0.887 . . . . 0.0 113.427 175.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.46 ' CG ' ' HA ' ' A' ' 36' ' ' LYS . 46.3 mt-10 57.77 72.17 0.95 Allowed Pre-proline 0 C--O 1.234 0.287 0 C-N-CA 122.936 0.494 . . . . 0.0 111.938 179.321 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.485 ' HD3' HG21 ' A' ' 38' ' ' VAL . 5.0 Cg_exo -74.74 173.25 14.72 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.764 2.309 . . . . 0.0 111.475 176.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -64.63 123.39 19.18 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.014 0.435 . . . . 0.0 110.849 179.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.477 ' HB3' ' CG2' ' A' ' 76' ' ' VAL . 86.4 mt -90.84 102.25 15.01 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.136 176.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -82.74 143.66 30.73 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 176.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 31.5 p -121.51 138.88 54.11 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.95 0.405 . . . . 0.0 111.195 -176.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 15.0 p90 -127.16 141.22 51.8 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 176.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.45 ' HA ' ' HA ' ' A' ' 74' ' ' LYS . 5.3 p -98.8 105.24 17.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-O 121.655 0.74 . . . . 0.0 110.28 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 14.7 tt -93.99 125.66 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 CA-C-N 115.679 -0.692 . . . . 0.0 109.599 179.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 . . . . . 0 C--N 1.314 -0.965 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.259 -176.616 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 66.3 mttm . . . . . 0 N--CA 1.452 -0.37 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 62.8 mt -101.69 114.24 40.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.539 0.685 . . . . 0.0 111.004 -177.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.545 ' O ' ' HB3' ' A' ' 90' ' ' TYR . 88.1 tttt -80.7 124.25 28.87 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.197 -179.414 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -120.15 163.81 17.15 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.639 -0.255 . . . . 0.0 110.367 178.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.477 ' CG2' ' HB3' ' A' ' 43' ' ' LEU . 10.9 p -122.92 148.35 26.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.904 -174.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.422 ' CE2' ' HD3' ' A' ' 85' ' ' ARG . 55.5 p90 -152.95 153.24 32.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.71 0.291 . . . . 0.0 111.144 178.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.445 ' HB3' HD22 ' A' ' 43' ' ' LEU . 47.8 p90 -122.41 156.94 32.95 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 172.204 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.498 ' HG2' ' HG2' ' A' ' 85' ' ' ARG . 29.3 mt-10 -103.86 149.91 24.64 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.626 -171.504 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 73.9 p -108.77 176.69 5.02 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.966 175.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 47.2 tp -66.84 -26.47 66.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.724 0.297 . . . . 0.0 111.069 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.511 ' OD2' ' HB3' ' A' ' 2' ' ' ASN . 1.4 m-20 -82.77 3.64 28.52 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.776 -176.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.444 ' HB2' ' O ' ' A' ' 82' ' ' ASP . 0.9 OUTLIER 71.51 10.52 6.52 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 123.55 0.532 . . . . 0.0 110.917 -175.875 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.451 HG22 ' HB2' ' A' ' 82' ' ' ASP . 62.5 t -84.3 128.08 39.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 176.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.498 ' HG2' ' HG2' ' A' ' 79' ' ' GLU . 82.9 mtt180 -107.38 129.12 54.96 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.469 0.652 . . . . 0.0 111.673 -173.121 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.504 HG21 ' HB ' ' A' ' 24' ' ' ILE . 58.3 t -91.38 112.62 25.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.946 -179.306 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 41.4 t -105.51 140.79 22.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.129 -173.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 93.0 m -151.63 148.89 28.51 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.321 174.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -58.45 129.23 41.07 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.537 0.684 . . . . 0.0 111.982 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.545 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 93.9 t80 -76.49 -23.99 53.79 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.008 -0.997 . . . . 0.0 110.603 -177.272 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.2 m -65.14 -54.21 33.22 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.437 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -71.38 -28.05 63.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.413 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -63.43 -49.22 74.6 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.951 0.405 . . . . 0.0 109.937 175.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.479 ' O ' ' HG3' ' A' ' 98' ' ' LYS . 68.2 mm-40 -65.2 -33.86 76.99 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.656 176.02 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -57.84 -44.25 86.39 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.739 177.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 40.6 mt -68.64 -34.26 64.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.076 178.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 74.9 mt -62.04 -37.09 83.63 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.951 0.405 . . . . 0.0 110.189 176.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.479 ' HG3' ' O ' ' A' ' 94' ' ' GLN . 86.0 mttt -73.05 -39.47 65.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.031 176.323 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 55.7 tptt -64.85 -46.33 82.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.374 -178.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 84.5 mtt-85 -89.67 -8.49 52.32 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.451 -177.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.278 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.42 177.315 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . 0.536 ' HA ' ' HB ' ' A' ' 80' ' ' THR . 95.0 m-20 . . . . . 0 N--CA 1.451 -0.387 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.439 ' HB3' HG21 ' A' ' 84' ' ' VAL . 35.3 p -62.36 -34.79 77.35 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.017 0.437 . . . . 0.0 110.824 -179.493 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -57.05 -54.37 47.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.852 -177.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.3 t -59.22 -41.37 83.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.849 0.357 . . . . 0.0 110.915 -178.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 50.7 mt -66.03 -39.99 86.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.463 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 51.3 mttm -58.77 -47.52 84.42 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.984 175.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -62.19 -41.09 98.03 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.759 179.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -62.11 -51.18 68.97 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.643 179.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 93.3 mt -62.44 -38.15 88.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.943 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -66.26 -40.74 90.34 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.452 178.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -70.67 -35.04 72.62 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.472 -176.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 39.2 pt -87.15 -8.38 11.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.798 0.332 . . . . 0.0 110.919 178.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 65.45 52.37 40.31 Favored Glycine 0 N--CA 1.452 -0.258 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.433 176.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -112.37 148.88 33.36 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.9 0.381 . . . . 0.0 110.724 -178.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -86.37 133.17 33.81 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.818 177.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 47.5 p90 -135.24 142.5 45.99 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.768 0.318 . . . . 0.0 110.455 179.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.53 ' HB ' ' HB2' ' A' ' 25' ' ' HIS . 66.5 mt -90.79 100.99 11.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.993 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -91.18 116.69 29.02 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.026 -178.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.503 ' HB2' ' HB2' ' A' ' 23' ' ' GLU . 89.9 mt -115.19 173.64 6.4 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 173.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -60.3 105.03 0.37 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.918 0.39 . . . . 0.0 111.118 -178.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 17.1 m120 68.0 16.75 9.56 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.633 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.503 ' HB2' ' HB2' ' A' ' 20' ' ' LEU . 91.1 mt-10 -133.95 113.97 12.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.959 0.409 . . . . 0.0 111.275 179.456 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 64.5 mt -97.39 103.4 14.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 172.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.53 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 35.6 m-70 -89.94 110.77 21.71 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 -179.076 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 63.9 mt -106.11 169.67 8.36 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.486 -175.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 51.5 mtpt -81.31 138.47 48.52 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.168 175.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.51 ' HA ' HG23 ' A' ' 88' ' ' THR . 3.4 Cg_exo -41.35 -51.91 3.86 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 124.117 3.211 . . . . 0.0 114.427 -173.506 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -70.31 -37.96 74.84 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.733 0.301 . . . . 0.0 111.076 -175.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 46.7 t -65.11 -42.13 93.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.222 0.534 . . . . 0.0 109.811 177.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -57.66 -41.29 81.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.816 178.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -59.29 -45.62 90.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.51 -178.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -64.29 -35.81 82.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.273 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 60.4 t -72.13 -38.22 62.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.198 0.523 . . . . 0.0 110.45 178.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.632 ' CZ2' ' HG3' ' A' ' 40' ' ' GLU . 30.0 t90 -57.12 -46.87 82.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.33 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 55.8 mttm -86.46 -2.2 58.25 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.895 0.379 . . . . 0.0 111.384 179.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -78.72 -35.47 44.81 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 176.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.507 HG23 ' HD3' ' A' ' 41' ' ' PRO . 3.2 m -85.9 3.85 3.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.603 177.228 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 97.21 17.72 31.03 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.696 -0.764 . . . . 0.0 113.444 174.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.632 ' HG3' ' CZ2' ' A' ' 35' ' ' TRP . 36.1 tt0 61.7 84.59 0.19 Allowed Pre-proline 0 N--CA 1.466 0.336 0 CA-C-O 121.06 0.457 . . . . 0.0 111.498 178.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.552 ' HD2' ' CD1' ' A' ' 35' ' ' TRP . 94.3 Cg_endo -90.64 162.92 4.25 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.745 2.297 . . . . 0.0 111.7 173.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -71.45 125.42 26.97 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 175.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.446 ' CD2' ' HB3' ' A' ' 78' ' ' PHE . 90.4 mt -90.53 150.09 21.91 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.348 0.594 . . . . 0.0 112.292 -170.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.429 ' HZ2' ' CD ' ' A' ' 79' ' ' GLU . 97.4 mttt -97.2 164.67 12.39 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.236 172.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' THR . . . . . 0.651 HG22 ' HE3' ' A' ' 74' ' ' LYS . 19.0 p -119.59 144.8 46.9 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.136 0.493 . . . . 0.0 111.22 177.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.571 ' HB2' ' CD2' ' A' ' 77' ' ' TYR . 32.4 t80 -118.69 114.49 22.81 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.044 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 95.6 t -100.23 121.43 50.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.972 -177.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.458 ' CG1' ' HB ' ' A' ' 73' ' ' ILE . 42.0 pt -105.59 132.16 53.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.732 174.24 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 . . . . . 0 C--N 1.32 -0.685 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.865 -178.65 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 58.4 mttp . . . . . 0 N--CA 1.45 -0.437 0 CA-C-O 120.928 0.394 . . . . 0.0 110.625 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.458 ' HB ' ' CG1' ' A' ' 48' ' ' ILE . 65.3 mt -91.15 113.67 27.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.659 178.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.651 ' HE3' HG22 ' A' ' 45' ' ' THR . 48.1 tttp -94.93 101.94 13.74 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.779 -173.119 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -96.62 167.54 11.07 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.427 176.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 12.5 p -116.64 148.66 19.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 110.4 -0.222 . . . . 0.0 110.4 -177.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.571 ' CD2' ' HB2' ' A' ' 46' ' ' TYR . 39.7 p90 -155.09 154.01 31.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.873 0.368 . . . . 0.0 111.242 177.309 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.446 ' HB3' ' CD2' ' A' ' 43' ' ' LEU . 48.8 p90 -119.09 160.68 21.61 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 171.304 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.429 ' CD ' ' HZ2' ' A' ' 44' ' ' LYS . 38.3 mt-10 -111.8 138.86 47.83 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.961 0.41 . . . . 0.0 111.23 -173.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.536 ' HB ' ' HA ' ' A' ' 2' ' ' ASN . 40.2 p -93.82 169.63 10.16 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.587 173.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.44 ' HB2' ' OD1' ' A' ' 2' ' ' ASN . 6.9 mp -74.5 -10.15 59.27 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.247 0.546 . . . . 0.0 110.026 178.14 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -92.35 10.98 27.54 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.619 -179.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 68.93 20.83 7.76 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.483 176.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.439 HG21 ' HB3' ' A' ' 3' ' ' SER . 48.3 t -101.82 126.08 55.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.241 177.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . 0.46 ' O ' ' HA ' ' A' ' 23' ' ' GLU . 40.5 mtm180 -95.08 124.52 39.17 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.46 -179.238 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 59.4 t -95.16 107.61 19.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 176.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 28.6 t -105.09 138.67 28.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.605 -170.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.51 HG23 ' HA ' ' A' ' 28' ' ' PRO . 86.5 m -152.61 157.06 40.46 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.288 176.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -68.8 124.66 24.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.324 0.583 . . . . 0.0 112.248 -178.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -68.46 -32.63 72.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.302 -178.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 6.5 m -56.73 -41.46 77.55 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.964 0.411 . . . . 0.0 110.966 177.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.43 ' O ' HG13 ' A' ' 96' ' ' ILE . 43.6 mt-10 -83.6 -30.63 26.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.796 -179.141 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -62.68 -47.82 81.98 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.116 0.484 . . . . 0.0 109.875 175.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -58.15 -40.93 82.62 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.245 174.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.41 ' HB3' ' O ' ' A' ' 92' ' ' GLU . 64.4 tttp -56.95 -44.84 82.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.11 178.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.546 ' O ' ' HG2' ' A' ' 99' ' ' LYS . 75.7 mt -64.84 -47.06 89.97 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-O 121.024 0.44 . . . . 0.0 111.182 -179.444 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 87.4 mt -60.13 -51.17 70.73 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.859 -179.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -72.72 -28.31 62.57 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -174.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.546 ' HG2' ' O ' ' A' ' 96' ' ' ILE . 19.8 pttp -70.76 -29.93 66.29 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.33 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 22.6 mtm105 -78.53 -43.22 27.31 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 173.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.502 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.193 -178.766 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . 0.417 ' OD1' ' HB2' ' A' ' 81' ' ' LEU . 47.5 m-80 . . . . . 0 CA--C 1.52 -0.194 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.492 ' HG ' ' CG ' ' A' ' 82' ' ' ASP . 52.2 p -65.85 -20.71 66.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.428 0.632 . . . . 0.0 109.611 177.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . 0.525 ' O ' ' HG3' ' A' ' 8' ' ' GLU . 20.9 tp10 -61.2 -36.6 80.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.424 177.049 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.3 t -63.95 -35.92 75.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-O 121.236 0.541 . . . . 0.0 110.182 179.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 61.6 mt -66.86 -40.35 85.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.025 177.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -58.24 -45.31 88.01 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.286 177.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . 0.525 ' HG3' ' O ' ' A' ' 4' ' ' GLU . 41.5 mt-10 -60.0 -44.54 94.48 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.754 179.302 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.446 ' O ' HG12 ' A' ' 13' ' ' ILE . 79.5 t80 -61.51 -47.72 84.34 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.312 -179.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 91.3 mt -63.5 -37.7 88.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.881 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -59.44 -50.94 72.0 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.558 177.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -68.09 -37.87 81.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.878 -175.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.446 HG12 ' O ' ' A' ' 9' ' ' PHE . 35.4 pt -81.68 -14.67 12.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.235 -179.421 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 81.16 45.75 7.37 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.785 177.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -119.45 166.07 13.55 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.8 0.334 . . . . 0.0 110.71 178.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -117.35 161.1 20.08 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.949 179.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 28.5 p90 -130.7 146.54 52.21 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.683 179.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.434 ' HB ' ' HB2' ' A' ' 25' ' ' HIS . 54.6 mt -91.43 97.03 6.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 178.058 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.428 ' HA ' ' O ' ' A' ' 23' ' ' GLU . 1.9 tm-20 -99.35 107.27 19.49 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -176.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 89.9 mt -116.01 86.66 2.52 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.862 -177.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.435 ' O ' ' HB2' ' A' ' 22' ' ' ASN . 34.4 tt0 59.29 60.25 2.41 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.058 176.228 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.435 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 0.9 OUTLIER 75.07 14.01 3.18 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.293 177.454 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.428 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 35.1 mt-10 -111.16 113.74 26.48 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.8 170.62 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 62.0 mt -96.33 97.5 6.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 177.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.575 ' HA ' ' O ' ' A' ' 87' ' ' VAL . 14.1 m-70 -86.14 107.9 18.07 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.475 178.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 62.3 mt -95.13 164.45 12.86 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.254 -175.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -82.16 132.24 53.98 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.238 177.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -49.49 -40.3 45.18 Favored 'Trans proline' 0 N--CA 1.471 0.197 0 C-N-CA 123.1 2.533 . . . . 0.0 112.977 -177.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -60.54 -47.07 87.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.08 179.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 41.3 t -77.08 -40.2 29.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.768 -177.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.786 ' HE1' ' HE1' ' A' ' 78' ' ' PHE . 85.6 t80 -58.53 -37.17 75.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.883 -179.143 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.645 ' HA ' ' HE1' ' A' ' 93' ' ' PHE . 24.8 t80 -53.25 -39.4 63.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.291 177.34 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -84.0 -39.25 19.91 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.985 -178.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 62.6 t -62.53 -36.88 77.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-O 120.744 0.307 . . . . 0.0 110.841 179.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.411 ' CE2' ' HB2' ' A' ' 40' ' ' GLU . 22.1 t90 -53.13 -59.23 4.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.732 -179.336 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -74.0 -20.72 60.24 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.664 0.269 . . . . 0.0 111.403 -179.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -64.74 -28.8 69.83 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.806 178.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 29.0 m -103.34 11.22 8.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.36 -179.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.48 9.25 56.82 Favored Glycine 0 CA--C 1.517 0.186 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.877 177.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.415 ' O ' ' HG3' ' A' ' 40' ' ' GLU . 15.5 pt-20 44.67 87.09 0.12 Allowed Pre-proline 0 N--CA 1.471 0.61 0 C-N-CA 124.527 1.131 . . . . 0.0 113.246 -179.394 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -76.08 165.76 29.1 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.456 2.104 . . . . 0.0 111.486 175.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -63.15 137.11 58.12 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.033 0.444 . . . . 0.0 110.325 177.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.436 ' HB3' ' CG2' ' A' ' 76' ' ' VAL . 95.6 mt -87.29 144.29 26.87 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.491 -174.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -118.83 118.18 30.88 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 177.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 24.9 p -107.54 137.55 45.36 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 120.92 0.39 . . . . 0.0 111.843 -173.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 19.0 p90 -120.87 140.66 51.48 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 176.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.505 HG11 ' HE3' ' A' ' 72' ' ' LYS . 55.4 t -103.73 117.45 49.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.273 178.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.992 HG22 HG13 ' A' ' 73' ' ' ILE . 2.9 tt -98.88 122.37 50.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-O 121.522 0.677 . . . . 0.0 110.167 177.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.451 ' OE1' ' HG3' ' A' ' 72' ' ' LYS . 4.4 mm-40 . . . . . 0 C--N 1.325 -0.472 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.952 -176.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.505 ' HE3' HG11 ' A' ' 47' ' ' VAL . 39.0 tttp . . . . . 0 N--CA 1.452 -0.36 0 CA-C-O 120.749 0.309 . . . . 0.0 110.178 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.992 HG13 HG22 ' A' ' 48' ' ' ILE . 4.6 pt -109.04 125.26 66.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.616 0.722 . . . . 0.0 111.143 -177.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -106.78 131.58 53.73 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.966 -177.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -130.16 166.2 20.73 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.163 178.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.436 ' CG2' ' HB3' ' A' ' 43' ' ' LEU . 9.0 p -122.92 145.15 30.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.72 0.295 . . . . 0.0 111.112 -174.421 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 44.9 p90 -146.27 164.72 31.42 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.536 178.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.786 ' HE1' ' HE1' ' A' ' 31' ' ' PHE . 52.3 p90 -141.64 148.29 38.94 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 169.436 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -102.14 128.56 48.58 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.429 -176.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 72.7 p -88.08 -179.3 6.16 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.88 176.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.417 ' HB2' ' OD1' ' A' ' 2' ' ' ASN . 7.1 mp -70.12 -18.31 63.23 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.08 0.466 . . . . 0.0 110.207 178.395 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.492 ' CG ' ' HG ' ' A' ' 3' ' ' SER . 2.6 m-20 -71.18 -13.29 61.88 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.717 179.261 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 66.4 t30 77.68 10.12 2.3 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 124.079 0.862 . . . . 0.0 109.33 -171.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 77.8 t -81.74 129.12 38.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.278 178.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 56.1 mtm180 -92.94 105.46 17.57 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.343 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.3 t -84.28 106.74 14.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 177.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.575 ' O ' ' HA ' ' A' ' 25' ' ' HIS . 30.5 t -108.51 141.08 24.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.954 -173.432 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 34.3 m -144.44 150.57 37.88 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 176.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -62.92 126.11 26.24 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.182 0.515 . . . . 0.0 111.358 179.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -70.22 -38.06 75.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.14 -176.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 24.9 m -60.25 -57.75 11.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.354 -177.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.479 ' O ' ' HB3' ' A' ' 95' ' ' LYS . 36.3 mm-40 -68.22 -29.86 68.79 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.731 -177.502 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.645 ' HE1' ' HA ' ' A' ' 32' ' ' TYR . 53.0 t80 -67.87 -49.27 62.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.955 0.407 . . . . 0.0 110.404 177.41 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.519 ' O ' ' HG3' ' A' ' 98' ' ' LYS . 79.2 mm-40 -66.85 -24.46 66.14 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.568 178.193 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.479 ' HB3' ' O ' ' A' ' 92' ' ' GLU . 44.6 tttp -59.69 -49.57 77.24 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.366 174.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.441 ' O ' ' HB3' ' A' ' 99' ' ' LYS . 58.4 mt -67.93 -33.17 59.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.815 -179.29 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 69.8 mt -64.75 -39.82 94.26 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.563 177.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.519 ' HG3' ' O ' ' A' ' 94' ' ' GLN . 57.1 mttp -70.42 -33.81 71.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.033 0.444 . . . . 0.0 109.924 175.306 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.441 ' HB3' ' O ' ' A' ' 96' ' ' ILE . 61.9 tttp -56.65 -57.9 10.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.283 -0.872 . . . . 0.0 110.925 179.377 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -74.9 -23.78 58.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.587 0.232 . . . . 0.0 111.274 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.506 0 N-CA-C 111.339 -0.704 . . . . 0.0 111.339 -175.859 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 . . . . . 0 N--CA 1.452 -0.365 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.8 m -62.55 -23.26 66.89 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.009 0.433 . . . . 0.0 111.242 -177.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -61.59 -37.56 84.36 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.972 179.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 62.1 t -68.62 -34.32 64.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.023 0.439 . . . . 0.0 110.348 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 50.8 mt -62.39 -43.12 97.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.71 176.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 57.1 mttm -60.33 -38.33 83.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.049 177.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -57.6 -48.71 78.65 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.862 0.363 . . . . 0.0 110.777 178.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -66.17 -44.22 84.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.895 -179.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 97.0 mt -66.66 -43.95 83.16 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.408 -177.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -69.3 -32.44 71.59 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.737 0.303 . . . . 0.0 110.37 -179.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -61.82 -48.68 79.51 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.12 178.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 38.3 pt -80.93 -12.55 12.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.165 -178.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 81.47 38.31 14.94 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.348 179.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -91.76 118.56 30.79 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.95 0.405 . . . . 0.0 110.197 178.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -97.8 102.78 14.63 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.964 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.456 ' CD2' HG22 ' A' ' 24' ' ' ILE . 29.0 p90 -97.97 170.59 8.84 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.469 -174.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.5 ' HB ' ' HB2' ' A' ' 25' ' ' HIS . 64.1 mt -94.25 100.33 10.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.99 177.333 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -90.54 135.53 33.64 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.245 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.68 ' HG ' ' H ' ' A' ' 21' ' ' GLU . 21.8 tp -133.28 177.22 7.85 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 175.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.68 ' H ' ' HG ' ' A' ' 20' ' ' LEU . 43.2 mt-10 -61.76 102.46 0.26 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.633 0.254 . . . . 0.0 110.902 -178.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.407 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 11.8 m120 71.68 16.25 5.78 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.999 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.536 ' HB2' ' HB3' ' A' ' 20' ' ' LEU . 41.4 mt-10 -131.63 134.96 46.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.056 0.455 . . . . 0.0 111.421 178.173 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.456 HG22 ' CD2' ' A' ' 17' ' ' TYR . 74.1 mt -118.69 107.53 21.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 171.54 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.5 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 73.0 m-70 -94.29 109.85 21.65 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.049 0.452 . . . . 0.0 110.491 -178.157 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.41 HD21 ' HB3' ' A' ' 17' ' ' TYR . 40.5 mt -109.25 150.54 27.8 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.936 -178.426 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 49.5 mtmt -64.38 135.61 96.42 Favored Pre-proline 0 C--N 1.326 -0.427 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 171.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.451 ' HB2' HD13 ' A' ' 96' ' ' ILE . 51.8 Cg_exo -54.27 -28.93 54.9 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.684 2.256 . . . . 0.0 112.075 -177.602 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -61.62 -56.38 20.51 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.49 177.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 49.2 t -68.14 -38.69 80.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.242 179.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -51.54 -46.86 63.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.238 -179.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 93.0 t80 -60.19 -43.38 95.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.137 -179.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.536 ' O ' ' HB2' ' A' ' 37' ' ' TYR . 43.6 mt-10 -76.96 -8.74 57.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.774 -175.448 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 62.5 t -93.07 -42.62 13.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.251 0.548 . . . . 0.0 109.522 171.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.56 ' CD1' ' HD2' ' A' ' 41' ' ' PRO . 44.2 t90 -55.82 -52.0 65.52 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.046 177.666 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 53.7 tttm -78.82 -14.35 59.3 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.015 0.436 . . . . 0.0 110.738 -177.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.536 ' HB2' ' O ' ' A' ' 33' ' ' GLU . 87.0 t80 -71.28 -44.77 64.59 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.814 -179.693 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 33.3 m -94.31 -3.66 10.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.338 -177.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 136.68 -85.28 0.24 Allowed Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.077 177.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 170.98 61.06 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.371 0 C-N-CA 122.969 0.508 . . . . 0.0 110.73 -175.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.56 ' HD2' ' CD1' ' A' ' 35' ' ' TRP . 71.1 Cg_exo -50.69 128.69 24.74 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.127 1.884 . . . . 0.0 111.584 177.126 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -61.16 116.07 4.28 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.318 0.58 . . . . 0.0 110.298 -177.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.563 ' HB3' ' CG2' ' A' ' 76' ' ' VAL . 93.3 mt -82.6 126.12 31.94 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.184 -0.917 . . . . 0.0 111.983 -170.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -92.06 139.21 30.86 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 175.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 69.5 p -118.68 145.85 45.17 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 121.148 -0.221 . . . . 0.0 110.599 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 25.7 p90 -133.46 143.49 48.87 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 176.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 48.4 t -94.98 110.72 24.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.24 -178.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 8.9 tt -118.9 111.17 32.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 121.425 0.631 . . . . 0.0 110.18 178.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.421 ' HG2' ' HG2' ' A' ' 72' ' ' LYS . 47.7 mt-10 . . . . . 0 C--N 1.321 -0.64 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 176.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.421 ' HG2' ' HG2' ' A' ' 49' ' ' GLU . 49.7 mttp . . . . . 0 C--O 1.234 0.253 0 CA-C-O 120.829 0.347 . . . . 0.0 110.537 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 49.3 mm -100.27 118.84 47.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.227 0.537 . . . . 0.0 110.572 -179.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.612 ' O ' ' HB3' ' A' ' 90' ' ' TYR . 49.5 tttp -92.8 118.55 31.22 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 176.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -118.44 159.61 23.18 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 179.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.563 ' CG2' ' HB3' ' A' ' 43' ' ' LEU . 14.2 p -131.03 147.94 33.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.978 -171.266 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 46.2 p90 -154.94 156.49 36.15 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.641 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -115.97 140.15 49.54 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 169.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -109.01 127.22 53.9 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.498 -170.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 44.5 p -88.89 -179.67 6.01 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.849 -175.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.9 mp -70.73 -22.84 62.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.229 178.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.436 ' O ' ' HB2' ' A' ' 83' ' ' ASN . 2.9 m-20 -75.07 -10.02 59.08 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.344 179.43 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.436 ' HB2' ' O ' ' A' ' 82' ' ' ASP . 9.0 m120 68.72 28.76 5.49 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.156 -171.602 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.42 HG23 ' HB2' ' A' ' 82' ' ' ASP . 68.9 t -98.66 126.18 51.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.265 -0.88 . . . . 0.0 108.847 173.158 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 65.8 mtt180 -100.95 114.79 29.01 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.05 0.452 . . . . 0.0 111.176 -173.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 46.9 t -83.88 99.85 6.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 175.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 22.1 t -102.72 140.02 22.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.274 -171.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.9 t -143.65 -178.57 5.96 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 174.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -93.25 123.3 36.43 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.601 -177.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.612 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 61.8 t80 -69.26 -34.55 74.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.176 -176.75 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 12.7 t -65.83 -49.5 67.99 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 -178.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.468 ' HA ' ' HD3' ' A' ' 95' ' ' LYS . 28.9 mm-40 -66.12 -39.2 89.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.944 177.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.437 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 58.1 t80 -60.93 -45.98 92.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.756 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.512 ' O ' ' HG2' ' A' ' 98' ' ' LYS . 48.5 mm-40 -58.92 -39.45 81.58 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.145 177.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.468 ' HD3' ' HA ' ' A' ' 92' ' ' GLU . 50.1 mtpt -62.78 -43.68 98.15 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.87 177.474 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.461 ' HA ' ' HD2' ' A' ' 99' ' ' LYS . 67.4 mt -68.6 -33.29 59.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.879 179.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 93' ' ' PHE . 86.5 mt -58.17 -37.18 74.21 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.979 0.418 . . . . 0.0 110.323 174.705 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.512 ' HG2' ' O ' ' A' ' 94' ' ' GLN . 38.6 mmtm -74.35 -34.78 63.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.253 178.065 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.461 ' HD2' ' HA ' ' A' ' 96' ' ' ILE . 68.7 mttm -63.45 -46.76 84.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.785 176.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.555 ' HE ' ' HA ' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -73.87 -20.84 60.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.294 179.517 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.351 0 CA-C-N 115.945 -0.571 . . . . 0.0 112.266 178.727 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 11.7 m120 . . . . . 0 N--CA 1.454 -0.253 0 CA-C-O 120.794 0.33 . . . . 0.0 110.553 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.481 ' O ' ' HG3' ' A' ' 7' ' ' LYS . 34.2 t -61.48 -29.79 70.2 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.569 174.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -52.76 -43.13 65.57 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.759 176.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.7 t -62.9 -38.91 83.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.67 -178.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.51 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 60.5 mt -66.42 -44.86 90.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.315 179.335 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.481 ' HG3' ' O ' ' A' ' 3' ' ' SER . 85.6 mttt -63.63 -36.45 83.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.467 -179.187 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -55.86 -49.58 72.97 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.738 175.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -60.13 -43.14 95.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.066 179.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.511 HD12 ' HB3' ' A' ' 17' ' ' TYR . 74.4 mt -63.25 -48.27 78.92 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.325 -177.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -74.59 -19.62 60.25 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.96 -179.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -72.32 -45.34 60.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.837 177.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 38.1 pt -73.56 -17.78 17.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.979 0.419 . . . . 0.0 110.31 177.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.11 30.44 14.35 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.677 173.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -115.25 168.08 10.28 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 177.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -113.18 155.06 25.68 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.956 0.408 . . . . 0.0 110.96 -175.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.511 ' HB3' HD12 ' A' ' 10' ' ' LEU . 14.8 p90 -125.7 147.56 49.32 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.117 -173.219 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 52.5 mt -89.09 93.96 4.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 177.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -98.63 116.25 30.44 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.24 -176.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 77.4 mt -111.43 -176.53 2.97 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 171.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.467 ' HA ' ' OE1' ' A' ' 21' ' ' GLU . 6.3 tp10 -72.23 109.57 6.08 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 120.427 -0.509 . . . . 0.0 109.936 179.347 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 66.49 15.12 10.01 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.733 179.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -138.41 113.92 9.65 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.843 0.354 . . . . 0.0 111.277 179.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.454 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 63.9 mt -110.09 112.1 39.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 172.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 53.5 m-70 -98.44 117.21 32.35 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 80.4 mt -114.92 173.37 6.52 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.192 -175.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 75.6 mttt -84.5 149.65 55.16 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.492 178.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_exo -51.52 -41.68 59.28 Favored 'Trans proline' 0 C--O 1.233 0.241 0 C-N-CA 122.907 2.405 . . . . 0.0 112.855 -179.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -65.6 -44.71 85.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.76 0.314 . . . . 0.0 110.541 -179.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 61.4 t -64.91 -45.09 95.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.131 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -58.1 -40.12 80.35 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.033 -179.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -57.49 -42.54 82.9 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.338 179.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -76.43 -40.81 49.61 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.921 -177.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 79.0 t -65.56 -32.37 57.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.536 178.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.522 ' CD1' ' HD2' ' A' ' 41' ' ' PRO . 25.8 t90 -52.97 -52.27 58.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.027 178.574 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -76.07 -26.82 56.87 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.756 0.312 . . . . 0.0 110.762 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -65.82 -34.7 78.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.053 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.411 HG21 ' HD3' ' A' ' 41' ' ' PRO . 35.9 m -89.73 9.94 2.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.788 0.327 . . . . 0.0 111.579 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 100.7 14.7 31.26 Favored Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 120.604 -0.807 . . . . 0.0 113.604 174.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 48.75 73.09 1.06 Allowed Pre-proline 0 N--CA 1.466 0.357 0 CA-C-O 121.279 0.562 . . . . 0.0 111.409 177.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.522 ' HD2' ' CD1' ' A' ' 35' ' ' TRP . 95.4 Cg_endo -90.4 163.8 4.47 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 122.679 2.253 . . . . 0.0 112.48 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -71.32 107.12 4.13 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 172.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 70.5 mt -73.43 146.42 45.04 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.812 -172.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -87.95 138.45 31.44 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.776 176.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 19.3 p -127.94 132.3 49.25 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 120.825 0.345 . . . . 0.0 110.218 176.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 14.7 p90 -119.21 144.64 46.61 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.758 -178.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 43.7 t -93.72 105.14 16.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.279 -0.419 . . . . 0.0 109.951 179.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 12.1 tt -105.77 130.6 56.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.061 179.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 . . . . . 0 C--N 1.32 -0.711 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 177.674 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 68.3 mttm . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.801 0.334 . . . . 0.0 110.556 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 56.8 mt -110.08 117.06 53.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.426 179.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.409 ' O ' ' HB3' ' A' ' 90' ' ' TYR . 52.9 tttm -87.44 91.77 8.85 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.554 179.06 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -92.04 160.96 14.98 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.08 -176.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 13.5 p -114.9 144.19 23.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.209 -173.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.405 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 37.6 p90 -154.99 162.7 41.01 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.729 176.499 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -137.1 150.18 47.84 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 170.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 54.9 tt0 -120.49 135.67 55.0 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.479 -173.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 73.0 p -94.8 -176.97 4.03 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.338 177.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.8 mp -65.05 -13.73 58.69 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.279 0.561 . . . . 0.0 110.727 179.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.429 ' O ' ' HB2' ' A' ' 83' ' ' ASN . 4.8 m-20 -79.22 -8.82 59.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.59 -179.548 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . 0.429 ' HB2' ' O ' ' A' ' 82' ' ' ASP . 14.3 m120 69.58 16.73 8.04 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.4 0.619 . . . . 0.0 110.252 -174.357 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 66.1 t -89.57 122.03 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.383 176.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -100.33 116.51 32.47 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.719 -176.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' A' ' 24' ' ' ILE . 59.1 t -86.31 104.72 14.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.552 176.482 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 22.0 t -101.65 142.65 15.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.607 -174.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 58.2 m -151.15 157.09 42.26 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 177.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -71.09 121.02 17.51 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.093 0.473 . . . . 0.0 110.409 -178.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.409 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 12.2 t80 -75.72 -27.5 58.19 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.981 -174.572 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 33.0 t -70.02 -43.66 70.87 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -64.25 -42.32 96.57 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.357 175.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -62.79 -46.6 87.23 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.856 -179.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -65.7 -29.61 70.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.011 178.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -63.83 -33.47 75.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.076 0.465 . . . . 0.0 110.302 176.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.488 ' HA ' ' HD2' ' A' ' 99' ' ' LYS . 68.0 mt -75.02 -39.89 44.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.381 176.405 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 84.2 mt -65.07 -30.52 71.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.172 0.51 . . . . 0.0 110.138 176.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 44.9 tttm -67.41 -37.29 82.85 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.421 175.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.488 ' HD2' ' HA ' ' A' ' 96' ' ' ILE . 60.3 mttm -64.44 -47.54 78.68 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.356 175.449 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 52.8 ttt-85 -68.64 -38.39 80.46 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.963 -177.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.686 0 N-CA-C 111.251 -0.74 . . . . 0.0 111.251 -176.456 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 . . . . . 0 C--O 1.233 0.191 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 36.9 t -68.68 -27.7 66.2 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 175.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -58.05 -36.94 73.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.165 173.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 98.3 t -68.54 -42.85 83.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.458 178.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 62.9 mt -60.81 -45.31 98.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.981 177.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 45.9 mttp -56.51 -52.61 64.09 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.575 175.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -58.12 -45.16 87.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.105 -178.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -63.67 -45.66 89.1 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.34 -178.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 83.9 mt -71.04 -34.6 71.43 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.636 -0.256 . . . . 0.0 111.282 -177.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 43.1 mm-40 -69.74 -33.55 72.61 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.046 0.451 . . . . 0.0 110.418 175.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -63.37 -52.33 62.16 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.556 178.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 39.5 pt -77.97 -17.46 13.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.55 -177.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 76.99 60.43 2.91 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.074 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -112.5 158.87 19.38 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 -178.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -71.15 117.61 12.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.08 0.467 . . . . 0.0 110.82 179.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -116.09 121.07 41.08 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.269 -176.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 61.1 mt -120.82 107.24 20.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.758 0.313 . . . . 0.0 110.776 -179.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -125.8 125.04 42.28 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.04 0.448 . . . . 0.0 110.064 175.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 97.3 mt -95.16 46.49 1.12 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.875 178.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 66.62 94.79 0.06 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.569 -177.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 13.6 m120 73.18 -8.25 1.35 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.844 179.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 32.2 tp10 -112.76 113.78 26.04 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 175.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.563 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 55.0 mt -107.19 133.48 51.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 110.335 -0.246 . . . . 0.0 110.335 -177.144 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -125.27 105.45 9.13 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 173.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 37.1 mt -95.26 -179.81 4.92 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.774 0.797 . . . . 0.0 113.026 -168.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -87.53 132.83 39.63 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 114.389 -1.278 . . . . 0.0 109.942 -179.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 99.8 Cg_exo -42.56 -70.42 0.07 OUTLIER 'Trans proline' 0 CA--C 1.532 0.421 0 C-N-CA 123.948 3.099 . . . . 0.0 114.811 -172.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -75.64 -3.15 32.86 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -172.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 98.5 t -90.02 -44.64 15.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 175.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -58.98 -34.66 72.07 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.609 177.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 67.5 t80 -54.14 -40.97 67.9 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.397 178.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -83.36 -29.02 28.55 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.116 -178.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 66.9 t -66.42 -36.79 78.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.375 0.607 . . . . 0.0 109.486 174.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 33.5 t90 -56.46 -52.97 62.69 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.557 175.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.778 ' HA ' ' HB3' ' A' ' 40' ' ' GLU . 53.5 mttm -66.84 -30.39 70.56 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.631 -0.258 . . . . 0.0 111.201 178.113 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -59.58 -40.71 88.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.367 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 19.4 m -88.32 7.67 3.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.924 -175.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 109.33 0.31 31.18 Favored Glycine 0 N--CA 1.453 -0.197 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.977 176.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.778 ' HB3' ' HA ' ' A' ' 36' ' ' LYS . 10.8 pt-20 44.8 69.46 2.5 Favored Pre-proline 0 N--CA 1.473 0.69 0 C-N-CA 124.267 1.027 . . . . 0.0 113.009 -179.342 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -94.04 -179.19 0.74 Allowed 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 123.096 2.53 . . . . 0.0 112.095 176.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -71.29 114.76 9.69 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.046 0.451 . . . . 0.0 110.691 176.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 68.5 mt -77.82 164.29 25.33 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.62 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 52.4 tttp -106.67 122.83 47.13 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.07 -176.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 39.9 p -102.66 148.67 25.28 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.673 -0.24 . . . . 0.0 111.489 -177.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -130.63 145.29 51.87 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 176.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 60.1 t -104.85 113.64 42.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 120.832 0.348 . . . . 0.0 110.572 -179.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 10.8 tt -111.05 112.75 41.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.371 0.605 . . . . 0.0 110.398 177.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.872 ' HG2' ' HG2' ' A' ' 72' ' ' LYS . 50.4 mt-10 . . . . . 0 C--N 1.322 -0.599 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.258 179.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.872 ' HG2' ' HG2' ' A' ' 49' ' ' GLU . 79.4 mttt . . . . . 0 N--CA 1.453 -0.289 0 CA-C-O 120.987 0.423 . . . . 0.0 110.352 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 57.0 mt -92.71 115.09 30.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.054 -179.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.58 ' O ' ' HB3' ' A' ' 90' ' ' TYR . 82.2 tttt -98.9 114.71 27.44 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.247 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -111.83 166.99 10.72 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 13.9 p -125.83 143.48 39.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 120.733 0.301 . . . . 0.0 111.074 -172.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 28.9 p90 -155.0 173.8 16.06 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.934 0.397 . . . . 0.0 110.941 178.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -145.1 151.44 38.51 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 170.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -102.07 128.97 48.3 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.843 0.354 . . . . 0.0 110.23 -176.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.4 p -84.09 173.59 10.98 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.201 179.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.407 HD13 ' N ' ' A' ' 81' ' ' LEU . 7.0 mp -68.33 -17.74 64.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.068 0.461 . . . . 0.0 111.36 -176.213 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -95.62 14.95 21.29 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.213 -179.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 70.44 23.68 4.82 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.143 173.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 59.3 t -100.14 141.93 16.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 120.962 0.41 . . . . 0.0 110.562 178.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 8.2 mtp180 -98.0 117.08 31.54 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.229 -178.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.563 ' HA ' ' HB ' ' A' ' 24' ' ' ILE . 20.5 t -96.89 97.1 5.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 176.627 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.423 ' C ' ' HG1' ' A' ' 88' ' ' THR . 31.8 t -103.7 144.4 14.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.079 0.466 . . . . 0.0 111.656 -172.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.423 ' HG1' ' C ' ' A' ' 87' ' ' VAL . 51.1 m -151.98 159.6 43.71 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 175.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -73.04 131.86 42.65 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 121.734 -0.604 . . . . 0.0 110.986 -176.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.58 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 88.9 t80 -73.93 -30.34 62.5 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.389 -176.725 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.25 -44.77 71.26 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.514 ' O ' ' HB3' ' A' ' 95' ' ' LYS . 5.3 tp10 -70.43 -34.66 72.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.233 179.301 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.413 ' O ' HD23 ' A' ' 97' ' ' LEU . 83.4 t80 -62.34 -51.5 67.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.325 176.588 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 72.5 mm-40 -64.31 -29.73 70.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.825 179.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.514 ' HB3' ' O ' ' A' ' 92' ' ' GLU . 23.4 tptm -55.72 -46.99 77.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.321 174.621 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 57.7 mt -68.84 -39.5 80.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.112 -179.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.413 HD23 ' O ' ' A' ' 93' ' ' PHE . 4.3 mm? -58.59 -45.25 89.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.788 178.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -74.27 -30.38 62.09 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.507 178.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -59.33 -45.35 91.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.908 -176.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 100' ' ' ARG . 21.3 ttp85 -104.35 -8.13 19.45 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.107 -179.127 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.261 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.111 179.046 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 . . . . . 0 C--O 1.235 0.327 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.577 ' O ' ' HG3' ' A' ' 7' ' ' LYS . 30.1 p -56.89 -31.69 65.12 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.764 0.316 . . . . 0.0 110.693 177.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -56.7 -52.62 64.24 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.975 175.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.1 t -60.42 -43.25 93.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.683 -179.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.437 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 67.1 mt -53.12 -45.33 53.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.88 174.68 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.577 ' HG3' ' O ' ' A' ' 3' ' ' SER . 91.6 mttt -62.48 -41.6 98.9 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.97 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -58.7 -42.69 89.21 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.993 0.425 . . . . 0.0 110.62 177.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -65.28 -43.83 89.97 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.412 179.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.496 HD13 ' HB3' ' A' ' 17' ' ' TYR . 85.4 mt -65.26 -39.3 92.46 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.996 179.673 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -67.26 -40.53 86.25 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.428 178.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -60.04 -43.38 95.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.795 177.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 62.5 mt -70.29 -41.35 78.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.544 177.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.74 35.76 5.02 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.99 -0.624 . . . . 0.0 111.784 -178.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -104.53 177.27 4.89 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.071 0.463 . . . . 0.0 111.245 -178.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -109.65 149.97 28.93 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.966 -178.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.496 ' HB3' HD13 ' A' ' 10' ' ' LEU . 34.1 p90 -144.84 144.52 31.17 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 176.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 67.3 mt -113.01 102.86 14.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 120.895 0.378 . . . . 0.0 110.103 178.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -92.2 133.22 36.0 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.275 0.559 . . . . 0.0 110.861 -178.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 88.9 mt -121.44 -162.24 0.96 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.788 177.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -71.62 102.06 2.66 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.892 -0.323 . . . . 0.0 110.399 177.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 67.3 20.48 10.04 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.33 177.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -136.77 138.86 41.35 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.287 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.4 HD13 ' HB2' ' A' ' 3' ' ' SER . 60.2 mt -122.86 113.01 36.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 170.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.494 ' HA ' ' O ' ' A' ' 87' ' ' VAL . 16.3 m-70 -95.87 123.72 39.57 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.251 -179.355 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 92.5 mt -114.98 177.55 4.61 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.345 -175.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.418 ' HB2' HG21 ' A' ' 30' ' ' VAL . 86.8 mttt -86.95 137.9 33.13 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 115.364 -0.835 . . . . 0.0 108.934 174.242 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.45 ' HA ' HG21 ' A' ' 88' ' ' THR . 57.6 Cg_exo -52.4 -38.05 73.12 Favored 'Trans proline' 0 CA--C 1.529 0.26 0 C-N-CA 122.92 2.414 . . . . 0.0 113.113 -177.218 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -73.6 -29.67 62.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.04 -177.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.418 HG21 ' HB2' ' A' ' 27' ' ' LYS . 27.0 t -84.54 -38.37 13.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.233 0.54 . . . . 0.0 110.134 179.557 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -57.63 -30.43 65.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.826 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -54.35 -45.95 72.85 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.271 178.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -82.05 -29.4 31.93 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.274 -177.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 79.5 t -67.8 -41.31 85.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.21 0.529 . . . . 0.0 109.977 176.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . 0.47 ' CD1' ' HD2' ' A' ' 41' ' ' PRO . 29.2 t90 -57.14 -45.29 83.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.342 176.121 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 56.8 mttm -76.23 -21.53 56.27 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.461 179.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -65.97 -35.64 81.15 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.998 0.428 . . . . 0.0 110.381 178.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.511 HG21 ' HD3' ' A' ' 41' ' ' PRO . 26.9 m -93.68 12.39 3.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.316 179.559 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 87.01 29.33 23.34 Favored Glycine 0 C--N 1.33 0.237 0 C-N-CA 121.055 -0.593 . . . . 0.0 113.481 174.183 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 36.42 75.21 0.53 Allowed Pre-proline 0 N--CA 1.473 0.701 0 C-N-CA 124.07 0.948 . . . . 0.0 113.218 179.082 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.511 ' HD3' HG21 ' A' ' 38' ' ' VAL . 82.1 Cg_endo -89.01 -159.32 0.09 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 123.307 2.671 . . . . 0.0 112.617 -178.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -70.18 123.74 22.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.684 -178.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 74.7 mt -89.07 117.54 28.15 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.239 175.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -95.66 119.47 34.23 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.227 -178.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.6 p -107.2 134.73 49.87 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.614 179.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' TYR . . . . . 0.5 ' CE1' ' HB2' ' A' ' 75' ' ' LYS . 15.1 p90 -128.29 140.45 51.87 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.329 -0.396 . . . . 0.0 109.975 178.492 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 61.7 t -99.18 110.55 26.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.584 -179.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.421 HG23 ' HB ' ' A' ' 73' ' ' ILE . 7.4 tt -106.86 106.68 21.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.645 175.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.422 ' HA ' ' HA ' ' A' ' 72' ' ' LYS . 39.6 tt0 . . . . . 0 C--N 1.322 -0.593 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.121 -179.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 61.6 mttp . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.768 0.318 . . . . 0.0 110.31 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.421 ' HB ' HG23 ' A' ' 48' ' ' ILE . 40.3 mt -91.19 108.59 20.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.254 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 54.1 tttp -91.57 106.18 18.3 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.56 178.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . 0.5 ' HB2' ' CE1' ' A' ' 46' ' ' TYR . 89.9 mttt -105.49 162.23 13.65 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.158 -178.725 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 10.7 p -124.19 142.42 41.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.605 0.24 . . . . 0.0 110.574 -178.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.447 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 43.5 p90 -153.6 167.8 28.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.095 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 44.1 p90 -136.49 151.11 49.1 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 168.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -102.48 131.6 49.07 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.01 0.433 . . . . 0.0 111.466 -174.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 75.0 p -83.97 -172.66 4.28 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.003 179.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 8.5 mp -73.81 -33.61 64.25 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.949 0.404 . . . . 0.0 110.424 178.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -92.16 24.57 3.26 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.369 -177.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 20.8 m120 69.81 20.76 6.67 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 169.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 86.1 t -94.41 124.42 46.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.595 179.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 51.9 mtt-85 -89.52 110.93 21.72 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.707 179.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 45.9 t -81.35 99.5 4.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 175.516 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.494 ' O ' ' HA ' ' A' ' 25' ' ' HIS . 22.2 t -102.57 138.88 25.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.879 -172.297 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' THR . . . . . 0.45 HG21 ' HA ' ' A' ' 28' ' ' PRO . 42.8 m -144.76 157.59 44.12 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 177.022 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ASP . . . . . 0.466 ' OD2' ' HG2' ' A' ' 92' ' ' GLU . 9.5 t70 -66.88 122.46 17.76 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.155 0.503 . . . . 0.0 111.57 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -69.28 -30.23 68.28 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.845 -177.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 35.1 t -62.84 -66.38 0.55 Allowed 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.077 -176.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLU . . . . . 0.466 ' HG2' ' OD2' ' A' ' 89' ' ' ASP . 12.3 mm-40 -68.66 -28.96 67.34 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 121.042 -0.263 . . . . 0.0 111.323 -175.48 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' PHE . . . . . 0.42 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 53.0 t80 -62.09 -47.4 84.82 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 121.079 -0.248 . . . . 0.0 110.872 178.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -64.14 -35.52 81.06 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.779 0.323 . . . . 0.0 110.838 179.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -61.39 -43.72 98.38 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.515 177.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.407 HG13 ' O ' ' A' ' 92' ' ' GLU . 78.9 mt -66.79 -36.77 78.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.033 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' A' ' 93' ' ' PHE . 97.8 mt -59.42 -49.95 75.85 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.943 0.401 . . . . 0.0 110.117 175.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 7.6 mtpm? -63.89 -42.61 97.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.602 177.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 7.6 tmtm? -59.76 -54.17 49.41 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.953 -177.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 49.4 mtt180 -82.65 -6.41 59.35 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.349 -175.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 0.173 0 C-N-CA 120.967 -0.635 . . . . 0.0 113.409 172.322 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.415 ' HE2' HG13 ' A' ' 38' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.965 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -91.72 166.13 12.94 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.006 174.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.6 m -63.93 -28.01 69.53 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.239 0.542 . . . . 0.0 110.36 178.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -62.71 -33.1 74.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.192 178.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 88.7 t -66.9 -39.42 83.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.164 177.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.459 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 64.0 mt -63.43 -39.9 87.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.422 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.461 ' HZ3' ' CD ' ' A' ' 19' ' ' GLU . 96.8 mttt -64.2 -40.24 95.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.755 179.213 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -68.1 -36.85 80.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.7 177.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -62.14 -43.52 98.65 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.255 176.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' A' ' 6' ' ' ILE . 94.0 mt -65.26 -32.4 74.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.662 177.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -62.92 -47.35 83.64 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.36 177.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -64.02 -52.37 59.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.16 -178.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 40.1 pt -67.5 -27.46 38.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.243 -177.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.62 58.21 1.45 Allowed Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.503 178.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.437 ' HG2' HG21 ' A' ' 30' ' ' VAL . 8.4 tp10 -136.36 148.22 47.75 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -95.92 139.93 31.42 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.682 -179.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.444 ' HB3' HD12 ' A' ' 10' ' ' LEU . 52.6 p90 -112.34 142.39 44.91 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.863 0.363 . . . . 0.0 110.49 176.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 62.1 mt -101.65 96.59 4.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 176.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.461 ' CD ' ' HZ3' ' A' ' 7' ' ' LYS . 39.9 tt0 -97.28 121.88 39.67 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.374 0.607 . . . . 0.0 110.813 -178.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 96.3 mt -109.22 34.01 3.98 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.334 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 69.8 101.12 0.06 Allowed 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.268 -177.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 7.7 m120 68.74 3.64 4.01 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.019 -177.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -129.32 113.9 15.55 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 110.406 -0.22 . . . . 0.0 110.406 172.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.403 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 67.6 mt -105.95 102.65 14.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 175.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 42.7 m-70 -87.81 120.99 29.68 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 59.9 mt -117.89 172.14 7.59 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.483 0.659 . . . . 0.0 111.634 -175.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -80.19 136.17 53.73 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.402 176.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.822 ' HG2' ' HG2' ' A' ' 92' ' ' GLU . 88.2 Cg_exo -49.01 -43.81 34.66 Favored 'Trans proline' 0 N--CA 1.474 0.367 0 C-N-CA 123.536 2.824 . . . . 0.0 114.073 -175.146 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -67.71 -36.66 81.02 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.784 0.326 . . . . 0.0 110.988 -179.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.437 HG21 ' HG2' ' A' ' 15' ' ' GLU . 41.2 t -68.96 -43.86 81.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.087 0.47 . . . . 0.0 109.881 176.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -55.87 -45.62 78.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.082 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 78.4 t80 -57.7 -39.45 77.2 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.28 -178.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -76.78 -42.29 41.31 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.032 -178.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 89.4 t -65.6 -37.16 79.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.791 0.329 . . . . 0.0 110.516 178.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 26.1 t90 -54.19 -53.92 46.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.665 177.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.514 ' HA ' ' HB3' ' A' ' 40' ' ' GLU . 65.9 mttm -71.88 -26.46 62.35 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 121.158 -0.217 . . . . 0.0 111.246 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 77.1 t80 -63.36 -38.59 91.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.733 0.301 . . . . 0.0 110.975 179.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.415 HG13 ' HE2' ' A' ' 1' ' ' MET . 29.0 m -88.39 10.42 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.827 0.346 . . . . 0.0 111.755 -177.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 99.86 8.18 51.83 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.934 176.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.514 ' HB3' ' HA ' ' A' ' 36' ' ' LYS . 19.1 pt-20 40.69 81.36 0.25 Allowed Pre-proline 0 N--CA 1.473 0.708 0 C-N-CA 124.335 1.054 . . . . 0.0 113.315 178.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -88.08 -168.68 0.39 Allowed 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.008 2.472 . . . . 0.0 111.842 175.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -75.85 136.4 40.17 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.008 0.432 . . . . 0.0 110.717 179.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 97.2 mt -97.08 146.66 24.81 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.71 -179.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 61.1 tttm -111.5 118.39 35.62 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.62 -179.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 37.2 p -105.19 141.94 35.84 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.178 -176.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 21.2 p90 -130.05 151.37 50.67 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.77 0.319 . . . . 0.0 110.273 177.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.508 HG22 ' HG3' ' A' ' 74' ' ' LYS . 42.5 t -107.23 129.86 60.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.632 177.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 6.4 tt -125.92 111.88 28.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 121.239 0.542 . . . . 0.0 110.543 177.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.573 ' HA ' ' HA ' ' A' ' 72' ' ' LYS . 1.6 mp0 -81.37 97.67 7.83 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.021 177.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -106.68 115.8 30.82 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.796 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.693 ' HG2' ' HA ' ' A' ' 70' ' ' LYS . 36.7 mt-10 -88.99 131.99 34.93 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.014 0.435 . . . . 0.0 110.921 -176.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 9.6 tt -86.46 125.55 40.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.498 175.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.613 ' HA ' HG11 ' A' ' 68' ' ' VAL . 9.1 p -90.75 164.28 2.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.602 -175.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -87.35 133.49 38.38 Favored Pre-proline 0 N--CA 1.449 -0.482 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.24 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -69.24 -67.39 0.03 OUTLIER 'Trans proline' 0 CA--C 1.531 0.359 0 C-N-CA 122.426 2.084 . . . . 0.0 112.472 178.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 164.4 43.56 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.436 0 N-CA-C 111.086 -0.805 . . . . 0.0 111.086 -178.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -61.08 112.61 2.16 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -173.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -94.82 84.84 4.27 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.385 0.612 . . . . 0.0 110.051 174.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.597 ' H ' ' HD2' ' A' ' 60' ' ' PRO . 25.2 t70 -141.12 -52.89 0.02 OUTLIER Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.778 178.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.597 ' HD2' ' H ' ' A' ' 59' ' ' ASP . 73.5 Cg_endo -78.16 140.02 17.4 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 121.541 1.494 . . . . 0.0 111.292 171.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -58.79 147.94 85.91 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 122.492 2.128 . . . . 0.0 111.925 178.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -69.61 87.43 0.49 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.359 0.6 . . . . 0.0 110.89 -179.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 55.9 ttm -164.24 -45.6 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 178.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 36.7 mttp -79.22 154.02 29.54 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.321 168.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -120.72 115.3 23.06 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 121.051 -0.259 . . . . 0.0 110.46 -172.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.01 151.36 26.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.585 177.079 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -123.31 144.74 49.23 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.078 0.466 . . . . 0.0 111.362 -176.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.613 HG11 ' HA ' ' A' ' 53' ' ' VAL . 27.4 m -80.56 152.7 4.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 173.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -116.66 132.9 56.57 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.222 0.534 . . . . 0.0 111.099 -177.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.693 ' HA ' ' HG2' ' A' ' 51' ' ' GLU . 85.4 tttt -90.51 102.28 15.02 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.656 -174.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 39.2 t -92.5 100.07 10.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.544 -179.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.573 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 20.5 pttp -88.27 99.03 11.92 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 176.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 13.9 tt -105.79 137.12 37.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 121.276 0.56 . . . . 0.0 110.945 -175.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.576 ' O ' ' HB3' ' A' ' 90' ' ' TYR . 28.7 tttm -95.52 125.82 40.38 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.07 178.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -125.03 158.66 33.17 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.701 0.286 . . . . 0.0 110.281 178.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 11.1 p -121.94 146.75 26.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.617 -175.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.401 ' CE1' ' HD2' ' A' ' 85' ' ' ARG . 48.7 p90 -152.67 164.53 37.55 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.81 0.338 . . . . 0.0 110.393 175.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -132.54 147.9 52.37 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 170.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.529 ' HG2' ' HG2' ' A' ' 85' ' ' ARG . 45.3 mt-10 -104.27 132.14 50.84 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.947 0.403 . . . . 0.0 110.91 -176.289 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 49.5 p -85.14 -175.65 5.83 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.164 -179.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 7.9 mp -66.86 -20.79 65.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.388 177.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.412 ' HB2' HG23 ' A' ' 84' ' ' VAL . 9.3 m-20 -92.08 6.58 45.92 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.287 -178.331 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 64.94 23.15 12.56 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.957 -177.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.412 HG23 ' HB2' ' A' ' 82' ' ' ASP . 79.3 t -87.87 126.51 41.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 176.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.529 ' HG2' ' HG2' ' A' ' 79' ' ' GLU . 31.1 mtm180 -96.74 111.09 23.4 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.446 -175.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.403 ' HA ' ' O ' ' A' ' 24' ' ' ILE . 59.7 t -83.43 103.33 10.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 175.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.4 t -99.21 144.08 12.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.002 -172.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.487 HG21 ' HA ' ' A' ' 28' ' ' PRO . 51.5 m -151.39 148.94 28.72 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.735 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -57.56 112.44 1.43 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.055 178.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.576 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 70.9 t80 -71.96 -30.12 64.97 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.09 0.471 . . . . 0.0 110.25 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.3 p -60.95 -47.28 87.15 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.574 175.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.822 ' HG2' ' HG2' ' A' ' 28' ' ' PRO . 15.1 tp10 -72.17 -36.03 69.17 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.147 178.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.448 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 58.3 t80 -60.49 -52.59 64.54 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.068 -179.158 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.537 ' NE2' ' HH ' ' A' ' 90' ' ' TYR . 47.8 mt-30 -64.84 -31.71 73.07 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.777 0.322 . . . . 0.0 110.876 177.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.442 ' HB3' ' O ' ' A' ' 92' ' ' GLU . 76.8 tttt -59.42 -41.71 90.14 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.504 175.291 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.432 HG13 ' O ' ' A' ' 92' ' ' GLU . 73.1 mt -72.2 -37.11 58.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.499 176.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 93' ' ' PHE . 86.5 mt -59.14 -48.96 79.7 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.62 177.016 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -65.3 -29.4 70.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.788 178.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 65.7 tttm -68.58 -52.05 35.92 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.795 -178.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 56.8 mtt180 -82.64 -10.36 58.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.224 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 74.3 33.65 56.21 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.021 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 38.8 m -78.16 101.29 6.97 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 177.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 53.2 tttm -83.94 122.12 28.31 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.256 -178.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 88.2 mt -85.05 113.16 21.26 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.929 0.395 . . . . 0.0 110.579 -179.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -66.08 154.99 38.09 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.765 178.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 20.3 m170 -74.57 -28.86 61.12 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.674 179.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 4.0 t60 -124.44 112.32 16.77 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 171.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 25.8 m170 -77.75 146.61 35.8 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.546 -177.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 34.9 m170 -81.07 38.19 0.46 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.857 -178.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -138.11 16.64 2.81 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.042 0.449 . . . . 0.0 110.183 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 19.4 t60 . . . . . 0 C--O 1.251 1.162 0 CA-C-N 115.921 -0.582 . . . . 0.0 109.972 -177.428 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.961 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -125.83 -179.92 4.89 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 173.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.2 m -60.06 -37.13 78.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.0 0.429 . . . . 0.0 111.241 -176.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -64.51 -35.99 82.74 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.577 -178.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 77.5 t -64.36 -40.57 89.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.347 177.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.54 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 65.9 mt -62.49 -46.4 96.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.216 177.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.405 ' O ' ' HG3' ' A' ' 11' ' ' GLU . 98.9 mttt -56.4 -49.23 75.11 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.622 178.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -57.92 -45.79 85.99 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.274 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 93.0 t80 -58.76 -40.67 84.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.352 178.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.54 ' HG ' ' O ' ' A' ' 6' ' ' ILE . 77.0 mt -66.48 -43.41 85.48 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.891 179.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.405 ' HG3' ' O ' ' A' ' 7' ' ' LYS . 52.4 mt-10 -62.46 -34.62 77.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.923 0.392 . . . . 0.0 110.624 178.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -66.16 -50.52 63.64 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.353 178.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 38.4 pt -75.98 -6.65 9.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.66 -177.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.73 24.19 39.58 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.614 175.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -89.91 154.16 20.07 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.837 0.351 . . . . 0.0 110.503 -177.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -103.36 122.87 45.72 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.136 177.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.501 ' HB3' HD12 ' A' ' 10' ' ' LEU . 39.8 p90 -115.25 133.24 56.22 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.029 176.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.531 ' HB ' ' HB2' ' A' ' 25' ' ' HIS . 44.0 mt -106.95 91.91 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 176.706 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.678 ' HA ' ' O ' ' A' ' 23' ' ' GLU . 1.0 OUTLIER -98.12 106.84 19.2 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.626 -179.081 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 97.0 mt -125.54 122.4 36.44 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.858 -178.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.47 ' O ' ' HB2' ' A' ' 22' ' ' ASN . 36.6 mt-10 58.43 36.64 25.51 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 123.577 0.548 . . . . 0.0 111.173 175.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.47 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 0.9 OUTLIER 73.92 25.71 1.87 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.08 -179.833 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.678 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 55.8 mt-10 -115.07 113.73 24.43 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.17 171.317 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.478 HG23 ' HG ' ' A' ' 26' ' ' LEU . 60.2 mt -91.55 101.62 12.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 177.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.531 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 12.3 m170 -87.29 121.95 30.41 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.201 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.478 ' HG ' HG23 ' A' ' 24' ' ' ILE . 63.6 mt -130.03 -174.83 3.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.243 0.544 . . . . 0.0 111.955 -175.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -92.02 144.7 29.59 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.091 177.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.478 ' HA ' HG23 ' A' ' 88' ' ' THR . 78.0 Cg_exo -50.19 -46.8 26.8 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 123.479 2.786 . . . . 0.0 113.911 -176.112 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -67.39 -36.52 81.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.791 0.329 . . . . 0.0 110.837 -177.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 48.4 t -68.46 -41.56 83.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.09 179.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -56.01 -42.07 75.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.373 177.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 79.7 t80 -60.78 -44.99 96.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.351 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -68.64 -42.37 78.12 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.177 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 93.5 t -64.9 -36.99 79.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.814 0.34 . . . . 0.0 110.16 177.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.511 ' CD1' ' HD2' ' A' ' 41' ' ' PRO . 27.6 t90 -52.8 -50.88 62.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.563 176.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -70.71 -34.84 72.36 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.322 178.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -57.97 -43.59 86.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.731 0.3 . . . . 0.0 111.29 179.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.509 HG23 ' HD3' ' A' ' 41' ' ' PRO . 27.6 m -82.35 14.43 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -175.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 101.89 1.96 52.19 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.743 175.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 57.22 70.45 1.35 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.19 0.519 . . . . 0.0 110.869 179.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.511 ' HD2' ' CD1' ' A' ' 35' ' ' TRP . 87.4 Cg_endo -88.28 -162.74 0.14 Allowed 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.967 2.445 . . . . 0.0 112.215 -179.153 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -88.11 145.12 26.11 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.247 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 96.0 mt -93.7 157.24 16.26 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.573 -175.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -125.3 148.3 48.76 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.184 176.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.6 p -141.15 153.13 45.22 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.797 0.332 . . . . 0.0 111.557 -175.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 16.8 p90 -145.04 148.86 34.17 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.839 176.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.414 ' HA ' ' HA ' ' A' ' 74' ' ' LYS . 45.7 t -102.03 122.28 54.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 17.5 tt -109.61 150.32 12.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.394 -178.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -87.74 96.19 10.35 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.359 -175.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -92.93 104.22 16.47 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.666 0.746 . . . . 0.0 109.241 173.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.544 ' HG2' ' HD3' ' A' ' 70' ' ' LYS . 22.9 mt-10 -96.16 113.64 25.27 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.07 -168.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.457 ' HB ' ' O ' ' A' ' 69' ' ' LYS . 51.7 mt -85.71 83.58 2.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 172.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.453 ' O ' ' HD3' ' A' ' 55' ' ' PRO . 19.8 m -91.14 170.36 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.21 179.159 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -87.44 108.83 21.67 Favored Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.453 ' HD3' ' O ' ' A' ' 53' ' ' VAL . 58.9 Cg_endo -90.94 82.48 0.39 Allowed 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 123.17 2.58 . . . . 0.0 112.543 -177.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 164.57 28.84 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.012 179.072 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -125.72 140.64 52.53 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.861 0.362 . . . . 0.0 110.461 -176.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 79.1 t80 -87.29 -30.54 20.79 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 175.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -94.87 139.74 22.26 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.213 178.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -58.0 116.63 3.37 Favored 'Trans proline' 0 C--O 1.236 0.379 0 C-N-CA 122.877 2.385 . . . . 0.0 112.568 -177.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_exo -62.11 -18.92 64.52 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 123.09 2.526 . . . . 0.0 112.07 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -53.04 -45.61 68.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.714 177.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 63.5 mtt -77.52 -16.4 58.71 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.11 0.481 . . . . 0.0 111.009 -176.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -90.38 -42.49 10.89 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.954 178.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 29.1 t80 52.07 68.89 0.74 Allowed 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.112 178.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 12.8 p -123.54 -61.08 1.42 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.602 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -109.34 11.75 25.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.576 0.227 . . . . 0.0 111.377 -179.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.4 t -75.26 94.18 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.854 0.359 . . . . 0.0 110.266 -178.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.457 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 29.5 tptp -116.7 107.79 15.11 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.201 -176.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.544 ' HD3' ' HG2' ' A' ' 51' ' ' GLU . 83.8 mttt -98.45 123.62 42.7 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.987 0.422 . . . . 0.0 110.688 -178.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 48.3 t -110.49 106.87 21.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.94 -179.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 51.3 mttm -78.03 112.76 15.29 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.021 -177.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 61.5 mt -98.63 125.6 51.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.238 0.542 . . . . 0.0 110.814 -176.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.502 ' O ' ' HB3' ' A' ' 90' ' ' TYR . 86.8 tttt -87.48 122.89 31.79 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.71 177.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -113.01 161.49 16.99 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.425 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.481 ' HB ' ' CD1' ' A' ' 90' ' ' TYR . 13.1 p -118.11 145.39 24.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.521 -0.308 . . . . 0.0 110.962 -175.392 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.404 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 38.8 p90 -154.94 159.55 40.5 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.909 178.313 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -133.4 152.29 51.9 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 170.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.536 ' HG2' ' HG2' ' A' ' 85' ' ' ARG . 24.9 mt-10 -104.61 138.82 40.37 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.987 0.423 . . . . 0.0 110.93 -173.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 73.0 p -97.54 -169.28 1.81 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.848 -175.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -69.9 -28.28 65.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.039 -179.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -95.71 19.5 11.14 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.086 -172.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 65.8 17.1 10.75 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.529 -179.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 85.2 t -88.34 137.9 20.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.108 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.536 ' HG2' ' HG2' ' A' ' 79' ' ' GLU . 90.5 mtt180 -107.84 113.87 27.41 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.453 -177.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 53.2 t -83.54 102.67 9.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 177.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' A' ' 25' ' ' HIS . 32.5 t -100.38 136.29 32.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.778 -174.098 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.478 HG23 ' HA ' ' A' ' 28' ' ' PRO . 52.3 m -146.98 157.62 43.68 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.07 178.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -67.11 122.88 18.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.337 0.589 . . . . 0.0 111.617 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.502 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 49.2 t80 -78.38 -20.1 51.97 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.691 -178.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.536 ' O ' ' HG3' ' A' ' 95' ' ' LYS . 4.1 m -62.22 -61.1 2.7 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.867 0.365 . . . . 0.0 110.253 179.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -71.17 -29.28 64.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.125 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.511 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 62.9 t80 -58.24 -45.18 88.24 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.875 0.369 . . . . 0.0 110.07 176.225 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.448 ' NE2' HD13 ' A' ' 97' ' ' LEU . 20.7 mm-40 -61.67 -40.38 94.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.049 176.138 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.536 ' HG3' ' O ' ' A' ' 91' ' ' SER . 90.3 mttt -65.18 -40.75 94.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.832 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.447 HD11 ' HB2' ' A' ' 28' ' ' PRO . 66.6 mt -71.5 -31.12 41.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.239 -179.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.511 ' HG ' ' O ' ' A' ' 93' ' ' PHE . 53.8 mt -61.7 -42.44 98.94 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.939 0.4 . . . . 0.0 110.419 175.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -73.94 -20.74 60.28 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.17 0.509 . . . . 0.0 110.521 177.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -74.38 -42.74 58.79 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.205 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 67.2 mtt180 -98.75 -4.12 34.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.843 0.354 . . . . 0.0 111.443 -177.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 76.95 60.31 2.95 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.588 177.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 38.6 m -120.58 115.58 23.69 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.874 0.368 . . . . 0.0 110.426 177.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -84.04 168.35 16.01 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.419 178.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 97.6 mt -83.23 -19.49 36.33 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.283 0.563 . . . . 0.0 109.811 176.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -83.6 120.55 26.1 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.936 176.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 74.6 m-70 -83.97 155.27 22.87 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.355 176.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 -72.51 -27.03 62.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.079 0.466 . . . . 0.0 110.436 -179.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 16.7 m-70 -128.53 124.37 35.85 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.346 173.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 46.0 m80 -93.88 159.12 15.32 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.84 179.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -94.3 9.01 39.81 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.45 0.643 . . . . 0.0 109.73 175.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 35.7 m80 . . . . . 0 C--O 1.246 0.89 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.51 176.689 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.525 ' HA ' HG21 ' A' ' 5' ' ' VAL . 14.9 tmm? . . . . . 0 N--CA 1.479 0.982 0 CA-C-O 121.046 0.45 . . . . 0.0 110.441 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.448 HD21 HD23 ' A' ' 81' ' ' LEU . 0.8 OUTLIER -119.64 -178.52 3.64 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 174.156 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 64.8 p -58.76 -31.2 68.15 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.953 0.406 . . . . 0.0 110.409 176.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.585 ' HA ' ' HD2' ' A' ' 7' ' ' LYS . 35.5 tt0 -62.32 -38.39 89.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.8 178.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.525 HG21 ' HA ' ' A' ' 1' ' ' MET . 93.0 t -65.55 -45.8 91.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.041 0.448 . . . . 0.0 110.046 178.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 59.6 mt -59.62 -41.72 85.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.657 174.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.585 ' HD2' ' HA ' ' A' ' 4' ' ' GLU . 62.9 mttm -50.9 -57.79 7.62 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.811 0.339 . . . . 0.0 110.614 175.109 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -56.39 -43.17 78.99 Favored 'General case' 0 C--O 1.223 -0.323 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.963 -179.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.464 ' O ' HG12 ' A' ' 13' ' ' ILE . 70.1 t80 -60.81 -48.96 79.44 Favored 'General case' 0 C--N 1.328 -0.358 0 O-C-N 123.123 0.265 . . . . 0.0 110.935 -178.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 96.7 mt -62.48 -47.85 82.2 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.986 0.422 . . . . 0.0 111.085 -178.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -73.73 -21.74 60.12 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.013 -177.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -75.61 -38.53 58.92 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.858 0.361 . . . . 0.0 110.7 177.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.464 HG12 ' O ' ' A' ' 9' ' ' PHE . 32.1 pt -87.33 -4.82 9.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.875 0.369 . . . . 0.0 110.711 177.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 74.53 43.14 31.03 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.104 -0.569 . . . . 0.0 112.655 175.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 46.7 mm-40 -109.94 151.12 27.5 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.395 0.617 . . . . 0.0 111.742 -179.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -89.26 150.89 22.41 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.006 -178.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 33.0 p90 -145.54 143.3 29.86 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.906 0.384 . . . . 0.0 111.091 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.536 ' HB ' ' HB2' ' A' ' 25' ' ' HIS . 48.9 mm -97.82 92.76 3.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 174.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.4 ' HG3' HG12 ' A' ' 24' ' ' ILE . 33.8 tt0 -91.52 109.49 20.79 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.875 -175.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 69.7 mt -105.04 -170.79 1.81 Allowed 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 175.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -79.69 109.67 14.3 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.089 -0.644 . . . . 0.0 110.258 178.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 60.0 m-80 70.27 18.51 6.81 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 114.946 -1.025 . . . . 0.0 111.41 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.478 ' HG2' ' HB2' ' A' ' 85' ' ' ARG . 37.7 mt-10 -144.55 131.43 20.27 Favored 'General case' 0 C--O 1.222 -0.36 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.07 177.132 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.4 HG12 ' HG3' ' A' ' 19' ' ' GLU . 76.2 mt -125.91 107.84 18.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 173.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.536 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 19.6 m-70 -92.08 127.24 37.48 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 -178.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 87.2 mt -118.34 169.34 9.81 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.453 -174.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 84.9 mttt -70.42 140.43 87.42 Favored Pre-proline 0 C--N 1.327 -0.4 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 173.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -47.6 -48.42 15.66 Favored 'Trans proline' 0 CA--C 1.531 0.342 0 C-N-CA 123.15 2.567 . . . . 0.0 113.592 -176.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -73.81 -31.09 63.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.788 0.327 . . . . 0.0 111.051 -175.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.425 ' O ' HG22 ' A' ' 34' ' ' VAL . 56.3 t -73.23 -41.44 58.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 178.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -56.53 -39.63 73.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.265 176.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.552 ' HA ' ' HE1' ' A' ' 93' ' ' PHE . 47.2 t80 -53.97 -44.36 70.71 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.513 178.146 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -76.6 -36.26 57.61 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.291 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.425 HG22 ' O ' ' A' ' 30' ' ' VAL . 76.8 t -67.13 -40.02 84.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.006 0.432 . . . . 0.0 110.475 178.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.597 ' CD1' ' HD2' ' A' ' 41' ' ' PRO . 27.8 t90 -56.68 -45.76 81.53 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.259 176.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 25.0 mttm -71.67 -34.75 69.96 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.243 178.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 90.6 t80 -58.26 -43.26 87.79 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.143 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.461 HG23 ' HD3' ' A' ' 41' ' ' PRO . 35.8 m -81.49 13.74 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -177.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 103.75 -0.37 45.53 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.971 174.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 59.99 70.11 1.1 Allowed Pre-proline 0 CA--C 1.536 0.427 0 CA-C-O 121.147 0.498 . . . . 0.0 110.457 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.597 ' HD2' ' CD1' ' A' ' 35' ' ' TRP . 66.2 Cg_endo -92.68 -162.47 0.1 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 123.282 2.655 . . . . 0.0 113.259 -177.089 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -58.06 144.75 38.86 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.176 -179.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 68.5 mt -105.29 112.01 24.96 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.066 173.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 60.6 mttm -107.72 140.5 40.68 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.5 p -127.87 157.37 40.67 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.706 0.289 . . . . 0.0 111.756 -174.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 38.7 p90 -138.55 136.73 36.35 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 172.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 58.3 t -98.96 122.03 50.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.312 -179.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 13.0 tt -104.3 128.88 57.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.191 0.519 . . . . 0.0 110.415 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -85.2 116.88 23.81 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.506 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -114.7 120.68 40.92 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.974 0.416 . . . . 0.0 110.358 -177.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -92.79 118.79 31.47 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.326 -173.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 74.4 mt -78.77 102.09 4.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.578 -0.526 . . . . 0.0 109.578 174.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.529 ' O ' ' HD3' ' A' ' 55' ' ' PRO . 9.3 p -115.11 161.34 13.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 178.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -87.63 107.66 16.47 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-O 120.752 0.311 . . . . 0.0 110.748 -179.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.529 ' HD3' ' O ' ' A' ' 53' ' ' VAL . 73.3 Cg_endo -100.16 70.18 0.05 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.18 0 C-N-CA 123.823 3.015 . . . . 0.0 112.357 178.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -134.94 -36.23 0.23 Allowed Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.317 -179.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -85.58 135.69 33.7 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 175.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -66.07 -36.26 82.73 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.012 -179.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -84.4 112.03 38.61 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.02 178.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -85.64 120.3 2.04 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 122.718 2.279 . . . . 0.0 112.586 -177.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_exo -70.78 121.16 7.65 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 122.641 2.227 . . . . 0.0 111.429 176.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -72.57 -42.88 64.12 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.27 0.557 . . . . 0.0 109.726 179.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 62.6 mtt -75.02 126.56 31.28 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.131 175.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -75.44 88.23 2.62 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.249 0.547 . . . . 0.0 110.377 -177.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -57.8 -62.84 1.51 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.326 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.2 t -87.98 153.41 21.31 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 175.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -77.66 102.21 6.97 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.87 0.367 . . . . 0.0 110.376 -178.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.1 m -62.74 135.71 26.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.772 179.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -97.31 116.7 30.01 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.833 -178.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -98.46 126.82 44.15 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.866 0.365 . . . . 0.0 110.713 -178.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 23.1 m -102.29 148.44 7.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.773 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 58.2 mttm -113.76 99.94 8.08 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.156 0.503 . . . . 0.0 110.204 -174.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 71.2 mt -93.77 134.64 30.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.066 -177.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -116.1 107.76 15.33 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.415 0.626 . . . . 0.0 110.961 -174.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 35.9 mmtp -96.4 149.15 22.04 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.982 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.477 ' HB ' ' HB2' ' A' ' 90' ' ' TYR . 9.7 p -114.07 142.84 25.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.539 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 37.5 p90 -151.36 159.03 44.48 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.152 0.501 . . . . 0.0 111.212 -177.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -132.27 147.84 52.42 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 168.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -102.21 137.78 40.02 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.944 0.402 . . . . 0.0 111.02 -174.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 82.8 p -91.48 -175.35 4.19 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.855 178.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.448 HD23 HD21 ' A' ' 2' ' ' ASN . 66.3 tp -60.92 -31.21 70.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.181 0.515 . . . . 0.0 110.356 176.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.503 ' HB2' HG22 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -79.84 -2.03 41.64 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.648 -178.142 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 59.3 m-80 70.87 23.11 4.48 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.346 0.658 . . . . 0.0 110.568 -176.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.503 HG22 ' HB2' ' A' ' 82' ' ' ASP . 70.7 t -86.24 126.49 40.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.438 178.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.478 ' HB2' ' HG2' ' A' ' 23' ' ' GLU . 63.4 mtt85 -86.03 110.02 19.21 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.666 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.539 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 49.1 t -82.66 109.05 16.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 171.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.441 HG22 ' HB3' ' A' ' 77' ' ' TYR . 9.6 t -116.79 147.59 20.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.22 0.533 . . . . 0.0 112.418 -167.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 6.0 t -155.76 -176.66 6.07 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 169.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -84.59 128.26 34.5 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 117.971 0.351 . . . . 0.0 110.561 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.477 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 11.2 t80 -77.46 -22.17 51.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.523 -174.066 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.3 -47.1 52.54 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.919 -0.401 . . . . 0.0 109.919 178.309 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.409 ' O ' ' HB3' ' A' ' 95' ' ' LYS . 54.8 mm-40 -70.21 -29.65 66.54 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.707 176.15 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.552 ' HE1' ' HA ' ' A' ' 32' ' ' TYR . 43.0 t80 -69.08 -47.65 64.68 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.662 0.267 . . . . 0.0 110.473 178.032 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.554 ' O ' ' HG3' ' A' ' 98' ' ' LYS . 43.1 mt-30 -60.95 -34.58 74.97 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.275 175.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.409 ' HB3' ' O ' ' A' ' 92' ' ' GLU . 42.4 tttt -52.98 -47.09 68.46 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.018 176.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.632 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 78.8 mt -68.94 -37.47 77.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.763 178.317 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 83.3 mt -65.34 -32.16 73.67 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.67 178.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.554 ' HG3' ' O ' ' A' ' 94' ' ' GLN . 96.8 mttt -65.35 -38.78 91.12 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 174.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.632 ' HE3' ' HA ' ' A' ' 96' ' ' ILE . 9.1 mtmp? -69.21 -33.24 73.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.716 178.246 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.54 ' HD3' ' OH ' ' A' ' 32' ' ' TYR . 13.0 ttp180 -71.16 -38.6 72.19 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.969 0.414 . . . . 0.0 110.365 175.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 100.56 36.16 4.13 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.937 -0.649 . . . . 0.0 111.742 -178.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 23.5 m -66.9 -28.04 67.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.099 0.476 . . . . 0.0 111.481 -178.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -105.65 26.59 9.35 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.284 0.564 . . . . 0.0 110.339 -178.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 49.3 tp -138.92 86.09 2.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.678 176.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 63.23 -175.51 0.15 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.956 -177.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 40.8 m80 -100.64 79.93 2.14 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.226 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 75.6 t60 -86.08 117.79 25.14 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.133 0.492 . . . . 0.0 110.396 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 11.9 m-70 -90.44 -171.17 2.99 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.369 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 19.0 t-80 -88.22 -9.41 53.08 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 171.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 79.4 m-70 -100.5 -63.07 1.16 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.321 175.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 85.4 t60 . . . . . 0 C--O 1.244 0.807 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.371 177.511 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.476 ' HE2' HG21 ' A' ' 80' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.163 0 CA-C-O 120.717 0.294 . . . . 0.0 110.38 . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -102.29 167.87 9.7 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 173.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.553 ' OG ' ' HB3' ' A' ' 82' ' ' ASP . 3.3 m -65.32 -35.06 79.85 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.797 0.332 . . . . 0.0 110.915 -177.246 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.447 ' O ' ' HG2' ' A' ' 8' ' ' GLU . 34.2 tt0 -58.51 -41.53 85.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.503 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 94.0 t -55.64 -45.2 78.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.825 177.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.507 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 64.4 mt -63.0 -43.59 99.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.554 -179.155 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.433 ' HE2' ' OE1' ' A' ' 19' ' ' GLU . 92.5 mttt -61.36 -46.62 89.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.784 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.447 ' HG2' ' O ' ' A' ' 4' ' ' GLU . 52.5 mm-40 -60.58 -48.01 83.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.271 177.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -59.69 -38.18 80.84 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.349 -178.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.507 ' HG ' ' O ' ' A' ' 6' ' ' ILE . 93.5 mt -65.26 -37.9 88.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.842 0.353 . . . . 0.0 110.488 178.267 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -69.97 -34.01 72.82 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.188 176.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -59.74 -43.61 94.17 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.052 175.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 35.1 pt -85.67 -7.51 10.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.841 0.353 . . . . 0.0 111.33 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 81.38 26.58 51.16 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 121.026 -0.606 . . . . 0.0 113.211 174.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -106.64 143.54 34.59 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.875 0.369 . . . . 0.0 110.408 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -102.29 147.92 26.08 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.885 -179.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 13.0 p90 -120.52 154.39 35.38 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.981 0.42 . . . . 0.0 111.672 -174.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 51.6 mt -101.51 96.84 5.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 174.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.433 ' OE1' ' HE2' ' A' ' 7' ' ' LYS . 61.1 tt0 -108.51 137.42 46.5 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.495 0.664 . . . . 0.0 112.02 -173.227 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 89.7 mt -116.73 -173.56 2.41 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 170.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -61.7 103.5 0.34 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.817 0.342 . . . . 0.0 110.831 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.446 ' HA ' HG21 ' A' ' 84' ' ' VAL . 4.2 m-20 66.94 23.0 9.98 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.725 178.305 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -134.81 113.95 12.12 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.681 0.277 . . . . 0.0 111.209 176.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.401 ' HB ' HG21 ' A' ' 86' ' ' VAL . 66.0 mt -103.33 109.68 27.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 175.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -92.55 120.31 32.88 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 64.8 mt -124.75 155.47 39.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.241 0.543 . . . . 0.0 111.691 -176.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -65.96 136.47 95.61 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.491 176.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -56.2 -33.46 90.72 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.319 2.013 . . . . 0.0 111.588 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -62.09 -43.91 97.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.956 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 45.9 t -81.36 -34.33 13.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.187 0.517 . . . . 0.0 110.244 179.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -55.64 -39.08 70.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.712 -176.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -58.46 -38.37 77.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.764 0.316 . . . . 0.0 111.113 -178.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -79.67 -34.53 40.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.838 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 95.9 t -64.53 -42.82 96.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.012 0.434 . . . . 0.0 110.024 176.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.503 ' CD1' ' HD2' ' A' ' 41' ' ' PRO . 29.6 t90 -57.6 -41.1 80.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.423 177.184 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -69.09 -43.61 74.19 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.884 176.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -60.92 -41.0 95.3 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.956 -178.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.488 HG21 ' HD3' ' A' ' 41' ' ' PRO . 35.1 m -76.9 4.42 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 112.308 0.485 . . . . 0.0 112.308 -175.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 105.82 -0.48 39.04 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.543 -0.837 . . . . 0.0 113.089 175.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 59.49 75.12 0.52 Allowed Pre-proline 0 CA--C 1.535 0.382 0 CA-C-O 120.987 0.422 . . . . 0.0 111.228 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.503 ' HD2' ' CD1' ' A' ' 35' ' ' TRP . 90.6 Cg_endo -91.58 -176.68 0.87 Allowed 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.791 2.327 . . . . 0.0 112.109 176.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 57.8 mm-40 -72.29 135.82 46.09 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.014 0.435 . . . . 0.0 110.765 178.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.453 ' HB3' ' CG2' ' A' ' 76' ' ' VAL . 95.2 mt -98.44 138.02 36.27 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.48 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -117.23 138.58 51.62 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.951 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 16.2 p -105.2 147.52 27.92 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 120.79 0.328 . . . . 0.0 111.443 -176.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.482 ' CE2' ' HB ' ' A' ' 48' ' ' ILE . 10.0 p90 -129.1 156.1 44.4 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 175.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 33.1 t -103.28 105.11 17.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.028 0.442 . . . . 0.0 110.945 -176.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.608 HG21 ' HB ' ' A' ' 73' ' ' ILE . 5.8 tt -95.83 101.33 12.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 121.672 0.749 . . . . 0.0 109.443 175.113 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -85.69 93.83 8.94 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.913 -177.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -103.11 135.75 44.19 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.883 -175.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.611 ' HG2' ' HG2' ' A' ' 70' ' ' LYS . 40.3 mt-10 -82.32 110.03 17.11 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.64 -0.254 . . . . 0.0 110.561 -176.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.658 HG21 ' HB3' ' A' ' 69' ' ' LYS . 8.1 pt 36.49 -104.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 O-C-N 124.437 1.086 . . . . 0.0 112.688 -174.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.549 ' H ' HG13 ' A' ' 52' ' ' ILE . 2.9 m -148.03 118.35 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 177.286 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -95.24 102.56 9.84 Favored Pre-proline 0 C--N 1.323 -0.576 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 174.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.502 ' HD3' ' O ' ' A' ' 53' ' ' VAL . 89.0 Cg_endo -92.7 155.48 2.86 Favored 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 122.88 2.387 . . . . 0.0 113.219 -175.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -135.22 3.01 3.99 Favored Glycine 0 N--CA 1.449 -0.454 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 173.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -78.86 -20.81 48.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.383 0.611 . . . . 0.0 109.841 176.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -130.32 146.58 51.93 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.481 -0.782 . . . . 0.0 109.317 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.473 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 44.7 m-20 -80.66 114.05 44.82 Favored Pre-proline 0 C--N 1.324 -0.529 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 173.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 59' ' ' ASP . 23.6 Cg_exo -63.56 117.69 4.65 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 122.997 2.465 . . . . 0.0 113.34 -172.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -72.08 103.03 1.43 Allowed 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 122.792 2.328 . . . . 0.0 110.129 172.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -67.24 138.11 56.67 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.556 0.693 . . . . 0.0 112.859 -170.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 59.2 mtt -123.38 152.34 41.64 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 166.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -81.01 2.32 27.5 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -171.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -134.5 59.15 1.74 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.097 0.475 . . . . 0.0 110.626 176.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.7 m -74.81 126.58 31.24 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.653 176.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -81.17 117.51 21.78 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.011 0.434 . . . . 0.0 111.596 -174.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.0 m -83.96 76.76 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.904 0.859 . . . . 0.0 110.34 176.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.658 ' HB3' HG21 ' A' ' 52' ' ' ILE . 89.2 tttt -92.27 107.61 19.34 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.872 -177.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.611 ' HG2' ' HG2' ' A' ' 51' ' ' GLU . 54.4 mttm -87.41 120.67 28.94 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.589 -175.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 31.2 t -104.4 115.57 46.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.441 -179.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 57.0 mttm -76.86 93.65 3.78 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 177.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.608 ' HB ' HG21 ' A' ' 48' ' ' ILE . 58.8 mt -91.03 129.44 41.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.301 -178.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -103.32 111.46 23.87 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.237 -178.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.405 ' HB3' ' O ' ' A' ' 88' ' ' THR . 65.6 mttm -114.96 167.15 11.05 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.235 -0.439 . . . . 0.0 109.832 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.453 ' CG2' ' HB3' ' A' ' 43' ' ' LEU . 14.4 p -123.48 147.98 27.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 120.794 0.331 . . . . 0.0 111.241 -172.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 51.6 p90 -145.66 163.81 33.72 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.137 178.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.444 ' HB3' HD22 ' A' ' 43' ' ' LEU . 43.1 p90 -128.14 155.42 44.47 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 169.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -102.22 137.07 40.97 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.323 -175.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.476 HG21 ' HE2' ' A' ' 1' ' ' MET . 69.8 p -90.31 169.08 11.41 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 175.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.3 mp -82.91 18.95 1.47 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.344 0.592 . . . . 0.0 109.638 174.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.553 ' HB3' ' OG ' ' A' ' 3' ' ' SER . 38.9 t70 -126.59 10.55 7.23 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.853 -177.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 66.3 t30 74.14 19.49 2.93 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 115.188 -0.915 . . . . 0.0 112.112 173.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.446 HG21 ' HA ' ' A' ' 22' ' ' ASN . 82.7 t -109.7 137.16 43.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 120.931 0.396 . . . . 0.0 110.413 177.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 84.0 mtt-85 -102.19 126.84 49.28 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.46 -178.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.401 HG21 ' HB ' ' A' ' 24' ' ' ILE . 61.0 t -98.67 113.93 34.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 174.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.8 t -111.02 147.13 15.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.146 -170.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.405 ' O ' ' HB3' ' A' ' 75' ' ' LYS . 4.9 t -152.74 -178.67 7.03 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.233 -0.439 . . . . 0.0 109.854 176.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -86.39 122.05 29.81 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.969 0.414 . . . . 0.0 110.885 -178.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 17.1 t80 -73.65 -23.87 59.91 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.28 -176.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 27.0 m -71.99 -52.34 17.52 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.848 0.356 . . . . 0.0 110.582 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.413 ' O ' ' HB3' ' A' ' 95' ' ' LYS . 10.0 mm-40 -71.26 -27.75 63.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.467 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.43 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 69.1 t80 -65.92 -42.82 89.65 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 175.267 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -63.3 -35.3 79.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.674 175.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.509 ' HZ1' ' HB2' ' A' ' 95' ' ' LYS . 3.7 ttmp? -56.49 -44.59 80.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.279 175.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 76.2 mt -69.27 -40.09 79.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.908 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.43 ' HG ' ' O ' ' A' ' 93' ' ' PHE . 99.5 mt -58.73 -50.95 72.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.412 177.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.589 ' HB3' ' HZ1' ' A' ' 98' ' ' LYS . 9.6 mtpm? -70.25 -25.43 63.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.198 -178.291 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -59.57 -53.3 59.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.569 174.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 39.8 ttt85 -77.41 -38.01 50.64 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.985 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 111.5 17.04 8.93 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.738 -0.744 . . . . 0.0 111.643 -176.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 38.8 m -70.97 134.29 47.07 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.794 0.331 . . . . 0.0 110.394 179.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -126.91 169.87 12.84 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.099 178.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 50.9 tp -79.49 -19.37 49.9 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.231 0.539 . . . . 0.0 110.29 -178.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -73.29 131.26 41.72 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.935 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 81.3 m-70 -110.7 103.94 12.55 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 172.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 64.1 m170 -97.0 134.44 40.37 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.961 0.41 . . . . 0.0 111.635 -172.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 60.1 m80 -139.64 100.99 4.1 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.124 177.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 17.5 m-70 -102.69 148.92 24.99 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.054 177.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 69.0 m80 -112.25 168.18 9.83 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.901 -177.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 33.9 t60 . . . . . 0 C--O 1.247 0.94 0 CA-C-O 118.497 -0.764 . . . . 0.0 109.592 176.659 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.761 ' HE1' ' HB ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.026 0 CA-C-O 120.926 0.393 . . . . 0.0 110.481 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -94.21 178.06 5.76 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 172.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.488 ' O ' ' HG3' ' A' ' 7' ' ' LYS . 89.3 p -62.95 -32.93 74.35 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.73 0.3 . . . . 0.0 111.118 -177.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.457 ' HA ' ' HD2' ' A' ' 7' ' ' LYS . 9.3 tp10 -56.81 -36.36 69.84 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.997 -178.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 66.5 t -64.38 -42.04 94.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.479 178.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.5 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 63.9 mt -63.95 -41.43 92.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.339 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.488 ' HG3' ' O ' ' A' ' 3' ' ' SER . 88.6 mttt -57.16 -52.45 65.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.426 178.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -69.27 -28.1 66.01 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.365 -178.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -64.92 -44.56 89.13 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.125 0.488 . . . . 0.0 109.892 175.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.5 ' HG ' ' O ' ' A' ' 6' ' ' ILE . 51.9 mt -64.52 -42.7 95.62 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.283 177.386 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -63.49 -38.0 89.47 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.504 178.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -62.82 -50.32 71.45 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.097 179.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 37.9 pt -78.44 -7.0 9.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.763 0.316 . . . . 0.0 111.382 -178.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 76.07 36.41 40.94 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 121.119 -0.562 . . . . 0.0 112.619 177.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -95.69 157.48 15.88 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 179.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -73.68 122.99 23.2 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.187 0.518 . . . . 0.0 111.093 -177.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 93.2 t80 -105.64 120.01 40.58 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.987 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 15.3 tt -131.34 121.39 48.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.314 0.578 . . . . 0.0 110.576 175.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -108.38 108.27 19.17 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.046 178.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 24.7 tp -93.39 75.46 4.51 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 59.3 71.5 0.58 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.537 -177.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 12.5 m120 68.38 11.64 8.43 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.172 -0.922 . . . . 0.0 112.004 178.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 79.3 mt-10 -115.13 113.99 24.72 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 174.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 40.7 mt -86.77 109.35 18.94 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 177.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.44 ' HA ' ' O ' ' A' ' 87' ' ' VAL . 24.8 m-70 -95.98 111.13 23.22 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -178.364 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.425 HD21 HD11 ' A' ' 10' ' ' LEU . 67.4 mt -113.32 163.3 15.01 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.44 0.638 . . . . 0.0 112.679 -170.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 33.7 tttp -62.63 129.61 92.94 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 114.46 -1.245 . . . . 0.0 109.681 173.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -51.12 -41.28 58.03 Favored 'Trans proline' 0 N--CA 1.473 0.308 0 C-N-CA 122.884 2.389 . . . . 0.0 112.518 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -53.78 -54.92 31.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.168 175.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 50.9 t -69.5 -41.12 80.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.712 -177.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -53.87 -42.01 68.15 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.476 179.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -59.18 -42.69 91.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.555 -179.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -78.26 -37.17 45.72 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.088 -178.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 95.8 t -62.43 -36.87 77.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.083 0.468 . . . . 0.0 109.86 175.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.419 ' CD1' ' HD2' ' A' ' 41' ' ' PRO . 35.3 t90 -55.78 -44.09 77.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.701 176.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.532 ' HA ' ' CG ' ' A' ' 40' ' ' GLU . 67.3 mttm -73.02 -31.67 64.61 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.656 -0.247 . . . . 0.0 111.325 179.23 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 83.8 t80 -67.23 -40.65 86.37 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.951 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.761 ' HB ' ' HE1' ' A' ' 1' ' ' MET . 35.0 m -79.04 4.12 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -177.086 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 102.64 4.11 49.35 Favored Glycine 0 C--N 1.33 0.231 0 C-N-CA 120.767 -0.73 . . . . 0.0 113.241 174.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.532 ' CG ' ' HA ' ' A' ' 36' ' ' LYS . 54.0 mt-10 57.59 78.29 0.37 Allowed Pre-proline 0 C--O 1.236 0.347 0 C-N-CA 122.925 0.49 . . . . 0.0 111.95 -179.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.492 ' HD3' HG22 ' A' ' 38' ' ' VAL . 4.9 Cg_exo -77.89 175.3 11.36 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.738 2.292 . . . . 0.0 110.659 173.163 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -81.46 133.72 35.44 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.18 0.514 . . . . 0.0 110.12 178.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 89.7 mt -73.17 120.94 19.48 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.774 -172.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -96.53 118.4 32.95 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.197 176.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 24.2 p -109.47 143.12 39.52 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.052 -176.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 17.9 p90 -126.27 133.53 51.41 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.728 177.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.41 HG21 ' HB2' ' A' ' 74' ' ' LYS . 60.5 t -93.63 125.95 46.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.717 -179.01 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.511 HD13 ' HE3' ' A' ' 75' ' ' LYS . 13.7 pt -125.7 131.0 72.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.576 174.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.543 ' HB3' ' HG2' ' A' ' 70' ' ' LYS . 45.9 mt-10 -102.41 98.38 8.49 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.136 -179.211 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -93.08 154.73 17.93 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.964 -178.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.595 ' HB3' ' CG1' ' A' ' 68' ' ' VAL . 43.3 mt-10 -105.41 111.04 23.61 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.338 -172.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 44.0 pt -110.28 139.19 34.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.113 0.482 . . . . 0.0 110.811 177.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 6.5 m -107.05 97.57 5.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-O 121.275 0.56 . . . . 0.0 110.569 175.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.444 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 13.0 pt-20 -87.62 143.92 34.58 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 116.156 -0.474 . . . . 0.0 109.739 178.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 54' ' ' GLU . 35.7 Cg_exo -62.4 177.93 1.05 Allowed 'Trans proline' 0 C--O 1.237 0.438 0 C-N-CA 122.788 2.325 . . . . 0.0 112.867 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -135.26 43.66 1.24 Allowed Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.605 -177.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -63.85 -39.17 93.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.729 0.776 . . . . 0.0 108.914 175.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -121.17 135.06 55.22 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.629 -1.169 . . . . 0.0 108.55 175.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 -73.46 123.02 89.03 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-O 121.211 0.529 . . . . 0.0 111.556 -174.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.895 ' HD2' ' HE1' ' A' ' 65' ' ' TYR . 17.1 Cg_exo -68.08 153.45 74.93 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 122.951 2.434 . . . . 0.0 111.851 174.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 60' ' ' PRO . 22.4 Cg_exo -65.89 -16.23 51.99 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 123.162 2.574 . . . . 0.0 112.751 -179.104 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -78.75 116.37 19.05 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 177.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 66.0 mtt -84.1 -15.8 46.0 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.661 -177.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -86.63 72.69 10.18 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 172.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.895 ' HE1' ' HD2' ' A' ' 60' ' ' PRO . 92.4 m-85 -64.83 121.38 14.45 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.633 -174.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 38.5 p -103.07 132.96 48.95 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.493 178.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -53.25 -51.98 60.47 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.219 0.533 . . . . 0.0 110.585 176.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.595 ' CG1' ' HB3' ' A' ' 51' ' ' GLU . 28.3 t -116.12 132.23 66.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.348 176.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.4 ' HA ' ' HD2' ' A' ' 69' ' ' LYS . 46.9 tptt -100.27 107.75 19.65 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.084 0.469 . . . . 0.0 110.264 -178.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.543 ' HG2' ' HB3' ' A' ' 49' ' ' GLU . 26.5 ttpp -85.41 116.51 23.78 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.759 178.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 49' ' ' GLU . 65.2 t -102.56 133.92 44.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.956 -174.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 60.9 mttm -86.06 96.96 10.03 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.328 179.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 15.1 tt -109.89 129.81 64.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.546 0.688 . . . . 0.0 110.66 178.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.476 ' O ' ' HB3' ' A' ' 90' ' ' TYR . 36.4 ttpt -108.86 115.71 30.59 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.075 -177.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.511 ' HE3' HD13 ' A' ' 48' ' ' ILE . 81.4 mttt -104.13 167.01 10.04 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.35 -0.386 . . . . 0.0 109.975 -179.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 14.6 p -122.51 146.79 27.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 120.925 0.393 . . . . 0.0 111.303 -173.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.437 ' HB3' HG22 ' A' ' 87' ' ' VAL . 48.1 p90 -149.85 164.82 34.34 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.132 175.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -134.23 149.25 50.96 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 169.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.55 ' HG2' ' HG2' ' A' ' 85' ' ' ARG . 41.6 mt-10 -102.5 138.21 39.72 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.681 -176.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 38.4 p -83.25 178.55 8.03 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.123 175.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.8 mp -62.73 -27.01 68.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.194 0.521 . . . . 0.0 110.726 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -99.98 15.04 28.48 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.715 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 10.0 m120 64.1 34.59 11.06 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 171.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 58.6 t -90.69 129.56 41.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 169.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.55 ' HG2' ' HG2' ' A' ' 79' ' ' GLU . 41.7 mtm-85 -98.88 114.91 27.73 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.976 0.417 . . . . 0.0 111.389 -172.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 45.6 t -89.7 113.09 25.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 174.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 25' ' ' HIS . 19.3 t -113.28 148.2 16.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.937 -171.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 6.2 t -152.13 171.52 17.78 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.065 174.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -73.02 111.71 8.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.188 0.518 . . . . 0.0 110.368 177.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.476 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 15.3 t80 -72.14 -20.94 61.53 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.595 -177.099 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.4 m -62.64 -58.22 8.29 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-O 121.184 0.516 . . . . 0.0 110.068 178.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -67.53 -35.28 78.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.406 178.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 55.2 t80 -59.78 -46.77 88.17 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.48 179.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.448 ' O ' ' HG3' ' A' ' 98' ' ' LYS . 69.5 mt-30 -58.61 -40.02 82.11 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.612 0.244 . . . . 0.0 110.906 176.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -63.22 -39.82 95.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.528 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 80.1 mt -63.58 -42.27 95.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.743 177.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -57.84 -43.31 85.78 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.681 176.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.448 ' HG3' ' O ' ' A' ' 94' ' ' GLN . 94.0 mttt -70.05 -41.83 73.67 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.693 178.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 60.5 tttm -60.3 -48.68 80.69 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.649 -178.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 62.4 ttt180 -78.38 -30.48 47.91 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.041 0.448 . . . . 0.0 110.523 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.72 45.35 6.83 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.681 -0.771 . . . . 0.0 111.869 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 23.1 m -72.24 -32.9 67.11 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.082 0.467 . . . . 0.0 110.267 178.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -107.5 149.99 27.33 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.715 176.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 86.5 mt -70.35 144.77 51.53 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.013 -175.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -68.85 -52.79 26.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.485 178.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 63.5 m80 -104.71 142.81 34.02 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.591 -176.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 56.8 m170 -100.62 134.07 44.13 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.622 -177.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -76.5 -29.7 56.92 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.473 178.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 72.3 t60 -128.65 133.5 48.27 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 173.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 33.3 m80 -81.6 138.59 35.34 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.788 0.328 . . . . 0.0 110.411 -176.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.233 -0.889 . . . . 0.0 109.641 176.605 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.939 ' HE2' HG12 ' A' ' 38' ' ' VAL . 26.0 mtm . . . . . 0 N--CA 1.476 0.866 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -98.01 153.89 18.08 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.795 175.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 36.6 p -61.28 -27.9 68.8 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.931 -177.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -57.59 -45.59 85.09 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.98 0.419 . . . . 0.0 110.38 178.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.1 t -62.85 -39.31 84.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.261 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 58.9 mt -62.45 -45.75 98.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.181 177.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 49.3 mttm -57.07 -48.73 77.86 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.091 177.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -59.45 -47.34 85.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.927 179.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -63.62 -47.71 80.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.354 -177.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.418 HD12 HD21 ' A' ' 26' ' ' LEU . 95.5 mt -62.31 -46.98 86.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.195 -177.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -79.01 -6.1 55.54 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.734 0.302 . . . . 0.0 111.497 -177.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -82.42 -45.97 14.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.126 0.489 . . . . 0.0 109.792 173.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 34.9 pt -77.48 -12.21 13.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.941 179.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.46 28.48 10.45 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.771 -0.728 . . . . 0.0 113.06 174.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.511 ' OE2' HG21 ' A' ' 30' ' ' VAL . 3.9 tp10 -88.05 137.23 32.51 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.153 0.501 . . . . 0.0 111.058 -179.037 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -104.3 110.54 22.8 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.301 175.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.402 ' CD1' ' HB2' ' A' ' 19' ' ' GLU . 27.1 p90 -102.79 154.73 18.89 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.152 -177.022 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 58.1 mt -97.34 102.06 12.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 175.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.402 ' HB2' ' CD1' ' A' ' 17' ' ' TYR . 35.9 tt0 -105.84 116.71 32.41 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.491 0.662 . . . . 0.0 111.822 -172.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -94.24 -168.17 1.81 Allowed 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 172.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -68.21 99.79 0.95 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.003 0.43 . . . . 0.0 110.304 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 62.53 32.86 16.35 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.498 -178.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.413 ' HG2' ' HB2' ' A' ' 85' ' ' ARG . 23.2 mt-10 -138.56 113.77 9.44 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.097 174.228 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.512 ' HB ' HG22 ' A' ' 86' ' ' VAL . 64.3 mt -99.8 104.5 16.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 178.127 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 31.1 m-70 -90.85 112.12 23.82 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.981 0.419 . . . . 0.0 110.032 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.418 HD21 HD12 ' A' ' 10' ' ' LEU . 56.5 mt -101.37 -175.62 2.91 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.525 -0.762 . . . . 0.0 111.524 -176.067 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.424 ' HZ2' ' CD ' ' A' ' 15' ' ' GLU . 61.2 mttp -95.35 144.16 27.34 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.389 176.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.499 ' HA ' HG23 ' A' ' 88' ' ' THR . 5.9 Cg_exo -41.59 -49.79 5.06 Favored 'Trans proline' 0 CA--C 1.534 0.486 0 C-N-CA 124.033 3.155 . . . . 0.0 114.391 -175.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -72.33 -40.69 67.22 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.845 0.355 . . . . 0.0 111.142 -175.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.511 HG21 ' OE2' ' A' ' 15' ' ' GLU . 58.3 t -67.01 -40.5 85.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.636 -178.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -59.19 -40.33 85.35 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.453 177.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.605 ' HA ' ' HE1' ' A' ' 93' ' ' PHE . 20.6 t80 -61.12 -33.12 72.88 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.024 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -80.11 -43.59 21.45 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.889 -179.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.441 ' O ' HG11 ' A' ' 38' ' ' VAL . 59.5 t -65.58 -33.11 61.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.848 0.356 . . . . 0.0 110.507 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.464 ' O ' HG22 ' A' ' 38' ' ' VAL . 27.6 t90 -53.05 -40.05 63.68 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.09 176.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 78.2 mttt -70.15 -36.97 75.11 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.271 0.558 . . . . 0.0 110.292 178.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 23.0 t80 -73.07 -30.57 63.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.548 -174.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.939 HG12 ' HE2' ' A' ' 1' ' ' MET . 18.4 m -75.27 -2.17 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-O 120.916 0.389 . . . . 0.0 111.335 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 116.84 -9.45 16.17 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.883 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.406 ' N ' ' HD3' ' A' ' 41' ' ' PRO . 33.4 tt0 58.85 64.73 3.18 Favored Pre-proline 0 CA--C 1.538 0.487 0 CA-C-O 121.044 0.45 . . . . 0.0 111.131 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.475 ' HD3' HG21 ' A' ' 38' ' ' VAL . 92.3 Cg_endo -98.06 -173.24 0.17 Allowed 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 123.331 2.687 . . . . 0.0 112.193 179.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -79.25 116.51 19.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.073 0.463 . . . . 0.0 109.814 176.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.6 mt -75.24 156.72 35.43 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.2 -176.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 57.5 tttm -109.96 129.31 55.68 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.817 -177.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.0 p -109.17 149.52 29.25 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.617 -175.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.52 ' OH ' ' HD2' ' A' ' 75' ' ' LYS . 28.2 p90 -134.85 159.85 40.09 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 176.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 50.6 t -111.98 120.37 62.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 120.948 0.404 . . . . 0.0 110.911 -177.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 8.4 tt -110.48 115.5 49.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.262 0.553 . . . . 0.0 109.561 174.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.46 ' HG2' ' HG2' ' A' ' 72' ' ' LYS . 43.4 mt-10 -95.48 118.91 33.07 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.265 -177.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -121.15 144.37 48.61 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 176.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.66 ' HG2' ' HG2' ' A' ' 70' ' ' LYS . 44.7 mt-10 -103.01 118.51 36.98 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.594 0.235 . . . . 0.0 110.62 -178.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 13.8 tt -74.35 138.73 20.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 176.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.8 m -90.46 131.31 37.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.362 0.601 . . . . 0.0 111.035 -175.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -87.28 162.61 42.59 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.024 -178.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.77 119.39 6.38 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.467 2.111 . . . . 0.0 112.071 175.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -135.39 44.17 1.19 Allowed Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -70.12 -172.79 0.59 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.724 -0.738 . . . . 0.0 111.635 -174.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 23.2 t80 -65.54 -27.44 68.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.125 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -147.55 106.79 3.78 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.264 177.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -85.31 138.62 6.59 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.682 2.255 . . . . 0.0 112.506 178.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -70.62 -22.4 28.18 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.52 2.146 . . . . 0.0 111.505 174.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 46.8 mm-40 -93.7 -159.41 0.69 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.476 175.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.432 ' HE1' ' O ' ' A' ' 65' ' ' TYR . 65.2 mtm -69.03 166.14 18.7 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 174.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -76.3 -8.78 57.83 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.289 0.566 . . . . 0.0 110.552 178.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . 0.432 ' O ' ' HE1' ' A' ' 63' ' ' MET . 91.7 m-85 -135.74 135.28 39.86 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 173.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 11.4 t -138.4 -175.38 4.1 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.669 0.271 . . . . 0.0 110.658 -176.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -90.15 102.51 15.23 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.807 0.337 . . . . 0.0 111.825 -171.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 50.9 t -70.85 136.14 26.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.438 173.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 47.4 mttp -110.47 119.26 38.61 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.119 0.485 . . . . 0.0 111.762 -172.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.66 ' HG2' ' HG2' ' A' ' 51' ' ' GLU . 58.4 mttm -87.11 116.91 25.5 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.083 174.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 30.8 m -99.13 118.34 45.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.362 0.601 . . . . 0.0 110.681 178.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.46 ' HG2' ' HG2' ' A' ' 49' ' ' GLU . 43.8 mttp -83.37 93.59 7.78 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.059 178.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 51.4 mm -92.03 110.26 22.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.27 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 41.0 ttpt -93.63 115.02 27.48 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.051 177.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.52 ' HD2' ' OH ' ' A' ' 46' ' ' TYR . 62.4 mttm -102.62 166.3 10.59 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 177.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 12.6 p -122.35 144.18 32.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.347 -176.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.437 ' HB3' HG22 ' A' ' 87' ' ' VAL . 36.8 p90 -149.8 165.94 30.98 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.02 0.438 . . . . 0.0 111.412 179.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.466 ' CE2' HG13 ' A' ' 38' ' ' VAL . 50.1 p90 -124.36 134.59 53.1 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.196 166.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.444 ' OE1' ' HD2' ' A' ' 85' ' ' ARG . 34.5 tt0 -103.87 118.11 35.93 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.164 -176.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 72.7 p -79.07 179.64 7.23 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.549 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 7.7 mp -66.6 -14.22 62.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.029 0.443 . . . . 0.0 110.658 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.468 ' HB2' HG22 ' A' ' 84' ' ' VAL . 1.9 m-20 -85.54 -1.73 57.41 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.621 -178.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 55.3 m-80 70.35 18.39 6.75 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 123.766 0.666 . . . . 0.0 110.423 -175.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.468 HG22 ' HB2' ' A' ' 82' ' ' ASP . 93.1 t -87.97 123.55 40.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.041 177.373 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.444 ' HD2' ' OE1' ' A' ' 79' ' ' GLU . 0.2 OUTLIER -100.01 108.87 21.17 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.905 -178.964 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.512 HG22 ' HB ' ' A' ' 24' ' ' ILE . 59.6 t -82.92 106.17 13.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 174.138 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.437 HG22 ' HB3' ' A' ' 77' ' ' TYR . 41.4 t -107.0 142.58 19.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.798 -169.131 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.499 HG23 ' HA ' ' A' ' 28' ' ' PRO . 96.0 m -152.07 153.81 34.69 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.309 174.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -64.41 119.02 9.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.288 0.566 . . . . 0.0 111.922 -178.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 83.2 t80 -63.18 -37.48 87.4 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.806 -179.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.6 m -60.2 -45.41 93.26 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.751 178.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.424 ' HA ' ' HB3' ' A' ' 95' ' ' LYS . 22.0 mm-40 -77.93 -30.67 50.64 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.112 -179.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.605 ' HE1' ' HA ' ' A' ' 32' ' ' TYR . 75.7 t80 -61.03 -50.61 72.63 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.966 0.413 . . . . 0.0 110.405 177.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.638 ' HG2' HD11 ' A' ' 97' ' ' LEU . 45.4 mt-30 -77.31 -17.17 58.53 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.991 179.391 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.424 ' HB3' ' HA ' ' A' ' 92' ' ' GLU . 0.8 OUTLIER -69.35 -32.42 71.48 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 173.298 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.423 HD12 ' HB2' ' A' ' 28' ' ' PRO . 56.1 mt -79.03 -33.68 16.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.268 174.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.638 HD11 ' HG2' ' A' ' 94' ' ' GLN . 90.5 mt -59.94 -41.71 92.39 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 171.004 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 7.3 tmtt? -64.36 -40.36 95.69 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.805 176.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 56.7 tttm -62.11 -43.69 98.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.845 178.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 78.2 ttt180 -71.56 -45.44 62.29 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.967 0.413 . . . . 0.0 110.64 177.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 112.5 25.97 4.42 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.846 -0.692 . . . . 0.0 111.811 -177.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 42.6 m -85.18 113.77 21.8 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.952 0.406 . . . . 0.0 110.572 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 45.6 tttm -101.95 111.64 23.98 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.607 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 36.8 tp -98.31 71.21 2.05 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.119 179.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.479 ' HB2' ' CD2' ' A' ' 107' ' ' HIS . 37.8 mt-10 58.27 -165.58 0.17 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.134 178.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 17.4 t-80 -105.39 65.87 0.73 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 174.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.479 ' CD2' ' HB2' ' A' ' 105' ' ' GLU . 14.2 m170 -65.49 127.4 31.68 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 176.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -49.13 -49.25 43.0 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 -160.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 10.4 m-70 -77.68 76.64 4.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.455 0.645 . . . . 0.0 111.734 -177.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 45.8 m80 -156.5 -47.08 0.07 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 114.581 -1.19 . . . . 0.0 107.833 175.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 6.2 t60 . . . . . 0 C--O 1.248 0.988 0 CA-C-N 114.462 -1.245 . . . . 0.0 108.421 172.817 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.487 ' HG2' ' HB ' ' A' ' 5' ' ' VAL . 15.0 tmm? . . . . . 0 N--CA 1.479 1.012 0 CA-C-O 121.098 0.475 . . . . 0.0 110.368 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -112.6 -172.66 2.09 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 174.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.479 ' O ' ' HG3' ' A' ' 7' ' ' LYS . 19.1 p -56.67 -33.02 65.97 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.947 0.404 . . . . 0.0 110.803 177.074 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -51.59 -51.52 54.84 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.801 178.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.487 ' HB ' ' HG2' ' A' ' 1' ' ' MET . 59.9 t -61.38 -48.65 87.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.928 -177.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.441 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 60.4 mt -54.4 -43.12 61.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.02 177.004 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.479 ' HG3' ' O ' ' A' ' 3' ' ' SER . 98.9 mttt -56.88 -49.24 76.13 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.163 178.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -61.01 -41.24 96.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.073 0.463 . . . . 0.0 110.529 -179.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.48 ' O ' HG13 ' A' ' 13' ' ' ILE . 74.5 t80 -62.22 -48.0 81.94 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.705 178.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.462 HD11 ' HB3' ' A' ' 17' ' ' TYR . 87.9 mt -69.45 -33.34 72.78 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.379 -177.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -65.66 -41.32 92.66 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.894 0.378 . . . . 0.0 110.137 176.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -64.05 -37.82 88.83 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.523 177.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.48 HG13 ' O ' ' A' ' 9' ' ' PHE . 59.6 mt -66.68 -41.05 87.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 121.432 0.634 . . . . 0.0 109.756 173.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.01 23.26 25.61 Favored Glycine 0 N--CA 1.446 -0.657 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.791 -179.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 47.8 mm-40 -98.02 158.92 15.26 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.152 0.501 . . . . 0.0 111.322 -178.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -77.72 114.36 16.49 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.981 -177.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.462 ' HB3' HD11 ' A' ' 10' ' ' LEU . 39.3 p90 -111.13 112.15 23.75 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 170.244 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.526 ' HB ' ' HB2' ' A' ' 25' ' ' HIS . 51.6 mt -84.91 95.17 4.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.473 -175.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -76.05 114.03 14.24 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.095 176.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.521 ' HB2' ' HB2' ' A' ' 23' ' ' GLU . 93.6 mt -114.84 169.22 9.24 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 172.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.441 ' O ' ' HB2' ' A' ' 22' ' ' ASN . 40.6 mt-10 -64.39 107.35 1.32 Allowed 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.474 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.441 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 88.2 m-20 80.48 2.95 1.84 Allowed 'General case' 0 N--CA 1.47 0.575 0 O-C-N 124.593 1.183 . . . . 0.0 112.031 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.521 ' HB2' ' HB2' ' A' ' 20' ' ' LEU . 54.6 mt-10 -134.3 150.98 51.01 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.442 0.639 . . . . 0.0 112.424 -177.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 59.1 mt -130.95 109.78 17.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 166.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.526 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 11.7 m170 -89.96 125.09 35.25 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.106 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.4 HD23 HD11 ' A' ' 10' ' ' LEU . 39.8 mt -120.81 175.29 6.11 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.236 0.541 . . . . 0.0 111.388 -177.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.406 ' HB2' HG21 ' A' ' 30' ' ' VAL . 87.2 mttt -93.54 153.66 41.27 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.481 178.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_exo -48.45 -53.08 7.35 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 123.143 2.562 . . . . 0.0 113.571 -176.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -72.02 -37.13 69.83 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.851 0.357 . . . . 0.0 110.88 -176.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.459 ' O ' HG21 ' A' ' 34' ' ' VAL . 47.4 t -63.69 -40.46 89.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.28 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -61.92 -39.22 91.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.431 177.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.41 ' HA ' ' HE1' ' A' ' 93' ' ' PHE . 66.3 t80 -60.63 -43.31 97.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.596 179.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -64.62 -44.56 90.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.062 178.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.459 HG21 ' O ' ' A' ' 30' ' ' VAL . 91.2 t -65.74 -40.95 89.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.99 -179.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.418 ' CD1' ' HD2' ' A' ' 41' ' ' PRO . 28.1 t90 -55.04 -48.09 73.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.623 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 62.9 mttm -72.4 -31.02 65.18 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.266 179.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -63.0 -43.71 98.03 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.231 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.475 HG21 ' HD3' ' A' ' 41' ' ' PRO . 34.9 m -80.54 -5.87 8.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -177.011 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 108.53 12.56 20.98 Favored Glycine 0 C--N 1.331 0.263 0 C-N-CA 120.575 -0.822 . . . . 0.0 113.728 174.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 55.25 78.39 0.39 Allowed Pre-proline 0 N--CA 1.466 0.359 0 C-N-CA 122.838 0.455 . . . . 0.0 111.856 178.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.475 ' HD3' HG21 ' A' ' 38' ' ' VAL . 95.1 Cg_endo -91.64 179.42 1.5 Allowed 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.852 2.368 . . . . 0.0 112.031 175.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -62.75 122.98 17.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.898 176.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 81.3 mt -92.2 132.16 36.87 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.669 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -97.57 137.62 36.21 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 31.6 p -122.41 135.48 54.7 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 120.825 0.345 . . . . 0.0 110.773 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.476 ' CE1' ' HB2' ' A' ' 75' ' ' LYS . 17.3 p90 -122.92 136.6 54.92 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.977 0.418 . . . . 0.0 110.294 179.127 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 50.3 t -96.89 105.0 16.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.981 178.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.451 HG23 ' HB ' ' A' ' 73' ' ' ILE . 8.4 tt -100.8 112.15 32.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 121.153 0.502 . . . . 0.0 110.189 178.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.488 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 45.4 tt0 -93.62 111.01 22.6 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 178.034 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -116.35 155.04 29.16 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.584 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.456 ' HG2' ' HG2' ' A' ' 70' ' ' LYS . 45.5 mt-10 -103.1 130.95 50.42 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.527 -177.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 60.2 mt 68.19 91.61 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.871 177.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 58.1 t -108.59 96.08 4.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.031 179.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.419 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 20.3 mt-10 -93.98 139.65 22.68 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.248 -178.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 54' ' ' GLU . 53.0 Cg_exo -55.2 -51.36 10.31 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 123.253 2.635 . . . . 0.0 113.199 -174.186 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -166.75 -36.11 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.661 -0.781 . . . . 0.0 111.812 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -98.46 136.83 38.03 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 172.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -84.03 152.71 24.25 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.696 -177.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -59.28 129.7 86.74 Favored Pre-proline 0 C--N 1.325 -0.481 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 172.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -40.95 111.86 0.17 Allowed 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 124.07 3.18 . . . . 0.0 112.969 -175.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -65.07 94.5 0.23 Allowed 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 123.076 2.517 . . . . 0.0 112.001 -178.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 54.7 mm-40 -127.33 177.24 6.84 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.431 -178.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 54.6 ttp -80.93 83.17 6.71 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 172.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -158.06 145.39 18.14 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.652 -171.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -96.85 94.19 7.09 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.82 0.343 . . . . 0.0 110.347 178.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 26.1 m -77.94 140.76 39.28 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.769 177.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -62.12 124.46 20.91 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.937 0.399 . . . . 0.0 111.304 -175.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 46.2 t -88.79 110.83 21.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.008 178.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 9.4 tmtm? -107.31 127.75 53.83 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.092 -179.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.456 ' HG2' ' HG2' ' A' ' 51' ' ' GLU . 67.3 mttm -87.22 128.34 35.15 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.858 179.188 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' A' ' 49' ' ' GLU . 41.0 t -117.85 115.36 48.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 C-N-CA 121.199 -0.2 . . . . 0.0 110.744 -179.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -81.77 103.26 11.33 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 174.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.451 ' HB ' HG23 ' A' ' 48' ' ' ILE . 55.1 mt -98.54 108.98 23.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.681 -178.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 57.4 tttp -87.12 103.03 15.01 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 176.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.476 ' HB2' ' CE1' ' A' ' 46' ' ' TYR . 97.5 mttt -104.91 163.73 12.31 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.337 178.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.9 p -116.84 141.11 36.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.946 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.464 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 33.8 p90 -149.01 152.4 36.22 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.612 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -131.28 144.43 51.28 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 170.477 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -102.03 130.4 48.57 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.305 -175.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 32.9 p -76.13 178.99 5.95 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.152 174.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 8.2 mp -70.46 -23.96 62.8 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.71 0.29 . . . . 0.0 110.822 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -90.06 8.92 30.22 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.337 0.589 . . . . 0.0 109.608 175.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 13.5 m120 65.77 30.39 10.16 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 114.711 -1.131 . . . . 0.0 112.906 171.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 43.3 t -87.89 127.28 41.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 171.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 34.2 mtt180 -93.25 108.38 20.02 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.214 -172.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.464 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 57.4 t -82.27 110.89 17.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 174.565 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 39.8 t -113.26 137.24 46.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.436 -171.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 59.1 m -148.27 154.74 40.44 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 174.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -66.61 126.27 28.4 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.95 0.405 . . . . 0.0 110.688 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -75.59 -26.19 57.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.68 -174.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.468 ' O ' ' HG3' ' A' ' 95' ' ' LYS . 28.1 t -69.74 -43.67 71.8 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -64.31 -39.16 93.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.102 0.477 . . . . 0.0 110.21 176.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.41 ' HE1' ' HA ' ' A' ' 32' ' ' TYR . 59.6 t80 -64.24 -42.32 96.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.372 178.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 26.3 mm-40 -60.58 -37.91 82.88 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.235 176.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.468 ' HG3' ' O ' ' A' ' 91' ' ' SER . 99.3 mttt -55.55 -49.68 72.03 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.862 0.363 . . . . 0.0 110.282 176.399 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 66.9 mt -64.05 -40.8 90.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.047 -178.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 97.4 mt -58.71 -46.65 86.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.1 0.476 . . . . 0.0 110.713 177.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.503 ' HB3' ' HZ3' ' A' ' 98' ' ' LYS . 9.0 mtpm? -73.65 -34.51 64.99 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.064 -179.175 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -64.39 -44.84 90.05 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.996 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.418 HH11 ' HD3' ' A' ' 100' ' ' ARG . 52.1 mtt180 -84.99 -18.65 33.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.795 0.331 . . . . 0.0 111.194 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 78.02 33.81 39.87 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.834 -0.698 . . . . 0.0 111.773 -179.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 27.2 m -62.95 128.11 34.36 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.886 0.374 . . . . 0.0 110.341 -179.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -80.61 109.44 15.14 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.071 0.462 . . . . 0.0 110.755 -176.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 89.4 mt -86.29 154.47 21.23 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.44 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -70.33 100.73 1.78 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.103 -178.134 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -78.54 103.85 8.76 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.071 177.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -101.8 139.9 36.81 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.121 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 12.8 t-80 -82.68 -29.03 30.23 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 12.7 m80 -134.75 111.54 10.03 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.349 174.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 53.1 p-80 -64.49 -47.54 78.58 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 175.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 . . . . . 0 C--O 1.247 0.944 0 C-N-CA 123.9 0.88 . . . . 0.0 109.464 175.819 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.433 ' HA ' HG22 ' A' ' 5' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.988 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -143.9 178.08 8.09 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 179.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 35.3 p -64.08 -29.96 71.06 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.15 0.5 . . . . 0.0 110.146 175.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -64.75 -38.1 89.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.012 176.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.433 HG22 ' HA ' ' A' ' 1' ' ' MET . 95.9 t -62.64 -41.66 93.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.879 175.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 73.8 mt -62.42 -43.72 98.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.36 176.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 53.5 mttp -52.27 -53.71 40.54 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.744 175.264 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -70.63 -25.81 63.19 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.915 -175.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -67.46 -43.51 80.89 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.353 0.596 . . . . 0.0 109.905 174.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.479 HD12 ' HB3' ' A' ' 17' ' ' TYR . 69.8 mt -72.29 -34.31 68.06 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.392 178.334 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -64.0 -32.31 73.81 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.385 177.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -63.74 -58.88 5.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.614 179.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.8 pt -76.89 -17.36 14.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.797 -176.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 79.42 46.9 7.74 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.806 -179.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -97.78 169.18 9.85 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.929 0.395 . . . . 0.0 110.985 -178.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -96.94 137.25 36.33 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.112 -177.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.479 ' HB3' HD12 ' A' ' 10' ' ' LEU . 24.6 p90 -133.32 115.89 15.46 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.224 0.535 . . . . 0.0 110.223 173.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.435 ' HB ' ' HB2' ' A' ' 25' ' ' HIS . 57.4 mt -85.48 92.11 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 175.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.5 ' HG3' HG12 ' A' ' 24' ' ' ILE . 33.2 tt0 -103.51 104.46 14.53 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.247 -171.034 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 85.5 mt -79.61 -174.32 4.23 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 173.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -69.47 100.44 1.4 Allowed 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.042 0.448 . . . . 0.0 109.875 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 71.17 29.42 2.87 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.517 -177.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.563 ' HA ' ' O ' ' A' ' 85' ' ' ARG . 5.1 mt-10 -144.61 113.51 6.81 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 177.04 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.5 HG12 ' HG3' ' A' ' 19' ' ' GLU . 51.2 mt -101.2 108.21 22.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 110.175 -0.306 . . . . 0.0 110.175 179.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.532 ' HA ' ' O ' ' A' ' 87' ' ' VAL . 24.4 m-70 -96.18 119.12 34.1 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.77 0.319 . . . . 0.0 110.263 178.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 98.3 mt -116.33 173.58 6.52 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.166 -176.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -73.8 147.1 86.24 Favored Pre-proline 0 C--N 1.329 -0.318 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 172.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.441 ' HA ' HG23 ' A' ' 88' ' ' THR . 82.5 Cg_exo -47.07 -51.28 9.61 Favored 'Trans proline' 0 CA--C 1.53 0.284 0 C-N-CA 123.137 2.558 . . . . 0.0 113.606 -178.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -71.22 -34.33 70.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.748 0.309 . . . . 0.0 111.196 -177.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.442 ' O ' HG22 ' A' ' 34' ' ' VAL . 58.1 t -67.41 -45.96 84.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.939 0.399 . . . . 0.0 110.187 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -61.15 -38.58 86.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.079 175.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.525 ' HA ' ' HE1' ' A' ' 93' ' ' PHE . 19.1 t80 -56.74 -38.56 72.56 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.274 178.053 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.419 ' CD ' ' HZ1' ' A' ' 36' ' ' LYS . 68.8 mm-40 -76.17 -36.68 58.59 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 121.139 -0.224 . . . . 0.0 111.182 177.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.442 HG22 ' O ' ' A' ' 30' ' ' VAL . 77.3 t -66.17 -33.12 61.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.093 0.473 . . . . 0.0 110.225 177.232 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.533 ' CZ2' ' HG3' ' A' ' 40' ' ' GLU . 45.9 t90 -56.98 -40.01 75.72 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.797 176.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.419 ' HZ1' ' CD ' ' A' ' 33' ' ' GLU . 80.8 mttt -70.42 -42.67 71.29 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.195 0.522 . . . . 0.0 109.679 175.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -58.64 -38.9 79.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.086 -176.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.465 HG23 ' HD3' ' A' ' 41' ' ' PRO . 34.6 m -82.53 3.89 2.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.958 -178.138 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 100.57 14.68 31.66 Favored Glycine 0 C--N 1.329 0.193 0 C-N-CA 120.665 -0.779 . . . . 0.0 114.489 170.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.533 ' HG3' ' CZ2' ' A' ' 35' ' ' TRP . 35.7 tt0 57.09 72.78 0.88 Allowed Pre-proline 0 N--CA 1.468 0.456 0 CA-C-O 120.965 0.412 . . . . 0.0 111.359 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.465 ' HD3' HG23 ' A' ' 38' ' ' VAL . 78.4 Cg_endo -98.26 173.15 0.56 Allowed 'Trans proline' 0 N--CA 1.449 -1.1 0 C-N-CA 123.091 2.527 . . . . 0.0 112.135 175.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -75.02 146.58 41.47 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 173.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 82.3 mt -112.34 153.85 26.62 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.913 0.387 . . . . 0.0 111.426 -173.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.501 ' HE3' ' OE1' ' A' ' 79' ' ' GLU . 64.4 mttm -101.46 145.43 28.98 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.6 178.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 24.4 p -127.83 138.58 52.76 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.906 0.384 . . . . 0.0 111.278 -178.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -134.28 146.79 50.36 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.862 179.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 41.3 t -107.93 116.0 50.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 120.739 0.304 . . . . 0.0 110.659 -179.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 10.2 pt -107.12 139.92 27.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.377 175.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.585 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 25.7 mt-10 -116.89 87.89 2.79 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.238 -177.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -118.96 103.37 9.52 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.193 0.521 . . . . 0.0 111.533 -177.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.557 ' HB2' HG11 ' A' ' 71' ' ' VAL . 35.5 tt0 -140.87 -62.99 0.48 Allowed 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 170.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.582 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 11.3 tt -159.82 109.02 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.318 0.58 . . . . 0.0 110.589 173.052 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.2 m -105.48 154.96 6.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.0 176.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.502 ' HB3' HG12 ' A' ' 68' ' ' VAL . 15.8 pt-20 -92.81 138.66 23.43 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-O 120.803 0.335 . . . . 0.0 111.058 -176.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -83.83 -167.67 0.47 Allowed 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 122.913 2.409 . . . . 0.0 111.408 173.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -135.55 33.01 2.47 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.546 -0.835 . . . . 0.0 111.686 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 51.6 tt0 -61.16 -39.85 91.65 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.135 0.493 . . . . 0.0 110.059 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -119.0 93.03 3.95 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 174.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -69.14 109.54 4.57 Favored Pre-proline 0 C--N 1.323 -0.568 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -178.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -84.12 159.98 13.45 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 122.97 2.447 . . . . 0.0 113.468 -169.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -62.75 165.41 16.11 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.782 2.321 . . . . 0.0 111.702 174.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -72.82 -5.8 40.6 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.424 -174.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 86.5 mtp -94.3 -10.71 31.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.938 178.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -121.08 136.53 54.96 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.444 -0.343 . . . . 0.0 110.76 -175.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 47.5 p90 -138.42 171.16 14.79 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.235 -0.439 . . . . 0.0 109.927 178.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 12.1 m -121.37 126.22 48.88 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.19 -177.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -80.81 100.91 9.05 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.141 0.495 . . . . 0.0 110.391 -177.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.582 ' HB ' ' O ' ' A' ' 52' ' ' ILE . 15.2 m -113.92 173.61 3.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.895 177.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.434 ' HB3' ' HE2' ' A' ' 69' ' ' LYS . 40.6 mtpt -130.33 135.96 48.61 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 121.369 0.604 . . . . 0.0 112.437 -172.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 49.4 mttm -113.96 114.1 25.72 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.324 175.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.585 ' O ' ' HA ' ' A' ' 49' ' ' GLU . 7.6 p -99.27 115.15 39.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 172.443 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -81.36 97.75 7.86 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.227 0.536 . . . . 0.0 110.927 -173.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 69.2 mt -102.96 109.23 26.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.075 177.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.509 ' O ' ' HB3' ' A' ' 90' ' ' TYR . 82.8 tttt -88.88 127.79 35.65 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.78 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 72.5 mttt -124.59 165.25 18.19 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.657 0.265 . . . . 0.0 110.58 179.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 8.4 p -125.91 141.86 44.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.839 -173.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 14.0 p90 -155.34 168.36 27.34 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.83 0.348 . . . . 0.0 111.014 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -135.09 157.61 46.49 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.435 -0.579 . . . . 0.0 109.435 171.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.501 ' OE1' ' HE3' ' A' ' 44' ' ' LYS . 39.3 mt-10 -106.49 132.59 52.32 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.378 -176.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 69.7 p -84.66 166.97 16.64 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 175.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -67.7 -21.36 65.33 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.911 0.386 . . . . 0.0 110.496 178.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -90.81 16.9 8.44 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.103 178.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 66.6 t30 70.33 20.72 6.02 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 115.604 -0.725 . . . . 0.0 112.269 170.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 96.0 t -99.68 133.36 42.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.228 0.537 . . . . 0.0 110.208 176.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.563 ' O ' ' HA ' ' A' ' 23' ' ' GLU . 66.3 mtm180 -101.99 115.4 30.46 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.429 -176.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 43.1 t -91.84 108.57 20.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 177.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.532 ' O ' ' HA ' ' A' ' 25' ' ' HIS . 16.8 t -111.89 143.16 22.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.527 -170.146 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.441 HG23 ' HA ' ' A' ' 28' ' ' PRO . 91.4 m -150.66 154.46 37.51 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.887 176.277 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.63 120.44 13.45 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.827 0.822 . . . . 0.0 111.972 -177.377 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.509 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 82.4 t80 -65.65 -38.39 89.22 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.343 -1.298 . . . . 0.0 111.774 -173.193 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.495 ' O ' ' HG3' ' A' ' 95' ' ' LYS . 42.9 t -54.73 -56.62 17.25 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.634 -177.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 20.5 tp10 -71.39 -34.55 70.5 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.777 -175.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.525 ' HE1' ' HA ' ' A' ' 32' ' ' TYR . 83.8 t80 -64.01 -42.58 97.11 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.777 178.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 53.4 mm-40 -65.73 -31.63 72.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.304 178.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.538 ' O ' ' HG3' ' A' ' 99' ' ' LYS . 91.3 mttt -59.53 -44.76 93.11 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 174.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 65.1 mt -56.04 -50.06 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.772 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 87.5 mt -63.82 -36.4 83.77 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.597 179.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 59.1 tttm -66.57 -41.96 87.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.653 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.538 ' HG3' ' O ' ' A' ' 95' ' ' LYS . 90.9 mttt -64.29 -37.17 86.53 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.755 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 33.1 mtp180 -67.43 -32.52 73.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.351 176.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 79.19 36.13 28.33 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.375 -0.917 . . . . 0.0 110.858 -175.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 21.6 m -71.37 129.22 38.28 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.304 -0.448 . . . . 0.0 110.873 -177.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -91.43 129.73 37.37 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.35 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 92.3 mt -80.78 4.47 18.93 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.5 0.667 . . . . 0.0 109.787 176.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -95.62 109.28 21.55 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.409 179.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 34.2 m170 -90.7 90.15 7.82 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 173.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 80.6 m-70 -83.36 125.66 31.89 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.988 0.423 . . . . 0.0 111.411 -176.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 14.6 t-80 -86.09 107.86 18.02 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.785 174.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 44.7 m-70 -91.54 169.84 10.42 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 55.1 t-80 -79.44 -49.24 12.62 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 85.9 t60 . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.223 -0.894 . . . . 0.0 110.769 178.375 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.0 ppp? . . . . . 0 N--CA 1.478 0.926 0 CA-C-O 121.114 0.483 . . . . 0.0 110.66 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -136.89 172.34 13.15 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.404 178.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.8 m -62.88 -34.34 77.18 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.307 0.575 . . . . 0.0 110.166 178.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -67.7 -35.38 78.69 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.899 176.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 89.8 t -64.59 -34.76 71.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.066 0.46 . . . . 0.0 110.131 178.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 74.7 mt -63.54 -44.82 98.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.91 -0.587 . . . . 0.0 109.948 174.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -59.84 -46.41 89.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.407 177.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -51.07 -49.59 60.34 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.173 176.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -62.4 -43.58 98.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.011 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.472 HD11 ' HB3' ' A' ' 17' ' ' TYR . 96.7 mt -69.61 -35.94 75.73 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.58 -177.227 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -70.24 -33.39 71.57 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 121.071 -0.252 . . . . 0.0 110.607 176.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -62.8 -53.77 49.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.584 178.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 30.1 pt -72.42 -24.49 22.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.121 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.54 47.43 4.59 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.022 178.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -111.37 -179.8 3.82 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.125 0.488 . . . . 0.0 111.387 -178.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -122.03 130.84 53.63 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.009 -173.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.472 ' HB3' HD11 ' A' ' 10' ' ' LEU . 51.5 p90 -123.04 144.56 49.2 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.565 177.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.541 ' HB ' ' HB2' ' A' ' 25' ' ' HIS . 75.5 mt -90.08 99.72 9.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 177.06 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.437 ' HB2' ' CE1' ' A' ' 17' ' ' TYR . 37.8 tt0 -92.56 106.98 18.86 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.089 -175.019 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 70.5 mt -112.58 166.31 11.45 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 172.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -60.39 106.03 0.49 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.043 0.449 . . . . 0.0 110.723 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 68.78 14.88 8.99 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 114.87 -1.059 . . . . 0.0 112.187 -179.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -138.46 113.71 9.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.873 0.368 . . . . 0.0 111.153 178.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.471 ' HB ' HG21 ' A' ' 86' ' ' VAL . 66.5 mt -105.28 104.76 17.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 174.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.541 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 20.0 m-70 -91.65 115.79 28.34 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -179.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 73.4 mt -105.16 153.76 21.11 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.953 -177.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.5 mtmm -77.22 133.76 68.08 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 173.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.442 ' HB2' HD13 ' A' ' 96' ' ' ILE . 7.0 Cg_endo -48.52 -43.97 31.62 Favored 'Trans proline' 0 CA--C 1.529 0.257 0 C-N-CA 123.685 2.923 . . . . 0.0 113.145 -175.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -57.4 -34.54 68.98 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 121.104 0.478 . . . . 0.0 111.504 -178.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 47.1 t -94.43 -32.17 4.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.733 -176.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.488 ' HE1' ' HE1' ' A' ' 78' ' ' PHE . 81.8 t80 -56.72 -35.23 68.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.187 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -58.98 -33.72 71.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.366 -178.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -77.94 -44.37 27.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.819 0.343 . . . . 0.0 110.594 179.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 46.3 t -63.67 -36.52 76.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.76 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.412 ' CD1' ' HD2' ' A' ' 41' ' ' PRO . 27.2 t90 -55.25 -45.38 76.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.941 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 74.8 mttt -78.2 -33.17 50.14 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.969 -0.293 . . . . 0.0 111.082 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 91.1 t80 -58.11 -37.37 74.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.879 178.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.415 HG22 ' HD3' ' A' ' 41' ' ' PRO . 33.6 m -89.73 7.83 3.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.757 -177.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 99.7 15.57 31.28 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.718 -0.753 . . . . 0.0 113.967 172.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 49.2 mt-10 54.54 67.7 3.17 Favored Pre-proline 0 N--CA 1.469 0.52 0 C-N-CA 122.693 0.397 . . . . 0.0 111.424 179.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.415 ' HD3' HG22 ' A' ' 38' ' ' VAL . 5.7 Cg_exo -78.05 162.86 28.68 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 122.884 2.39 . . . . 0.0 111.958 -179.307 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -69.24 139.01 54.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.628 176.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.547 ' HB3' ' CG2' ' A' ' 76' ' ' VAL . 94.8 mt -111.05 134.29 52.77 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.216 -173.287 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -104.59 139.05 40.02 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.269 -0.423 . . . . 0.0 109.918 177.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 19.4 p -106.33 140.97 38.42 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.186 -178.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 6.5 p90 -124.84 153.71 42.15 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 175.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 66.5 t -111.91 113.51 44.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-O 121.024 0.44 . . . . 0.0 111.183 -174.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.43 HG22 ' HB ' ' A' ' 73' ' ' ILE . 8.2 tt -104.69 105.51 18.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 173.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.508 ' HB2' ' HG2' ' A' ' 72' ' ' LYS . 39.1 tt0 -85.49 116.56 23.87 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.606 -178.281 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -109.22 147.23 32.9 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.278 178.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.684 ' HG2' ' HG2' ' A' ' 70' ' ' LYS . 49.4 mt-10 -103.21 117.57 34.83 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.114 0.483 . . . . 0.0 111.252 -178.267 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 6.4 tp -89.71 132.13 35.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.762 178.203 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.1 t -90.59 141.95 13.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.173 -177.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -87.41 139.0 31.81 Favored Pre-proline 0 C--N 1.321 -0.654 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -31.93 110.24 0.04 OUTLIER 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 124.345 3.364 . . . . 0.0 114.065 -178.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -135.5 38.39 1.8 Allowed Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.044 178.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -68.82 -30.56 69.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.629 0.728 . . . . 0.0 109.324 179.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -124.8 -175.62 3.33 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.13 174.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.459 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 9.5 m-20 -101.73 146.29 31.99 Favored Pre-proline 0 C--N 1.321 -0.672 0 CA-C-O 120.78 0.324 . . . . 0.0 111.022 -177.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 59' ' ' ASP . 12.1 Cg_exo -71.02 160.92 47.81 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 123.013 2.476 . . . . 0.0 111.699 177.145 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -65.94 -24.15 53.59 Favored 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 122.725 2.284 . . . . 0.0 112.318 178.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -93.12 167.82 11.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.482 177.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 91.2 mmm -97.79 21.41 10.53 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.038 -175.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 52.0 mttp -120.93 144.56 48.38 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.806 0.336 . . . . 0.0 110.725 -178.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -111.39 144.18 41.01 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.548 176.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 16.4 p -92.48 -179.3 5.16 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.895 0.379 . . . . 0.0 111.905 -176.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 34.1 m-80 -93.13 166.23 12.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.124 -178.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.501 ' CG1' ' HB3' ' A' ' 51' ' ' GLU . 3.8 t -79.43 153.85 4.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 -179.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 17.1 tttp -100.06 116.47 32.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.712 0.291 . . . . 0.0 110.28 -176.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.684 ' HG2' ' HG2' ' A' ' 51' ' ' GLU . 58.5 mttp -84.99 130.88 34.55 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.805 0.336 . . . . 0.0 111.689 -177.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 15.3 m -127.97 120.23 53.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.46 0.648 . . . . 0.0 110.464 173.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.508 ' HG2' ' HB2' ' A' ' 49' ' ' GLU . 60.5 mttp -81.57 115.26 20.77 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.934 -179.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.43 ' HB ' HG22 ' A' ' 48' ' ' ILE . 60.9 mt -95.17 110.58 24.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.934 177.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -90.02 115.4 27.27 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.464 -178.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -118.22 167.11 11.82 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.299 178.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.547 ' CG2' ' HB3' ' A' ' 43' ' ' LEU . 12.0 p -126.19 150.09 31.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.636 -0.256 . . . . 0.0 110.616 -174.204 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -155.09 164.68 38.53 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.798 0.332 . . . . 0.0 110.77 179.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.488 ' HE1' ' HE1' ' A' ' 31' ' ' PHE . 50.7 p90 -134.69 152.67 51.94 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 170.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.529 ' HG2' ' HG2' ' A' ' 85' ' ' ARG . 33.7 mt-10 -102.31 127.07 49.46 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.162 -175.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 81.1 p -83.97 174.88 9.97 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.742 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.9 mp -71.2 -12.08 61.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.113 0.482 . . . . 0.0 110.613 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -92.22 4.76 52.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.491 -179.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 66.8 t30 70.88 21.26 5.13 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.728 0.775 . . . . 0.0 109.884 -178.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 99.2 t -100.05 136.46 31.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.643 178.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.529 ' HG2' ' HG2' ' A' ' 79' ' ' GLU . 69.0 mtt180 -107.5 119.22 38.8 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.148 0.499 . . . . 0.0 111.243 -176.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.471 HG21 ' HB ' ' A' ' 24' ' ' ILE . 87.1 t -89.63 111.06 22.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.675 177.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 25' ' ' HIS . 40.9 t -105.62 140.42 23.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.18 -173.233 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 58.9 m -147.91 152.45 37.58 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 176.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -67.87 126.92 30.96 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.782 0.325 . . . . 0.0 110.724 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -77.97 -30.23 50.14 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.045 -174.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 9.4 t -71.96 -40.63 68.52 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 -179.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.417 ' O ' HG13 ' A' ' 96' ' ' ILE . 35.8 mt-10 -69.49 -37.55 77.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.635 176.122 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -61.75 -47.22 86.18 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.931 0.396 . . . . 0.0 110.479 177.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 68.4 mm-40 -65.65 -31.33 72.28 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.016 178.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 57.9 tptt -66.19 -36.13 82.27 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 176.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.443 ' HA ' ' HG3' ' A' ' 99' ' ' LYS . 64.7 mt -67.12 -38.8 81.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.054 0.454 . . . . 0.0 110.501 176.013 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 73.1 mt -63.13 -25.97 68.6 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.166 176.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -79.37 -26.68 41.98 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.064 176.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.443 ' HG3' ' HA ' ' A' ' 96' ' ' ILE . 33.5 mttp -61.92 -51.62 67.38 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-O 121.239 0.542 . . . . 0.0 109.875 175.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -86.19 -30.03 22.75 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.035 -173.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.15 50.58 4.78 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.266 -175.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 35.9 m -64.68 115.01 4.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.983 0.42 . . . . 0.0 110.882 -178.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -80.37 6.32 12.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.055 -173.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 72.3 mt -72.22 -23.54 61.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.886 0.374 . . . . 0.0 110.667 178.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -132.74 157.88 43.81 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.769 175.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 67.1 m-70 57.77 87.35 0.07 Allowed 'General case' 0 N--CA 1.466 0.358 0 O-C-N 123.851 0.719 . . . . 0.0 111.179 174.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -95.11 -16.92 22.26 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.34 -175.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 48.5 m-70 -107.89 137.8 45.27 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.29 176.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 59.9 m80 -88.9 87.85 7.38 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.465 0.65 . . . . 0.0 110.676 -178.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -91.22 134.4 34.59 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.047 -178.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 46.0 m80 . . . . . 0 C--O 1.248 0.992 0 CA-C-O 118.369 -0.824 . . . . 0.0 110.163 179.52 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.067 0 CA-C-O 120.821 0.343 . . . . 0.0 110.119 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -120.42 172.14 8.03 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 176.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.7 p -63.83 -28.29 69.75 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.089 0.471 . . . . 0.0 110.102 175.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -62.33 -43.47 98.75 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.031 175.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 99.5 t -61.26 -39.63 83.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.033 176.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.541 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 63.5 mt -63.44 -41.48 92.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.3 177.386 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -54.95 -49.56 71.08 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.768 177.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -60.3 -36.9 78.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.898 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.454 ' O ' HG12 ' A' ' 13' ' ' ILE . 90.5 t80 -67.95 -44.43 76.78 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.299 177.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.541 ' HG ' ' O ' ' A' ' 6' ' ' ILE . 86.2 mt -66.73 -43.37 84.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.261 -178.467 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -65.57 -30.07 70.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.954 0.406 . . . . 0.0 110.938 179.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -75.23 -47.3 28.81 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.26 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.454 HG12 ' O ' ' A' ' 9' ' ' PHE . 40.3 pt -77.85 -37.92 24.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 121.041 -0.264 . . . . 0.0 111.504 -178.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 114.36 75.76 0.67 Allowed Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.904 178.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.514 ' HG2' HD23 ' A' ' 26' ' ' LEU . 3.8 tp10 -132.83 133.59 43.55 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 174.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -102.09 106.9 17.84 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 176.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.499 ' HB3' HD22 ' A' ' 26' ' ' LEU . 11.0 p90 -111.08 153.02 26.26 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.199 0.524 . . . . 0.0 112.241 -171.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.509 ' HB ' ' HB2' ' A' ' 25' ' ' HIS . 64.5 mt -89.35 107.18 17.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.355 174.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -94.29 97.74 10.44 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.38 0.61 . . . . 0.0 110.789 -179.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 91.9 mt -101.4 162.04 13.19 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 171.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -64.66 116.32 6.11 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 119.954 -0.699 . . . . 0.0 109.931 -178.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.428 ' O ' ' HG2' ' A' ' 85' ' ' ARG . 72.5 m-20 75.65 7.32 3.87 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 114.977 -1.011 . . . . 0.0 111.765 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -140.03 113.83 8.77 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-O 121.083 0.468 . . . . 0.0 112.191 -179.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 70.8 mt -109.4 116.36 51.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 173.495 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.509 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 23.6 m-70 -98.44 121.77 40.79 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.644 0.259 . . . . 0.0 111.073 -177.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.514 HD23 ' HG2' ' A' ' 15' ' ' GLU . 91.8 mt -117.25 161.81 18.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.633 -179.191 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 34.1 mttp -72.63 144.98 86.75 Favored Pre-proline 0 C--N 1.328 -0.356 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 172.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_exo -52.01 -33.75 54.05 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.25 1.966 . . . . 0.0 111.391 174.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -53.28 -57.31 10.98 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.168 175.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 45.1 t -79.57 -36.35 17.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.048 -175.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -55.21 -38.85 68.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.411 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.605 ' HA ' ' HE1' ' A' ' 93' ' ' PHE . 23.8 t80 -55.56 -44.82 77.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.426 177.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -78.89 -32.52 45.87 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.176 -177.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 84.7 t -65.22 -38.59 83.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 175.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 29.6 t90 -57.89 -42.33 84.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.117 176.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -63.02 -47.09 84.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.643 174.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 88.9 t80 -59.06 -43.88 91.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.044 -177.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.493 HG21 ' HD3' ' A' ' 41' ' ' PRO . 34.1 m -75.23 -8.46 11.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -175.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 108.21 5.02 32.93 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.442 -0.885 . . . . 0.0 113.107 175.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 57.02 76.03 0.52 Allowed Pre-proline 0 C--N 1.329 -0.307 0 C-N-CA 122.862 0.465 . . . . 0.0 112.014 178.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.493 ' HD3' HG21 ' A' ' 38' ' ' VAL . 57.7 Cg_endo -93.5 -172.63 0.33 Allowed 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 123.218 2.612 . . . . 0.0 111.22 175.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -72.02 148.15 46.15 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.085 0.469 . . . . 0.0 110.557 176.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 83.7 mt -111.95 132.76 54.56 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.225 -179.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -96.37 140.23 31.33 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 177.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 43.7 p -119.87 140.77 50.32 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 120.695 0.283 . . . . 0.0 110.527 178.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -122.68 141.8 51.36 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 177.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 48.2 t -97.37 108.57 21.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.786 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 10.1 tt -113.17 137.64 45.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.207 -179.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -96.1 87.85 4.67 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.26 177.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -94.12 100.26 12.39 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 167.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.714 ' HG2' ' HA ' ' A' ' 70' ' ' LYS . 30.8 mt-10 -77.87 147.02 35.31 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.574 -1.194 . . . . 0.0 111.438 -168.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 51.3 mm -110.86 88.61 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.365 0.602 . . . . 0.0 109.495 176.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.577 HG23 ' HA ' ' A' ' 68' ' ' VAL . 46.1 t -94.63 95.41 5.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.698 179.155 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.411 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 10.9 pt-20 -99.36 125.58 40.69 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-O 121.124 0.488 . . . . 0.0 110.175 179.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 54' ' ' GLU . 19.6 Cg_exo -67.03 169.13 15.62 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.705 2.27 . . . . 0.0 112.383 178.216 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -135.35 44.03 1.2 Allowed Glycine 0 N--CA 1.447 -0.592 0 N-CA-C 110.661 -0.976 . . . . 0.0 110.661 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -65.32 76.44 0.06 Allowed 'General case' 0 C--O 1.234 0.274 0 N-CA-C 112.454 0.538 . . . . 0.0 112.454 -173.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -145.84 -80.18 0.16 Allowed 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 173.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 34.3 t70 172.37 101.27 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 114.051 -1.431 . . . . 0.0 107.805 172.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -53.31 111.73 0.75 Allowed 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 123.302 2.668 . . . . 0.0 113.428 -173.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -86.67 -20.81 2.4 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 122.937 2.425 . . . . 0.0 111.957 176.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -119.26 148.37 43.22 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.752 -178.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 95.6 mmm -102.62 -167.79 1.44 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.661 -179.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 62.1 mttp 63.2 26.69 15.33 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.542 0.687 . . . . 0.0 109.287 -171.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 22.6 t80 -91.52 128.51 37.38 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.224 -175.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.2 m -130.48 113.0 13.74 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.445 -179.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.497 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 6.0 m-20 -70.69 -44.06 67.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.937 0.399 . . . . 0.0 110.817 178.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.577 ' HA ' HG23 ' A' ' 53' ' ' VAL . 40.1 t -78.79 88.04 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.099 0.476 . . . . 0.0 110.548 -177.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 60.4 tttm -100.24 107.82 19.74 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.723 176.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.714 ' HA ' ' HG2' ' A' ' 51' ' ' GLU . 66.2 mttm -80.3 111.49 16.74 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.262 -178.182 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.8 t -103.47 102.94 14.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.766 -175.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 51.8 mttm -81.88 99.04 8.82 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.304 176.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.565 HG23 ' HG3' ' A' ' 75' ' ' LYS . 44.3 mm -97.46 120.23 46.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.174 0.511 . . . . 0.0 110.55 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.525 ' O ' ' HB3' ' A' ' 90' ' ' TYR . 57.2 tttp -85.58 101.87 13.06 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.283 178.312 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.565 ' HG3' HG23 ' A' ' 73' ' ' ILE . 74.6 mttt -102.43 154.96 18.58 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.171 -177.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 14.9 p -116.84 147.79 19.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.639 0.256 . . . . 0.0 111.258 -172.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.47 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 50.6 p90 -153.79 154.04 33.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.935 178.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -123.76 149.54 45.49 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 171.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -102.77 135.71 43.92 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.709 -174.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 59.7 p -89.85 -176.3 4.89 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.617 179.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.519 ' O ' HD12 ' A' ' 81' ' ' LEU . 2.1 tm? -63.89 -24.64 67.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.28 0.562 . . . . 0.0 109.803 178.047 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.422 ' O ' ' HB2' ' A' ' 83' ' ' ASN . 0.8 OUTLIER -81.75 1.33 34.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.841 -177.237 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.422 ' HB2' ' O ' ' A' ' 82' ' ' ASP . 47.1 m-80 71.46 6.62 5.8 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 123.572 0.545 . . . . 0.0 110.776 -176.114 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 85.1 t -83.55 132.54 31.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.731 178.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.428 ' HG2' ' O ' ' A' ' 22' ' ' ASN . 40.9 ptt180 -101.4 131.35 47.54 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.398 0.618 . . . . 0.0 111.109 -177.369 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 59.5 t -94.17 111.26 24.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.384 177.092 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.45 HG22 ' HB3' ' A' ' 77' ' ' TYR . 16.1 t -104.92 142.91 17.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.285 -171.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 8.1 t -151.42 -173.21 4.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.646 175.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -84.83 119.51 25.4 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.899 0.381 . . . . 0.0 110.56 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.525 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 76.3 t80 -70.28 -40.85 74.08 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.484 -176.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.584 ' O ' ' HG3' ' A' ' 95' ' ' LYS . 18.0 m -58.75 -56.94 15.72 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.36 -174.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.466 ' O ' HG13 ' A' ' 96' ' ' ILE . 33.1 mt-10 -75.29 -27.35 59.32 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 -176.268 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.605 ' HE1' ' HA ' ' A' ' 32' ' ' TYR . 65.7 t80 -61.78 -47.86 83.24 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 175.174 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 81.5 mm-40 -65.33 -28.84 69.58 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.946 178.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.584 ' HG3' ' O ' ' A' ' 91' ' ' SER . 65.9 mttm -68.49 -25.01 64.76 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.495 176.185 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.466 HG13 ' O ' ' A' ' 92' ' ' GLU . 77.0 mt -72.93 -39.4 58.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 174.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -63.11 -39.43 94.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.167 0.508 . . . . 0.0 109.822 173.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 62.6 mmtt -65.19 -37.34 87.04 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.114 174.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -63.11 -47.63 82.02 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.69 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 55.2 ttt180 -72.15 -34.31 68.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.747 177.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 94.22 41.03 4.38 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.871 -178.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 20.1 m -84.2 -24.09 30.25 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.406 0.622 . . . . 0.0 110.212 177.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -116.04 103.63 10.76 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.144 174.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 91.7 mt -85.53 139.73 31.22 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.598 -172.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 24.0 mp0 -92.74 -176.87 4.38 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.791 175.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 73.9 t60 -77.86 -14.71 59.47 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.376 0.608 . . . . 0.0 110.335 177.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 21.4 t-160 -82.95 42.33 0.79 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.398 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 63.7 m-70 -130.4 -40.58 1.26 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.811 176.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 16.8 t60 -71.65 -28.88 64.06 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 177.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -116.29 131.74 56.86 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.348 173.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 45.1 t-80 . . . . . 0 C--O 1.246 0.89 0 CA-C-O 118.568 -0.73 . . . . 0.0 109.974 -179.814 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.427 ' HE2' HG23 ' A' ' 80' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.045 0 CA-C-O 120.734 0.302 . . . . 0.0 110.627 . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -136.86 171.05 15.07 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 176.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.424 ' O ' ' HG3' ' A' ' 7' ' ' LYS . 7.1 m -61.97 -36.03 80.25 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.861 0.363 . . . . 0.0 110.282 179.542 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -62.44 -42.5 99.5 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.152 175.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 67.3 t -60.06 -42.21 89.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.696 178.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.463 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 67.3 mt -62.18 -42.13 94.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.396 178.53 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.424 ' HG3' ' O ' ' A' ' 3' ' ' SER . 95.5 mttt -57.43 -51.23 70.26 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.839 178.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -60.28 -48.18 82.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.475 178.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.488 ' CE2' HD11 ' A' ' 13' ' ' ILE . 72.5 t80 -55.41 -41.73 73.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.99 -178.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.467 HD12 ' HB3' ' A' ' 17' ' ' TYR . 93.0 mt -64.64 -42.67 95.3 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.094 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -70.81 -34.45 71.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.776 0.322 . . . . 0.0 110.606 178.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -60.49 -37.46 81.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.568 175.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.488 HD11 ' CE2' ' A' ' 9' ' ' PHE . 64.2 mt -74.19 -41.87 51.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.157 0.503 . . . . 0.0 109.949 174.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 109.17 24.5 5.95 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.485 -175.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 82.5 mm-40 -102.3 -179.73 4.07 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.74 0.305 . . . . 0.0 110.584 -179.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -128.13 173.27 10.24 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 -179.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.467 ' HB3' HD12 ' A' ' 10' ' ' LEU . 30.0 p90 -158.51 141.32 14.57 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.765 0.317 . . . . 0.0 110.371 -178.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.523 ' HB ' ' HB2' ' A' ' 25' ' ' HIS . 69.7 mt -97.76 103.22 14.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 120.937 0.399 . . . . 0.0 110.2 179.549 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -89.49 118.21 28.97 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.55 -179.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 83.4 mt -116.07 -166.4 1.14 Allowed 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 175.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -67.15 101.79 0.94 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.888 0.375 . . . . 0.0 111.067 -179.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 48.6 m-80 64.88 15.98 10.22 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.601 177.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -132.44 128.25 37.08 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.301 -179.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.42 ' HB ' HG21 ' A' ' 86' ' ' VAL . 65.1 mt -109.55 106.65 21.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 172.208 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.523 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 20.4 m170 -87.41 115.49 24.86 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -178.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.18 161.01 13.93 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.391 -173.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -74.63 131.25 80.08 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.139 174.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.452 ' HA ' HG23 ' A' ' 88' ' ' THR . 89.8 Cg_exo -43.01 -50.23 6.41 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 123.825 3.017 . . . . 0.0 114.29 -174.07 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -75.15 -33.01 61.47 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.703 0.287 . . . . 0.0 111.655 -175.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.424 ' O ' HG23 ' A' ' 34' ' ' VAL . 21.8 t -74.12 -35.49 41.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.842 0.353 . . . . 0.0 110.305 -178.271 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -54.93 -38.49 67.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.877 179.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 73.8 t80 -59.14 -42.22 90.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.154 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -78.03 -31.16 50.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.985 -178.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 30' ' ' VAL . 92.8 t -65.38 -38.66 83.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.013 0.435 . . . . 0.0 109.838 175.25 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 26.9 t90 -57.34 -44.87 84.64 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.785 176.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.505 ' HB3' ' HZ3' ' A' ' 36' ' ' LYS . 8.3 mtpm? -80.02 -0.09 33.95 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.78 0.324 . . . . 0.0 111.24 -179.191 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -96.19 -39.58 9.61 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.012 0.434 . . . . 0.0 110.619 175.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 29.3 m -82.13 19.66 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.055 -0.52 . . . . 0.0 112.303 -173.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 91.02 19.48 42.79 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.97 176.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 37.17 65.82 2.33 Favored Pre-proline 0 N--CA 1.473 0.722 0 C-N-CA 123.884 0.874 . . . . 0.0 112.941 179.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -83.11 175.51 8.36 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 122.482 2.122 . . . . 0.0 111.953 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -71.55 110.4 6.11 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.844 175.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.493 ' HB3' ' CG2' ' A' ' 76' ' ' VAL . 81.0 mt -73.7 129.14 37.33 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.795 -178.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 25.6 tptp -92.54 121.98 34.52 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.959 -178.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 41.7 p -103.24 156.19 17.9 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.805 -178.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 30.6 p90 -132.83 146.5 51.88 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 173.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 57.9 t -99.28 116.55 42.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.45 -179.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.646 HG21 ' HB ' ' A' ' 73' ' ' ILE . 6.2 tt -102.95 101.29 11.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 174.189 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -85.25 105.27 15.81 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.172 -175.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -94.67 154.33 17.38 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.895 -174.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.412 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 40.6 mt-10 60.46 -133.62 0.76 Allowed 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.132 179.524 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.619 HG12 ' HG3' ' A' ' 70' ' ' LYS . 42.2 mt 72.25 -63.8 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 C-N-CA 123.711 0.805 . . . . 0.0 110.307 -169.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.508 HG12 HG22 ' A' ' 52' ' ' ILE . 16.0 m -141.53 158.37 21.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.11 178.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -87.44 120.9 71.36 Favored Pre-proline 0 C--N 1.321 -0.647 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 173.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -59.99 -40.02 65.46 Favored 'Trans proline' 0 C--O 1.234 0.284 0 C-N-CA 122.822 2.348 . . . . 0.0 113.054 -172.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 164.48 -33.53 0.27 Allowed Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.487 -0.863 . . . . 0.0 112.214 -178.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -52.51 -35.25 52.7 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.878 0.371 . . . . 0.0 111.001 177.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -113.34 94.35 4.83 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 170.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -107.88 110.04 62.28 Favored Pre-proline 0 C--N 1.318 -0.761 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 174.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -64.07 107.62 0.82 Allowed 'Trans proline' 0 C--O 1.235 0.326 0 C-N-CA 122.698 2.265 . . . . 0.0 113.066 -174.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -80.54 -5.79 13.41 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 123.182 2.588 . . . . 0.0 110.624 178.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -95.61 -2.13 48.91 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.468 178.354 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 86.3 mtp 57.78 31.02 19.87 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.353 -176.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -99.87 115.15 28.93 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.99 -177.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -97.62 128.18 44.14 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.935 -178.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 22.4 p -99.12 175.54 5.86 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.449 -175.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -83.94 97.29 9.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.089 0.471 . . . . 0.0 110.025 178.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 16.9 t -97.81 138.8 21.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.967 -179.107 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -91.67 162.2 14.59 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.721 0.296 . . . . 0.0 110.991 -176.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.619 ' HG3' HG12 ' A' ' 52' ' ' ILE . 86.0 tttt -129.26 95.79 4.13 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.342 -0.39 . . . . 0.0 109.997 -178.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 18.8 m -139.26 146.35 25.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.186 -177.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -101.41 111.77 24.1 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.74 175.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.646 ' HB ' HG21 ' A' ' 48' ' ' ILE . 57.9 mt -91.1 132.96 34.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.598 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -117.7 126.75 53.06 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 120.885 0.374 . . . . 0.0 110.81 -174.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -123.07 159.01 29.37 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.22 176.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.493 ' CG2' ' HB3' ' A' ' 43' ' ' LEU . 9.9 p -122.71 145.36 29.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.638 -175.364 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -152.51 165.29 35.57 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.964 0.412 . . . . 0.0 110.365 178.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -137.69 144.97 42.05 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 169.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.542 ' HG2' ' HG3' ' A' ' 85' ' ' ARG . 43.7 mt-10 -101.93 122.51 44.16 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.183 -177.462 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.427 HG23 ' HE2' ' A' ' 1' ' ' MET . 49.6 p -73.17 178.25 4.55 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.044 -178.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.406 HD11 ' O ' ' A' ' 1' ' ' MET . 8.0 mp -64.06 -24.3 67.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.06 0.457 . . . . 0.0 109.851 176.131 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -83.26 -2.19 55.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.982 179.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 15.5 m120 71.03 24.57 3.92 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.35 178.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 62.0 t -90.33 134.71 28.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.779 176.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.542 ' HG3' ' HG2' ' A' ' 79' ' ' GLU . 4.3 mpt_? -92.3 110.3 21.69 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.035 -176.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.42 HG21 ' HB ' ' A' ' 24' ' ' ILE . 49.4 t -89.22 103.36 13.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 173.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.8 t -107.09 141.41 22.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.683 -170.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.452 HG23 ' HA ' ' A' ' 28' ' ' PRO . 73.0 m -149.56 153.73 37.59 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.583 175.308 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -64.43 127.96 33.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.931 0.396 . . . . 0.0 111.047 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -80.69 -26.68 37.37 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.034 -174.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 47.3 t -62.94 -44.15 96.85 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.434 ' O ' ' HB3' ' A' ' 95' ' ' LYS . 39.8 mt-10 -80.05 -20.2 45.8 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.068 177.294 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -70.38 -49.53 48.14 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.406 173.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.448 ' HA ' HD12 ' A' ' 97' ' ' LEU . 19.6 pt20 -68.05 -22.6 64.94 Favored 'General case' 0 C--N 1.334 -0.074 0 CA-C-O 121.034 0.445 . . . . 0.0 110.05 177.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.434 ' HB3' ' O ' ' A' ' 92' ' ' GLU . 86.7 tttt -61.43 -45.05 95.91 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.726 173.284 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.428 HG13 ' O ' ' A' ' 92' ' ' GLU . 66.3 mt -68.49 -34.93 68.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.166 176.079 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.467 ' HB3' ' O ' ' A' ' 102' ' ' THR . 75.7 mt -60.83 -41.65 96.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.641 176.196 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.428 ' HG2' ' O ' ' A' ' 94' ' ' GLN . 34.4 mmtp -67.25 -38.77 85.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.177 0.513 . . . . 0.0 110.225 176.301 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -60.92 -50.22 74.3 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.31 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 73.9 mtp85 -95.44 1.17 53.99 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.641 -174.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 69.92 29.88 70.56 Favored Glycine 0 C--O 1.229 -0.203 0 C-N-CA 121.171 -0.538 . . . . 0.0 113.191 175.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.473 ' HA ' ' HE1' ' A' ' 108' ' ' HIS . 5.0 m -111.94 155.74 23.22 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 -178.447 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -128.58 156.87 42.66 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.834 0.349 . . . . 0.0 110.585 178.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 51.9 tp -76.44 -33.18 58.78 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 176.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -74.03 -46.52 42.9 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.085 178.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 79.9 m-70 -112.63 107.7 16.49 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.702 -172.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 11.1 m170 -88.7 144.76 26.06 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 172.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . 0.473 ' HE1' ' HA ' ' A' ' 102' ' ' THR . 46.4 m80 -101.22 160.13 14.66 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 -174.334 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 29.9 m80 -78.92 41.5 0.43 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.279 0.561 . . . . 0.0 110.614 177.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.408 ' H ' ' C ' ' A' ' 108' ' ' HIS . 20.1 t-160 -170.32 -39.81 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -179.008 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 3.6 p80 . . . . . 0 C--O 1.245 0.828 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.621 174.879 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.5 mtm . . . . . 0 N--CA 1.481 1.081 0 CA-C-O 120.999 0.428 . . . . 0.0 111.006 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -86.47 162.4 18.11 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 167.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.5 p -57.48 -32.37 66.92 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.068 0.461 . . . . 0.0 111.078 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.469 ' HA ' ' HD2' ' A' ' 7' ' ' LYS . 35.3 tt0 -61.0 -42.3 98.18 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.697 178.071 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.3 t -68.01 -35.21 71.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.373 179.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.497 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 59.7 mt -62.73 -39.77 86.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.138 176.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.469 ' HD2' ' HA ' ' A' ' 4' ' ' GLU . 61.8 mttm -56.78 -44.66 82.07 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.488 176.097 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -57.67 -44.1 85.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.022 178.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -66.9 -43.54 83.13 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.878 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.501 HD11 ' HB3' ' A' ' 17' ' ' TYR . 87.3 mt -66.57 -40.03 88.76 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.371 -177.487 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -67.44 -39.46 85.4 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.922 0.391 . . . . 0.0 110.17 176.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -58.24 -51.04 71.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.183 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 33.7 pt -72.38 -26.26 24.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.405 -178.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.32 44.16 4.75 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.723 177.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -123.19 149.66 44.35 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.009 0.433 . . . . 0.0 110.813 178.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -93.99 131.96 38.93 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.294 -177.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.501 ' HB3' HD11 ' A' ' 10' ' ' LEU . 27.9 p90 -115.23 136.28 53.28 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.051 179.048 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 57.1 mt -87.45 97.81 6.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 120.848 0.356 . . . . 0.0 110.107 -179.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -91.12 106.63 18.65 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.352 0.596 . . . . 0.0 110.459 -179.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.494 ' HB2' ' HB2' ' A' ' 23' ' ' GLU . 88.1 mt -93.95 -164.84 1.22 Allowed 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.222 -0.899 . . . . 0.0 108.803 174.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -69.56 92.73 0.65 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.635 0.255 . . . . 0.0 110.52 179.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 10.0 m120 69.54 18.55 7.72 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.643 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.494 ' HB2' ' HB2' ' A' ' 20' ' ' LEU . 41.6 mt-10 -130.18 113.71 14.8 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.937 178.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 59.5 mt -96.04 102.55 13.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 173.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.494 ' HA ' ' O ' ' A' ' 87' ' ' VAL . 13.6 m-70 -90.35 117.74 29.31 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.016 0.436 . . . . 0.0 109.949 -179.076 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 70.6 mt -107.56 168.96 8.88 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.519 0.676 . . . . 0.0 111.562 -176.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -82.57 140.27 44.43 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 115.011 -0.995 . . . . 0.0 108.364 171.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.489 ' HA ' HG21 ' A' ' 88' ' ' THR . 3.2 Cg_endo -47.06 -43.69 24.53 Favored 'Trans proline' 0 CA--C 1.534 0.495 0 C-N-CA 123.195 2.597 . . . . 0.0 113.298 -176.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -61.15 -41.19 96.31 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.998 0.428 . . . . 0.0 111.197 179.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 47.9 t -73.82 -37.78 49.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.852 -178.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -60.62 -40.59 92.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.632 179.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 85.1 t80 -60.49 -39.69 88.6 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.576 178.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 38.2 mm-40 -59.6 -50.84 72.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.842 177.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 41.4 t -65.62 -40.33 87.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.996 -177.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.69 ' CD1' ' HD2' ' A' ' 41' ' ' PRO . 32.5 t90 -57.02 -44.62 83.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.708 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.422 ' HE2' ' HB3' ' A' ' 36' ' ' LYS . 51.1 mtpt -89.5 3.7 51.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.881 0.372 . . . . 0.0 111.108 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -83.6 -38.6 21.4 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -96.84 9.29 6.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.915 177.194 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 79.04 50.4 5.87 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.739 -0.744 . . . . 0.0 113.763 173.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 58.24 78.33 0.36 Allowed Pre-proline 0 N--CA 1.467 0.41 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 172.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.69 ' HD2' ' CD1' ' A' ' 35' ' ' TRP . 5.4 Cg_exo -78.76 173.73 13.22 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.374 2.049 . . . . 0.0 111.39 172.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -76.99 123.58 26.54 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.046 177.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.442 ' HB3' ' CG2' ' A' ' 76' ' ' VAL . 87.6 mt -94.36 132.03 39.41 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.809 -177.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -107.44 141.81 38.25 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.768 178.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 24.1 p -120.76 146.09 46.85 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.775 0.321 . . . . 0.0 111.487 -176.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 17.8 p90 -133.09 154.98 50.06 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 177.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.5 t -106.01 114.61 45.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.274 178.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 8.6 tt -110.53 118.03 56.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.267 0.556 . . . . 0.0 109.95 177.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.48 ' HG2' ' HG2' ' A' ' 72' ' ' LYS . 50.2 mt-10 -84.56 118.78 24.55 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.917 -178.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -96.13 103.13 15.0 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 174.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.468 ' HG2' ' HD3' ' A' ' 70' ' ' LYS . 56.2 mt-10 -77.23 122.69 25.41 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.792 -178.162 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.553 ' HB ' ' HB3' ' A' ' 69' ' ' LYS . 68.5 mt -87.05 108.94 18.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.855 177.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.5 t -126.46 100.02 6.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.346 179.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.603 ' HB2' ' HD2' ' A' ' 55' ' ' PRO . 10.1 pt-20 -137.11 165.71 32.7 Favored Pre-proline 0 C--N 1.32 -0.69 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.193 -177.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.603 ' HD2' ' HB2' ' A' ' 54' ' ' GLU . 9.7 Cg_endo -51.21 138.69 45.06 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 123.146 2.564 . . . . 0.0 112.976 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -135.11 23.73 3.47 Favored Glycine 0 N--CA 1.447 -0.606 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.313 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -79.55 -19.46 49.42 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.147 0.498 . . . . 0.0 110.284 177.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -80.29 -22.4 41.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.391 178.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -134.44 97.07 14.82 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.753 178.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -53.63 133.92 55.96 Favored 'Trans proline' 0 C--O 1.236 0.41 0 C-N-CA 123.288 2.659 . . . . 0.0 113.008 -174.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -61.0 116.12 3.15 Favored 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 123.042 2.494 . . . . 0.0 111.979 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.501 ' CD ' ' H ' ' A' ' 63' ' ' MET . 0.4 OUTLIER -90.23 -158.06 0.51 Allowed 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 178.156 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.501 ' H ' ' CD ' ' A' ' 62' ' ' GLU . 80.7 mtp -62.36 -18.21 60.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.112 0.482 . . . . 0.0 109.808 171.147 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -86.13 101.64 13.17 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 169.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -85.01 97.92 10.1 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.002 -175.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.5 p -76.49 45.1 0.38 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.981 176.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -75.32 -49.1 20.19 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.716 -176.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.4 p -148.09 120.42 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.272 0.558 . . . . 0.0 110.635 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.553 ' HB3' ' HB ' ' A' ' 52' ' ' ILE . 27.0 tptp -101.06 110.46 22.49 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.24 177.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.468 ' HD3' ' HG2' ' A' ' 51' ' ' GLU . 71.3 mmtt -84.26 105.38 15.06 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.686 177.304 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 49' ' ' GLU . 48.0 t -101.53 100.28 10.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 176.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.48 ' HG2' ' HG2' ' A' ' 49' ' ' GLU . 61.5 mttm -78.85 98.36 6.31 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.389 -177.38 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 65.4 mt -97.77 118.91 45.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.131 0.491 . . . . 0.0 110.553 -178.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.409 ' O ' ' HB3' ' A' ' 90' ' ' TYR . 87.8 tttt -89.58 128.43 36.03 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.958 178.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.458 ' HG2' ' HA ' ' A' ' 89' ' ' ASP . 68.3 mttm -129.73 164.17 24.57 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 177.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.442 ' CG2' ' HB3' ' A' ' 43' ' ' LEU . 11.1 p -119.82 148.03 23.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.513 -174.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -154.79 162.35 41.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.058 0.456 . . . . 0.0 111.108 -179.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -132.45 142.21 49.15 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 168.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -102.16 132.43 48.07 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.633 -173.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 72.4 p -82.31 179.53 7.77 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.926 0.394 . . . . 0.0 109.994 176.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 5.9 mp -77.11 -6.45 52.87 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.85 0.357 . . . . 0.0 110.7 -178.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.506 ' HB2' HG23 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -97.89 8.85 44.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.203 -179.384 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 63.4 t30 67.14 28.42 8.22 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.865 0.84 . . . . 0.0 110.133 -176.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.506 HG23 ' HB2' ' A' ' 82' ' ' ASP . 59.2 t -98.72 113.72 34.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 175.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 85.6 mtt180 -94.69 110.51 22.35 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.567 -176.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 58.0 t -81.63 104.62 10.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.724 179.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.494 ' O ' ' HA ' ' A' ' 25' ' ' HIS . 41.4 t -103.53 140.97 20.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.236 -172.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.489 HG21 ' HA ' ' A' ' 28' ' ' PRO . 98.6 m -147.58 151.43 36.25 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.33 174.359 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.458 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 20.3 t70 -59.97 134.8 57.38 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.063 0.458 . . . . 0.0 111.563 -177.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.409 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 88.1 t80 -76.64 -41.04 47.29 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.62 -175.26 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 11.0 p -68.65 -37.57 79.78 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.911 -0.316 . . . . 0.0 111.058 -176.699 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 43.1 mm-40 -72.65 -31.75 65.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.594 0.235 . . . . 0.0 110.992 176.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -69.34 -49.77 52.56 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 121.078 -0.249 . . . . 0.0 111.078 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.431 ' HA ' HD11 ' A' ' 97' ' ' LEU . 11.0 pt20 -63.86 -28.66 70.0 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.146 0.498 . . . . 0.0 110.094 178.511 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 53.7 tttt -60.59 -45.55 93.55 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.414 173.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.511 ' HA ' ' HB3' ' A' ' 99' ' ' LYS . 21.7 mt -71.07 -33.1 50.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.458 -179.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.431 HD11 ' HA ' ' A' ' 94' ' ' GLN . 98.4 mt -56.62 -40.92 76.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.031 0.443 . . . . 0.0 110.197 175.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -81.06 -31.92 34.25 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.624 177.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.511 ' HB3' ' HA ' ' A' ' 96' ' ' ILE . 46.9 tttm -56.59 -46.69 80.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.11 178.404 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 68.6 mtp85 -95.03 -14.47 24.29 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.576 179.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.407 ' HA2' HD22 ' A' ' 104' ' ' LEU . . . 73.65 67.19 1.83 Allowed Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.673 -0.775 . . . . 0.0 111.779 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 12.8 m -92.5 97.72 11.01 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.619 0.247 . . . . 0.0 111.026 -176.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.843 ' HG2' ' HB2' ' A' ' 111' ' ' HIS . 95.1 mttt 57.62 70.07 0.68 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.079 175.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.407 HD22 ' HA2' ' A' ' 101' ' ' GLY . 98.6 mt -73.81 166.42 23.36 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.483 -171.44 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -78.48 -21.49 48.9 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 114.989 -1.005 . . . . 0.0 112.238 -174.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 32.9 m170 -85.47 17.44 3.19 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.263 0.554 . . . . 0.0 111.159 -173.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.444 ' C ' ' H ' ' A' ' 109' ' ' HIS . 83.8 m-70 -121.43 130.55 53.65 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 172.45 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 19.3 m170 -77.34 42.08 0.33 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.481 0.658 . . . . 0.0 110.814 -178.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.444 ' H ' ' C ' ' A' ' 107' ' ' HIS . 31.4 t-80 -172.39 -7.29 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.902 -1.045 . . . . 0.0 109.295 -179.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.755 ' HB3' ' HB3' ' A' ' 103' ' ' LYS . 59.8 m-70 68.3 -62.68 0.36 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.639 0.776 . . . . 0.0 111.344 -174.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.843 ' HB2' ' HG2' ' A' ' 103' ' ' LYS . 29.6 t-80 . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.203 -0.903 . . . . 0.0 109.327 178.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.57 ' HE1' HG23 ' A' ' 80' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.1 0 CA-C-O 120.84 0.352 . . . . 0.0 110.424 . . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -88.11 163.9 15.98 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.642 175.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.0 t -67.78 -25.99 65.87 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 175.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.42 ' O ' ' HG3' ' A' ' 8' ' ' GLU . 35.5 tt0 -51.94 -45.77 64.47 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.012 175.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.3 t -61.01 -41.38 88.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.854 -178.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 56.6 mt -65.14 -41.91 92.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.284 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.485 ' HZ1' ' CD ' ' A' ' 19' ' ' GLU . 55.9 mttm -56.18 -44.44 79.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.24 177.496 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.42 ' HG3' ' O ' ' A' ' 4' ' ' GLU . 39.0 mt-10 -63.05 -41.65 99.53 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.595 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -66.02 -46.28 78.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.849 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 96.3 mt -68.16 -34.17 75.82 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.227 -177.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -67.15 -33.69 75.97 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.292 179.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -63.73 -55.06 26.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.844 178.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 19.6 pt -69.56 -39.55 78.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.688 -177.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 95.36 21.73 23.9 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.815 177.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 23.5 mm-40 -85.94 130.05 34.66 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 175.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -69.16 122.59 19.1 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.732 -176.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 43.8 p90 -112.95 133.91 54.7 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 171.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.529 ' HB ' ' HB2' ' A' ' 25' ' ' HIS . 57.8 mt -90.08 94.74 5.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 120.938 0.399 . . . . 0.0 110.081 -178.278 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.485 ' CD ' ' HZ1' ' A' ' 7' ' ' LYS . 36.5 tt0 -84.95 109.48 18.2 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.306 0.574 . . . . 0.0 110.598 179.433 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.4 mt -101.32 -161.86 0.89 Allowed 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.1 -0.954 . . . . 0.0 108.706 174.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -66.37 96.09 0.34 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.772 0.32 . . . . 0.0 110.61 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 65.25 20.14 11.84 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.65 179.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -134.24 114.22 12.82 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.801 0.334 . . . . 0.0 111.623 -178.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.444 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 54.3 mt -94.36 101.21 12.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 173.503 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.529 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 18.8 m-70 -84.87 107.07 16.84 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 177.605 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.9 mt -95.2 169.72 9.89 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.424 0.631 . . . . 0.0 111.752 -175.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 44.8 mtpt -87.11 136.02 34.3 Favored Pre-proline 0 C--N 1.319 -0.728 0 CA-C-N 114.904 -1.044 . . . . 0.0 108.688 175.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.421 ' HA ' HG23 ' A' ' 88' ' ' THR . 82.9 Cg_exo -47.0 -43.53 24.46 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 123.305 2.67 . . . . 0.0 113.245 -177.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -56.86 -44.56 82.3 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.29 0.567 . . . . 0.0 110.86 178.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 17.1 t -76.68 -46.83 30.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.73 -175.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -56.4 -37.97 70.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.524 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.651 ' OH ' ' HD2' ' A' ' 100' ' ' ARG . 6.6 t80 -58.27 -32.14 68.12 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.701 178.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 50.7 mm-40 -95.21 -37.17 11.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.546 0.212 . . . . 0.0 111.555 179.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.492 ' O ' HG22 ' A' ' 38' ' ' VAL . 93.4 t -62.67 -35.86 72.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.69 0.281 . . . . 0.0 110.789 179.673 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.673 ' CD1' ' HD2' ' A' ' 41' ' ' PRO . 46.2 t90 -55.56 -36.94 67.36 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.665 176.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.441 ' HA ' ' OE2' ' A' ' 40' ' ' GLU . 93.1 mttt -74.85 -40.98 60.71 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.483 179.14 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -58.02 -41.62 83.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.657 -178.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.536 HG21 ' HD3' ' A' ' 41' ' ' PRO . 15.5 m -85.54 1.46 5.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.753 -178.434 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 90.89 41.07 5.42 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.97 -0.633 . . . . 0.0 114.289 169.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.441 ' OE2' ' HA ' ' A' ' 36' ' ' LYS . 21.3 mp0 51.25 67.18 4.48 Favored Pre-proline 0 N--CA 1.467 0.416 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 176.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.673 ' HD2' ' CD1' ' A' ' 35' ' ' TRP . 72.5 Cg_endo -77.41 -179.58 5.57 Favored 'Trans proline' 0 C--O 1.24 0.598 0 C-N-CA 122.461 2.108 . . . . 0.0 112.119 178.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -68.47 132.13 46.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.683 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.453 ' HB3' ' CG2' ' A' ' 76' ' ' VAL . 77.8 mt -106.31 107.73 18.88 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.212 178.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.523 ' HE2' ' HG3' ' A' ' 79' ' ' GLU . 31.1 mttm -88.51 118.11 27.92 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 -179.315 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 41.8 p -95.62 119.42 34.08 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.33 177.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 14.6 p90 -118.56 152.88 35.16 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 60.3 t -104.17 112.6 38.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.18 178.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.485 HG22 ' HB ' ' A' ' 73' ' ' ILE . 11.6 tt -102.09 123.9 55.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 176.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -103.73 113.11 26.38 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.154 0.502 . . . . 0.0 110.731 -176.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -116.91 172.17 7.43 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.167 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -73.06 162.45 29.46 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 110.248 -0.278 . . . . 0.0 110.248 179.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.2 tt -65.6 100.01 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.651 0.739 . . . . 0.0 110.56 178.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 20.3 m -90.55 137.59 21.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.597 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.3 pp20? -92.92 145.7 30.67 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.48 -175.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -98.86 8.42 0.92 Allowed 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 123.455 2.77 . . . . 0.0 113.07 176.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 172.67 35.97 0.03 OUTLIER Glycine 0 CA--C 1.518 0.262 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.725 -177.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -137.22 46.18 2.18 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 179.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -57.19 -35.5 69.67 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.245 -176.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -109.47 98.1 30.49 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-N 116.295 -0.411 . . . . 0.0 109.981 175.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -89.12 155.78 5.71 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.661 2.24 . . . . 0.0 112.472 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -74.34 113.02 3.69 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.112 1.875 . . . . 0.0 110.669 171.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -65.35 110.61 2.69 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.151 0.5 . . . . 0.0 111.054 -175.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.465 ' HE1' HG21 ' A' ' 66' ' ' THR . 62.0 mtm -105.24 167.57 9.64 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.147 179.345 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -89.94 -49.98 6.29 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.984 0.421 . . . . 0.0 111.252 -175.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -104.72 56.73 0.7 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.157 0.503 . . . . 0.0 110.34 -175.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.465 HG21 ' HE1' ' A' ' 63' ' ' MET . 5.5 p -61.41 125.29 23.23 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.473 -175.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -75.1 115.18 14.45 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.92 174.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 60.1 t -88.17 118.74 34.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 120.904 0.383 . . . . 0.0 110.39 -179.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 54.8 tttp -113.44 142.57 45.75 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.287 -179.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -110.78 148.17 32.92 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.279 176.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 18.2 m -110.74 124.11 67.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.345 0.593 . . . . 0.0 110.61 177.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -88.55 95.24 10.16 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.893 178.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.485 ' HB ' HG22 ' A' ' 48' ' ' ILE . 49.0 mt -91.25 128.9 42.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.647 -176.007 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -101.32 113.11 25.88 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.009 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -122.17 167.1 13.59 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.358 -179.199 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.453 ' CG2' ' HB3' ' A' ' 43' ' ' LEU . 14.8 p -126.31 147.39 31.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.819 -175.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 44.1 p90 -152.65 155.8 37.99 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.695 0.283 . . . . 0.0 110.782 175.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -124.71 157.73 34.93 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 171.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.525 ' HG2' ' HG2' ' A' ' 85' ' ' ARG . 29.4 mt-10 -109.07 146.34 34.16 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.908 0.385 . . . . 0.0 111.191 -174.524 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.57 HG23 ' HE1' ' A' ' 1' ' ' MET . 32.5 p -102.6 179.46 4.29 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.995 175.183 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 11.2 mp -67.49 -18.16 64.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.066 0.46 . . . . 0.0 110.907 178.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -94.28 9.61 37.38 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.599 -177.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 14.7 t30 69.64 1.98 3.6 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.427 0.632 . . . . 0.0 110.808 -179.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 52.6 t -72.49 115.63 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 178.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.525 ' HG2' ' HG2' ' A' ' 79' ' ' GLU . 91.8 mtt180 -94.23 118.59 31.8 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.786 -176.572 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.444 ' HA ' ' O ' ' A' ' 24' ' ' ILE . 59.7 t -87.12 104.96 14.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 178.09 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 23.9 t -102.07 141.19 18.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.061 -173.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.421 HG23 ' HA ' ' A' ' 28' ' ' PRO . 97.9 m -150.99 150.02 30.27 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.363 175.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -64.88 125.83 26.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.943 0.401 . . . . 0.0 110.349 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -75.85 -25.28 56.07 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.512 -173.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 10.9 t -74.31 -44.72 51.44 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 -70.36 -29.95 66.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.806 176.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.526 ' HE1' ' HA ' ' A' ' 32' ' ' TYR . 72.4 t80 -65.34 -52.17 55.66 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.365 -0.38 . . . . 0.0 109.985 174.942 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -63.16 -27.87 69.67 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.004 177.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -58.44 -51.3 70.41 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.013 176.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.424 ' HA ' ' HB3' ' A' ' 99' ' ' LYS . 62.3 mt -72.99 -32.57 40.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.22 0.533 . . . . 0.0 110.436 179.372 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.73 HD13 ' HB ' ' A' ' 102' ' ' THR . 0.2 OUTLIER -59.2 -50.2 74.95 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.509 -0.768 . . . . 0.0 110.033 176.853 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -65.96 -36.13 82.5 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.576 176.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.424 ' HB3' ' HA ' ' A' ' 96' ' ' ILE . 47.8 tttp -57.37 -42.39 82.01 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.29 -179.174 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.651 ' HD2' ' OH ' ' A' ' 32' ' ' TYR . 63.5 ttt180 -73.1 -40.59 64.86 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.079 0.466 . . . . 0.0 110.924 179.26 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 110.7 16.1 10.39 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.962 -176.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.73 ' HB ' HD13 ' A' ' 97' ' ' LEU . 18.8 m -82.47 139.62 33.85 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 176.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -112.73 125.42 54.29 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.847 0.356 . . . . 0.0 110.222 178.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 93.9 mt -72.5 129.36 38.14 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.46 -179.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.17 -34.05 71.65 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.9 -177.048 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 30.8 t60 -69.92 -5.22 24.54 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 120.959 0.409 . . . . 0.0 111.318 -177.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 29.2 t60 -91.23 -16.19 28.02 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.508 0.671 . . . . 0.0 109.296 175.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 45.3 t60 -115.42 4.63 14.37 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.079 -0.964 . . . . 0.0 108.591 179.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 4.8 t-160 -142.24 109.7 5.68 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.368 -1.287 . . . . 0.0 107.912 -177.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 44.2 m170 -56.25 -48.49 76.43 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 123.2 0.313 . . . . 0.0 111.708 -171.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 33.5 m80 . . . . . 0 C--O 1.246 0.879 0 CA-C-O 118.692 -0.67 . . . . 0.0 109.816 175.716 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.999 0 CA-C-O 120.847 0.356 . . . . 0.0 110.599 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.511 ' HB3' ' OD2' ' A' ' 82' ' ' ASP . 2.0 m-20 -118.13 176.58 5.15 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 176.542 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.426 ' O ' ' HG3' ' A' ' 7' ' ' LYS . 14.8 p -62.27 -29.36 70.36 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.081 0.467 . . . . 0.0 110.374 178.465 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -57.08 -46.76 82.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.984 176.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.8 t -63.0 -38.9 83.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.266 -178.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.477 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 61.5 mt -63.58 -43.56 98.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.209 178.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.426 ' HG3' ' O ' ' A' ' 3' ' ' SER . 99.0 mttt -58.51 -45.13 89.45 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.817 178.255 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -57.43 -47.28 82.19 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.108 179.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -61.04 -46.05 92.27 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.768 178.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 6' ' ' ILE . 95.7 mt -64.69 -37.12 86.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.454 -177.398 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -74.5 -36.02 63.23 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.785 0.326 . . . . 0.0 110.842 177.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -67.88 -35.06 77.86 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.848 0.356 . . . . 0.0 110.861 -179.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 39.0 pt -82.34 -17.2 11.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.854 0.359 . . . . 0.0 110.576 175.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 77.09 48.45 8.35 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 121.119 -0.562 . . . . 0.0 113.045 174.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.03 158.55 26.56 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.871 0.367 . . . . 0.0 110.431 179.435 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -95.99 120.41 36.22 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.822 -178.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 42.1 p90 -116.25 145.92 42.76 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.09 179.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.464 ' HB ' ' HB2' ' A' ' 25' ' ' HIS . 51.1 mt -96.39 97.97 7.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 120.76 0.314 . . . . 0.0 110.859 -177.222 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 47.2 tt0 -90.58 125.51 35.65 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.072 0.463 . . . . 0.0 110.171 176.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.552 ' HB2' ' HB2' ' A' ' 23' ' ' GLU . 90.4 mt -120.39 -161.65 0.9 Allowed 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 174.447 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -78.67 101.16 7.36 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.796 0.331 . . . . 0.0 110.407 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 58.7 m-80 69.43 10.07 7.55 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.724 -178.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.552 ' HB2' ' HB2' ' A' ' 20' ' ' LEU . 46.9 mt-10 -123.48 132.98 54.08 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.71 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.504 ' HB ' HG21 ' A' ' 86' ' ' VAL . 69.5 mt -120.98 111.59 32.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 170.582 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.464 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 66.3 m-70 -100.97 127.17 47.58 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 110.132 -0.322 . . . . 0.0 110.132 -178.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 69.9 mt -118.01 177.08 4.92 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.413 -176.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 58.7 mttp -92.61 154.9 42.4 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.118 175.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.26 -48.52 21.58 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.795 2.33 . . . . 0.0 113.07 -174.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -64.08 -47.61 79.43 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.841 0.353 . . . . 0.0 110.773 -177.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 42.0 t -62.48 -45.86 97.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.775 -178.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -57.1 -44.76 83.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.842 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -59.48 -42.29 91.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.324 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -75.72 -44.37 42.32 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.91 -177.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 97.5 t -61.83 -36.52 74.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-O 120.744 0.307 . . . . 0.0 110.571 178.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 28.3 t90 -53.77 -53.83 46.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.816 177.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.46 ' HA ' ' CG ' ' A' ' 40' ' ' GLU . 65.4 mttm -71.38 -29.9 65.5 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.039 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 86.4 t80 -60.91 -42.09 97.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.458 179.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.485 HG21 ' HD3' ' A' ' 41' ' ' PRO . 30.3 m -86.29 -0.37 6.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 -176.276 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 109.36 11.01 22.72 Favored Glycine 0 C--N 1.329 0.187 0 C-N-CA 120.437 -0.887 . . . . 0.0 113.427 175.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.46 ' CG ' ' HA ' ' A' ' 36' ' ' LYS . 46.3 mt-10 57.77 72.17 0.95 Allowed Pre-proline 0 C--O 1.234 0.287 0 C-N-CA 122.936 0.494 . . . . 0.0 111.938 179.321 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.485 ' HD3' HG21 ' A' ' 38' ' ' VAL . 5.0 Cg_exo -74.74 173.25 14.72 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.764 2.309 . . . . 0.0 111.475 176.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -64.63 123.39 19.18 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.014 0.435 . . . . 0.0 110.849 179.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.477 ' HB3' ' CG2' ' A' ' 76' ' ' VAL . 86.4 mt -90.84 102.25 15.01 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.136 176.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -82.74 143.66 30.73 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 176.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 31.5 p -121.51 138.88 54.11 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.95 0.405 . . . . 0.0 111.195 -176.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 15.0 p90 -127.16 141.22 51.8 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 176.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.45 ' HA ' ' HA ' ' A' ' 74' ' ' LYS . 5.3 p -98.8 105.24 17.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-O 121.655 0.74 . . . . 0.0 110.28 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 14.7 tt -93.99 125.66 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 CA-C-N 115.679 -0.692 . . . . 0.0 109.599 179.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -92.21 105.71 17.87 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.259 -176.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -92.92 123.71 36.38 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.663 -178.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.435 ' HG2' ' HG2' ' A' ' 70' ' ' LYS . 38.1 mt-10 -95.33 98.11 10.34 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.115 0.483 . . . . 0.0 110.342 -179.546 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.546 HG21 ' HB2' ' A' ' 69' ' ' LYS . 8.5 tt -93.07 120.69 42.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.749 -177.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.462 HG22 HG13 ' A' ' 68' ' ' VAL . 34.1 t -90.67 132.15 35.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.508 177.232 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.457 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 36.4 mt-10 -87.73 121.98 70.6 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-O 120.959 0.409 . . . . 0.0 109.957 -178.297 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 54' ' ' GLU . 27.4 Cg_exo -62.86 113.01 1.81 Allowed 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 123.185 2.59 . . . . 0.0 112.872 -176.191 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -135.42 35.7 2.14 Favored Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 175.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -98.25 9.94 41.81 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.376 0.608 . . . . 0.0 109.881 -175.267 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -87.72 -10.61 50.65 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.035 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -145.16 139.72 15.36 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.364 -177.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -47.57 113.78 0.86 Allowed 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.863 2.375 . . . . 0.0 112.26 176.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -58.63 127.93 26.37 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 123.264 2.642 . . . . 0.0 113.265 -172.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -63.08 -45.4 92.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.842 175.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 92.8 mmm -123.42 125.95 45.9 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.241 176.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -62.72 -37.91 88.41 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.318 0.58 . . . . 0.0 110.758 -178.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -100.89 112.56 25.01 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.273 -175.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 87.3 m -129.08 134.28 48.02 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.211 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -72.71 131.67 42.67 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.02 0.438 . . . . 0.0 110.944 -177.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.462 HG13 HG22 ' A' ' 53' ' ' VAL . 19.7 m -86.86 168.83 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.35 178.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.546 ' HB2' HG21 ' A' ' 52' ' ' ILE . 56.3 mttm -96.3 107.7 20.09 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.014 0.435 . . . . 0.0 110.907 -179.218 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.435 ' HG2' ' HG2' ' A' ' 51' ' ' GLU . 26.0 mtpp -89.78 98.72 11.93 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 175.399 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 27.4 m -99.47 128.55 51.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.337 0.589 . . . . 0.0 111.072 -176.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -87.69 99.44 12.07 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.828 -0.623 . . . . 0.0 109.749 179.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 62.8 mt -101.69 114.24 40.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.539 0.685 . . . . 0.0 111.004 -177.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.545 ' O ' ' HB3' ' A' ' 90' ' ' TYR . 88.1 tttt -80.7 124.25 28.87 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.197 -179.414 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -120.15 163.81 17.15 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.639 -0.255 . . . . 0.0 110.367 178.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.477 ' CG2' ' HB3' ' A' ' 43' ' ' LEU . 10.9 p -122.92 148.35 26.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.904 -174.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.422 ' CE2' ' HD3' ' A' ' 85' ' ' ARG . 55.5 p90 -152.95 153.24 32.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.71 0.291 . . . . 0.0 111.144 178.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.445 ' HB3' HD22 ' A' ' 43' ' ' LEU . 47.8 p90 -122.41 156.94 32.95 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 172.204 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.498 ' HG2' ' HG2' ' A' ' 85' ' ' ARG . 29.3 mt-10 -103.86 149.91 24.64 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.626 -171.504 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 73.9 p -108.77 176.69 5.02 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.966 175.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 47.2 tp -66.84 -26.47 66.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.724 0.297 . . . . 0.0 111.069 179.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.511 ' OD2' ' HB3' ' A' ' 2' ' ' ASN . 1.4 m-20 -82.77 3.64 28.52 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.776 -176.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.444 ' HB2' ' O ' ' A' ' 82' ' ' ASP . 0.9 OUTLIER 71.51 10.52 6.52 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 123.55 0.532 . . . . 0.0 110.917 -175.875 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.451 HG22 ' HB2' ' A' ' 82' ' ' ASP . 62.5 t -84.3 128.08 39.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 176.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.498 ' HG2' ' HG2' ' A' ' 79' ' ' GLU . 82.9 mtt180 -107.38 129.12 54.96 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.469 0.652 . . . . 0.0 111.673 -173.121 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.504 HG21 ' HB ' ' A' ' 24' ' ' ILE . 58.3 t -91.38 112.62 25.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.946 -179.306 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 41.4 t -105.51 140.79 22.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.129 -173.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 93.0 m -151.63 148.89 28.51 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.321 174.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -58.45 129.23 41.07 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.537 0.684 . . . . 0.0 111.982 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.545 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 93.9 t80 -76.49 -23.99 53.79 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.008 -0.997 . . . . 0.0 110.603 -177.272 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.2 m -65.14 -54.21 33.22 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.437 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -71.38 -28.05 63.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.413 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -63.43 -49.22 74.6 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.951 0.405 . . . . 0.0 109.937 175.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.479 ' O ' ' HG3' ' A' ' 98' ' ' LYS . 68.2 mm-40 -65.2 -33.86 76.99 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.656 176.02 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -57.84 -44.25 86.39 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.739 177.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 40.6 mt -68.64 -34.26 64.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.076 178.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 74.9 mt -62.04 -37.09 83.63 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.951 0.405 . . . . 0.0 110.189 176.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.479 ' HG3' ' O ' ' A' ' 94' ' ' GLN . 86.0 mttt -73.05 -39.47 65.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.031 176.323 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 55.7 tptt -64.85 -46.33 82.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.374 -178.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 84.5 mtt-85 -89.67 -8.49 52.32 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.451 -177.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.5 27.47 63.35 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.42 177.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 23.1 m -78.77 -24.23 44.83 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.193 0.52 . . . . 0.0 110.387 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 54.6 tttm -96.35 93.45 6.87 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.956 179.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -75.81 146.3 40.02 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.63 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.61 -32.85 11.57 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.859 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 53.9 m80 -118.76 116.98 27.68 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.482 176.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 10.9 t-160 -85.81 -14.56 44.7 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.025 -178.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -119.07 132.97 56.06 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.705 179.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 34.0 m-70 -128.7 175.85 8.27 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.376 178.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.436 ' O ' ' HB2' ' A' ' 111' ' ' HIS . 22.3 p-80 -68.86 -38.09 79.53 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 176.629 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . 0.436 ' HB2' ' O ' ' A' ' 110' ' ' HIS . 72.2 t60 . . . . . 0 C--O 1.245 0.858 0 CA-C-O 118.163 -0.922 . . . . 0.0 108.796 177.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.64 ' HE2' HG11 ' A' ' 38' ' ' VAL . 43.4 mtm . . . . . 0 N--CA 1.483 1.22 0 CA-C-O 120.916 0.388 . . . . 0.0 110.883 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.536 ' HA ' ' HB ' ' A' ' 80' ' ' THR . 95.0 m-20 -114.37 -175.74 2.75 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.369 170.407 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.439 ' HB3' HG21 ' A' ' 84' ' ' VAL . 35.3 p -62.36 -34.79 77.35 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.017 0.437 . . . . 0.0 110.824 -179.493 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -57.05 -54.37 47.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.852 -177.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.3 t -59.22 -41.37 83.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.849 0.357 . . . . 0.0 110.915 -178.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 50.7 mt -66.03 -39.99 86.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.463 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 51.3 mttm -58.77 -47.52 84.42 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.984 175.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -62.19 -41.09 98.03 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.759 179.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -62.11 -51.18 68.97 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.643 179.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 93.3 mt -62.44 -38.15 88.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.943 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -66.26 -40.74 90.34 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.452 178.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -70.67 -35.04 72.62 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.472 -176.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 39.2 pt -87.15 -8.38 11.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.798 0.332 . . . . 0.0 110.919 178.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 65.45 52.37 40.31 Favored Glycine 0 N--CA 1.452 -0.258 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.433 176.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -112.37 148.88 33.36 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.9 0.381 . . . . 0.0 110.724 -178.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -86.37 133.17 33.81 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.818 177.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 47.5 p90 -135.24 142.5 45.99 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.768 0.318 . . . . 0.0 110.455 179.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.53 ' HB ' ' HB2' ' A' ' 25' ' ' HIS . 66.5 mt -90.79 100.99 11.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.993 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -91.18 116.69 29.02 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.026 -178.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.503 ' HB2' ' HB2' ' A' ' 23' ' ' GLU . 89.9 mt -115.19 173.64 6.4 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 173.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -60.3 105.03 0.37 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.918 0.39 . . . . 0.0 111.118 -178.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 17.1 m120 68.0 16.75 9.56 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.633 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.503 ' HB2' ' HB2' ' A' ' 20' ' ' LEU . 91.1 mt-10 -133.95 113.97 12.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.959 0.409 . . . . 0.0 111.275 179.456 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 64.5 mt -97.39 103.4 14.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 172.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.53 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 35.6 m-70 -89.94 110.77 21.71 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 -179.076 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 63.9 mt -106.11 169.67 8.36 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.486 -175.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 51.5 mtpt -81.31 138.47 48.52 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.168 175.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.51 ' HA ' HG23 ' A' ' 88' ' ' THR . 3.4 Cg_exo -41.35 -51.91 3.86 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 124.117 3.211 . . . . 0.0 114.427 -173.506 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -70.31 -37.96 74.84 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.733 0.301 . . . . 0.0 111.076 -175.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 46.7 t -65.11 -42.13 93.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.222 0.534 . . . . 0.0 109.811 177.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -57.66 -41.29 81.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.816 178.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -59.29 -45.62 90.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.51 -178.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -64.29 -35.81 82.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.273 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 60.4 t -72.13 -38.22 62.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.198 0.523 . . . . 0.0 110.45 178.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.632 ' CZ2' ' HG3' ' A' ' 40' ' ' GLU . 30.0 t90 -57.12 -46.87 82.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.33 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 55.8 mttm -86.46 -2.2 58.25 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.895 0.379 . . . . 0.0 111.384 179.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -78.72 -35.47 44.81 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 176.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.64 HG11 ' HE2' ' A' ' 1' ' ' MET . 3.2 m -85.9 3.85 3.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.603 177.228 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 97.21 17.72 31.03 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.696 -0.764 . . . . 0.0 113.444 174.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.632 ' HG3' ' CZ2' ' A' ' 35' ' ' TRP . 36.1 tt0 61.7 84.59 0.19 Allowed Pre-proline 0 N--CA 1.466 0.336 0 CA-C-O 121.06 0.457 . . . . 0.0 111.498 178.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.552 ' HD2' ' CD1' ' A' ' 35' ' ' TRP . 94.3 Cg_endo -90.64 162.92 4.25 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.745 2.297 . . . . 0.0 111.7 173.817 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -71.45 125.42 26.97 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 175.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.446 ' CD2' ' HB3' ' A' ' 78' ' ' PHE . 90.4 mt -90.53 150.09 21.91 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.348 0.594 . . . . 0.0 112.292 -170.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.429 ' HZ2' ' CD ' ' A' ' 79' ' ' GLU . 97.4 mttt -97.2 164.67 12.39 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.236 172.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' THR . . . . . 0.651 HG22 ' HE3' ' A' ' 74' ' ' LYS . 19.0 p -119.59 144.8 46.9 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.136 0.493 . . . . 0.0 111.22 177.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.571 ' HB2' ' CD2' ' A' ' 77' ' ' TYR . 32.4 t80 -118.69 114.49 22.81 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.044 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 95.6 t -100.23 121.43 50.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.972 -177.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.458 ' CG1' ' HB ' ' A' ' 73' ' ' ILE . 42.0 pt -105.59 132.16 53.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.732 174.24 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.494 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 37.8 tt0 -115.55 103.6 10.9 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.865 -178.65 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -153.29 123.73 7.14 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -176.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.529 ' HG2' HG13 ' A' ' 52' ' ' ILE . 31.5 tt0 -179.51 -81.65 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.113 168.407 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.529 HG13 ' HG2' ' A' ' 51' ' ' GLU . 64.3 mt -117.85 101.02 11.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 178.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.439 ' HA ' HG12 ' A' ' 68' ' ' VAL . 4.3 m -134.76 104.22 5.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.198 0.523 . . . . 0.0 111.774 -176.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 64.1 mt-10 -89.61 114.29 60.02 Favored Pre-proline 0 C--N 1.324 -0.515 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 172.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -54.45 118.18 4.77 Favored 'Trans proline' 0 C--O 1.234 0.284 0 C-N-CA 122.892 2.394 . . . . 0.0 112.391 -176.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.606 ' HA2' ' HB3' ' A' ' 59' ' ' ASP . . . -149.29 23.54 1.23 Allowed Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.875 -0.678 . . . . 0.0 111.846 -178.734 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -70.33 -37.19 74.66 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.741 0.305 . . . . 0.0 110.675 -178.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 42.7 p90 -122.11 1.81 9.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.168 0.509 . . . . 0.0 110.008 177.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.606 ' HB3' ' HA2' ' A' ' 56' ' ' GLY . 23.4 t70 -95.66 132.72 26.83 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.357 -176.02 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 59' ' ' ASP . 34.3 Cg_exo -60.21 125.96 18.9 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 123.134 2.556 . . . . 0.0 113.089 -177.094 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -74.51 125.12 9.36 Favored 'Trans proline' 0 CA--C 1.529 0.235 0 C-N-CA 122.799 2.332 . . . . 0.0 112.399 179.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.411 ' HB3' ' H ' ' A' ' 63' ' ' MET . 35.8 mt-10 -105.6 -165.07 1.08 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.294 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' MET . . . . . 0.411 ' H ' ' HB3' ' A' ' 62' ' ' GLU . 67.0 mtt -76.91 -19.7 57.09 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.692 -175.115 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -82.44 92.18 6.99 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.028 0.442 . . . . 0.0 110.269 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -93.66 100.02 12.34 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.172 178.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.2 m -81.39 150.94 28.16 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.501 178.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -74.46 81.86 1.94 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.524 0.678 . . . . 0.0 110.546 177.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.439 HG12 ' HA ' ' A' ' 53' ' ' VAL . 71.2 t -71.87 110.15 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.719 179.088 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.5 ' H ' ' HB ' ' A' ' 52' ' ' ILE . 95.9 mttt -91.98 107.54 19.28 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.176 0.512 . . . . 0.0 110.589 -179.504 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -97.14 95.74 7.97 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 174.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.494 ' O ' ' HA ' ' A' ' 49' ' ' GLU . 59.8 t -92.56 108.37 20.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.945 -176.329 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -90.5 100.87 13.64 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.625 -178.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.458 ' HB ' ' CG1' ' A' ' 48' ' ' ILE . 65.3 mt -91.15 113.67 27.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.659 178.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.651 ' HE3' HG22 ' A' ' 45' ' ' THR . 48.1 tttp -94.93 101.94 13.74 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.779 -173.119 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -96.62 167.54 11.07 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.427 176.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 12.5 p -116.64 148.66 19.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 110.4 -0.222 . . . . 0.0 110.4 -177.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.571 ' CD2' ' HB2' ' A' ' 46' ' ' TYR . 39.7 p90 -155.09 154.01 31.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.873 0.368 . . . . 0.0 111.242 177.309 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.446 ' HB3' ' CD2' ' A' ' 43' ' ' LEU . 48.8 p90 -119.09 160.68 21.61 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 171.304 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.429 ' CD ' ' HZ2' ' A' ' 44' ' ' LYS . 38.3 mt-10 -111.8 138.86 47.83 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.961 0.41 . . . . 0.0 111.23 -173.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.536 ' HB ' ' HA ' ' A' ' 2' ' ' ASN . 40.2 p -93.82 169.63 10.16 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.587 173.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.44 ' HB2' ' OD1' ' A' ' 2' ' ' ASN . 6.9 mp -74.5 -10.15 59.27 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.247 0.546 . . . . 0.0 110.026 178.14 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -92.35 10.98 27.54 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.619 -179.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 68.93 20.83 7.76 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.483 176.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.439 HG21 ' HB3' ' A' ' 3' ' ' SER . 48.3 t -101.82 126.08 55.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.241 177.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . 0.46 ' O ' ' HA ' ' A' ' 23' ' ' GLU . 40.5 mtm180 -95.08 124.52 39.17 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.46 -179.238 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 59.4 t -95.16 107.61 19.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 176.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 28.6 t -105.09 138.67 28.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.605 -170.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.51 HG23 ' HA ' ' A' ' 28' ' ' PRO . 86.5 m -152.61 157.06 40.46 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.288 176.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -68.8 124.66 24.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.324 0.583 . . . . 0.0 112.248 -178.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -68.46 -32.63 72.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.302 -178.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 6.5 m -56.73 -41.46 77.55 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.964 0.411 . . . . 0.0 110.966 177.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.43 ' O ' HG13 ' A' ' 96' ' ' ILE . 43.6 mt-10 -83.6 -30.63 26.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.796 -179.141 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -62.68 -47.82 81.98 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.116 0.484 . . . . 0.0 109.875 175.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -58.15 -40.93 82.62 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.245 174.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.41 ' HB3' ' O ' ' A' ' 92' ' ' GLU . 64.4 tttp -56.95 -44.84 82.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.11 178.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.546 ' O ' ' HG2' ' A' ' 99' ' ' LYS . 75.7 mt -64.84 -47.06 89.97 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-O 121.024 0.44 . . . . 0.0 111.182 -179.444 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 87.4 mt -60.13 -51.17 70.73 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.859 -179.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -72.72 -28.31 62.57 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -174.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.546 ' HG2' ' O ' ' A' ' 96' ' ' ILE . 19.8 pttp -70.76 -29.93 66.29 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.33 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 22.6 mtm105 -78.53 -43.22 27.31 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 173.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 125.18 26.88 1.28 Allowed Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.193 -178.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 21.2 m -97.14 139.06 33.69 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.692 0.282 . . . . 0.0 110.443 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -98.53 163.58 12.61 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.352 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 91.4 mt -89.57 -20.43 23.78 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.861 0.363 . . . . 0.0 111.235 -175.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -101.51 124.47 47.23 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.961 -178.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 70.6 m80 -83.46 83.4 7.9 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.661 178.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 18.1 m170 -92.65 125.12 37.13 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.164 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 8.1 t-160 -100.25 -18.7 16.72 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 173.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 9.1 m170 -114.05 -176.29 2.87 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.937 173.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 34.7 m-70 -105.88 -71.93 0.73 Allowed 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 171.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 67.7 m-70 . . . . . 0 C--O 1.243 0.757 0 CA-C-N 115.022 -0.99 . . . . 0.0 108.746 169.114 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.701 ' HE2' HG11 ' A' ' 38' ' ' VAL . 3.8 ppp? . . . . . 0 N--CA 1.477 0.876 0 CA-C-O 121.032 0.444 . . . . 0.0 110.828 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.417 ' OD1' ' HB2' ' A' ' 81' ' ' LEU . 47.5 m-80 -128.38 178.5 6.23 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 176.328 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.492 ' HG ' ' CG ' ' A' ' 82' ' ' ASP . 52.2 p -65.85 -20.71 66.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.428 0.632 . . . . 0.0 109.611 177.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.525 ' O ' ' HG3' ' A' ' 8' ' ' GLU . 20.9 tp10 -61.2 -36.6 80.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.424 177.049 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.3 t -63.95 -35.92 75.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-O 121.236 0.541 . . . . 0.0 110.182 179.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 61.6 mt -66.86 -40.35 85.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.025 177.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -58.24 -45.31 88.01 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.286 177.362 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . 0.525 ' HG3' ' O ' ' A' ' 4' ' ' GLU . 41.5 mt-10 -60.0 -44.54 94.48 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.754 179.302 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.446 ' O ' HG12 ' A' ' 13' ' ' ILE . 79.5 t80 -61.51 -47.72 84.34 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.312 -179.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 91.3 mt -63.5 -37.7 88.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.881 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -59.44 -50.94 72.0 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.558 177.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -68.09 -37.87 81.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.878 -175.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.446 HG12 ' O ' ' A' ' 9' ' ' PHE . 35.4 pt -81.68 -14.67 12.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.235 -179.421 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 81.16 45.75 7.37 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.785 177.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -119.45 166.07 13.55 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.8 0.334 . . . . 0.0 110.71 178.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -117.35 161.1 20.08 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.949 179.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 28.5 p90 -130.7 146.54 52.21 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.683 179.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.434 ' HB ' ' HB2' ' A' ' 25' ' ' HIS . 54.6 mt -91.43 97.03 6.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 178.058 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.428 ' HA ' ' O ' ' A' ' 23' ' ' GLU . 1.9 tm-20 -99.35 107.27 19.49 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -176.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 89.9 mt -116.01 86.66 2.52 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.862 -177.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.435 ' O ' ' HB2' ' A' ' 22' ' ' ASN . 34.4 tt0 59.29 60.25 2.41 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.058 176.228 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.435 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 0.9 OUTLIER 75.07 14.01 3.18 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.293 177.454 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.428 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 35.1 mt-10 -111.16 113.74 26.48 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.8 170.62 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 62.0 mt -96.33 97.5 6.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 177.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.575 ' HA ' ' O ' ' A' ' 87' ' ' VAL . 14.1 m-70 -86.14 107.9 18.07 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.475 178.562 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 62.3 mt -95.13 164.45 12.86 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.254 -175.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -82.16 132.24 53.98 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.238 177.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -49.49 -40.3 45.18 Favored 'Trans proline' 0 N--CA 1.471 0.197 0 C-N-CA 123.1 2.533 . . . . 0.0 112.977 -177.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -60.54 -47.07 87.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.08 179.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 41.3 t -77.08 -40.2 29.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.768 -177.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.786 ' HE1' ' HE1' ' A' ' 78' ' ' PHE . 85.6 t80 -58.53 -37.17 75.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.883 -179.143 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.645 ' HA ' ' HE1' ' A' ' 93' ' ' PHE . 24.8 t80 -53.25 -39.4 63.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.291 177.34 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -84.0 -39.25 19.91 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.985 -178.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 62.6 t -62.53 -36.88 77.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-O 120.744 0.307 . . . . 0.0 110.841 179.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.411 ' CE2' ' HB2' ' A' ' 40' ' ' GLU . 22.1 t90 -53.13 -59.23 4.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.732 -179.336 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -74.0 -20.72 60.24 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.664 0.269 . . . . 0.0 111.403 -179.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -64.74 -28.8 69.83 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.806 178.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.701 HG11 ' HE2' ' A' ' 1' ' ' MET . 29.0 m -103.34 11.22 8.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.36 -179.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.48 9.25 56.82 Favored Glycine 0 CA--C 1.517 0.186 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.877 177.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.415 ' O ' ' HG3' ' A' ' 40' ' ' GLU . 15.5 pt-20 44.67 87.09 0.12 Allowed Pre-proline 0 N--CA 1.471 0.61 0 C-N-CA 124.527 1.131 . . . . 0.0 113.246 -179.394 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -76.08 165.76 29.1 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.456 2.104 . . . . 0.0 111.486 175.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -63.15 137.11 58.12 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.033 0.444 . . . . 0.0 110.325 177.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.436 ' HB3' ' CG2' ' A' ' 76' ' ' VAL . 95.6 mt -87.29 144.29 26.87 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.491 -174.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -118.83 118.18 30.88 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 177.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 24.9 p -107.54 137.55 45.36 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 120.92 0.39 . . . . 0.0 111.843 -173.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 19.0 p90 -120.87 140.66 51.48 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 176.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.505 HG11 ' HE3' ' A' ' 72' ' ' LYS . 55.4 t -103.73 117.45 49.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.273 178.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.992 HG22 HG13 ' A' ' 73' ' ' ILE . 2.9 tt -98.88 122.37 50.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-O 121.522 0.677 . . . . 0.0 110.167 177.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.451 ' OE1' ' HG3' ' A' ' 72' ' ' LYS . 4.4 mm-40 -90.14 94.49 9.8 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.952 -176.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -101.61 126.62 48.46 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.639 0.257 . . . . 0.0 110.31 -178.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.942 ' HG2' ' HG2' ' A' ' 70' ' ' LYS . 28.8 mt-10 -101.09 108.11 19.72 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.837 0.351 . . . . 0.0 110.376 178.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 47.5 pt -79.95 137.83 20.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.166 0.508 . . . . 0.0 110.899 -177.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.9 p -102.13 113.47 38.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.856 176.15 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.44 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 41.0 mt-10 -87.61 115.26 62.34 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.818 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 54' ' ' GLU . 22.7 Cg_exo -65.09 154.42 73.56 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 123.157 2.571 . . . . 0.0 112.995 -174.531 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -135.35 44.06 1.2 Allowed Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 178.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -57.94 -30.91 66.35 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.347 0.659 . . . . 0.0 112.302 -172.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 93.0 t80 -70.75 -14.31 62.39 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.929 0.395 . . . . 0.0 110.333 178.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 39.0 t70 60.32 81.82 0.24 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.232 -174.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.48 151.91 48.26 Favored 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 122.56 2.174 . . . . 0.0 112.456 -176.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -69.49 -11.02 30.28 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.801 2.334 . . . . 0.0 111.525 175.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -66.6 149.95 49.74 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.638 176.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 32.9 mtt -59.95 120.9 10.52 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.234 0.54 . . . . 0.0 110.527 177.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 33.6 mttm -75.45 104.94 6.23 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.24 -174.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -78.69 131.24 36.56 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.142 -176.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -87.26 -16.91 33.82 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.261 178.208 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -91.29 139.27 30.89 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.003 176.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.443 HG21 ' HB3' ' A' ' 51' ' ' GLU . 22.9 m -102.11 177.65 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.342 -179.145 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 51.6 tttm -111.77 138.45 48.35 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.417 -176.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.942 ' HG2' ' HG2' ' A' ' 51' ' ' GLU . 62.4 mttp -87.45 137.46 32.32 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.118 0.485 . . . . 0.0 111.421 -177.627 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.424 HG13 HG21 ' A' ' 73' ' ' ILE . 79.8 t -110.17 100.66 11.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 170.657 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.505 ' HE3' HG11 ' A' ' 47' ' ' VAL . 39.0 tttp -75.59 101.03 4.78 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.178 -175.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.992 HG13 HG22 ' A' ' 48' ' ' ILE . 4.6 pt -109.04 125.26 66.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.616 0.722 . . . . 0.0 111.143 -177.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -106.78 131.58 53.73 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.966 -177.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -130.16 166.2 20.73 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.163 178.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.436 ' CG2' ' HB3' ' A' ' 43' ' ' LEU . 9.0 p -122.92 145.15 30.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.72 0.295 . . . . 0.0 111.112 -174.421 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 44.9 p90 -146.27 164.72 31.42 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.536 178.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.786 ' HE1' ' HE1' ' A' ' 31' ' ' PHE . 52.3 p90 -141.64 148.29 38.94 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 169.436 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -102.14 128.56 48.58 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.429 -176.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 72.7 p -88.08 -179.3 6.16 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.88 176.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.417 ' HB2' ' OD1' ' A' ' 2' ' ' ASN . 7.1 mp -70.12 -18.31 63.23 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.08 0.466 . . . . 0.0 110.207 178.395 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.492 ' CG ' ' HG ' ' A' ' 3' ' ' SER . 2.6 m-20 -71.18 -13.29 61.88 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.717 179.261 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 66.4 t30 77.68 10.12 2.3 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 124.079 0.862 . . . . 0.0 109.33 -171.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 77.8 t -81.74 129.12 38.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.278 178.418 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 56.1 mtm180 -92.94 105.46 17.57 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.343 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.3 t -84.28 106.74 14.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 177.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.575 ' O ' ' HA ' ' A' ' 25' ' ' HIS . 30.5 t -108.51 141.08 24.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.954 -173.432 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 34.3 m -144.44 150.57 37.88 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 176.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -62.92 126.11 26.24 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.182 0.515 . . . . 0.0 111.358 179.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -70.22 -38.06 75.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.14 -176.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 24.9 m -60.25 -57.75 11.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.354 -177.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.479 ' O ' ' HB3' ' A' ' 95' ' ' LYS . 36.3 mm-40 -68.22 -29.86 68.79 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.731 -177.502 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.645 ' HE1' ' HA ' ' A' ' 32' ' ' TYR . 53.0 t80 -67.87 -49.27 62.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.955 0.407 . . . . 0.0 110.404 177.41 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.519 ' O ' ' HG3' ' A' ' 98' ' ' LYS . 79.2 mm-40 -66.85 -24.46 66.14 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.568 178.193 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.479 ' HB3' ' O ' ' A' ' 92' ' ' GLU . 44.6 tttp -59.69 -49.57 77.24 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.366 174.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.441 ' O ' ' HB3' ' A' ' 99' ' ' LYS . 58.4 mt -67.93 -33.17 59.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.815 -179.29 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 69.8 mt -64.75 -39.82 94.26 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.563 177.344 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.519 ' HG3' ' O ' ' A' ' 94' ' ' GLN . 57.1 mttp -70.42 -33.81 71.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.033 0.444 . . . . 0.0 109.924 175.306 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.441 ' HB3' ' O ' ' A' ' 96' ' ' ILE . 61.9 tttp -56.65 -57.9 10.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.283 -0.872 . . . . 0.0 110.925 179.377 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -74.9 -23.78 58.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.587 0.232 . . . . 0.0 111.274 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 93.37 95.1 1.5 Allowed Glycine 0 N--CA 1.448 -0.506 0 N-CA-C 111.339 -0.704 . . . . 0.0 111.339 -175.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.7 m -127.06 -38.43 2.01 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.165 0.507 . . . . 0.0 110.592 -177.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -109.5 115.49 30.02 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 177.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 88.3 mt -91.8 163.98 13.86 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.19 -176.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -72.35 164.79 25.73 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.262 -178.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 41.5 m80 -127.47 126.72 42.82 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 174.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 10.9 t-160 -61.52 -40.14 93.54 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 -179.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -102.67 124.03 47.46 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 170.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -71.87 -18.28 62.06 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.955 0.407 . . . . 0.0 110.212 -175.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 18.9 t60 -127.44 127.42 44.08 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 174.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 47.8 t60 . . . . . 0 C--O 1.247 0.925 0 CA-C-O 118.509 -0.758 . . . . 0.0 110.068 179.402 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.556 ' SD ' HG11 ' A' ' 38' ' ' VAL . 21.0 ptt? . . . . . 0 N--CA 1.478 0.971 0 CA-C-O 120.98 0.419 . . . . 0.0 110.26 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -94.15 174.79 6.97 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.56 174.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.8 m -62.55 -23.26 66.89 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.009 0.433 . . . . 0.0 111.242 -177.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -61.59 -37.56 84.36 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.972 179.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 62.1 t -68.62 -34.32 64.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.023 0.439 . . . . 0.0 110.348 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 50.8 mt -62.39 -43.12 97.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.71 176.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 57.1 mttm -60.33 -38.33 83.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.049 177.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -57.6 -48.71 78.65 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.862 0.363 . . . . 0.0 110.777 178.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -66.17 -44.22 84.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.895 -179.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 97.0 mt -66.66 -43.95 83.16 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.408 -177.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -69.3 -32.44 71.59 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.737 0.303 . . . . 0.0 110.37 -179.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -61.82 -48.68 79.51 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.12 178.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 38.3 pt -80.93 -12.55 12.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.165 -178.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 81.47 38.31 14.94 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.348 179.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -91.76 118.56 30.79 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.95 0.405 . . . . 0.0 110.197 178.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -97.8 102.78 14.63 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.964 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.456 ' CD2' HG22 ' A' ' 24' ' ' ILE . 29.0 p90 -97.97 170.59 8.84 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.469 -174.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.5 ' HB ' ' HB2' ' A' ' 25' ' ' HIS . 64.1 mt -94.25 100.33 10.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.99 177.333 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -90.54 135.53 33.64 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.245 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.68 ' HG ' ' H ' ' A' ' 21' ' ' GLU . 21.8 tp -133.28 177.22 7.85 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 175.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.68 ' H ' ' HG ' ' A' ' 20' ' ' LEU . 43.2 mt-10 -61.76 102.46 0.26 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.633 0.254 . . . . 0.0 110.902 -178.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.407 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 11.8 m120 71.68 16.25 5.78 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.999 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.536 ' HB2' ' HB3' ' A' ' 20' ' ' LEU . 41.4 mt-10 -131.63 134.96 46.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.056 0.455 . . . . 0.0 111.421 178.173 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.456 HG22 ' CD2' ' A' ' 17' ' ' TYR . 74.1 mt -118.69 107.53 21.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 171.54 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.5 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 73.0 m-70 -94.29 109.85 21.65 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.049 0.452 . . . . 0.0 110.491 -178.157 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.41 HD21 ' HB3' ' A' ' 17' ' ' TYR . 40.5 mt -109.25 150.54 27.8 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.936 -178.426 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 49.5 mtmt -64.38 135.61 96.42 Favored Pre-proline 0 C--N 1.326 -0.427 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 171.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.451 ' HB2' HD13 ' A' ' 96' ' ' ILE . 51.8 Cg_exo -54.27 -28.93 54.9 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.684 2.256 . . . . 0.0 112.075 -177.602 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -61.62 -56.38 20.51 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.49 177.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 49.2 t -68.14 -38.69 80.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.242 179.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -51.54 -46.86 63.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.238 -179.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 93.0 t80 -60.19 -43.38 95.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.137 -179.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.536 ' O ' ' HB2' ' A' ' 37' ' ' TYR . 43.6 mt-10 -76.96 -8.74 57.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.774 -175.448 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 62.5 t -93.07 -42.62 13.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.251 0.548 . . . . 0.0 109.522 171.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.56 ' CD1' ' HD2' ' A' ' 41' ' ' PRO . 44.2 t90 -55.82 -52.0 65.52 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.046 177.666 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 53.7 tttm -78.82 -14.35 59.3 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.015 0.436 . . . . 0.0 110.738 -177.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.536 ' HB2' ' O ' ' A' ' 33' ' ' GLU . 87.0 t80 -71.28 -44.77 64.59 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.814 -179.693 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.556 HG11 ' SD ' ' A' ' 1' ' ' MET . 33.3 m -94.31 -3.66 10.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.338 -177.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 136.68 -85.28 0.24 Allowed Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.077 177.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 170.98 61.06 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.371 0 C-N-CA 122.969 0.508 . . . . 0.0 110.73 -175.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.56 ' HD2' ' CD1' ' A' ' 35' ' ' TRP . 71.1 Cg_exo -50.69 128.69 24.74 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.127 1.884 . . . . 0.0 111.584 177.126 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -61.16 116.07 4.28 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.318 0.58 . . . . 0.0 110.298 -177.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.563 ' HB3' ' CG2' ' A' ' 76' ' ' VAL . 93.3 mt -82.6 126.12 31.94 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.184 -0.917 . . . . 0.0 111.983 -170.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -92.06 139.21 30.86 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 175.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 69.5 p -118.68 145.85 45.17 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 121.148 -0.221 . . . . 0.0 110.599 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 25.7 p90 -133.46 143.49 48.87 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 176.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 48.4 t -94.98 110.72 24.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.24 -178.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 8.9 tt -118.9 111.17 32.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 121.425 0.631 . . . . 0.0 110.18 178.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.421 ' HG2' ' HG2' ' A' ' 72' ' ' LYS . 47.7 mt-10 -76.95 125.18 28.88 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 176.161 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -92.97 118.68 31.43 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 -176.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -103.6 125.12 49.92 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.895 -174.165 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 65.9 mt 69.02 94.4 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.652 178.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.472 ' O ' ' HD3' ' A' ' 55' ' ' PRO . 42.7 t -90.96 138.1 20.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.45 -0.795 . . . . 0.0 108.89 178.339 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -87.57 111.82 44.32 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-O 121.235 0.541 . . . . 0.0 111.521 -174.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.472 ' HD3' ' O ' ' A' ' 53' ' ' VAL . 86.1 Cg_endo -92.69 145.47 2.56 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 123.321 2.681 . . . . 0.0 112.12 176.487 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -135.89 1.44 3.51 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.836 -0.697 . . . . 0.0 111.759 178.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -82.87 -43.2 16.86 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.922 0.391 . . . . 0.0 110.449 -178.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -130.21 174.68 9.59 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.256 -178.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -137.39 149.69 66.3 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.022 178.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.54 138.84 19.85 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.504 2.136 . . . . 0.0 111.986 178.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -49.81 -48.13 20.55 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.973 2.449 . . . . 0.0 112.088 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.44 ' C ' ' H ' ' A' ' 64' ' ' LYS . 43.1 mt-10 -108.21 118.18 36.08 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.595 174.293 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 60.8 mtm -72.4 9.26 1.08 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.267 -177.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.44 ' H ' ' C ' ' A' ' 62' ' ' GLU . 68.8 mttt -85.07 -14.86 45.91 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.262 -179.129 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -113.01 147.83 36.36 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.954 -176.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 36.4 m -139.91 107.15 5.49 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.857 177.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -64.41 113.42 3.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.065 0.459 . . . . 0.0 110.67 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 48.7 t -83.06 105.41 12.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.553 -178.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -95.92 128.01 42.45 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.595 175.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -127.06 101.42 6.53 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 178.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 30.6 t -109.97 131.89 59.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.869 -174.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.421 ' HG2' ' HG2' ' A' ' 49' ' ' GLU . 49.7 mttp -73.56 101.09 3.48 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.537 177.69 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 49.3 mm -100.27 118.84 47.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.227 0.537 . . . . 0.0 110.572 -179.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.612 ' O ' ' HB3' ' A' ' 90' ' ' TYR . 49.5 tttp -92.8 118.55 31.22 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 176.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -118.44 159.61 23.18 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 179.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.563 ' CG2' ' HB3' ' A' ' 43' ' ' LEU . 14.2 p -131.03 147.94 33.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.978 -171.266 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 46.2 p90 -154.94 156.49 36.15 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.641 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -115.97 140.15 49.54 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 169.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -109.01 127.22 53.9 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.498 -170.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 44.5 p -88.89 -179.67 6.01 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.849 -175.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.9 mp -70.73 -22.84 62.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.229 178.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.436 ' O ' ' HB2' ' A' ' 83' ' ' ASN . 2.9 m-20 -75.07 -10.02 59.08 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.344 179.43 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.436 ' HB2' ' O ' ' A' ' 82' ' ' ASP . 9.0 m120 68.72 28.76 5.49 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.156 -171.602 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.42 HG23 ' HB2' ' A' ' 82' ' ' ASP . 68.9 t -98.66 126.18 51.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.265 -0.88 . . . . 0.0 108.847 173.158 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 65.8 mtt180 -100.95 114.79 29.01 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.05 0.452 . . . . 0.0 111.176 -173.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 46.9 t -83.88 99.85 6.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 175.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 22.1 t -102.72 140.02 22.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.274 -171.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.9 t -143.65 -178.57 5.96 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 174.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -93.25 123.3 36.43 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.601 -177.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.612 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 61.8 t80 -69.26 -34.55 74.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.176 -176.75 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 12.7 t -65.83 -49.5 67.99 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 -178.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.468 ' HA ' ' HD3' ' A' ' 95' ' ' LYS . 28.9 mm-40 -66.12 -39.2 89.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.944 177.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.437 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 58.1 t80 -60.93 -45.98 92.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.756 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.512 ' O ' ' HG2' ' A' ' 98' ' ' LYS . 48.5 mm-40 -58.92 -39.45 81.58 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.145 177.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.468 ' HD3' ' HA ' ' A' ' 92' ' ' GLU . 50.1 mtpt -62.78 -43.68 98.15 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.87 177.474 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.461 ' HA ' ' HD2' ' A' ' 99' ' ' LYS . 67.4 mt -68.6 -33.29 59.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.879 179.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 93' ' ' PHE . 86.5 mt -58.17 -37.18 74.21 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.979 0.418 . . . . 0.0 110.323 174.705 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.512 ' HG2' ' O ' ' A' ' 94' ' ' GLN . 38.6 mmtm -74.35 -34.78 63.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.253 178.065 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.461 ' HD2' ' HA ' ' A' ' 96' ' ' ILE . 68.7 mttm -63.45 -46.76 84.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.785 176.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.555 ' HE ' ' HA ' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -73.87 -20.84 60.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.294 179.517 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 77.42 35.28 37.64 Favored Glycine 0 N--CA 1.451 -0.351 0 CA-C-N 115.945 -0.571 . . . . 0.0 112.266 178.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.7 m -87.02 65.13 8.82 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.402 0.62 . . . . 0.0 110.385 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 59.7 tttm -178.13 142.19 0.27 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.199 -0.909 . . . . 0.0 109.859 176.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.455 HD13 ' HA ' ' A' ' 110' ' ' HIS . 88.4 mt -88.92 150.8 22.68 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 174.671 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -77.45 -50.24 13.11 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.249 0.547 . . . . 0.0 110.026 178.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -92.48 -177.66 4.67 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.015 -178.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 71.3 t60 -135.54 -25.45 1.3 Allowed 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.525 -178.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 6.0 t-80 -92.12 -10.26 39.57 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 177.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -132.32 140.12 48.44 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.878 -1.055 . . . . 0.0 108.888 175.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . 0.455 ' HA ' HD13 ' A' ' 104' ' ' LEU . 11.8 p-80 -77.48 78.67 3.99 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.862 0.839 . . . . 0.0 111.104 179.13 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 36.2 t60 . . . . . 0 C--O 1.244 0.764 0 CA-C-N 114.814 -1.084 . . . . 0.0 108.84 176.495 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.91 ' HE3' ' HB ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.938 0 CA-C-O 120.954 0.407 . . . . 0.0 110.552 . . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -93.92 170.95 9.17 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.553 175.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.481 ' O ' ' HG3' ' A' ' 7' ' ' LYS . 34.2 t -61.48 -29.79 70.2 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.569 174.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -52.76 -43.13 65.57 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.759 176.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.7 t -62.9 -38.91 83.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.67 -178.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.51 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 60.5 mt -66.42 -44.86 90.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.315 179.335 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.481 ' HG3' ' O ' ' A' ' 3' ' ' SER . 85.6 mttt -63.63 -36.45 83.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.467 -179.187 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -55.86 -49.58 72.97 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.738 175.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -60.13 -43.14 95.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.066 179.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.511 HD12 ' HB3' ' A' ' 17' ' ' TYR . 74.4 mt -63.25 -48.27 78.92 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.325 -177.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -74.59 -19.62 60.25 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.96 -179.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -72.32 -45.34 60.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.837 177.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 38.1 pt -73.56 -17.78 17.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.979 0.419 . . . . 0.0 110.31 177.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.11 30.44 14.35 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.677 173.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -115.25 168.08 10.28 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 177.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -113.18 155.06 25.68 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.956 0.408 . . . . 0.0 110.96 -175.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.511 ' HB3' HD12 ' A' ' 10' ' ' LEU . 14.8 p90 -125.7 147.56 49.32 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.117 -173.219 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 52.5 mt -89.09 93.96 4.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 177.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -98.63 116.25 30.44 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.24 -176.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 77.4 mt -111.43 -176.53 2.97 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 171.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.467 ' HA ' ' OE1' ' A' ' 21' ' ' GLU . 6.3 tp10 -72.23 109.57 6.08 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 120.427 -0.509 . . . . 0.0 109.936 179.347 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 66.49 15.12 10.01 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.733 179.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -138.41 113.92 9.65 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.843 0.354 . . . . 0.0 111.277 179.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.454 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 63.9 mt -110.09 112.1 39.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 172.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 53.5 m-70 -98.44 117.21 32.35 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 80.4 mt -114.92 173.37 6.52 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.192 -175.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 75.6 mttt -84.5 149.65 55.16 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.492 178.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_exo -51.52 -41.68 59.28 Favored 'Trans proline' 0 C--O 1.233 0.241 0 C-N-CA 122.907 2.405 . . . . 0.0 112.855 -179.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -65.6 -44.71 85.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.76 0.314 . . . . 0.0 110.541 -179.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 61.4 t -64.91 -45.09 95.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.131 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -58.1 -40.12 80.35 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.033 -179.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -57.49 -42.54 82.9 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.338 179.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -76.43 -40.81 49.61 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.921 -177.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 79.0 t -65.56 -32.37 57.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.536 178.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.522 ' CD1' ' HD2' ' A' ' 41' ' ' PRO . 25.8 t90 -52.97 -52.27 58.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.027 178.574 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -76.07 -26.82 56.87 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.756 0.312 . . . . 0.0 110.762 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -65.82 -34.7 78.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.053 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.91 ' HB ' ' HE3' ' A' ' 1' ' ' MET . 35.9 m -89.73 9.94 2.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.788 0.327 . . . . 0.0 111.579 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 100.7 14.7 31.26 Favored Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 120.604 -0.807 . . . . 0.0 113.604 174.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 48.75 73.09 1.06 Allowed Pre-proline 0 N--CA 1.466 0.357 0 CA-C-O 121.279 0.562 . . . . 0.0 111.409 177.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.522 ' HD2' ' CD1' ' A' ' 35' ' ' TRP . 95.4 Cg_endo -90.4 163.8 4.47 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 122.679 2.253 . . . . 0.0 112.48 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -71.32 107.12 4.13 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 172.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 70.5 mt -73.43 146.42 45.04 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.812 -172.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -87.95 138.45 31.44 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.776 176.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 19.3 p -127.94 132.3 49.25 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 120.825 0.345 . . . . 0.0 110.218 176.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 14.7 p90 -119.21 144.64 46.61 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.758 -178.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 43.7 t -93.72 105.14 16.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.279 -0.419 . . . . 0.0 109.951 179.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 12.1 tt -105.77 130.6 56.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.061 179.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.69 ' HB3' ' HB3' ' A' ' 70' ' ' LYS . 45.4 mt-10 -88.83 106.66 18.53 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 177.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.528 ' O ' HG22 ' A' ' 71' ' ' VAL . 10.6 t70 -92.9 111.2 22.74 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.453 -174.753 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.465 ' HA ' ' O ' ' A' ' 69' ' ' LYS . 41.8 mt-10 -81.39 93.49 6.6 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.372 0.606 . . . . 0.0 109.764 -179.15 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.1 tp -63.55 -25.85 39.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.043 -0.981 . . . . 0.0 111.882 -171.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.2 p -125.85 123.54 64.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 120.972 0.415 . . . . 0.0 110.596 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -132.03 101.56 15.08 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.4 177.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -65.53 120.19 7.34 Favored 'Trans proline' 0 N--CA 1.463 -0.268 0 C-N-CA 122.835 2.357 . . . . 0.0 111.685 177.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -135.65 -35.89 0.22 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.343 -0.932 . . . . 0.0 111.899 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -71.46 -63.02 1.2 Allowed 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 174.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -134.26 170.33 15.87 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.71 -1.132 . . . . 0.0 108.408 170.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.491 ' OD2' ' HB2' ' A' ' 62' ' ' GLU . 15.0 t0 -125.18 81.15 63.7 Favored Pre-proline 0 C--N 1.319 -0.735 0 CA-C-O 121.247 0.546 . . . . 0.0 111.299 -176.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -58.95 -42.75 49.03 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 123.07 2.513 . . . . 0.0 113.966 172.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.681 ' HB2' ' HA ' ' A' ' 67' ' ' ASN . 31.4 Cg_exo -61.74 -2.8 3.0 Favored 'Trans proline' 0 C--N 1.365 1.421 0 C-N-CA 122.348 2.032 . . . . 0.0 113.772 -179.229 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.491 ' HB2' ' OD2' ' A' ' 59' ' ' ASP . 33.4 tt0 -60.42 -26.43 66.7 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.054 0.454 . . . . 0.0 109.935 173.233 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 85.8 mtp -67.07 -18.16 65.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.536 177.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -120.66 -162.22 0.94 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.284 -177.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -113.03 4.86 16.9 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.074 0.464 . . . . 0.0 111.004 -173.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 41.4 m -137.45 105.18 5.58 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.813 -178.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.681 ' HA ' ' HB2' ' A' ' 61' ' ' PRO . 13.2 m120 -83.63 -41.63 17.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.652 -178.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 30.6 m -118.64 145.21 24.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.328 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.465 ' O ' ' HA ' ' A' ' 51' ' ' GLU . 53.8 tttm -113.84 108.9 17.69 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.856 0.36 . . . . 0.0 110.252 178.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.69 ' HB3' ' HB3' ' A' ' 49' ' ' GLU . 59.5 mttm -85.2 109.0 17.99 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.309 179.574 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.528 HG22 ' O ' ' A' ' 50' ' ' ASP . 35.7 m -97.84 122.64 49.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.161 0.505 . . . . 0.0 110.164 175.092 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -76.45 104.13 6.81 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.556 -177.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 56.8 mt -110.08 117.06 53.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.426 179.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.409 ' O ' ' HB3' ' A' ' 90' ' ' TYR . 52.9 tttm -87.44 91.77 8.85 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.554 179.06 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -92.04 160.96 14.98 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.08 -176.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 13.5 p -114.9 144.19 23.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.209 -173.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.405 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 37.6 p90 -154.99 162.7 41.01 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.729 176.499 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -137.1 150.18 47.84 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 170.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 54.9 tt0 -120.49 135.67 55.0 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.479 -173.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 73.0 p -94.8 -176.97 4.03 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.338 177.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.8 mp -65.05 -13.73 58.69 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.279 0.561 . . . . 0.0 110.727 179.004 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.429 ' O ' ' HB2' ' A' ' 83' ' ' ASN . 4.8 m-20 -79.22 -8.82 59.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.59 -179.548 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . 0.429 ' HB2' ' O ' ' A' ' 82' ' ' ASP . 14.3 m120 69.58 16.73 8.04 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.4 0.619 . . . . 0.0 110.252 -174.357 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 66.1 t -89.57 122.03 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.383 176.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -100.33 116.51 32.47 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.719 -176.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' A' ' 24' ' ' ILE . 59.1 t -86.31 104.72 14.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.552 176.482 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 22.0 t -101.65 142.65 15.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.607 -174.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 58.2 m -151.15 157.09 42.26 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 177.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -71.09 121.02 17.51 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.093 0.473 . . . . 0.0 110.409 -178.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.409 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 12.2 t80 -75.72 -27.5 58.19 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.981 -174.572 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 33.0 t -70.02 -43.66 70.87 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -64.25 -42.32 96.57 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.357 175.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -62.79 -46.6 87.23 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.856 -179.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -65.7 -29.61 70.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.011 178.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -63.83 -33.47 75.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.076 0.465 . . . . 0.0 110.302 176.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.488 ' HA ' ' HD2' ' A' ' 99' ' ' LYS . 68.0 mt -75.02 -39.89 44.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.381 176.405 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.449 HD22 ' HG1' ' A' ' 102' ' ' THR . 84.2 mt -65.07 -30.52 71.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.172 0.51 . . . . 0.0 110.138 176.406 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 44.9 tttm -67.41 -37.29 82.85 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.421 175.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.488 ' HD2' ' HA ' ' A' ' 96' ' ' ILE . 60.3 mttm -64.44 -47.54 78.68 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.356 175.449 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 52.8 ttt-85 -68.64 -38.39 80.46 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.963 -177.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 87.43 40.12 6.99 Favored Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 111.251 -0.74 . . . . 0.0 111.251 -176.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.451 HG21 ' H ' ' A' ' 104' ' ' LEU . 20.7 m -63.26 130.16 43.35 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.012 0.434 . . . . 0.0 111.354 -177.448 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.444 ' HA ' ' O ' ' A' ' 106' ' ' HIS . 85.6 tttt -63.83 -17.16 62.85 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.408 -0.814 . . . . 0.0 112.099 -175.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . 0.451 ' H ' HG21 ' A' ' 102' ' ' THR . 91.2 mt -57.2 -39.21 74.97 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.852 0.358 . . . . 0.0 111.002 179.612 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -91.83 -63.17 1.28 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.139 0.495 . . . . 0.0 109.885 175.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . 0.444 ' O ' ' HA ' ' A' ' 103' ' ' LYS . 42.6 m170 -84.13 92.94 8.03 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.677 178.168 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 40.4 m80 -65.92 -35.97 82.09 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.938 -177.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 23.2 m-70 -103.04 113.86 27.67 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 170.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 8.7 t-80 -57.73 -71.79 0.1 Allowed 'General case' 0 C--N 1.329 -0.305 0 O-C-N 123.531 0.519 . . . . 0.0 111.372 -172.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 2.1 m170 174.0 -68.22 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.053 0.941 . . . . 0.0 108.748 178.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 53.5 t60 . . . . . 0 C--O 1.244 0.771 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 173.081 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.481 ' HG2' HG12 ' A' ' 38' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.029 0 CA-C-O 120.744 0.307 . . . . 0.0 110.767 . . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -140.04 173.9 11.06 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 176.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 36.9 t -68.68 -27.7 66.2 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 175.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -58.05 -36.94 73.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.165 173.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 98.3 t -68.54 -42.85 83.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.458 178.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 62.9 mt -60.81 -45.31 98.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.981 177.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 45.9 mttp -56.51 -52.61 64.09 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.575 175.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -58.12 -45.16 87.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.105 -178.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -63.67 -45.66 89.1 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.34 -178.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 83.9 mt -71.04 -34.6 71.43 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.636 -0.256 . . . . 0.0 111.282 -177.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 43.1 mm-40 -69.74 -33.55 72.61 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.046 0.451 . . . . 0.0 110.418 175.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -63.37 -52.33 62.16 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.556 178.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 39.5 pt -77.97 -17.46 13.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.55 -177.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 76.99 60.43 2.91 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.074 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -112.5 158.87 19.38 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 -178.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -71.15 117.61 12.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.08 0.467 . . . . 0.0 110.82 179.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -116.09 121.07 41.08 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.269 -176.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 61.1 mt -120.82 107.24 20.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.758 0.313 . . . . 0.0 110.776 -179.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -125.8 125.04 42.28 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.04 0.448 . . . . 0.0 110.064 175.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 97.3 mt -95.16 46.49 1.12 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.875 178.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 66.62 94.79 0.06 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.569 -177.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 13.6 m120 73.18 -8.25 1.35 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.844 179.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 32.2 tp10 -112.76 113.78 26.04 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 175.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.563 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 55.0 mt -107.19 133.48 51.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 110.335 -0.246 . . . . 0.0 110.335 -177.144 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -125.27 105.45 9.13 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 173.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 37.1 mt -95.26 -179.81 4.92 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.774 0.797 . . . . 0.0 113.026 -168.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -87.53 132.83 39.63 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 114.389 -1.278 . . . . 0.0 109.942 -179.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 99.8 Cg_exo -42.56 -70.42 0.07 OUTLIER 'Trans proline' 0 CA--C 1.532 0.421 0 C-N-CA 123.948 3.099 . . . . 0.0 114.811 -172.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -75.64 -3.15 32.86 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -172.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 98.5 t -90.02 -44.64 15.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 175.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -58.98 -34.66 72.07 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.609 177.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 67.5 t80 -54.14 -40.97 67.9 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.397 178.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -83.36 -29.02 28.55 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.116 -178.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 66.9 t -66.42 -36.79 78.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.375 0.607 . . . . 0.0 109.486 174.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 33.5 t90 -56.46 -52.97 62.69 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.557 175.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.778 ' HA ' ' HB3' ' A' ' 40' ' ' GLU . 53.5 mttm -66.84 -30.39 70.56 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.631 -0.258 . . . . 0.0 111.201 178.113 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -59.58 -40.71 88.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.367 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.481 HG12 ' HG2' ' A' ' 1' ' ' MET . 19.4 m -88.32 7.67 3.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.924 -175.468 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 109.33 0.31 31.18 Favored Glycine 0 N--CA 1.453 -0.197 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.977 176.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.778 ' HB3' ' HA ' ' A' ' 36' ' ' LYS . 10.8 pt-20 44.8 69.46 2.5 Favored Pre-proline 0 N--CA 1.473 0.69 0 C-N-CA 124.267 1.027 . . . . 0.0 113.009 -179.342 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -94.04 -179.19 0.74 Allowed 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 123.096 2.53 . . . . 0.0 112.095 176.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -71.29 114.76 9.69 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.046 0.451 . . . . 0.0 110.691 176.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 68.5 mt -77.82 164.29 25.33 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.62 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 52.4 tttp -106.67 122.83 47.13 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.07 -176.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 39.9 p -102.66 148.67 25.28 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.673 -0.24 . . . . 0.0 111.489 -177.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -130.63 145.29 51.87 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 176.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 60.1 t -104.85 113.64 42.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 120.832 0.348 . . . . 0.0 110.572 -179.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 10.8 tt -111.05 112.75 41.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.371 0.605 . . . . 0.0 110.398 177.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.872 ' HG2' ' HG2' ' A' ' 72' ' ' LYS . 50.4 mt-10 -77.48 107.01 9.62 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.258 179.097 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -93.13 126.18 38.1 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -179.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -94.03 104.82 16.85 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 120.997 0.427 . . . . 0.0 111.199 -174.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 67.1 mt -87.19 110.71 20.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.098 178.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.436 HG13 ' HA ' ' A' ' 68' ' ' VAL . 21.2 m -132.23 144.9 35.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.685 178.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -97.75 117.95 64.64 Favored Pre-proline 0 C--N 1.321 -0.663 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 172.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.32 -175.96 1.47 Allowed 'Trans proline' 0 C--O 1.234 0.288 0 C-N-CA 122.836 2.357 . . . . 0.0 113.205 -174.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -135.27 43.99 1.21 Allowed Glycine 0 N--CA 1.444 -0.796 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.981 -177.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -46.28 -43.9 16.06 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 123.296 0.639 . . . . 0.0 111.567 -177.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -123.22 94.59 4.31 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.226 179.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -95.68 115.22 65.34 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.105 -179.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.47 ' HG2' ' HE2' ' A' ' 64' ' ' LYS . 8.3 Cg_exo -73.47 165.06 33.44 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 122.933 2.422 . . . . 0.0 111.099 173.768 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.44 43.67 0.65 Allowed 'Trans proline' 0 CA--C 1.534 0.507 0 C-N-CA 122.864 2.376 . . . . 0.0 112.719 179.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -123.47 -176.23 3.4 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.783 -179.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 68.3 mtm -113.34 83.39 1.83 Allowed 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 174.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.47 ' HE2' ' HG2' ' A' ' 60' ' ' PRO . 68.0 mttm -93.59 132.73 37.64 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 177.225 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -107.9 147.18 31.34 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.293 0.568 . . . . 0.0 111.757 -172.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.2 t -163.43 153.32 15.33 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.18 -0.918 . . . . 0.0 108.558 178.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 29.2 p-10 -134.85 161.18 35.94 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.223 0.535 . . . . 0.0 112.06 -174.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.436 ' HA ' HG13 ' A' ' 53' ' ' VAL . 3.3 p -83.23 133.18 29.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.165 179.238 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -128.95 107.86 9.96 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.075 0.464 . . . . 0.0 110.303 176.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 48.7 mttm -92.14 132.92 36.24 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.146 -177.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 18.9 m -115.8 128.26 73.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.115 0.483 . . . . 0.0 110.524 176.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.872 ' HG2' ' HG2' ' A' ' 49' ' ' GLU . 79.4 mttt -86.74 100.06 12.22 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.987 0.423 . . . . 0.0 110.352 -178.483 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 57.0 mt -92.71 115.09 30.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.054 -179.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.58 ' O ' ' HB3' ' A' ' 90' ' ' TYR . 82.2 tttt -98.9 114.71 27.44 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.247 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -111.83 166.99 10.72 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 13.9 p -125.83 143.48 39.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 120.733 0.301 . . . . 0.0 111.074 -172.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 28.9 p90 -155.0 173.8 16.06 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.934 0.397 . . . . 0.0 110.941 178.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -145.1 151.44 38.51 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 170.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -102.07 128.97 48.3 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.843 0.354 . . . . 0.0 110.23 -176.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.4 p -84.09 173.59 10.98 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.201 179.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.407 HD13 ' N ' ' A' ' 81' ' ' LEU . 7.0 mp -68.33 -17.74 64.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.068 0.461 . . . . 0.0 111.36 -176.213 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -95.62 14.95 21.29 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.213 -179.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 70.44 23.68 4.82 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.143 173.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 59.3 t -100.14 141.93 16.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 120.962 0.41 . . . . 0.0 110.562 178.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 8.2 mtp180 -98.0 117.08 31.54 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.229 -178.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.563 ' HA ' ' HB ' ' A' ' 24' ' ' ILE . 20.5 t -96.89 97.1 5.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 176.627 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.423 ' C ' ' HG1' ' A' ' 88' ' ' THR . 31.8 t -103.7 144.4 14.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.079 0.466 . . . . 0.0 111.656 -172.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.423 ' HG1' ' C ' ' A' ' 87' ' ' VAL . 51.1 m -151.98 159.6 43.71 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 175.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -73.04 131.86 42.65 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 121.734 -0.604 . . . . 0.0 110.986 -176.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.58 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 88.9 t80 -73.93 -30.34 62.5 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.389 -176.725 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.25 -44.77 71.26 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.514 ' O ' ' HB3' ' A' ' 95' ' ' LYS . 5.3 tp10 -70.43 -34.66 72.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.233 179.301 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.413 ' O ' HD23 ' A' ' 97' ' ' LEU . 83.4 t80 -62.34 -51.5 67.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.325 176.588 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 72.5 mm-40 -64.31 -29.73 70.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.825 179.138 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.514 ' HB3' ' O ' ' A' ' 92' ' ' GLU . 23.4 tptm -55.72 -46.99 77.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.321 174.621 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 57.7 mt -68.84 -39.5 80.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.112 -179.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.558 HD13 ' HG3' ' A' ' 103' ' ' LYS . 4.3 mm? -58.59 -45.25 89.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.788 178.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -74.27 -30.38 62.09 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.507 178.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -59.33 -45.35 91.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.908 -176.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 100' ' ' ARG . 21.3 ttp85 -104.35 -8.13 19.45 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.107 -179.127 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 72.04 46.59 35.3 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.111 179.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.515 ' HB ' HD12 ' A' ' 97' ' ' LEU . 15.1 m -72.7 -24.92 61.07 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.166 0.508 . . . . 0.0 111.1 -177.225 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.558 ' HG3' HD13 ' A' ' 97' ' ' LEU . 55.7 mtmt -106.27 69.89 0.81 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.303 0.573 . . . . 0.0 109.829 175.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 8.1 tt -159.43 123.54 3.86 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.086 -179.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -113.92 113.1 24.38 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 12.4 t-80 -57.96 -30.44 65.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.794 -174.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -118.3 128.26 54.49 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 28.3 m80 -111.42 131.87 54.88 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.719 0.295 . . . . 0.0 110.679 177.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 -83.59 135.62 34.55 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 176.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 61.2 t60 67.51 -81.62 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 O-C-N 123.857 0.723 . . . . 0.0 109.579 -174.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 16.1 t-80 . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.085 -0.96 . . . . 0.0 109.805 175.578 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.0 tmm? . . . . . 0 N--CA 1.479 1.024 0 CA-C-O 120.969 0.414 . . . . 0.0 110.723 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 -127.16 -178.11 4.31 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 173.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.577 ' O ' ' HG3' ' A' ' 7' ' ' LYS . 30.1 p -56.89 -31.69 65.12 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.764 0.316 . . . . 0.0 110.693 177.81 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -56.7 -52.62 64.24 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.975 175.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.1 t -60.42 -43.25 93.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.683 -179.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.437 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 67.1 mt -53.12 -45.33 53.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.88 174.68 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.577 ' HG3' ' O ' ' A' ' 3' ' ' SER . 91.6 mttt -62.48 -41.6 98.9 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.97 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -58.7 -42.69 89.21 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.993 0.425 . . . . 0.0 110.62 177.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -65.28 -43.83 89.97 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.412 179.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.496 HD13 ' HB3' ' A' ' 17' ' ' TYR . 85.4 mt -65.26 -39.3 92.46 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.996 179.673 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -67.26 -40.53 86.25 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.428 178.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -60.04 -43.38 95.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.795 177.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 62.5 mt -70.29 -41.35 78.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.544 177.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.74 35.76 5.02 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.99 -0.624 . . . . 0.0 111.784 -178.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -104.53 177.27 4.89 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.071 0.463 . . . . 0.0 111.245 -178.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -109.65 149.97 28.93 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.966 -178.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.496 ' HB3' HD13 ' A' ' 10' ' ' LEU . 34.1 p90 -144.84 144.52 31.17 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 176.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 67.3 mt -113.01 102.86 14.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 120.895 0.378 . . . . 0.0 110.103 178.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -92.2 133.22 36.0 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.275 0.559 . . . . 0.0 110.861 -178.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 88.9 mt -121.44 -162.24 0.96 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.788 177.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -71.62 102.06 2.66 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.892 -0.323 . . . . 0.0 110.399 177.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 67.3 20.48 10.04 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.33 177.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -136.77 138.86 41.35 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.287 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.4 HD13 ' HB2' ' A' ' 3' ' ' SER . 60.2 mt -122.86 113.01 36.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 170.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.494 ' HA ' ' O ' ' A' ' 87' ' ' VAL . 16.3 m-70 -95.87 123.72 39.57 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.251 -179.355 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 92.5 mt -114.98 177.55 4.61 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.345 -175.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.418 ' HB2' HG21 ' A' ' 30' ' ' VAL . 86.8 mttt -86.95 137.9 33.13 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 115.364 -0.835 . . . . 0.0 108.934 174.242 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.45 ' HA ' HG21 ' A' ' 88' ' ' THR . 57.6 Cg_exo -52.4 -38.05 73.12 Favored 'Trans proline' 0 CA--C 1.529 0.26 0 C-N-CA 122.92 2.414 . . . . 0.0 113.113 -177.218 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -73.6 -29.67 62.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.04 -177.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.418 HG21 ' HB2' ' A' ' 27' ' ' LYS . 27.0 t -84.54 -38.37 13.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.233 0.54 . . . . 0.0 110.134 179.557 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -57.63 -30.43 65.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.826 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -54.35 -45.95 72.85 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.271 178.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -82.05 -29.4 31.93 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.274 -177.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 79.5 t -67.8 -41.31 85.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.21 0.529 . . . . 0.0 109.977 176.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . 0.47 ' CD1' ' HD2' ' A' ' 41' ' ' PRO . 29.2 t90 -57.14 -45.29 83.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.342 176.121 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 56.8 mttm -76.23 -21.53 56.27 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.461 179.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -65.97 -35.64 81.15 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.998 0.428 . . . . 0.0 110.381 178.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.511 HG21 ' HD3' ' A' ' 41' ' ' PRO . 26.9 m -93.68 12.39 3.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.316 179.559 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 87.01 29.33 23.34 Favored Glycine 0 C--N 1.33 0.237 0 C-N-CA 121.055 -0.593 . . . . 0.0 113.481 174.183 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 36.42 75.21 0.53 Allowed Pre-proline 0 N--CA 1.473 0.701 0 C-N-CA 124.07 0.948 . . . . 0.0 113.218 179.082 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.511 ' HD3' HG21 ' A' ' 38' ' ' VAL . 82.1 Cg_endo -89.01 -159.32 0.09 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 123.307 2.671 . . . . 0.0 112.617 -178.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -70.18 123.74 22.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.684 -178.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 74.7 mt -89.07 117.54 28.15 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.239 175.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -95.66 119.47 34.23 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.227 -178.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.6 p -107.2 134.73 49.87 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.614 179.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' TYR . . . . . 0.5 ' CE1' ' HB2' ' A' ' 75' ' ' LYS . 15.1 p90 -128.29 140.45 51.87 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.329 -0.396 . . . . 0.0 109.975 178.492 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 61.7 t -99.18 110.55 26.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.584 -179.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.421 HG23 ' HB ' ' A' ' 73' ' ' ILE . 7.4 tt -106.86 106.68 21.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.645 175.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.477 ' OE1' ' HD3' ' A' ' 70' ' ' LYS . 39.6 tt0 -81.94 104.05 12.03 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.121 -179.014 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -102.36 146.72 27.65 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -99.09 125.16 44.55 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.778 0.323 . . . . 0.0 111.074 -174.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 53.2 mt 63.72 85.63 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.788 -177.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.453 HG21 HD13 ' A' ' 73' ' ' ILE . 48.1 t -110.04 96.86 5.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.992 178.224 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -96.38 159.38 32.06 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.497 -178.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -54.9 -32.94 80.22 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 123.124 2.55 . . . . 0.0 113.189 179.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 176.12 -35.32 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.259 -0.972 . . . . 0.0 113.263 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -114.12 145.12 42.07 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.813 0.307 . . . . 0.0 111.008 -177.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -104.86 174.3 5.94 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 176.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -83.01 156.21 67.2 Favored Pre-proline 0 C--N 1.327 -0.4 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 177.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.48 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 88.5 Cg_exo -42.65 124.9 3.54 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 123.8 3.0 . . . . 0.0 113.872 -175.383 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' ' 60' ' ' PRO . 10.2 Cg_exo -70.42 87.3 0.64 Allowed 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 123.289 2.659 . . . . 0.0 112.517 -178.527 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -122.14 -177.53 3.62 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.766 178.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 46.8 ttp -75.03 82.07 2.23 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 173.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 72.7 tttt -153.78 138.29 16.82 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.803 -1.09 . . . . 0.0 109.464 -172.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 77.9 t80 -87.6 99.95 12.43 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.875 0.369 . . . . 0.0 110.811 178.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 32.9 m -71.04 119.4 15.11 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 169.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 -52.34 112.7 0.85 Allowed 'General case' 0 C--N 1.329 -0.313 0 O-C-N 123.372 0.42 . . . . 0.0 111.627 -175.082 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 45.4 t -75.63 86.67 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.827 178.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 32.4 tttm -96.66 127.22 42.43 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.665 -178.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.477 ' HD3' ' OE1' ' A' ' 49' ' ' GLU . 62.8 mttm -79.91 129.96 34.91 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.979 -175.392 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 53.8 t -116.75 109.94 29.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.452 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 61.6 mttp -76.06 100.34 4.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.31 177.471 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.453 HD13 HG21 ' A' ' 53' ' ' VAL . 40.3 mt -91.19 108.59 20.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.254 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 54.1 tttp -91.57 106.18 18.3 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.56 178.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.5 ' HB2' ' CE1' ' A' ' 46' ' ' TYR . 89.9 mttt -105.49 162.23 13.65 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.158 -178.725 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 10.7 p -124.19 142.42 41.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.605 0.24 . . . . 0.0 110.574 -178.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.447 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 43.5 p90 -153.6 167.8 28.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.095 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 44.1 p90 -136.49 151.11 49.1 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 168.073 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -102.48 131.6 49.07 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.01 0.433 . . . . 0.0 111.466 -174.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 75.0 p -83.97 -172.66 4.28 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.003 179.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 8.5 mp -73.81 -33.61 64.25 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.949 0.404 . . . . 0.0 110.424 178.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -92.16 24.57 3.26 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.369 -177.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 20.8 m120 69.81 20.76 6.67 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 169.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 86.1 t -94.41 124.42 46.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.595 179.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 51.9 mtt-85 -89.52 110.93 21.72 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.707 179.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 45.9 t -81.35 99.5 4.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 175.516 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.494 ' O ' ' HA ' ' A' ' 25' ' ' HIS . 22.2 t -102.57 138.88 25.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.879 -172.297 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' THR . . . . . 0.45 HG21 ' HA ' ' A' ' 28' ' ' PRO . 42.8 m -144.76 157.59 44.12 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 177.022 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ASP . . . . . 0.466 ' OD2' ' HG2' ' A' ' 92' ' ' GLU . 9.5 t70 -66.88 122.46 17.76 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.155 0.503 . . . . 0.0 111.57 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -69.28 -30.23 68.28 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.845 -177.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 35.1 t -62.84 -66.38 0.55 Allowed 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.077 -176.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLU . . . . . 0.466 ' HG2' ' OD2' ' A' ' 89' ' ' ASP . 12.3 mm-40 -68.66 -28.96 67.34 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 121.042 -0.263 . . . . 0.0 111.323 -175.48 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.42 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 53.0 t80 -62.09 -47.4 84.82 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 121.079 -0.248 . . . . 0.0 110.872 178.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -64.14 -35.52 81.06 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.779 0.323 . . . . 0.0 110.838 179.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -61.39 -43.72 98.38 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.515 177.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.407 HG13 ' O ' ' A' ' 92' ' ' GLU . 78.9 mt -66.79 -36.77 78.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.033 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' A' ' 93' ' ' PHE . 97.8 mt -59.42 -49.95 75.85 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.943 0.401 . . . . 0.0 110.117 175.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 7.6 mtpm? -63.89 -42.61 97.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.602 177.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 7.6 tmtm? -59.76 -54.17 49.41 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.953 -177.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 49.4 mtt180 -82.65 -6.41 59.35 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.349 -175.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 81.22 40.62 11.12 Favored Glycine 0 C--N 1.329 0.173 0 C-N-CA 120.967 -0.635 . . . . 0.0 113.409 172.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 37.1 m -78.77 133.49 37.1 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.702 0.287 . . . . 0.0 110.345 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -95.44 119.19 33.51 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.911 0.386 . . . . 0.0 111.029 -176.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 87.1 mt -105.69 164.83 11.61 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.959 177.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -70.44 138.36 51.15 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.359 0.6 . . . . 0.0 112.294 -176.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 17.9 m-70 -127.07 102.39 6.95 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.17 172.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 10.7 m170 -99.92 164.19 12.12 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.061 -175.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -87.37 -11.35 49.59 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.526 0.679 . . . . 0.0 109.262 177.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 32.3 m80 -134.96 130.04 35.17 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.985 -1.007 . . . . 0.0 108.934 173.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 53.8 p-80 -65.27 -36.77 85.13 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 174.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 1.9 m80 . . . . . 0 C--O 1.246 0.884 0 CA-C-N 115.347 -0.842 . . . . 0.0 108.963 175.742 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 14.7 m120 . . . . . 0 C--O 1.232 0.166 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.6 m -63.93 -28.01 69.53 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.239 0.542 . . . . 0.0 110.36 178.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -62.71 -33.1 74.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.192 178.156 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 88.7 t -66.9 -39.42 83.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.164 177.298 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.472 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 64.0 mt -63.43 -39.9 87.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.422 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -64.2 -40.24 95.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.755 179.213 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -68.1 -36.85 80.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.7 177.388 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -62.14 -43.52 98.65 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.255 176.252 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' A' ' 6' ' ' ILE . 94.0 mt -65.26 -32.4 74.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.662 177.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -62.92 -47.35 83.64 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.36 177.058 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -64.02 -52.37 59.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.16 -178.248 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 40.1 pt -67.5 -27.46 38.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.243 -177.198 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.62 58.21 1.45 Allowed Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.503 178.072 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.452 ' HG2' HG21 ' A' ' 30' ' ' VAL . 8.4 tp10 -136.36 148.22 47.75 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -95.92 139.93 31.42 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.682 -179.077 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.464 ' HB3' HD13 ' A' ' 10' ' ' LEU . 52.6 p90 -112.34 142.39 44.91 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.863 0.363 . . . . 0.0 110.49 176.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 62.1 mt -101.65 96.59 4.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 176.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.406 ' HA ' ' O ' ' A' ' 23' ' ' GLU . 39.9 tt0 -97.28 121.88 39.67 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.374 0.607 . . . . 0.0 110.813 -178.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 96.3 mt -109.22 34.01 3.98 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.334 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 69.8 101.12 0.06 Allowed 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.268 -177.4 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 7.7 m120 68.74 3.64 4.01 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.019 -177.481 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.406 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 12.9 mt-10 -129.32 113.9 15.55 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 110.406 -0.22 . . . . 0.0 110.406 172.065 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.405 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 67.6 mt -105.95 102.65 14.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 175.541 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 42.7 m-70 -87.81 120.99 29.68 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.231 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 59.9 mt -117.89 172.14 7.59 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.483 0.659 . . . . 0.0 111.634 -175.439 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -80.19 136.17 53.73 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.402 176.191 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.83 ' HG2' ' HG2' ' A' ' 92' ' ' GLU . 88.2 Cg_exo -49.01 -43.81 34.66 Favored 'Trans proline' 0 N--CA 1.474 0.367 0 C-N-CA 123.536 2.824 . . . . 0.0 114.073 -175.146 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -67.71 -36.66 81.02 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.784 0.326 . . . . 0.0 110.988 -179.251 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.452 HG21 ' HG2' ' A' ' 15' ' ' GLU . 41.2 t -68.96 -43.86 81.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.087 0.47 . . . . 0.0 109.881 176.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -55.87 -45.62 78.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.082 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 78.4 t80 -57.7 -39.45 77.2 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.28 -178.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -76.78 -42.29 41.31 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.032 -178.351 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 89.4 t -65.6 -37.16 79.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.791 0.329 . . . . 0.0 110.516 178.591 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 26.1 t90 -54.19 -53.92 46.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.665 177.598 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.507 ' HA ' ' HB3' ' A' ' 40' ' ' GLU . 65.9 mttm -71.88 -26.46 62.35 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 121.158 -0.217 . . . . 0.0 111.246 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 77.1 t80 -63.36 -38.59 91.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.733 0.301 . . . . 0.0 110.975 179.004 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 29.0 m -88.39 10.42 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.827 0.346 . . . . 0.0 111.755 -177.368 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 99.86 8.18 51.83 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.934 176.046 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.507 ' HB3' ' HA ' ' A' ' 36' ' ' LYS . 19.1 pt-20 40.69 81.36 0.25 Allowed Pre-proline 0 N--CA 1.473 0.708 0 C-N-CA 124.335 1.054 . . . . 0.0 113.315 178.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -88.08 -168.68 0.39 Allowed 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.008 2.472 . . . . 0.0 111.842 175.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -75.85 136.4 40.17 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.008 0.432 . . . . 0.0 110.717 179.098 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 97.2 mt -97.08 146.66 24.81 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.71 -179.006 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 61.1 tttm -111.5 118.39 35.62 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.62 -179.2 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 37.2 p -105.19 141.94 35.84 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.178 -176.177 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 21.2 p90 -130.05 151.37 50.67 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.77 0.319 . . . . 0.0 110.273 177.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.544 HG22 ' HG3' ' A' ' 74' ' ' LYS . 42.5 t -107.23 129.86 60.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.632 177.724 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 6.4 tt -125.92 111.88 28.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 121.239 0.542 . . . . 0.0 110.543 177.44 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.593 ' HA ' ' HA ' ' A' ' 72' ' ' LYS . 1.6 mp0 . . . . . 0 C--N 1.324 -0.509 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.021 177.335 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.593 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 20.5 pttp . . . . . 0 N--CA 1.453 -0.296 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 13.9 tt -105.79 137.12 37.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 121.276 0.56 . . . . 0.0 110.945 -175.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.592 ' O ' ' HB3' ' A' ' 90' ' ' TYR . 28.7 tttm -95.52 125.82 40.38 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.07 178.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -125.03 158.66 33.17 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.701 0.286 . . . . 0.0 110.281 178.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 11.1 p -121.94 146.75 26.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.617 -175.195 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.409 ' CE1' ' HD2' ' A' ' 85' ' ' ARG . 48.7 p90 -152.67 164.53 37.55 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.81 0.338 . . . . 0.0 110.393 175.283 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -132.54 147.9 52.37 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 170.025 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.529 ' HG2' ' HG2' ' A' ' 85' ' ' ARG . 45.3 mt-10 -104.27 132.14 50.84 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.947 0.403 . . . . 0.0 110.91 -176.289 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 49.5 p -85.14 -175.65 5.83 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.164 -179.473 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 7.9 mp -66.86 -20.79 65.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.388 177.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.44 ' HB2' HG23 ' A' ' 84' ' ' VAL . 9.3 m-20 -92.08 6.58 45.92 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.287 -178.331 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 64.94 23.15 12.56 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.957 -177.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.44 HG23 ' HB2' ' A' ' 82' ' ' ASP . 79.3 t -87.87 126.51 41.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 176.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.529 ' HG2' ' HG2' ' A' ' 79' ' ' GLU . 31.1 mtm180 -96.74 111.09 23.4 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.446 -175.346 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 24' ' ' ILE . 59.7 t -83.43 103.33 10.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 175.726 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.4 t -99.21 144.08 12.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.002 -172.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.519 HG21 ' HA ' ' A' ' 28' ' ' PRO . 51.5 m -151.39 148.94 28.72 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.735 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -57.56 112.44 1.43 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.055 178.145 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.592 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 70.9 t80 -71.96 -30.12 64.97 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.09 0.471 . . . . 0.0 110.25 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.3 p -60.95 -47.28 87.15 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.574 175.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.83 ' HG2' ' HG2' ' A' ' 28' ' ' PRO . 15.1 tp10 -72.17 -36.03 69.17 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.147 178.611 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.46 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 58.3 t80 -60.49 -52.59 64.54 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.068 -179.158 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 15.4 mt-30 -64.84 -31.71 73.07 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.777 0.322 . . . . 0.0 110.876 177.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.45 ' HB3' ' O ' ' A' ' 92' ' ' GLU . 76.8 tttt -59.42 -41.71 90.14 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.504 175.291 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.43 HG13 ' O ' ' A' ' 92' ' ' GLU . 73.1 mt -72.2 -37.11 58.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.499 176.733 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' A' ' 93' ' ' PHE . 86.5 mt -59.14 -48.96 79.7 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.62 177.016 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -65.3 -29.4 70.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.788 178.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 65.7 tttm -68.58 -52.05 35.92 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.795 -178.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 100' ' ' ARG . 56.8 mtt180 -82.64 -10.36 58.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.224 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.576 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.021 -179.549 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 . . . . . 0 C--O 1.233 0.222 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.2 m -60.06 -37.13 78.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.0 0.429 . . . . 0.0 111.241 -176.208 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -64.51 -35.99 82.74 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.577 -178.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 77.5 t -64.36 -40.57 89.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.347 177.359 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.554 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 65.9 mt -62.49 -46.4 96.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.216 177.319 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.409 ' O ' ' HG3' ' A' ' 11' ' ' GLU . 98.9 mttt -56.4 -49.23 75.11 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.622 178.142 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -57.92 -45.79 85.99 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.274 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 93.0 t80 -58.76 -40.67 84.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.352 178.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.554 ' HG ' ' O ' ' A' ' 6' ' ' ILE . 77.0 mt -66.48 -43.41 85.48 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.891 179.302 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.409 ' HG3' ' O ' ' A' ' 7' ' ' LYS . 52.4 mt-10 -62.46 -34.62 77.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.923 0.392 . . . . 0.0 110.624 178.762 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -66.16 -50.52 63.64 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.353 178.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 38.4 pt -75.98 -6.65 9.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.66 -177.49 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.73 24.19 39.58 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.614 175.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -89.91 154.16 20.07 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.837 0.351 . . . . 0.0 110.503 -177.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -103.36 122.87 45.72 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.136 177.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.539 ' HB3' HD13 ' A' ' 10' ' ' LEU . 39.8 p90 -115.25 133.24 56.22 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.029 176.706 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.551 ' HB ' ' HB2' ' A' ' 25' ' ' HIS . 44.0 mt -106.95 91.91 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 176.706 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.686 ' HA ' ' O ' ' A' ' 23' ' ' GLU . 1.0 OUTLIER -98.12 106.84 19.2 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.626 -179.081 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 97.0 mt -125.54 122.4 36.44 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.858 -178.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.47 ' O ' ' HB2' ' A' ' 22' ' ' ASN . 36.6 mt-10 58.43 36.64 25.51 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 123.577 0.548 . . . . 0.0 111.173 175.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.47 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 5.2 m-20 73.92 25.71 1.87 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.08 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.686 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 55.8 mt-10 -115.07 113.73 24.43 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.17 171.317 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.49 HG22 ' HG ' ' A' ' 26' ' ' LEU . 60.2 mt -91.55 101.62 12.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 177.157 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.551 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 12.3 m170 -87.29 121.95 30.41 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.201 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.49 ' HG ' HG22 ' A' ' 24' ' ' ILE . 63.6 mt -130.03 -174.83 3.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.243 0.544 . . . . 0.0 111.955 -175.563 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -92.02 144.7 29.59 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.091 177.223 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.523 ' HA ' HG21 ' A' ' 88' ' ' THR . 78.0 Cg_exo -50.19 -46.8 26.8 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 123.479 2.786 . . . . 0.0 113.911 -176.112 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -67.39 -36.52 81.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.791 0.329 . . . . 0.0 110.837 -177.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.407 ' O ' HG23 ' A' ' 34' ' ' VAL . 48.4 t -68.46 -41.56 83.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.09 179.046 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -56.01 -42.07 75.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.373 177.246 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 79.7 t80 -60.78 -44.99 96.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.351 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -68.64 -42.37 78.12 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.177 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 30' ' ' VAL . 93.5 t -64.9 -36.99 79.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.814 0.34 . . . . 0.0 110.16 177.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.52 ' CD1' ' HD2' ' A' ' 41' ' ' PRO . 27.6 t90 -52.8 -50.88 62.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.563 176.758 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -70.71 -34.84 72.36 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.322 178.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -57.97 -43.59 86.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.731 0.3 . . . . 0.0 111.29 179.12 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.534 HG23 ' HD3' ' A' ' 41' ' ' PRO . 27.6 m -82.35 14.43 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -175.46 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 101.89 1.96 52.19 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.743 175.344 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 57.22 70.45 1.35 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.19 0.519 . . . . 0.0 110.869 179.302 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.534 ' HD3' HG23 ' A' ' 38' ' ' VAL . 87.4 Cg_endo -88.28 -162.74 0.14 Allowed 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.967 2.445 . . . . 0.0 112.215 -179.153 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -88.11 145.12 26.11 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.247 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 96.0 mt -93.7 157.24 16.26 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.573 -175.268 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -125.3 148.3 48.76 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.184 176.465 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.6 p -141.15 153.13 45.22 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.797 0.332 . . . . 0.0 111.557 -175.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 16.8 p90 -145.04 148.86 34.17 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.839 176.057 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.43 ' HA ' ' HA ' ' A' ' 74' ' ' LYS . 45.7 t -102.03 122.28 54.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 17.5 tt -109.61 150.32 12.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.394 -178.045 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 . . . . . 0 C--N 1.327 -0.403 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.359 -175.186 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 51.3 mttm . . . . . 0 N--CA 1.451 -0.415 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 61.5 mt -98.63 125.6 51.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.238 0.542 . . . . 0.0 110.814 -176.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.517 ' O ' ' HB3' ' A' ' 90' ' ' TYR . 86.8 tttt -87.48 122.89 31.79 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.71 177.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -113.01 161.49 16.99 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.425 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.484 ' HB ' ' CD1' ' A' ' 90' ' ' TYR . 13.1 p -118.11 145.39 24.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.521 -0.308 . . . . 0.0 110.962 -175.392 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.413 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 38.8 p90 -154.94 159.55 40.5 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.909 178.313 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -133.4 152.29 51.9 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 170.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.548 ' HG2' ' HG2' ' A' ' 85' ' ' ARG . 24.9 mt-10 -104.61 138.82 40.37 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.987 0.423 . . . . 0.0 110.93 -173.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 73.0 p -97.54 -169.28 1.81 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.848 -175.361 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -69.9 -28.28 65.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.039 -179.367 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -95.71 19.5 11.14 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.086 -172.296 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 65.8 17.1 10.75 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.529 -179.124 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 85.2 t -88.34 137.9 20.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.108 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.548 ' HG2' ' HG2' ' A' ' 79' ' ' GLU . 90.5 mtt180 -107.84 113.87 27.41 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.453 -177.727 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 53.2 t -83.54 102.67 9.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 177.315 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 25' ' ' HIS . 32.5 t -100.38 136.29 32.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.778 -174.098 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.523 HG21 ' HA ' ' A' ' 28' ' ' PRO . 52.3 m -146.98 157.62 43.68 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.07 178.585 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -67.11 122.88 18.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.337 0.589 . . . . 0.0 111.617 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.517 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 49.2 t80 -78.38 -20.1 51.97 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.691 -178.508 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.543 ' O ' ' HG3' ' A' ' 95' ' ' LYS . 4.1 m -62.22 -61.1 2.7 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.867 0.365 . . . . 0.0 110.253 179.378 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -71.17 -29.28 64.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.125 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.524 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 62.9 t80 -58.24 -45.18 88.24 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.875 0.369 . . . . 0.0 110.07 176.225 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -61.67 -40.38 94.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.049 176.138 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.543 ' HG3' ' O ' ' A' ' 91' ' ' SER . 90.3 mttt -65.18 -40.75 94.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.832 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.473 HD12 ' HB2' ' A' ' 28' ' ' PRO . 66.6 mt -71.5 -31.12 41.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.239 -179.489 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.524 ' HG ' ' O ' ' A' ' 93' ' ' PHE . 53.8 mt -61.7 -42.44 98.94 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.939 0.4 . . . . 0.0 110.419 175.509 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -73.94 -20.74 60.28 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.17 0.509 . . . . 0.0 110.521 177.515 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -74.38 -42.74 58.79 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.205 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 67.2 mtt180 -98.75 -4.12 34.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.843 0.354 . . . . 0.0 111.443 -177.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.455 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.588 177.915 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.234 0.279 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 64.8 p -58.76 -31.2 68.15 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.953 0.406 . . . . 0.0 110.409 176.014 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.598 ' HA ' ' HD2' ' A' ' 7' ' ' LYS . 35.5 tt0 -62.32 -38.39 89.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.8 178.44 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 93.0 t -65.55 -45.8 91.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.041 0.448 . . . . 0.0 110.046 178.554 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 59.6 mt -59.62 -41.72 85.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.657 174.483 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.598 ' HD2' ' HA ' ' A' ' 4' ' ' GLU . 62.9 mttm -50.9 -57.79 7.62 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.811 0.339 . . . . 0.0 110.614 175.109 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -56.39 -43.17 78.99 Favored 'General case' 0 C--O 1.223 -0.323 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.963 -179.432 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.467 ' O ' HG12 ' A' ' 13' ' ' ILE . 70.1 t80 -60.81 -48.96 79.44 Favored 'General case' 0 C--N 1.328 -0.358 0 O-C-N 123.123 0.265 . . . . 0.0 110.935 -178.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 96.7 mt -62.48 -47.85 82.2 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.986 0.422 . . . . 0.0 111.085 -178.501 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -73.73 -21.74 60.12 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.013 -177.416 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -75.61 -38.53 58.92 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.858 0.361 . . . . 0.0 110.7 177.187 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.467 HG12 ' O ' ' A' ' 9' ' ' PHE . 32.1 pt -87.33 -4.82 9.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.875 0.369 . . . . 0.0 110.711 177.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 74.53 43.14 31.03 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.104 -0.569 . . . . 0.0 112.655 175.065 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 46.7 mm-40 -109.94 151.12 27.5 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.395 0.617 . . . . 0.0 111.742 -179.261 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -89.26 150.89 22.41 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.006 -178.009 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 33.0 p90 -145.54 143.3 29.86 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.906 0.384 . . . . 0.0 111.091 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.561 ' HB ' ' HB2' ' A' ' 25' ' ' HIS . 48.9 mm -97.82 92.76 3.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 174.322 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.405 ' HG3' HG12 ' A' ' 24' ' ' ILE . 33.8 tt0 -91.52 109.49 20.79 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.875 -175.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 69.7 mt -105.04 -170.79 1.81 Allowed 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 175.18 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -79.69 109.67 14.3 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.089 -0.644 . . . . 0.0 110.258 178.333 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 60.0 m-80 70.27 18.51 6.81 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 114.946 -1.025 . . . . 0.0 111.41 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.502 ' HG2' ' HB2' ' A' ' 85' ' ' ARG . 37.7 mt-10 -144.55 131.43 20.27 Favored 'General case' 0 C--O 1.222 -0.36 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.07 177.132 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.405 HG12 ' HG3' ' A' ' 19' ' ' GLU . 76.2 mt -125.91 107.84 18.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 173.584 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.561 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 19.6 m-70 -92.08 127.24 37.48 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 -178.775 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 87.2 mt -118.34 169.34 9.81 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.453 -174.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 84.9 mttt -70.42 140.43 87.42 Favored Pre-proline 0 C--N 1.327 -0.4 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 173.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -47.6 -48.42 15.66 Favored 'Trans proline' 0 CA--C 1.531 0.342 0 C-N-CA 123.15 2.567 . . . . 0.0 113.592 -176.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -73.81 -31.09 63.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.788 0.327 . . . . 0.0 111.051 -175.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.44 ' O ' HG23 ' A' ' 34' ' ' VAL . 56.3 t -73.23 -41.44 58.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 178.247 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -56.53 -39.63 73.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.265 176.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.554 ' OH ' ' HD3' ' A' ' 100' ' ' ARG . 47.2 t80 -53.97 -44.36 70.71 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.513 178.146 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -76.6 -36.26 57.61 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.291 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 30' ' ' VAL . 76.8 t -67.13 -40.02 84.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.006 0.432 . . . . 0.0 110.475 178.393 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.611 ' CD1' ' HD2' ' A' ' 41' ' ' PRO . 27.8 t90 -56.68 -45.76 81.53 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.259 176.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 25.0 mttm -71.67 -34.75 69.96 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.243 178.44 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 90.6 t80 -58.26 -43.26 87.79 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.143 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.477 HG23 ' HD3' ' A' ' 41' ' ' PRO . 35.8 m -81.49 13.74 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -177.24 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 103.75 -0.37 45.53 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.971 174.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 59.99 70.11 1.1 Allowed Pre-proline 0 CA--C 1.536 0.427 0 CA-C-O 121.147 0.498 . . . . 0.0 110.457 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.611 ' HD2' ' CD1' ' A' ' 35' ' ' TRP . 66.2 Cg_endo -92.68 -162.47 0.1 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 123.282 2.655 . . . . 0.0 113.259 -177.089 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -58.06 144.75 38.86 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.176 -179.281 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 68.5 mt -105.29 112.01 24.96 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.066 173.529 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 60.6 mttm -107.72 140.5 40.68 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.5 p -127.87 157.37 40.67 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.706 0.289 . . . . 0.0 111.756 -174.381 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 38.7 p90 -138.55 136.73 36.35 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 172.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 58.3 t -98.96 122.03 50.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.312 -179.061 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 13.0 tt -104.3 128.88 57.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.191 0.519 . . . . 0.0 110.415 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 . . . . . 0 C--N 1.323 -0.56 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.506 -179.749 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 58.2 mttm . . . . . 0 N--CA 1.449 -0.486 0 CA-C-O 121.156 0.503 . . . . 0.0 110.204 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 71.2 mt -93.77 134.64 30.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.066 -177.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -116.1 107.76 15.33 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.415 0.626 . . . . 0.0 110.961 -174.51 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 35.9 mmtp -96.4 149.15 22.04 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.982 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.474 ' HB ' ' HB2' ' A' ' 90' ' ' TYR . 9.7 p -114.07 142.84 25.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.546 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 37.5 p90 -151.36 159.03 44.48 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.152 0.501 . . . . 0.0 111.212 -177.503 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -132.27 147.84 52.42 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 168.172 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -102.21 137.78 40.02 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.944 0.402 . . . . 0.0 111.02 -174.504 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 82.8 p -91.48 -175.35 4.19 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.855 178.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 66.3 tp -60.92 -31.21 70.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.181 0.515 . . . . 0.0 110.356 176.379 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.618 ' HB2' HG23 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -79.84 -2.03 41.64 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.648 -178.142 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 59.3 m-80 70.87 23.11 4.48 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.346 0.658 . . . . 0.0 110.568 -176.378 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.618 HG23 ' HB2' ' A' ' 82' ' ' ASP . 70.7 t -86.24 126.49 40.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.438 178.742 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.502 ' HB2' ' HG2' ' A' ' 23' ' ' GLU . 63.4 mtt85 -86.03 110.02 19.21 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.666 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.546 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 49.1 t -82.66 109.05 16.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 171.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.468 HG22 ' HB3' ' A' ' 77' ' ' TYR . 9.6 t -116.79 147.59 20.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.22 0.533 . . . . 0.0 112.418 -167.122 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 6.0 t -155.76 -176.66 6.07 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 169.128 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -84.59 128.26 34.5 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 117.971 0.351 . . . . 0.0 110.561 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.474 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 11.2 t80 -77.46 -22.17 51.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.523 -174.066 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.3 -47.1 52.54 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.919 -0.401 . . . . 0.0 109.919 178.309 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.422 ' O ' ' HB3' ' A' ' 95' ' ' LYS . 54.8 mm-40 -70.21 -29.65 66.54 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.707 176.15 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.528 ' HE1' ' HA ' ' A' ' 32' ' ' TYR . 43.0 t80 -69.08 -47.65 64.68 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.662 0.267 . . . . 0.0 110.473 178.032 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.555 ' O ' ' HG3' ' A' ' 98' ' ' LYS . 43.1 mt-30 -60.95 -34.58 74.97 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.275 175.594 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.422 ' HB3' ' O ' ' A' ' 92' ' ' GLU . 42.4 tttt -52.98 -47.09 68.46 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.018 176.272 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.637 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 78.8 mt -68.94 -37.47 77.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.763 178.317 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 83.3 mt -65.34 -32.16 73.67 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.67 178.448 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.555 ' HG3' ' O ' ' A' ' 94' ' ' GLN . 96.8 mttt -65.35 -38.78 91.12 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 174.463 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.637 ' HE3' ' HA ' ' A' ' 96' ' ' ILE . 9.1 mtmp? -69.21 -33.24 73.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.716 178.246 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.554 ' HD3' ' OH ' ' A' ' 32' ' ' TYR . 13.0 ttp180 -71.16 -38.6 72.19 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.969 0.414 . . . . 0.0 110.365 175.682 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.52 0 C-N-CA 120.937 -0.649 . . . . 0.0 111.742 -178.283 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 24.4 m-80 . . . . . 0 CA--C 1.522 -0.135 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.556 ' OG ' ' HB3' ' A' ' 82' ' ' ASP . 3.3 m -65.32 -35.06 79.85 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.797 0.332 . . . . 0.0 110.915 -177.246 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.458 ' O ' ' HG2' ' A' ' 8' ' ' GLU . 34.2 tt0 -58.51 -41.53 85.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.503 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 94.0 t -55.64 -45.2 78.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.825 177.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.521 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 64.4 mt -63.0 -43.59 99.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.554 -179.155 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.429 ' HE2' ' OE1' ' A' ' 19' ' ' GLU . 92.5 mttt -61.36 -46.62 89.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.784 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.458 ' HG2' ' O ' ' A' ' 4' ' ' GLU . 52.5 mm-40 -60.58 -48.01 83.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.271 177.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -59.69 -38.18 80.84 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.349 -178.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.521 ' HG ' ' O ' ' A' ' 6' ' ' ILE . 93.5 mt -65.26 -37.9 88.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.842 0.353 . . . . 0.0 110.488 178.267 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -69.97 -34.01 72.82 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.188 176.366 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -59.74 -43.61 94.17 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.052 175.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 35.1 pt -85.67 -7.51 10.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.841 0.353 . . . . 0.0 111.33 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 81.38 26.58 51.16 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 121.026 -0.606 . . . . 0.0 113.211 174.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -106.64 143.54 34.59 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.875 0.369 . . . . 0.0 110.408 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -102.29 147.92 26.08 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.885 -179.01 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 13.0 p90 -120.52 154.39 35.38 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.981 0.42 . . . . 0.0 111.672 -174.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 51.6 mt -101.51 96.84 5.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 174.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.429 ' OE1' ' HE2' ' A' ' 7' ' ' LYS . 61.1 tt0 -108.51 137.42 46.5 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.495 0.664 . . . . 0.0 112.02 -173.227 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 89.7 mt -116.73 -173.56 2.41 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 170.363 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -61.7 103.5 0.34 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.817 0.342 . . . . 0.0 110.831 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.462 ' HA ' HG22 ' A' ' 84' ' ' VAL . 4.2 m-20 66.94 23.0 9.98 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.725 178.305 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -134.81 113.95 12.12 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.681 0.277 . . . . 0.0 111.209 176.095 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.42 ' HB ' HG22 ' A' ' 86' ' ' VAL . 66.0 mt -103.33 109.68 27.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 175.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -92.55 120.31 32.88 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.415 ' HG ' HG22 ' A' ' 24' ' ' ILE . 64.8 mt -124.75 155.47 39.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.241 0.543 . . . . 0.0 111.691 -176.269 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -65.96 136.47 95.61 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.491 176.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -56.2 -33.46 90.72 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.319 2.013 . . . . 0.0 111.588 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -62.09 -43.91 97.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.956 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 45.9 t -81.36 -34.33 13.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.187 0.517 . . . . 0.0 110.244 179.048 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -55.64 -39.08 70.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.712 -176.752 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -58.46 -38.37 77.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.764 0.316 . . . . 0.0 111.113 -178.318 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -79.67 -34.53 40.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.838 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 95.9 t -64.53 -42.82 96.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.012 0.434 . . . . 0.0 110.024 176.159 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.518 ' CD1' ' HD2' ' A' ' 41' ' ' PRO . 29.6 t90 -57.6 -41.1 80.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.423 177.184 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -69.09 -43.61 74.19 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.884 176.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -60.92 -41.0 95.3 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.956 -178.17 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.516 HG23 ' HD3' ' A' ' 41' ' ' PRO . 35.1 m -76.9 4.42 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 112.308 0.485 . . . . 0.0 112.308 -175.416 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 105.82 -0.48 39.04 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.543 -0.837 . . . . 0.0 113.089 175.147 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 59.49 75.12 0.52 Allowed Pre-proline 0 CA--C 1.535 0.382 0 CA-C-O 120.987 0.422 . . . . 0.0 111.228 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.518 ' HD2' ' CD1' ' A' ' 35' ' ' TRP . 90.6 Cg_endo -91.58 -176.68 0.87 Allowed 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.791 2.327 . . . . 0.0 112.109 176.835 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 57.8 mm-40 -72.29 135.82 46.09 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.014 0.435 . . . . 0.0 110.765 178.353 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.465 ' HB3' ' CG2' ' A' ' 76' ' ' VAL . 95.2 mt -98.44 138.02 36.27 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.48 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -117.23 138.58 51.62 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.951 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 16.2 p -105.2 147.52 27.92 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 120.79 0.328 . . . . 0.0 111.443 -176.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.492 ' CE2' ' HB ' ' A' ' 48' ' ' ILE . 10.0 p90 -129.1 156.1 44.4 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 175.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 33.1 t -103.28 105.11 17.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.028 0.442 . . . . 0.0 110.945 -176.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.625 HG23 ' HB ' ' A' ' 73' ' ' ILE . 5.8 tt -95.83 101.33 12.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 121.672 0.749 . . . . 0.0 109.443 175.113 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 . . . . . 0 C--N 1.318 -0.802 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.913 -177.576 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 57.0 mttm . . . . . 0 N--CA 1.454 -0.262 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.625 ' HB ' HG23 ' A' ' 48' ' ' ILE . 58.8 mt -91.03 129.44 41.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.301 -178.449 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -103.32 111.46 23.87 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.237 -178.659 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.413 ' HB3' ' O ' ' A' ' 88' ' ' THR . 65.6 mttm -114.96 167.15 11.05 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.235 -0.439 . . . . 0.0 109.832 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.465 ' CG2' ' HB3' ' A' ' 43' ' ' LEU . 14.4 p -123.48 147.98 27.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 120.794 0.331 . . . . 0.0 111.241 -172.022 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 51.6 p90 -145.66 163.81 33.72 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.137 178.319 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.462 ' HB3' HD23 ' A' ' 43' ' ' LEU . 43.1 p90 -128.14 155.42 44.47 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 169.808 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -102.22 137.07 40.97 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.323 -175.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 69.8 p -90.31 169.08 11.41 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 175.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.3 mp -82.91 18.95 1.47 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.344 0.592 . . . . 0.0 109.638 174.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.556 ' HB3' ' OG ' ' A' ' 3' ' ' SER . 38.9 t70 -126.59 10.55 7.23 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.853 -177.408 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 66.3 t30 74.14 19.49 2.93 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 115.188 -0.915 . . . . 0.0 112.112 173.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.462 HG22 ' HA ' ' A' ' 22' ' ' ASN . 82.7 t -109.7 137.16 43.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 120.931 0.396 . . . . 0.0 110.413 177.651 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 84.0 mtt-85 -102.19 126.84 49.28 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.46 -178.627 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.42 HG22 ' HB ' ' A' ' 24' ' ' ILE . 61.0 t -98.67 113.93 34.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 174.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.8 t -111.02 147.13 15.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.146 -170.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.413 ' O ' ' HB3' ' A' ' 75' ' ' LYS . 4.9 t -152.74 -178.67 7.03 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.233 -0.439 . . . . 0.0 109.854 176.365 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -86.39 122.05 29.81 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.969 0.414 . . . . 0.0 110.885 -178.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 17.1 t80 -73.65 -23.87 59.91 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.28 -176.009 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 27.0 m -71.99 -52.34 17.52 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.848 0.356 . . . . 0.0 110.582 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.425 ' O ' ' HB3' ' A' ' 95' ' ' LYS . 10.0 mm-40 -71.26 -27.75 63.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.467 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.441 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 69.1 t80 -65.92 -42.82 89.65 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 175.267 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -63.3 -35.3 79.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.674 175.49 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.425 ' HB3' ' O ' ' A' ' 92' ' ' GLU . 3.7 ttmp? -56.49 -44.59 80.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.279 175.627 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 76.2 mt -69.27 -40.09 79.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.908 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 93' ' ' PHE . 99.5 mt -58.73 -50.95 72.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.412 177.216 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 9.6 mtpm? -70.25 -25.43 63.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.198 -178.291 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -59.57 -53.3 59.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.569 174.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 39.8 ttt85 -77.41 -38.01 50.64 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.985 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.559 0 C-N-CA 120.738 -0.744 . . . . 0.0 111.643 -176.632 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 . . . . . 0 C--O 1.233 0.228 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.492 ' O ' ' HG3' ' A' ' 7' ' ' LYS . 89.3 p -62.95 -32.93 74.35 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.73 0.3 . . . . 0.0 111.118 -177.56 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.452 ' HA ' ' HD2' ' A' ' 7' ' ' LYS . 9.3 tp10 -56.81 -36.36 69.84 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.997 -178.247 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 66.5 t -64.38 -42.04 94.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.479 178.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.51 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 63.9 mt -63.95 -41.43 92.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.339 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.492 ' HG3' ' O ' ' A' ' 3' ' ' SER . 88.6 mttt -57.16 -52.45 65.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.426 178.529 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -69.27 -28.1 66.01 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.365 -178.331 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -64.92 -44.56 89.13 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.125 0.488 . . . . 0.0 109.892 175.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.51 ' HG ' ' O ' ' A' ' 6' ' ' ILE . 51.9 mt -64.52 -42.7 95.62 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.283 177.386 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -63.49 -38.0 89.47 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.504 178.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -62.82 -50.32 71.45 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.097 179.056 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 37.9 pt -78.44 -7.0 9.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.763 0.316 . . . . 0.0 111.382 -178.567 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 76.07 36.41 40.94 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 121.119 -0.562 . . . . 0.0 112.619 177.138 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -95.69 157.48 15.88 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 179.345 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -73.68 122.99 23.2 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.187 0.518 . . . . 0.0 111.093 -177.358 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 93.2 t80 -105.64 120.01 40.58 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.987 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 15.3 tt -131.34 121.39 48.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.314 0.578 . . . . 0.0 110.576 175.148 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -108.38 108.27 19.17 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.046 178.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 24.7 tp -93.39 75.46 4.51 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 59.3 71.5 0.58 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.537 -177.421 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 68.38 11.64 8.43 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.172 -0.922 . . . . 0.0 112.004 178.357 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 79.3 mt-10 -115.13 113.99 24.72 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 174.531 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 40.7 mt -86.77 109.35 18.94 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 177.357 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.452 ' HA ' ' O ' ' A' ' 87' ' ' VAL . 24.8 m-70 -95.98 111.13 23.22 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -178.364 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.476 HD21 HD13 ' A' ' 10' ' ' LEU . 67.4 mt -113.32 163.3 15.01 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.44 0.638 . . . . 0.0 112.679 -170.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 33.7 tttp -62.63 129.61 92.94 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 114.46 -1.245 . . . . 0.0 109.681 173.439 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -51.12 -41.28 58.03 Favored 'Trans proline' 0 N--CA 1.473 0.308 0 C-N-CA 122.884 2.389 . . . . 0.0 112.518 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -53.78 -54.92 31.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.168 175.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 50.9 t -69.5 -41.12 80.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.712 -177.642 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -53.87 -42.01 68.15 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.476 179.105 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -59.18 -42.69 91.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.555 -179.285 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -78.26 -37.17 45.72 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.088 -178.087 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 95.8 t -62.43 -36.87 77.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.083 0.468 . . . . 0.0 109.86 175.016 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.443 ' CD1' ' HD2' ' A' ' 41' ' ' PRO . 35.3 t90 -55.78 -44.09 77.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.701 176.289 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.543 ' HA ' ' HG3' ' A' ' 40' ' ' GLU . 67.3 mttm -73.02 -31.67 64.61 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.656 -0.247 . . . . 0.0 111.325 179.23 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 83.8 t80 -67.23 -40.65 86.37 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.951 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.517 HG23 ' HD3' ' A' ' 41' ' ' PRO . 35.0 m -79.04 4.12 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -177.086 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 102.64 4.11 49.35 Favored Glycine 0 C--N 1.33 0.231 0 C-N-CA 120.767 -0.73 . . . . 0.0 113.241 174.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.543 ' HG3' ' HA ' ' A' ' 36' ' ' LYS . 54.0 mt-10 57.59 78.29 0.37 Allowed Pre-proline 0 C--O 1.236 0.347 0 C-N-CA 122.925 0.49 . . . . 0.0 111.95 -179.341 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.517 ' HD3' HG23 ' A' ' 38' ' ' VAL . 4.9 Cg_exo -77.89 175.3 11.36 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.738 2.292 . . . . 0.0 110.659 173.163 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -81.46 133.72 35.44 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.18 0.514 . . . . 0.0 110.12 178.262 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 89.7 mt -73.17 120.94 19.48 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.774 -172.462 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -96.53 118.4 32.95 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.197 176.148 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 24.2 p -109.47 143.12 39.52 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.052 -176.403 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 17.9 p90 -126.27 133.53 51.41 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.728 177.13 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.408 HG22 ' HB2' ' A' ' 74' ' ' LYS . 60.5 t -93.63 125.95 46.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.717 -179.01 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.518 HD11 ' HE3' ' A' ' 75' ' ' LYS . 13.7 pt -125.7 131.0 72.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.576 174.376 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 . . . . . 0 C--N 1.315 -0.919 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.136 -179.211 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 60.9 mttm . . . . . 0 N--CA 1.452 -0.348 0 N-CA-C 110.328 -0.249 . . . . 0.0 110.328 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 15.1 tt -109.89 129.81 64.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.546 0.688 . . . . 0.0 110.66 178.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.491 ' O ' ' HB3' ' A' ' 90' ' ' TYR . 36.4 ttpt -108.86 115.71 30.59 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.075 -177.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.518 ' HE3' HD11 ' A' ' 48' ' ' ILE . 81.4 mttt -104.13 167.01 10.04 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.35 -0.386 . . . . 0.0 109.975 -179.316 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 14.6 p -122.51 146.79 27.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 120.925 0.393 . . . . 0.0 111.303 -173.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.463 ' HB3' HG22 ' A' ' 87' ' ' VAL . 48.1 p90 -149.85 164.82 34.34 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.132 175.55 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -134.23 149.25 50.96 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 169.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.569 ' HG2' ' HG2' ' A' ' 85' ' ' ARG . 41.6 mt-10 -102.5 138.21 39.72 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.681 -176.674 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 38.4 p -83.25 178.55 8.03 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.123 175.334 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.8 mp -62.73 -27.01 68.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.194 0.521 . . . . 0.0 110.726 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -99.98 15.04 28.48 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.715 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 64.1 34.59 11.06 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 171.574 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.409 ' HB ' ' HB3' ' A' ' 3' ' ' SER . 58.6 t -90.69 129.56 41.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 169.193 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.569 ' HG2' ' HG2' ' A' ' 79' ' ' GLU . 41.7 mtm-85 -98.88 114.91 27.73 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.976 0.417 . . . . 0.0 111.389 -172.684 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 45.6 t -89.7 113.09 25.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 174.557 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.463 HG22 ' HB3' ' A' ' 77' ' ' TYR . 19.3 t -113.28 148.2 16.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.937 -171.675 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 6.2 t -152.13 171.52 17.78 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.065 174.477 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -73.02 111.71 8.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.188 0.518 . . . . 0.0 110.368 177.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.491 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 15.3 t80 -72.14 -20.94 61.53 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.595 -177.099 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.4 m -62.64 -58.22 8.29 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-O 121.184 0.516 . . . . 0.0 110.068 178.389 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.402 ' O ' HG13 ' A' ' 96' ' ' ILE . 28.4 tt0 -67.53 -35.28 78.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.406 178.377 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.403 ' O ' HD23 ' A' ' 97' ' ' LEU . 55.2 t80 -59.78 -46.77 88.17 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.48 179.223 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.446 ' O ' ' HG3' ' A' ' 98' ' ' LYS . 69.5 mt-30 -58.61 -40.02 82.11 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.612 0.244 . . . . 0.0 110.906 176.361 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -63.22 -39.82 95.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.528 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.402 HG13 ' O ' ' A' ' 92' ' ' GLU . 80.1 mt -63.58 -42.27 95.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.743 177.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.403 HD23 ' O ' ' A' ' 93' ' ' PHE . 4.1 mm? -57.84 -43.31 85.78 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.681 176.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.446 ' HG3' ' O ' ' A' ' 94' ' ' GLN . 94.0 mttt -70.05 -41.83 73.67 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.693 178.461 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 60.5 tttm -60.3 -48.68 80.69 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.649 -178.053 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 62.4 ttt180 -78.38 -30.48 47.91 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.041 0.448 . . . . 0.0 110.523 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.674 0 C-N-CA 120.681 -0.771 . . . . 0.0 111.869 -179.871 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ASN . . . . . 0.485 ' N ' HD21 ' A' ' 2' ' ' ASN . 0.8 OUTLIER . . . . . 0 C--O 1.234 0.286 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 36.6 p -61.28 -27.9 68.8 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.931 -177.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -57.59 -45.59 85.09 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.98 0.419 . . . . 0.0 110.38 178.336 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.1 t -62.85 -39.31 84.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.261 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.405 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 58.9 mt -62.45 -45.75 98.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.181 177.704 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 49.3 mttm -57.07 -48.73 77.86 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.091 177.258 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -59.45 -47.34 85.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.927 179.258 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -63.62 -47.71 80.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.354 -177.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.472 HD13 HD21 ' A' ' 26' ' ' LEU . 95.5 mt -62.31 -46.98 86.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.195 -177.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -79.01 -6.1 55.54 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.734 0.302 . . . . 0.0 111.497 -177.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -82.42 -45.97 14.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.126 0.489 . . . . 0.0 109.792 173.094 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 34.9 pt -77.48 -12.21 13.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.941 179.124 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.46 28.48 10.45 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.771 -0.728 . . . . 0.0 113.06 174.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.513 ' OE2' HG21 ' A' ' 30' ' ' VAL . 3.9 tp10 -88.05 137.23 32.51 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.153 0.501 . . . . 0.0 111.058 -179.037 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -104.3 110.54 22.8 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.301 175.521 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.414 ' CD1' ' HB2' ' A' ' 19' ' ' GLU . 27.1 p90 -102.79 154.73 18.89 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.152 -177.022 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 58.1 mt -97.34 102.06 12.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 175.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.414 ' HB2' ' CD1' ' A' ' 17' ' ' TYR . 35.9 tt0 -105.84 116.71 32.41 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.491 0.662 . . . . 0.0 111.822 -172.607 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -94.24 -168.17 1.81 Allowed 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 172.52 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -68.21 99.79 0.95 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.003 0.43 . . . . 0.0 110.304 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 62.53 32.86 16.35 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.498 -178.463 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.453 ' HG2' ' HB2' ' A' ' 85' ' ' ARG . 23.2 mt-10 -138.56 113.77 9.44 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.097 174.228 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.534 ' HB ' HG22 ' A' ' 86' ' ' VAL . 64.3 mt -99.8 104.5 16.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 178.127 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 31.1 m-70 -90.85 112.12 23.82 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.981 0.419 . . . . 0.0 110.032 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.472 HD21 HD13 ' A' ' 10' ' ' LEU . 56.5 mt -101.37 -175.62 2.91 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.525 -0.762 . . . . 0.0 111.524 -176.067 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -95.35 144.16 27.34 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.389 176.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.545 ' HA ' HG21 ' A' ' 88' ' ' THR . 5.9 Cg_exo -41.59 -49.79 5.06 Favored 'Trans proline' 0 CA--C 1.534 0.486 0 C-N-CA 124.033 3.155 . . . . 0.0 114.391 -175.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -72.33 -40.69 67.22 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.845 0.355 . . . . 0.0 111.142 -175.136 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.513 HG21 ' OE2' ' A' ' 15' ' ' GLU . 58.3 t -67.01 -40.5 85.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.636 -178.35 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -59.19 -40.33 85.35 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.453 177.597 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.596 ' HA ' ' HE1' ' A' ' 93' ' ' PHE . 20.6 t80 -61.12 -33.12 72.88 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.024 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -80.11 -43.59 21.45 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.889 -179.295 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.451 ' O ' HG13 ' A' ' 38' ' ' VAL . 59.5 t -65.58 -33.11 61.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.848 0.356 . . . . 0.0 110.507 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.469 ' O ' HG22 ' A' ' 38' ' ' VAL . 27.6 t90 -53.05 -40.05 63.68 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.09 176.558 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 78.2 mttt -70.15 -36.97 75.11 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.271 0.558 . . . . 0.0 110.292 178.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 23.0 t80 -73.07 -30.57 63.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.548 -174.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.504 HG23 ' HD3' ' A' ' 41' ' ' PRO . 18.4 m -75.27 -2.17 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-O 120.916 0.389 . . . . 0.0 111.335 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 116.84 -9.45 16.17 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.883 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.413 ' N ' ' HD3' ' A' ' 41' ' ' PRO . 33.4 tt0 58.85 64.73 3.18 Favored Pre-proline 0 CA--C 1.538 0.487 0 CA-C-O 121.044 0.45 . . . . 0.0 111.131 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.504 ' HD3' HG23 ' A' ' 38' ' ' VAL . 92.3 Cg_endo -98.06 -173.24 0.17 Allowed 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 123.331 2.687 . . . . 0.0 112.193 179.448 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -79.25 116.51 19.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.073 0.463 . . . . 0.0 109.814 176.031 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.6 mt -75.24 156.72 35.43 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.2 -176.727 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 57.5 tttm -109.96 129.31 55.68 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.817 -177.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.0 p -109.17 149.52 29.25 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.617 -175.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.536 ' OH ' ' HD2' ' A' ' 75' ' ' LYS . 28.2 p90 -134.85 159.85 40.09 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 176.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 50.6 t -111.98 120.37 62.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 120.948 0.404 . . . . 0.0 110.911 -177.399 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 8.4 tt -110.48 115.5 49.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.262 0.553 . . . . 0.0 109.561 174.615 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.484 ' HG2' ' HG2' ' A' ' 72' ' ' LYS . 43.4 mt-10 . . . . . 0 C--N 1.321 -0.643 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.265 -177.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.484 ' HG2' ' HG2' ' A' ' 49' ' ' GLU . 43.8 mttp . . . . . 0 N--CA 1.452 -0.325 0 CA-C-O 120.93 0.395 . . . . 0.0 110.059 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 51.4 mm -92.03 110.26 22.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.27 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 41.0 ttpt -93.63 115.02 27.48 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.051 177.64 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.536 ' HD2' ' OH ' ' A' ' 46' ' ' TYR . 62.4 mttm -102.62 166.3 10.59 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 177.815 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 12.6 p -122.35 144.18 32.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.347 -176.076 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.452 ' HB3' HG22 ' A' ' 87' ' ' VAL . 36.8 p90 -149.8 165.94 30.98 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.02 0.438 . . . . 0.0 111.412 179.192 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.477 ' CE2' HG11 ' A' ' 38' ' ' VAL . 50.1 p90 -124.36 134.59 53.1 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.196 166.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.443 ' OE1' ' HD2' ' A' ' 85' ' ' ARG . 34.5 tt0 -103.87 118.11 35.93 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.164 -176.507 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 72.7 p -79.07 179.64 7.23 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.549 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 7.7 mp -66.6 -14.22 62.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.029 0.443 . . . . 0.0 110.658 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.514 ' HB2' HG23 ' A' ' 84' ' ' VAL . 1.9 m-20 -85.54 -1.73 57.41 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.621 -178.282 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 55.3 m-80 70.35 18.39 6.75 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 123.766 0.666 . . . . 0.0 110.423 -175.025 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.514 HG23 ' HB2' ' A' ' 82' ' ' ASP . 93.1 t -87.97 123.55 40.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.041 177.373 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.453 ' HB2' ' HG2' ' A' ' 23' ' ' GLU . 0.2 OUTLIER -100.01 108.87 21.17 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.905 -178.964 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.534 HG22 ' HB ' ' A' ' 24' ' ' ILE . 59.6 t -82.92 106.17 13.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 174.138 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.452 HG22 ' HB3' ' A' ' 77' ' ' TYR . 41.4 t -107.0 142.58 19.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.798 -169.131 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.545 HG21 ' HA ' ' A' ' 28' ' ' PRO . 96.0 m -152.07 153.81 34.69 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.309 174.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -64.41 119.02 9.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.288 0.566 . . . . 0.0 111.922 -178.113 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.43 ' H ' ' HA ' ' A' ' 75' ' ' LYS . 83.2 t80 -63.18 -37.48 87.4 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.806 -179.032 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.6 m -60.2 -45.41 93.26 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.751 178.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.449 ' HA ' ' HB3' ' A' ' 95' ' ' LYS . 22.0 mm-40 -77.93 -30.67 50.64 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.112 -179.403 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.596 ' HE1' ' HA ' ' A' ' 32' ' ' TYR . 75.7 t80 -61.03 -50.61 72.63 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.966 0.413 . . . . 0.0 110.405 177.204 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.649 ' HG2' HD12 ' A' ' 97' ' ' LEU . 15.9 mt-30 -77.31 -17.17 58.53 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.991 179.391 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.449 ' HB3' ' HA ' ' A' ' 92' ' ' GLU . 0.8 OUTLIER -69.35 -32.42 71.48 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 173.298 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.46 HD11 ' HB2' ' A' ' 28' ' ' PRO . 56.1 mt -79.03 -33.68 16.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.268 174.471 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.649 HD12 ' HG2' ' A' ' 94' ' ' GLN . 90.5 mt -59.94 -41.71 92.39 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 171.004 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 7.3 tmtt? -64.36 -40.36 95.69 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.805 176.065 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 56.7 tttm -62.11 -43.69 98.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.845 178.525 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 78.2 ttt180 -71.56 -45.44 62.29 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.967 0.413 . . . . 0.0 110.64 177.615 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.42 0 C-N-CA 120.846 -0.692 . . . . 0.0 111.811 -177.329 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 . . . . . 0 N--CA 1.453 -0.28 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.478 ' O ' ' HG3' ' A' ' 7' ' ' LYS . 19.1 p -56.67 -33.02 65.97 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.947 0.404 . . . . 0.0 110.803 177.074 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -51.59 -51.52 54.84 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.801 178.004 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.9 t -61.38 -48.65 87.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.928 -177.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.456 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 60.4 mt -54.4 -43.12 61.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.02 177.004 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.478 ' HG3' ' O ' ' A' ' 3' ' ' SER . 98.9 mttt -56.88 -49.24 76.13 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.163 178.574 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -61.01 -41.24 96.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.073 0.463 . . . . 0.0 110.529 -179.359 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.485 ' O ' HG13 ' A' ' 13' ' ' ILE . 74.5 t80 -62.22 -48.0 81.94 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.705 178.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.522 HD13 ' HB3' ' A' ' 17' ' ' TYR . 87.9 mt -69.45 -33.34 72.78 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.379 -177.383 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -65.66 -41.32 92.66 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.894 0.378 . . . . 0.0 110.137 176.641 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -64.05 -37.82 88.83 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.523 177.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.485 HG13 ' O ' ' A' ' 9' ' ' PHE . 59.6 mt -66.68 -41.05 87.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 121.432 0.634 . . . . 0.0 109.756 173.583 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.01 23.26 25.61 Favored Glycine 0 N--CA 1.446 -0.657 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.791 -179.251 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 47.8 mm-40 -98.02 158.92 15.26 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.152 0.501 . . . . 0.0 111.322 -178.531 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.403 ' HB2' ' HE3' ' A' ' 27' ' ' LYS . 9.3 m-20 -77.72 114.36 16.49 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.981 -177.517 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.522 ' HB3' HD13 ' A' ' 10' ' ' LEU . 39.3 p90 -111.13 112.15 23.75 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 170.244 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.553 ' HB ' ' HB2' ' A' ' 25' ' ' HIS . 51.6 mt -84.91 95.17 4.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.473 -175.601 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -76.05 114.03 14.24 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.095 176.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.551 ' HB2' ' HB2' ' A' ' 23' ' ' GLU . 93.6 mt -114.84 169.22 9.24 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 172.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.434 ' O ' ' HB2' ' A' ' 22' ' ' ASN . 40.6 mt-10 -64.39 107.35 1.32 Allowed 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.474 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.434 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 88.2 m-20 80.48 2.95 1.84 Allowed 'General case' 0 N--CA 1.47 0.575 0 O-C-N 124.593 1.183 . . . . 0.0 112.031 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.551 ' HB2' ' HB2' ' A' ' 20' ' ' LEU . 54.6 mt-10 -134.3 150.98 51.01 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.442 0.639 . . . . 0.0 112.424 -177.555 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 59.1 mt -130.95 109.78 17.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 166.435 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.553 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 11.7 m170 -89.96 125.09 35.25 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.106 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 39.8 mt -120.81 175.29 6.11 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.236 0.541 . . . . 0.0 111.388 -177.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.403 ' HE3' ' HB2' ' A' ' 16' ' ' ASP . 87.2 mttt -93.54 153.66 41.27 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.481 178.391 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_exo -48.45 -53.08 7.35 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 123.143 2.562 . . . . 0.0 113.571 -176.126 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -72.02 -37.13 69.83 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.851 0.357 . . . . 0.0 110.88 -176.396 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.462 ' O ' HG23 ' A' ' 34' ' ' VAL . 47.4 t -63.69 -40.46 89.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.28 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -61.92 -39.22 91.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.431 177.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -60.63 -43.31 97.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.596 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -64.62 -44.56 90.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.062 178.535 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 30' ' ' VAL . 91.2 t -65.74 -40.95 89.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.99 -179.506 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.433 ' CD1' ' HD2' ' A' ' 41' ' ' PRO . 28.1 t90 -55.04 -48.09 73.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.623 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.414 ' HA ' ' HG3' ' A' ' 40' ' ' GLU . 62.9 mttm -72.4 -31.02 65.18 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.266 179.287 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -63.0 -43.71 98.03 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.231 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.493 HG23 ' HD3' ' A' ' 41' ' ' PRO . 34.9 m -80.54 -5.87 8.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -177.011 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 108.53 12.56 20.98 Favored Glycine 0 C--N 1.331 0.263 0 C-N-CA 120.575 -0.822 . . . . 0.0 113.728 174.51 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.414 ' HG3' ' HA ' ' A' ' 36' ' ' LYS . 54.2 mt-10 55.25 78.39 0.39 Allowed Pre-proline 0 N--CA 1.466 0.359 0 C-N-CA 122.838 0.455 . . . . 0.0 111.856 178.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.493 ' HD3' HG23 ' A' ' 38' ' ' VAL . 95.1 Cg_endo -91.64 179.42 1.5 Allowed 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.852 2.368 . . . . 0.0 112.031 175.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -62.75 122.98 17.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.898 176.303 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 81.3 mt -92.2 132.16 36.87 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.669 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -97.57 137.62 36.21 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 31.6 p -122.41 135.48 54.7 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 120.825 0.345 . . . . 0.0 110.773 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.493 ' CE1' ' HB2' ' A' ' 75' ' ' LYS . 17.3 p90 -122.92 136.6 54.92 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.977 0.418 . . . . 0.0 110.294 179.127 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 50.3 t -96.89 105.0 16.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.981 178.103 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.469 HG23 ' HB ' ' A' ' 73' ' ' ILE . 8.4 tt -100.8 112.15 32.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 121.153 0.502 . . . . 0.0 110.189 178.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 . . . . . 0 C--N 1.322 -0.617 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 178.034 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 58.6 mttp . . . . . 0 N--CA 1.456 -0.152 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.469 ' HB ' HG23 ' A' ' 48' ' ' ILE . 55.1 mt -98.54 108.98 23.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.681 -178.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 57.4 tttp -87.12 103.03 15.01 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 176.601 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.493 ' HB2' ' CE1' ' A' ' 46' ' ' TYR . 97.5 mttt -104.91 163.73 12.31 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.337 178.682 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.9 p -116.84 141.11 36.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.946 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.473 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 33.8 p90 -149.01 152.4 36.22 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.612 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -131.28 144.43 51.28 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 170.477 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -102.03 130.4 48.57 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.305 -175.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 32.9 p -76.13 178.99 5.95 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.152 174.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 8.2 mp -70.46 -23.96 62.8 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.71 0.29 . . . . 0.0 110.822 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -90.06 8.92 30.22 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.337 0.589 . . . . 0.0 109.608 175.239 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 65.77 30.39 10.16 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 114.711 -1.131 . . . . 0.0 112.906 171.417 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 43.3 t -87.89 127.28 41.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 171.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 34.2 mtt180 -93.25 108.38 20.02 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.214 -172.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 57.4 t -82.27 110.89 17.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 174.565 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 39.8 t -113.26 137.24 46.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.436 -171.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 59.1 m -148.27 154.74 40.44 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 174.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -66.61 126.27 28.4 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.95 0.405 . . . . 0.0 110.688 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -75.59 -26.19 57.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.68 -174.666 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.474 ' O ' ' HG3' ' A' ' 95' ' ' LYS . 28.1 t -69.74 -43.67 71.8 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.445 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -64.31 -39.16 93.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.102 0.477 . . . . 0.0 110.21 176.388 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -64.24 -42.32 96.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.372 178.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 26.3 mm-40 -60.58 -37.91 82.88 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.235 176.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.474 ' HG3' ' O ' ' A' ' 91' ' ' SER . 99.3 mttt -55.55 -49.68 72.03 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.862 0.363 . . . . 0.0 110.282 176.399 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 66.9 mt -64.05 -40.8 90.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.047 -178.284 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 97.4 mt -58.71 -46.65 86.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.1 0.476 . . . . 0.0 110.713 177.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 9.0 mtpm? -73.65 -34.51 64.99 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.064 -179.175 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -64.39 -44.84 90.05 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.996 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.43 HH11 ' HD3' ' A' ' 100' ' ' ARG . 52.1 mtt180 -84.99 -18.65 33.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.795 0.331 . . . . 0.0 111.194 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.417 0 C-N-CA 120.834 -0.698 . . . . 0.0 111.773 -179.047 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 18.0 m120 . . . . . 0 CA--C 1.517 -0.311 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 35.3 p -64.08 -29.96 71.06 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.15 0.5 . . . . 0.0 110.146 175.592 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -64.75 -38.1 89.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.012 176.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 95.9 t -62.64 -41.66 93.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.879 175.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 73.8 mt -62.42 -43.72 98.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.36 176.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 53.5 mttp -52.27 -53.71 40.54 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.744 175.264 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -70.63 -25.81 63.19 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.915 -175.302 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -67.46 -43.51 80.89 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.353 0.596 . . . . 0.0 109.905 174.381 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.489 HD13 ' HB3' ' A' ' 17' ' ' TYR . 69.8 mt -72.29 -34.31 68.06 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.392 178.334 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -64.0 -32.31 73.81 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.385 177.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -63.74 -58.88 5.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.614 179.05 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.8 pt -76.89 -17.36 14.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.797 -176.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 79.42 46.9 7.74 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.806 -179.493 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -97.78 169.18 9.85 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.929 0.395 . . . . 0.0 110.985 -178.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -96.94 137.25 36.33 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.112 -177.354 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.489 ' HB3' HD13 ' A' ' 10' ' ' LEU . 24.6 p90 -133.32 115.89 15.46 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.224 0.535 . . . . 0.0 110.223 173.389 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.461 ' HB ' ' HB2' ' A' ' 25' ' ' HIS . 57.4 mt -85.48 92.11 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 175.385 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.521 ' HG3' HG12 ' A' ' 24' ' ' ILE . 33.2 tt0 -103.51 104.46 14.53 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.247 -171.034 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 85.5 mt -79.61 -174.32 4.23 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 173.086 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -69.47 100.44 1.4 Allowed 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.042 0.448 . . . . 0.0 109.875 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 71.17 29.42 2.87 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.517 -177.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.565 ' HA ' ' O ' ' A' ' 85' ' ' ARG . 5.1 mt-10 -144.61 113.51 6.81 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 177.04 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.521 HG12 ' HG3' ' A' ' 19' ' ' GLU . 51.2 mt -101.2 108.21 22.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 110.175 -0.306 . . . . 0.0 110.175 179.343 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.54 ' HA ' ' O ' ' A' ' 87' ' ' VAL . 24.4 m-70 -96.18 119.12 34.1 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.77 0.319 . . . . 0.0 110.263 178.416 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 98.3 mt -116.33 173.58 6.52 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.166 -176.532 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.403 ' HB2' HG23 ' A' ' 30' ' ' VAL . 61.5 mttp -73.8 147.1 86.24 Favored Pre-proline 0 C--N 1.329 -0.318 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 172.397 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.472 ' HA ' HG21 ' A' ' 88' ' ' THR . 82.5 Cg_exo -47.07 -51.28 9.61 Favored 'Trans proline' 0 CA--C 1.53 0.284 0 C-N-CA 123.137 2.558 . . . . 0.0 113.606 -178.562 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -71.22 -34.33 70.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.748 0.309 . . . . 0.0 111.196 -177.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.453 ' O ' HG23 ' A' ' 34' ' ' VAL . 58.1 t -67.41 -45.96 84.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.939 0.399 . . . . 0.0 110.187 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -61.15 -38.58 86.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.079 175.026 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.509 ' HA ' ' HE1' ' A' ' 93' ' ' PHE . 19.1 t80 -56.74 -38.56 72.56 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.274 178.053 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -76.17 -36.68 58.59 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 121.139 -0.224 . . . . 0.0 111.182 177.577 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 30' ' ' VAL . 77.3 t -66.17 -33.12 61.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.093 0.473 . . . . 0.0 110.225 177.232 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.551 ' CZ2' ' HG3' ' A' ' 40' ' ' GLU . 45.9 t90 -56.98 -40.01 75.72 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.797 176.433 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 80.8 mttt -70.42 -42.67 71.29 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.195 0.522 . . . . 0.0 109.679 175.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -58.64 -38.9 79.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.086 -176.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.478 HG23 ' HD3' ' A' ' 41' ' ' PRO . 34.6 m -82.53 3.89 2.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.958 -178.138 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 100.57 14.68 31.66 Favored Glycine 0 C--N 1.329 0.193 0 C-N-CA 120.665 -0.779 . . . . 0.0 114.489 170.257 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.551 ' HG3' ' CZ2' ' A' ' 35' ' ' TRP . 35.7 tt0 57.09 72.78 0.88 Allowed Pre-proline 0 N--CA 1.468 0.456 0 CA-C-O 120.965 0.412 . . . . 0.0 111.359 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.478 ' HD3' HG23 ' A' ' 38' ' ' VAL . 78.4 Cg_endo -98.26 173.15 0.56 Allowed 'Trans proline' 0 N--CA 1.449 -1.1 0 C-N-CA 123.091 2.527 . . . . 0.0 112.135 175.784 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -75.02 146.58 41.47 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 173.654 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 82.3 mt -112.34 153.85 26.62 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.913 0.387 . . . . 0.0 111.426 -173.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.512 ' HE3' ' OE1' ' A' ' 79' ' ' GLU . 64.4 mttm -101.46 145.43 28.98 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.6 178.823 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 24.4 p -127.83 138.58 52.76 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.906 0.384 . . . . 0.0 111.278 -178.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -134.28 146.79 50.36 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.862 179.049 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.403 ' HA ' ' HA ' ' A' ' 74' ' ' LYS . 41.3 t -107.93 116.0 50.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 120.739 0.304 . . . . 0.0 110.659 -179.43 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 10.2 pt -107.12 139.92 27.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.377 175.655 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 . . . . . 0 C--N 1.323 -0.565 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.238 -177.518 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 63.0 mttm . . . . . 0 N--CA 1.452 -0.326 0 CA-C-O 121.227 0.536 . . . . 0.0 110.927 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 69.2 mt -102.96 109.23 26.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.075 177.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.526 ' O ' ' HB3' ' A' ' 90' ' ' TYR . 82.8 tttt -88.88 127.79 35.65 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.78 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.449 ' HA ' ' H ' ' A' ' 90' ' ' TYR . 72.5 mttt -124.59 165.25 18.19 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.657 0.265 . . . . 0.0 110.58 179.428 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 8.4 p -125.91 141.86 44.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.839 -173.627 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 14.0 p90 -155.34 168.36 27.34 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.83 0.348 . . . . 0.0 111.014 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -135.09 157.61 46.49 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.435 -0.579 . . . . 0.0 109.435 171.757 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.512 ' OE1' ' HE3' ' A' ' 44' ' ' LYS . 39.3 mt-10 -106.49 132.59 52.32 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.378 -176.547 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 69.7 p -84.66 166.97 16.64 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 175.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.469 HD23 ' H ' ' A' ' 81' ' ' LEU . 0.7 OUTLIER -67.7 -21.36 65.33 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.911 0.386 . . . . 0.0 110.496 178.022 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -90.81 16.9 8.44 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.103 178.785 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 66.6 t30 70.33 20.72 6.02 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 115.604 -0.725 . . . . 0.0 112.269 170.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 96.0 t -99.68 133.36 42.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.228 0.537 . . . . 0.0 110.208 176.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.565 ' O ' ' HA ' ' A' ' 23' ' ' GLU . 66.3 mtm180 -101.99 115.4 30.46 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.429 -176.75 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 43.1 t -91.84 108.57 20.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 177.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.54 ' O ' ' HA ' ' A' ' 25' ' ' HIS . 16.8 t -111.89 143.16 22.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.527 -170.146 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.472 HG21 ' HA ' ' A' ' 28' ' ' PRO . 91.4 m -150.66 154.46 37.51 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.887 176.277 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.63 120.44 13.45 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.827 0.822 . . . . 0.0 111.972 -177.377 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.526 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 82.4 t80 -65.65 -38.39 89.22 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.343 -1.298 . . . . 0.0 111.774 -173.193 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.503 ' O ' ' HG3' ' A' ' 95' ' ' LYS . 42.9 t -54.73 -56.62 17.25 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.634 -177.307 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 20.5 tp10 -71.39 -34.55 70.5 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.777 -175.471 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.509 ' HE1' ' HA ' ' A' ' 32' ' ' TYR . 83.8 t80 -64.01 -42.58 97.11 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.777 178.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 53.4 mm-40 -65.73 -31.63 72.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.304 178.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.535 ' O ' ' HG3' ' A' ' 99' ' ' LYS . 91.3 mttt -59.53 -44.76 93.11 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 174.769 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 65.1 mt -56.04 -50.06 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.772 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 87.5 mt -63.82 -36.4 83.77 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.597 179.467 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 59.1 tttm -66.57 -41.96 87.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.653 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.535 ' HG3' ' O ' ' A' ' 95' ' ' LYS . 90.9 mttt -64.29 -37.17 86.53 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.755 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 33.1 mtp180 -67.43 -32.52 73.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.351 176.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.469 0 C-N-CA 120.375 -0.917 . . . . 0.0 110.858 -175.119 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 13.7 m120 . . . . . 0 CA--C 1.516 -0.361 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.8 m -62.88 -34.34 77.18 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.307 0.575 . . . . 0.0 110.166 178.594 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -67.7 -35.38 78.69 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.899 176.459 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 89.8 t -64.59 -34.76 71.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.066 0.46 . . . . 0.0 110.131 178.239 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 74.7 mt -63.54 -44.82 98.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.91 -0.587 . . . . 0.0 109.948 174.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -59.84 -46.41 89.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.407 177.555 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -51.07 -49.59 60.34 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.173 176.055 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -62.4 -43.58 98.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.011 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.482 HD13 ' HB3' ' A' ' 17' ' ' TYR . 96.7 mt -69.61 -35.94 75.73 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.58 -177.227 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -70.24 -33.39 71.57 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 121.071 -0.252 . . . . 0.0 110.607 176.495 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -62.8 -53.77 49.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.584 178.152 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 30.1 pt -72.42 -24.49 22.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.121 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.54 47.43 4.59 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.022 178.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -111.37 -179.8 3.82 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.125 0.488 . . . . 0.0 111.387 -178.22 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -122.03 130.84 53.63 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.009 -173.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.482 ' HB3' HD13 ' A' ' 10' ' ' LEU . 51.5 p90 -123.04 144.56 49.2 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.565 177.597 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.573 ' HB ' ' HB2' ' A' ' 25' ' ' HIS . 75.5 mt -90.08 99.72 9.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 177.06 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.446 ' HB2' ' CE1' ' A' ' 17' ' ' TYR . 37.8 tt0 -92.56 106.98 18.86 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.089 -175.019 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 70.5 mt -112.58 166.31 11.45 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 172.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -60.39 106.03 0.49 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.043 0.449 . . . . 0.0 110.723 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 68.78 14.88 8.99 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 114.87 -1.059 . . . . 0.0 112.187 -179.226 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -138.46 113.71 9.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.873 0.368 . . . . 0.0 111.153 178.204 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.494 ' HB ' HG22 ' A' ' 86' ' ' VAL . 66.5 mt -105.28 104.76 17.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 174.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.573 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 20.0 m-70 -91.65 115.79 28.34 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -179.225 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 73.4 mt -105.16 153.76 21.11 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.953 -177.123 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.5 mtmm -77.22 133.76 68.08 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 173.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.488 ' HB2' HD11 ' A' ' 96' ' ' ILE . 7.0 Cg_endo -48.52 -43.97 31.62 Favored 'Trans proline' 0 CA--C 1.529 0.257 0 C-N-CA 123.685 2.923 . . . . 0.0 113.145 -175.408 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -57.4 -34.54 68.98 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 121.104 0.478 . . . . 0.0 111.504 -178.195 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 47.1 t -94.43 -32.17 4.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.733 -176.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.488 ' HE1' ' HE1' ' A' ' 78' ' ' PHE . 81.8 t80 -56.72 -35.23 68.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.187 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -58.98 -33.72 71.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.366 -178.452 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -77.94 -44.37 27.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.819 0.343 . . . . 0.0 110.594 179.191 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 46.3 t -63.67 -36.52 76.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.76 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.434 ' CD1' ' HD2' ' A' ' 41' ' ' PRO . 27.2 t90 -55.25 -45.38 76.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.941 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.417 ' HG2' ' HG2' ' A' ' 40' ' ' GLU . 74.8 mttt -78.2 -33.17 50.14 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.969 -0.293 . . . . 0.0 111.082 -179.673 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 91.1 t80 -58.11 -37.37 74.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.879 178.562 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.424 HG23 ' HD3' ' A' ' 41' ' ' PRO . 33.6 m -89.73 7.83 3.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.757 -177.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 99.7 15.57 31.28 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.718 -0.753 . . . . 0.0 113.967 172.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.417 ' HG2' ' HG2' ' A' ' 36' ' ' LYS . 49.2 mt-10 54.54 67.7 3.17 Favored Pre-proline 0 N--CA 1.469 0.52 0 C-N-CA 122.693 0.397 . . . . 0.0 111.424 179.105 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.434 ' HD2' ' CD1' ' A' ' 35' ' ' TRP . 5.7 Cg_exo -78.05 162.86 28.68 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 122.884 2.39 . . . . 0.0 111.958 -179.307 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -69.24 139.01 54.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.628 176.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.565 ' HB3' ' CG2' ' A' ' 76' ' ' VAL . 94.8 mt -111.05 134.29 52.77 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.216 -173.287 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -104.59 139.05 40.02 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.269 -0.423 . . . . 0.0 109.918 177.253 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 19.4 p -106.33 140.97 38.42 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.186 -178.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 6.5 p90 -124.84 153.71 42.15 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 175.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 66.5 t -111.91 113.51 44.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-O 121.024 0.44 . . . . 0.0 111.183 -174.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.451 HG23 ' HB ' ' A' ' 73' ' ' ILE . 8.2 tt -104.69 105.51 18.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 173.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.522 ' HB2' ' HG2' ' A' ' 72' ' ' LYS . 39.1 tt0 . . . . . 0 C--N 1.322 -0.619 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.606 -178.281 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.522 ' HG2' ' HB2' ' A' ' 49' ' ' GLU . 60.5 mttp . . . . . 0 C--O 1.234 0.274 0 CA-C-O 120.793 0.33 . . . . 0.0 110.934 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.451 ' HB ' HG23 ' A' ' 48' ' ' ILE . 60.9 mt -95.17 110.58 24.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.934 177.456 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -90.02 115.4 27.27 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.464 -178.445 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.451 ' HA ' ' H ' ' A' ' 90' ' ' TYR . 68.6 mttm -118.22 167.11 11.82 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.299 178.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.565 ' CG2' ' HB3' ' A' ' 43' ' ' LEU . 12.0 p -126.19 150.09 31.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.636 -0.256 . . . . 0.0 110.616 -174.204 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -155.09 164.68 38.53 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.798 0.332 . . . . 0.0 110.77 179.277 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.488 ' HE1' ' HE1' ' A' ' 31' ' ' PHE . 50.7 p90 -134.69 152.67 51.94 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 170.716 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.543 ' HG2' ' HG2' ' A' ' 85' ' ' ARG . 33.7 mt-10 -102.31 127.07 49.46 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.162 -175.732 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 81.1 p -83.97 174.88 9.97 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.742 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.9 mp -71.2 -12.08 61.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.113 0.482 . . . . 0.0 110.613 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -92.22 4.76 52.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.491 -179.157 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 66.8 t30 70.88 21.26 5.13 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.728 0.775 . . . . 0.0 109.884 -178.092 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 99.2 t -100.05 136.46 31.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.643 178.371 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.543 ' HG2' ' HG2' ' A' ' 79' ' ' GLU . 69.0 mtt180 -107.5 119.22 38.8 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.148 0.499 . . . . 0.0 111.243 -176.704 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.494 HG22 ' HB ' ' A' ' 24' ' ' ILE . 87.1 t -89.63 111.06 22.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.675 177.406 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.412 ' O ' ' HA ' ' A' ' 25' ' ' HIS . 40.9 t -105.62 140.42 23.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.18 -173.233 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 58.9 m -147.91 152.45 37.58 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 176.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -67.87 126.92 30.96 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.782 0.325 . . . . 0.0 110.724 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.451 ' H ' ' HA ' ' A' ' 75' ' ' LYS . 49.9 t80 -77.97 -30.23 50.14 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.045 -174.636 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 9.4 t -71.96 -40.63 68.52 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 -179.071 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.423 ' O ' HG13 ' A' ' 96' ' ' ILE . 35.8 mt-10 -69.49 -37.55 77.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.635 176.122 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -61.75 -47.22 86.18 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.931 0.396 . . . . 0.0 110.479 177.341 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 68.4 mm-40 -65.65 -31.33 72.28 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.016 178.138 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 57.9 tptt -66.19 -36.13 82.27 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 176.139 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.488 HD11 ' HB2' ' A' ' 28' ' ' PRO . 64.7 mt -67.12 -38.8 81.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.054 0.454 . . . . 0.0 110.501 176.013 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 73.1 mt -63.13 -25.97 68.6 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.166 176.767 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -79.37 -26.68 41.98 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.064 176.287 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.445 ' HG3' ' HA ' ' A' ' 96' ' ' ILE . 33.5 mttp -61.92 -51.62 67.38 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-O 121.239 0.542 . . . . 0.0 109.875 175.514 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -86.19 -30.03 22.75 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.035 -173.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.658 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.266 -175.655 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ASN . . . . . 0.424 ' N ' HD21 ' A' ' 2' ' ' ASN . 0.8 OUTLIER . . . . . 0 CA--C 1.519 -0.249 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.7 p -63.83 -28.29 69.75 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.089 0.471 . . . . 0.0 110.102 175.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -62.33 -43.47 98.75 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.031 175.27 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 99.5 t -61.26 -39.63 83.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.033 176.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.555 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 63.5 mt -63.44 -41.48 92.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.3 177.386 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -54.95 -49.56 71.08 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.768 177.037 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -60.3 -36.9 78.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.898 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.464 ' O ' HG12 ' A' ' 13' ' ' ILE . 90.5 t80 -67.95 -44.43 76.78 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.299 177.431 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.555 ' HG ' ' O ' ' A' ' 6' ' ' ILE . 86.2 mt -66.73 -43.37 84.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.261 -178.467 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -65.57 -30.07 70.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.954 0.406 . . . . 0.0 110.938 179.01 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -75.23 -47.3 28.81 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.26 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.464 HG12 ' O ' ' A' ' 9' ' ' PHE . 40.3 pt -77.85 -37.92 24.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 121.041 -0.264 . . . . 0.0 111.504 -178.186 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 114.36 75.76 0.67 Allowed Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.904 178.759 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.571 ' HG2' HD22 ' A' ' 26' ' ' LEU . 3.8 tp10 -132.83 133.59 43.55 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 174.735 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -102.09 106.9 17.84 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 176.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.572 ' HB3' HD23 ' A' ' 26' ' ' LEU . 11.0 p90 -111.08 153.02 26.26 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.199 0.524 . . . . 0.0 112.241 -171.673 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.532 ' HB ' ' HB2' ' A' ' 25' ' ' HIS . 64.5 mt -89.35 107.18 17.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.355 174.531 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -94.29 97.74 10.44 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.38 0.61 . . . . 0.0 110.789 -179.373 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 91.9 mt -101.4 162.04 13.19 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 171.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -64.66 116.32 6.11 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 119.954 -0.699 . . . . 0.0 109.931 -178.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.445 ' O ' ' HG2' ' A' ' 85' ' ' ARG . 72.5 m-20 75.65 7.32 3.87 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 114.977 -1.011 . . . . 0.0 111.765 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -140.03 113.83 8.77 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-O 121.083 0.468 . . . . 0.0 112.191 -179.296 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 70.8 mt -109.4 116.36 51.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 173.495 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.532 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 23.6 m-70 -98.44 121.77 40.79 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.644 0.259 . . . . 0.0 111.073 -177.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.572 HD23 ' HB3' ' A' ' 17' ' ' TYR . 91.8 mt -117.25 161.81 18.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.633 -179.191 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 34.1 mttp -72.63 144.98 86.75 Favored Pre-proline 0 C--N 1.328 -0.356 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 172.568 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_exo -52.01 -33.75 54.05 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.25 1.966 . . . . 0.0 111.391 174.47 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -53.28 -57.31 10.98 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.168 175.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.4 ' O ' HG23 ' A' ' 34' ' ' VAL . 45.1 t -79.57 -36.35 17.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.048 -175.615 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -55.21 -38.85 68.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.411 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.584 ' HA ' ' HE1' ' A' ' 93' ' ' PHE . 23.8 t80 -55.56 -44.82 77.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.426 177.817 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -78.89 -32.52 45.87 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.176 -177.442 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 30' ' ' VAL . 84.7 t -65.22 -38.59 83.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 175.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 29.6 t90 -57.89 -42.33 84.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.117 176.485 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -63.02 -47.09 84.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.643 174.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 88.9 t80 -59.06 -43.88 91.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.044 -177.238 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.532 HG23 ' HD3' ' A' ' 41' ' ' PRO . 34.1 m -75.23 -8.46 11.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -175.287 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 108.21 5.02 32.93 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.442 -0.885 . . . . 0.0 113.107 175.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 57.02 76.03 0.52 Allowed Pre-proline 0 C--N 1.329 -0.307 0 C-N-CA 122.862 0.465 . . . . 0.0 112.014 178.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.532 ' HD3' HG23 ' A' ' 38' ' ' VAL . 57.7 Cg_endo -93.5 -172.63 0.33 Allowed 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 123.218 2.612 . . . . 0.0 111.22 175.481 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -72.02 148.15 46.15 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.085 0.469 . . . . 0.0 110.557 176.573 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.406 ' HB3' ' CG2' ' A' ' 76' ' ' VAL . 83.7 mt -111.95 132.76 54.56 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.225 -179.376 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -96.37 140.23 31.33 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 177.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 43.7 p -119.87 140.77 50.32 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 120.695 0.283 . . . . 0.0 110.527 178.372 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.401 ' CE1' ' HB2' ' A' ' 75' ' ' LYS . 10.4 p90 -122.68 141.8 51.36 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 177.612 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 48.2 t -97.37 108.57 21.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.786 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 10.1 tt -113.17 137.64 45.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.207 -179.008 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 . . . . . 0 N--CA 1.446 -0.629 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.26 177.097 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 51.8 mttm . . . . . 0 C--O 1.236 0.364 0 CA-C-O 120.813 0.34 . . . . 0.0 110.304 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.586 HG22 ' HG3' ' A' ' 75' ' ' LYS . 44.3 mm -97.46 120.23 46.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.174 0.511 . . . . 0.0 110.55 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.539 ' O ' ' HB3' ' A' ' 90' ' ' TYR . 57.2 tttp -85.58 101.87 13.06 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.283 178.312 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.586 ' HG3' HG22 ' A' ' 73' ' ' ILE . 74.6 mttt -102.43 154.96 18.58 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.171 -177.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.406 ' CG2' ' HB3' ' A' ' 43' ' ' LEU . 14.9 p -116.84 147.79 19.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.639 0.256 . . . . 0.0 111.258 -172.347 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.477 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 50.6 p90 -153.79 154.04 33.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.935 178.434 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -123.76 149.54 45.49 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 171.145 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -102.77 135.71 43.92 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.709 -174.469 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 59.7 p -89.85 -176.3 4.89 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.617 179.161 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.525 HD13 ' O ' ' A' ' 81' ' ' LEU . 2.1 tm? -63.89 -24.64 67.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.28 0.562 . . . . 0.0 109.803 178.047 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.426 ' O ' ' HB2' ' A' ' 83' ' ' ASN . 0.8 OUTLIER -81.75 1.33 34.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.841 -177.237 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.426 ' HB2' ' O ' ' A' ' 82' ' ' ASP . 47.1 m-80 71.46 6.62 5.8 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 123.572 0.545 . . . . 0.0 110.776 -176.114 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 85.1 t -83.55 132.54 31.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.731 178.16 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.445 ' HG2' ' O ' ' A' ' 22' ' ' ASN . 40.9 ptt180 -101.4 131.35 47.54 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.398 0.618 . . . . 0.0 111.109 -177.369 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.477 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 59.5 t -94.17 111.26 24.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.384 177.092 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.473 HG22 ' HB3' ' A' ' 77' ' ' TYR . 16.1 t -104.92 142.91 17.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.285 -171.529 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 8.1 t -151.42 -173.21 4.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.646 175.247 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -84.83 119.51 25.4 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.899 0.381 . . . . 0.0 110.56 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.539 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 76.3 t80 -70.28 -40.85 74.08 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.484 -176.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.587 ' O ' ' HG3' ' A' ' 95' ' ' LYS . 18.0 m -58.75 -56.94 15.72 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.36 -174.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.47 ' O ' HG13 ' A' ' 96' ' ' ILE . 33.1 mt-10 -75.29 -27.35 59.32 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 -176.268 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.584 ' HE1' ' HA ' ' A' ' 32' ' ' TYR . 65.7 t80 -61.78 -47.86 83.24 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 175.174 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 81.5 mm-40 -65.33 -28.84 69.58 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.946 178.652 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.587 ' HG3' ' O ' ' A' ' 91' ' ' SER . 65.9 mttm -68.49 -25.01 64.76 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.495 176.185 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.47 HG13 ' O ' ' A' ' 92' ' ' GLU . 77.0 mt -72.93 -39.4 58.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 174.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -63.11 -39.43 94.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.167 0.508 . . . . 0.0 109.822 173.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 62.6 mmtt -65.19 -37.34 87.04 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.114 174.515 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -63.11 -47.63 82.02 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.69 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 55.2 ttt180 -72.15 -34.31 68.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.747 177.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.73 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.871 -178.291 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 13.0 m120 . . . . . 0 CA--C 1.516 -0.333 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.423 ' O ' ' HG3' ' A' ' 7' ' ' LYS . 7.1 m -61.97 -36.03 80.25 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.861 0.363 . . . . 0.0 110.282 179.542 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -62.44 -42.5 99.5 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.152 175.643 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 67.3 t -60.06 -42.21 89.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.696 178.793 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.477 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 67.3 mt -62.18 -42.13 94.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.396 178.53 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.423 ' HG3' ' O ' ' A' ' 3' ' ' SER . 95.5 mttt -57.43 -51.23 70.26 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.839 178.674 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -60.28 -48.18 82.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.475 178.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.491 ' CE2' HD11 ' A' ' 13' ' ' ILE . 72.5 t80 -55.41 -41.73 73.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.99 -178.811 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 6' ' ' ILE . 93.0 mt -64.64 -42.67 95.3 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.094 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -70.81 -34.45 71.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.776 0.322 . . . . 0.0 110.606 178.249 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -60.49 -37.46 81.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.568 175.629 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.491 HD11 ' CE2' ' A' ' 9' ' ' PHE . 64.2 mt -74.19 -41.87 51.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.157 0.503 . . . . 0.0 109.949 174.826 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 109.17 24.5 5.95 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.485 -175.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 82.5 mm-40 -102.3 -179.73 4.07 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.74 0.305 . . . . 0.0 110.584 -179.34 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -128.13 173.27 10.24 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 -179.287 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.476 ' HB3' HD13 ' A' ' 10' ' ' LEU . 30.0 p90 -158.51 141.32 14.57 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.765 0.317 . . . . 0.0 110.371 -178.417 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.551 ' HB ' ' HB2' ' A' ' 25' ' ' HIS . 69.7 mt -97.76 103.22 14.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 120.937 0.399 . . . . 0.0 110.2 179.549 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -89.49 118.21 28.97 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.55 -179.526 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 83.4 mt -116.07 -166.4 1.14 Allowed 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 175.102 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -67.15 101.79 0.94 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.888 0.375 . . . . 0.0 111.067 -179.335 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 48.6 m-80 64.88 15.98 10.22 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.601 177.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -132.44 128.25 37.08 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.301 -179.259 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.439 ' HB ' HG22 ' A' ' 86' ' ' VAL . 65.1 mt -109.55 106.65 21.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 172.208 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.551 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 20.4 m170 -87.41 115.49 24.86 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -178.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.42 HD21 HD11 ' A' ' 10' ' ' LEU . 0.3 OUTLIER -98.18 161.01 13.93 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.391 -173.806 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -74.63 131.25 80.08 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.139 174.366 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.495 ' HA ' HG21 ' A' ' 88' ' ' THR . 89.8 Cg_exo -43.01 -50.23 6.41 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 123.825 3.017 . . . . 0.0 114.29 -174.07 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -75.15 -33.01 61.47 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.703 0.287 . . . . 0.0 111.655 -175.452 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.436 ' O ' HG23 ' A' ' 34' ' ' VAL . 21.8 t -74.12 -35.49 41.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.842 0.353 . . . . 0.0 110.305 -178.271 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -54.93 -38.49 67.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.877 179.32 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 73.8 t80 -59.14 -42.22 90.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.154 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -78.03 -31.16 50.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.985 -178.546 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 30' ' ' VAL . 92.8 t -65.38 -38.66 83.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.013 0.435 . . . . 0.0 109.838 175.25 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 26.9 t90 -57.34 -44.87 84.64 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.785 176.752 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.413 ' NZ ' ' HB3' ' A' ' 36' ' ' LYS . 8.3 mtpm? -80.02 -0.09 33.95 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.78 0.324 . . . . 0.0 111.24 -179.191 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -96.19 -39.58 9.61 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.012 0.434 . . . . 0.0 110.619 175.024 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 29.3 m -82.13 19.66 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.055 -0.52 . . . . 0.0 112.303 -173.77 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 91.02 19.48 42.79 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.97 176.518 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 37.17 65.82 2.33 Favored Pre-proline 0 N--CA 1.473 0.722 0 C-N-CA 123.884 0.874 . . . . 0.0 112.941 179.548 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -83.11 175.51 8.36 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 122.482 2.122 . . . . 0.0 111.953 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -71.55 110.4 6.11 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.844 175.384 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.509 ' HB3' ' CG2' ' A' ' 76' ' ' VAL . 81.0 mt -73.7 129.14 37.33 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.795 -178.709 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 25.6 tptp -92.54 121.98 34.52 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.959 -178.594 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.403 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 41.7 p -103.24 156.19 17.9 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.805 -178.812 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 30.6 p90 -132.83 146.5 51.88 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 173.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 57.9 t -99.28 116.55 42.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.45 -179.362 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.659 HG23 ' HB ' ' A' ' 73' ' ' ILE . 6.2 tt -102.95 101.29 11.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 174.189 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 . . . . . 0 C--N 1.319 -0.722 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.172 -175.963 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 67.3 mttm . . . . . 0 N--CA 1.454 -0.236 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.659 ' HB ' HG23 ' A' ' 48' ' ' ILE . 57.9 mt -91.1 132.96 34.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.598 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -117.7 126.75 53.06 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 120.885 0.374 . . . . 0.0 110.81 -174.654 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.437 ' HA ' ' H ' ' A' ' 90' ' ' TYR . 97.7 mttt -123.07 159.01 29.37 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.22 176.709 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.509 ' CG2' ' HB3' ' A' ' 43' ' ' LEU . 9.9 p -122.71 145.36 29.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.638 -175.364 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.405 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 53.2 p90 -152.51 165.29 35.57 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.964 0.412 . . . . 0.0 110.365 178.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -137.69 144.97 42.05 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 169.798 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.566 ' HG2' ' HG3' ' A' ' 85' ' ' ARG . 43.7 mt-10 -101.93 122.51 44.16 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.183 -177.462 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 49.6 p -73.17 178.25 4.55 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.044 -178.59 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 8.0 mp -64.06 -24.3 67.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.06 0.457 . . . . 0.0 109.851 176.131 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -83.26 -2.19 55.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.982 179.301 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 71.03 24.57 3.92 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.35 178.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 62.0 t -90.33 134.71 28.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.779 176.696 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.566 ' HG3' ' HG2' ' A' ' 79' ' ' GLU . 4.3 mpt_? -92.3 110.3 21.69 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.035 -176.545 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.439 HG22 ' HB ' ' A' ' 24' ' ' ILE . 49.4 t -89.22 103.36 13.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 173.513 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.8 t -107.09 141.41 22.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.683 -170.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.495 HG21 ' HA ' ' A' ' 28' ' ' PRO . 73.0 m -149.56 153.73 37.59 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.583 175.308 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -64.43 127.96 33.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.931 0.396 . . . . 0.0 111.047 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.437 ' H ' ' HA ' ' A' ' 75' ' ' LYS . 83.7 t80 -80.69 -26.68 37.37 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.034 -174.86 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 47.3 t -62.94 -44.15 96.85 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.312 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.441 ' O ' ' HB3' ' A' ' 95' ' ' LYS . 39.8 mt-10 -80.05 -20.2 45.8 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.068 177.294 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -70.38 -49.53 48.14 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.406 173.662 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.472 ' HA ' HD12 ' A' ' 97' ' ' LEU . 19.6 pt20 -68.05 -22.6 64.94 Favored 'General case' 0 C--N 1.334 -0.074 0 CA-C-O 121.034 0.445 . . . . 0.0 110.05 177.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.441 ' HB3' ' O ' ' A' ' 92' ' ' GLU . 86.7 tttt -61.43 -45.05 95.91 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.726 173.284 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.43 HG13 ' O ' ' A' ' 92' ' ' GLU . 66.3 mt -68.49 -34.93 68.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.166 176.079 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.472 HD12 ' HA ' ' A' ' 94' ' ' GLN . 75.7 mt -60.83 -41.65 96.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.641 176.196 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.442 ' HG2' ' O ' ' A' ' 94' ' ' GLN . 34.4 mmtp -67.25 -38.77 85.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.177 0.513 . . . . 0.0 110.225 176.301 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -60.92 -50.22 74.3 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.31 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 73.9 mtp85 -95.44 1.17 53.99 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.641 -174.578 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.229 -0.203 0 C-N-CA 121.171 -0.538 . . . . 0.0 113.191 175.248 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 15.8 m120 . . . . . 0 C--O 1.234 0.287 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.5 p -57.48 -32.37 66.92 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.068 0.461 . . . . 0.0 111.078 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.475 ' HA ' ' HD2' ' A' ' 7' ' ' LYS . 35.3 tt0 -61.0 -42.3 98.18 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.697 178.071 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.3 t -68.01 -35.21 71.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.373 179.663 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.509 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 59.7 mt -62.73 -39.77 86.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.138 176.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.475 ' HD2' ' HA ' ' A' ' 4' ' ' GLU . 61.8 mttm -56.78 -44.66 82.07 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.488 176.097 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -57.67 -44.1 85.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.022 178.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -66.9 -43.54 83.13 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.878 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.513 HD13 ' HB3' ' A' ' 17' ' ' TYR . 87.3 mt -66.57 -40.03 88.76 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.371 -177.487 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -67.44 -39.46 85.4 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.922 0.391 . . . . 0.0 110.17 176.394 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -58.24 -51.04 71.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.183 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 33.7 pt -72.38 -26.26 24.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.405 -178.233 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.32 44.16 4.75 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.723 177.651 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -123.19 149.66 44.35 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.009 0.433 . . . . 0.0 110.813 178.416 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -93.99 131.96 38.93 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.294 -177.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.513 ' HB3' HD13 ' A' ' 10' ' ' LEU . 27.9 p90 -115.23 136.28 53.28 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.051 179.048 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 57.1 mt -87.45 97.81 6.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 120.848 0.356 . . . . 0.0 110.107 -179.208 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -91.12 106.63 18.65 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.352 0.596 . . . . 0.0 110.459 -179.244 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.516 ' HB2' ' HB2' ' A' ' 23' ' ' GLU . 88.1 mt -93.95 -164.84 1.22 Allowed 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.222 -0.899 . . . . 0.0 108.803 174.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -69.56 92.73 0.65 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.635 0.255 . . . . 0.0 110.52 179.553 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 10.0 m120 69.54 18.55 7.72 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.643 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.516 ' HB2' ' HB2' ' A' ' 20' ' ' LEU . 41.6 mt-10 -130.18 113.71 14.8 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.937 178.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 59.5 mt -96.04 102.55 13.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 173.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.507 ' HA ' ' O ' ' A' ' 87' ' ' VAL . 13.6 m-70 -90.35 117.74 29.31 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.016 0.436 . . . . 0.0 109.949 -179.076 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 70.6 mt -107.56 168.96 8.88 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.519 0.676 . . . . 0.0 111.562 -176.284 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -82.57 140.27 44.43 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 115.011 -0.995 . . . . 0.0 108.364 171.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.496 ' HA ' HG21 ' A' ' 88' ' ' THR . 3.2 Cg_endo -47.06 -43.69 24.53 Favored 'Trans proline' 0 CA--C 1.534 0.495 0 C-N-CA 123.195 2.597 . . . . 0.0 113.298 -176.84 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -61.15 -41.19 96.31 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.998 0.428 . . . . 0.0 111.197 179.144 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 47.9 t -73.82 -37.78 49.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.852 -178.491 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -60.62 -40.59 92.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.632 179.54 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 85.1 t80 -60.49 -39.69 88.6 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.576 178.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 38.2 mm-40 -59.6 -50.84 72.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.842 177.195 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 41.4 t -65.62 -40.33 87.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.996 -177.261 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.712 ' CD1' ' HD2' ' A' ' 41' ' ' PRO . 32.5 t90 -57.02 -44.62 83.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.708 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.423 ' HE2' ' HB3' ' A' ' 36' ' ' LYS . 51.1 mtpt -89.5 3.7 51.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.881 0.372 . . . . 0.0 111.108 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -83.6 -38.6 21.4 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.094 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -96.84 9.29 6.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.915 177.194 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 79.04 50.4 5.87 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.739 -0.744 . . . . 0.0 113.763 173.219 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 58.24 78.33 0.36 Allowed Pre-proline 0 N--CA 1.467 0.41 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 172.166 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.712 ' HD2' ' CD1' ' A' ' 35' ' ' TRP . 5.4 Cg_exo -78.76 173.73 13.22 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.374 2.049 . . . . 0.0 111.39 172.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -76.99 123.58 26.54 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.046 177.176 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.453 ' HB3' ' CG2' ' A' ' 76' ' ' VAL . 87.6 mt -94.36 132.03 39.41 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.809 -177.783 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -107.44 141.81 38.25 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.768 178.36 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 24.1 p -120.76 146.09 46.85 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.775 0.321 . . . . 0.0 111.487 -176.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 17.8 p90 -133.09 154.98 50.06 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 177.409 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.5 t -106.01 114.61 45.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.274 178.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 8.6 tt -110.53 118.03 56.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.267 0.556 . . . . 0.0 109.95 177.8 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.489 ' HG2' ' HG2' ' A' ' 72' ' ' LYS . 50.2 mt-10 . . . . . 0 C--N 1.322 -0.621 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.917 -178.632 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.489 ' HG2' ' HG2' ' A' ' 49' ' ' GLU . 61.5 mttm . . . . . 0 N--CA 1.453 -0.288 0 CA-C-O 120.749 0.309 . . . . 0.0 110.389 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 65.4 mt -97.77 118.91 45.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.131 0.491 . . . . 0.0 110.553 -178.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.427 ' O ' ' HB3' ' A' ' 90' ' ' TYR . 87.8 tttt -89.58 128.43 36.03 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.958 178.703 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.458 ' HG2' ' HA ' ' A' ' 89' ' ' ASP . 68.3 mttm -129.73 164.17 24.57 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 177.708 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.453 ' CG2' ' HB3' ' A' ' 43' ' ' LEU . 11.1 p -119.82 148.03 23.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.513 -174.912 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -154.79 162.35 41.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.058 0.456 . . . . 0.0 111.108 -179.357 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -132.45 142.21 49.15 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 168.789 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -102.16 132.43 48.07 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.633 -173.369 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 72.4 p -82.31 179.53 7.77 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.926 0.394 . . . . 0.0 109.994 176.767 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.407 HD12 ' N ' ' A' ' 81' ' ' LEU . 5.9 mp -77.11 -6.45 52.87 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.85 0.357 . . . . 0.0 110.7 -178.71 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.524 ' HB2' HG23 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -97.89 8.85 44.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.203 -179.384 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 63.4 t30 67.14 28.42 8.22 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.865 0.84 . . . . 0.0 110.133 -176.578 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.524 HG23 ' HB2' ' A' ' 82' ' ' ASP . 59.2 t -98.72 113.72 34.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 175.486 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 85.6 mtt180 -94.69 110.51 22.35 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.567 -176.09 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 58.0 t -81.63 104.62 10.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.724 179.03 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.507 ' O ' ' HA ' ' A' ' 25' ' ' HIS . 41.4 t -103.53 140.97 20.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.236 -172.483 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.496 HG21 ' HA ' ' A' ' 28' ' ' PRO . 98.6 m -147.58 151.43 36.25 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.33 174.359 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.458 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 20.3 t70 -59.97 134.8 57.38 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.063 0.458 . . . . 0.0 111.563 -177.77 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.427 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 88.1 t80 -76.64 -41.04 47.29 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.62 -175.26 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 11.0 p -68.65 -37.57 79.78 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.911 -0.316 . . . . 0.0 111.058 -176.699 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 43.1 mm-40 -72.65 -31.75 65.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.594 0.235 . . . . 0.0 110.992 176.055 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -69.34 -49.77 52.56 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 121.078 -0.249 . . . . 0.0 111.078 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.469 ' HA ' HD12 ' A' ' 97' ' ' LEU . 11.0 pt20 -63.86 -28.66 70.0 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.146 0.498 . . . . 0.0 110.094 178.511 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 53.7 tttt -60.59 -45.55 93.55 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.414 173.275 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.541 ' HA ' ' HB3' ' A' ' 99' ' ' LYS . 21.7 mt -71.07 -33.1 50.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.458 -179.536 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.469 HD12 ' HA ' ' A' ' 94' ' ' GLN . 98.4 mt -56.62 -40.92 76.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.031 0.443 . . . . 0.0 110.197 175.728 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -81.06 -31.92 34.25 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.624 177.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.541 ' HB3' ' HA ' ' A' ' 96' ' ' ILE . 46.9 tttm -56.59 -46.69 80.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.11 178.404 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 68.6 mtp85 -95.03 -14.47 24.29 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.576 179.392 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.442 0 C-N-CA 120.673 -0.775 . . . . 0.0 111.779 -179.997 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 17.3 m120 . . . . . 0 C--O 1.234 0.239 0 CA-C-O 120.848 0.356 . . . . 0.0 110.642 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.0 t -67.78 -25.99 65.87 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 175.159 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.422 ' O ' ' HG3' ' A' ' 8' ' ' GLU . 35.5 tt0 -51.94 -45.77 64.47 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.012 175.735 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.3 t -61.01 -41.38 88.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.854 -178.253 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 56.6 mt -65.14 -41.91 92.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.284 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 55.9 mttm -56.18 -44.44 79.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.24 177.496 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.422 ' HG3' ' O ' ' A' ' 4' ' ' GLU . 39.0 mt-10 -63.05 -41.65 99.53 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.595 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -66.02 -46.28 78.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.849 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 96.3 mt -68.16 -34.17 75.82 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.227 -177.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -67.15 -33.69 75.97 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.292 179.563 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -63.73 -55.06 26.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.844 178.572 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.415 HG13 ' H ' ' A' ' 15' ' ' GLU . 19.6 pt -69.56 -39.55 78.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.688 -177.334 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 95.36 21.73 23.9 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.815 177.309 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.415 ' H ' HG13 ' A' ' 13' ' ' ILE . 23.5 mm-40 -85.94 130.05 34.66 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 175.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -69.16 122.59 19.1 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.732 -176.273 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 43.8 p90 -112.95 133.91 54.7 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 171.404 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.556 ' HB ' ' HB2' ' A' ' 25' ' ' HIS . 57.8 mt -90.08 94.74 5.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 120.938 0.399 . . . . 0.0 110.081 -178.278 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -84.95 109.48 18.2 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.306 0.574 . . . . 0.0 110.598 179.433 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.4 mt -101.32 -161.86 0.89 Allowed 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.1 -0.954 . . . . 0.0 108.706 174.661 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -66.37 96.09 0.34 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.772 0.32 . . . . 0.0 110.61 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 65.25 20.14 11.84 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.65 179.279 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -134.24 114.22 12.82 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.801 0.334 . . . . 0.0 111.623 -178.245 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.446 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 54.3 mt -94.36 101.21 12.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 173.503 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.556 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 18.8 m-70 -84.87 107.07 16.84 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 177.605 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.9 mt -95.2 169.72 9.89 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.424 0.631 . . . . 0.0 111.752 -175.078 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.403 ' HB2' HG23 ' A' ' 30' ' ' VAL . 44.8 mtpt -87.11 136.02 34.3 Favored Pre-proline 0 C--N 1.319 -0.728 0 CA-C-N 114.904 -1.044 . . . . 0.0 108.688 175.217 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.412 ' HA ' HG21 ' A' ' 88' ' ' THR . 82.9 Cg_exo -47.0 -43.53 24.46 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 123.305 2.67 . . . . 0.0 113.245 -177.689 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -56.86 -44.56 82.3 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.29 0.567 . . . . 0.0 110.86 178.816 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.403 HG23 ' HB2' ' A' ' 27' ' ' LYS . 17.1 t -76.68 -46.83 30.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.73 -175.631 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -56.4 -37.97 70.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.524 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.652 ' OH ' ' HD2' ' A' ' 100' ' ' ARG . 6.6 t80 -58.27 -32.14 68.12 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.701 178.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 50.7 mm-40 -95.21 -37.17 11.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.546 0.212 . . . . 0.0 111.555 179.467 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.507 ' O ' HG22 ' A' ' 38' ' ' VAL . 93.4 t -62.67 -35.86 72.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.69 0.281 . . . . 0.0 110.789 179.673 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.675 ' CD1' ' HD2' ' A' ' 41' ' ' PRO . 46.2 t90 -55.56 -36.94 67.36 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.665 176.611 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.45 ' HA ' ' OE2' ' A' ' 40' ' ' GLU . 93.1 mttt -74.85 -40.98 60.71 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.483 179.14 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -58.02 -41.62 83.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.657 -178.464 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.577 HG23 ' HD3' ' A' ' 41' ' ' PRO . 15.5 m -85.54 1.46 5.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.753 -178.434 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 90.89 41.07 5.42 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.97 -0.633 . . . . 0.0 114.289 169.719 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.45 ' OE2' ' HA ' ' A' ' 36' ' ' LYS . 21.3 mp0 51.25 67.18 4.48 Favored Pre-proline 0 N--CA 1.467 0.416 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 176.708 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.675 ' HD2' ' CD1' ' A' ' 35' ' ' TRP . 72.5 Cg_endo -77.41 -179.58 5.57 Favored 'Trans proline' 0 C--O 1.24 0.598 0 C-N-CA 122.461 2.108 . . . . 0.0 112.119 178.593 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -68.47 132.13 46.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.683 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.459 ' HB3' ' CG2' ' A' ' 76' ' ' VAL . 77.8 mt -106.31 107.73 18.88 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.212 178.68 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.545 ' HE2' ' HG3' ' A' ' 79' ' ' GLU . 31.1 mttm -88.51 118.11 27.92 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 -179.315 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 41.8 p -95.62 119.42 34.08 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.33 177.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 14.6 p90 -118.56 152.88 35.16 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.265 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 60.3 t -104.17 112.6 38.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.18 178.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.496 HG23 ' HB ' ' A' ' 73' ' ' ILE . 11.6 tt -102.09 123.9 55.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 176.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 . . . . . 0 C--N 1.319 -0.757 0 CA-C-O 121.154 0.502 . . . . 0.0 110.731 -176.169 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 65.0 mttm . . . . . 0 N--CA 1.455 -0.217 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.496 ' HB ' HG23 ' A' ' 48' ' ' ILE . 49.0 mt -91.25 128.9 42.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.647 -176.007 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -101.32 113.11 25.88 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.009 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.449 ' HA ' ' H ' ' A' ' 90' ' ' TYR . 68.4 mttm -122.17 167.1 13.59 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.358 -179.199 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.459 ' CG2' ' HB3' ' A' ' 43' ' ' LEU . 14.8 p -126.31 147.39 31.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.819 -175.603 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 44.1 p90 -152.65 155.8 37.99 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.695 0.283 . . . . 0.0 110.782 175.276 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -124.71 157.73 34.93 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 171.317 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.545 ' HG3' ' HE2' ' A' ' 44' ' ' LYS . 29.4 mt-10 -109.07 146.34 34.16 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.908 0.385 . . . . 0.0 111.191 -174.524 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 32.5 p -102.6 179.46 4.29 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.995 175.183 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 11.2 mp -67.49 -18.16 64.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.066 0.46 . . . . 0.0 110.907 178.096 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -94.28 9.61 37.38 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.599 -177.288 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 14.7 t30 69.64 1.98 3.6 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.427 0.632 . . . . 0.0 110.808 -179.037 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 52.6 t -72.49 115.63 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 178.298 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.545 ' HG2' ' HG2' ' A' ' 79' ' ' GLU . 91.8 mtt180 -94.23 118.59 31.8 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.786 -176.572 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.446 ' HA ' ' O ' ' A' ' 24' ' ' ILE . 59.7 t -87.12 104.96 14.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 178.09 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 23.9 t -102.07 141.19 18.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.061 -173.344 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.412 HG21 ' HA ' ' A' ' 28' ' ' PRO . 97.9 m -150.99 150.02 30.27 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.363 175.616 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -64.88 125.83 26.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.943 0.401 . . . . 0.0 110.349 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.449 ' H ' ' HA ' ' A' ' 75' ' ' LYS . 18.3 t80 -75.85 -25.28 56.07 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.512 -173.109 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 10.9 t -74.31 -44.72 51.44 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 -70.36 -29.95 66.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.806 176.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.511 ' HE1' ' HA ' ' A' ' 32' ' ' TYR . 72.4 t80 -65.34 -52.17 55.66 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.365 -0.38 . . . . 0.0 109.985 174.942 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -63.16 -27.87 69.67 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.004 177.727 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -58.44 -51.3 70.41 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.013 176.699 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.446 ' HA ' ' HB3' ' A' ' 99' ' ' LYS . 62.3 mt -72.99 -32.57 40.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.22 0.533 . . . . 0.0 110.436 179.372 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.41 ' HA ' HD22 ' A' ' 97' ' ' LEU . 0.2 OUTLIER -59.2 -50.2 74.95 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.509 -0.768 . . . . 0.0 110.033 176.853 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -65.96 -36.13 82.5 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.576 176.251 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.446 ' HB3' ' HA ' ' A' ' 96' ' ' ILE . 47.8 tttp -57.37 -42.39 82.01 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.29 -179.174 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.652 ' HD2' ' OH ' ' A' ' 32' ' ' TYR . 63.5 ttt180 -73.1 -40.59 64.86 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.079 0.466 . . . . 0.0 110.924 179.26 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.562 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.962 -176.984 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ASN . . . . . 0.513 ' HB3' ' OD2' ' A' ' 82' ' ' ASP . 2.0 m-20 . . . . . 0 N--CA 1.455 -0.225 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.427 ' O ' ' HG3' ' A' ' 7' ' ' LYS . 14.8 p -62.27 -29.36 70.36 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.081 0.467 . . . . 0.0 110.374 178.465 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -57.08 -46.76 82.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.984 176.705 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.8 t -63.0 -38.9 83.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.266 -178.423 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.491 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 61.5 mt -63.58 -43.56 98.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.209 178.382 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.427 ' HG3' ' O ' ' A' ' 3' ' ' SER . 99.0 mttt -58.51 -45.13 89.45 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.817 178.255 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -57.43 -47.28 82.19 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.108 179.585 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -61.04 -46.05 92.27 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.768 178.488 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.491 ' HG ' ' O ' ' A' ' 6' ' ' ILE . 95.7 mt -64.69 -37.12 86.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.454 -177.398 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -74.5 -36.02 63.23 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.785 0.326 . . . . 0.0 110.842 177.063 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -67.88 -35.06 77.86 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.848 0.356 . . . . 0.0 110.861 -179.686 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 39.0 pt -82.34 -17.2 11.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.854 0.359 . . . . 0.0 110.576 175.562 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 77.09 48.45 8.35 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 121.119 -0.562 . . . . 0.0 113.045 174.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.03 158.55 26.56 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.871 0.367 . . . . 0.0 110.431 179.435 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -95.99 120.41 36.22 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.822 -178.772 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 42.1 p90 -116.25 145.92 42.76 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.09 179.414 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.491 ' HB ' ' HB2' ' A' ' 25' ' ' HIS . 51.1 mt -96.39 97.97 7.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 120.76 0.314 . . . . 0.0 110.859 -177.222 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 47.2 tt0 -90.58 125.51 35.65 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.072 0.463 . . . . 0.0 110.171 176.115 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.585 ' HB2' ' HB2' ' A' ' 23' ' ' GLU . 90.4 mt -120.39 -161.65 0.9 Allowed 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 174.447 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -78.67 101.16 7.36 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.796 0.331 . . . . 0.0 110.407 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 58.7 m-80 69.43 10.07 7.55 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.724 -178.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.585 ' HB2' ' HB2' ' A' ' 20' ' ' LEU . 46.9 mt-10 -123.48 132.98 54.08 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.71 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.53 ' HB ' HG22 ' A' ' 86' ' ' VAL . 69.5 mt -120.98 111.59 32.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 170.582 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.491 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 66.3 m-70 -100.97 127.17 47.58 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 110.132 -0.322 . . . . 0.0 110.132 -178.763 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 69.9 mt -118.01 177.08 4.92 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.413 -176.834 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 58.7 mttp -92.61 154.9 42.4 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.118 175.296 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.26 -48.52 21.58 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.795 2.33 . . . . 0.0 113.07 -174.858 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -64.08 -47.61 79.43 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.841 0.353 . . . . 0.0 110.773 -177.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.404 ' O ' HG23 ' A' ' 34' ' ' VAL . 42.0 t -62.48 -45.86 97.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.775 -178.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -57.1 -44.76 83.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.842 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -59.48 -42.29 91.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.324 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -75.72 -44.37 42.32 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.91 -177.072 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 30' ' ' VAL . 97.5 t -61.83 -36.52 74.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-O 120.744 0.307 . . . . 0.0 110.571 178.633 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 28.3 t90 -53.77 -53.83 46.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.816 177.7 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.468 ' HA ' ' HG3' ' A' ' 40' ' ' GLU . 65.4 mttm -71.38 -29.9 65.5 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.039 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 86.4 t80 -60.91 -42.09 97.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.458 179.408 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.498 HG23 ' HD3' ' A' ' 41' ' ' PRO . 30.3 m -86.29 -0.37 6.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 -176.276 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 109.36 11.01 22.72 Favored Glycine 0 C--N 1.329 0.187 0 C-N-CA 120.437 -0.887 . . . . 0.0 113.427 175.125 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.468 ' HG3' ' HA ' ' A' ' 36' ' ' LYS . 46.3 mt-10 57.77 72.17 0.95 Allowed Pre-proline 0 C--O 1.234 0.287 0 C-N-CA 122.936 0.494 . . . . 0.0 111.938 179.321 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.498 ' HD3' HG23 ' A' ' 38' ' ' VAL . 5.0 Cg_exo -74.74 173.25 14.72 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.764 2.309 . . . . 0.0 111.475 176.801 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -64.63 123.39 19.18 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.014 0.435 . . . . 0.0 110.849 179.038 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.485 ' HB3' ' CG2' ' A' ' 76' ' ' VAL . 86.4 mt -90.84 102.25 15.01 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.136 176.932 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -82.74 143.66 30.73 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 176.555 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 31.5 p -121.51 138.88 54.11 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.95 0.405 . . . . 0.0 111.195 -176.615 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 15.0 p90 -127.16 141.22 51.8 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 176.68 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.464 ' HA ' ' HA ' ' A' ' 74' ' ' LYS . 5.3 p -98.8 105.24 17.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-O 121.655 0.74 . . . . 0.0 110.28 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 14.7 tt -93.99 125.66 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 CA-C-N 115.679 -0.692 . . . . 0.0 109.599 179.544 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 . . . . . 0 C--N 1.314 -0.965 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.259 -176.616 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 66.3 mttm . . . . . 0 N--CA 1.452 -0.37 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 62.8 mt -101.69 114.24 40.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.539 0.685 . . . . 0.0 111.004 -177.083 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.56 ' O ' ' HB3' ' A' ' 90' ' ' TYR . 88.1 tttt -80.7 124.25 28.87 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.197 -179.414 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -120.15 163.81 17.15 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.639 -0.255 . . . . 0.0 110.367 178.001 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.485 ' CG2' ' HB3' ' A' ' 43' ' ' LEU . 10.9 p -122.92 148.35 26.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.904 -174.797 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.422 ' CE2' ' HD3' ' A' ' 85' ' ' ARG . 55.5 p90 -152.95 153.24 32.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.71 0.291 . . . . 0.0 111.144 178.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.464 ' HB3' HD23 ' A' ' 43' ' ' LEU . 47.8 p90 -122.41 156.94 32.95 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 172.204 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.512 ' HG2' ' HG2' ' A' ' 85' ' ' ARG . 29.3 mt-10 -103.86 149.91 24.64 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.626 -171.504 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 73.9 p -108.77 176.69 5.02 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.966 175.506 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.41 HD23 HD21 ' A' ' 2' ' ' ASN . 47.2 tp -66.84 -26.47 66.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.724 0.297 . . . . 0.0 111.069 179.551 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.513 ' OD2' ' HB3' ' A' ' 2' ' ' ASN . 1.4 m-20 -82.77 3.64 28.52 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.776 -176.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.447 ' HB2' ' O ' ' A' ' 82' ' ' ASP . 4.3 m-20 71.51 10.52 6.52 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 123.55 0.532 . . . . 0.0 110.917 -175.875 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.47 HG23 ' HB2' ' A' ' 82' ' ' ASP . 62.5 t -84.3 128.08 39.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 176.604 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.512 ' HG2' ' HG2' ' A' ' 79' ' ' GLU . 82.9 mtt180 -107.38 129.12 54.96 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.469 0.652 . . . . 0.0 111.673 -173.121 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.53 HG22 ' HB ' ' A' ' 24' ' ' ILE . 58.3 t -91.38 112.62 25.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.946 -179.306 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 41.4 t -105.51 140.79 22.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.129 -173.146 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 93.0 m -151.63 148.89 28.51 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.321 174.598 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -58.45 129.23 41.07 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.537 0.684 . . . . 0.0 111.982 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.56 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 93.9 t80 -76.49 -23.99 53.79 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.008 -0.997 . . . . 0.0 110.603 -177.272 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.2 m -65.14 -54.21 33.22 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.437 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -71.38 -28.05 63.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.413 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -63.43 -49.22 74.6 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.951 0.405 . . . . 0.0 109.937 175.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.475 ' O ' ' HG3' ' A' ' 98' ' ' LYS . 68.2 mm-40 -65.2 -33.86 76.99 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.656 176.02 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -57.84 -44.25 86.39 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.739 177.241 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 40.6 mt -68.64 -34.26 64.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.076 178.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 74.9 mt -62.04 -37.09 83.63 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.951 0.405 . . . . 0.0 110.189 176.498 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.475 ' HG3' ' O ' ' A' ' 94' ' ' GLN . 86.0 mttt -73.05 -39.47 65.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.031 176.323 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 55.7 tptt -64.85 -46.33 82.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.374 -178.514 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 84.5 mtt-85 -89.67 -8.49 52.32 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.451 -177.508 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.278 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.42 177.315 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ASN . . . . . 0.548 ' HA ' ' HB ' ' A' ' 80' ' ' THR . 95.0 m-20 . . . . . 0 N--CA 1.451 -0.387 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.453 ' HB3' HG21 ' A' ' 84' ' ' VAL . 35.3 p -62.36 -34.79 77.35 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.017 0.437 . . . . 0.0 110.824 -179.493 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -57.05 -54.37 47.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.852 -177.345 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.3 t -59.22 -41.37 83.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.849 0.357 . . . . 0.0 110.915 -178.64 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 50.7 mt -66.03 -39.99 86.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.463 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 51.3 mttm -58.77 -47.52 84.42 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.984 175.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -62.19 -41.09 98.03 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.759 179.268 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -62.11 -51.18 68.97 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.643 179.124 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 93.3 mt -62.44 -38.15 88.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.943 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -66.26 -40.74 90.34 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.452 178.287 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -70.67 -35.04 72.62 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.472 -176.607 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 39.2 pt -87.15 -8.38 11.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.798 0.332 . . . . 0.0 110.919 178.053 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 65.45 52.37 40.31 Favored Glycine 0 N--CA 1.452 -0.258 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.433 176.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -112.37 148.88 33.36 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.9 0.381 . . . . 0.0 110.724 -178.482 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -86.37 133.17 33.81 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.818 177.16 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 47.5 p90 -135.24 142.5 45.99 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.768 0.318 . . . . 0.0 110.455 179.59 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.56 ' HB ' ' HB2' ' A' ' 25' ' ' HIS . 66.5 mt -90.79 100.99 11.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.993 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -91.18 116.69 29.02 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.026 -178.695 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.538 ' HB2' ' HB2' ' A' ' 23' ' ' GLU . 89.9 mt -115.19 173.64 6.4 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 173.446 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -60.3 105.03 0.37 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.918 0.39 . . . . 0.0 111.118 -178.083 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 17.1 m120 68.0 16.75 9.56 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.633 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.538 ' HB2' ' HB2' ' A' ' 20' ' ' LEU . 91.1 mt-10 -133.95 113.97 12.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.959 0.409 . . . . 0.0 111.275 179.456 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 64.5 mt -97.39 103.4 14.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 172.071 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.56 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 35.6 m-70 -89.94 110.77 21.71 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 -179.076 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 63.9 mt -106.11 169.67 8.36 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.486 -175.318 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 51.5 mtpt -81.31 138.47 48.52 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.168 175.536 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.539 ' HA ' HG21 ' A' ' 88' ' ' THR . 3.4 Cg_exo -41.35 -51.91 3.86 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 124.117 3.211 . . . . 0.0 114.427 -173.506 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -70.31 -37.96 74.84 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.733 0.301 . . . . 0.0 111.076 -175.384 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 46.7 t -65.11 -42.13 93.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.222 0.534 . . . . 0.0 109.811 177.758 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -57.66 -41.29 81.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.816 178.19 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -59.29 -45.62 90.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.51 -178.558 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -64.29 -35.81 82.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.273 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 60.4 t -72.13 -38.22 62.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.198 0.523 . . . . 0.0 110.45 178.81 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.646 ' CZ2' ' HG3' ' A' ' 40' ' ' GLU . 30.0 t90 -57.12 -46.87 82.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.33 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 55.8 mttm -86.46 -2.2 58.25 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.895 0.379 . . . . 0.0 111.384 179.509 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -78.72 -35.47 44.81 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 176.781 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.526 HG23 ' HD3' ' A' ' 41' ' ' PRO . 3.2 m -85.9 3.85 3.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.603 177.228 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 97.21 17.72 31.03 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.696 -0.764 . . . . 0.0 113.444 174.35 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.646 ' HG3' ' CZ2' ' A' ' 35' ' ' TRP . 36.1 tt0 61.7 84.59 0.19 Allowed Pre-proline 0 N--CA 1.466 0.336 0 CA-C-O 121.06 0.457 . . . . 0.0 111.498 178.641 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.565 ' HD2' ' CD1' ' A' ' 35' ' ' TRP . 94.3 Cg_endo -90.64 162.92 4.25 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.745 2.297 . . . . 0.0 111.7 173.817 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -71.45 125.42 26.97 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 175.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.459 ' CD2' ' HB3' ' A' ' 78' ' ' PHE . 90.4 mt -90.53 150.09 21.91 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.348 0.594 . . . . 0.0 112.292 -170.821 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -97.2 164.67 12.39 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.236 172.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.662 HG21 ' HE3' ' A' ' 74' ' ' LYS . 19.0 p -119.59 144.8 46.9 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.136 0.493 . . . . 0.0 111.22 177.556 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.586 ' HB2' ' CD2' ' A' ' 77' ' ' TYR . 32.4 t80 -118.69 114.49 22.81 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.044 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 95.6 t -100.23 121.43 50.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.972 -177.299 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.468 ' CG1' ' HB ' ' A' ' 73' ' ' ILE . 42.0 pt -105.59 132.16 53.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.732 174.24 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 . . . . . 0 C--N 1.32 -0.685 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.865 -178.65 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 58.4 mttp . . . . . 0 N--CA 1.45 -0.437 0 CA-C-O 120.928 0.394 . . . . 0.0 110.625 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.468 ' HB ' ' CG1' ' A' ' 48' ' ' ILE . 65.3 mt -91.15 113.67 27.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.659 178.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.662 ' HE3' HG21 ' A' ' 45' ' ' THR . 48.1 tttp -94.93 101.94 13.74 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.779 -173.119 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -96.62 167.54 11.07 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.427 176.447 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 12.5 p -116.64 148.66 19.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 110.4 -0.222 . . . . 0.0 110.4 -177.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.586 ' CD2' ' HB2' ' A' ' 46' ' ' TYR . 39.7 p90 -155.09 154.01 31.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.873 0.368 . . . . 0.0 111.242 177.309 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.459 ' HB3' ' CD2' ' A' ' 43' ' ' LEU . 48.8 p90 -119.09 160.68 21.61 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 171.304 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -111.8 138.86 47.83 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.961 0.41 . . . . 0.0 111.23 -173.713 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.548 ' HB ' ' HA ' ' A' ' 2' ' ' ASN . 40.2 p -93.82 169.63 10.16 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.587 173.527 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.446 ' HB2' ' OD1' ' A' ' 2' ' ' ASN . 6.9 mp -74.5 -10.15 59.27 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.247 0.546 . . . . 0.0 110.026 178.14 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -92.35 10.98 27.54 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.619 -179.184 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 68.93 20.83 7.76 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.483 176.347 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.453 HG21 ' HB3' ' A' ' 3' ' ' SER . 48.3 t -101.82 126.08 55.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.241 177.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ARG . . . . . 0.457 ' O ' ' HA ' ' A' ' 23' ' ' GLU . 40.5 mtm180 -95.08 124.52 39.17 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.46 -179.238 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 59.4 t -95.16 107.61 19.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 176.485 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 28.6 t -105.09 138.67 28.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.605 -170.447 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.539 HG21 ' HA ' ' A' ' 28' ' ' PRO . 86.5 m -152.61 157.06 40.46 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.288 176.687 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -68.8 124.66 24.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.324 0.583 . . . . 0.0 112.248 -178.25 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -68.46 -32.63 72.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.302 -178.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 6.5 m -56.73 -41.46 77.55 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.964 0.411 . . . . 0.0 110.966 177.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.431 ' O ' HG13 ' A' ' 96' ' ' ILE . 43.6 mt-10 -83.6 -30.63 26.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.796 -179.141 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -62.68 -47.82 81.98 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.116 0.484 . . . . 0.0 109.875 175.372 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -58.15 -40.93 82.62 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.245 174.599 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.418 ' HB3' ' O ' ' A' ' 92' ' ' GLU . 64.4 tttp -56.95 -44.84 82.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.11 178.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.565 ' O ' ' HG2' ' A' ' 99' ' ' LYS . 75.7 mt -64.84 -47.06 89.97 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-O 121.024 0.44 . . . . 0.0 111.182 -179.444 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 87.4 mt -60.13 -51.17 70.73 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.859 -179.19 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -72.72 -28.31 62.57 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -174.589 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.565 ' HG2' ' O ' ' A' ' 96' ' ' ILE . 19.8 pttp -70.76 -29.93 66.29 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.33 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 22.6 mtm105 -78.53 -43.22 27.31 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 173.039 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.502 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.193 -178.766 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ASN . . . . . 0.43 ' OD1' ' HB2' ' A' ' 81' ' ' LEU . 47.5 m-80 . . . . . 0 CA--C 1.52 -0.194 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 52.2 p -65.85 -20.71 66.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.428 0.632 . . . . 0.0 109.611 177.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLU . . . . . 0.535 ' O ' ' HG3' ' A' ' 8' ' ' GLU . 20.9 tp10 -61.2 -36.6 80.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.424 177.049 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.3 t -63.95 -35.92 75.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-O 121.236 0.541 . . . . 0.0 110.182 179.124 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 61.6 mt -66.86 -40.35 85.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.025 177.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -58.24 -45.31 88.01 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.286 177.362 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLU . . . . . 0.535 ' HG3' ' O ' ' A' ' 4' ' ' GLU . 41.5 mt-10 -60.0 -44.54 94.48 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.754 179.302 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.447 ' O ' HG12 ' A' ' 13' ' ' ILE . 79.5 t80 -61.51 -47.72 84.34 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.312 -179.537 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 91.3 mt -63.5 -37.7 88.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.881 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -59.44 -50.94 72.0 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.558 177.881 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -68.09 -37.87 81.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.878 -175.394 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.447 HG12 ' O ' ' A' ' 9' ' ' PHE . 35.4 pt -81.68 -14.67 12.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.235 -179.421 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 81.16 45.75 7.37 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.785 177.39 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -119.45 166.07 13.55 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.8 0.334 . . . . 0.0 110.71 178.296 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -117.35 161.1 20.08 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.949 179.049 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 28.5 p90 -130.7 146.54 52.21 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.683 179.527 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.46 ' HB ' ' HB2' ' A' ' 25' ' ' HIS . 54.6 mt -91.43 97.03 6.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 178.058 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.439 ' HA ' ' O ' ' A' ' 23' ' ' GLU . 1.9 tm-20 -99.35 107.27 19.49 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -176.789 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 89.9 mt -116.01 86.66 2.52 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.862 -177.259 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.438 ' O ' ' HB2' ' A' ' 22' ' ' ASN . 34.4 tt0 59.29 60.25 2.41 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.058 176.228 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.438 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 5.5 m-20 75.07 14.01 3.18 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.293 177.454 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.439 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 35.1 mt-10 -111.16 113.74 26.48 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.8 170.62 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 62.0 mt -96.33 97.5 6.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 177.369 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.586 ' HA ' ' O ' ' A' ' 87' ' ' VAL . 14.1 m-70 -86.14 107.9 18.07 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.475 178.562 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 62.3 mt -95.13 164.45 12.86 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.254 -175.166 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -82.16 132.24 53.98 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.238 177.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -49.49 -40.3 45.18 Favored 'Trans proline' 0 N--CA 1.471 0.197 0 C-N-CA 123.1 2.533 . . . . 0.0 112.977 -177.057 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -60.54 -47.07 87.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.08 179.575 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 41.3 t -77.08 -40.2 29.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.768 -177.594 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.785 ' HE1' ' HE1' ' A' ' 78' ' ' PHE . 85.6 t80 -58.53 -37.17 75.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.883 -179.143 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.645 ' HA ' ' HE1' ' A' ' 93' ' ' PHE . 24.8 t80 -53.25 -39.4 63.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.291 177.34 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -84.0 -39.25 19.91 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.985 -178.76 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 62.6 t -62.53 -36.88 77.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-O 120.744 0.307 . . . . 0.0 110.841 179.443 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.428 ' CE2' ' HB2' ' A' ' 40' ' ' GLU . 22.1 t90 -53.13 -59.23 4.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.732 -179.336 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -74.0 -20.72 60.24 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.664 0.269 . . . . 0.0 111.403 -179.617 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -64.74 -28.8 69.83 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.806 178.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.411 HG23 ' HD3' ' A' ' 41' ' ' PRO . 29.0 m -103.34 11.22 8.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.36 -179.74 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.48 9.25 56.82 Favored Glycine 0 CA--C 1.517 0.186 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.877 177.395 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.428 ' HB2' ' CE2' ' A' ' 35' ' ' TRP . 15.5 pt-20 44.67 87.09 0.12 Allowed Pre-proline 0 N--CA 1.471 0.61 0 C-N-CA 124.527 1.131 . . . . 0.0 113.246 -179.394 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.411 ' HD3' HG23 ' A' ' 38' ' ' VAL . 74.5 Cg_endo -76.08 165.76 29.1 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.456 2.104 . . . . 0.0 111.486 175.585 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -63.15 137.11 58.12 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.033 0.444 . . . . 0.0 110.325 177.263 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.443 ' HB3' ' CG2' ' A' ' 76' ' ' VAL . 95.6 mt -87.29 144.29 26.87 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.491 -174.681 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -118.83 118.18 30.88 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 177.022 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 24.9 p -107.54 137.55 45.36 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 120.92 0.39 . . . . 0.0 111.843 -173.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 19.0 p90 -120.87 140.66 51.48 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 176.661 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.508 HG11 ' HE3' ' A' ' 72' ' ' LYS . 55.4 t -103.73 117.45 49.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.273 178.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 1.011 HG23 HG13 ' A' ' 73' ' ' ILE . 2.9 tt -98.88 122.37 50.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-O 121.522 0.677 . . . . 0.0 110.167 177.889 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.461 ' OE1' ' HG3' ' A' ' 72' ' ' LYS . 4.4 mm-40 . . . . . 0 C--N 1.325 -0.472 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.952 -176.757 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.508 ' HE3' HG11 ' A' ' 47' ' ' VAL . 39.0 tttp . . . . . 0 N--CA 1.452 -0.36 0 CA-C-O 120.749 0.309 . . . . 0.0 110.178 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 1.011 HG13 HG23 ' A' ' 48' ' ' ILE . 4.6 pt -109.04 125.26 66.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.616 0.722 . . . . 0.0 111.143 -177.779 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -106.78 131.58 53.73 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.966 -177.39 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -130.16 166.2 20.73 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.163 178.774 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.443 ' CG2' ' HB3' ' A' ' 43' ' ' LEU . 9.0 p -122.92 145.15 30.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.72 0.295 . . . . 0.0 111.112 -174.421 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 44.9 p90 -146.27 164.72 31.42 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.536 178.757 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.785 ' HE1' ' HE1' ' A' ' 31' ' ' PHE . 52.3 p90 -141.64 148.29 38.94 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 169.436 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -102.14 128.56 48.58 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.429 -176.016 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 72.7 p -88.08 -179.3 6.16 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.88 176.452 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.43 ' HB2' ' OD1' ' A' ' 2' ' ' ASN . 7.1 mp -70.12 -18.31 63.23 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.08 0.466 . . . . 0.0 110.207 178.395 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -71.18 -13.29 61.88 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.717 179.261 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 66.4 t30 77.68 10.12 2.3 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 124.079 0.862 . . . . 0.0 109.33 -171.858 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 77.8 t -81.74 129.12 38.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.278 178.418 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 56.1 mtm180 -92.94 105.46 17.57 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.343 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.3 t -84.28 106.74 14.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 177.205 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.586 ' O ' ' HA ' ' A' ' 25' ' ' HIS . 30.5 t -108.51 141.08 24.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.954 -173.432 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 34.3 m -144.44 150.57 37.88 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 176.299 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -62.92 126.11 26.24 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.182 0.515 . . . . 0.0 111.358 179.28 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -70.22 -38.06 75.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.14 -176.24 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 24.9 m -60.25 -57.75 11.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.354 -177.037 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.494 ' O ' ' HB3' ' A' ' 95' ' ' LYS . 36.3 mm-40 -68.22 -29.86 68.79 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.731 -177.502 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.645 ' HE1' ' HA ' ' A' ' 32' ' ' TYR . 53.0 t80 -67.87 -49.27 62.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.955 0.407 . . . . 0.0 110.404 177.41 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.52 ' O ' ' HG3' ' A' ' 98' ' ' LYS . 79.2 mm-40 -66.85 -24.46 66.14 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.568 178.193 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.494 ' HB3' ' O ' ' A' ' 92' ' ' GLU . 44.6 tttp -59.69 -49.57 77.24 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.366 174.827 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.453 ' O ' ' HB3' ' A' ' 99' ' ' LYS . 58.4 mt -67.93 -33.17 59.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.815 -179.29 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 69.8 mt -64.75 -39.82 94.26 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.563 177.344 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.52 ' HG3' ' O ' ' A' ' 94' ' ' GLN . 57.1 mttp -70.42 -33.81 71.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.033 0.444 . . . . 0.0 109.924 175.306 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.453 ' HB3' ' O ' ' A' ' 96' ' ' ILE . 61.9 tttp -56.65 -57.9 10.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.283 -0.872 . . . . 0.0 110.925 179.377 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -74.9 -23.78 58.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.587 0.232 . . . . 0.0 111.274 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.506 0 N-CA-C 111.339 -0.704 . . . . 0.0 111.339 -175.859 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 . . . . . 0 N--CA 1.452 -0.365 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.8 m -62.55 -23.26 66.89 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.009 0.433 . . . . 0.0 111.242 -177.566 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -61.59 -37.56 84.36 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.972 179.424 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 62.1 t -68.62 -34.32 64.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.023 0.439 . . . . 0.0 110.348 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.409 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 50.8 mt -62.39 -43.12 97.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.71 176.468 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 57.1 mttm -60.33 -38.33 83.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.049 177.726 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -57.6 -48.71 78.65 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.862 0.363 . . . . 0.0 110.777 178.61 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -66.17 -44.22 84.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.895 -179.415 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 6' ' ' ILE . 97.0 mt -66.66 -43.95 83.16 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.408 -177.287 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -69.3 -32.44 71.59 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.737 0.303 . . . . 0.0 110.37 -179.312 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -61.82 -48.68 79.51 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.12 178.308 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 38.3 pt -80.93 -12.55 12.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.165 -178.766 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 81.47 38.31 14.94 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.348 179.231 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -91.76 118.56 30.79 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.95 0.405 . . . . 0.0 110.197 178.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -97.8 102.78 14.63 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.964 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.467 ' CD2' HG23 ' A' ' 24' ' ' ILE . 29.0 p90 -97.97 170.59 8.84 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.469 -174.788 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.525 ' HB ' ' HB2' ' A' ' 25' ' ' HIS . 64.1 mt -94.25 100.33 10.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.99 177.333 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -90.54 135.53 33.64 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.245 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.673 ' HG ' ' H ' ' A' ' 21' ' ' GLU . 21.8 tp -133.28 177.22 7.85 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 175.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.673 ' H ' ' HG ' ' A' ' 20' ' ' LEU . 43.2 mt-10 -61.76 102.46 0.26 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.633 0.254 . . . . 0.0 110.902 -178.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.408 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 11.8 m120 71.68 16.25 5.78 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.999 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.56 ' HB2' ' HB3' ' A' ' 20' ' ' LEU . 41.4 mt-10 -131.63 134.96 46.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.056 0.455 . . . . 0.0 111.421 178.173 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.467 HG23 ' CD2' ' A' ' 17' ' ' TYR . 74.1 mt -118.69 107.53 21.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 171.54 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.525 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 73.0 m-70 -94.29 109.85 21.65 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.049 0.452 . . . . 0.0 110.491 -178.157 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.463 HD23 ' HB3' ' A' ' 17' ' ' TYR . 40.5 mt -109.25 150.54 27.8 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.936 -178.426 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 49.5 mtmt -64.38 135.61 96.42 Favored Pre-proline 0 C--N 1.326 -0.427 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 171.633 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.5 ' HB2' HD12 ' A' ' 96' ' ' ILE . 51.8 Cg_exo -54.27 -28.93 54.9 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.684 2.256 . . . . 0.0 112.075 -177.602 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -61.62 -56.38 20.51 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.49 177.656 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 49.2 t -68.14 -38.69 80.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.242 179.419 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -51.54 -46.86 63.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.238 -179.246 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 93.0 t80 -60.19 -43.38 95.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.137 -179.296 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.556 ' O ' ' HB2' ' A' ' 37' ' ' TYR . 43.6 mt-10 -76.96 -8.74 57.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.774 -175.448 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 62.5 t -93.07 -42.62 13.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.251 0.548 . . . . 0.0 109.522 171.058 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.553 ' CD1' ' HD2' ' A' ' 41' ' ' PRO . 44.2 t90 -55.82 -52.0 65.52 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.046 177.666 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 53.7 tttm -78.82 -14.35 59.3 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.015 0.436 . . . . 0.0 110.738 -177.34 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.556 ' HB2' ' O ' ' A' ' 33' ' ' GLU . 87.0 t80 -71.28 -44.77 64.59 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.814 -179.693 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 33.3 m -94.31 -3.66 10.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.338 -177.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 136.68 -85.28 0.24 Allowed Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.077 177.749 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 170.98 61.06 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.371 0 C-N-CA 122.969 0.508 . . . . 0.0 110.73 -175.1 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.553 ' HD2' ' CD1' ' A' ' 35' ' ' TRP . 71.1 Cg_exo -50.69 128.69 24.74 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.127 1.884 . . . . 0.0 111.584 177.126 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -61.16 116.07 4.28 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.318 0.58 . . . . 0.0 110.298 -177.263 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.576 ' HB3' ' CG2' ' A' ' 76' ' ' VAL . 93.3 mt -82.6 126.12 31.94 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.184 -0.917 . . . . 0.0 111.983 -170.81 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -92.06 139.21 30.86 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 175.732 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 69.5 p -118.68 145.85 45.17 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 121.148 -0.221 . . . . 0.0 110.599 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 25.7 p90 -133.46 143.49 48.87 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 176.153 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 48.4 t -94.98 110.72 24.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.24 -178.331 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 8.9 tt -118.9 111.17 32.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 121.425 0.631 . . . . 0.0 110.18 178.1 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.453 ' HG2' ' HG2' ' A' ' 72' ' ' LYS . 47.7 mt-10 . . . . . 0 C--N 1.321 -0.64 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 176.161 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.453 ' HG2' ' HG2' ' A' ' 49' ' ' GLU . 49.7 mttp . . . . . 0 C--O 1.234 0.253 0 CA-C-O 120.829 0.347 . . . . 0.0 110.537 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 49.3 mm -100.27 118.84 47.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.227 0.537 . . . . 0.0 110.572 -179.474 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.626 ' O ' ' HB3' ' A' ' 90' ' ' TYR . 49.5 tttp -92.8 118.55 31.22 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 176.896 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -118.44 159.61 23.18 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 179.051 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.576 ' CG2' ' HB3' ' A' ' 43' ' ' LEU . 14.2 p -131.03 147.94 33.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.978 -171.266 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 46.2 p90 -154.94 156.49 36.15 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.641 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -115.97 140.15 49.54 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 169.167 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -109.01 127.22 53.9 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.498 -170.019 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 44.5 p -88.89 -179.67 6.01 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.849 -175.157 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.9 mp -70.73 -22.84 62.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.229 178.246 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.445 ' HB2' HG23 ' A' ' 84' ' ' VAL . 2.9 m-20 -75.07 -10.02 59.08 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.344 179.43 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.438 ' HB2' ' O ' ' A' ' 82' ' ' ASP . 9.0 m120 68.72 28.76 5.49 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.156 -171.602 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.445 HG23 ' HB2' ' A' ' 82' ' ' ASP . 68.9 t -98.66 126.18 51.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.265 -0.88 . . . . 0.0 108.847 173.158 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 65.8 mtt180 -100.95 114.79 29.01 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.05 0.452 . . . . 0.0 111.176 -173.218 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 46.9 t -83.88 99.85 6.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 175.445 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 22.1 t -102.72 140.02 22.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.274 -171.499 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.9 t -143.65 -178.57 5.96 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 174.688 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -93.25 123.3 36.43 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.601 -177.592 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.626 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 61.8 t80 -69.26 -34.55 74.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.176 -176.75 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 12.7 t -65.83 -49.5 67.99 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 -178.237 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.479 ' HA ' ' HD3' ' A' ' 95' ' ' LYS . 28.9 mm-40 -66.12 -39.2 89.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.944 177.594 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.45 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 58.1 t80 -60.93 -45.98 92.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.756 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.526 ' O ' ' HG2' ' A' ' 98' ' ' LYS . 48.5 mm-40 -58.92 -39.45 81.58 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.145 177.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.479 ' HD3' ' HA ' ' A' ' 92' ' ' GLU . 50.1 mtpt -62.78 -43.68 98.15 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.87 177.474 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.5 HD12 ' HB2' ' A' ' 28' ' ' PRO . 67.4 mt -68.6 -33.29 59.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.879 179.699 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 93' ' ' PHE . 86.5 mt -58.17 -37.18 74.21 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.979 0.418 . . . . 0.0 110.323 174.705 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.526 ' HG2' ' O ' ' A' ' 94' ' ' GLN . 38.6 mmtm -74.35 -34.78 63.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.253 178.065 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.466 ' HD2' ' HA ' ' A' ' 96' ' ' ILE . 68.7 mttm -63.45 -46.76 84.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.785 176.712 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.597 ' HE ' ' HA ' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -73.87 -20.84 60.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.294 179.517 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.351 0 CA-C-N 115.945 -0.571 . . . . 0.0 112.266 178.727 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 11.7 m120 . . . . . 0 N--CA 1.454 -0.253 0 CA-C-O 120.794 0.33 . . . . 0.0 110.553 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.483 ' O ' ' HG3' ' A' ' 7' ' ' LYS . 34.2 t -61.48 -29.79 70.2 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.569 174.9 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -52.76 -43.13 65.57 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.759 176.274 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.7 t -62.9 -38.91 83.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.67 -178.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.522 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 60.5 mt -66.42 -44.86 90.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.315 179.335 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.483 ' HG3' ' O ' ' A' ' 3' ' ' SER . 85.6 mttt -63.63 -36.45 83.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.467 -179.187 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -55.86 -49.58 72.97 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.738 175.565 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -60.13 -43.14 95.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.066 179.218 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.531 HD13 ' HB3' ' A' ' 17' ' ' TYR . 74.4 mt -63.25 -48.27 78.92 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.325 -177.704 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -74.59 -19.62 60.25 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.96 -179.114 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -72.32 -45.34 60.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.837 177.076 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 38.1 pt -73.56 -17.78 17.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.979 0.419 . . . . 0.0 110.31 177.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.11 30.44 14.35 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.677 173.349 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -115.25 168.08 10.28 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 177.796 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -113.18 155.06 25.68 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.956 0.408 . . . . 0.0 110.96 -175.001 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.531 ' HB3' HD13 ' A' ' 10' ' ' LEU . 14.8 p90 -125.7 147.56 49.32 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.117 -173.219 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 52.5 mt -89.09 93.96 4.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 177.435 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -98.63 116.25 30.44 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.24 -176.323 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 77.4 mt -111.43 -176.53 2.97 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 171.727 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.491 ' HA ' ' OE1' ' A' ' 21' ' ' GLU . 6.3 tp10 -72.23 109.57 6.08 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 120.427 -0.509 . . . . 0.0 109.936 179.347 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 66.49 15.12 10.01 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.733 179.373 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -138.41 113.92 9.65 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.843 0.354 . . . . 0.0 111.277 179.311 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.453 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 63.9 mt -110.09 112.1 39.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 172.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 53.5 m-70 -98.44 117.21 32.35 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.486 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 80.4 mt -114.92 173.37 6.52 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.192 -175.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 75.6 mttt -84.5 149.65 55.16 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.492 178.089 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_exo -51.52 -41.68 59.28 Favored 'Trans proline' 0 C--O 1.233 0.241 0 C-N-CA 122.907 2.405 . . . . 0.0 112.855 -179.57 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -65.6 -44.71 85.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.76 0.314 . . . . 0.0 110.541 -179.547 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 61.4 t -64.91 -45.09 95.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.131 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -58.1 -40.12 80.35 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.033 -179.021 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -57.49 -42.54 82.9 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.338 179.152 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -76.43 -40.81 49.61 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.921 -177.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 79.0 t -65.56 -32.37 57.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.536 178.781 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.532 ' CD1' ' HD2' ' A' ' 41' ' ' PRO . 25.8 t90 -52.97 -52.27 58.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.027 178.574 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -76.07 -26.82 56.87 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.756 0.312 . . . . 0.0 110.762 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -65.82 -34.7 78.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.053 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.428 HG23 ' HD3' ' A' ' 41' ' ' PRO . 35.9 m -89.73 9.94 2.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.788 0.327 . . . . 0.0 111.579 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 100.7 14.7 31.26 Favored Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 120.604 -0.807 . . . . 0.0 113.604 174.102 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 48.75 73.09 1.06 Allowed Pre-proline 0 N--CA 1.466 0.357 0 CA-C-O 121.279 0.562 . . . . 0.0 111.409 177.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.532 ' HD2' ' CD1' ' A' ' 35' ' ' TRP . 95.4 Cg_endo -90.4 163.8 4.47 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 122.679 2.253 . . . . 0.0 112.48 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -71.32 107.12 4.13 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 172.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 70.5 mt -73.43 146.42 45.04 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.812 -172.238 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -87.95 138.45 31.44 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.776 176.379 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 19.3 p -127.94 132.3 49.25 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 120.825 0.345 . . . . 0.0 110.218 176.492 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.406 ' CE2' ' HB ' ' A' ' 48' ' ' ILE . 14.7 p90 -119.21 144.64 46.61 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.758 -178.557 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 43.7 t -93.72 105.14 16.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.279 -0.419 . . . . 0.0 109.951 179.503 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.406 ' HB ' ' CE2' ' A' ' 46' ' ' TYR . 12.1 tt -105.77 130.6 56.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.061 179.06 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.414 ' HG2' ' HG2' ' A' ' 72' ' ' LYS . 45.4 mt-10 . . . . . 0 C--N 1.32 -0.711 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 177.674 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.414 ' HG2' ' HG2' ' A' ' 49' ' ' GLU . 68.3 mttm . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.801 0.334 . . . . 0.0 110.556 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 56.8 mt -110.08 117.06 53.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.426 179.383 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.422 ' O ' ' HB3' ' A' ' 90' ' ' TYR . 52.9 tttm -87.44 91.77 8.85 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.554 179.06 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -92.04 160.96 14.98 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.08 -176.151 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 13.5 p -114.9 144.19 23.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.209 -173.255 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.413 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 37.6 p90 -154.99 162.7 41.01 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.729 176.499 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -137.1 150.18 47.84 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 170.488 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 54.9 tt0 -120.49 135.67 55.0 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.479 -173.756 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 73.0 p -94.8 -176.97 4.03 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.338 177.231 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.8 mp -65.05 -13.73 58.69 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.279 0.561 . . . . 0.0 110.727 179.004 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.426 ' O ' ' HB2' ' A' ' 83' ' ' ASN . 4.8 m-20 -79.22 -8.82 59.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.59 -179.548 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ASN . . . . . 0.426 ' HB2' ' O ' ' A' ' 82' ' ' ASP . 14.3 m120 69.58 16.73 8.04 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.4 0.619 . . . . 0.0 110.252 -174.357 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 66.1 t -89.57 122.03 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.383 176.064 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -100.33 116.51 32.47 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.719 -176.83 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.453 ' HA ' ' O ' ' A' ' 24' ' ' ILE . 59.1 t -86.31 104.72 14.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.552 176.482 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 22.0 t -101.65 142.65 15.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.607 -174.735 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 58.2 m -151.15 157.09 42.26 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 177.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -71.09 121.02 17.51 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.093 0.473 . . . . 0.0 110.409 -178.432 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.422 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 12.2 t80 -75.72 -27.5 58.19 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.981 -174.572 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 33.0 t -70.02 -43.66 70.87 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.397 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -64.25 -42.32 96.57 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.357 175.071 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -62.79 -46.6 87.23 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.856 -179.652 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -65.7 -29.61 70.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.011 178.356 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -63.83 -33.47 75.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.076 0.465 . . . . 0.0 110.302 176.514 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.493 ' HA ' ' HD2' ' A' ' 99' ' ' LYS . 68.0 mt -75.02 -39.89 44.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.381 176.405 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 84.2 mt -65.07 -30.52 71.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.172 0.51 . . . . 0.0 110.138 176.406 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 44.9 tttm -67.41 -37.29 82.85 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.421 175.509 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.493 ' HD2' ' HA ' ' A' ' 96' ' ' ILE . 60.3 mttm -64.44 -47.54 78.68 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.356 175.449 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 52.8 ttt-85 -68.64 -38.39 80.46 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.963 -177.764 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.686 0 N-CA-C 111.251 -0.74 . . . . 0.0 111.251 -176.456 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 . . . . . 0 C--O 1.233 0.191 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 36.9 t -68.68 -27.7 66.2 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 175.648 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -58.05 -36.94 73.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.165 173.451 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 98.3 t -68.54 -42.85 83.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.458 178.753 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 62.9 mt -60.81 -45.31 98.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.981 177.012 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 45.9 mttp -56.51 -52.61 64.09 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.575 175.616 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -58.12 -45.16 87.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.105 -178.302 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -63.67 -45.66 89.1 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.34 -178.713 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 83.9 mt -71.04 -34.6 71.43 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.636 -0.256 . . . . 0.0 111.282 -177.302 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 43.1 mm-40 -69.74 -33.55 72.61 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.046 0.451 . . . . 0.0 110.418 175.326 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -63.37 -52.33 62.16 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.556 178.753 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 39.5 pt -77.97 -17.46 13.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.55 -177.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 76.99 60.43 2.91 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.074 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -112.5 158.87 19.38 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 -178.56 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -71.15 117.61 12.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.08 0.467 . . . . 0.0 110.82 179.084 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -116.09 121.07 41.08 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.269 -176.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 61.1 mt -120.82 107.24 20.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.758 0.313 . . . . 0.0 110.776 -179.226 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -125.8 125.04 42.28 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.04 0.448 . . . . 0.0 110.064 175.213 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 97.3 mt -95.16 46.49 1.12 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.875 178.754 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 66.62 94.79 0.06 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.569 -177.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 73.18 -8.25 1.35 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.844 179.21 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 32.2 tp10 -112.76 113.78 26.04 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 175.351 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.583 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 55.0 mt -107.19 133.48 51.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 110.335 -0.246 . . . . 0.0 110.335 -177.144 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -125.27 105.45 9.13 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 173.194 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 37.1 mt -95.26 -179.81 4.92 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.774 0.797 . . . . 0.0 113.026 -168.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -87.53 132.83 39.63 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 114.389 -1.278 . . . . 0.0 109.942 -179.057 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 99.8 Cg_exo -42.56 -70.42 0.07 OUTLIER 'Trans proline' 0 CA--C 1.532 0.421 0 C-N-CA 123.948 3.099 . . . . 0.0 114.811 -172.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.41 ' HA ' HD13 ' A' ' 96' ' ' ILE . 41.4 mt-10 -75.64 -3.15 32.86 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -172.856 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 98.5 t -90.02 -44.64 15.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 175.576 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -58.98 -34.66 72.07 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.609 177.834 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 67.5 t80 -54.14 -40.97 67.9 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.397 178.621 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -83.36 -29.02 28.55 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.116 -178.222 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 66.9 t -66.42 -36.79 78.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.375 0.607 . . . . 0.0 109.486 174.325 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 33.5 t90 -56.46 -52.97 62.69 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.557 175.139 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.791 ' HA ' ' HB3' ' A' ' 40' ' ' GLU . 53.5 mttm -66.84 -30.39 70.56 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.631 -0.258 . . . . 0.0 111.201 178.113 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -59.58 -40.71 88.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.367 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 19.4 m -88.32 7.67 3.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.924 -175.468 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.417 ' O ' ' HG2' ' A' ' 40' ' ' GLU . . . 109.33 0.31 31.18 Favored Glycine 0 N--CA 1.453 -0.197 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.977 176.702 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.791 ' HB3' ' HA ' ' A' ' 36' ' ' LYS . 10.8 pt-20 44.8 69.46 2.5 Favored Pre-proline 0 N--CA 1.473 0.69 0 C-N-CA 124.267 1.027 . . . . 0.0 113.009 -179.342 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -94.04 -179.19 0.74 Allowed 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 123.096 2.53 . . . . 0.0 112.095 176.568 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -71.29 114.76 9.69 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.046 0.451 . . . . 0.0 110.691 176.032 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 68.5 mt -77.82 164.29 25.33 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.62 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 52.4 tttp -106.67 122.83 47.13 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.07 -176.636 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' THR . . . . . 0.413 ' OG1' ' HE2' ' A' ' 74' ' ' LYS . 39.9 p -102.66 148.67 25.28 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.673 -0.24 . . . . 0.0 111.489 -177.477 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -130.63 145.29 51.87 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 176.375 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 60.1 t -104.85 113.64 42.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 120.832 0.348 . . . . 0.0 110.572 -179.114 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 10.8 tt -111.05 112.75 41.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.371 0.605 . . . . 0.0 110.398 177.31 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.877 ' HG2' ' HG2' ' A' ' 72' ' ' LYS . 50.4 mt-10 . . . . . 0 C--N 1.322 -0.599 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.258 179.097 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.877 ' HG2' ' HG2' ' A' ' 49' ' ' GLU . 79.4 mttt . . . . . 0 N--CA 1.453 -0.289 0 CA-C-O 120.987 0.423 . . . . 0.0 110.352 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 57.0 mt -92.71 115.09 30.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.054 -179.54 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.594 ' O ' ' HB3' ' A' ' 90' ' ' TYR . 82.2 tttt -98.9 114.71 27.44 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.247 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -111.83 166.99 10.72 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 13.9 p -125.83 143.48 39.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 120.733 0.301 . . . . 0.0 111.074 -172.789 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 28.9 p90 -155.0 173.8 16.06 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.934 0.397 . . . . 0.0 110.941 178.543 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -145.1 151.44 38.51 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 170.692 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -102.07 128.97 48.3 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.843 0.354 . . . . 0.0 110.23 -176.799 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.4 p -84.09 173.59 10.98 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.201 179.359 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.412 HD12 ' N ' ' A' ' 81' ' ' LEU . 7.0 mp -68.33 -17.74 64.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.068 0.461 . . . . 0.0 111.36 -176.213 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -95.62 14.95 21.29 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.213 -179.171 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 70.44 23.68 4.82 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.143 173.576 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 59.3 t -100.14 141.93 16.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 120.962 0.41 . . . . 0.0 110.562 178.227 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 8.2 mtp180 -98.0 117.08 31.54 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.229 -178.402 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.583 ' HA ' ' HB ' ' A' ' 24' ' ' ILE . 20.5 t -96.89 97.1 5.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 176.627 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 31.8 t -103.7 144.4 14.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.079 0.466 . . . . 0.0 111.656 -172.821 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 51.1 m -151.98 159.6 43.71 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 175.715 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -73.04 131.86 42.65 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 121.734 -0.604 . . . . 0.0 110.986 -176.709 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.594 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 88.9 t80 -73.93 -30.34 62.5 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.389 -176.725 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.25 -44.77 71.26 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.528 ' O ' ' HB3' ' A' ' 95' ' ' LYS . 5.3 tp10 -70.43 -34.66 72.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.233 179.301 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.414 ' O ' HD23 ' A' ' 97' ' ' LEU . 83.4 t80 -62.34 -51.5 67.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.325 176.588 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 72.5 mm-40 -64.31 -29.73 70.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.825 179.138 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.528 ' HB3' ' O ' ' A' ' 92' ' ' GLU . 23.4 tptm -55.72 -46.99 77.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.321 174.621 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.41 HD13 ' HA ' ' A' ' 29' ' ' GLU . 57.7 mt -68.84 -39.5 80.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.112 -179.052 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.414 HD23 ' O ' ' A' ' 93' ' ' PHE . 4.3 mm? -58.59 -45.25 89.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.788 178.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -74.27 -30.38 62.09 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.507 178.516 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -59.33 -45.35 91.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.908 -176.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 100' ' ' ARG . 21.3 ttp85 -104.35 -8.13 19.45 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.107 -179.127 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.261 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.111 179.046 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 . . . . . 0 C--O 1.235 0.327 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.579 ' O ' ' HG3' ' A' ' 7' ' ' LYS . 30.1 p -56.89 -31.69 65.12 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.764 0.316 . . . . 0.0 110.693 177.81 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -56.7 -52.62 64.24 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.975 175.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.1 t -60.42 -43.25 93.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.683 -179.561 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.45 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 67.1 mt -53.12 -45.33 53.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.88 174.68 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.579 ' HG3' ' O ' ' A' ' 3' ' ' SER . 91.6 mttt -62.48 -41.6 98.9 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.97 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -58.7 -42.69 89.21 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.993 0.425 . . . . 0.0 110.62 177.018 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -65.28 -43.83 89.97 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.412 179.685 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.509 HD13 ' HB3' ' A' ' 17' ' ' TYR . 85.4 mt -65.26 -39.3 92.46 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.996 179.673 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -67.26 -40.53 86.25 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.428 178.839 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -60.04 -43.38 95.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.795 177.435 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 62.5 mt -70.29 -41.35 78.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.544 177.129 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.74 35.76 5.02 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.99 -0.624 . . . . 0.0 111.784 -178.51 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -104.53 177.27 4.89 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.071 0.463 . . . . 0.0 111.245 -178.544 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -109.65 149.97 28.93 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.966 -178.421 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.509 ' HB3' HD13 ' A' ' 10' ' ' LEU . 34.1 p90 -144.84 144.52 31.17 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 176.836 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 67.3 mt -113.01 102.86 14.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 120.895 0.378 . . . . 0.0 110.103 178.395 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -92.2 133.22 36.0 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.275 0.559 . . . . 0.0 110.861 -178.865 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 88.9 mt -121.44 -162.24 0.96 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.788 177.85 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -71.62 102.06 2.66 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.892 -0.323 . . . . 0.0 110.399 177.746 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 67.3 20.48 10.04 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.33 177.752 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -136.77 138.86 41.35 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.287 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.44 HD11 ' HB2' ' A' ' 3' ' ' SER . 60.2 mt -122.86 113.01 36.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 170.744 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.51 ' HA ' ' O ' ' A' ' 87' ' ' VAL . 16.3 m-70 -95.87 123.72 39.57 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.251 -179.355 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 92.5 mt -114.98 177.55 4.61 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.345 -175.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.436 ' HB2' HG23 ' A' ' 30' ' ' VAL . 86.8 mttt -86.95 137.9 33.13 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 115.364 -0.835 . . . . 0.0 108.934 174.242 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.453 ' HA ' HG21 ' A' ' 88' ' ' THR . 57.6 Cg_exo -52.4 -38.05 73.12 Favored 'Trans proline' 0 CA--C 1.529 0.26 0 C-N-CA 122.92 2.414 . . . . 0.0 113.113 -177.218 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -73.6 -29.67 62.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.04 -177.196 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.436 HG23 ' HB2' ' A' ' 27' ' ' LYS . 27.0 t -84.54 -38.37 13.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.233 0.54 . . . . 0.0 110.134 179.557 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -57.63 -30.43 65.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.826 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -54.35 -45.95 72.85 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.271 178.304 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -82.05 -29.4 31.93 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.274 -177.82 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 79.5 t -67.8 -41.31 85.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.21 0.529 . . . . 0.0 109.977 176.404 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.483 ' CD1' ' HD2' ' A' ' 41' ' ' PRO . 29.2 t90 -57.14 -45.29 83.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.342 176.121 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 56.8 mttm -76.23 -21.53 56.27 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.461 179.079 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -65.97 -35.64 81.15 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.998 0.428 . . . . 0.0 110.381 178.021 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.535 HG23 ' HD3' ' A' ' 41' ' ' PRO . 26.9 m -93.68 12.39 3.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.316 179.559 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 87.01 29.33 23.34 Favored Glycine 0 C--N 1.33 0.237 0 C-N-CA 121.055 -0.593 . . . . 0.0 113.481 174.183 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 36.42 75.21 0.53 Allowed Pre-proline 0 N--CA 1.473 0.701 0 C-N-CA 124.07 0.948 . . . . 0.0 113.218 179.082 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.535 ' HD3' HG23 ' A' ' 38' ' ' VAL . 82.1 Cg_endo -89.01 -159.32 0.09 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 123.307 2.671 . . . . 0.0 112.617 -178.873 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -70.18 123.74 22.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.684 -178.685 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 74.7 mt -89.07 117.54 28.15 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.239 175.825 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -95.66 119.47 34.23 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.227 -178.646 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.6 p -107.2 134.73 49.87 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.614 179.346 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' TYR . . . . . 0.518 ' CE1' ' HB2' ' A' ' 75' ' ' LYS . 15.1 p90 -128.29 140.45 51.87 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.329 -0.396 . . . . 0.0 109.975 178.492 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 61.7 t -99.18 110.55 26.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.584 -179.317 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.446 HG23 ' HB ' ' A' ' 73' ' ' ILE . 7.4 tt -106.86 106.68 21.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.645 175.718 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.436 ' HA ' ' HA ' ' A' ' 72' ' ' LYS . 39.6 tt0 . . . . . 0 C--N 1.322 -0.593 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.121 -179.014 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.436 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 61.6 mttp . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.768 0.318 . . . . 0.0 110.31 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.446 ' HB ' HG23 ' A' ' 48' ' ' ILE . 40.3 mt -91.19 108.59 20.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.254 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 54.1 tttp -91.57 106.18 18.3 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.56 178.631 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LYS . . . . . 0.518 ' HB2' ' CE1' ' A' ' 46' ' ' TYR . 89.9 mttt -105.49 162.23 13.65 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.158 -178.725 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 10.7 p -124.19 142.42 41.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.605 0.24 . . . . 0.0 110.574 -178.316 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.445 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 43.5 p90 -153.6 167.8 28.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.095 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 44.1 p90 -136.49 151.11 49.1 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 168.073 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -102.48 131.6 49.07 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.01 0.433 . . . . 0.0 111.466 -174.494 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 75.0 p -83.97 -172.66 4.28 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.003 179.283 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 8.5 mp -73.81 -33.61 64.25 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.949 0.404 . . . . 0.0 110.424 178.171 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -92.16 24.57 3.26 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.369 -177.669 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 20.8 m120 69.81 20.76 6.67 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 169.747 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 86.1 t -94.41 124.42 46.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.595 179.181 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 51.9 mtt-85 -89.52 110.93 21.72 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.707 179.102 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 45.9 t -81.35 99.5 4.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 175.516 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.51 ' O ' ' HA ' ' A' ' 25' ' ' HIS . 22.2 t -102.57 138.88 25.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.879 -172.297 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' THR . . . . . 0.453 HG21 ' HA ' ' A' ' 28' ' ' PRO . 42.8 m -144.76 157.59 44.12 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 177.022 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ASP . . . . . 0.47 ' OD2' ' HG2' ' A' ' 92' ' ' GLU . 9.5 t70 -66.88 122.46 17.76 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.155 0.503 . . . . 0.0 111.57 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -69.28 -30.23 68.28 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.845 -177.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 35.1 t -62.84 -66.38 0.55 Allowed 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.077 -176.856 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLU . . . . . 0.47 ' HG2' ' OD2' ' A' ' 89' ' ' ASP . 12.3 mm-40 -68.66 -28.96 67.34 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 121.042 -0.263 . . . . 0.0 111.323 -175.48 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' PHE . . . . . 0.432 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 53.0 t80 -62.09 -47.4 84.82 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 121.079 -0.248 . . . . 0.0 110.872 178.483 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -64.14 -35.52 81.06 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.779 0.323 . . . . 0.0 110.838 179.563 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -61.39 -43.72 98.38 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.515 177.397 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.407 HG13 ' O ' ' A' ' 92' ' ' GLU . 78.9 mt -66.79 -36.77 78.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.033 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 93' ' ' PHE . 97.8 mt -59.42 -49.95 75.85 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.943 0.401 . . . . 0.0 110.117 175.794 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 7.6 mtpm? -63.89 -42.61 97.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.602 177.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 7.6 tmtm? -59.76 -54.17 49.41 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.953 -177.19 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 100' ' ' ARG . 49.4 mtt180 -82.65 -6.41 59.35 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.349 -175.285 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 0.173 0 C-N-CA 120.967 -0.635 . . . . 0.0 113.409 172.322 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.965 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -91.72 166.13 12.94 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.006 174.057 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.6 m -63.93 -28.01 69.53 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.239 0.542 . . . . 0.0 110.36 178.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -62.71 -33.1 74.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.192 178.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 88.7 t -66.9 -39.42 83.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.164 177.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.472 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 64.0 mt -63.43 -39.9 87.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.422 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -64.2 -40.24 95.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.755 179.213 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -68.1 -36.85 80.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.7 177.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -62.14 -43.52 98.65 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.255 176.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' A' ' 6' ' ' ILE . 94.0 mt -65.26 -32.4 74.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.662 177.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -62.92 -47.35 83.64 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.36 177.058 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -64.02 -52.37 59.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.16 -178.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 40.1 pt -67.5 -27.46 38.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.243 -177.198 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.62 58.21 1.45 Allowed Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.503 178.072 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.452 ' HG2' HG21 ' A' ' 30' ' ' VAL . 8.4 tp10 -136.36 148.22 47.75 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -95.92 139.93 31.42 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.682 -179.077 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.464 ' HB3' HD13 ' A' ' 10' ' ' LEU . 52.6 p90 -112.34 142.39 44.91 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.863 0.363 . . . . 0.0 110.49 176.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 62.1 mt -101.65 96.59 4.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 176.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.406 ' HA ' ' O ' ' A' ' 23' ' ' GLU . 39.9 tt0 -97.28 121.88 39.67 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.374 0.607 . . . . 0.0 110.813 -178.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 96.3 mt -109.22 34.01 3.98 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.334 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 69.8 101.12 0.06 Allowed 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.268 -177.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 7.7 m120 68.74 3.64 4.01 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.019 -177.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.406 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 12.9 mt-10 -129.32 113.9 15.55 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 110.406 -0.22 . . . . 0.0 110.406 172.065 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.405 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 67.6 mt -105.95 102.65 14.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 175.541 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 42.7 m-70 -87.81 120.99 29.68 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.231 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 59.9 mt -117.89 172.14 7.59 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.483 0.659 . . . . 0.0 111.634 -175.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -80.19 136.17 53.73 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.402 176.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.83 ' HG2' ' HG2' ' A' ' 92' ' ' GLU . 88.2 Cg_exo -49.01 -43.81 34.66 Favored 'Trans proline' 0 N--CA 1.474 0.367 0 C-N-CA 123.536 2.824 . . . . 0.0 114.073 -175.146 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -67.71 -36.66 81.02 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.784 0.326 . . . . 0.0 110.988 -179.251 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.452 HG21 ' HG2' ' A' ' 15' ' ' GLU . 41.2 t -68.96 -43.86 81.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.087 0.47 . . . . 0.0 109.881 176.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -55.87 -45.62 78.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.082 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 78.4 t80 -57.7 -39.45 77.2 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.28 -178.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -76.78 -42.29 41.31 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.032 -178.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 89.4 t -65.6 -37.16 79.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.791 0.329 . . . . 0.0 110.516 178.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 26.1 t90 -54.19 -53.92 46.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.665 177.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.507 ' HA ' ' HB3' ' A' ' 40' ' ' GLU . 65.9 mttm -71.88 -26.46 62.35 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 121.158 -0.217 . . . . 0.0 111.246 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 77.1 t80 -63.36 -38.59 91.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.733 0.301 . . . . 0.0 110.975 179.004 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 29.0 m -88.39 10.42 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.827 0.346 . . . . 0.0 111.755 -177.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 99.86 8.18 51.83 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.934 176.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.507 ' HB3' ' HA ' ' A' ' 36' ' ' LYS . 19.1 pt-20 40.69 81.36 0.25 Allowed Pre-proline 0 N--CA 1.473 0.708 0 C-N-CA 124.335 1.054 . . . . 0.0 113.315 178.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -88.08 -168.68 0.39 Allowed 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.008 2.472 . . . . 0.0 111.842 175.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -75.85 136.4 40.17 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.008 0.432 . . . . 0.0 110.717 179.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 97.2 mt -97.08 146.66 24.81 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.71 -179.006 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 61.1 tttm -111.5 118.39 35.62 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.62 -179.2 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 37.2 p -105.19 141.94 35.84 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.178 -176.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 21.2 p90 -130.05 151.37 50.67 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.77 0.319 . . . . 0.0 110.273 177.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.544 HG22 ' HG3' ' A' ' 74' ' ' LYS . 42.5 t -107.23 129.86 60.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.632 177.724 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 6.4 tt -125.92 111.88 28.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 121.239 0.542 . . . . 0.0 110.543 177.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.593 ' HA ' ' HA ' ' A' ' 72' ' ' LYS . 1.6 mp0 -81.37 97.67 7.83 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.021 177.335 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -106.68 115.8 30.82 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.796 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.7 ' HG2' ' HA ' ' A' ' 70' ' ' LYS . 36.7 mt-10 -88.99 131.99 34.93 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.014 0.435 . . . . 0.0 110.921 -176.569 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 9.6 tt -86.46 125.55 40.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.498 175.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.62 ' HA ' HG12 ' A' ' 68' ' ' VAL . 9.1 p -90.75 164.28 2.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.602 -175.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -87.35 133.49 38.38 Favored Pre-proline 0 N--CA 1.449 -0.482 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.24 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -69.24 -67.39 0.03 OUTLIER 'Trans proline' 0 CA--C 1.531 0.359 0 C-N-CA 122.426 2.084 . . . . 0.0 112.472 178.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 164.4 43.56 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.436 0 N-CA-C 111.086 -0.805 . . . . 0.0 111.086 -178.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -61.08 112.61 2.16 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -173.045 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -94.82 84.84 4.27 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.385 0.612 . . . . 0.0 110.051 174.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.676 ' H ' ' HD2' ' A' ' 60' ' ' PRO . 25.2 t70 -141.12 -52.89 0.02 OUTLIER Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.778 178.138 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.676 ' HD2' ' H ' ' A' ' 59' ' ' ASP . 73.5 Cg_endo -78.16 140.02 17.4 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 121.541 1.494 . . . . 0.0 111.292 171.685 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 60' ' ' PRO . 32.4 Cg_exo -58.79 147.94 85.91 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 122.492 2.128 . . . . 0.0 111.925 178.18 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -69.61 87.43 0.49 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.359 0.6 . . . . 0.0 110.89 -179.022 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 55.9 ttm -164.24 -45.6 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 178.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 36.7 mttp -79.22 154.02 29.54 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.321 168.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -120.72 115.3 23.06 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 121.051 -0.259 . . . . 0.0 110.46 -172.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.01 151.36 26.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.585 177.079 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -123.31 144.74 49.23 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.078 0.466 . . . . 0.0 111.362 -176.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.62 HG12 ' HA ' ' A' ' 53' ' ' VAL . 27.4 m -80.56 152.7 4.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 173.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -116.66 132.9 56.57 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.222 0.534 . . . . 0.0 111.099 -177.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.7 ' HA ' ' HG2' ' A' ' 51' ' ' GLU . 85.4 tttt -90.51 102.28 15.02 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.656 -174.361 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 39.2 t -92.5 100.07 10.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.544 -179.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.593 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 20.5 pttp -88.27 99.03 11.92 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 176.342 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 13.9 tt -105.79 137.12 37.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 121.276 0.56 . . . . 0.0 110.945 -175.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.592 ' O ' ' HB3' ' A' ' 90' ' ' TYR . 28.7 tttm -95.52 125.82 40.38 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.07 178.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -125.03 158.66 33.17 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.701 0.286 . . . . 0.0 110.281 178.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 11.1 p -121.94 146.75 26.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.617 -175.195 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.409 ' CE1' ' HD2' ' A' ' 85' ' ' ARG . 48.7 p90 -152.67 164.53 37.55 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.81 0.338 . . . . 0.0 110.393 175.283 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -132.54 147.9 52.37 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 170.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.529 ' HG2' ' HG2' ' A' ' 85' ' ' ARG . 45.3 mt-10 -104.27 132.14 50.84 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.947 0.403 . . . . 0.0 110.91 -176.289 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 49.5 p -85.14 -175.65 5.83 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.164 -179.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 7.9 mp -66.86 -20.79 65.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.388 177.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.44 ' HB2' HG23 ' A' ' 84' ' ' VAL . 9.3 m-20 -92.08 6.58 45.92 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.287 -178.331 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 64.94 23.15 12.56 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.957 -177.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.44 HG23 ' HB2' ' A' ' 82' ' ' ASP . 79.3 t -87.87 126.51 41.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 176.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.529 ' HG2' ' HG2' ' A' ' 79' ' ' GLU . 31.1 mtm180 -96.74 111.09 23.4 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.446 -175.346 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 24' ' ' ILE . 59.7 t -83.43 103.33 10.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 175.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.4 t -99.21 144.08 12.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.002 -172.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.519 HG21 ' HA ' ' A' ' 28' ' ' PRO . 51.5 m -151.39 148.94 28.72 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.735 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -57.56 112.44 1.43 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.055 178.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.592 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 70.9 t80 -71.96 -30.12 64.97 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.09 0.471 . . . . 0.0 110.25 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.3 p -60.95 -47.28 87.15 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.574 175.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.83 ' HG2' ' HG2' ' A' ' 28' ' ' PRO . 15.1 tp10 -72.17 -36.03 69.17 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.147 178.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.46 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 58.3 t80 -60.49 -52.59 64.54 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.068 -179.158 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 15.4 mt-30 -64.84 -31.71 73.07 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.777 0.322 . . . . 0.0 110.876 177.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.45 ' HB3' ' O ' ' A' ' 92' ' ' GLU . 76.8 tttt -59.42 -41.71 90.14 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.504 175.291 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.43 HG13 ' O ' ' A' ' 92' ' ' GLU . 73.1 mt -72.2 -37.11 58.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.499 176.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' A' ' 93' ' ' PHE . 86.5 mt -59.14 -48.96 79.7 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.62 177.016 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -65.3 -29.4 70.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.788 178.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 65.7 tttm -68.58 -52.05 35.92 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.795 -178.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 100' ' ' ARG . 56.8 mtt180 -82.64 -10.36 58.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.224 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 74.3 33.65 56.21 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.021 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 38.8 m -78.16 101.29 6.97 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 177.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 53.2 tttm -83.94 122.12 28.31 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.256 -178.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 88.2 mt -85.05 113.16 21.26 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.929 0.395 . . . . 0.0 110.579 -179.264 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -66.08 154.99 38.09 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.765 178.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 20.3 m170 -74.57 -28.86 61.12 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.674 179.34 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 4.0 t60 -124.44 112.32 16.77 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 171.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 25.8 m170 -77.75 146.61 35.8 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.546 -177.197 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 34.9 m170 -81.07 38.19 0.46 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.857 -178.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -138.11 16.64 2.81 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.042 0.449 . . . . 0.0 110.183 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 19.4 t60 . . . . . 0 C--O 1.251 1.162 0 CA-C-N 115.921 -0.582 . . . . 0.0 109.972 -177.428 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.961 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -125.83 -179.92 4.89 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 173.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.2 m -60.06 -37.13 78.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.0 0.429 . . . . 0.0 111.241 -176.208 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -64.51 -35.99 82.74 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.577 -178.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 77.5 t -64.36 -40.57 89.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.347 177.359 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.554 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 65.9 mt -62.49 -46.4 96.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.216 177.319 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.409 ' O ' ' HG3' ' A' ' 11' ' ' GLU . 98.9 mttt -56.4 -49.23 75.11 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.622 178.142 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -57.92 -45.79 85.99 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.274 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 93.0 t80 -58.76 -40.67 84.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.352 178.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.554 ' HG ' ' O ' ' A' ' 6' ' ' ILE . 77.0 mt -66.48 -43.41 85.48 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.891 179.302 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.409 ' HG3' ' O ' ' A' ' 7' ' ' LYS . 52.4 mt-10 -62.46 -34.62 77.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.923 0.392 . . . . 0.0 110.624 178.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -66.16 -50.52 63.64 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.353 178.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 38.4 pt -75.98 -6.65 9.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.66 -177.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.73 24.19 39.58 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.614 175.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -89.91 154.16 20.07 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.837 0.351 . . . . 0.0 110.503 -177.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -103.36 122.87 45.72 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.136 177.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.539 ' HB3' HD13 ' A' ' 10' ' ' LEU . 39.8 p90 -115.25 133.24 56.22 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.029 176.706 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.551 ' HB ' ' HB2' ' A' ' 25' ' ' HIS . 44.0 mt -106.95 91.91 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 176.706 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.686 ' HA ' ' O ' ' A' ' 23' ' ' GLU . 1.0 OUTLIER -98.12 106.84 19.2 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.626 -179.081 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 97.0 mt -125.54 122.4 36.44 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.858 -178.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.47 ' O ' ' HB2' ' A' ' 22' ' ' ASN . 36.6 mt-10 58.43 36.64 25.51 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 123.577 0.548 . . . . 0.0 111.173 175.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.47 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 5.2 m-20 73.92 25.71 1.87 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.08 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.686 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 55.8 mt-10 -115.07 113.73 24.43 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.17 171.317 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.49 HG22 ' HG ' ' A' ' 26' ' ' LEU . 60.2 mt -91.55 101.62 12.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 177.157 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.551 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 12.3 m170 -87.29 121.95 30.41 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.201 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.49 ' HG ' HG22 ' A' ' 24' ' ' ILE . 63.6 mt -130.03 -174.83 3.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.243 0.544 . . . . 0.0 111.955 -175.563 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -92.02 144.7 29.59 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.091 177.223 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.523 ' HA ' HG21 ' A' ' 88' ' ' THR . 78.0 Cg_exo -50.19 -46.8 26.8 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 123.479 2.786 . . . . 0.0 113.911 -176.112 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -67.39 -36.52 81.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.791 0.329 . . . . 0.0 110.837 -177.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.407 ' O ' HG23 ' A' ' 34' ' ' VAL . 48.4 t -68.46 -41.56 83.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.09 179.046 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -56.01 -42.07 75.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.373 177.246 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 79.7 t80 -60.78 -44.99 96.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.351 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -68.64 -42.37 78.12 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.177 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 30' ' ' VAL . 93.5 t -64.9 -36.99 79.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.814 0.34 . . . . 0.0 110.16 177.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.52 ' CD1' ' HD2' ' A' ' 41' ' ' PRO . 27.6 t90 -52.8 -50.88 62.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.563 176.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -70.71 -34.84 72.36 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.322 178.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -57.97 -43.59 86.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.731 0.3 . . . . 0.0 111.29 179.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.534 HG23 ' HD3' ' A' ' 41' ' ' PRO . 27.6 m -82.35 14.43 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -175.46 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 101.89 1.96 52.19 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.743 175.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 57.22 70.45 1.35 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.19 0.519 . . . . 0.0 110.869 179.302 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.534 ' HD3' HG23 ' A' ' 38' ' ' VAL . 87.4 Cg_endo -88.28 -162.74 0.14 Allowed 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.967 2.445 . . . . 0.0 112.215 -179.153 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -88.11 145.12 26.11 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.247 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 96.0 mt -93.7 157.24 16.26 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.573 -175.268 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -125.3 148.3 48.76 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.184 176.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.6 p -141.15 153.13 45.22 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.797 0.332 . . . . 0.0 111.557 -175.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 16.8 p90 -145.04 148.86 34.17 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.839 176.057 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.43 ' HA ' ' HA ' ' A' ' 74' ' ' LYS . 45.7 t -102.03 122.28 54.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 17.5 tt -109.61 150.32 12.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.394 -178.045 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -87.74 96.19 10.35 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.359 -175.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -92.93 104.22 16.47 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.666 0.746 . . . . 0.0 109.241 173.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.533 ' HG2' ' HD3' ' A' ' 70' ' ' LYS . 22.9 mt-10 -96.16 113.64 25.27 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.07 -168.631 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.468 ' HB ' ' O ' ' A' ' 69' ' ' LYS . 51.7 mt -85.71 83.58 2.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 172.591 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.448 ' O ' ' HD3' ' A' ' 55' ' ' PRO . 19.8 m -91.14 170.36 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.21 179.159 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -87.44 108.83 21.67 Favored Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.448 ' HD3' ' O ' ' A' ' 53' ' ' VAL . 58.9 Cg_endo -90.94 82.48 0.39 Allowed 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 123.17 2.58 . . . . 0.0 112.543 -177.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 164.57 28.84 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.012 179.072 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -125.72 140.64 52.53 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.861 0.362 . . . . 0.0 110.461 -176.178 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 79.1 t80 -87.29 -30.54 20.79 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 175.071 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -94.87 139.74 22.26 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.213 178.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -58.0 116.63 3.37 Favored 'Trans proline' 0 C--O 1.236 0.379 0 C-N-CA 122.877 2.385 . . . . 0.0 112.568 -177.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_exo -62.11 -18.92 64.52 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 123.09 2.526 . . . . 0.0 112.07 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -53.04 -45.61 68.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.714 177.086 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 63.5 mtt -77.52 -16.4 58.71 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.11 0.481 . . . . 0.0 111.009 -176.111 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -90.38 -42.49 10.89 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.954 178.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 29.1 t80 52.07 68.89 0.74 Allowed 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.112 178.133 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 12.8 p -123.54 -61.08 1.42 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.602 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -109.34 11.75 25.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.576 0.227 . . . . 0.0 111.377 -179.109 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.4 t -75.26 94.18 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.854 0.359 . . . . 0.0 110.266 -178.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.468 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 29.5 tptp -116.7 107.79 15.11 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.201 -176.318 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.533 ' HD3' ' HG2' ' A' ' 51' ' ' GLU . 83.8 mttt -98.45 123.62 42.7 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.987 0.422 . . . . 0.0 110.688 -178.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 48.3 t -110.49 106.87 21.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.94 -179.037 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 51.3 mttm -78.03 112.76 15.29 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.021 -177.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 61.5 mt -98.63 125.6 51.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.238 0.542 . . . . 0.0 110.814 -176.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.517 ' O ' ' HB3' ' A' ' 90' ' ' TYR . 86.8 tttt -87.48 122.89 31.79 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.71 177.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -113.01 161.49 16.99 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.425 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.484 ' HB ' ' CD1' ' A' ' 90' ' ' TYR . 13.1 p -118.11 145.39 24.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.521 -0.308 . . . . 0.0 110.962 -175.392 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.413 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 38.8 p90 -154.94 159.55 40.5 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.909 178.313 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -133.4 152.29 51.9 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 170.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.548 ' HG2' ' HG2' ' A' ' 85' ' ' ARG . 24.9 mt-10 -104.61 138.82 40.37 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.987 0.423 . . . . 0.0 110.93 -173.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 73.0 p -97.54 -169.28 1.81 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.848 -175.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -69.9 -28.28 65.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.039 -179.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -95.71 19.5 11.14 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.086 -172.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 65.8 17.1 10.75 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.529 -179.124 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 85.2 t -88.34 137.9 20.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.108 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.548 ' HG2' ' HG2' ' A' ' 79' ' ' GLU . 90.5 mtt180 -107.84 113.87 27.41 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.453 -177.727 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 53.2 t -83.54 102.67 9.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 177.315 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 25' ' ' HIS . 32.5 t -100.38 136.29 32.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.778 -174.098 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.523 HG21 ' HA ' ' A' ' 28' ' ' PRO . 52.3 m -146.98 157.62 43.68 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.07 178.585 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -67.11 122.88 18.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.337 0.589 . . . . 0.0 111.617 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.517 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 49.2 t80 -78.38 -20.1 51.97 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.691 -178.508 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.543 ' O ' ' HG3' ' A' ' 95' ' ' LYS . 4.1 m -62.22 -61.1 2.7 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.867 0.365 . . . . 0.0 110.253 179.378 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -71.17 -29.28 64.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.125 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.524 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 62.9 t80 -58.24 -45.18 88.24 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.875 0.369 . . . . 0.0 110.07 176.225 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 13.3 mm100 -61.67 -40.38 94.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.049 176.138 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.543 ' HG3' ' O ' ' A' ' 91' ' ' SER . 90.3 mttt -65.18 -40.75 94.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.832 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.473 HD12 ' HB2' ' A' ' 28' ' ' PRO . 66.6 mt -71.5 -31.12 41.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.239 -179.489 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.524 ' HG ' ' O ' ' A' ' 93' ' ' PHE . 53.8 mt -61.7 -42.44 98.94 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.939 0.4 . . . . 0.0 110.419 175.509 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -73.94 -20.74 60.28 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.17 0.509 . . . . 0.0 110.521 177.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -74.38 -42.74 58.79 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.205 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 67.2 mtt180 -98.75 -4.12 34.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.843 0.354 . . . . 0.0 111.443 -177.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 76.95 60.31 2.95 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.588 177.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 38.6 m -120.58 115.58 23.69 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.874 0.368 . . . . 0.0 110.426 177.249 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -84.04 168.35 16.01 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.419 178.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 97.6 mt -83.23 -19.49 36.33 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.283 0.563 . . . . 0.0 109.811 176.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -83.6 120.55 26.1 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.936 176.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 74.6 m-70 -83.97 155.27 22.87 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.355 176.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 -72.51 -27.03 62.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.079 0.466 . . . . 0.0 110.436 -179.001 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 16.7 m-70 -128.53 124.37 35.85 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.346 173.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 46.0 m80 -93.88 159.12 15.32 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.84 179.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -94.3 9.01 39.81 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.45 0.643 . . . . 0.0 109.73 175.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 35.7 m80 . . . . . 0 C--O 1.246 0.89 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.51 176.689 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.556 ' HA ' HG21 ' A' ' 5' ' ' VAL . 14.9 tmm? . . . . . 0 N--CA 1.479 0.982 0 CA-C-O 121.046 0.45 . . . . 0.0 110.441 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -119.64 -178.52 3.64 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 174.156 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 64.8 p -58.76 -31.2 68.15 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.953 0.406 . . . . 0.0 110.409 176.014 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.598 ' HA ' ' HD2' ' A' ' 7' ' ' LYS . 35.5 tt0 -62.32 -38.39 89.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.8 178.44 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.556 HG21 ' HA ' ' A' ' 1' ' ' MET . 93.0 t -65.55 -45.8 91.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.041 0.448 . . . . 0.0 110.046 178.554 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 59.6 mt -59.62 -41.72 85.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.657 174.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.598 ' HD2' ' HA ' ' A' ' 4' ' ' GLU . 62.9 mttm -50.9 -57.79 7.62 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.811 0.339 . . . . 0.0 110.614 175.109 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -56.39 -43.17 78.99 Favored 'General case' 0 C--O 1.223 -0.323 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.963 -179.432 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.467 ' O ' HG12 ' A' ' 13' ' ' ILE . 70.1 t80 -60.81 -48.96 79.44 Favored 'General case' 0 C--N 1.328 -0.358 0 O-C-N 123.123 0.265 . . . . 0.0 110.935 -178.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 96.7 mt -62.48 -47.85 82.2 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.986 0.422 . . . . 0.0 111.085 -178.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -73.73 -21.74 60.12 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.013 -177.416 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -75.61 -38.53 58.92 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.858 0.361 . . . . 0.0 110.7 177.187 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.467 HG12 ' O ' ' A' ' 9' ' ' PHE . 32.1 pt -87.33 -4.82 9.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.875 0.369 . . . . 0.0 110.711 177.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 74.53 43.14 31.03 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.104 -0.569 . . . . 0.0 112.655 175.065 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 46.7 mm-40 -109.94 151.12 27.5 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.395 0.617 . . . . 0.0 111.742 -179.261 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -89.26 150.89 22.41 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.006 -178.009 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 33.0 p90 -145.54 143.3 29.86 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.906 0.384 . . . . 0.0 111.091 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.561 ' HB ' ' HB2' ' A' ' 25' ' ' HIS . 48.9 mm -97.82 92.76 3.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 174.322 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.405 ' HG3' HG12 ' A' ' 24' ' ' ILE . 33.8 tt0 -91.52 109.49 20.79 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.875 -175.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 69.7 mt -105.04 -170.79 1.81 Allowed 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 175.18 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -79.69 109.67 14.3 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.089 -0.644 . . . . 0.0 110.258 178.333 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 60.0 m-80 70.27 18.51 6.81 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 114.946 -1.025 . . . . 0.0 111.41 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.502 ' HG2' ' HB2' ' A' ' 85' ' ' ARG . 37.7 mt-10 -144.55 131.43 20.27 Favored 'General case' 0 C--O 1.222 -0.36 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.07 177.132 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.405 HG12 ' HG3' ' A' ' 19' ' ' GLU . 76.2 mt -125.91 107.84 18.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 173.584 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.561 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 19.6 m-70 -92.08 127.24 37.48 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 -178.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 87.2 mt -118.34 169.34 9.81 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.453 -174.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 84.9 mttt -70.42 140.43 87.42 Favored Pre-proline 0 C--N 1.327 -0.4 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 173.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -47.6 -48.42 15.66 Favored 'Trans proline' 0 CA--C 1.531 0.342 0 C-N-CA 123.15 2.567 . . . . 0.0 113.592 -176.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -73.81 -31.09 63.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.788 0.327 . . . . 0.0 111.051 -175.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.44 ' O ' HG23 ' A' ' 34' ' ' VAL . 56.3 t -73.23 -41.44 58.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 178.247 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -56.53 -39.63 73.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.265 176.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.554 ' OH ' ' HD3' ' A' ' 100' ' ' ARG . 47.2 t80 -53.97 -44.36 70.71 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.513 178.146 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -76.6 -36.26 57.61 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.291 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 30' ' ' VAL . 76.8 t -67.13 -40.02 84.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.006 0.432 . . . . 0.0 110.475 178.393 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.611 ' CD1' ' HD2' ' A' ' 41' ' ' PRO . 27.8 t90 -56.68 -45.76 81.53 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.259 176.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 25.0 mttm -71.67 -34.75 69.96 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.243 178.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 90.6 t80 -58.26 -43.26 87.79 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.143 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.477 HG23 ' HD3' ' A' ' 41' ' ' PRO . 35.8 m -81.49 13.74 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -177.24 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 103.75 -0.37 45.53 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.971 174.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 59.99 70.11 1.1 Allowed Pre-proline 0 CA--C 1.536 0.427 0 CA-C-O 121.147 0.498 . . . . 0.0 110.457 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.611 ' HD2' ' CD1' ' A' ' 35' ' ' TRP . 66.2 Cg_endo -92.68 -162.47 0.1 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 123.282 2.655 . . . . 0.0 113.259 -177.089 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -58.06 144.75 38.86 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.176 -179.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 68.5 mt -105.29 112.01 24.96 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.066 173.529 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 60.6 mttm -107.72 140.5 40.68 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.5 p -127.87 157.37 40.67 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.706 0.289 . . . . 0.0 111.756 -174.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 38.7 p90 -138.55 136.73 36.35 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 172.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 58.3 t -98.96 122.03 50.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.312 -179.061 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 13.0 tt -104.3 128.88 57.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.191 0.519 . . . . 0.0 110.415 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -85.2 116.88 23.81 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.506 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -114.7 120.68 40.92 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.974 0.416 . . . . 0.0 110.358 -177.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -92.79 118.79 31.47 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.326 -173.068 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 74.4 mt -78.77 102.09 4.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.578 -0.526 . . . . 0.0 109.578 174.014 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.516 ' O ' ' HD3' ' A' ' 55' ' ' PRO . 9.3 p -115.11 161.34 13.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 178.534 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -87.63 107.66 16.47 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-O 120.752 0.311 . . . . 0.0 110.748 -179.32 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.516 ' HD3' ' O ' ' A' ' 53' ' ' VAL . 73.3 Cg_endo -100.16 70.18 0.05 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.18 0 C-N-CA 123.823 3.015 . . . . 0.0 112.357 178.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -134.94 -36.23 0.23 Allowed Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.317 -179.205 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -85.58 135.69 33.7 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 175.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -66.07 -36.26 82.73 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.012 -179.148 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -84.4 112.03 38.61 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.02 178.11 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.41 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 71.7 Cg_endo -85.64 120.3 2.04 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 122.718 2.279 . . . . 0.0 112.586 -177.55 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 60' ' ' PRO . 12.1 Cg_exo -70.78 121.16 7.65 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 122.641 2.227 . . . . 0.0 111.429 176.471 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -72.57 -42.88 64.12 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.27 0.557 . . . . 0.0 109.726 179.245 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 62.6 mtt -75.02 126.56 31.28 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.131 175.433 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -75.44 88.23 2.62 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.249 0.547 . . . . 0.0 110.377 -177.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -57.8 -62.84 1.51 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.326 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.2 t -87.98 153.41 21.31 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 175.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -77.66 102.21 6.97 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.87 0.367 . . . . 0.0 110.376 -178.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.1 m -62.74 135.71 26.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.772 179.367 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -97.31 116.7 30.01 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.833 -178.224 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -98.46 126.82 44.15 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.866 0.365 . . . . 0.0 110.713 -178.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 23.1 m -102.29 148.44 7.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.773 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 58.2 mttm -113.76 99.94 8.08 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.156 0.503 . . . . 0.0 110.204 -174.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 71.2 mt -93.77 134.64 30.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.066 -177.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -116.1 107.76 15.33 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.415 0.626 . . . . 0.0 110.961 -174.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 35.9 mmtp -96.4 149.15 22.04 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.982 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.474 ' HB ' ' HB2' ' A' ' 90' ' ' TYR . 9.7 p -114.07 142.84 25.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.546 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 37.5 p90 -151.36 159.03 44.48 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.152 0.501 . . . . 0.0 111.212 -177.503 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -132.27 147.84 52.42 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 168.172 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -102.21 137.78 40.02 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.944 0.402 . . . . 0.0 111.02 -174.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 82.8 p -91.48 -175.35 4.19 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.855 178.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 66.3 tp -60.92 -31.21 70.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.181 0.515 . . . . 0.0 110.356 176.379 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.618 ' HB2' HG23 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -79.84 -2.03 41.64 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.648 -178.142 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 59.3 m-80 70.87 23.11 4.48 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.346 0.658 . . . . 0.0 110.568 -176.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.618 HG23 ' HB2' ' A' ' 82' ' ' ASP . 70.7 t -86.24 126.49 40.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.438 178.742 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.502 ' HB2' ' HG2' ' A' ' 23' ' ' GLU . 63.4 mtt85 -86.03 110.02 19.21 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.666 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.546 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 49.1 t -82.66 109.05 16.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 171.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.468 HG22 ' HB3' ' A' ' 77' ' ' TYR . 9.6 t -116.79 147.59 20.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.22 0.533 . . . . 0.0 112.418 -167.122 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 6.0 t -155.76 -176.66 6.07 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 169.128 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -84.59 128.26 34.5 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 117.971 0.351 . . . . 0.0 110.561 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.474 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 11.2 t80 -77.46 -22.17 51.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.523 -174.066 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.3 -47.1 52.54 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.919 -0.401 . . . . 0.0 109.919 178.309 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.422 ' O ' ' HB3' ' A' ' 95' ' ' LYS . 54.8 mm-40 -70.21 -29.65 66.54 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.707 176.15 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.528 ' HE1' ' HA ' ' A' ' 32' ' ' TYR . 43.0 t80 -69.08 -47.65 64.68 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.662 0.267 . . . . 0.0 110.473 178.032 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.555 ' O ' ' HG3' ' A' ' 98' ' ' LYS . 43.1 mt-30 -60.95 -34.58 74.97 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.275 175.594 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.422 ' HB3' ' O ' ' A' ' 92' ' ' GLU . 42.4 tttt -52.98 -47.09 68.46 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.018 176.272 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.637 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 78.8 mt -68.94 -37.47 77.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.763 178.317 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 83.3 mt -65.34 -32.16 73.67 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.67 178.448 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.555 ' HG3' ' O ' ' A' ' 94' ' ' GLN . 96.8 mttt -65.35 -38.78 91.12 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 174.463 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.637 ' HE3' ' HA ' ' A' ' 96' ' ' ILE . 9.1 mtmp? -69.21 -33.24 73.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.716 178.246 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.554 ' HD3' ' OH ' ' A' ' 32' ' ' TYR . 13.0 ttp180 -71.16 -38.6 72.19 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.969 0.414 . . . . 0.0 110.365 175.682 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 100.56 36.16 4.13 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.937 -0.649 . . . . 0.0 111.742 -178.283 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 23.5 m -66.9 -28.04 67.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.099 0.476 . . . . 0.0 111.481 -178.11 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -105.65 26.59 9.35 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.284 0.564 . . . . 0.0 110.339 -178.32 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 49.3 tp -138.92 86.09 2.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.678 176.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 63.23 -175.51 0.15 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.956 -177.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 40.8 m80 -100.64 79.93 2.14 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.226 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 75.6 t60 -86.08 117.79 25.14 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.133 0.492 . . . . 0.0 110.396 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 4.2 m80 -90.44 -171.17 2.99 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.369 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 19.0 t-80 -88.22 -9.41 53.08 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 171.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 79.4 m-70 -100.5 -63.07 1.16 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.321 175.318 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 85.4 t60 . . . . . 0 C--O 1.244 0.807 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.371 177.511 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.163 0 CA-C-O 120.717 0.294 . . . . 0.0 110.38 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 24.4 m-80 -102.29 167.87 9.7 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 173.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.556 ' OG ' ' HB3' ' A' ' 82' ' ' ASP . 3.3 m -65.32 -35.06 79.85 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.797 0.332 . . . . 0.0 110.915 -177.246 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.458 ' O ' ' HG2' ' A' ' 8' ' ' GLU . 34.2 tt0 -58.51 -41.53 85.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.503 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 94.0 t -55.64 -45.2 78.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.825 177.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.521 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 64.4 mt -63.0 -43.59 99.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.554 -179.155 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.429 ' HE2' ' OE1' ' A' ' 19' ' ' GLU . 92.5 mttt -61.36 -46.62 89.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.784 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.458 ' HG2' ' O ' ' A' ' 4' ' ' GLU . 52.5 mm-40 -60.58 -48.01 83.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.271 177.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -59.69 -38.18 80.84 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.349 -178.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.521 ' HG ' ' O ' ' A' ' 6' ' ' ILE . 93.5 mt -65.26 -37.9 88.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.842 0.353 . . . . 0.0 110.488 178.267 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -69.97 -34.01 72.82 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.188 176.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -59.74 -43.61 94.17 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.052 175.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 35.1 pt -85.67 -7.51 10.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.841 0.353 . . . . 0.0 111.33 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 81.38 26.58 51.16 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 121.026 -0.606 . . . . 0.0 113.211 174.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -106.64 143.54 34.59 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.875 0.369 . . . . 0.0 110.408 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -102.29 147.92 26.08 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.885 -179.01 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 13.0 p90 -120.52 154.39 35.38 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.981 0.42 . . . . 0.0 111.672 -174.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 51.6 mt -101.51 96.84 5.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 174.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.429 ' OE1' ' HE2' ' A' ' 7' ' ' LYS . 61.1 tt0 -108.51 137.42 46.5 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.495 0.664 . . . . 0.0 112.02 -173.227 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 89.7 mt -116.73 -173.56 2.41 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 170.363 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -61.7 103.5 0.34 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.817 0.342 . . . . 0.0 110.831 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.462 ' HA ' HG22 ' A' ' 84' ' ' VAL . 4.2 m-20 66.94 23.0 9.98 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.725 178.305 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -134.81 113.95 12.12 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.681 0.277 . . . . 0.0 111.209 176.095 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.42 ' HB ' HG22 ' A' ' 86' ' ' VAL . 66.0 mt -103.33 109.68 27.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 175.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -92.55 120.31 32.88 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.415 ' HG ' HG22 ' A' ' 24' ' ' ILE . 64.8 mt -124.75 155.47 39.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.241 0.543 . . . . 0.0 111.691 -176.269 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -65.96 136.47 95.61 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.491 176.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -56.2 -33.46 90.72 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.319 2.013 . . . . 0.0 111.588 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -62.09 -43.91 97.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.956 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 45.9 t -81.36 -34.33 13.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.187 0.517 . . . . 0.0 110.244 179.048 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -55.64 -39.08 70.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.712 -176.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -58.46 -38.37 77.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.764 0.316 . . . . 0.0 111.113 -178.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -79.67 -34.53 40.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.838 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 95.9 t -64.53 -42.82 96.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.012 0.434 . . . . 0.0 110.024 176.159 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.518 ' CD1' ' HD2' ' A' ' 41' ' ' PRO . 29.6 t90 -57.6 -41.1 80.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.423 177.184 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -69.09 -43.61 74.19 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.884 176.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -60.92 -41.0 95.3 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.956 -178.17 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.516 HG23 ' HD3' ' A' ' 41' ' ' PRO . 35.1 m -76.9 4.42 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 112.308 0.485 . . . . 0.0 112.308 -175.416 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 105.82 -0.48 39.04 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.543 -0.837 . . . . 0.0 113.089 175.147 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 59.49 75.12 0.52 Allowed Pre-proline 0 CA--C 1.535 0.382 0 CA-C-O 120.987 0.422 . . . . 0.0 111.228 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.518 ' HD2' ' CD1' ' A' ' 35' ' ' TRP . 90.6 Cg_endo -91.58 -176.68 0.87 Allowed 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.791 2.327 . . . . 0.0 112.109 176.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 57.8 mm-40 -72.29 135.82 46.09 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.014 0.435 . . . . 0.0 110.765 178.353 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.465 ' HB3' ' CG2' ' A' ' 76' ' ' VAL . 95.2 mt -98.44 138.02 36.27 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.48 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -117.23 138.58 51.62 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.951 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 16.2 p -105.2 147.52 27.92 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 120.79 0.328 . . . . 0.0 111.443 -176.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.492 ' CE2' ' HB ' ' A' ' 48' ' ' ILE . 10.0 p90 -129.1 156.1 44.4 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 175.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 33.1 t -103.28 105.11 17.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.028 0.442 . . . . 0.0 110.945 -176.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.625 HG23 ' HB ' ' A' ' 73' ' ' ILE . 5.8 tt -95.83 101.33 12.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 121.672 0.749 . . . . 0.0 109.443 175.113 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -85.69 93.83 8.94 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.913 -177.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -103.11 135.75 44.19 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.883 -175.086 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.637 ' HG2' ' HG2' ' A' ' 70' ' ' LYS . 40.3 mt-10 -82.32 110.03 17.11 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.64 -0.254 . . . . 0.0 110.561 -176.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.658 HG23 ' HB3' ' A' ' 69' ' ' LYS . 8.1 pt 36.49 -104.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 O-C-N 124.437 1.086 . . . . 0.0 112.688 -174.501 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.53 ' H ' HG13 ' A' ' 52' ' ' ILE . 2.9 m -148.03 118.35 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 177.286 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -95.24 102.56 9.84 Favored Pre-proline 0 C--N 1.323 -0.576 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 174.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.505 ' HD3' ' O ' ' A' ' 53' ' ' VAL . 89.0 Cg_endo -92.7 155.48 2.86 Favored 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 122.88 2.387 . . . . 0.0 113.219 -175.62 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -135.22 3.01 3.99 Favored Glycine 0 N--CA 1.449 -0.454 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 173.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -78.86 -20.81 48.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.383 0.611 . . . . 0.0 109.841 176.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -130.32 146.58 51.93 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.481 -0.782 . . . . 0.0 109.317 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.466 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 44.7 m-20 -80.66 114.05 44.82 Favored Pre-proline 0 C--N 1.324 -0.529 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 173.528 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 59' ' ' ASP . 23.6 Cg_exo -63.56 117.69 4.65 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 122.997 2.465 . . . . 0.0 113.34 -172.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -72.08 103.03 1.43 Allowed 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 122.792 2.328 . . . . 0.0 110.129 172.128 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -67.24 138.11 56.67 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.556 0.693 . . . . 0.0 112.859 -170.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 59.2 mtt -123.38 152.34 41.64 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 166.051 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -81.01 2.32 27.5 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -171.042 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -134.5 59.15 1.74 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.097 0.475 . . . . 0.0 110.626 176.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.7 m -74.81 126.58 31.24 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.653 176.427 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 89.6 m-20 -81.17 117.51 21.78 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.011 0.434 . . . . 0.0 111.596 -174.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.0 m -83.96 76.76 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.904 0.859 . . . . 0.0 110.34 176.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.658 ' HB3' HG23 ' A' ' 52' ' ' ILE . 89.2 tttt -92.27 107.61 19.34 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.872 -177.239 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.637 ' HG2' ' HG2' ' A' ' 51' ' ' GLU . 54.4 mttm -87.41 120.67 28.94 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.589 -175.719 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 31.2 t -104.4 115.57 46.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.441 -179.099 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 57.0 mttm -76.86 93.65 3.78 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 177.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.625 ' HB ' HG23 ' A' ' 48' ' ' ILE . 58.8 mt -91.03 129.44 41.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.301 -178.449 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -103.32 111.46 23.87 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.237 -178.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.413 ' HB3' ' O ' ' A' ' 88' ' ' THR . 65.6 mttm -114.96 167.15 11.05 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.235 -0.439 . . . . 0.0 109.832 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.465 ' CG2' ' HB3' ' A' ' 43' ' ' LEU . 14.4 p -123.48 147.98 27.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 120.794 0.331 . . . . 0.0 111.241 -172.022 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 51.6 p90 -145.66 163.81 33.72 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.137 178.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.462 ' HB3' HD23 ' A' ' 43' ' ' LEU . 43.1 p90 -128.14 155.42 44.47 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 169.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -102.22 137.07 40.97 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.323 -175.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 69.8 p -90.31 169.08 11.41 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 175.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.3 mp -82.91 18.95 1.47 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.344 0.592 . . . . 0.0 109.638 174.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.556 ' HB3' ' OG ' ' A' ' 3' ' ' SER . 38.9 t70 -126.59 10.55 7.23 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.853 -177.408 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 66.3 t30 74.14 19.49 2.93 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 115.188 -0.915 . . . . 0.0 112.112 173.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.462 HG22 ' HA ' ' A' ' 22' ' ' ASN . 82.7 t -109.7 137.16 43.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 120.931 0.396 . . . . 0.0 110.413 177.651 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 84.0 mtt-85 -102.19 126.84 49.28 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.46 -178.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.42 HG22 ' HB ' ' A' ' 24' ' ' ILE . 61.0 t -98.67 113.93 34.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 174.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.8 t -111.02 147.13 15.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.146 -170.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.413 ' O ' ' HB3' ' A' ' 75' ' ' LYS . 4.9 t -152.74 -178.67 7.03 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.233 -0.439 . . . . 0.0 109.854 176.365 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -86.39 122.05 29.81 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.969 0.414 . . . . 0.0 110.885 -178.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 17.1 t80 -73.65 -23.87 59.91 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.28 -176.009 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 27.0 m -71.99 -52.34 17.52 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.848 0.356 . . . . 0.0 110.582 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.425 ' O ' ' HB3' ' A' ' 95' ' ' LYS . 10.0 mm-40 -71.26 -27.75 63.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.467 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.441 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 69.1 t80 -65.92 -42.82 89.65 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 175.267 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -63.3 -35.3 79.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.674 175.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.425 ' HB3' ' O ' ' A' ' 92' ' ' GLU . 3.7 ttmp? -56.49 -44.59 80.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.279 175.627 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 76.2 mt -69.27 -40.09 79.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.908 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 93' ' ' PHE . 99.5 mt -58.73 -50.95 72.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.412 177.216 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 9.6 mtpm? -70.25 -25.43 63.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.198 -178.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -59.57 -53.3 59.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.569 174.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 39.8 ttt85 -77.41 -38.01 50.64 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.985 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 111.5 17.04 8.93 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.738 -0.744 . . . . 0.0 111.643 -176.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 38.8 m -70.97 134.29 47.07 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.794 0.331 . . . . 0.0 110.394 179.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -126.91 169.87 12.84 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.099 178.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 50.9 tp -79.49 -19.37 49.9 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.231 0.539 . . . . 0.0 110.29 -178.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -73.29 131.26 41.72 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.935 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 81.3 m-70 -110.7 103.94 12.55 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 172.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 64.1 m170 -97.0 134.44 40.37 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.961 0.41 . . . . 0.0 111.635 -172.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 60.1 m80 -139.64 100.99 4.1 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.124 177.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 17.5 m-70 -102.69 148.92 24.99 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.054 177.4 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 69.0 m80 -112.25 168.18 9.83 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.901 -177.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 33.9 t60 . . . . . 0 C--O 1.247 0.94 0 CA-C-O 118.497 -0.764 . . . . 0.0 109.592 176.659 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.026 0 CA-C-O 120.926 0.393 . . . . 0.0 110.481 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -94.21 178.06 5.76 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 172.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.492 ' O ' ' HG3' ' A' ' 7' ' ' LYS . 89.3 p -62.95 -32.93 74.35 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.73 0.3 . . . . 0.0 111.118 -177.56 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.452 ' HA ' ' HD2' ' A' ' 7' ' ' LYS . 9.3 tp10 -56.81 -36.36 69.84 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.997 -178.247 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 66.5 t -64.38 -42.04 94.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.479 178.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.51 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 63.9 mt -63.95 -41.43 92.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.339 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.492 ' HG3' ' O ' ' A' ' 3' ' ' SER . 88.6 mttt -57.16 -52.45 65.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.426 178.529 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -69.27 -28.1 66.01 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.365 -178.331 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -64.92 -44.56 89.13 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.125 0.488 . . . . 0.0 109.892 175.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.51 ' HG ' ' O ' ' A' ' 6' ' ' ILE . 51.9 mt -64.52 -42.7 95.62 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.283 177.386 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -63.49 -38.0 89.47 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.504 178.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -62.82 -50.32 71.45 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.097 179.056 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 37.9 pt -78.44 -7.0 9.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.763 0.316 . . . . 0.0 111.382 -178.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 76.07 36.41 40.94 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 121.119 -0.562 . . . . 0.0 112.619 177.138 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -95.69 157.48 15.88 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 179.345 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -73.68 122.99 23.2 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.187 0.518 . . . . 0.0 111.093 -177.358 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 93.2 t80 -105.64 120.01 40.58 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.987 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 15.3 tt -131.34 121.39 48.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.314 0.578 . . . . 0.0 110.576 175.148 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -108.38 108.27 19.17 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.046 178.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 24.7 tp -93.39 75.46 4.51 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 59.3 71.5 0.58 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.537 -177.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 68.38 11.64 8.43 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.172 -0.922 . . . . 0.0 112.004 178.357 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 79.3 mt-10 -115.13 113.99 24.72 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 174.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 40.7 mt -86.77 109.35 18.94 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 177.357 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.452 ' HA ' ' O ' ' A' ' 87' ' ' VAL . 24.8 m-70 -95.98 111.13 23.22 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -178.364 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.476 HD21 HD13 ' A' ' 10' ' ' LEU . 67.4 mt -113.32 163.3 15.01 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.44 0.638 . . . . 0.0 112.679 -170.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 33.7 tttp -62.63 129.61 92.94 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 114.46 -1.245 . . . . 0.0 109.681 173.439 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -51.12 -41.28 58.03 Favored 'Trans proline' 0 N--CA 1.473 0.308 0 C-N-CA 122.884 2.389 . . . . 0.0 112.518 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -53.78 -54.92 31.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.168 175.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 50.9 t -69.5 -41.12 80.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.712 -177.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -53.87 -42.01 68.15 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.476 179.105 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -59.18 -42.69 91.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.555 -179.285 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -78.26 -37.17 45.72 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.088 -178.087 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 95.8 t -62.43 -36.87 77.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.083 0.468 . . . . 0.0 109.86 175.016 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.443 ' CD1' ' HD2' ' A' ' 41' ' ' PRO . 35.3 t90 -55.78 -44.09 77.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.701 176.289 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.543 ' HA ' ' HG3' ' A' ' 40' ' ' GLU . 67.3 mttm -73.02 -31.67 64.61 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.656 -0.247 . . . . 0.0 111.325 179.23 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 83.8 t80 -67.23 -40.65 86.37 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.951 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.517 HG23 ' HD3' ' A' ' 41' ' ' PRO . 35.0 m -79.04 4.12 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -177.086 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 102.64 4.11 49.35 Favored Glycine 0 C--N 1.33 0.231 0 C-N-CA 120.767 -0.73 . . . . 0.0 113.241 174.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.543 ' HG3' ' HA ' ' A' ' 36' ' ' LYS . 54.0 mt-10 57.59 78.29 0.37 Allowed Pre-proline 0 C--O 1.236 0.347 0 C-N-CA 122.925 0.49 . . . . 0.0 111.95 -179.341 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.517 ' HD3' HG23 ' A' ' 38' ' ' VAL . 4.9 Cg_exo -77.89 175.3 11.36 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.738 2.292 . . . . 0.0 110.659 173.163 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -81.46 133.72 35.44 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.18 0.514 . . . . 0.0 110.12 178.262 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 89.7 mt -73.17 120.94 19.48 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.774 -172.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -96.53 118.4 32.95 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.197 176.148 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 24.2 p -109.47 143.12 39.52 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.052 -176.403 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 17.9 p90 -126.27 133.53 51.41 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.728 177.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.408 HG22 ' HB2' ' A' ' 74' ' ' LYS . 60.5 t -93.63 125.95 46.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.717 -179.01 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.518 HD11 ' HE3' ' A' ' 75' ' ' LYS . 13.7 pt -125.7 131.0 72.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.576 174.376 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.581 ' HB3' ' HG2' ' A' ' 70' ' ' LYS . 45.9 mt-10 -102.41 98.38 8.49 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.136 -179.211 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -93.08 154.73 17.93 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.964 -178.068 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.607 ' HB3' ' CG1' ' A' ' 68' ' ' VAL . 43.3 mt-10 -105.41 111.04 23.61 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.338 -172.453 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 44.0 pt -110.28 139.19 34.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.113 0.482 . . . . 0.0 110.811 177.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 6.5 m -107.05 97.57 5.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-O 121.275 0.56 . . . . 0.0 110.569 175.492 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.46 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 13.0 pt-20 -87.62 143.92 34.58 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 116.156 -0.474 . . . . 0.0 109.739 178.634 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 54' ' ' GLU . 35.7 Cg_exo -62.4 177.93 1.05 Allowed 'Trans proline' 0 C--O 1.237 0.438 0 C-N-CA 122.788 2.325 . . . . 0.0 112.867 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -135.26 43.66 1.24 Allowed Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.605 -177.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -63.85 -39.17 93.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.729 0.776 . . . . 0.0 108.914 175.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -121.17 135.06 55.22 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.629 -1.169 . . . . 0.0 108.55 175.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.41 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 10.9 p-10 -73.46 123.02 89.03 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-O 121.211 0.529 . . . . 0.0 111.556 -174.529 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.892 ' HD2' ' HE1' ' A' ' 65' ' ' TYR . 17.1 Cg_exo -68.08 153.45 74.93 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 122.951 2.434 . . . . 0.0 111.851 174.496 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 60' ' ' PRO . 22.4 Cg_exo -65.89 -16.23 51.99 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 123.162 2.574 . . . . 0.0 112.751 -179.104 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -78.75 116.37 19.05 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 177.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 66.0 mtt -84.1 -15.8 46.0 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.661 -177.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -86.63 72.69 10.18 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 172.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' TYR . . . . . 0.892 ' HE1' ' HD2' ' A' ' 60' ' ' PRO . 92.4 m-85 -64.83 121.38 14.45 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.633 -174.517 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 38.5 p -103.07 132.96 48.95 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.493 178.44 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -53.25 -51.98 60.47 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.219 0.533 . . . . 0.0 110.585 176.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.607 ' CG1' ' HB3' ' A' ' 51' ' ' GLU . 28.3 t -116.12 132.23 66.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.348 176.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 46.9 tptt -100.27 107.75 19.65 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.084 0.469 . . . . 0.0 110.264 -178.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.581 ' HG2' ' HB3' ' A' ' 49' ' ' GLU . 26.5 ttpp -85.41 116.51 23.78 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.759 178.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.478 ' O ' ' HA ' ' A' ' 49' ' ' GLU . 65.2 t -102.56 133.92 44.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.956 -174.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 60.9 mttm -86.06 96.96 10.03 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.328 179.15 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 15.1 tt -109.89 129.81 64.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.546 0.688 . . . . 0.0 110.66 178.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.491 ' O ' ' HB3' ' A' ' 90' ' ' TYR . 36.4 ttpt -108.86 115.71 30.59 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.075 -177.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.518 ' HE3' HD11 ' A' ' 48' ' ' ILE . 81.4 mttt -104.13 167.01 10.04 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.35 -0.386 . . . . 0.0 109.975 -179.316 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 14.6 p -122.51 146.79 27.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 120.925 0.393 . . . . 0.0 111.303 -173.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.463 ' HB3' HG22 ' A' ' 87' ' ' VAL . 48.1 p90 -149.85 164.82 34.34 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.132 175.55 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -134.23 149.25 50.96 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 169.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.569 ' HG2' ' HG2' ' A' ' 85' ' ' ARG . 41.6 mt-10 -102.5 138.21 39.72 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.681 -176.674 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 38.4 p -83.25 178.55 8.03 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.123 175.334 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.8 mp -62.73 -27.01 68.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.194 0.521 . . . . 0.0 110.726 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -99.98 15.04 28.48 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.715 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 64.1 34.59 11.06 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 171.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.409 ' HB ' ' HB3' ' A' ' 3' ' ' SER . 58.6 t -90.69 129.56 41.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 169.193 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.569 ' HG2' ' HG2' ' A' ' 79' ' ' GLU . 41.7 mtm-85 -98.88 114.91 27.73 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.976 0.417 . . . . 0.0 111.389 -172.684 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 45.6 t -89.7 113.09 25.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 174.557 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.463 HG22 ' HB3' ' A' ' 77' ' ' TYR . 19.3 t -113.28 148.2 16.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.937 -171.675 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 6.2 t -152.13 171.52 17.78 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.065 174.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -73.02 111.71 8.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.188 0.518 . . . . 0.0 110.368 177.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.491 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 15.3 t80 -72.14 -20.94 61.53 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.595 -177.099 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.4 m -62.64 -58.22 8.29 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-O 121.184 0.516 . . . . 0.0 110.068 178.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.402 ' O ' HG13 ' A' ' 96' ' ' ILE . 28.4 tt0 -67.53 -35.28 78.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.406 178.377 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.403 ' O ' HD23 ' A' ' 97' ' ' LEU . 55.2 t80 -59.78 -46.77 88.17 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.48 179.223 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.446 ' O ' ' HG3' ' A' ' 98' ' ' LYS . 69.5 mt-30 -58.61 -40.02 82.11 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.612 0.244 . . . . 0.0 110.906 176.361 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -63.22 -39.82 95.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.528 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.402 HG13 ' O ' ' A' ' 92' ' ' GLU . 80.1 mt -63.58 -42.27 95.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.743 177.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.403 HD23 ' O ' ' A' ' 93' ' ' PHE . 4.1 mm? -57.84 -43.31 85.78 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.681 176.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.446 ' HG3' ' O ' ' A' ' 94' ' ' GLN . 94.0 mttt -70.05 -41.83 73.67 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.693 178.461 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 60.5 tttm -60.3 -48.68 80.69 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.649 -178.053 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 62.4 ttt180 -78.38 -30.48 47.91 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.041 0.448 . . . . 0.0 110.523 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.72 45.35 6.83 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.681 -0.771 . . . . 0.0 111.869 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 23.1 m -72.24 -32.9 67.11 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.082 0.467 . . . . 0.0 110.267 178.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -107.5 149.99 27.33 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.715 176.364 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 86.5 mt -70.35 144.77 51.53 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.013 -175.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -68.85 -52.79 26.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.485 178.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 63.5 m80 -104.71 142.81 34.02 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.591 -176.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 56.8 m170 -100.62 134.07 44.13 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.622 -177.126 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -76.5 -29.7 56.92 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.473 178.249 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 72.3 t60 -128.65 133.5 48.27 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 173.056 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 33.3 m80 -81.6 138.59 35.34 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.788 0.328 . . . . 0.0 110.411 -176.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.233 -0.889 . . . . 0.0 109.641 176.605 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.611 ' HE2' HG12 ' A' ' 38' ' ' VAL . 26.0 mtm . . . . . 0 N--CA 1.476 0.866 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -98.01 153.89 18.08 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.795 175.342 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 36.6 p -61.28 -27.9 68.8 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.931 -177.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -57.59 -45.59 85.09 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.98 0.419 . . . . 0.0 110.38 178.336 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.1 t -62.85 -39.31 84.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.261 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.405 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 58.9 mt -62.45 -45.75 98.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.181 177.704 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 49.3 mttm -57.07 -48.73 77.86 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.091 177.258 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -59.45 -47.34 85.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.927 179.258 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -63.62 -47.71 80.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.354 -177.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.472 HD13 HD21 ' A' ' 26' ' ' LEU . 95.5 mt -62.31 -46.98 86.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.195 -177.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -79.01 -6.1 55.54 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.734 0.302 . . . . 0.0 111.497 -177.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -82.42 -45.97 14.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.126 0.489 . . . . 0.0 109.792 173.094 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 34.9 pt -77.48 -12.21 13.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.941 179.124 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.46 28.48 10.45 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.771 -0.728 . . . . 0.0 113.06 174.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.513 ' OE2' HG21 ' A' ' 30' ' ' VAL . 3.9 tp10 -88.05 137.23 32.51 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.153 0.501 . . . . 0.0 111.058 -179.037 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -104.3 110.54 22.8 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.301 175.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.414 ' CD1' ' HB2' ' A' ' 19' ' ' GLU . 27.1 p90 -102.79 154.73 18.89 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.152 -177.022 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 58.1 mt -97.34 102.06 12.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 175.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.414 ' HB2' ' CD1' ' A' ' 17' ' ' TYR . 35.9 tt0 -105.84 116.71 32.41 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.491 0.662 . . . . 0.0 111.822 -172.607 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -94.24 -168.17 1.81 Allowed 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 172.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -68.21 99.79 0.95 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.003 0.43 . . . . 0.0 110.304 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 62.53 32.86 16.35 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.498 -178.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.453 ' HG2' ' HB2' ' A' ' 85' ' ' ARG . 23.2 mt-10 -138.56 113.77 9.44 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.097 174.228 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.534 ' HB ' HG22 ' A' ' 86' ' ' VAL . 64.3 mt -99.8 104.5 16.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 178.127 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 31.1 m-70 -90.85 112.12 23.82 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.981 0.419 . . . . 0.0 110.032 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.472 HD21 HD13 ' A' ' 10' ' ' LEU . 56.5 mt -101.37 -175.62 2.91 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.525 -0.762 . . . . 0.0 111.524 -176.067 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -95.35 144.16 27.34 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.389 176.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.545 ' HA ' HG21 ' A' ' 88' ' ' THR . 5.9 Cg_exo -41.59 -49.79 5.06 Favored 'Trans proline' 0 CA--C 1.534 0.486 0 C-N-CA 124.033 3.155 . . . . 0.0 114.391 -175.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -72.33 -40.69 67.22 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.845 0.355 . . . . 0.0 111.142 -175.136 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.513 HG21 ' OE2' ' A' ' 15' ' ' GLU . 58.3 t -67.01 -40.5 85.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.636 -178.35 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -59.19 -40.33 85.35 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.453 177.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.596 ' HA ' ' HE1' ' A' ' 93' ' ' PHE . 20.6 t80 -61.12 -33.12 72.88 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.024 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -80.11 -43.59 21.45 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.889 -179.295 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.451 ' O ' HG13 ' A' ' 38' ' ' VAL . 59.5 t -65.58 -33.11 61.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.848 0.356 . . . . 0.0 110.507 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.469 ' O ' HG22 ' A' ' 38' ' ' VAL . 27.6 t90 -53.05 -40.05 63.68 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.09 176.558 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 78.2 mttt -70.15 -36.97 75.11 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.271 0.558 . . . . 0.0 110.292 178.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 23.0 t80 -73.07 -30.57 63.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.548 -174.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.611 HG12 ' HE2' ' A' ' 1' ' ' MET . 18.4 m -75.27 -2.17 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-O 120.916 0.389 . . . . 0.0 111.335 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 116.84 -9.45 16.17 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.883 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.413 ' N ' ' HD3' ' A' ' 41' ' ' PRO . 33.4 tt0 58.85 64.73 3.18 Favored Pre-proline 0 CA--C 1.538 0.487 0 CA-C-O 121.044 0.45 . . . . 0.0 111.131 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.504 ' HD3' HG23 ' A' ' 38' ' ' VAL . 92.3 Cg_endo -98.06 -173.24 0.17 Allowed 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 123.331 2.687 . . . . 0.0 112.193 179.448 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -79.25 116.51 19.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.073 0.463 . . . . 0.0 109.814 176.031 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.6 mt -75.24 156.72 35.43 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.2 -176.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 57.5 tttm -109.96 129.31 55.68 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.817 -177.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.0 p -109.17 149.52 29.25 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.617 -175.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.536 ' OH ' ' HD2' ' A' ' 75' ' ' LYS . 28.2 p90 -134.85 159.85 40.09 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 176.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 50.6 t -111.98 120.37 62.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 120.948 0.404 . . . . 0.0 110.911 -177.399 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 8.4 tt -110.48 115.5 49.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.262 0.553 . . . . 0.0 109.561 174.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.484 ' HG2' ' HG2' ' A' ' 72' ' ' LYS . 43.4 mt-10 -95.48 118.91 33.07 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.265 -177.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.4 ' O ' HG22 ' A' ' 71' ' ' VAL . 36.1 t70 -121.15 144.37 48.61 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 176.76 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.685 ' HG2' ' HG2' ' A' ' 70' ' ' LYS . 44.7 mt-10 -103.01 118.51 36.98 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.594 0.235 . . . . 0.0 110.62 -178.265 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 13.8 tt -74.35 138.73 20.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 176.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.8 m -90.46 131.31 37.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.362 0.601 . . . . 0.0 111.035 -175.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -87.28 162.61 42.59 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.024 -178.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.77 119.39 6.38 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.467 2.111 . . . . 0.0 112.071 175.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -135.39 44.17 1.19 Allowed Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -70.12 -172.79 0.59 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.724 -0.738 . . . . 0.0 111.635 -174.066 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 23.2 t80 -65.54 -27.44 68.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.125 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -147.55 106.79 3.78 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.264 177.124 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -85.31 138.62 6.59 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.682 2.255 . . . . 0.0 112.506 178.355 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -70.62 -22.4 28.18 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.52 2.146 . . . . 0.0 111.505 174.47 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 46.8 mm-40 -93.7 -159.41 0.69 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.476 175.238 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 65.2 mtm -69.03 166.14 18.7 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 174.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -76.3 -8.78 57.83 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.289 0.566 . . . . 0.0 110.552 178.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -135.74 135.28 39.86 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 173.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 11.4 t -138.4 -175.38 4.1 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.669 0.271 . . . . 0.0 110.658 -176.113 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -90.15 102.51 15.23 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.807 0.337 . . . . 0.0 111.825 -171.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 50.9 t -70.85 136.14 26.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.438 173.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 47.4 mttp -110.47 119.26 38.61 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.119 0.485 . . . . 0.0 111.762 -172.217 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.685 ' HG2' ' HG2' ' A' ' 51' ' ' GLU . 58.4 mttm -87.11 116.91 25.5 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.083 174.544 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.4 HG22 ' O ' ' A' ' 50' ' ' ASP . 30.8 m -99.13 118.34 45.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.362 0.601 . . . . 0.0 110.681 178.511 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.484 ' HG2' ' HG2' ' A' ' 49' ' ' GLU . 43.8 mttp -83.37 93.59 7.78 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.059 178.491 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 51.4 mm -92.03 110.26 22.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.27 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 41.0 ttpt -93.63 115.02 27.48 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.051 177.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.536 ' HD2' ' OH ' ' A' ' 46' ' ' TYR . 62.4 mttm -102.62 166.3 10.59 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 177.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 12.6 p -122.35 144.18 32.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.347 -176.076 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.452 ' HB3' HG22 ' A' ' 87' ' ' VAL . 36.8 p90 -149.8 165.94 30.98 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.02 0.438 . . . . 0.0 111.412 179.192 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.477 ' CE2' HG11 ' A' ' 38' ' ' VAL . 50.1 p90 -124.36 134.59 53.1 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.196 166.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.443 ' OE1' ' HD2' ' A' ' 85' ' ' ARG . 34.5 tt0 -103.87 118.11 35.93 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.164 -176.507 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 72.7 p -79.07 179.64 7.23 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.549 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 7.7 mp -66.6 -14.22 62.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.029 0.443 . . . . 0.0 110.658 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.514 ' HB2' HG23 ' A' ' 84' ' ' VAL . 1.9 m-20 -85.54 -1.73 57.41 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.621 -178.282 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 55.3 m-80 70.35 18.39 6.75 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 123.766 0.666 . . . . 0.0 110.423 -175.025 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.514 HG23 ' HB2' ' A' ' 82' ' ' ASP . 93.1 t -87.97 123.55 40.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.041 177.373 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.453 ' HB2' ' HG2' ' A' ' 23' ' ' GLU . 0.2 OUTLIER -100.01 108.87 21.17 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.905 -178.964 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.534 HG22 ' HB ' ' A' ' 24' ' ' ILE . 59.6 t -82.92 106.17 13.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 174.138 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.452 HG22 ' HB3' ' A' ' 77' ' ' TYR . 41.4 t -107.0 142.58 19.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.798 -169.131 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.545 HG21 ' HA ' ' A' ' 28' ' ' PRO . 96.0 m -152.07 153.81 34.69 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.309 174.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -64.41 119.02 9.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.288 0.566 . . . . 0.0 111.922 -178.113 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.43 ' H ' ' HA ' ' A' ' 75' ' ' LYS . 83.2 t80 -63.18 -37.48 87.4 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.806 -179.032 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.6 m -60.2 -45.41 93.26 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.751 178.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.449 ' HA ' ' HB3' ' A' ' 95' ' ' LYS . 22.0 mm-40 -77.93 -30.67 50.64 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.112 -179.403 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.596 ' HE1' ' HA ' ' A' ' 32' ' ' TYR . 75.7 t80 -61.03 -50.61 72.63 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.966 0.413 . . . . 0.0 110.405 177.204 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.649 ' HG2' HD12 ' A' ' 97' ' ' LEU . 45.4 mt-30 -77.31 -17.17 58.53 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.991 179.391 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.449 ' HB3' ' HA ' ' A' ' 92' ' ' GLU . 0.8 OUTLIER -69.35 -32.42 71.48 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 173.298 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.46 HD11 ' HB2' ' A' ' 28' ' ' PRO . 56.1 mt -79.03 -33.68 16.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.268 174.471 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.649 HD12 ' HG2' ' A' ' 94' ' ' GLN . 90.5 mt -59.94 -41.71 92.39 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 171.004 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 7.3 tmtt? -64.36 -40.36 95.69 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.805 176.065 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 56.7 tttm -62.11 -43.69 98.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.845 178.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 78.2 ttt180 -71.56 -45.44 62.29 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.967 0.413 . . . . 0.0 110.64 177.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 112.5 25.97 4.42 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.846 -0.692 . . . . 0.0 111.811 -177.329 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 42.6 m -85.18 113.77 21.8 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.952 0.406 . . . . 0.0 110.572 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 45.6 tttm -101.95 111.64 23.98 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.607 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 36.8 tp -98.31 71.21 2.05 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.119 179.348 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.491 ' HB2' ' CD2' ' A' ' 107' ' ' HIS . 37.8 mt-10 58.27 -165.58 0.17 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.134 178.566 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 17.4 t-80 -105.39 65.87 0.73 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 174.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.491 ' CD2' ' HB2' ' A' ' 105' ' ' GLU . 14.2 m170 -65.49 127.4 31.68 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 176.489 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -49.13 -49.25 43.0 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 -160.576 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 10.4 m-70 -77.68 76.64 4.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.455 0.645 . . . . 0.0 111.734 -177.218 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 45.8 m80 -156.5 -47.08 0.07 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 114.581 -1.19 . . . . 0.0 107.833 175.177 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 21.7 t-80 . . . . . 0 C--O 1.248 0.988 0 CA-C-N 114.462 -1.245 . . . . 0.0 108.421 172.817 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.501 ' HG2' ' HB ' ' A' ' 5' ' ' VAL . 15.0 tmm? . . . . . 0 N--CA 1.479 1.012 0 CA-C-O 121.098 0.475 . . . . 0.0 110.368 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -112.6 -172.66 2.09 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 174.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.478 ' O ' ' HG3' ' A' ' 7' ' ' LYS . 19.1 p -56.67 -33.02 65.97 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.947 0.404 . . . . 0.0 110.803 177.074 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -51.59 -51.52 54.84 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.801 178.004 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.501 ' HB ' ' HG2' ' A' ' 1' ' ' MET . 59.9 t -61.38 -48.65 87.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.928 -177.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.456 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 60.4 mt -54.4 -43.12 61.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.02 177.004 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.478 ' HG3' ' O ' ' A' ' 3' ' ' SER . 98.9 mttt -56.88 -49.24 76.13 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.163 178.574 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -61.01 -41.24 96.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.073 0.463 . . . . 0.0 110.529 -179.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.485 ' O ' HG13 ' A' ' 13' ' ' ILE . 74.5 t80 -62.22 -48.0 81.94 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.705 178.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.522 HD13 ' HB3' ' A' ' 17' ' ' TYR . 87.9 mt -69.45 -33.34 72.78 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.379 -177.383 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -65.66 -41.32 92.66 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.894 0.378 . . . . 0.0 110.137 176.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -64.05 -37.82 88.83 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.523 177.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.485 HG13 ' O ' ' A' ' 9' ' ' PHE . 59.6 mt -66.68 -41.05 87.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 121.432 0.634 . . . . 0.0 109.756 173.583 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.01 23.26 25.61 Favored Glycine 0 N--CA 1.446 -0.657 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.791 -179.251 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 47.8 mm-40 -98.02 158.92 15.26 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.152 0.501 . . . . 0.0 111.322 -178.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.403 ' HB2' ' HE3' ' A' ' 27' ' ' LYS . 9.3 m-20 -77.72 114.36 16.49 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.981 -177.517 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.522 ' HB3' HD13 ' A' ' 10' ' ' LEU . 39.3 p90 -111.13 112.15 23.75 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 170.244 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.553 ' HB ' ' HB2' ' A' ' 25' ' ' HIS . 51.6 mt -84.91 95.17 4.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.473 -175.601 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -76.05 114.03 14.24 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.095 176.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.551 ' HB2' ' HB2' ' A' ' 23' ' ' GLU . 93.6 mt -114.84 169.22 9.24 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 172.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.434 ' O ' ' HB2' ' A' ' 22' ' ' ASN . 40.6 mt-10 -64.39 107.35 1.32 Allowed 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.474 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.434 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 88.2 m-20 80.48 2.95 1.84 Allowed 'General case' 0 N--CA 1.47 0.575 0 O-C-N 124.593 1.183 . . . . 0.0 112.031 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.551 ' HB2' ' HB2' ' A' ' 20' ' ' LEU . 54.6 mt-10 -134.3 150.98 51.01 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.442 0.639 . . . . 0.0 112.424 -177.555 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 59.1 mt -130.95 109.78 17.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 166.435 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.553 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 11.7 m170 -89.96 125.09 35.25 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.106 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 39.8 mt -120.81 175.29 6.11 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.236 0.541 . . . . 0.0 111.388 -177.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.403 ' HE3' ' HB2' ' A' ' 16' ' ' ASP . 87.2 mttt -93.54 153.66 41.27 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.481 178.391 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_exo -48.45 -53.08 7.35 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 123.143 2.562 . . . . 0.0 113.571 -176.126 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -72.02 -37.13 69.83 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.851 0.357 . . . . 0.0 110.88 -176.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.462 ' O ' HG23 ' A' ' 34' ' ' VAL . 47.4 t -63.69 -40.46 89.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.28 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -61.92 -39.22 91.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.431 177.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -60.63 -43.31 97.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.596 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -64.62 -44.56 90.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.062 178.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 30' ' ' VAL . 91.2 t -65.74 -40.95 89.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.99 -179.506 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.433 ' CD1' ' HD2' ' A' ' 41' ' ' PRO . 28.1 t90 -55.04 -48.09 73.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.623 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.414 ' HA ' ' HG3' ' A' ' 40' ' ' GLU . 62.9 mttm -72.4 -31.02 65.18 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.266 179.287 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -63.0 -43.71 98.03 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.231 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.493 HG23 ' HD3' ' A' ' 41' ' ' PRO . 34.9 m -80.54 -5.87 8.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -177.011 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 108.53 12.56 20.98 Favored Glycine 0 C--N 1.331 0.263 0 C-N-CA 120.575 -0.822 . . . . 0.0 113.728 174.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.414 ' HG3' ' HA ' ' A' ' 36' ' ' LYS . 54.2 mt-10 55.25 78.39 0.39 Allowed Pre-proline 0 N--CA 1.466 0.359 0 C-N-CA 122.838 0.455 . . . . 0.0 111.856 178.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.493 ' HD3' HG23 ' A' ' 38' ' ' VAL . 95.1 Cg_endo -91.64 179.42 1.5 Allowed 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.852 2.368 . . . . 0.0 112.031 175.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -62.75 122.98 17.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.898 176.303 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 81.3 mt -92.2 132.16 36.87 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.669 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -97.57 137.62 36.21 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 31.6 p -122.41 135.48 54.7 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 120.825 0.345 . . . . 0.0 110.773 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.493 ' CE1' ' HB2' ' A' ' 75' ' ' LYS . 17.3 p90 -122.92 136.6 54.92 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.977 0.418 . . . . 0.0 110.294 179.127 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 50.3 t -96.89 105.0 16.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.981 178.103 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.469 HG23 ' HB ' ' A' ' 73' ' ' ILE . 8.4 tt -100.8 112.15 32.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 121.153 0.502 . . . . 0.0 110.189 178.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.492 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 45.4 tt0 -93.62 111.01 22.6 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 178.034 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -116.35 155.04 29.16 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.584 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.481 ' HG2' ' HG2' ' A' ' 70' ' ' LYS . 45.5 mt-10 -103.1 130.95 50.42 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.527 -177.536 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 60.2 mt 68.19 91.61 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.871 177.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 58.1 t -108.59 96.08 4.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.031 179.093 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.455 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 20.3 mt-10 -93.98 139.65 22.68 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.248 -178.779 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 54' ' ' GLU . 53.0 Cg_exo -55.2 -51.36 10.31 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 123.253 2.635 . . . . 0.0 113.199 -174.186 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -166.75 -36.11 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.661 -0.781 . . . . 0.0 111.812 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -98.46 136.83 38.03 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 172.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -84.03 152.71 24.25 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.696 -177.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.411 ' HA ' ' HD2' ' A' ' 60' ' ' PRO . 34.6 t70 -59.28 129.7 86.74 Favored Pre-proline 0 C--N 1.325 -0.481 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 172.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 59' ' ' ASP . 2.2 Cg_endo -40.95 111.86 0.17 Allowed 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 124.07 3.18 . . . . 0.0 112.969 -175.436 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 60' ' ' PRO . 33.9 Cg_endo -65.07 94.5 0.23 Allowed 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 123.076 2.517 . . . . 0.0 112.001 -178.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 54.7 mm-40 -127.33 177.24 6.84 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.431 -178.424 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 54.6 ttp -80.93 83.17 6.71 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 172.258 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -158.06 145.39 18.14 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.652 -171.178 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -96.85 94.19 7.09 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.82 0.343 . . . . 0.0 110.347 178.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 26.1 m -77.94 140.76 39.28 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.769 177.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -62.12 124.46 20.91 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.937 0.399 . . . . 0.0 111.304 -175.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 46.2 t -88.79 110.83 21.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.008 178.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 9.4 tmtm? -107.31 127.75 53.83 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.092 -179.005 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.481 ' HG2' ' HG2' ' A' ' 51' ' ' GLU . 67.3 mttm -87.22 128.34 35.15 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.858 179.188 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.492 ' O ' ' HA ' ' A' ' 49' ' ' GLU . 41.0 t -117.85 115.36 48.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 C-N-CA 121.199 -0.2 . . . . 0.0 110.744 -179.49 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -81.77 103.26 11.33 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 174.093 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.469 ' HB ' HG23 ' A' ' 48' ' ' ILE . 55.1 mt -98.54 108.98 23.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.681 -178.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 57.4 tttp -87.12 103.03 15.01 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 176.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.493 ' HB2' ' CE1' ' A' ' 46' ' ' TYR . 97.5 mttt -104.91 163.73 12.31 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.337 178.682 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.9 p -116.84 141.11 36.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.946 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.473 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 33.8 p90 -149.01 152.4 36.22 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.612 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -131.28 144.43 51.28 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 170.477 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -102.03 130.4 48.57 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.305 -175.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 32.9 p -76.13 178.99 5.95 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.152 174.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 8.2 mp -70.46 -23.96 62.8 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.71 0.29 . . . . 0.0 110.822 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -90.06 8.92 30.22 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.337 0.589 . . . . 0.0 109.608 175.239 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 65.77 30.39 10.16 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 114.711 -1.131 . . . . 0.0 112.906 171.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 43.3 t -87.89 127.28 41.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 171.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 34.2 mtt180 -93.25 108.38 20.02 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.214 -172.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 57.4 t -82.27 110.89 17.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 174.565 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 39.8 t -113.26 137.24 46.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.436 -171.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 59.1 m -148.27 154.74 40.44 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 174.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -66.61 126.27 28.4 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.95 0.405 . . . . 0.0 110.688 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -75.59 -26.19 57.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.68 -174.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.474 ' O ' ' HG3' ' A' ' 95' ' ' LYS . 28.1 t -69.74 -43.67 71.8 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.445 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -64.31 -39.16 93.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.102 0.477 . . . . 0.0 110.21 176.388 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -64.24 -42.32 96.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.372 178.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 26.3 mm-40 -60.58 -37.91 82.88 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.235 176.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.474 ' HG3' ' O ' ' A' ' 91' ' ' SER . 99.3 mttt -55.55 -49.68 72.03 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.862 0.363 . . . . 0.0 110.282 176.399 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 66.9 mt -64.05 -40.8 90.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.047 -178.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 97.4 mt -58.71 -46.65 86.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.1 0.476 . . . . 0.0 110.713 177.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 9.0 mtpm? -73.65 -34.51 64.99 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.064 -179.175 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -64.39 -44.84 90.05 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.996 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.43 HH11 ' HD3' ' A' ' 100' ' ' ARG . 52.1 mtt180 -84.99 -18.65 33.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.795 0.331 . . . . 0.0 111.194 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 78.02 33.81 39.87 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.834 -0.698 . . . . 0.0 111.773 -179.047 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 27.2 m -62.95 128.11 34.36 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.886 0.374 . . . . 0.0 110.341 -179.081 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -80.61 109.44 15.14 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.071 0.462 . . . . 0.0 110.755 -176.01 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 89.4 mt -86.29 154.47 21.23 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.44 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -70.33 100.73 1.78 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.103 -178.134 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -78.54 103.85 8.76 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.071 177.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -101.8 139.9 36.81 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.121 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 12.8 t-80 -82.68 -29.03 30.23 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 12.7 m80 -134.75 111.54 10.03 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.349 174.223 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 53.1 p-80 -64.49 -47.54 78.58 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 175.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 . . . . . 0 C--O 1.247 0.944 0 C-N-CA 123.9 0.88 . . . . 0.0 109.464 175.819 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.457 ' HA ' HG21 ' A' ' 5' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.988 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -143.9 178.08 8.09 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 179.202 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 35.3 p -64.08 -29.96 71.06 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.15 0.5 . . . . 0.0 110.146 175.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -64.75 -38.1 89.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.012 176.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.457 HG21 ' HA ' ' A' ' 1' ' ' MET . 95.9 t -62.64 -41.66 93.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.879 175.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 73.8 mt -62.42 -43.72 98.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.36 176.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 53.5 mttp -52.27 -53.71 40.54 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.744 175.264 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -70.63 -25.81 63.19 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.915 -175.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -67.46 -43.51 80.89 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.353 0.596 . . . . 0.0 109.905 174.381 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.489 HD13 ' HB3' ' A' ' 17' ' ' TYR . 69.8 mt -72.29 -34.31 68.06 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.392 178.334 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -64.0 -32.31 73.81 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.385 177.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -63.74 -58.88 5.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.614 179.05 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.8 pt -76.89 -17.36 14.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.797 -176.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 79.42 46.9 7.74 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.806 -179.493 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -97.78 169.18 9.85 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.929 0.395 . . . . 0.0 110.985 -178.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -96.94 137.25 36.33 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.112 -177.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.489 ' HB3' HD13 ' A' ' 10' ' ' LEU . 24.6 p90 -133.32 115.89 15.46 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.224 0.535 . . . . 0.0 110.223 173.389 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.461 ' HB ' ' HB2' ' A' ' 25' ' ' HIS . 57.4 mt -85.48 92.11 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 175.385 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.521 ' HG3' HG12 ' A' ' 24' ' ' ILE . 33.2 tt0 -103.51 104.46 14.53 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.247 -171.034 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 85.5 mt -79.61 -174.32 4.23 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 173.086 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -69.47 100.44 1.4 Allowed 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.042 0.448 . . . . 0.0 109.875 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 71.17 29.42 2.87 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.517 -177.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.565 ' HA ' ' O ' ' A' ' 85' ' ' ARG . 5.1 mt-10 -144.61 113.51 6.81 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 177.04 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.521 HG12 ' HG3' ' A' ' 19' ' ' GLU . 51.2 mt -101.2 108.21 22.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 110.175 -0.306 . . . . 0.0 110.175 179.343 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.54 ' HA ' ' O ' ' A' ' 87' ' ' VAL . 24.4 m-70 -96.18 119.12 34.1 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.77 0.319 . . . . 0.0 110.263 178.416 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 98.3 mt -116.33 173.58 6.52 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.166 -176.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.403 ' HB2' HG23 ' A' ' 30' ' ' VAL . 61.5 mttp -73.8 147.1 86.24 Favored Pre-proline 0 C--N 1.329 -0.318 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 172.397 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.472 ' HA ' HG21 ' A' ' 88' ' ' THR . 82.5 Cg_exo -47.07 -51.28 9.61 Favored 'Trans proline' 0 CA--C 1.53 0.284 0 C-N-CA 123.137 2.558 . . . . 0.0 113.606 -178.562 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -71.22 -34.33 70.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.748 0.309 . . . . 0.0 111.196 -177.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.453 ' O ' HG23 ' A' ' 34' ' ' VAL . 58.1 t -67.41 -45.96 84.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.939 0.399 . . . . 0.0 110.187 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -61.15 -38.58 86.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.079 175.026 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.509 ' HA ' ' HE1' ' A' ' 93' ' ' PHE . 19.1 t80 -56.74 -38.56 72.56 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.274 178.053 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -76.17 -36.68 58.59 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 121.139 -0.224 . . . . 0.0 111.182 177.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 30' ' ' VAL . 77.3 t -66.17 -33.12 61.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.093 0.473 . . . . 0.0 110.225 177.232 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.551 ' CZ2' ' HG3' ' A' ' 40' ' ' GLU . 45.9 t90 -56.98 -40.01 75.72 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.797 176.433 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 80.8 mttt -70.42 -42.67 71.29 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.195 0.522 . . . . 0.0 109.679 175.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -58.64 -38.9 79.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.086 -176.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.478 HG23 ' HD3' ' A' ' 41' ' ' PRO . 34.6 m -82.53 3.89 2.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.958 -178.138 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 100.57 14.68 31.66 Favored Glycine 0 C--N 1.329 0.193 0 C-N-CA 120.665 -0.779 . . . . 0.0 114.489 170.257 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.551 ' HG3' ' CZ2' ' A' ' 35' ' ' TRP . 35.7 tt0 57.09 72.78 0.88 Allowed Pre-proline 0 N--CA 1.468 0.456 0 CA-C-O 120.965 0.412 . . . . 0.0 111.359 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.478 ' HD3' HG23 ' A' ' 38' ' ' VAL . 78.4 Cg_endo -98.26 173.15 0.56 Allowed 'Trans proline' 0 N--CA 1.449 -1.1 0 C-N-CA 123.091 2.527 . . . . 0.0 112.135 175.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -75.02 146.58 41.47 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 173.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 82.3 mt -112.34 153.85 26.62 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.913 0.387 . . . . 0.0 111.426 -173.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.512 ' HE3' ' OE1' ' A' ' 79' ' ' GLU . 64.4 mttm -101.46 145.43 28.98 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.6 178.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 24.4 p -127.83 138.58 52.76 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.906 0.384 . . . . 0.0 111.278 -178.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -134.28 146.79 50.36 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.862 179.049 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.403 ' HA ' ' HA ' ' A' ' 74' ' ' LYS . 41.3 t -107.93 116.0 50.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 120.739 0.304 . . . . 0.0 110.659 -179.43 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 10.2 pt -107.12 139.92 27.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.377 175.655 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.595 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 25.7 mt-10 -116.89 87.89 2.79 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.238 -177.518 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -118.96 103.37 9.52 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.193 0.521 . . . . 0.0 111.533 -177.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.585 ' HB2' HG12 ' A' ' 71' ' ' VAL . 35.5 tt0 -140.87 -62.99 0.48 Allowed 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 170.611 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.591 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 11.3 tt -159.82 109.02 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.318 0.58 . . . . 0.0 110.589 173.052 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.2 m -105.48 154.96 6.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.0 176.399 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.477 ' HB3' HG11 ' A' ' 68' ' ' VAL . 15.8 pt-20 -92.81 138.66 23.43 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-O 120.803 0.335 . . . . 0.0 111.058 -176.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -83.83 -167.67 0.47 Allowed 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 122.913 2.409 . . . . 0.0 111.408 173.189 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -135.55 33.01 2.47 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.546 -0.835 . . . . 0.0 111.686 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 51.6 tt0 -61.16 -39.85 91.65 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.135 0.493 . . . . 0.0 110.059 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -119.0 93.03 3.95 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 174.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -69.14 109.54 4.57 Favored Pre-proline 0 C--N 1.323 -0.568 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -178.199 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.431 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 97.5 Cg_endo -84.12 159.98 13.45 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 122.97 2.447 . . . . 0.0 113.468 -169.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 60' ' ' PRO . 36.4 Cg_exo -62.75 165.41 16.11 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.782 2.321 . . . . 0.0 111.702 174.442 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -72.82 -5.8 40.6 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.424 -174.11 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 86.5 mtp -94.3 -10.71 31.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.938 178.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -121.08 136.53 54.96 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.444 -0.343 . . . . 0.0 110.76 -175.134 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 47.5 p90 -138.42 171.16 14.79 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.235 -0.439 . . . . 0.0 109.927 178.024 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 12.1 m -121.37 126.22 48.88 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.19 -177.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -80.81 100.91 9.05 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.141 0.495 . . . . 0.0 110.391 -177.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.591 ' HB ' ' O ' ' A' ' 52' ' ' ILE . 15.2 m -113.92 173.61 3.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.895 177.586 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.487 ' HE2' ' HB3' ' A' ' 69' ' ' LYS . 40.6 mtpt -130.33 135.96 48.61 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 121.369 0.604 . . . . 0.0 112.437 -172.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 49.4 mttm -113.96 114.1 25.72 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.324 175.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.595 ' O ' ' HA ' ' A' ' 49' ' ' GLU . 7.6 p -99.27 115.15 39.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 172.443 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -81.36 97.75 7.86 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.227 0.536 . . . . 0.0 110.927 -173.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 69.2 mt -102.96 109.23 26.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.075 177.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.526 ' O ' ' HB3' ' A' ' 90' ' ' TYR . 82.8 tttt -88.88 127.79 35.65 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.78 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.449 ' HA ' ' H ' ' A' ' 90' ' ' TYR . 72.5 mttt -124.59 165.25 18.19 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.657 0.265 . . . . 0.0 110.58 179.428 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 8.4 p -125.91 141.86 44.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.839 -173.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 14.0 p90 -155.34 168.36 27.34 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.83 0.348 . . . . 0.0 111.014 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -135.09 157.61 46.49 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.435 -0.579 . . . . 0.0 109.435 171.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.512 ' OE1' ' HE3' ' A' ' 44' ' ' LYS . 39.3 mt-10 -106.49 132.59 52.32 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.378 -176.547 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 69.7 p -84.66 166.97 16.64 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 175.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.469 HD23 ' H ' ' A' ' 81' ' ' LEU . 0.7 OUTLIER -67.7 -21.36 65.33 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.911 0.386 . . . . 0.0 110.496 178.022 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -90.81 16.9 8.44 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.103 178.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 66.6 t30 70.33 20.72 6.02 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 115.604 -0.725 . . . . 0.0 112.269 170.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 96.0 t -99.68 133.36 42.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.228 0.537 . . . . 0.0 110.208 176.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.565 ' O ' ' HA ' ' A' ' 23' ' ' GLU . 66.3 mtm180 -101.99 115.4 30.46 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.429 -176.75 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 43.1 t -91.84 108.57 20.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 177.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.54 ' O ' ' HA ' ' A' ' 25' ' ' HIS . 16.8 t -111.89 143.16 22.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.527 -170.146 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.472 HG21 ' HA ' ' A' ' 28' ' ' PRO . 91.4 m -150.66 154.46 37.51 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.887 176.277 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.63 120.44 13.45 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.827 0.822 . . . . 0.0 111.972 -177.377 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.526 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 82.4 t80 -65.65 -38.39 89.22 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.343 -1.298 . . . . 0.0 111.774 -173.193 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.503 ' O ' ' HG3' ' A' ' 95' ' ' LYS . 42.9 t -54.73 -56.62 17.25 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.634 -177.307 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 20.5 tp10 -71.39 -34.55 70.5 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.777 -175.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.509 ' HE1' ' HA ' ' A' ' 32' ' ' TYR . 83.8 t80 -64.01 -42.58 97.11 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.777 178.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 53.4 mm-40 -65.73 -31.63 72.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.304 178.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.535 ' O ' ' HG3' ' A' ' 99' ' ' LYS . 91.3 mttt -59.53 -44.76 93.11 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 174.769 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 65.1 mt -56.04 -50.06 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.772 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 87.5 mt -63.82 -36.4 83.77 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.597 179.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 59.1 tttm -66.57 -41.96 87.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.653 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.535 ' HG3' ' O ' ' A' ' 95' ' ' LYS . 90.9 mttt -64.29 -37.17 86.53 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.755 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 33.1 mtp180 -67.43 -32.52 73.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.351 176.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 79.19 36.13 28.33 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.375 -0.917 . . . . 0.0 110.858 -175.119 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 21.6 m -71.37 129.22 38.28 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.304 -0.448 . . . . 0.0 110.873 -177.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -91.43 129.73 37.37 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.35 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 92.3 mt -80.78 4.47 18.93 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.5 0.667 . . . . 0.0 109.787 176.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -95.62 109.28 21.55 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.409 179.232 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 34.2 m170 -90.7 90.15 7.82 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 173.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 80.6 m-70 -83.36 125.66 31.89 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.988 0.423 . . . . 0.0 111.411 -176.099 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 14.6 t-80 -86.09 107.86 18.02 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.785 174.378 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 44.7 m-70 -91.54 169.84 10.42 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 55.1 t-80 -79.44 -49.24 12.62 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 85.9 t60 . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.223 -0.894 . . . . 0.0 110.769 178.375 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.0 ppp? . . . . . 0 N--CA 1.478 0.926 0 CA-C-O 121.114 0.483 . . . . 0.0 110.66 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -136.89 172.34 13.15 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.404 178.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.8 m -62.88 -34.34 77.18 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.307 0.575 . . . . 0.0 110.166 178.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -67.7 -35.38 78.69 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.899 176.459 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 89.8 t -64.59 -34.76 71.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.066 0.46 . . . . 0.0 110.131 178.239 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 74.7 mt -63.54 -44.82 98.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.91 -0.587 . . . . 0.0 109.948 174.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -59.84 -46.41 89.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.407 177.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -51.07 -49.59 60.34 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.173 176.055 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -62.4 -43.58 98.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.011 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.482 HD13 ' HB3' ' A' ' 17' ' ' TYR . 96.7 mt -69.61 -35.94 75.73 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.58 -177.227 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -70.24 -33.39 71.57 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 121.071 -0.252 . . . . 0.0 110.607 176.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -62.8 -53.77 49.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.584 178.152 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 30.1 pt -72.42 -24.49 22.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.121 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.54 47.43 4.59 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.022 178.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -111.37 -179.8 3.82 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.125 0.488 . . . . 0.0 111.387 -178.22 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -122.03 130.84 53.63 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.009 -173.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.482 ' HB3' HD13 ' A' ' 10' ' ' LEU . 51.5 p90 -123.04 144.56 49.2 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.565 177.597 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.573 ' HB ' ' HB2' ' A' ' 25' ' ' HIS . 75.5 mt -90.08 99.72 9.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 177.06 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.446 ' HB2' ' CE1' ' A' ' 17' ' ' TYR . 37.8 tt0 -92.56 106.98 18.86 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.089 -175.019 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 70.5 mt -112.58 166.31 11.45 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 172.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -60.39 106.03 0.49 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.043 0.449 . . . . 0.0 110.723 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 68.78 14.88 8.99 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 114.87 -1.059 . . . . 0.0 112.187 -179.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -138.46 113.71 9.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.873 0.368 . . . . 0.0 111.153 178.204 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.494 ' HB ' HG22 ' A' ' 86' ' ' VAL . 66.5 mt -105.28 104.76 17.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 174.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.573 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 20.0 m-70 -91.65 115.79 28.34 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -179.225 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 73.4 mt -105.16 153.76 21.11 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.953 -177.123 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.5 mtmm -77.22 133.76 68.08 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 173.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.488 ' HB2' HD11 ' A' ' 96' ' ' ILE . 7.0 Cg_endo -48.52 -43.97 31.62 Favored 'Trans proline' 0 CA--C 1.529 0.257 0 C-N-CA 123.685 2.923 . . . . 0.0 113.145 -175.408 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -57.4 -34.54 68.98 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 121.104 0.478 . . . . 0.0 111.504 -178.195 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 47.1 t -94.43 -32.17 4.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.733 -176.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.488 ' HE1' ' HE1' ' A' ' 78' ' ' PHE . 81.8 t80 -56.72 -35.23 68.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.187 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -58.98 -33.72 71.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.366 -178.452 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -77.94 -44.37 27.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.819 0.343 . . . . 0.0 110.594 179.191 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 46.3 t -63.67 -36.52 76.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.76 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.434 ' CD1' ' HD2' ' A' ' 41' ' ' PRO . 27.2 t90 -55.25 -45.38 76.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.941 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.417 ' HG2' ' HG2' ' A' ' 40' ' ' GLU . 74.8 mttt -78.2 -33.17 50.14 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.969 -0.293 . . . . 0.0 111.082 -179.673 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 91.1 t80 -58.11 -37.37 74.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.879 178.562 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.424 HG23 ' HD3' ' A' ' 41' ' ' PRO . 33.6 m -89.73 7.83 3.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.757 -177.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 99.7 15.57 31.28 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.718 -0.753 . . . . 0.0 113.967 172.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.417 ' HG2' ' HG2' ' A' ' 36' ' ' LYS . 49.2 mt-10 54.54 67.7 3.17 Favored Pre-proline 0 N--CA 1.469 0.52 0 C-N-CA 122.693 0.397 . . . . 0.0 111.424 179.105 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.434 ' HD2' ' CD1' ' A' ' 35' ' ' TRP . 5.7 Cg_exo -78.05 162.86 28.68 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 122.884 2.39 . . . . 0.0 111.958 -179.307 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -69.24 139.01 54.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.628 176.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.565 ' HB3' ' CG2' ' A' ' 76' ' ' VAL . 94.8 mt -111.05 134.29 52.77 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.216 -173.287 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -104.59 139.05 40.02 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.269 -0.423 . . . . 0.0 109.918 177.253 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 19.4 p -106.33 140.97 38.42 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.186 -178.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 6.5 p90 -124.84 153.71 42.15 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 175.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 66.5 t -111.91 113.51 44.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-O 121.024 0.44 . . . . 0.0 111.183 -174.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.451 HG23 ' HB ' ' A' ' 73' ' ' ILE . 8.2 tt -104.69 105.51 18.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 173.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.522 ' HB2' ' HG2' ' A' ' 72' ' ' LYS . 39.1 tt0 -85.49 116.56 23.87 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.606 -178.281 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -109.22 147.23 32.9 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.278 178.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.719 ' HG2' ' HG2' ' A' ' 70' ' ' LYS . 49.4 mt-10 -103.21 117.57 34.83 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.114 0.483 . . . . 0.0 111.252 -178.267 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 6.4 tp -89.71 132.13 35.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.762 178.203 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.1 t -90.59 141.95 13.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.173 -177.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -87.41 139.0 31.81 Favored Pre-proline 0 C--N 1.321 -0.654 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -31.93 110.24 0.04 OUTLIER 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 124.345 3.364 . . . . 0.0 114.065 -178.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -135.5 38.39 1.8 Allowed Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.044 178.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -68.82 -30.56 69.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.629 0.728 . . . . 0.0 109.324 179.037 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -124.8 -175.62 3.33 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.13 174.13 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.472 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 9.5 m-20 -101.73 146.29 31.99 Favored Pre-proline 0 C--N 1.321 -0.672 0 CA-C-O 120.78 0.324 . . . . 0.0 111.022 -177.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' A' ' 59' ' ' ASP . 12.1 Cg_exo -71.02 160.92 47.81 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 123.013 2.476 . . . . 0.0 111.699 177.145 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -65.94 -24.15 53.59 Favored 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 122.725 2.284 . . . . 0.0 112.318 178.309 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -93.12 167.82 11.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.482 177.43 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 91.2 mmm -97.79 21.41 10.53 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.038 -175.263 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 52.0 mttp -120.93 144.56 48.38 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.806 0.336 . . . . 0.0 110.725 -178.132 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -111.39 144.18 41.01 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.548 176.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 16.4 p -92.48 -179.3 5.16 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.895 0.379 . . . . 0.0 111.905 -176.036 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 34.1 m-80 -93.13 166.23 12.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.124 -178.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.518 ' CG1' ' HB3' ' A' ' 51' ' ' GLU . 3.8 t -79.43 153.85 4.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 -179.346 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 17.1 tttp -100.06 116.47 32.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.712 0.291 . . . . 0.0 110.28 -176.042 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.719 ' HG2' ' HG2' ' A' ' 51' ' ' GLU . 58.5 mttp -84.99 130.88 34.55 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.805 0.336 . . . . 0.0 111.689 -177.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 15.3 m -127.97 120.23 53.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.46 0.648 . . . . 0.0 110.464 173.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.522 ' HG2' ' HB2' ' A' ' 49' ' ' GLU . 60.5 mttp -81.57 115.26 20.77 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.934 -179.555 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.451 ' HB ' HG23 ' A' ' 48' ' ' ILE . 60.9 mt -95.17 110.58 24.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.934 177.456 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -90.02 115.4 27.27 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.464 -178.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.451 ' HA ' ' H ' ' A' ' 90' ' ' TYR . 68.6 mttm -118.22 167.11 11.82 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.299 178.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.565 ' CG2' ' HB3' ' A' ' 43' ' ' LEU . 12.0 p -126.19 150.09 31.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.636 -0.256 . . . . 0.0 110.616 -174.204 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -155.09 164.68 38.53 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.798 0.332 . . . . 0.0 110.77 179.277 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.488 ' HE1' ' HE1' ' A' ' 31' ' ' PHE . 50.7 p90 -134.69 152.67 51.94 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 170.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.543 ' HG2' ' HG2' ' A' ' 85' ' ' ARG . 33.7 mt-10 -102.31 127.07 49.46 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.162 -175.732 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 81.1 p -83.97 174.88 9.97 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.742 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.9 mp -71.2 -12.08 61.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.113 0.482 . . . . 0.0 110.613 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -92.22 4.76 52.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.491 -179.157 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 66.8 t30 70.88 21.26 5.13 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.728 0.775 . . . . 0.0 109.884 -178.092 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 99.2 t -100.05 136.46 31.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.643 178.371 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.543 ' HG2' ' HG2' ' A' ' 79' ' ' GLU . 69.0 mtt180 -107.5 119.22 38.8 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.148 0.499 . . . . 0.0 111.243 -176.704 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.494 HG22 ' HB ' ' A' ' 24' ' ' ILE . 87.1 t -89.63 111.06 22.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.675 177.406 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.412 ' O ' ' HA ' ' A' ' 25' ' ' HIS . 40.9 t -105.62 140.42 23.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.18 -173.233 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 58.9 m -147.91 152.45 37.58 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 176.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -67.87 126.92 30.96 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.782 0.325 . . . . 0.0 110.724 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.451 ' H ' ' HA ' ' A' ' 75' ' ' LYS . 49.9 t80 -77.97 -30.23 50.14 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.045 -174.636 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 9.4 t -71.96 -40.63 68.52 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 -179.071 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.423 ' O ' HG13 ' A' ' 96' ' ' ILE . 35.8 mt-10 -69.49 -37.55 77.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.635 176.122 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -61.75 -47.22 86.18 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.931 0.396 . . . . 0.0 110.479 177.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 68.4 mm-40 -65.65 -31.33 72.28 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.016 178.138 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 57.9 tptt -66.19 -36.13 82.27 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 176.139 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.488 HD11 ' HB2' ' A' ' 28' ' ' PRO . 64.7 mt -67.12 -38.8 81.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.054 0.454 . . . . 0.0 110.501 176.013 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 73.1 mt -63.13 -25.97 68.6 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.166 176.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -79.37 -26.68 41.98 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.064 176.287 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.445 ' HG3' ' HA ' ' A' ' 96' ' ' ILE . 33.5 mttp -61.92 -51.62 67.38 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-O 121.239 0.542 . . . . 0.0 109.875 175.514 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -86.19 -30.03 22.75 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.035 -173.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.15 50.58 4.78 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.266 -175.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.43 HG22 ' H ' ' A' ' 104' ' ' LEU . 35.9 m -64.68 115.01 4.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.983 0.42 . . . . 0.0 110.882 -178.46 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -80.37 6.32 12.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.055 -173.376 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.43 ' H ' HG22 ' A' ' 102' ' ' THR . 72.3 mt -72.22 -23.54 61.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.886 0.374 . . . . 0.0 110.667 178.35 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -132.74 157.88 43.81 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.769 175.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 67.1 m-70 57.77 87.35 0.07 Allowed 'General case' 0 N--CA 1.466 0.358 0 O-C-N 123.851 0.719 . . . . 0.0 111.179 174.382 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -95.11 -16.92 22.26 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.34 -175.599 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 48.5 m-70 -107.89 137.8 45.27 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.29 176.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 59.9 m80 -88.9 87.85 7.38 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.465 0.65 . . . . 0.0 110.676 -178.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -91.22 134.4 34.59 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.047 -178.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 46.0 m80 . . . . . 0 C--O 1.248 0.992 0 CA-C-O 118.369 -0.824 . . . . 0.0 110.163 179.52 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.067 0 CA-C-O 120.821 0.343 . . . . 0.0 110.119 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -120.42 172.14 8.03 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 176.252 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.7 p -63.83 -28.29 69.75 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.089 0.471 . . . . 0.0 110.102 175.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -62.33 -43.47 98.75 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.031 175.27 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 99.5 t -61.26 -39.63 83.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.033 176.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.555 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 63.5 mt -63.44 -41.48 92.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.3 177.386 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -54.95 -49.56 71.08 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.768 177.037 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -60.3 -36.9 78.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.898 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.464 ' O ' HG12 ' A' ' 13' ' ' ILE . 90.5 t80 -67.95 -44.43 76.78 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.299 177.431 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.555 ' HG ' ' O ' ' A' ' 6' ' ' ILE . 86.2 mt -66.73 -43.37 84.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.261 -178.467 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -65.57 -30.07 70.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.954 0.406 . . . . 0.0 110.938 179.01 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -75.23 -47.3 28.81 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.26 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.464 HG12 ' O ' ' A' ' 9' ' ' PHE . 40.3 pt -77.85 -37.92 24.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 121.041 -0.264 . . . . 0.0 111.504 -178.186 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 114.36 75.76 0.67 Allowed Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.904 178.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.571 ' HG2' HD22 ' A' ' 26' ' ' LEU . 3.8 tp10 -132.83 133.59 43.55 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 174.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -102.09 106.9 17.84 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 176.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.572 ' HB3' HD23 ' A' ' 26' ' ' LEU . 11.0 p90 -111.08 153.02 26.26 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.199 0.524 . . . . 0.0 112.241 -171.673 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.532 ' HB ' ' HB2' ' A' ' 25' ' ' HIS . 64.5 mt -89.35 107.18 17.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.355 174.531 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -94.29 97.74 10.44 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.38 0.61 . . . . 0.0 110.789 -179.373 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 91.9 mt -101.4 162.04 13.19 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 171.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -64.66 116.32 6.11 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 119.954 -0.699 . . . . 0.0 109.931 -178.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.445 ' O ' ' HG2' ' A' ' 85' ' ' ARG . 72.5 m-20 75.65 7.32 3.87 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 114.977 -1.011 . . . . 0.0 111.765 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -140.03 113.83 8.77 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-O 121.083 0.468 . . . . 0.0 112.191 -179.296 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 70.8 mt -109.4 116.36 51.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 173.495 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.532 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 23.6 m-70 -98.44 121.77 40.79 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.644 0.259 . . . . 0.0 111.073 -177.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.572 HD23 ' HB3' ' A' ' 17' ' ' TYR . 91.8 mt -117.25 161.81 18.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.633 -179.191 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 34.1 mttp -72.63 144.98 86.75 Favored Pre-proline 0 C--N 1.328 -0.356 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 172.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_exo -52.01 -33.75 54.05 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.25 1.966 . . . . 0.0 111.391 174.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -53.28 -57.31 10.98 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.168 175.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.4 ' O ' HG23 ' A' ' 34' ' ' VAL . 45.1 t -79.57 -36.35 17.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.048 -175.615 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -55.21 -38.85 68.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.411 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.584 ' HA ' ' HE1' ' A' ' 93' ' ' PHE . 23.8 t80 -55.56 -44.82 77.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.426 177.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -78.89 -32.52 45.87 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.176 -177.442 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 30' ' ' VAL . 84.7 t -65.22 -38.59 83.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 175.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 29.6 t90 -57.89 -42.33 84.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.117 176.485 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -63.02 -47.09 84.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.643 174.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 88.9 t80 -59.06 -43.88 91.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.044 -177.238 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.532 HG23 ' HD3' ' A' ' 41' ' ' PRO . 34.1 m -75.23 -8.46 11.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -175.287 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 108.21 5.02 32.93 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.442 -0.885 . . . . 0.0 113.107 175.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 57.02 76.03 0.52 Allowed Pre-proline 0 C--N 1.329 -0.307 0 C-N-CA 122.862 0.465 . . . . 0.0 112.014 178.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.532 ' HD3' HG23 ' A' ' 38' ' ' VAL . 57.7 Cg_endo -93.5 -172.63 0.33 Allowed 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 123.218 2.612 . . . . 0.0 111.22 175.481 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -72.02 148.15 46.15 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.085 0.469 . . . . 0.0 110.557 176.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.406 ' HB3' ' CG2' ' A' ' 76' ' ' VAL . 83.7 mt -111.95 132.76 54.56 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.225 -179.376 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -96.37 140.23 31.33 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 177.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 43.7 p -119.87 140.77 50.32 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 120.695 0.283 . . . . 0.0 110.527 178.372 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.401 ' CE1' ' HB2' ' A' ' 75' ' ' LYS . 10.4 p90 -122.68 141.8 51.36 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 177.612 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 48.2 t -97.37 108.57 21.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.786 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 10.1 tt -113.17 137.64 45.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.207 -179.008 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -96.1 87.85 4.67 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.26 177.097 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -94.12 100.26 12.39 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 167.345 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.735 ' HG2' ' HA ' ' A' ' 70' ' ' LYS . 30.8 mt-10 -77.87 147.02 35.31 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.574 -1.194 . . . . 0.0 111.438 -168.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 51.3 mm -110.86 88.61 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.365 0.602 . . . . 0.0 109.495 176.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.598 HG22 ' HA ' ' A' ' 68' ' ' VAL . 46.1 t -94.63 95.41 5.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.698 179.155 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.417 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 10.9 pt-20 -99.36 125.58 40.69 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-O 121.124 0.488 . . . . 0.0 110.175 179.417 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 54' ' ' GLU . 19.6 Cg_exo -67.03 169.13 15.62 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.705 2.27 . . . . 0.0 112.383 178.216 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -135.35 44.03 1.2 Allowed Glycine 0 N--CA 1.447 -0.592 0 N-CA-C 110.661 -0.976 . . . . 0.0 110.661 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -65.32 76.44 0.06 Allowed 'General case' 0 C--O 1.234 0.274 0 N-CA-C 112.454 0.538 . . . . 0.0 112.454 -173.382 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.413 ' HB2' ' H ' ' A' ' 59' ' ' ASP . 37.3 m-85 -145.84 -80.18 0.16 Allowed 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 173.125 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.413 ' H ' ' HB2' ' A' ' 58' ' ' TYR . 34.3 t70 172.37 101.27 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 114.051 -1.431 . . . . 0.0 107.805 172.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -53.31 111.73 0.75 Allowed 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 123.302 2.668 . . . . 0.0 113.428 -173.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -86.67 -20.81 2.4 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 122.937 2.425 . . . . 0.0 111.957 176.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -119.26 148.37 43.22 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.752 -178.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 95.6 mmm -102.62 -167.79 1.44 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.661 -179.118 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 62.1 mttp 63.2 26.69 15.33 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.542 0.687 . . . . 0.0 109.287 -171.173 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 22.6 t80 -91.52 128.51 37.38 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.224 -175.341 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.2 m -130.48 113.0 13.74 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.445 -179.136 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.509 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 6.0 m-20 -70.69 -44.06 67.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.937 0.399 . . . . 0.0 110.817 178.187 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.598 ' HA ' HG22 ' A' ' 53' ' ' VAL . 40.1 t -78.79 88.04 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.099 0.476 . . . . 0.0 110.548 -177.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 60.4 tttm -100.24 107.82 19.74 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.723 176.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.735 ' HA ' ' HG2' ' A' ' 51' ' ' GLU . 66.2 mttm -80.3 111.49 16.74 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.262 -178.182 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.8 t -103.47 102.94 14.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.766 -175.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 51.8 mttm -81.88 99.04 8.82 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.304 176.069 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.586 HG22 ' HG3' ' A' ' 75' ' ' LYS . 44.3 mm -97.46 120.23 46.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.174 0.511 . . . . 0.0 110.55 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.539 ' O ' ' HB3' ' A' ' 90' ' ' TYR . 57.2 tttp -85.58 101.87 13.06 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.283 178.312 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.586 ' HG3' HG22 ' A' ' 73' ' ' ILE . 74.6 mttt -102.43 154.96 18.58 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.171 -177.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.406 ' CG2' ' HB3' ' A' ' 43' ' ' LEU . 14.9 p -116.84 147.79 19.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.639 0.256 . . . . 0.0 111.258 -172.347 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.477 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 50.6 p90 -153.79 154.04 33.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.935 178.434 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -123.76 149.54 45.49 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 171.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -102.77 135.71 43.92 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.709 -174.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 59.7 p -89.85 -176.3 4.89 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.617 179.161 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.525 HD13 ' O ' ' A' ' 81' ' ' LEU . 2.1 tm? -63.89 -24.64 67.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.28 0.562 . . . . 0.0 109.803 178.047 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.426 ' O ' ' HB2' ' A' ' 83' ' ' ASN . 0.8 OUTLIER -81.75 1.33 34.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.841 -177.237 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.426 ' HB2' ' O ' ' A' ' 82' ' ' ASP . 47.1 m-80 71.46 6.62 5.8 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 123.572 0.545 . . . . 0.0 110.776 -176.114 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 85.1 t -83.55 132.54 31.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.731 178.16 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.445 ' HG2' ' O ' ' A' ' 22' ' ' ASN . 40.9 ptt180 -101.4 131.35 47.54 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.398 0.618 . . . . 0.0 111.109 -177.369 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.477 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 59.5 t -94.17 111.26 24.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.384 177.092 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.473 HG22 ' HB3' ' A' ' 77' ' ' TYR . 16.1 t -104.92 142.91 17.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.285 -171.529 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 8.1 t -151.42 -173.21 4.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.646 175.247 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -84.83 119.51 25.4 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.899 0.381 . . . . 0.0 110.56 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.539 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 76.3 t80 -70.28 -40.85 74.08 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.484 -176.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.587 ' O ' ' HG3' ' A' ' 95' ' ' LYS . 18.0 m -58.75 -56.94 15.72 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.36 -174.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.47 ' O ' HG13 ' A' ' 96' ' ' ILE . 33.1 mt-10 -75.29 -27.35 59.32 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 -176.268 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.584 ' HE1' ' HA ' ' A' ' 32' ' ' TYR . 65.7 t80 -61.78 -47.86 83.24 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 175.174 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 81.5 mm-40 -65.33 -28.84 69.58 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.946 178.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.587 ' HG3' ' O ' ' A' ' 91' ' ' SER . 65.9 mttm -68.49 -25.01 64.76 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.495 176.185 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.47 HG13 ' O ' ' A' ' 92' ' ' GLU . 77.0 mt -72.93 -39.4 58.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 174.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -63.11 -39.43 94.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.167 0.508 . . . . 0.0 109.822 173.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 62.6 mmtt -65.19 -37.34 87.04 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.114 174.515 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -63.11 -47.63 82.02 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.69 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 55.2 ttt180 -72.15 -34.31 68.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.747 177.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 94.22 41.03 4.38 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.871 -178.291 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 20.1 m -84.2 -24.09 30.25 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.406 0.622 . . . . 0.0 110.212 177.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -116.04 103.63 10.76 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.144 174.244 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 91.7 mt -85.53 139.73 31.22 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.598 -172.114 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 24.0 mp0 -92.74 -176.87 4.38 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.791 175.149 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 73.9 t60 -77.86 -14.71 59.47 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.376 0.608 . . . . 0.0 110.335 177.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 21.4 t-160 -82.95 42.33 0.79 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.398 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 63.7 m-70 -130.4 -40.58 1.26 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.811 176.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 16.8 t60 -71.65 -28.88 64.06 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 177.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -116.29 131.74 56.86 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.348 173.431 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 45.1 t-80 . . . . . 0 C--O 1.246 0.89 0 CA-C-O 118.568 -0.73 . . . . 0.0 109.974 -179.814 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.414 ' O ' HD13 ' A' ' 81' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.045 0 CA-C-O 120.734 0.302 . . . . 0.0 110.627 . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -136.86 171.05 15.07 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 176.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.423 ' O ' ' HG3' ' A' ' 7' ' ' LYS . 7.1 m -61.97 -36.03 80.25 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.861 0.363 . . . . 0.0 110.282 179.542 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -62.44 -42.5 99.5 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.152 175.643 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 67.3 t -60.06 -42.21 89.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.696 178.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.477 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 67.3 mt -62.18 -42.13 94.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.396 178.53 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.423 ' HG3' ' O ' ' A' ' 3' ' ' SER . 95.5 mttt -57.43 -51.23 70.26 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.839 178.674 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -60.28 -48.18 82.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.475 178.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.491 ' CE2' HD11 ' A' ' 13' ' ' ILE . 72.5 t80 -55.41 -41.73 73.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.99 -178.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 6' ' ' ILE . 93.0 mt -64.64 -42.67 95.3 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.094 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -70.81 -34.45 71.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.776 0.322 . . . . 0.0 110.606 178.249 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -60.49 -37.46 81.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.568 175.629 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.491 HD11 ' CE2' ' A' ' 9' ' ' PHE . 64.2 mt -74.19 -41.87 51.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.157 0.503 . . . . 0.0 109.949 174.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 109.17 24.5 5.95 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.485 -175.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 82.5 mm-40 -102.3 -179.73 4.07 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.74 0.305 . . . . 0.0 110.584 -179.34 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -128.13 173.27 10.24 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 -179.287 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.476 ' HB3' HD13 ' A' ' 10' ' ' LEU . 30.0 p90 -158.51 141.32 14.57 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.765 0.317 . . . . 0.0 110.371 -178.417 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.551 ' HB ' ' HB2' ' A' ' 25' ' ' HIS . 69.7 mt -97.76 103.22 14.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 120.937 0.399 . . . . 0.0 110.2 179.549 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -89.49 118.21 28.97 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.55 -179.526 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 83.4 mt -116.07 -166.4 1.14 Allowed 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 175.102 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -67.15 101.79 0.94 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.888 0.375 . . . . 0.0 111.067 -179.335 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 48.6 m-80 64.88 15.98 10.22 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.601 177.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -132.44 128.25 37.08 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.301 -179.259 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.439 ' HB ' HG22 ' A' ' 86' ' ' VAL . 65.1 mt -109.55 106.65 21.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 172.208 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.551 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 20.4 m170 -87.41 115.49 24.86 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -178.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.42 HD21 HD11 ' A' ' 10' ' ' LEU . 0.3 OUTLIER -98.18 161.01 13.93 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.391 -173.806 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -74.63 131.25 80.08 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.139 174.366 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.495 ' HA ' HG21 ' A' ' 88' ' ' THR . 89.8 Cg_exo -43.01 -50.23 6.41 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 123.825 3.017 . . . . 0.0 114.29 -174.07 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -75.15 -33.01 61.47 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.703 0.287 . . . . 0.0 111.655 -175.452 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.436 ' O ' HG23 ' A' ' 34' ' ' VAL . 21.8 t -74.12 -35.49 41.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.842 0.353 . . . . 0.0 110.305 -178.271 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -54.93 -38.49 67.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.877 179.32 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 73.8 t80 -59.14 -42.22 90.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.154 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -78.03 -31.16 50.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.985 -178.546 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 30' ' ' VAL . 92.8 t -65.38 -38.66 83.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.013 0.435 . . . . 0.0 109.838 175.25 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 26.9 t90 -57.34 -44.87 84.64 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.785 176.752 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.413 ' NZ ' ' HB3' ' A' ' 36' ' ' LYS . 8.3 mtpm? -80.02 -0.09 33.95 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.78 0.324 . . . . 0.0 111.24 -179.191 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -96.19 -39.58 9.61 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.012 0.434 . . . . 0.0 110.619 175.024 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 29.3 m -82.13 19.66 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.055 -0.52 . . . . 0.0 112.303 -173.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 91.02 19.48 42.79 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.97 176.518 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 37.17 65.82 2.33 Favored Pre-proline 0 N--CA 1.473 0.722 0 C-N-CA 123.884 0.874 . . . . 0.0 112.941 179.548 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -83.11 175.51 8.36 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 122.482 2.122 . . . . 0.0 111.953 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -71.55 110.4 6.11 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.844 175.384 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.509 ' HB3' ' CG2' ' A' ' 76' ' ' VAL . 81.0 mt -73.7 129.14 37.33 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.795 -178.709 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 25.6 tptp -92.54 121.98 34.52 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.959 -178.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.403 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 41.7 p -103.24 156.19 17.9 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.805 -178.812 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 30.6 p90 -132.83 146.5 51.88 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 173.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 57.9 t -99.28 116.55 42.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.45 -179.362 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.659 HG23 ' HB ' ' A' ' 73' ' ' ILE . 6.2 tt -102.95 101.29 11.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 174.189 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -85.25 105.27 15.81 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.172 -175.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -94.67 154.33 17.38 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.895 -174.193 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.414 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 40.6 mt-10 60.46 -133.62 0.76 Allowed 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.132 179.524 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.608 HG12 ' HG3' ' A' ' 70' ' ' LYS . 42.2 mt 72.25 -63.8 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 C-N-CA 123.711 0.805 . . . . 0.0 110.307 -169.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.526 HG13 HG22 ' A' ' 52' ' ' ILE . 16.0 m -141.53 158.37 21.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.11 178.585 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -87.44 120.9 71.36 Favored Pre-proline 0 C--N 1.321 -0.647 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 173.326 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -59.99 -40.02 65.46 Favored 'Trans proline' 0 C--O 1.234 0.284 0 C-N-CA 122.822 2.348 . . . . 0.0 113.054 -172.529 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 164.48 -33.53 0.27 Allowed Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.487 -0.863 . . . . 0.0 112.214 -178.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -52.51 -35.25 52.7 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.878 0.371 . . . . 0.0 111.001 177.6 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -113.34 94.35 4.83 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 170.371 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -107.88 110.04 62.28 Favored Pre-proline 0 C--N 1.318 -0.761 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 174.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -64.07 107.62 0.82 Allowed 'Trans proline' 0 C--O 1.235 0.326 0 C-N-CA 122.698 2.265 . . . . 0.0 113.066 -174.535 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -80.54 -5.79 13.41 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 123.182 2.588 . . . . 0.0 110.624 178.387 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -95.61 -2.13 48.91 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.468 178.354 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 86.3 mtp 57.78 31.02 19.87 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.353 -176.35 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -99.87 115.15 28.93 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.99 -177.546 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -97.62 128.18 44.14 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.935 -178.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 22.4 p -99.12 175.54 5.86 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.449 -175.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -83.94 97.29 9.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.089 0.471 . . . . 0.0 110.025 178.206 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.413 HG12 ' HB3' ' A' ' 51' ' ' GLU . 16.9 t -97.81 138.8 21.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.967 -179.107 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -91.67 162.2 14.59 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.721 0.296 . . . . 0.0 110.991 -176.656 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.608 ' HG3' HG12 ' A' ' 52' ' ' ILE . 86.0 tttt -129.26 95.79 4.13 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.342 -0.39 . . . . 0.0 109.997 -178.774 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 18.8 m -139.26 146.35 25.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.186 -177.708 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -101.41 111.77 24.1 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.74 175.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.659 ' HB ' HG23 ' A' ' 48' ' ' ILE . 57.9 mt -91.1 132.96 34.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.598 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -117.7 126.75 53.06 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 120.885 0.374 . . . . 0.0 110.81 -174.654 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.437 ' HA ' ' H ' ' A' ' 90' ' ' TYR . 97.7 mttt -123.07 159.01 29.37 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.22 176.709 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.509 ' CG2' ' HB3' ' A' ' 43' ' ' LEU . 9.9 p -122.71 145.36 29.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.638 -175.364 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.405 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 53.2 p90 -152.51 165.29 35.57 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.964 0.412 . . . . 0.0 110.365 178.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -137.69 144.97 42.05 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 169.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.566 ' HG2' ' HG3' ' A' ' 85' ' ' ARG . 43.7 mt-10 -101.93 122.51 44.16 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.183 -177.462 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 49.6 p -73.17 178.25 4.55 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.044 -178.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.414 HD13 ' O ' ' A' ' 1' ' ' MET . 8.0 mp -64.06 -24.3 67.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.06 0.457 . . . . 0.0 109.851 176.131 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -83.26 -2.19 55.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.982 179.301 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 71.03 24.57 3.92 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.35 178.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 62.0 t -90.33 134.71 28.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.779 176.696 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.566 ' HG3' ' HG2' ' A' ' 79' ' ' GLU . 4.3 mpt_? -92.3 110.3 21.69 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.035 -176.545 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.439 HG22 ' HB ' ' A' ' 24' ' ' ILE . 49.4 t -89.22 103.36 13.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 173.513 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.8 t -107.09 141.41 22.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.683 -170.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.495 HG21 ' HA ' ' A' ' 28' ' ' PRO . 73.0 m -149.56 153.73 37.59 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.583 175.308 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -64.43 127.96 33.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.931 0.396 . . . . 0.0 111.047 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.437 ' H ' ' HA ' ' A' ' 75' ' ' LYS . 83.7 t80 -80.69 -26.68 37.37 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.034 -174.86 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 47.3 t -62.94 -44.15 96.85 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.312 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.441 ' O ' ' HB3' ' A' ' 95' ' ' LYS . 39.8 mt-10 -80.05 -20.2 45.8 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.068 177.294 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -70.38 -49.53 48.14 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.406 173.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.472 ' HA ' HD12 ' A' ' 97' ' ' LEU . 19.6 pt20 -68.05 -22.6 64.94 Favored 'General case' 0 C--N 1.334 -0.074 0 CA-C-O 121.034 0.445 . . . . 0.0 110.05 177.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.441 ' HB3' ' O ' ' A' ' 92' ' ' GLU . 86.7 tttt -61.43 -45.05 95.91 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.726 173.284 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.43 HG13 ' O ' ' A' ' 92' ' ' GLU . 66.3 mt -68.49 -34.93 68.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.166 176.079 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.472 HD12 ' HA ' ' A' ' 94' ' ' GLN . 75.7 mt -60.83 -41.65 96.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.641 176.196 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.442 ' HG2' ' O ' ' A' ' 94' ' ' GLN . 34.4 mmtp -67.25 -38.77 85.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.177 0.513 . . . . 0.0 110.225 176.301 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -60.92 -50.22 74.3 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.31 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 73.9 mtp85 -95.44 1.17 53.99 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.641 -174.578 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 69.92 29.88 70.56 Favored Glycine 0 C--O 1.229 -0.203 0 C-N-CA 121.171 -0.538 . . . . 0.0 113.191 175.248 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.479 ' HA ' ' HE1' ' A' ' 108' ' ' HIS . 5.0 m -111.94 155.74 23.22 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 -178.447 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -128.58 156.87 42.66 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.834 0.349 . . . . 0.0 110.585 178.569 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 51.9 tp -76.44 -33.18 58.78 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 176.318 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -74.03 -46.52 42.9 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.085 178.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 79.9 m-70 -112.63 107.7 16.49 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.702 -172.242 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 11.1 m170 -88.7 144.76 26.06 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 172.19 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' HIS . . . . . 0.479 ' HE1' ' HA ' ' A' ' 102' ' ' THR . 46.4 m80 -101.22 160.13 14.66 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 -174.334 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 29.9 m80 -78.92 41.5 0.43 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.279 0.561 . . . . 0.0 110.614 177.076 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 20.1 t-160 -170.32 -39.81 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -179.008 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 3.6 p80 . . . . . 0 C--O 1.245 0.828 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.621 174.879 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.51 ' HE3' HG12 ' A' ' 6' ' ' ILE . 48.5 mtm . . . . . 0 N--CA 1.481 1.081 0 CA-C-O 120.999 0.428 . . . . 0.0 111.006 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -86.47 162.4 18.11 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 167.614 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.5 p -57.48 -32.37 66.92 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.068 0.461 . . . . 0.0 111.078 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.475 ' HA ' ' HD2' ' A' ' 7' ' ' LYS . 35.3 tt0 -61.0 -42.3 98.18 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.697 178.071 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.3 t -68.01 -35.21 71.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.373 179.663 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.51 HG12 ' HE3' ' A' ' 1' ' ' MET . 59.7 mt -62.73 -39.77 86.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.138 176.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.475 ' HD2' ' HA ' ' A' ' 4' ' ' GLU . 61.8 mttm -56.78 -44.66 82.07 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.488 176.097 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -57.67 -44.1 85.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.022 178.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -66.9 -43.54 83.13 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.878 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.513 HD13 ' HB3' ' A' ' 17' ' ' TYR . 87.3 mt -66.57 -40.03 88.76 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.371 -177.487 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -67.44 -39.46 85.4 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.922 0.391 . . . . 0.0 110.17 176.394 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -58.24 -51.04 71.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.183 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 33.7 pt -72.38 -26.26 24.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.405 -178.233 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.32 44.16 4.75 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.723 177.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -123.19 149.66 44.35 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.009 0.433 . . . . 0.0 110.813 178.416 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -93.99 131.96 38.93 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.294 -177.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.513 ' HB3' HD13 ' A' ' 10' ' ' LEU . 27.9 p90 -115.23 136.28 53.28 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.051 179.048 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 57.1 mt -87.45 97.81 6.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 120.848 0.356 . . . . 0.0 110.107 -179.208 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -91.12 106.63 18.65 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.352 0.596 . . . . 0.0 110.459 -179.244 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.516 ' HB2' ' HB2' ' A' ' 23' ' ' GLU . 88.1 mt -93.95 -164.84 1.22 Allowed 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.222 -0.899 . . . . 0.0 108.803 174.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -69.56 92.73 0.65 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.635 0.255 . . . . 0.0 110.52 179.553 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 10.0 m120 69.54 18.55 7.72 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.643 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.516 ' HB2' ' HB2' ' A' ' 20' ' ' LEU . 41.6 mt-10 -130.18 113.71 14.8 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.937 178.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 59.5 mt -96.04 102.55 13.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 173.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.507 ' HA ' ' O ' ' A' ' 87' ' ' VAL . 13.6 m-70 -90.35 117.74 29.31 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.016 0.436 . . . . 0.0 109.949 -179.076 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 70.6 mt -107.56 168.96 8.88 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.519 0.676 . . . . 0.0 111.562 -176.284 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -82.57 140.27 44.43 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 115.011 -0.995 . . . . 0.0 108.364 171.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.496 ' HA ' HG21 ' A' ' 88' ' ' THR . 3.2 Cg_endo -47.06 -43.69 24.53 Favored 'Trans proline' 0 CA--C 1.534 0.495 0 C-N-CA 123.195 2.597 . . . . 0.0 113.298 -176.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -61.15 -41.19 96.31 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.998 0.428 . . . . 0.0 111.197 179.144 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 47.9 t -73.82 -37.78 49.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.852 -178.491 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -60.62 -40.59 92.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.632 179.54 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 85.1 t80 -60.49 -39.69 88.6 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.576 178.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 38.2 mm-40 -59.6 -50.84 72.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.842 177.195 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 41.4 t -65.62 -40.33 87.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.996 -177.261 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.712 ' CD1' ' HD2' ' A' ' 41' ' ' PRO . 32.5 t90 -57.02 -44.62 83.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.708 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.423 ' HE2' ' HB3' ' A' ' 36' ' ' LYS . 51.1 mtpt -89.5 3.7 51.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.881 0.372 . . . . 0.0 111.108 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -83.6 -38.6 21.4 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.094 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -96.84 9.29 6.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.915 177.194 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 79.04 50.4 5.87 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.739 -0.744 . . . . 0.0 113.763 173.219 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 58.24 78.33 0.36 Allowed Pre-proline 0 N--CA 1.467 0.41 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 172.166 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.712 ' HD2' ' CD1' ' A' ' 35' ' ' TRP . 5.4 Cg_exo -78.76 173.73 13.22 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.374 2.049 . . . . 0.0 111.39 172.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -76.99 123.58 26.54 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.046 177.176 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.453 ' HB3' ' CG2' ' A' ' 76' ' ' VAL . 87.6 mt -94.36 132.03 39.41 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.809 -177.783 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -107.44 141.81 38.25 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.768 178.36 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 24.1 p -120.76 146.09 46.85 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.775 0.321 . . . . 0.0 111.487 -176.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 17.8 p90 -133.09 154.98 50.06 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 177.409 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.5 t -106.01 114.61 45.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.274 178.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 8.6 tt -110.53 118.03 56.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.267 0.556 . . . . 0.0 109.95 177.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.489 ' HG2' ' HG2' ' A' ' 72' ' ' LYS . 50.2 mt-10 -84.56 118.78 24.55 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.917 -178.632 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -96.13 103.13 15.0 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 174.603 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.486 ' HG2' ' HD3' ' A' ' 70' ' ' LYS . 56.2 mt-10 -77.23 122.69 25.41 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.792 -178.162 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.574 ' HB ' ' HB3' ' A' ' 69' ' ' LYS . 68.5 mt -87.05 108.94 18.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.855 177.669 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.5 t -126.46 100.02 6.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.346 179.327 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.605 ' HB2' ' HD2' ' A' ' 55' ' ' PRO . 10.1 pt-20 -137.11 165.71 32.7 Favored Pre-proline 0 C--N 1.32 -0.69 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.193 -177.316 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.605 ' HD2' ' HB2' ' A' ' 54' ' ' GLU . 9.7 Cg_endo -51.21 138.69 45.06 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 123.146 2.564 . . . . 0.0 112.976 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -135.11 23.73 3.47 Favored Glycine 0 N--CA 1.447 -0.606 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.313 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -79.55 -19.46 49.42 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.147 0.498 . . . . 0.0 110.284 177.612 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -80.29 -22.4 41.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.391 178.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -134.44 97.07 14.82 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.753 178.23 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.42 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 51.1 Cg_exo -53.63 133.92 55.96 Favored 'Trans proline' 0 C--O 1.236 0.41 0 C-N-CA 123.288 2.659 . . . . 0.0 113.008 -174.459 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 60' ' ' PRO . 39.6 Cg_exo -61.0 116.12 3.15 Favored 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 123.042 2.494 . . . . 0.0 111.979 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.507 ' CD ' ' H ' ' A' ' 63' ' ' MET . 0.4 OUTLIER -90.23 -158.06 0.51 Allowed 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 178.156 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 63' ' ' MET . . . . . 0.507 ' H ' ' CD ' ' A' ' 62' ' ' GLU . 80.7 mtp -62.36 -18.21 60.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.112 0.482 . . . . 0.0 109.808 171.147 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -86.13 101.64 13.17 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 169.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -85.01 97.92 10.1 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.002 -175.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.5 p -76.49 45.1 0.38 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.981 176.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 48.7 t30 -75.32 -49.1 20.19 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.716 -176.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.4 p -148.09 120.42 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.272 0.558 . . . . 0.0 110.635 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.574 ' HB3' ' HB ' ' A' ' 52' ' ' ILE . 27.0 tptp -101.06 110.46 22.49 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.24 177.792 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.486 ' HD3' ' HG2' ' A' ' 51' ' ' GLU . 71.3 mmtt -84.26 105.38 15.06 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.686 177.304 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' A' ' 49' ' ' GLU . 48.0 t -101.53 100.28 10.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 176.668 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.489 ' HG2' ' HG2' ' A' ' 49' ' ' GLU . 61.5 mttm -78.85 98.36 6.31 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.389 -177.38 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 65.4 mt -97.77 118.91 45.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.131 0.491 . . . . 0.0 110.553 -178.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.427 ' O ' ' HB3' ' A' ' 90' ' ' TYR . 87.8 tttt -89.58 128.43 36.03 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.958 178.703 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.458 ' HG2' ' HA ' ' A' ' 89' ' ' ASP . 68.3 mttm -129.73 164.17 24.57 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 177.708 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.453 ' CG2' ' HB3' ' A' ' 43' ' ' LEU . 11.1 p -119.82 148.03 23.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.513 -174.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -154.79 162.35 41.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.058 0.456 . . . . 0.0 111.108 -179.357 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -132.45 142.21 49.15 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 168.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -102.16 132.43 48.07 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.633 -173.369 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 72.4 p -82.31 179.53 7.77 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.926 0.394 . . . . 0.0 109.994 176.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.407 ' N ' HD12 ' A' ' 81' ' ' LEU . 5.9 mp -77.11 -6.45 52.87 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.85 0.357 . . . . 0.0 110.7 -178.71 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.524 ' HB2' HG23 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -97.89 8.85 44.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.203 -179.384 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 63.4 t30 67.14 28.42 8.22 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.865 0.84 . . . . 0.0 110.133 -176.578 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.524 HG23 ' HB2' ' A' ' 82' ' ' ASP . 59.2 t -98.72 113.72 34.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 175.486 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 85.6 mtt180 -94.69 110.51 22.35 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.567 -176.09 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 58.0 t -81.63 104.62 10.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.724 179.03 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.507 ' O ' ' HA ' ' A' ' 25' ' ' HIS . 41.4 t -103.53 140.97 20.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.236 -172.483 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.496 HG21 ' HA ' ' A' ' 28' ' ' PRO . 98.6 m -147.58 151.43 36.25 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.33 174.359 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.458 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 20.3 t70 -59.97 134.8 57.38 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.063 0.458 . . . . 0.0 111.563 -177.77 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.427 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 88.1 t80 -76.64 -41.04 47.29 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.62 -175.26 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 11.0 p -68.65 -37.57 79.78 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.911 -0.316 . . . . 0.0 111.058 -176.699 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 43.1 mm-40 -72.65 -31.75 65.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.594 0.235 . . . . 0.0 110.992 176.055 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -69.34 -49.77 52.56 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 121.078 -0.249 . . . . 0.0 111.078 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.469 ' HA ' HD12 ' A' ' 97' ' ' LEU . 11.0 pt20 -63.86 -28.66 70.0 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.146 0.498 . . . . 0.0 110.094 178.511 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 53.7 tttt -60.59 -45.55 93.55 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.414 173.275 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.541 ' HA ' ' HB3' ' A' ' 99' ' ' LYS . 21.7 mt -71.07 -33.1 50.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.458 -179.536 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.469 HD12 ' HA ' ' A' ' 94' ' ' GLN . 98.4 mt -56.62 -40.92 76.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.031 0.443 . . . . 0.0 110.197 175.728 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -81.06 -31.92 34.25 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.624 177.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.541 ' HB3' ' HA ' ' A' ' 96' ' ' ILE . 46.9 tttm -56.59 -46.69 80.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.11 178.404 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 68.6 mtp85 -95.03 -14.47 24.29 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.576 179.392 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.43 ' HA2' HD21 ' A' ' 104' ' ' LEU . . . 73.65 67.19 1.83 Allowed Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.673 -0.775 . . . . 0.0 111.779 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 12.8 m -92.5 97.72 11.01 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.619 0.247 . . . . 0.0 111.026 -176.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.856 ' HG2' ' HB2' ' A' ' 111' ' ' HIS . 95.1 mttt 57.62 70.07 0.68 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.079 175.563 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.43 HD21 ' HA2' ' A' ' 101' ' ' GLY . 98.6 mt -73.81 166.42 23.36 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.483 -171.44 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -78.48 -21.49 48.9 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 114.989 -1.005 . . . . 0.0 112.238 -174.268 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 32.9 m170 -85.47 17.44 3.19 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.263 0.554 . . . . 0.0 111.159 -173.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.411 ' C ' ' H ' ' A' ' 109' ' ' HIS . 83.8 m-70 -121.43 130.55 53.65 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 172.45 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 19.3 m170 -77.34 42.08 0.33 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.481 0.658 . . . . 0.0 110.814 -178.189 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.411 ' H ' ' C ' ' A' ' 107' ' ' HIS . 31.4 t-80 -172.39 -7.29 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.902 -1.045 . . . . 0.0 109.295 -179.737 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.776 ' HB3' ' HB3' ' A' ' 103' ' ' LYS . 59.8 m-70 68.3 -62.68 0.36 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.639 0.776 . . . . 0.0 111.344 -174.81 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.856 ' HB2' ' HG2' ' A' ' 103' ' ' LYS . 29.6 t-80 . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.203 -0.903 . . . . 0.0 109.327 178.158 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.1 0 CA-C-O 120.84 0.352 . . . . 0.0 110.424 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -88.11 163.9 15.98 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.642 175.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.0 t -67.78 -25.99 65.87 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 175.159 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.422 ' O ' ' HG3' ' A' ' 8' ' ' GLU . 35.5 tt0 -51.94 -45.77 64.47 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.012 175.735 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.3 t -61.01 -41.38 88.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.854 -178.253 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 56.6 mt -65.14 -41.91 92.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.284 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 55.9 mttm -56.18 -44.44 79.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.24 177.496 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.422 ' HG3' ' O ' ' A' ' 4' ' ' GLU . 39.0 mt-10 -63.05 -41.65 99.53 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.595 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -66.02 -46.28 78.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.849 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 96.3 mt -68.16 -34.17 75.82 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.227 -177.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -67.15 -33.69 75.97 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.292 179.563 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -63.73 -55.06 26.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.844 178.572 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.415 HG13 ' H ' ' A' ' 15' ' ' GLU . 19.6 pt -69.56 -39.55 78.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.688 -177.334 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 95.36 21.73 23.9 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.815 177.309 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.415 ' H ' HG13 ' A' ' 13' ' ' ILE . 23.5 mm-40 -85.94 130.05 34.66 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 175.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -69.16 122.59 19.1 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.732 -176.273 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 43.8 p90 -112.95 133.91 54.7 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 171.404 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.556 ' HB ' ' HB2' ' A' ' 25' ' ' HIS . 57.8 mt -90.08 94.74 5.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 120.938 0.399 . . . . 0.0 110.081 -178.278 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -84.95 109.48 18.2 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.306 0.574 . . . . 0.0 110.598 179.433 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.4 mt -101.32 -161.86 0.89 Allowed 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.1 -0.954 . . . . 0.0 108.706 174.661 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -66.37 96.09 0.34 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.772 0.32 . . . . 0.0 110.61 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 65.25 20.14 11.84 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.65 179.279 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -134.24 114.22 12.82 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.801 0.334 . . . . 0.0 111.623 -178.245 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.446 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 54.3 mt -94.36 101.21 12.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 173.503 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.556 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 18.8 m-70 -84.87 107.07 16.84 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 177.605 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.9 mt -95.2 169.72 9.89 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.424 0.631 . . . . 0.0 111.752 -175.078 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.403 ' HB2' HG23 ' A' ' 30' ' ' VAL . 44.8 mtpt -87.11 136.02 34.3 Favored Pre-proline 0 C--N 1.319 -0.728 0 CA-C-N 114.904 -1.044 . . . . 0.0 108.688 175.217 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.412 ' HA ' HG21 ' A' ' 88' ' ' THR . 82.9 Cg_exo -47.0 -43.53 24.46 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 123.305 2.67 . . . . 0.0 113.245 -177.689 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -56.86 -44.56 82.3 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.29 0.567 . . . . 0.0 110.86 178.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.403 HG23 ' HB2' ' A' ' 27' ' ' LYS . 17.1 t -76.68 -46.83 30.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.73 -175.631 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -56.4 -37.97 70.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.524 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.652 ' OH ' ' HD2' ' A' ' 100' ' ' ARG . 6.6 t80 -58.27 -32.14 68.12 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.701 178.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 50.7 mm-40 -95.21 -37.17 11.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.546 0.212 . . . . 0.0 111.555 179.467 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.507 ' O ' HG22 ' A' ' 38' ' ' VAL . 93.4 t -62.67 -35.86 72.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.69 0.281 . . . . 0.0 110.789 179.673 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.675 ' CD1' ' HD2' ' A' ' 41' ' ' PRO . 46.2 t90 -55.56 -36.94 67.36 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.665 176.611 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.45 ' HA ' ' OE2' ' A' ' 40' ' ' GLU . 93.1 mttt -74.85 -40.98 60.71 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.483 179.14 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -58.02 -41.62 83.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.657 -178.464 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.577 HG23 ' HD3' ' A' ' 41' ' ' PRO . 15.5 m -85.54 1.46 5.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.753 -178.434 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 90.89 41.07 5.42 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.97 -0.633 . . . . 0.0 114.289 169.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.45 ' OE2' ' HA ' ' A' ' 36' ' ' LYS . 21.3 mp0 51.25 67.18 4.48 Favored Pre-proline 0 N--CA 1.467 0.416 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 176.708 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.675 ' HD2' ' CD1' ' A' ' 35' ' ' TRP . 72.5 Cg_endo -77.41 -179.58 5.57 Favored 'Trans proline' 0 C--O 1.24 0.598 0 C-N-CA 122.461 2.108 . . . . 0.0 112.119 178.593 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -68.47 132.13 46.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.683 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.459 ' HB3' ' CG2' ' A' ' 76' ' ' VAL . 77.8 mt -106.31 107.73 18.88 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.212 178.68 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.545 ' HE2' ' HG3' ' A' ' 79' ' ' GLU . 31.1 mttm -88.51 118.11 27.92 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 -179.315 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 41.8 p -95.62 119.42 34.08 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.33 177.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 14.6 p90 -118.56 152.88 35.16 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.265 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 60.3 t -104.17 112.6 38.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.18 178.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.496 HG23 ' HB ' ' A' ' 73' ' ' ILE . 11.6 tt -102.09 123.9 55.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 176.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -103.73 113.11 26.38 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.154 0.502 . . . . 0.0 110.731 -176.169 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -116.91 172.17 7.43 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.167 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -73.06 162.45 29.46 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 110.248 -0.278 . . . . 0.0 110.248 179.057 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.2 tt -65.6 100.01 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.651 0.739 . . . . 0.0 110.56 178.407 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 20.3 m -90.55 137.59 21.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.597 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.422 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 2.3 pp20? -92.92 145.7 30.67 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.48 -175.11 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 54' ' ' GLU . 73.1 Cg_endo -98.86 8.42 0.92 Allowed 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 123.455 2.77 . . . . 0.0 113.07 176.189 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 172.67 35.97 0.03 OUTLIER Glycine 0 CA--C 1.518 0.262 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.725 -177.384 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -137.22 46.18 2.18 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 179.379 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -57.19 -35.5 69.67 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.245 -176.514 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -109.47 98.1 30.49 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-N 116.295 -0.411 . . . . 0.0 109.981 175.35 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -89.12 155.78 5.71 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.661 2.24 . . . . 0.0 112.472 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -74.34 113.02 3.69 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.112 1.875 . . . . 0.0 110.669 171.473 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -65.35 110.61 2.69 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.151 0.5 . . . . 0.0 111.054 -175.408 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 62.0 mtm -105.24 167.57 9.64 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.147 179.345 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -89.94 -49.98 6.29 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.984 0.421 . . . . 0.0 111.252 -175.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -104.72 56.73 0.7 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.157 0.503 . . . . 0.0 110.34 -175.334 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.5 p -61.41 125.29 23.23 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.473 -175.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -75.1 115.18 14.45 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.92 174.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 60.1 t -88.17 118.74 34.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 120.904 0.383 . . . . 0.0 110.39 -179.137 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 54.8 tttp -113.44 142.57 45.75 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.287 -179.241 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -110.78 148.17 32.92 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.279 176.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 18.2 m -110.74 124.11 67.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.345 0.593 . . . . 0.0 110.61 177.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -88.55 95.24 10.16 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.893 178.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.496 ' HB ' HG23 ' A' ' 48' ' ' ILE . 49.0 mt -91.25 128.9 42.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.647 -176.007 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -101.32 113.11 25.88 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.009 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.449 ' HA ' ' H ' ' A' ' 90' ' ' TYR . 68.4 mttm -122.17 167.1 13.59 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.358 -179.199 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.459 ' CG2' ' HB3' ' A' ' 43' ' ' LEU . 14.8 p -126.31 147.39 31.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.819 -175.603 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 44.1 p90 -152.65 155.8 37.99 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.695 0.283 . . . . 0.0 110.782 175.276 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -124.71 157.73 34.93 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 171.317 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.545 ' HG3' ' HE2' ' A' ' 44' ' ' LYS . 29.4 mt-10 -109.07 146.34 34.16 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.908 0.385 . . . . 0.0 111.191 -174.524 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 32.5 p -102.6 179.46 4.29 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.995 175.183 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 11.2 mp -67.49 -18.16 64.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.066 0.46 . . . . 0.0 110.907 178.096 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -94.28 9.61 37.38 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.599 -177.288 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 14.7 t30 69.64 1.98 3.6 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.427 0.632 . . . . 0.0 110.808 -179.037 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 52.6 t -72.49 115.63 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 178.298 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.545 ' HG2' ' HG2' ' A' ' 79' ' ' GLU . 91.8 mtt180 -94.23 118.59 31.8 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.786 -176.572 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.446 ' HA ' ' O ' ' A' ' 24' ' ' ILE . 59.7 t -87.12 104.96 14.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 178.09 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 23.9 t -102.07 141.19 18.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.061 -173.344 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.412 HG21 ' HA ' ' A' ' 28' ' ' PRO . 97.9 m -150.99 150.02 30.27 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.363 175.616 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -64.88 125.83 26.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.943 0.401 . . . . 0.0 110.349 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.449 ' H ' ' HA ' ' A' ' 75' ' ' LYS . 18.3 t80 -75.85 -25.28 56.07 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.512 -173.109 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 10.9 t -74.31 -44.72 51.44 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 -70.36 -29.95 66.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.806 176.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.511 ' HE1' ' HA ' ' A' ' 32' ' ' TYR . 72.4 t80 -65.34 -52.17 55.66 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.365 -0.38 . . . . 0.0 109.985 174.942 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -63.16 -27.87 69.67 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.004 177.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -58.44 -51.3 70.41 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.013 176.699 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.446 ' HA ' ' HB3' ' A' ' 99' ' ' LYS . 62.3 mt -72.99 -32.57 40.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.22 0.533 . . . . 0.0 110.436 179.372 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.726 HD13 ' HB ' ' A' ' 102' ' ' THR . 0.2 OUTLIER -59.2 -50.2 74.95 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.509 -0.768 . . . . 0.0 110.033 176.853 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -65.96 -36.13 82.5 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.576 176.251 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.446 ' HB3' ' HA ' ' A' ' 96' ' ' ILE . 47.8 tttp -57.37 -42.39 82.01 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.29 -179.174 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.652 ' HD2' ' OH ' ' A' ' 32' ' ' TYR . 63.5 ttt180 -73.1 -40.59 64.86 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.079 0.466 . . . . 0.0 110.924 179.26 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 110.7 16.1 10.39 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.962 -176.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.726 ' HB ' HD13 ' A' ' 97' ' ' LEU . 18.8 m -82.47 139.62 33.85 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 176.752 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -112.73 125.42 54.29 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.847 0.356 . . . . 0.0 110.222 178.266 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 93.9 mt -72.5 129.36 38.14 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.46 -179.396 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.17 -34.05 71.65 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.9 -177.048 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 30.8 t60 -69.92 -5.22 24.54 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 120.959 0.409 . . . . 0.0 111.318 -177.086 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 29.2 t60 -91.23 -16.19 28.02 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.508 0.671 . . . . 0.0 109.296 175.19 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 45.3 t60 -115.42 4.63 14.37 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.079 -0.964 . . . . 0.0 108.591 179.293 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 4.8 t-160 -142.24 109.7 5.68 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.368 -1.287 . . . . 0.0 107.912 -177.416 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 44.2 m170 -56.25 -48.49 76.43 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 123.2 0.313 . . . . 0.0 111.708 -171.14 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 33.5 m80 . . . . . 0 C--O 1.246 0.879 0 CA-C-O 118.692 -0.67 . . . . 0.0 109.816 175.716 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.999 0 CA-C-O 120.847 0.356 . . . . 0.0 110.599 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.513 ' HB3' ' OD2' ' A' ' 82' ' ' ASP . 2.0 m-20 -118.13 176.58 5.15 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 176.542 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.427 ' O ' ' HG3' ' A' ' 7' ' ' LYS . 14.8 p -62.27 -29.36 70.36 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.081 0.467 . . . . 0.0 110.374 178.465 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -57.08 -46.76 82.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.984 176.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.8 t -63.0 -38.9 83.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.266 -178.423 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.491 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 61.5 mt -63.58 -43.56 98.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.209 178.382 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.427 ' HG3' ' O ' ' A' ' 3' ' ' SER . 99.0 mttt -58.51 -45.13 89.45 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.817 178.255 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -57.43 -47.28 82.19 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.108 179.585 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -61.04 -46.05 92.27 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.768 178.488 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.491 ' HG ' ' O ' ' A' ' 6' ' ' ILE . 95.7 mt -64.69 -37.12 86.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.454 -177.398 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -74.5 -36.02 63.23 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.785 0.326 . . . . 0.0 110.842 177.063 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -67.88 -35.06 77.86 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.848 0.356 . . . . 0.0 110.861 -179.686 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 39.0 pt -82.34 -17.2 11.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.854 0.359 . . . . 0.0 110.576 175.562 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 77.09 48.45 8.35 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 121.119 -0.562 . . . . 0.0 113.045 174.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.03 158.55 26.56 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.871 0.367 . . . . 0.0 110.431 179.435 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -95.99 120.41 36.22 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.822 -178.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 42.1 p90 -116.25 145.92 42.76 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.09 179.414 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.491 ' HB ' ' HB2' ' A' ' 25' ' ' HIS . 51.1 mt -96.39 97.97 7.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 120.76 0.314 . . . . 0.0 110.859 -177.222 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 47.2 tt0 -90.58 125.51 35.65 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.072 0.463 . . . . 0.0 110.171 176.115 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.585 ' HB2' ' HB2' ' A' ' 23' ' ' GLU . 90.4 mt -120.39 -161.65 0.9 Allowed 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 174.447 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -78.67 101.16 7.36 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.796 0.331 . . . . 0.0 110.407 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 58.7 m-80 69.43 10.07 7.55 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.724 -178.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.585 ' HB2' ' HB2' ' A' ' 20' ' ' LEU . 46.9 mt-10 -123.48 132.98 54.08 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.71 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.53 ' HB ' HG22 ' A' ' 86' ' ' VAL . 69.5 mt -120.98 111.59 32.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 170.582 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.491 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 66.3 m-70 -100.97 127.17 47.58 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 110.132 -0.322 . . . . 0.0 110.132 -178.763 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 69.9 mt -118.01 177.08 4.92 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.413 -176.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 58.7 mttp -92.61 154.9 42.4 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.118 175.296 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.26 -48.52 21.58 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.795 2.33 . . . . 0.0 113.07 -174.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -64.08 -47.61 79.43 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.841 0.353 . . . . 0.0 110.773 -177.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.404 ' O ' HG23 ' A' ' 34' ' ' VAL . 42.0 t -62.48 -45.86 97.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.775 -178.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -57.1 -44.76 83.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.842 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -59.48 -42.29 91.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.324 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -75.72 -44.37 42.32 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.91 -177.072 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 30' ' ' VAL . 97.5 t -61.83 -36.52 74.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-O 120.744 0.307 . . . . 0.0 110.571 178.633 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 28.3 t90 -53.77 -53.83 46.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.816 177.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.468 ' HA ' ' HG3' ' A' ' 40' ' ' GLU . 65.4 mttm -71.38 -29.9 65.5 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.039 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 86.4 t80 -60.91 -42.09 97.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.458 179.408 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.498 HG23 ' HD3' ' A' ' 41' ' ' PRO . 30.3 m -86.29 -0.37 6.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 -176.276 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 109.36 11.01 22.72 Favored Glycine 0 C--N 1.329 0.187 0 C-N-CA 120.437 -0.887 . . . . 0.0 113.427 175.125 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.468 ' HG3' ' HA ' ' A' ' 36' ' ' LYS . 46.3 mt-10 57.77 72.17 0.95 Allowed Pre-proline 0 C--O 1.234 0.287 0 C-N-CA 122.936 0.494 . . . . 0.0 111.938 179.321 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.498 ' HD3' HG23 ' A' ' 38' ' ' VAL . 5.0 Cg_exo -74.74 173.25 14.72 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.764 2.309 . . . . 0.0 111.475 176.801 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -64.63 123.39 19.18 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.014 0.435 . . . . 0.0 110.849 179.038 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.485 ' HB3' ' CG2' ' A' ' 76' ' ' VAL . 86.4 mt -90.84 102.25 15.01 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.136 176.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -82.74 143.66 30.73 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 176.555 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 31.5 p -121.51 138.88 54.11 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.95 0.405 . . . . 0.0 111.195 -176.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 15.0 p90 -127.16 141.22 51.8 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 176.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.464 ' HA ' ' HA ' ' A' ' 74' ' ' LYS . 5.3 p -98.8 105.24 17.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-O 121.655 0.74 . . . . 0.0 110.28 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 14.7 tt -93.99 125.66 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 CA-C-N 115.679 -0.692 . . . . 0.0 109.599 179.544 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -92.21 105.71 17.87 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.259 -176.616 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -92.92 123.71 36.38 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.663 -178.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.429 ' HG2' ' HG2' ' A' ' 70' ' ' LYS . 38.1 mt-10 -95.33 98.11 10.34 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.115 0.483 . . . . 0.0 110.342 -179.546 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.57 HG23 ' HB2' ' A' ' 69' ' ' LYS . 8.5 tt -93.07 120.69 42.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.749 -177.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.486 HG22 HG11 ' A' ' 68' ' ' VAL . 34.1 t -90.67 132.15 35.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.508 177.232 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.468 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 36.4 mt-10 -87.73 121.98 70.6 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-O 120.959 0.409 . . . . 0.0 109.957 -178.297 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 54' ' ' GLU . 27.4 Cg_exo -62.86 113.01 1.81 Allowed 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 123.185 2.59 . . . . 0.0 112.872 -176.191 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -135.42 35.7 2.14 Favored Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 175.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -98.25 9.94 41.81 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.376 0.608 . . . . 0.0 109.881 -175.267 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -87.72 -10.61 50.65 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.035 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -145.16 139.72 15.36 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.364 -177.399 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -47.57 113.78 0.86 Allowed 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.863 2.375 . . . . 0.0 112.26 176.258 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -58.63 127.93 26.37 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 123.264 2.642 . . . . 0.0 113.265 -172.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -63.08 -45.4 92.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.842 175.25 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 92.8 mmm -123.42 125.95 45.9 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.241 176.676 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -62.72 -37.91 88.41 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.318 0.58 . . . . 0.0 110.758 -178.048 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -100.89 112.56 25.01 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.273 -175.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 87.3 m -129.08 134.28 48.02 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.211 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -72.71 131.67 42.67 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.02 0.438 . . . . 0.0 110.944 -177.189 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.486 HG11 HG22 ' A' ' 53' ' ' VAL . 19.7 m -86.86 168.83 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.35 178.649 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.57 ' HB2' HG23 ' A' ' 52' ' ' ILE . 56.3 mttm -96.3 107.7 20.09 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.014 0.435 . . . . 0.0 110.907 -179.218 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.429 ' HG2' ' HG2' ' A' ' 51' ' ' GLU . 26.0 mtpp -89.78 98.72 11.93 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 175.399 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 27.4 m -99.47 128.55 51.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.337 0.589 . . . . 0.0 111.072 -176.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -87.69 99.44 12.07 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.828 -0.623 . . . . 0.0 109.749 179.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 62.8 mt -101.69 114.24 40.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.539 0.685 . . . . 0.0 111.004 -177.083 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.56 ' O ' ' HB3' ' A' ' 90' ' ' TYR . 88.1 tttt -80.7 124.25 28.87 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.197 -179.414 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -120.15 163.81 17.15 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.639 -0.255 . . . . 0.0 110.367 178.001 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.485 ' CG2' ' HB3' ' A' ' 43' ' ' LEU . 10.9 p -122.92 148.35 26.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.904 -174.797 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.422 ' CE2' ' HD3' ' A' ' 85' ' ' ARG . 55.5 p90 -152.95 153.24 32.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.71 0.291 . . . . 0.0 111.144 178.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.464 ' HB3' HD23 ' A' ' 43' ' ' LEU . 47.8 p90 -122.41 156.94 32.95 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 172.204 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.512 ' HG2' ' HG2' ' A' ' 85' ' ' ARG . 29.3 mt-10 -103.86 149.91 24.64 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.626 -171.504 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 73.9 p -108.77 176.69 5.02 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.966 175.506 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.41 HD23 HD21 ' A' ' 2' ' ' ASN . 47.2 tp -66.84 -26.47 66.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.724 0.297 . . . . 0.0 111.069 179.551 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.513 ' OD2' ' HB3' ' A' ' 2' ' ' ASN . 1.4 m-20 -82.77 3.64 28.52 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.776 -176.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.447 ' HB2' ' O ' ' A' ' 82' ' ' ASP . 4.3 m-20 71.51 10.52 6.52 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 123.55 0.532 . . . . 0.0 110.917 -175.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.47 HG23 ' HB2' ' A' ' 82' ' ' ASP . 62.5 t -84.3 128.08 39.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 176.604 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.512 ' HG2' ' HG2' ' A' ' 79' ' ' GLU . 82.9 mtt180 -107.38 129.12 54.96 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.469 0.652 . . . . 0.0 111.673 -173.121 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.53 HG22 ' HB ' ' A' ' 24' ' ' ILE . 58.3 t -91.38 112.62 25.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.946 -179.306 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 41.4 t -105.51 140.79 22.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.129 -173.146 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 93.0 m -151.63 148.89 28.51 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.321 174.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -58.45 129.23 41.07 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.537 0.684 . . . . 0.0 111.982 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.56 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 93.9 t80 -76.49 -23.99 53.79 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.008 -0.997 . . . . 0.0 110.603 -177.272 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.2 m -65.14 -54.21 33.22 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.437 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -71.38 -28.05 63.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.413 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -63.43 -49.22 74.6 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.951 0.405 . . . . 0.0 109.937 175.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.475 ' O ' ' HG3' ' A' ' 98' ' ' LYS . 68.2 mm-40 -65.2 -33.86 76.99 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.656 176.02 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -57.84 -44.25 86.39 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.739 177.241 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 40.6 mt -68.64 -34.26 64.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.076 178.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.43 ' HB3' ' HB2' ' A' ' 103' ' ' LYS . 74.9 mt -62.04 -37.09 83.63 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.951 0.405 . . . . 0.0 110.189 176.498 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.475 ' HG3' ' O ' ' A' ' 94' ' ' GLN . 86.0 mttt -73.05 -39.47 65.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.031 176.323 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 55.7 tptt -64.85 -46.33 82.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.374 -178.514 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 84.5 mtt-85 -89.67 -8.49 52.32 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.451 -177.508 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.5 27.47 63.35 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.42 177.315 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 23.1 m -78.77 -24.23 44.83 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.193 0.52 . . . . 0.0 110.387 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.43 ' HB2' ' HB3' ' A' ' 97' ' ' LEU . 54.6 tttm -96.35 93.45 6.87 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.956 179.515 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -75.81 146.3 40.02 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.63 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.61 -32.85 11.57 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.859 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 53.9 m80 -118.76 116.98 27.68 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.482 176.337 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 10.9 t-160 -85.81 -14.56 44.7 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.025 -178.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -119.07 132.97 56.06 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.705 179.034 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 34.0 m-70 -128.7 175.85 8.27 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.376 178.086 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.449 ' O ' ' HB2' ' A' ' 111' ' ' HIS . 22.3 p-80 -68.86 -38.09 79.53 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 176.629 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' HIS . . . . . 0.449 ' HB2' ' O ' ' A' ' 110' ' ' HIS . 72.2 t60 . . . . . 0 C--O 1.245 0.858 0 CA-C-O 118.163 -0.922 . . . . 0.0 108.796 177.66 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.646 ' HE3' HG12 ' A' ' 6' ' ' ILE . 43.4 mtm . . . . . 0 N--CA 1.483 1.22 0 CA-C-O 120.916 0.388 . . . . 0.0 110.883 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.548 ' HA ' ' HB ' ' A' ' 80' ' ' THR . 95.0 m-20 -114.37 -175.74 2.75 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.369 170.407 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.453 ' HB3' HG21 ' A' ' 84' ' ' VAL . 35.3 p -62.36 -34.79 77.35 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.017 0.437 . . . . 0.0 110.824 -179.493 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -57.05 -54.37 47.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.852 -177.345 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.3 t -59.22 -41.37 83.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.849 0.357 . . . . 0.0 110.915 -178.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.646 HG12 ' HE3' ' A' ' 1' ' ' MET . 50.7 mt -66.03 -39.99 86.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.463 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 51.3 mttm -58.77 -47.52 84.42 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.984 175.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -62.19 -41.09 98.03 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.759 179.268 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -62.11 -51.18 68.97 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.643 179.124 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 93.3 mt -62.44 -38.15 88.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.943 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -66.26 -40.74 90.34 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.452 178.287 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -70.67 -35.04 72.62 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.472 -176.607 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 39.2 pt -87.15 -8.38 11.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.798 0.332 . . . . 0.0 110.919 178.053 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 65.45 52.37 40.31 Favored Glycine 0 N--CA 1.452 -0.258 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.433 176.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -112.37 148.88 33.36 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.9 0.381 . . . . 0.0 110.724 -178.482 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -86.37 133.17 33.81 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.818 177.16 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 47.5 p90 -135.24 142.5 45.99 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.768 0.318 . . . . 0.0 110.455 179.59 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.56 ' HB ' ' HB2' ' A' ' 25' ' ' HIS . 66.5 mt -90.79 100.99 11.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.993 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -91.18 116.69 29.02 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.026 -178.695 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.538 ' HB2' ' HB2' ' A' ' 23' ' ' GLU . 89.9 mt -115.19 173.64 6.4 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 173.446 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -60.3 105.03 0.37 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.918 0.39 . . . . 0.0 111.118 -178.083 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 17.1 m120 68.0 16.75 9.56 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.633 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.538 ' HB2' ' HB2' ' A' ' 20' ' ' LEU . 91.1 mt-10 -133.95 113.97 12.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.959 0.409 . . . . 0.0 111.275 179.456 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 64.5 mt -97.39 103.4 14.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 172.071 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.56 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 35.6 m-70 -89.94 110.77 21.71 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 -179.076 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 63.9 mt -106.11 169.67 8.36 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.486 -175.318 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 51.5 mtpt -81.31 138.47 48.52 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.168 175.536 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.539 ' HA ' HG21 ' A' ' 88' ' ' THR . 3.4 Cg_exo -41.35 -51.91 3.86 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 124.117 3.211 . . . . 0.0 114.427 -173.506 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -70.31 -37.96 74.84 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.733 0.301 . . . . 0.0 111.076 -175.384 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 46.7 t -65.11 -42.13 93.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.222 0.534 . . . . 0.0 109.811 177.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -57.66 -41.29 81.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.816 178.19 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -59.29 -45.62 90.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.51 -178.558 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -64.29 -35.81 82.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.273 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 60.4 t -72.13 -38.22 62.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.198 0.523 . . . . 0.0 110.45 178.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.646 ' CZ2' ' HG3' ' A' ' 40' ' ' GLU . 30.0 t90 -57.12 -46.87 82.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.33 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 55.8 mttm -86.46 -2.2 58.25 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.895 0.379 . . . . 0.0 111.384 179.509 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -78.72 -35.47 44.81 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 176.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.526 HG23 ' HD3' ' A' ' 41' ' ' PRO . 3.2 m -85.9 3.85 3.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.603 177.228 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 97.21 17.72 31.03 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.696 -0.764 . . . . 0.0 113.444 174.35 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.646 ' HG3' ' CZ2' ' A' ' 35' ' ' TRP . 36.1 tt0 61.7 84.59 0.19 Allowed Pre-proline 0 N--CA 1.466 0.336 0 CA-C-O 121.06 0.457 . . . . 0.0 111.498 178.641 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.565 ' HD2' ' CD1' ' A' ' 35' ' ' TRP . 94.3 Cg_endo -90.64 162.92 4.25 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.745 2.297 . . . . 0.0 111.7 173.817 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -71.45 125.42 26.97 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 175.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.459 ' CD2' ' HB3' ' A' ' 78' ' ' PHE . 90.4 mt -90.53 150.09 21.91 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.348 0.594 . . . . 0.0 112.292 -170.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -97.2 164.67 12.39 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.236 172.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.662 HG21 ' HE3' ' A' ' 74' ' ' LYS . 19.0 p -119.59 144.8 46.9 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.136 0.493 . . . . 0.0 111.22 177.556 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.586 ' HB2' ' CD2' ' A' ' 77' ' ' TYR . 32.4 t80 -118.69 114.49 22.81 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.044 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 95.6 t -100.23 121.43 50.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.972 -177.299 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.468 ' CG1' ' HB ' ' A' ' 73' ' ' ILE . 42.0 pt -105.59 132.16 53.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.732 174.24 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.504 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 37.8 tt0 -115.55 103.6 10.9 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.865 -178.65 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -153.29 123.73 7.14 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -176.032 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.547 ' HG2' HG13 ' A' ' 52' ' ' ILE . 31.5 tt0 -179.51 -81.65 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.113 168.407 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.578 ' HB ' ' H ' ' A' ' 69' ' ' LYS . 64.3 mt -117.85 101.02 11.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 178.739 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.462 ' HA ' HG13 ' A' ' 68' ' ' VAL . 4.3 m -134.76 104.22 5.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.198 0.523 . . . . 0.0 111.774 -176.789 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 64.1 mt-10 -89.61 114.29 60.02 Favored Pre-proline 0 C--N 1.324 -0.515 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 172.278 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -54.45 118.18 4.77 Favored 'Trans proline' 0 C--O 1.234 0.284 0 C-N-CA 122.892 2.394 . . . . 0.0 112.391 -176.161 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.633 ' HA2' ' HB3' ' A' ' 59' ' ' ASP . . . -149.29 23.54 1.23 Allowed Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.875 -0.678 . . . . 0.0 111.846 -178.734 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -70.33 -37.19 74.66 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.741 0.305 . . . . 0.0 110.675 -178.46 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 42.7 p90 -122.11 1.81 9.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.168 0.509 . . . . 0.0 110.008 177.458 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.633 ' HB3' ' HA2' ' A' ' 56' ' ' GLY . 23.4 t70 -95.66 132.72 26.83 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.357 -176.02 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 59' ' ' ASP . 34.3 Cg_exo -60.21 125.96 18.9 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 123.134 2.556 . . . . 0.0 113.089 -177.094 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -74.51 125.12 9.36 Favored 'Trans proline' 0 CA--C 1.529 0.235 0 C-N-CA 122.799 2.332 . . . . 0.0 112.399 179.457 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -105.6 -165.07 1.08 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.294 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 67.0 mtt -76.91 -19.7 57.09 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.692 -175.115 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -82.44 92.18 6.99 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.028 0.442 . . . . 0.0 110.269 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -93.66 100.02 12.34 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.172 178.549 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.2 m -81.39 150.94 28.16 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.501 178.533 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -74.46 81.86 1.94 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.524 0.678 . . . . 0.0 110.546 177.357 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.462 HG13 ' HA ' ' A' ' 53' ' ' VAL . 71.2 t -71.87 110.15 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.719 179.088 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.578 ' H ' ' HB ' ' A' ' 52' ' ' ILE . 95.9 mttt -91.98 107.54 19.28 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.176 0.512 . . . . 0.0 110.589 -179.504 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -97.14 95.74 7.97 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 174.192 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.504 ' O ' ' HA ' ' A' ' 49' ' ' GLU . 59.8 t -92.56 108.37 20.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.945 -176.329 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -90.5 100.87 13.64 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.625 -178.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.468 ' HB ' ' CG1' ' A' ' 48' ' ' ILE . 65.3 mt -91.15 113.67 27.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.659 178.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.662 ' HE3' HG21 ' A' ' 45' ' ' THR . 48.1 tttp -94.93 101.94 13.74 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.779 -173.119 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -96.62 167.54 11.07 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.427 176.447 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 12.5 p -116.64 148.66 19.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 110.4 -0.222 . . . . 0.0 110.4 -177.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.586 ' CD2' ' HB2' ' A' ' 46' ' ' TYR . 39.7 p90 -155.09 154.01 31.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.873 0.368 . . . . 0.0 111.242 177.309 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.459 ' HB3' ' CD2' ' A' ' 43' ' ' LEU . 48.8 p90 -119.09 160.68 21.61 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 171.304 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -111.8 138.86 47.83 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.961 0.41 . . . . 0.0 111.23 -173.713 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.548 ' HB ' ' HA ' ' A' ' 2' ' ' ASN . 40.2 p -93.82 169.63 10.16 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.587 173.527 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.446 ' HB2' ' OD1' ' A' ' 2' ' ' ASN . 6.9 mp -74.5 -10.15 59.27 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.247 0.546 . . . . 0.0 110.026 178.14 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -92.35 10.98 27.54 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.619 -179.184 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 68.93 20.83 7.76 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.483 176.347 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.453 HG21 ' HB3' ' A' ' 3' ' ' SER . 48.3 t -101.82 126.08 55.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.241 177.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ARG . . . . . 0.457 ' O ' ' HA ' ' A' ' 23' ' ' GLU . 40.5 mtm180 -95.08 124.52 39.17 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.46 -179.238 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 59.4 t -95.16 107.61 19.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 176.485 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 28.6 t -105.09 138.67 28.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.605 -170.447 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.539 HG21 ' HA ' ' A' ' 28' ' ' PRO . 86.5 m -152.61 157.06 40.46 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.288 176.687 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -68.8 124.66 24.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.324 0.583 . . . . 0.0 112.248 -178.25 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -68.46 -32.63 72.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.302 -178.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 6.5 m -56.73 -41.46 77.55 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.964 0.411 . . . . 0.0 110.966 177.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.431 ' O ' HG13 ' A' ' 96' ' ' ILE . 43.6 mt-10 -83.6 -30.63 26.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.796 -179.141 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -62.68 -47.82 81.98 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.116 0.484 . . . . 0.0 109.875 175.372 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -58.15 -40.93 82.62 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.245 174.599 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.418 ' HB3' ' O ' ' A' ' 92' ' ' GLU . 64.4 tttp -56.95 -44.84 82.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.11 178.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.565 ' O ' ' HG2' ' A' ' 99' ' ' LYS . 75.7 mt -64.84 -47.06 89.97 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-O 121.024 0.44 . . . . 0.0 111.182 -179.444 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 87.4 mt -60.13 -51.17 70.73 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.859 -179.19 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -72.72 -28.31 62.57 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -174.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.565 ' HG2' ' O ' ' A' ' 96' ' ' ILE . 19.8 pttp -70.76 -29.93 66.29 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.33 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 22.6 mtm105 -78.53 -43.22 27.31 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 173.039 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 125.18 26.88 1.28 Allowed Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.193 -178.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 21.2 m -97.14 139.06 33.69 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.692 0.282 . . . . 0.0 110.443 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -98.53 163.58 12.61 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.352 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 91.4 mt -89.57 -20.43 23.78 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.861 0.363 . . . . 0.0 111.235 -175.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -101.51 124.47 47.23 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.961 -178.299 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 70.6 m80 -83.46 83.4 7.9 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.661 178.74 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 18.1 m170 -92.65 125.12 37.13 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.164 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 8.1 t-160 -100.25 -18.7 16.72 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 173.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 9.1 m170 -114.05 -176.29 2.87 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.937 173.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 34.7 m-70 -105.88 -71.93 0.73 Allowed 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 171.258 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 67.7 m-70 . . . . . 0 C--O 1.243 0.757 0 CA-C-N 115.022 -0.99 . . . . 0.0 108.746 169.114 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 ppp? . . . . . 0 N--CA 1.477 0.876 0 CA-C-O 121.032 0.444 . . . . 0.0 110.828 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.43 ' OD1' ' HB2' ' A' ' 81' ' ' LEU . 47.5 m-80 -128.38 178.5 6.23 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 176.328 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 52.2 p -65.85 -20.71 66.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.428 0.632 . . . . 0.0 109.611 177.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.535 ' O ' ' HG3' ' A' ' 8' ' ' GLU . 20.9 tp10 -61.2 -36.6 80.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.424 177.049 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.3 t -63.95 -35.92 75.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-O 121.236 0.541 . . . . 0.0 110.182 179.124 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 61.6 mt -66.86 -40.35 85.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.025 177.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -58.24 -45.31 88.01 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.286 177.362 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLU . . . . . 0.535 ' HG3' ' O ' ' A' ' 4' ' ' GLU . 41.5 mt-10 -60.0 -44.54 94.48 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.754 179.302 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.447 ' O ' HG12 ' A' ' 13' ' ' ILE . 79.5 t80 -61.51 -47.72 84.34 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.312 -179.537 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 91.3 mt -63.5 -37.7 88.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.881 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -59.44 -50.94 72.0 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.558 177.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -68.09 -37.87 81.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.878 -175.394 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.447 HG12 ' O ' ' A' ' 9' ' ' PHE . 35.4 pt -81.68 -14.67 12.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.235 -179.421 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 81.16 45.75 7.37 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.785 177.39 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -119.45 166.07 13.55 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.8 0.334 . . . . 0.0 110.71 178.296 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -117.35 161.1 20.08 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.949 179.049 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 28.5 p90 -130.7 146.54 52.21 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.683 179.527 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.46 ' HB ' ' HB2' ' A' ' 25' ' ' HIS . 54.6 mt -91.43 97.03 6.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 178.058 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.439 ' HA ' ' O ' ' A' ' 23' ' ' GLU . 1.9 tm-20 -99.35 107.27 19.49 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -176.789 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 89.9 mt -116.01 86.66 2.52 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.862 -177.259 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.438 ' O ' ' HB2' ' A' ' 22' ' ' ASN . 34.4 tt0 59.29 60.25 2.41 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.058 176.228 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.438 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 5.5 m-20 75.07 14.01 3.18 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.293 177.454 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.439 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 35.1 mt-10 -111.16 113.74 26.48 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.8 170.62 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 62.0 mt -96.33 97.5 6.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 177.369 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.586 ' HA ' ' O ' ' A' ' 87' ' ' VAL . 14.1 m-70 -86.14 107.9 18.07 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.475 178.562 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 62.3 mt -95.13 164.45 12.86 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.254 -175.166 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -82.16 132.24 53.98 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.238 177.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -49.49 -40.3 45.18 Favored 'Trans proline' 0 N--CA 1.471 0.197 0 C-N-CA 123.1 2.533 . . . . 0.0 112.977 -177.057 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -60.54 -47.07 87.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.08 179.575 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 41.3 t -77.08 -40.2 29.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.768 -177.594 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.785 ' HE1' ' HE1' ' A' ' 78' ' ' PHE . 85.6 t80 -58.53 -37.17 75.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.883 -179.143 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.645 ' HA ' ' HE1' ' A' ' 93' ' ' PHE . 24.8 t80 -53.25 -39.4 63.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.291 177.34 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -84.0 -39.25 19.91 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.985 -178.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 62.6 t -62.53 -36.88 77.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-O 120.744 0.307 . . . . 0.0 110.841 179.443 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.428 ' CE2' ' HB2' ' A' ' 40' ' ' GLU . 22.1 t90 -53.13 -59.23 4.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.732 -179.336 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -74.0 -20.72 60.24 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.664 0.269 . . . . 0.0 111.403 -179.617 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -64.74 -28.8 69.83 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.806 178.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.411 HG23 ' HD3' ' A' ' 41' ' ' PRO . 29.0 m -103.34 11.22 8.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.36 -179.74 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.48 9.25 56.82 Favored Glycine 0 CA--C 1.517 0.186 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.877 177.395 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.428 ' HB2' ' CE2' ' A' ' 35' ' ' TRP . 15.5 pt-20 44.67 87.09 0.12 Allowed Pre-proline 0 N--CA 1.471 0.61 0 C-N-CA 124.527 1.131 . . . . 0.0 113.246 -179.394 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.411 ' HD3' HG23 ' A' ' 38' ' ' VAL . 74.5 Cg_endo -76.08 165.76 29.1 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.456 2.104 . . . . 0.0 111.486 175.585 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -63.15 137.11 58.12 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.033 0.444 . . . . 0.0 110.325 177.263 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.443 ' HB3' ' CG2' ' A' ' 76' ' ' VAL . 95.6 mt -87.29 144.29 26.87 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.491 -174.681 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -118.83 118.18 30.88 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 177.022 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 24.9 p -107.54 137.55 45.36 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 120.92 0.39 . . . . 0.0 111.843 -173.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 19.0 p90 -120.87 140.66 51.48 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 176.661 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.508 HG11 ' HE3' ' A' ' 72' ' ' LYS . 55.4 t -103.73 117.45 49.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.273 178.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 1.011 HG23 HG13 ' A' ' 73' ' ' ILE . 2.9 tt -98.88 122.37 50.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-O 121.522 0.677 . . . . 0.0 110.167 177.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.461 ' OE1' ' HG3' ' A' ' 72' ' ' LYS . 4.4 mm-40 -90.14 94.49 9.8 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.952 -176.757 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -101.61 126.62 48.46 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.639 0.257 . . . . 0.0 110.31 -178.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.977 ' HG2' ' HG2' ' A' ' 70' ' ' LYS . 28.8 mt-10 -101.09 108.11 19.72 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.837 0.351 . . . . 0.0 110.376 178.713 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 47.5 pt -79.95 137.83 20.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.166 0.508 . . . . 0.0 110.899 -177.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.9 p -102.13 113.47 38.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.856 176.15 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.442 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 41.0 mt-10 -87.61 115.26 62.34 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.818 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 54' ' ' GLU . 22.7 Cg_exo -65.09 154.42 73.56 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 123.157 2.571 . . . . 0.0 112.995 -174.531 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -135.35 44.06 1.2 Allowed Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 178.683 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -57.94 -30.91 66.35 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.347 0.659 . . . . 0.0 112.302 -172.334 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 93.0 t80 -70.75 -14.31 62.39 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.929 0.395 . . . . 0.0 110.333 178.273 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 39.0 t70 60.32 81.82 0.24 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.232 -174.724 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.48 151.91 48.26 Favored 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 122.56 2.174 . . . . 0.0 112.456 -176.783 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -69.49 -11.02 30.28 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.801 2.334 . . . . 0.0 111.525 175.77 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -66.6 149.95 49.74 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.638 176.414 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 32.9 mtt -59.95 120.9 10.52 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.234 0.54 . . . . 0.0 110.527 177.271 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 33.6 mttm -75.45 104.94 6.23 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.24 -174.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -78.69 131.24 36.56 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.142 -176.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -87.26 -16.91 33.82 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.261 178.208 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -91.29 139.27 30.89 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.003 176.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.453 HG23 ' HB3' ' A' ' 51' ' ' GLU . 22.9 m -102.11 177.65 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.342 -179.145 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 51.6 tttm -111.77 138.45 48.35 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.417 -176.356 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.977 ' HG2' ' HG2' ' A' ' 51' ' ' GLU . 62.4 mttp -87.45 137.46 32.32 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.118 0.485 . . . . 0.0 111.421 -177.627 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.45 HG12 HG23 ' A' ' 73' ' ' ILE . 79.8 t -110.17 100.66 11.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 170.657 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.508 ' HE3' HG11 ' A' ' 47' ' ' VAL . 39.0 tttp -75.59 101.03 4.78 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.178 -175.826 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 1.011 HG13 HG23 ' A' ' 48' ' ' ILE . 4.6 pt -109.04 125.26 66.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.616 0.722 . . . . 0.0 111.143 -177.779 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -106.78 131.58 53.73 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.966 -177.39 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -130.16 166.2 20.73 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.163 178.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.443 ' CG2' ' HB3' ' A' ' 43' ' ' LEU . 9.0 p -122.92 145.15 30.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.72 0.295 . . . . 0.0 111.112 -174.421 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 44.9 p90 -146.27 164.72 31.42 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.536 178.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.785 ' HE1' ' HE1' ' A' ' 31' ' ' PHE . 52.3 p90 -141.64 148.29 38.94 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 169.436 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -102.14 128.56 48.58 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.429 -176.016 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 72.7 p -88.08 -179.3 6.16 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.88 176.452 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.43 ' HB2' ' OD1' ' A' ' 2' ' ' ASN . 7.1 mp -70.12 -18.31 63.23 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.08 0.466 . . . . 0.0 110.207 178.395 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -71.18 -13.29 61.88 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.717 179.261 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 66.4 t30 77.68 10.12 2.3 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 124.079 0.862 . . . . 0.0 109.33 -171.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 77.8 t -81.74 129.12 38.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.278 178.418 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 56.1 mtm180 -92.94 105.46 17.57 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.343 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.3 t -84.28 106.74 14.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 177.205 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.586 ' O ' ' HA ' ' A' ' 25' ' ' HIS . 30.5 t -108.51 141.08 24.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.954 -173.432 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 34.3 m -144.44 150.57 37.88 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 176.299 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -62.92 126.11 26.24 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.182 0.515 . . . . 0.0 111.358 179.28 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -70.22 -38.06 75.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.14 -176.24 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 24.9 m -60.25 -57.75 11.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.354 -177.037 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.494 ' O ' ' HB3' ' A' ' 95' ' ' LYS . 36.3 mm-40 -68.22 -29.86 68.79 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.731 -177.502 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.645 ' HE1' ' HA ' ' A' ' 32' ' ' TYR . 53.0 t80 -67.87 -49.27 62.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.955 0.407 . . . . 0.0 110.404 177.41 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.52 ' O ' ' HG3' ' A' ' 98' ' ' LYS . 79.2 mm-40 -66.85 -24.46 66.14 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.568 178.193 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.494 ' HB3' ' O ' ' A' ' 92' ' ' GLU . 44.6 tttp -59.69 -49.57 77.24 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.366 174.827 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.453 ' O ' ' HB3' ' A' ' 99' ' ' LYS . 58.4 mt -67.93 -33.17 59.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.815 -179.29 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 69.8 mt -64.75 -39.82 94.26 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.563 177.344 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.52 ' HG3' ' O ' ' A' ' 94' ' ' GLN . 57.1 mttp -70.42 -33.81 71.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.033 0.444 . . . . 0.0 109.924 175.306 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.453 ' HB3' ' O ' ' A' ' 96' ' ' ILE . 61.9 tttp -56.65 -57.9 10.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.283 -0.872 . . . . 0.0 110.925 179.377 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -74.9 -23.78 58.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.587 0.232 . . . . 0.0 111.274 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 93.37 95.1 1.5 Allowed Glycine 0 N--CA 1.448 -0.506 0 N-CA-C 111.339 -0.704 . . . . 0.0 111.339 -175.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.7 m -127.06 -38.43 2.01 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.165 0.507 . . . . 0.0 110.592 -177.446 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -109.5 115.49 30.02 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 177.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 88.3 mt -91.8 163.98 13.86 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.19 -176.018 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -72.35 164.79 25.73 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.262 -178.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 41.5 m80 -127.47 126.72 42.82 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 174.249 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 10.9 t-160 -61.52 -40.14 93.54 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 -179.433 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -102.67 124.03 47.46 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 170.473 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -71.87 -18.28 62.06 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.955 0.407 . . . . 0.0 110.212 -175.716 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 18.9 t60 -127.44 127.42 44.08 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 174.059 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 47.8 t60 . . . . . 0 C--O 1.247 0.925 0 CA-C-O 118.509 -0.758 . . . . 0.0 110.068 179.402 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.563 ' SD ' HG11 ' A' ' 38' ' ' VAL . 21.0 ptt? . . . . . 0 N--CA 1.478 0.971 0 CA-C-O 120.98 0.419 . . . . 0.0 110.26 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -94.15 174.79 6.97 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.56 174.666 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.8 m -62.55 -23.26 66.89 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.009 0.433 . . . . 0.0 111.242 -177.566 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -61.59 -37.56 84.36 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.972 179.424 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 62.1 t -68.62 -34.32 64.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.023 0.439 . . . . 0.0 110.348 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.409 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 50.8 mt -62.39 -43.12 97.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.71 176.468 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 57.1 mttm -60.33 -38.33 83.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.049 177.726 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -57.6 -48.71 78.65 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.862 0.363 . . . . 0.0 110.777 178.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -66.17 -44.22 84.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.895 -179.415 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 6' ' ' ILE . 97.0 mt -66.66 -43.95 83.16 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.408 -177.287 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -69.3 -32.44 71.59 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.737 0.303 . . . . 0.0 110.37 -179.312 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -61.82 -48.68 79.51 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.12 178.308 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 38.3 pt -80.93 -12.55 12.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.165 -178.766 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 81.47 38.31 14.94 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.348 179.231 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -91.76 118.56 30.79 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.95 0.405 . . . . 0.0 110.197 178.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -97.8 102.78 14.63 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.964 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.467 ' CD2' HG23 ' A' ' 24' ' ' ILE . 29.0 p90 -97.97 170.59 8.84 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.469 -174.788 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.525 ' HB ' ' HB2' ' A' ' 25' ' ' HIS . 64.1 mt -94.25 100.33 10.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.99 177.333 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -90.54 135.53 33.64 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.245 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.673 ' HG ' ' H ' ' A' ' 21' ' ' GLU . 21.8 tp -133.28 177.22 7.85 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 175.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.673 ' H ' ' HG ' ' A' ' 20' ' ' LEU . 43.2 mt-10 -61.76 102.46 0.26 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.633 0.254 . . . . 0.0 110.902 -178.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.408 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 11.8 m120 71.68 16.25 5.78 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.999 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.56 ' HB2' ' HB3' ' A' ' 20' ' ' LEU . 41.4 mt-10 -131.63 134.96 46.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.056 0.455 . . . . 0.0 111.421 178.173 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.467 HG23 ' CD2' ' A' ' 17' ' ' TYR . 74.1 mt -118.69 107.53 21.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 171.54 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.525 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 73.0 m-70 -94.29 109.85 21.65 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.049 0.452 . . . . 0.0 110.491 -178.157 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.463 HD23 ' HB3' ' A' ' 17' ' ' TYR . 40.5 mt -109.25 150.54 27.8 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.936 -178.426 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 49.5 mtmt -64.38 135.61 96.42 Favored Pre-proline 0 C--N 1.326 -0.427 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 171.633 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.5 ' HB2' HD12 ' A' ' 96' ' ' ILE . 51.8 Cg_exo -54.27 -28.93 54.9 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.684 2.256 . . . . 0.0 112.075 -177.602 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -61.62 -56.38 20.51 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.49 177.656 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 49.2 t -68.14 -38.69 80.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.242 179.419 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -51.54 -46.86 63.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.238 -179.246 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 93.0 t80 -60.19 -43.38 95.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.137 -179.296 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.556 ' O ' ' HB2' ' A' ' 37' ' ' TYR . 43.6 mt-10 -76.96 -8.74 57.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.774 -175.448 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 62.5 t -93.07 -42.62 13.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.251 0.548 . . . . 0.0 109.522 171.058 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.553 ' CD1' ' HD2' ' A' ' 41' ' ' PRO . 44.2 t90 -55.82 -52.0 65.52 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.046 177.666 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 53.7 tttm -78.82 -14.35 59.3 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.015 0.436 . . . . 0.0 110.738 -177.34 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.556 ' HB2' ' O ' ' A' ' 33' ' ' GLU . 87.0 t80 -71.28 -44.77 64.59 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.814 -179.693 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.563 HG11 ' SD ' ' A' ' 1' ' ' MET . 33.3 m -94.31 -3.66 10.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.338 -177.846 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 136.68 -85.28 0.24 Allowed Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.077 177.749 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 170.98 61.06 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.371 0 C-N-CA 122.969 0.508 . . . . 0.0 110.73 -175.1 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.553 ' HD2' ' CD1' ' A' ' 35' ' ' TRP . 71.1 Cg_exo -50.69 128.69 24.74 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.127 1.884 . . . . 0.0 111.584 177.126 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -61.16 116.07 4.28 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.318 0.58 . . . . 0.0 110.298 -177.263 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.576 ' HB3' ' CG2' ' A' ' 76' ' ' VAL . 93.3 mt -82.6 126.12 31.94 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.184 -0.917 . . . . 0.0 111.983 -170.81 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -92.06 139.21 30.86 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 175.732 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 69.5 p -118.68 145.85 45.17 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 121.148 -0.221 . . . . 0.0 110.599 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 25.7 p90 -133.46 143.49 48.87 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 176.153 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 48.4 t -94.98 110.72 24.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.24 -178.331 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 8.9 tt -118.9 111.17 32.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 121.425 0.631 . . . . 0.0 110.18 178.1 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.453 ' HG2' ' HG2' ' A' ' 72' ' ' LYS . 47.7 mt-10 -76.95 125.18 28.88 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 176.161 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -92.97 118.68 31.43 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 -176.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -103.6 125.12 49.92 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.895 -174.165 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 65.9 mt 69.02 94.4 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.652 178.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.474 ' O ' ' HD3' ' A' ' 55' ' ' PRO . 42.7 t -90.96 138.1 20.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.45 -0.795 . . . . 0.0 108.89 178.339 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -87.57 111.82 44.32 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-O 121.235 0.541 . . . . 0.0 111.521 -174.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.474 ' HD3' ' O ' ' A' ' 53' ' ' VAL . 86.1 Cg_endo -92.69 145.47 2.56 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 123.321 2.681 . . . . 0.0 112.12 176.487 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -135.89 1.44 3.51 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.836 -0.697 . . . . 0.0 111.759 178.339 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -82.87 -43.2 16.86 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.922 0.391 . . . . 0.0 110.449 -178.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -130.21 174.68 9.59 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.256 -178.494 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -137.39 149.69 66.3 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.022 178.244 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.54 138.84 19.85 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.504 2.136 . . . . 0.0 111.986 178.128 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -49.81 -48.13 20.55 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.973 2.449 . . . . 0.0 112.088 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.418 ' C ' ' H ' ' A' ' 64' ' ' LYS . 43.1 mt-10 -108.21 118.18 36.08 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.595 174.293 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 60.8 mtm -72.4 9.26 1.08 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.267 -177.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.418 ' H ' ' C ' ' A' ' 62' ' ' GLU . 68.8 mttt -85.07 -14.86 45.91 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.262 -179.129 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -113.01 147.83 36.36 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.954 -176.183 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 36.4 m -139.91 107.15 5.49 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.857 177.342 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -64.41 113.42 3.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.065 0.459 . . . . 0.0 110.67 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 48.7 t -83.06 105.41 12.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.553 -178.498 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -95.92 128.01 42.45 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.595 175.623 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -127.06 101.42 6.53 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 178.156 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 30.6 t -109.97 131.89 59.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.869 -174.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.453 ' HG2' ' HG2' ' A' ' 49' ' ' GLU . 49.7 mttp -73.56 101.09 3.48 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.537 177.69 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 49.3 mm -100.27 118.84 47.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.227 0.537 . . . . 0.0 110.572 -179.474 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.626 ' O ' ' HB3' ' A' ' 90' ' ' TYR . 49.5 tttp -92.8 118.55 31.22 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 176.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -118.44 159.61 23.18 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 179.051 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.576 ' CG2' ' HB3' ' A' ' 43' ' ' LEU . 14.2 p -131.03 147.94 33.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.978 -171.266 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 46.2 p90 -154.94 156.49 36.15 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.641 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -115.97 140.15 49.54 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 169.167 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -109.01 127.22 53.9 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.498 -170.019 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 44.5 p -88.89 -179.67 6.01 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.849 -175.157 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.9 mp -70.73 -22.84 62.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.229 178.246 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.445 ' HB2' HG23 ' A' ' 84' ' ' VAL . 2.9 m-20 -75.07 -10.02 59.08 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.344 179.43 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.438 ' HB2' ' O ' ' A' ' 82' ' ' ASP . 9.0 m120 68.72 28.76 5.49 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.156 -171.602 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.445 HG23 ' HB2' ' A' ' 82' ' ' ASP . 68.9 t -98.66 126.18 51.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.265 -0.88 . . . . 0.0 108.847 173.158 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 65.8 mtt180 -100.95 114.79 29.01 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.05 0.452 . . . . 0.0 111.176 -173.218 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 46.9 t -83.88 99.85 6.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 175.445 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 22.1 t -102.72 140.02 22.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.274 -171.499 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.9 t -143.65 -178.57 5.96 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 174.688 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -93.25 123.3 36.43 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.601 -177.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.626 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 61.8 t80 -69.26 -34.55 74.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.176 -176.75 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 12.7 t -65.83 -49.5 67.99 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 -178.237 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.479 ' HA ' ' HD3' ' A' ' 95' ' ' LYS . 28.9 mm-40 -66.12 -39.2 89.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.944 177.594 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.45 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 58.1 t80 -60.93 -45.98 92.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.756 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.526 ' O ' ' HG2' ' A' ' 98' ' ' LYS . 48.5 mm-40 -58.92 -39.45 81.58 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.145 177.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.479 ' HD3' ' HA ' ' A' ' 92' ' ' GLU . 50.1 mtpt -62.78 -43.68 98.15 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.87 177.474 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.5 HD12 ' HB2' ' A' ' 28' ' ' PRO . 67.4 mt -68.6 -33.29 59.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.879 179.699 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 93' ' ' PHE . 86.5 mt -58.17 -37.18 74.21 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.979 0.418 . . . . 0.0 110.323 174.705 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.526 ' HG2' ' O ' ' A' ' 94' ' ' GLN . 38.6 mmtm -74.35 -34.78 63.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.253 178.065 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.466 ' HD2' ' HA ' ' A' ' 96' ' ' ILE . 68.7 mttm -63.45 -46.76 84.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.785 176.712 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.597 ' HE ' ' HA ' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -73.87 -20.84 60.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.294 179.517 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 77.42 35.28 37.64 Favored Glycine 0 N--CA 1.451 -0.351 0 CA-C-N 115.945 -0.571 . . . . 0.0 112.266 178.727 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.7 m -87.02 65.13 8.82 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.402 0.62 . . . . 0.0 110.385 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 59.7 tttm -178.13 142.19 0.27 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.199 -0.909 . . . . 0.0 109.859 176.636 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.464 HD13 ' HA ' ' A' ' 110' ' ' HIS . 88.4 mt -88.92 150.8 22.68 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 174.671 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -77.45 -50.24 13.11 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.249 0.547 . . . . 0.0 110.026 178.187 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -92.48 -177.66 4.67 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.015 -178.574 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 71.3 t60 -135.54 -25.45 1.3 Allowed 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.525 -178.431 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 6.0 t-80 -92.12 -10.26 39.57 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 177.726 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -132.32 140.12 48.44 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.878 -1.055 . . . . 0.0 108.888 175.458 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' HIS . . . . . 0.464 ' HA ' HD13 ' A' ' 104' ' ' LEU . 11.8 p-80 -77.48 78.67 3.99 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.862 0.839 . . . . 0.0 111.104 179.13 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 36.2 t60 . . . . . 0 C--O 1.244 0.764 0 CA-C-N 114.814 -1.084 . . . . 0.0 108.84 176.495 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.445 ' CE ' ' HB ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.938 0 CA-C-O 120.954 0.407 . . . . 0.0 110.552 . . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -93.92 170.95 9.17 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.553 175.578 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.483 ' O ' ' HG3' ' A' ' 7' ' ' LYS . 34.2 t -61.48 -29.79 70.2 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.569 174.9 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -52.76 -43.13 65.57 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.759 176.274 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.7 t -62.9 -38.91 83.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.67 -178.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.522 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 60.5 mt -66.42 -44.86 90.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.315 179.335 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.483 ' HG3' ' O ' ' A' ' 3' ' ' SER . 85.6 mttt -63.63 -36.45 83.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.467 -179.187 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -55.86 -49.58 72.97 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.738 175.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -60.13 -43.14 95.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.066 179.218 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.531 HD13 ' HB3' ' A' ' 17' ' ' TYR . 74.4 mt -63.25 -48.27 78.92 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.325 -177.704 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -74.59 -19.62 60.25 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.96 -179.114 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -72.32 -45.34 60.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.837 177.076 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 38.1 pt -73.56 -17.78 17.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.979 0.419 . . . . 0.0 110.31 177.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.11 30.44 14.35 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.677 173.349 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -115.25 168.08 10.28 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 177.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -113.18 155.06 25.68 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.956 0.408 . . . . 0.0 110.96 -175.001 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.531 ' HB3' HD13 ' A' ' 10' ' ' LEU . 14.8 p90 -125.7 147.56 49.32 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.117 -173.219 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 52.5 mt -89.09 93.96 4.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 177.435 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -98.63 116.25 30.44 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.24 -176.323 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 77.4 mt -111.43 -176.53 2.97 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 171.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.491 ' HA ' ' OE1' ' A' ' 21' ' ' GLU . 6.3 tp10 -72.23 109.57 6.08 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 120.427 -0.509 . . . . 0.0 109.936 179.347 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 66.49 15.12 10.01 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.733 179.373 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -138.41 113.92 9.65 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.843 0.354 . . . . 0.0 111.277 179.311 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.453 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 63.9 mt -110.09 112.1 39.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 172.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 53.5 m-70 -98.44 117.21 32.35 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.486 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 80.4 mt -114.92 173.37 6.52 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.192 -175.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 75.6 mttt -84.5 149.65 55.16 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.492 178.089 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_exo -51.52 -41.68 59.28 Favored 'Trans proline' 0 C--O 1.233 0.241 0 C-N-CA 122.907 2.405 . . . . 0.0 112.855 -179.57 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -65.6 -44.71 85.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.76 0.314 . . . . 0.0 110.541 -179.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 61.4 t -64.91 -45.09 95.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.131 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -58.1 -40.12 80.35 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.033 -179.021 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -57.49 -42.54 82.9 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.338 179.152 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -76.43 -40.81 49.61 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.921 -177.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 79.0 t -65.56 -32.37 57.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.536 178.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.532 ' CD1' ' HD2' ' A' ' 41' ' ' PRO . 25.8 t90 -52.97 -52.27 58.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.027 178.574 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -76.07 -26.82 56.87 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.756 0.312 . . . . 0.0 110.762 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -65.82 -34.7 78.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.053 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.445 ' HB ' ' CE ' ' A' ' 1' ' ' MET . 35.9 m -89.73 9.94 2.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.788 0.327 . . . . 0.0 111.579 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 100.7 14.7 31.26 Favored Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 120.604 -0.807 . . . . 0.0 113.604 174.102 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 48.75 73.09 1.06 Allowed Pre-proline 0 N--CA 1.466 0.357 0 CA-C-O 121.279 0.562 . . . . 0.0 111.409 177.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.532 ' HD2' ' CD1' ' A' ' 35' ' ' TRP . 95.4 Cg_endo -90.4 163.8 4.47 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 122.679 2.253 . . . . 0.0 112.48 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -71.32 107.12 4.13 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 172.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 70.5 mt -73.43 146.42 45.04 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.812 -172.238 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -87.95 138.45 31.44 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.776 176.379 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 19.3 p -127.94 132.3 49.25 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 120.825 0.345 . . . . 0.0 110.218 176.492 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.406 ' CE2' ' HB ' ' A' ' 48' ' ' ILE . 14.7 p90 -119.21 144.64 46.61 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.758 -178.557 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 43.7 t -93.72 105.14 16.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.279 -0.419 . . . . 0.0 109.951 179.503 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.406 ' HB ' ' CE2' ' A' ' 46' ' ' TYR . 12.1 tt -105.77 130.6 56.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.061 179.06 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.709 ' HB3' ' HB3' ' A' ' 70' ' ' LYS . 45.4 mt-10 -88.83 106.66 18.53 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 177.674 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.535 ' O ' HG22 ' A' ' 71' ' ' VAL . 10.6 t70 -92.9 111.2 22.74 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.453 -174.753 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.48 ' HG2' ' HG2' ' A' ' 70' ' ' LYS . 41.8 mt-10 -81.39 93.49 6.6 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.372 0.606 . . . . 0.0 109.764 -179.15 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.1 tp -63.55 -25.85 39.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.043 -0.981 . . . . 0.0 111.882 -171.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.2 p -125.85 123.54 64.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 120.972 0.415 . . . . 0.0 110.596 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -132.03 101.56 15.08 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.4 177.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -65.53 120.19 7.34 Favored 'Trans proline' 0 N--CA 1.463 -0.268 0 C-N-CA 122.835 2.357 . . . . 0.0 111.685 177.298 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -135.65 -35.89 0.22 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.343 -0.932 . . . . 0.0 111.899 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -71.46 -63.02 1.2 Allowed 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 174.496 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -134.26 170.33 15.87 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.71 -1.132 . . . . 0.0 108.408 170.663 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.496 ' OD2' ' HB2' ' A' ' 62' ' ' GLU . 15.0 t0 -125.18 81.15 63.7 Favored Pre-proline 0 C--N 1.319 -0.735 0 CA-C-O 121.247 0.546 . . . . 0.0 111.299 -176.859 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -58.95 -42.75 49.03 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 123.07 2.513 . . . . 0.0 113.966 172.511 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.723 ' HB2' ' HA ' ' A' ' 67' ' ' ASN . 31.4 Cg_exo -61.74 -2.8 3.0 Favored 'Trans proline' 0 C--N 1.365 1.421 0 C-N-CA 122.348 2.032 . . . . 0.0 113.772 -179.229 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.496 ' HB2' ' OD2' ' A' ' 59' ' ' ASP . 33.4 tt0 -60.42 -26.43 66.7 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.054 0.454 . . . . 0.0 109.935 173.233 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 85.8 mtp -67.07 -18.16 65.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.536 177.413 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -120.66 -162.22 0.94 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.284 -177.645 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -113.03 4.86 16.9 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.074 0.464 . . . . 0.0 111.004 -173.199 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 41.4 m -137.45 105.18 5.58 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.813 -178.006 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.723 ' HA ' ' HB2' ' A' ' 61' ' ' PRO . 13.2 m120 -83.63 -41.63 17.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.652 -178.781 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 30.6 m -118.64 145.21 24.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.328 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.478 ' O ' ' HA ' ' A' ' 51' ' ' GLU . 53.8 tttm -113.84 108.9 17.69 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.856 0.36 . . . . 0.0 110.252 178.79 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.709 ' HB3' ' HB3' ' A' ' 49' ' ' GLU . 59.5 mttm -85.2 109.0 17.99 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.309 179.574 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.535 HG22 ' O ' ' A' ' 50' ' ' ASP . 35.7 m -97.84 122.64 49.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.161 0.505 . . . . 0.0 110.164 175.092 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.414 ' HG2' ' HG2' ' A' ' 49' ' ' GLU . 68.3 mttm -76.45 104.13 6.81 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.556 -177.698 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 56.8 mt -110.08 117.06 53.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.426 179.383 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.422 ' O ' ' HB3' ' A' ' 90' ' ' TYR . 52.9 tttm -87.44 91.77 8.85 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.554 179.06 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -92.04 160.96 14.98 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.08 -176.151 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 13.5 p -114.9 144.19 23.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.209 -173.255 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.413 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 37.6 p90 -154.99 162.7 41.01 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.729 176.499 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -137.1 150.18 47.84 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 170.488 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 54.9 tt0 -120.49 135.67 55.0 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.479 -173.756 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 73.0 p -94.8 -176.97 4.03 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.338 177.231 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.8 mp -65.05 -13.73 58.69 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.279 0.561 . . . . 0.0 110.727 179.004 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.426 ' O ' ' HB2' ' A' ' 83' ' ' ASN . 4.8 m-20 -79.22 -8.82 59.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.59 -179.548 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ASN . . . . . 0.426 ' HB2' ' O ' ' A' ' 82' ' ' ASP . 14.3 m120 69.58 16.73 8.04 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.4 0.619 . . . . 0.0 110.252 -174.357 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 66.1 t -89.57 122.03 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.383 176.064 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -100.33 116.51 32.47 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.719 -176.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.453 ' HA ' ' O ' ' A' ' 24' ' ' ILE . 59.1 t -86.31 104.72 14.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.552 176.482 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 22.0 t -101.65 142.65 15.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.607 -174.735 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 58.2 m -151.15 157.09 42.26 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 177.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -71.09 121.02 17.51 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.093 0.473 . . . . 0.0 110.409 -178.432 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.422 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 12.2 t80 -75.72 -27.5 58.19 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.981 -174.572 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 33.0 t -70.02 -43.66 70.87 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.397 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -64.25 -42.32 96.57 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.357 175.071 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -62.79 -46.6 87.23 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.856 -179.652 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -65.7 -29.61 70.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.011 178.356 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -63.83 -33.47 75.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.076 0.465 . . . . 0.0 110.302 176.514 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.493 ' HA ' ' HD2' ' A' ' 99' ' ' LYS . 68.0 mt -75.02 -39.89 44.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.381 176.405 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 84.2 mt -65.07 -30.52 71.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.172 0.51 . . . . 0.0 110.138 176.406 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 44.9 tttm -67.41 -37.29 82.85 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.421 175.509 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.493 ' HD2' ' HA ' ' A' ' 96' ' ' ILE . 60.3 mttm -64.44 -47.54 78.68 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.356 175.449 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 52.8 ttt-85 -68.64 -38.39 80.46 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.963 -177.764 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 87.43 40.12 6.99 Favored Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 111.251 -0.74 . . . . 0.0 111.251 -176.456 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.517 HG22 ' H ' ' A' ' 104' ' ' LEU . 20.7 m -63.26 130.16 43.35 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.012 0.434 . . . . 0.0 111.354 -177.448 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.46 ' HA ' ' O ' ' A' ' 106' ' ' HIS . 85.6 tttt -63.83 -17.16 62.85 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.408 -0.814 . . . . 0.0 112.099 -175.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.517 ' H ' HG22 ' A' ' 102' ' ' THR . 91.2 mt -57.2 -39.21 74.97 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.852 0.358 . . . . 0.0 111.002 179.612 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -91.83 -63.17 1.28 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.139 0.495 . . . . 0.0 109.885 175.593 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' HIS . . . . . 0.46 ' O ' ' HA ' ' A' ' 103' ' ' LYS . 42.6 m170 -84.13 92.94 8.03 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.677 178.168 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 40.4 m80 -65.92 -35.97 82.09 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.938 -177.232 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 23.2 m-70 -103.04 113.86 27.67 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 170.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 8.7 t-80 -57.73 -71.79 0.1 Allowed 'General case' 0 C--N 1.329 -0.305 0 O-C-N 123.531 0.519 . . . . 0.0 111.372 -172.784 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 2.1 m170 174.0 -68.22 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.053 0.941 . . . . 0.0 108.748 178.439 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 53.5 t60 . . . . . 0 C--O 1.244 0.771 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 173.081 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.511 ' HG2' HG12 ' A' ' 38' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.029 0 CA-C-O 120.744 0.307 . . . . 0.0 110.767 . . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -140.04 173.9 11.06 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 176.474 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 36.9 t -68.68 -27.7 66.2 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 175.648 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -58.05 -36.94 73.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.165 173.451 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 98.3 t -68.54 -42.85 83.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.458 178.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 62.9 mt -60.81 -45.31 98.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.981 177.012 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 45.9 mttp -56.51 -52.61 64.09 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.575 175.616 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -58.12 -45.16 87.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.105 -178.302 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -63.67 -45.66 89.1 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.34 -178.713 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 83.9 mt -71.04 -34.6 71.43 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.636 -0.256 . . . . 0.0 111.282 -177.302 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 43.1 mm-40 -69.74 -33.55 72.61 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.046 0.451 . . . . 0.0 110.418 175.326 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -63.37 -52.33 62.16 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.556 178.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 39.5 pt -77.97 -17.46 13.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.55 -177.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 76.99 60.43 2.91 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.074 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -112.5 158.87 19.38 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 -178.56 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -71.15 117.61 12.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.08 0.467 . . . . 0.0 110.82 179.084 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -116.09 121.07 41.08 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.269 -176.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 61.1 mt -120.82 107.24 20.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.758 0.313 . . . . 0.0 110.776 -179.226 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -125.8 125.04 42.28 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.04 0.448 . . . . 0.0 110.064 175.213 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 97.3 mt -95.16 46.49 1.12 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.875 178.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 66.62 94.79 0.06 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.569 -177.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 73.18 -8.25 1.35 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.844 179.21 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 32.2 tp10 -112.76 113.78 26.04 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 175.351 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.583 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 55.0 mt -107.19 133.48 51.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 110.335 -0.246 . . . . 0.0 110.335 -177.144 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -125.27 105.45 9.13 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 173.194 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 37.1 mt -95.26 -179.81 4.92 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.774 0.797 . . . . 0.0 113.026 -168.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -87.53 132.83 39.63 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 114.389 -1.278 . . . . 0.0 109.942 -179.057 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 99.8 Cg_exo -42.56 -70.42 0.07 OUTLIER 'Trans proline' 0 CA--C 1.532 0.421 0 C-N-CA 123.948 3.099 . . . . 0.0 114.811 -172.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.41 ' HA ' HD13 ' A' ' 96' ' ' ILE . 41.4 mt-10 -75.64 -3.15 32.86 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -172.856 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 98.5 t -90.02 -44.64 15.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 175.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -58.98 -34.66 72.07 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.609 177.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 67.5 t80 -54.14 -40.97 67.9 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.397 178.621 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -83.36 -29.02 28.55 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.116 -178.222 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 66.9 t -66.42 -36.79 78.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.375 0.607 . . . . 0.0 109.486 174.325 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 33.5 t90 -56.46 -52.97 62.69 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.557 175.139 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.791 ' HA ' ' HB3' ' A' ' 40' ' ' GLU . 53.5 mttm -66.84 -30.39 70.56 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.631 -0.258 . . . . 0.0 111.201 178.113 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -59.58 -40.71 88.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.367 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.511 HG12 ' HG2' ' A' ' 1' ' ' MET . 19.4 m -88.32 7.67 3.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.924 -175.468 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.417 ' O ' ' HG2' ' A' ' 40' ' ' GLU . . . 109.33 0.31 31.18 Favored Glycine 0 N--CA 1.453 -0.197 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.977 176.702 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.791 ' HB3' ' HA ' ' A' ' 36' ' ' LYS . 10.8 pt-20 44.8 69.46 2.5 Favored Pre-proline 0 N--CA 1.473 0.69 0 C-N-CA 124.267 1.027 . . . . 0.0 113.009 -179.342 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -94.04 -179.19 0.74 Allowed 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 123.096 2.53 . . . . 0.0 112.095 176.568 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -71.29 114.76 9.69 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.046 0.451 . . . . 0.0 110.691 176.032 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 68.5 mt -77.82 164.29 25.33 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.62 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 52.4 tttp -106.67 122.83 47.13 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.07 -176.636 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.413 ' OG1' ' HE2' ' A' ' 74' ' ' LYS . 39.9 p -102.66 148.67 25.28 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.673 -0.24 . . . . 0.0 111.489 -177.477 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -130.63 145.29 51.87 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 176.375 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 60.1 t -104.85 113.64 42.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 120.832 0.348 . . . . 0.0 110.572 -179.114 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 10.8 tt -111.05 112.75 41.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.371 0.605 . . . . 0.0 110.398 177.31 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.877 ' HG2' ' HG2' ' A' ' 72' ' ' LYS . 50.4 mt-10 -77.48 107.01 9.62 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.258 179.097 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -93.13 126.18 38.1 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -179.432 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.402 ' HG2' HG13 ' A' ' 53' ' ' VAL . 40.2 tt0 -94.03 104.82 16.85 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 120.997 0.427 . . . . 0.0 111.199 -174.429 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 67.1 mt -87.19 110.71 20.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.098 178.536 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.45 HG12 ' HA ' ' A' ' 68' ' ' VAL . 21.2 m -132.23 144.9 35.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.685 178.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -97.75 117.95 64.64 Favored Pre-proline 0 C--N 1.321 -0.663 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 172.007 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.32 -175.96 1.47 Allowed 'Trans proline' 0 C--O 1.234 0.288 0 C-N-CA 122.836 2.357 . . . . 0.0 113.205 -174.185 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -135.27 43.99 1.21 Allowed Glycine 0 N--CA 1.444 -0.796 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.981 -177.318 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -46.28 -43.9 16.06 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 123.296 0.639 . . . . 0.0 111.567 -177.719 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -123.22 94.59 4.31 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.226 179.481 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -95.68 115.22 65.34 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.105 -179.296 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.48 ' HG2' ' HE2' ' A' ' 64' ' ' LYS . 8.3 Cg_exo -73.47 165.06 33.44 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 122.933 2.422 . . . . 0.0 111.099 173.768 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.44 43.67 0.65 Allowed 'Trans proline' 0 CA--C 1.534 0.507 0 C-N-CA 122.864 2.376 . . . . 0.0 112.719 179.182 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -123.47 -176.23 3.4 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.783 -179.108 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 68.3 mtm -113.34 83.39 1.83 Allowed 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 174.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.48 ' HE2' ' HG2' ' A' ' 60' ' ' PRO . 68.0 mttm -93.59 132.73 37.64 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 177.225 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -107.9 147.18 31.34 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.293 0.568 . . . . 0.0 111.757 -172.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.2 t -163.43 153.32 15.33 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.18 -0.918 . . . . 0.0 108.558 178.616 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 29.2 p-10 -134.85 161.18 35.94 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.223 0.535 . . . . 0.0 112.06 -174.202 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.45 ' HA ' HG12 ' A' ' 53' ' ' VAL . 3.3 p -83.23 133.18 29.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.165 179.238 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -128.95 107.86 9.96 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.075 0.464 . . . . 0.0 110.303 176.333 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 48.7 mttm -92.14 132.92 36.24 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.146 -177.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 18.9 m -115.8 128.26 73.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.115 0.483 . . . . 0.0 110.524 176.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.877 ' HG2' ' HG2' ' A' ' 49' ' ' GLU . 79.4 mttt -86.74 100.06 12.22 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.987 0.423 . . . . 0.0 110.352 -178.483 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 57.0 mt -92.71 115.09 30.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.054 -179.54 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.594 ' O ' ' HB3' ' A' ' 90' ' ' TYR . 82.2 tttt -98.9 114.71 27.44 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.247 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -111.83 166.99 10.72 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 13.9 p -125.83 143.48 39.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 120.733 0.301 . . . . 0.0 111.074 -172.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 28.9 p90 -155.0 173.8 16.06 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.934 0.397 . . . . 0.0 110.941 178.543 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -145.1 151.44 38.51 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 170.692 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -102.07 128.97 48.3 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.843 0.354 . . . . 0.0 110.23 -176.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.4 p -84.09 173.59 10.98 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.201 179.359 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.412 HD12 ' N ' ' A' ' 81' ' ' LEU . 7.0 mp -68.33 -17.74 64.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.068 0.461 . . . . 0.0 111.36 -176.213 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -95.62 14.95 21.29 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.213 -179.171 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 70.44 23.68 4.82 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.143 173.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 59.3 t -100.14 141.93 16.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 120.962 0.41 . . . . 0.0 110.562 178.227 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 8.2 mtp180 -98.0 117.08 31.54 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.229 -178.402 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.583 ' HA ' ' HB ' ' A' ' 24' ' ' ILE . 20.5 t -96.89 97.1 5.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 176.627 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 31.8 t -103.7 144.4 14.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.079 0.466 . . . . 0.0 111.656 -172.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 51.1 m -151.98 159.6 43.71 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 175.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -73.04 131.86 42.65 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 121.734 -0.604 . . . . 0.0 110.986 -176.709 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.594 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 88.9 t80 -73.93 -30.34 62.5 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.389 -176.725 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.25 -44.77 71.26 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.528 ' O ' ' HB3' ' A' ' 95' ' ' LYS . 5.3 tp10 -70.43 -34.66 72.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.233 179.301 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.414 ' O ' HD23 ' A' ' 97' ' ' LEU . 83.4 t80 -62.34 -51.5 67.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.325 176.588 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 72.5 mm-40 -64.31 -29.73 70.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.825 179.138 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.528 ' HB3' ' O ' ' A' ' 92' ' ' GLU . 23.4 tptm -55.72 -46.99 77.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.321 174.621 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.41 HD13 ' HA ' ' A' ' 29' ' ' GLU . 57.7 mt -68.84 -39.5 80.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.112 -179.052 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.575 HD12 ' HG3' ' A' ' 103' ' ' LYS . 4.3 mm? -58.59 -45.25 89.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.788 178.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -74.27 -30.38 62.09 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.507 178.516 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -59.33 -45.35 91.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.908 -176.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 100' ' ' ARG . 21.3 ttp85 -104.35 -8.13 19.45 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.107 -179.127 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 72.04 46.59 35.3 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.111 179.046 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.515 ' HB ' HD13 ' A' ' 97' ' ' LEU . 15.1 m -72.7 -24.92 61.07 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.166 0.508 . . . . 0.0 111.1 -177.225 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.575 ' HG3' HD12 ' A' ' 97' ' ' LEU . 55.7 mtmt -106.27 69.89 0.81 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.303 0.573 . . . . 0.0 109.829 175.658 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 8.1 tt -159.43 123.54 3.86 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.086 -179.218 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -113.92 113.1 24.38 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.008 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 12.4 t-80 -57.96 -30.44 65.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.794 -174.732 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -118.3 128.26 54.49 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.031 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 28.3 m80 -111.42 131.87 54.88 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.719 0.295 . . . . 0.0 110.679 177.531 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 -83.59 135.62 34.55 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 176.255 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 61.2 t60 67.51 -81.62 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 O-C-N 123.857 0.723 . . . . 0.0 109.579 -174.067 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 16.1 t-80 . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.085 -0.96 . . . . 0.0 109.805 175.578 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.0 tmm? . . . . . 0 N--CA 1.479 1.024 0 CA-C-O 120.969 0.414 . . . . 0.0 110.723 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 -127.16 -178.11 4.31 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 173.479 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.579 ' O ' ' HG3' ' A' ' 7' ' ' LYS . 30.1 p -56.89 -31.69 65.12 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.764 0.316 . . . . 0.0 110.693 177.81 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -56.7 -52.62 64.24 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.975 175.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.1 t -60.42 -43.25 93.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.683 -179.561 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.45 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 67.1 mt -53.12 -45.33 53.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.88 174.68 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.579 ' HG3' ' O ' ' A' ' 3' ' ' SER . 91.6 mttt -62.48 -41.6 98.9 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.97 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -58.7 -42.69 89.21 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.993 0.425 . . . . 0.0 110.62 177.018 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -65.28 -43.83 89.97 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.412 179.685 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.509 HD13 ' HB3' ' A' ' 17' ' ' TYR . 85.4 mt -65.26 -39.3 92.46 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.996 179.673 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -67.26 -40.53 86.25 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.428 178.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -60.04 -43.38 95.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.795 177.435 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 62.5 mt -70.29 -41.35 78.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.544 177.129 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.74 35.76 5.02 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.99 -0.624 . . . . 0.0 111.784 -178.51 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -104.53 177.27 4.89 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.071 0.463 . . . . 0.0 111.245 -178.544 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -109.65 149.97 28.93 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.966 -178.421 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.509 ' HB3' HD13 ' A' ' 10' ' ' LEU . 34.1 p90 -144.84 144.52 31.17 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 176.836 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 67.3 mt -113.01 102.86 14.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 120.895 0.378 . . . . 0.0 110.103 178.395 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -92.2 133.22 36.0 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.275 0.559 . . . . 0.0 110.861 -178.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 88.9 mt -121.44 -162.24 0.96 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.788 177.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -71.62 102.06 2.66 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.892 -0.323 . . . . 0.0 110.399 177.746 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 67.3 20.48 10.04 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.33 177.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -136.77 138.86 41.35 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.287 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.44 HD11 ' HB2' ' A' ' 3' ' ' SER . 60.2 mt -122.86 113.01 36.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 170.744 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.51 ' HA ' ' O ' ' A' ' 87' ' ' VAL . 16.3 m-70 -95.87 123.72 39.57 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.251 -179.355 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 92.5 mt -114.98 177.55 4.61 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.345 -175.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.436 ' HB2' HG23 ' A' ' 30' ' ' VAL . 86.8 mttt -86.95 137.9 33.13 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 115.364 -0.835 . . . . 0.0 108.934 174.242 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.453 ' HA ' HG21 ' A' ' 88' ' ' THR . 57.6 Cg_exo -52.4 -38.05 73.12 Favored 'Trans proline' 0 CA--C 1.529 0.26 0 C-N-CA 122.92 2.414 . . . . 0.0 113.113 -177.218 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -73.6 -29.67 62.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.04 -177.196 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.436 HG23 ' HB2' ' A' ' 27' ' ' LYS . 27.0 t -84.54 -38.37 13.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.233 0.54 . . . . 0.0 110.134 179.557 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -57.63 -30.43 65.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.826 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -54.35 -45.95 72.85 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.271 178.304 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -82.05 -29.4 31.93 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.274 -177.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 79.5 t -67.8 -41.31 85.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.21 0.529 . . . . 0.0 109.977 176.404 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.483 ' CD1' ' HD2' ' A' ' 41' ' ' PRO . 29.2 t90 -57.14 -45.29 83.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.342 176.121 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 56.8 mttm -76.23 -21.53 56.27 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.461 179.079 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -65.97 -35.64 81.15 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.998 0.428 . . . . 0.0 110.381 178.021 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.535 HG23 ' HD3' ' A' ' 41' ' ' PRO . 26.9 m -93.68 12.39 3.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.316 179.559 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 87.01 29.33 23.34 Favored Glycine 0 C--N 1.33 0.237 0 C-N-CA 121.055 -0.593 . . . . 0.0 113.481 174.183 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 36.42 75.21 0.53 Allowed Pre-proline 0 N--CA 1.473 0.701 0 C-N-CA 124.07 0.948 . . . . 0.0 113.218 179.082 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.535 ' HD3' HG23 ' A' ' 38' ' ' VAL . 82.1 Cg_endo -89.01 -159.32 0.09 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 123.307 2.671 . . . . 0.0 112.617 -178.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -70.18 123.74 22.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.684 -178.685 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 74.7 mt -89.07 117.54 28.15 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.239 175.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -95.66 119.47 34.23 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.227 -178.646 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.6 p -107.2 134.73 49.87 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.614 179.346 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' TYR . . . . . 0.518 ' CE1' ' HB2' ' A' ' 75' ' ' LYS . 15.1 p90 -128.29 140.45 51.87 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.329 -0.396 . . . . 0.0 109.975 178.492 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 61.7 t -99.18 110.55 26.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.584 -179.317 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.446 HG23 ' HB ' ' A' ' 73' ' ' ILE . 7.4 tt -106.86 106.68 21.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.645 175.718 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.482 ' OE1' ' HD3' ' A' ' 70' ' ' LYS . 39.6 tt0 -81.94 104.05 12.03 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.121 -179.014 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -102.36 146.72 27.65 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.441 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -99.09 125.16 44.55 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.778 0.323 . . . . 0.0 111.074 -174.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 53.2 mt 63.72 85.63 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.788 -177.639 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.472 HG21 HD11 ' A' ' 73' ' ' ILE . 48.1 t -110.04 96.86 5.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.992 178.224 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -96.38 159.38 32.06 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.497 -178.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -54.9 -32.94 80.22 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 123.124 2.55 . . . . 0.0 113.189 179.656 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 176.12 -35.32 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.259 -0.972 . . . . 0.0 113.263 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -114.12 145.12 42.07 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.813 0.307 . . . . 0.0 111.008 -177.143 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -104.86 174.3 5.94 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 176.744 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -83.01 156.21 67.2 Favored Pre-proline 0 C--N 1.327 -0.4 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 177.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.539 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 88.5 Cg_exo -42.65 124.9 3.54 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 123.8 3.0 . . . . 0.0 113.872 -175.383 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.539 ' HD3' ' HA ' ' A' ' 60' ' ' PRO . 10.2 Cg_exo -70.42 87.3 0.64 Allowed 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 123.289 2.659 . . . . 0.0 112.517 -178.527 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -122.14 -177.53 3.62 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.766 178.728 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 46.8 ttp -75.03 82.07 2.23 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 173.181 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 72.7 tttt -153.78 138.29 16.82 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.803 -1.09 . . . . 0.0 109.464 -172.753 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 77.9 t80 -87.6 99.95 12.43 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.875 0.369 . . . . 0.0 110.811 178.67 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 32.9 m -71.04 119.4 15.11 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 169.654 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 -52.34 112.7 0.85 Allowed 'General case' 0 C--N 1.329 -0.313 0 O-C-N 123.372 0.42 . . . . 0.0 111.627 -175.082 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 45.4 t -75.63 86.67 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.827 178.178 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 32.4 tttm -96.66 127.22 42.43 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.665 -178.393 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.482 ' HD3' ' OE1' ' A' ' 49' ' ' GLU . 62.8 mttm -79.91 129.96 34.91 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.979 -175.392 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 53.8 t -116.75 109.94 29.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.452 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.436 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 61.6 mttp -76.06 100.34 4.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.31 177.471 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.472 HD11 HG21 ' A' ' 53' ' ' VAL . 40.3 mt -91.19 108.59 20.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.254 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 54.1 tttp -91.57 106.18 18.3 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.56 178.631 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.518 ' HB2' ' CE1' ' A' ' 46' ' ' TYR . 89.9 mttt -105.49 162.23 13.65 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.158 -178.725 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 10.7 p -124.19 142.42 41.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.605 0.24 . . . . 0.0 110.574 -178.316 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.445 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 43.5 p90 -153.6 167.8 28.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.095 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 44.1 p90 -136.49 151.11 49.1 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 168.073 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -102.48 131.6 49.07 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.01 0.433 . . . . 0.0 111.466 -174.494 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 75.0 p -83.97 -172.66 4.28 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.003 179.283 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 8.5 mp -73.81 -33.61 64.25 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.949 0.404 . . . . 0.0 110.424 178.171 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -92.16 24.57 3.26 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.369 -177.669 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 20.8 m120 69.81 20.76 6.67 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 169.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 86.1 t -94.41 124.42 46.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.595 179.181 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 51.9 mtt-85 -89.52 110.93 21.72 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.707 179.102 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 45.9 t -81.35 99.5 4.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 175.516 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.51 ' O ' ' HA ' ' A' ' 25' ' ' HIS . 22.2 t -102.57 138.88 25.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.879 -172.297 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' THR . . . . . 0.453 HG21 ' HA ' ' A' ' 28' ' ' PRO . 42.8 m -144.76 157.59 44.12 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 177.022 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ASP . . . . . 0.47 ' OD2' ' HG2' ' A' ' 92' ' ' GLU . 9.5 t70 -66.88 122.46 17.76 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.155 0.503 . . . . 0.0 111.57 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -69.28 -30.23 68.28 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.845 -177.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 35.1 t -62.84 -66.38 0.55 Allowed 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.077 -176.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLU . . . . . 0.47 ' HG2' ' OD2' ' A' ' 89' ' ' ASP . 12.3 mm-40 -68.66 -28.96 67.34 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 121.042 -0.263 . . . . 0.0 111.323 -175.48 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.432 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 53.0 t80 -62.09 -47.4 84.82 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 121.079 -0.248 . . . . 0.0 110.872 178.483 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -64.14 -35.52 81.06 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.779 0.323 . . . . 0.0 110.838 179.563 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -61.39 -43.72 98.38 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.515 177.397 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.407 HG13 ' O ' ' A' ' 92' ' ' GLU . 78.9 mt -66.79 -36.77 78.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.033 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 93' ' ' PHE . 97.8 mt -59.42 -49.95 75.85 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.943 0.401 . . . . 0.0 110.117 175.794 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 7.6 mtpm? -63.89 -42.61 97.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.602 177.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 7.6 tmtm? -59.76 -54.17 49.41 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.953 -177.19 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 100' ' ' ARG . 49.4 mtt180 -82.65 -6.41 59.35 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.349 -175.285 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 81.22 40.62 11.12 Favored Glycine 0 C--N 1.329 0.173 0 C-N-CA 120.967 -0.635 . . . . 0.0 113.409 172.322 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 37.1 m -78.77 133.49 37.1 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.702 0.287 . . . . 0.0 110.345 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -95.44 119.19 33.51 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.911 0.386 . . . . 0.0 111.029 -176.187 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 87.1 mt -105.69 164.83 11.61 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.959 177.291 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -70.44 138.36 51.15 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.359 0.6 . . . . 0.0 112.294 -176.434 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 17.9 m-70 -127.07 102.39 6.95 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.17 172.679 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 10.7 m170 -99.92 164.19 12.12 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.061 -175.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -87.37 -11.35 49.59 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.526 0.679 . . . . 0.0 109.262 177.089 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 32.3 m80 -134.96 130.04 35.17 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.985 -1.007 . . . . 0.0 108.934 173.19 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 53.8 p-80 -65.27 -36.77 85.13 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 174.525 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 1.9 m80 . . . . . 0 C--O 1.246 0.884 0 CA-C-N 115.347 -0.842 . . . . 0.0 108.963 175.742 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 14.7 m120 . . . . . 0 C--O 1.232 0.166 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.6 m -63.93 -28.01 69.53 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.239 0.542 . . . . 0.0 110.36 178.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -62.71 -33.1 74.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.192 178.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 88.7 t -66.9 -39.42 83.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.164 177.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.472 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 64.0 mt -63.43 -39.9 87.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.422 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -64.2 -40.24 95.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.755 179.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -68.1 -36.85 80.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.7 177.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -62.14 -43.52 98.65 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.255 176.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' A' ' 6' ' ' ILE . 94.0 mt -65.26 -32.4 74.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.662 177.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -62.92 -47.35 83.64 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.36 177.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -64.02 -52.37 59.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.16 -178.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 40.1 pt -67.5 -27.46 38.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.243 -177.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.62 58.21 1.45 Allowed Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.503 178.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.452 ' HG2' HG21 ' A' ' 30' ' ' VAL . 8.4 tp10 -136.36 148.22 47.75 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -95.92 139.93 31.42 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.682 -179.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.464 ' HB3' HD13 ' A' ' 10' ' ' LEU . 52.6 p90 -112.34 142.39 44.91 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.863 0.363 . . . . 0.0 110.49 176.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 62.1 mt -101.65 96.59 4.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 176.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.406 ' HA ' ' O ' ' A' ' 23' ' ' GLU . 39.9 tt0 -97.28 121.88 39.67 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.374 0.607 . . . . 0.0 110.813 -178.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 96.3 mt -109.22 34.01 3.98 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.334 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 69.8 101.12 0.06 Allowed 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.268 -177.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 7.7 m120 68.74 3.64 4.01 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.019 -177.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.406 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 12.9 mt-10 -129.32 113.9 15.55 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 110.406 -0.22 . . . . 0.0 110.406 172.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.405 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 67.6 mt -105.95 102.65 14.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 175.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 42.7 m-70 -87.81 120.99 29.68 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 59.9 mt -117.89 172.14 7.59 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.483 0.659 . . . . 0.0 111.634 -175.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -80.19 136.17 53.73 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.402 176.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.83 ' HG2' ' HG2' ' A' ' 92' ' ' GLU . 88.2 Cg_exo -49.01 -43.81 34.66 Favored 'Trans proline' 0 N--CA 1.474 0.367 0 C-N-CA 123.536 2.824 . . . . 0.0 114.073 -175.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -67.71 -36.66 81.02 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.784 0.326 . . . . 0.0 110.988 -179.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.452 HG21 ' HG2' ' A' ' 15' ' ' GLU . 41.2 t -68.96 -43.86 81.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.087 0.47 . . . . 0.0 109.881 176.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -55.87 -45.62 78.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.082 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 78.4 t80 -57.7 -39.45 77.2 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.28 -178.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -76.78 -42.29 41.31 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.032 -178.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 89.4 t -65.6 -37.16 79.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.791 0.329 . . . . 0.0 110.516 178.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 26.1 t90 -54.19 -53.92 46.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.665 177.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.507 ' HA ' ' HB3' ' A' ' 40' ' ' GLU . 65.9 mttm -71.88 -26.46 62.35 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 121.158 -0.217 . . . . 0.0 111.246 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 77.1 t80 -63.36 -38.59 91.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.733 0.301 . . . . 0.0 110.975 179.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 29.0 m -88.39 10.42 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.827 0.346 . . . . 0.0 111.755 -177.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 99.86 8.18 51.83 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.934 176.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.507 ' HB3' ' HA ' ' A' ' 36' ' ' LYS . 19.1 pt-20 40.69 81.36 0.25 Allowed Pre-proline 0 N--CA 1.473 0.708 0 C-N-CA 124.335 1.054 . . . . 0.0 113.315 178.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -88.08 -168.68 0.39 Allowed 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.008 2.472 . . . . 0.0 111.842 175.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -75.85 136.4 40.17 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.008 0.432 . . . . 0.0 110.717 179.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 97.2 mt -97.08 146.66 24.81 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.71 -179.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 61.1 tttm -111.5 118.39 35.62 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.62 -179.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 37.2 p -105.19 141.94 35.84 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.178 -176.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 21.2 p90 -130.05 151.37 50.67 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.77 0.319 . . . . 0.0 110.273 177.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.544 HG22 ' HG3' ' A' ' 74' ' ' LYS . 42.5 t -107.23 129.86 60.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.632 177.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 6.4 tt -125.92 111.88 28.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 121.239 0.542 . . . . 0.0 110.543 177.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.593 ' HA ' ' HA ' ' A' ' 72' ' ' LYS . 1.6 mp0 . . . . . 0 C--N 1.324 -0.509 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.021 177.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.593 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 20.5 pttp . . . . . 0 N--CA 1.453 -0.296 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 13.9 tt -105.79 137.12 37.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 121.276 0.56 . . . . 0.0 110.945 -175.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.592 ' O ' ' HB3' ' A' ' 90' ' ' TYR . 28.7 tttm -95.52 125.82 40.38 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.07 178.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -125.03 158.66 33.17 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.701 0.286 . . . . 0.0 110.281 178.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 11.1 p -121.94 146.75 26.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.617 -175.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.409 ' CE1' ' HD2' ' A' ' 85' ' ' ARG . 48.7 p90 -152.67 164.53 37.55 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.81 0.338 . . . . 0.0 110.393 175.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -132.54 147.9 52.37 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 170.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.529 ' HG2' ' HG2' ' A' ' 85' ' ' ARG . 45.3 mt-10 -104.27 132.14 50.84 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.947 0.403 . . . . 0.0 110.91 -176.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 49.5 p -85.14 -175.65 5.83 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.164 -179.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 7.9 mp -66.86 -20.79 65.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.388 177.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.44 ' HB2' HG23 ' A' ' 84' ' ' VAL . 9.3 m-20 -92.08 6.58 45.92 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.287 -178.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 64.94 23.15 12.56 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.957 -177.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.44 HG23 ' HB2' ' A' ' 82' ' ' ASP . 79.3 t -87.87 126.51 41.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 176.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.529 ' HG2' ' HG2' ' A' ' 79' ' ' GLU . 31.1 mtm180 -96.74 111.09 23.4 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.446 -175.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 24' ' ' ILE . 59.7 t -83.43 103.33 10.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 175.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.4 t -99.21 144.08 12.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.002 -172.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.519 HG21 ' HA ' ' A' ' 28' ' ' PRO . 51.5 m -151.39 148.94 28.72 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.735 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -57.56 112.44 1.43 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.055 178.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.592 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 70.9 t80 -71.96 -30.12 64.97 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.09 0.471 . . . . 0.0 110.25 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.3 p -60.95 -47.28 87.15 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.574 175.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.83 ' HG2' ' HG2' ' A' ' 28' ' ' PRO . 15.1 tp10 -72.17 -36.03 69.17 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.147 178.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.46 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 58.3 t80 -60.49 -52.59 64.54 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.068 -179.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -64.84 -31.71 73.07 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.777 0.322 . . . . 0.0 110.876 177.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.45 ' HB3' ' O ' ' A' ' 92' ' ' GLU . 76.8 tttt -59.42 -41.71 90.14 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.504 175.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.43 HG13 ' O ' ' A' ' 92' ' ' GLU . 73.1 mt -72.2 -37.11 58.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.499 176.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' A' ' 93' ' ' PHE . 86.5 mt -59.14 -48.96 79.7 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.62 177.016 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -65.3 -29.4 70.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.788 178.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 65.7 tttm -68.58 -52.05 35.92 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.795 -178.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 100' ' ' ARG . 56.8 mtt180 -82.64 -10.36 58.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.224 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.576 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.021 -179.549 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 . . . . . 0 C--O 1.233 0.222 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.2 m -60.06 -37.13 78.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.0 0.429 . . . . 0.0 111.241 -176.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -64.51 -35.99 82.74 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.577 -178.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 77.5 t -64.36 -40.57 89.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.347 177.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.554 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 65.9 mt -62.49 -46.4 96.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.216 177.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.409 ' O ' ' HG3' ' A' ' 11' ' ' GLU . 98.9 mttt -56.4 -49.23 75.11 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.622 178.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -57.92 -45.79 85.99 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.274 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 93.0 t80 -58.76 -40.67 84.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.352 178.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.554 ' HG ' ' O ' ' A' ' 6' ' ' ILE . 77.0 mt -66.48 -43.41 85.48 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.891 179.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.409 ' HG3' ' O ' ' A' ' 7' ' ' LYS . 52.4 mt-10 -62.46 -34.62 77.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.923 0.392 . . . . 0.0 110.624 178.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -66.16 -50.52 63.64 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.353 178.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 38.4 pt -75.98 -6.65 9.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.66 -177.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.73 24.19 39.58 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.614 175.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -89.91 154.16 20.07 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.837 0.351 . . . . 0.0 110.503 -177.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -103.36 122.87 45.72 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.136 177.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.539 ' HB3' HD13 ' A' ' 10' ' ' LEU . 39.8 p90 -115.25 133.24 56.22 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.029 176.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.551 ' HB ' ' HB2' ' A' ' 25' ' ' HIS . 44.0 mt -106.95 91.91 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 176.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.686 ' HA ' ' O ' ' A' ' 23' ' ' GLU . 1.0 OUTLIER -98.12 106.84 19.2 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.626 -179.081 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 97.0 mt -125.54 122.4 36.44 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.858 -178.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.47 ' O ' ' HB2' ' A' ' 22' ' ' ASN . 36.6 mt-10 58.43 36.64 25.51 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 123.577 0.548 . . . . 0.0 111.173 175.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.47 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 0.9 OUTLIER 73.92 25.71 1.87 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.08 -179.833 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.686 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 55.8 mt-10 -115.07 113.73 24.43 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.17 171.317 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.49 HG22 ' HG ' ' A' ' 26' ' ' LEU . 60.2 mt -91.55 101.62 12.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 177.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.551 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 12.3 m170 -87.29 121.95 30.41 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.49 ' HG ' HG22 ' A' ' 24' ' ' ILE . 63.6 mt -130.03 -174.83 3.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.243 0.544 . . . . 0.0 111.955 -175.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -92.02 144.7 29.59 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.091 177.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.523 ' HA ' HG21 ' A' ' 88' ' ' THR . 78.0 Cg_exo -50.19 -46.8 26.8 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 123.479 2.786 . . . . 0.0 113.911 -176.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -67.39 -36.52 81.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.791 0.329 . . . . 0.0 110.837 -177.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.407 ' O ' HG23 ' A' ' 34' ' ' VAL . 48.4 t -68.46 -41.56 83.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.09 179.046 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -56.01 -42.07 75.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.373 177.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 79.7 t80 -60.78 -44.99 96.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.351 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -68.64 -42.37 78.12 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.177 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 30' ' ' VAL . 93.5 t -64.9 -36.99 79.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.814 0.34 . . . . 0.0 110.16 177.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.52 ' CD1' ' HD2' ' A' ' 41' ' ' PRO . 27.6 t90 -52.8 -50.88 62.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.563 176.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -70.71 -34.84 72.36 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.322 178.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -57.97 -43.59 86.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.731 0.3 . . . . 0.0 111.29 179.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.534 HG23 ' HD3' ' A' ' 41' ' ' PRO . 27.6 m -82.35 14.43 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -175.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 101.89 1.96 52.19 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.743 175.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 57.22 70.45 1.35 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.19 0.519 . . . . 0.0 110.869 179.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.534 ' HD3' HG23 ' A' ' 38' ' ' VAL . 87.4 Cg_endo -88.28 -162.74 0.14 Allowed 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.967 2.445 . . . . 0.0 112.215 -179.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -88.11 145.12 26.11 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.247 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 96.0 mt -93.7 157.24 16.26 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.573 -175.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -125.3 148.3 48.76 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.184 176.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.6 p -141.15 153.13 45.22 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.797 0.332 . . . . 0.0 111.557 -175.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 16.8 p90 -145.04 148.86 34.17 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.839 176.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.43 ' HA ' ' HA ' ' A' ' 74' ' ' LYS . 45.7 t -102.03 122.28 54.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 17.5 tt -109.61 150.32 12.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.394 -178.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 . . . . . 0 C--N 1.327 -0.403 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.359 -175.186 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 51.3 mttm . . . . . 0 N--CA 1.451 -0.415 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 61.5 mt -98.63 125.6 51.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.238 0.542 . . . . 0.0 110.814 -176.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.517 ' O ' ' HB3' ' A' ' 90' ' ' TYR . 86.8 tttt -87.48 122.89 31.79 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.71 177.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -113.01 161.49 16.99 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.425 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.484 ' HB ' ' CD1' ' A' ' 90' ' ' TYR . 13.1 p -118.11 145.39 24.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.521 -0.308 . . . . 0.0 110.962 -175.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.413 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 38.8 p90 -154.94 159.55 40.5 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.909 178.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -133.4 152.29 51.9 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 170.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.548 ' HG2' ' HG2' ' A' ' 85' ' ' ARG . 24.9 mt-10 -104.61 138.82 40.37 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.987 0.423 . . . . 0.0 110.93 -173.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 73.0 p -97.54 -169.28 1.81 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.848 -175.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -69.9 -28.28 65.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.039 -179.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -95.71 19.5 11.14 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.086 -172.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 65.8 17.1 10.75 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.529 -179.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 85.2 t -88.34 137.9 20.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.108 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.548 ' HG2' ' HG2' ' A' ' 79' ' ' GLU . 90.5 mtt180 -107.84 113.87 27.41 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.453 -177.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 53.2 t -83.54 102.67 9.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 177.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 25' ' ' HIS . 32.5 t -100.38 136.29 32.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.778 -174.098 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.523 HG21 ' HA ' ' A' ' 28' ' ' PRO . 52.3 m -146.98 157.62 43.68 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.07 178.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -67.11 122.88 18.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.337 0.589 . . . . 0.0 111.617 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.517 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 49.2 t80 -78.38 -20.1 51.97 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.691 -178.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.543 ' O ' ' HG3' ' A' ' 95' ' ' LYS . 4.1 m -62.22 -61.1 2.7 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.867 0.365 . . . . 0.0 110.253 179.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -71.17 -29.28 64.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.125 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.524 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 62.9 t80 -58.24 -45.18 88.24 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.875 0.369 . . . . 0.0 110.07 176.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.461 ' NE2' HD12 ' A' ' 97' ' ' LEU . 20.7 mm-40 -61.67 -40.38 94.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.049 176.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.543 ' HG3' ' O ' ' A' ' 91' ' ' SER . 90.3 mttt -65.18 -40.75 94.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.832 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.473 HD12 ' HB2' ' A' ' 28' ' ' PRO . 66.6 mt -71.5 -31.12 41.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.239 -179.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.524 ' HG ' ' O ' ' A' ' 93' ' ' PHE . 53.8 mt -61.7 -42.44 98.94 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.939 0.4 . . . . 0.0 110.419 175.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -73.94 -20.74 60.28 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.17 0.509 . . . . 0.0 110.521 177.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -74.38 -42.74 58.79 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.205 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 67.2 mtt180 -98.75 -4.12 34.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.843 0.354 . . . . 0.0 111.443 -177.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.455 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.588 177.915 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . 0.508 HD22 HD23 ' A' ' 81' ' ' LEU . 0.8 OUTLIER . . . . . 0 C--O 1.234 0.279 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 64.8 p -58.76 -31.2 68.15 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.953 0.406 . . . . 0.0 110.409 176.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.598 ' HA ' ' HD2' ' A' ' 7' ' ' LYS . 35.5 tt0 -62.32 -38.39 89.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.8 178.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 93.0 t -65.55 -45.8 91.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.041 0.448 . . . . 0.0 110.046 178.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 59.6 mt -59.62 -41.72 85.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.657 174.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.598 ' HD2' ' HA ' ' A' ' 4' ' ' GLU . 62.9 mttm -50.9 -57.79 7.62 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.811 0.339 . . . . 0.0 110.614 175.109 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -56.39 -43.17 78.99 Favored 'General case' 0 C--O 1.223 -0.323 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.963 -179.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.467 ' O ' HG12 ' A' ' 13' ' ' ILE . 70.1 t80 -60.81 -48.96 79.44 Favored 'General case' 0 C--N 1.328 -0.358 0 O-C-N 123.123 0.265 . . . . 0.0 110.935 -178.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 96.7 mt -62.48 -47.85 82.2 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.986 0.422 . . . . 0.0 111.085 -178.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -73.73 -21.74 60.12 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.013 -177.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -75.61 -38.53 58.92 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.858 0.361 . . . . 0.0 110.7 177.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.467 HG12 ' O ' ' A' ' 9' ' ' PHE . 32.1 pt -87.33 -4.82 9.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.875 0.369 . . . . 0.0 110.711 177.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 74.53 43.14 31.03 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.104 -0.569 . . . . 0.0 112.655 175.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 46.7 mm-40 -109.94 151.12 27.5 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.395 0.617 . . . . 0.0 111.742 -179.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -89.26 150.89 22.41 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.006 -178.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 33.0 p90 -145.54 143.3 29.86 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.906 0.384 . . . . 0.0 111.091 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.561 ' HB ' ' HB2' ' A' ' 25' ' ' HIS . 48.9 mm -97.82 92.76 3.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 174.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.405 ' HG3' HG12 ' A' ' 24' ' ' ILE . 33.8 tt0 -91.52 109.49 20.79 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.875 -175.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 69.7 mt -105.04 -170.79 1.81 Allowed 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 175.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -79.69 109.67 14.3 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.089 -0.644 . . . . 0.0 110.258 178.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 60.0 m-80 70.27 18.51 6.81 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 114.946 -1.025 . . . . 0.0 111.41 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.502 ' HG2' ' HB2' ' A' ' 85' ' ' ARG . 37.7 mt-10 -144.55 131.43 20.27 Favored 'General case' 0 C--O 1.222 -0.36 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.07 177.132 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.405 HG12 ' HG3' ' A' ' 19' ' ' GLU . 76.2 mt -125.91 107.84 18.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 173.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.561 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 19.6 m-70 -92.08 127.24 37.48 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 -178.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 87.2 mt -118.34 169.34 9.81 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.453 -174.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 84.9 mttt -70.42 140.43 87.42 Favored Pre-proline 0 C--N 1.327 -0.4 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 173.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -47.6 -48.42 15.66 Favored 'Trans proline' 0 CA--C 1.531 0.342 0 C-N-CA 123.15 2.567 . . . . 0.0 113.592 -176.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -73.81 -31.09 63.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.788 0.327 . . . . 0.0 111.051 -175.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.44 ' O ' HG23 ' A' ' 34' ' ' VAL . 56.3 t -73.23 -41.44 58.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 178.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -56.53 -39.63 73.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.265 176.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.554 ' OH ' ' HD3' ' A' ' 100' ' ' ARG . 47.2 t80 -53.97 -44.36 70.71 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.513 178.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -76.6 -36.26 57.61 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.291 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 30' ' ' VAL . 76.8 t -67.13 -40.02 84.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.006 0.432 . . . . 0.0 110.475 178.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.611 ' CD1' ' HD2' ' A' ' 41' ' ' PRO . 27.8 t90 -56.68 -45.76 81.53 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.259 176.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 25.0 mttm -71.67 -34.75 69.96 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.243 178.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 90.6 t80 -58.26 -43.26 87.79 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.143 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.477 HG23 ' HD3' ' A' ' 41' ' ' PRO . 35.8 m -81.49 13.74 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -177.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 103.75 -0.37 45.53 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.971 174.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 59.99 70.11 1.1 Allowed Pre-proline 0 CA--C 1.536 0.427 0 CA-C-O 121.147 0.498 . . . . 0.0 110.457 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.611 ' HD2' ' CD1' ' A' ' 35' ' ' TRP . 66.2 Cg_endo -92.68 -162.47 0.1 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 123.282 2.655 . . . . 0.0 113.259 -177.089 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -58.06 144.75 38.86 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.176 -179.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 68.5 mt -105.29 112.01 24.96 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.066 173.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 60.6 mttm -107.72 140.5 40.68 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.5 p -127.87 157.37 40.67 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.706 0.289 . . . . 0.0 111.756 -174.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 38.7 p90 -138.55 136.73 36.35 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 172.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 58.3 t -98.96 122.03 50.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.312 -179.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 13.0 tt -104.3 128.88 57.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.191 0.519 . . . . 0.0 110.415 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 . . . . . 0 C--N 1.323 -0.56 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.506 -179.749 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 58.2 mttm . . . . . 0 N--CA 1.449 -0.486 0 CA-C-O 121.156 0.503 . . . . 0.0 110.204 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 71.2 mt -93.77 134.64 30.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.066 -177.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -116.1 107.76 15.33 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.415 0.626 . . . . 0.0 110.961 -174.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 35.9 mmtp -96.4 149.15 22.04 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.982 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.474 ' HB ' ' HB2' ' A' ' 90' ' ' TYR . 9.7 p -114.07 142.84 25.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.546 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 37.5 p90 -151.36 159.03 44.48 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.152 0.501 . . . . 0.0 111.212 -177.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -132.27 147.84 52.42 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 168.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -102.21 137.78 40.02 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.944 0.402 . . . . 0.0 111.02 -174.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 82.8 p -91.48 -175.35 4.19 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.855 178.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.508 HD23 HD22 ' A' ' 2' ' ' ASN . 66.3 tp -60.92 -31.21 70.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.181 0.515 . . . . 0.0 110.356 176.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.618 ' HB2' HG23 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -79.84 -2.03 41.64 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.648 -178.142 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 59.3 m-80 70.87 23.11 4.48 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.346 0.658 . . . . 0.0 110.568 -176.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.618 HG23 ' HB2' ' A' ' 82' ' ' ASP . 70.7 t -86.24 126.49 40.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.438 178.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.502 ' HB2' ' HG2' ' A' ' 23' ' ' GLU . 63.4 mtt85 -86.03 110.02 19.21 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.666 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.546 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 49.1 t -82.66 109.05 16.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 171.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.468 HG22 ' HB3' ' A' ' 77' ' ' TYR . 9.6 t -116.79 147.59 20.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.22 0.533 . . . . 0.0 112.418 -167.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 6.0 t -155.76 -176.66 6.07 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 169.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -84.59 128.26 34.5 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 117.971 0.351 . . . . 0.0 110.561 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.474 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 11.2 t80 -77.46 -22.17 51.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.523 -174.066 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.3 -47.1 52.54 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.919 -0.401 . . . . 0.0 109.919 178.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.422 ' O ' ' HB3' ' A' ' 95' ' ' LYS . 54.8 mm-40 -70.21 -29.65 66.54 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.707 176.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.528 ' HE1' ' HA ' ' A' ' 32' ' ' TYR . 43.0 t80 -69.08 -47.65 64.68 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.662 0.267 . . . . 0.0 110.473 178.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.555 ' O ' ' HG3' ' A' ' 98' ' ' LYS . 43.1 mt-30 -60.95 -34.58 74.97 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.275 175.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.422 ' HB3' ' O ' ' A' ' 92' ' ' GLU . 42.4 tttt -52.98 -47.09 68.46 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.018 176.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.637 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 78.8 mt -68.94 -37.47 77.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.763 178.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 83.3 mt -65.34 -32.16 73.67 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.67 178.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.555 ' HG3' ' O ' ' A' ' 94' ' ' GLN . 96.8 mttt -65.35 -38.78 91.12 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 174.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.637 ' HE3' ' HA ' ' A' ' 96' ' ' ILE . 9.1 mtmp? -69.21 -33.24 73.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.716 178.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.554 ' HD3' ' OH ' ' A' ' 32' ' ' TYR . 13.0 ttp180 -71.16 -38.6 72.19 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.969 0.414 . . . . 0.0 110.365 175.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.52 0 C-N-CA 120.937 -0.649 . . . . 0.0 111.742 -178.283 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . 0.4 HD22 ' HB2' ' A' ' 82' ' ' ASP . 13.0 m120 . . . . . 0 CA--C 1.522 -0.135 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.556 ' OG ' ' HB3' ' A' ' 82' ' ' ASP . 3.3 m -65.32 -35.06 79.85 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.797 0.332 . . . . 0.0 110.915 -177.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.458 ' O ' ' HG2' ' A' ' 8' ' ' GLU . 34.2 tt0 -58.51 -41.53 85.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.503 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 94.0 t -55.64 -45.2 78.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.825 177.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.521 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 64.4 mt -63.0 -43.59 99.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.554 -179.155 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.429 ' HE2' ' OE1' ' A' ' 19' ' ' GLU . 92.5 mttt -61.36 -46.62 89.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.784 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.458 ' HG2' ' O ' ' A' ' 4' ' ' GLU . 52.5 mm-40 -60.58 -48.01 83.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.271 177.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -59.69 -38.18 80.84 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.349 -178.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.521 ' HG ' ' O ' ' A' ' 6' ' ' ILE . 93.5 mt -65.26 -37.9 88.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.842 0.353 . . . . 0.0 110.488 178.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -69.97 -34.01 72.82 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.188 176.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -59.74 -43.61 94.17 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.052 175.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 35.1 pt -85.67 -7.51 10.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.841 0.353 . . . . 0.0 111.33 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 81.38 26.58 51.16 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 121.026 -0.606 . . . . 0.0 113.211 174.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -106.64 143.54 34.59 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.875 0.369 . . . . 0.0 110.408 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -102.29 147.92 26.08 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.885 -179.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 13.0 p90 -120.52 154.39 35.38 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.981 0.42 . . . . 0.0 111.672 -174.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 51.6 mt -101.51 96.84 5.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 174.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.429 ' OE1' ' HE2' ' A' ' 7' ' ' LYS . 61.1 tt0 -108.51 137.42 46.5 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.495 0.664 . . . . 0.0 112.02 -173.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 89.7 mt -116.73 -173.56 2.41 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 170.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -61.7 103.5 0.34 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.817 0.342 . . . . 0.0 110.831 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.462 ' HA ' HG22 ' A' ' 84' ' ' VAL . 4.2 m-20 66.94 23.0 9.98 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.725 178.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -134.81 113.95 12.12 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.681 0.277 . . . . 0.0 111.209 176.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.42 ' HB ' HG22 ' A' ' 86' ' ' VAL . 66.0 mt -103.33 109.68 27.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 175.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -92.55 120.31 32.88 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.415 ' HG ' HG22 ' A' ' 24' ' ' ILE . 64.8 mt -124.75 155.47 39.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.241 0.543 . . . . 0.0 111.691 -176.269 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -65.96 136.47 95.61 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.491 176.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -56.2 -33.46 90.72 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.319 2.013 . . . . 0.0 111.588 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -62.09 -43.91 97.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.956 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 45.9 t -81.36 -34.33 13.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.187 0.517 . . . . 0.0 110.244 179.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -55.64 -39.08 70.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.712 -176.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -58.46 -38.37 77.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.764 0.316 . . . . 0.0 111.113 -178.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -79.67 -34.53 40.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.838 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 95.9 t -64.53 -42.82 96.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.012 0.434 . . . . 0.0 110.024 176.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.518 ' CD1' ' HD2' ' A' ' 41' ' ' PRO . 29.6 t90 -57.6 -41.1 80.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.423 177.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -69.09 -43.61 74.19 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.884 176.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -60.92 -41.0 95.3 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.956 -178.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.516 HG23 ' HD3' ' A' ' 41' ' ' PRO . 35.1 m -76.9 4.42 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 112.308 0.485 . . . . 0.0 112.308 -175.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 105.82 -0.48 39.04 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.543 -0.837 . . . . 0.0 113.089 175.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 59.49 75.12 0.52 Allowed Pre-proline 0 CA--C 1.535 0.382 0 CA-C-O 120.987 0.422 . . . . 0.0 111.228 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.518 ' HD2' ' CD1' ' A' ' 35' ' ' TRP . 90.6 Cg_endo -91.58 -176.68 0.87 Allowed 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.791 2.327 . . . . 0.0 112.109 176.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 57.8 mm-40 -72.29 135.82 46.09 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.014 0.435 . . . . 0.0 110.765 178.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.465 ' HB3' ' CG2' ' A' ' 76' ' ' VAL . 95.2 mt -98.44 138.02 36.27 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.48 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -117.23 138.58 51.62 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.951 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 16.2 p -105.2 147.52 27.92 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 120.79 0.328 . . . . 0.0 111.443 -176.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.492 ' CE2' ' HB ' ' A' ' 48' ' ' ILE . 10.0 p90 -129.1 156.1 44.4 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 175.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 33.1 t -103.28 105.11 17.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.028 0.442 . . . . 0.0 110.945 -176.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.625 HG23 ' HB ' ' A' ' 73' ' ' ILE . 5.8 tt -95.83 101.33 12.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 121.672 0.749 . . . . 0.0 109.443 175.113 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 . . . . . 0 C--N 1.318 -0.802 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.913 -177.576 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 57.0 mttm . . . . . 0 N--CA 1.454 -0.262 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.625 ' HB ' HG23 ' A' ' 48' ' ' ILE . 58.8 mt -91.03 129.44 41.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.301 -178.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -103.32 111.46 23.87 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.237 -178.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.413 ' HB3' ' O ' ' A' ' 88' ' ' THR . 65.6 mttm -114.96 167.15 11.05 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.235 -0.439 . . . . 0.0 109.832 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.465 ' CG2' ' HB3' ' A' ' 43' ' ' LEU . 14.4 p -123.48 147.98 27.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 120.794 0.331 . . . . 0.0 111.241 -172.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 51.6 p90 -145.66 163.81 33.72 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.137 178.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.462 ' HB3' HD23 ' A' ' 43' ' ' LEU . 43.1 p90 -128.14 155.42 44.47 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 169.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -102.22 137.07 40.97 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.323 -175.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 69.8 p -90.31 169.08 11.41 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 175.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.3 mp -82.91 18.95 1.47 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.344 0.592 . . . . 0.0 109.638 174.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.556 ' HB3' ' OG ' ' A' ' 3' ' ' SER . 38.9 t70 -126.59 10.55 7.23 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.853 -177.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 66.3 t30 74.14 19.49 2.93 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 115.188 -0.915 . . . . 0.0 112.112 173.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.462 HG22 ' HA ' ' A' ' 22' ' ' ASN . 82.7 t -109.7 137.16 43.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 120.931 0.396 . . . . 0.0 110.413 177.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 84.0 mtt-85 -102.19 126.84 49.28 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.46 -178.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.42 HG22 ' HB ' ' A' ' 24' ' ' ILE . 61.0 t -98.67 113.93 34.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 174.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.8 t -111.02 147.13 15.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.146 -170.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.413 ' O ' ' HB3' ' A' ' 75' ' ' LYS . 4.9 t -152.74 -178.67 7.03 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.233 -0.439 . . . . 0.0 109.854 176.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -86.39 122.05 29.81 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.969 0.414 . . . . 0.0 110.885 -178.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 17.1 t80 -73.65 -23.87 59.91 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.28 -176.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 27.0 m -71.99 -52.34 17.52 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.848 0.356 . . . . 0.0 110.582 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.425 ' O ' ' HB3' ' A' ' 95' ' ' LYS . 10.0 mm-40 -71.26 -27.75 63.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.467 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.441 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 69.1 t80 -65.92 -42.82 89.65 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 175.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -63.3 -35.3 79.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.674 175.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.425 ' HB3' ' O ' ' A' ' 92' ' ' GLU . 3.7 ttmp? -56.49 -44.59 80.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.279 175.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 76.2 mt -69.27 -40.09 79.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.908 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 93' ' ' PHE . 99.5 mt -58.73 -50.95 72.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.412 177.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 9.6 mtpm? -70.25 -25.43 63.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.198 -178.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -59.57 -53.3 59.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.569 174.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 39.8 ttt85 -77.41 -38.01 50.64 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.985 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.559 0 C-N-CA 120.738 -0.744 . . . . 0.0 111.643 -176.632 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 . . . . . 0 C--O 1.233 0.228 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.492 ' O ' ' HG3' ' A' ' 7' ' ' LYS . 89.3 p -62.95 -32.93 74.35 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.73 0.3 . . . . 0.0 111.118 -177.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.452 ' HA ' ' HD2' ' A' ' 7' ' ' LYS . 9.3 tp10 -56.81 -36.36 69.84 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.997 -178.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 66.5 t -64.38 -42.04 94.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.479 178.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.51 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 63.9 mt -63.95 -41.43 92.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.339 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.492 ' HG3' ' O ' ' A' ' 3' ' ' SER . 88.6 mttt -57.16 -52.45 65.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.426 178.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -69.27 -28.1 66.01 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.365 -178.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -64.92 -44.56 89.13 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.125 0.488 . . . . 0.0 109.892 175.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.51 ' HG ' ' O ' ' A' ' 6' ' ' ILE . 51.9 mt -64.52 -42.7 95.62 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.283 177.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -63.49 -38.0 89.47 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.504 178.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -62.82 -50.32 71.45 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.097 179.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 37.9 pt -78.44 -7.0 9.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.763 0.316 . . . . 0.0 111.382 -178.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 76.07 36.41 40.94 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 121.119 -0.562 . . . . 0.0 112.619 177.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -95.69 157.48 15.88 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 179.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -73.68 122.99 23.2 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.187 0.518 . . . . 0.0 111.093 -177.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 93.2 t80 -105.64 120.01 40.58 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.987 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 15.3 tt -131.34 121.39 48.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.314 0.578 . . . . 0.0 110.576 175.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -108.38 108.27 19.17 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.046 178.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 24.7 tp -93.39 75.46 4.51 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 59.3 71.5 0.58 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.537 -177.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 12.5 m120 68.38 11.64 8.43 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.172 -0.922 . . . . 0.0 112.004 178.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 79.3 mt-10 -115.13 113.99 24.72 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 174.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 40.7 mt -86.77 109.35 18.94 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 177.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.452 ' HA ' ' O ' ' A' ' 87' ' ' VAL . 24.8 m-70 -95.98 111.13 23.22 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -178.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.476 HD21 HD13 ' A' ' 10' ' ' LEU . 67.4 mt -113.32 163.3 15.01 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.44 0.638 . . . . 0.0 112.679 -170.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 33.7 tttp -62.63 129.61 92.94 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 114.46 -1.245 . . . . 0.0 109.681 173.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -51.12 -41.28 58.03 Favored 'Trans proline' 0 N--CA 1.473 0.308 0 C-N-CA 122.884 2.389 . . . . 0.0 112.518 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -53.78 -54.92 31.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.168 175.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 50.9 t -69.5 -41.12 80.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.712 -177.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -53.87 -42.01 68.15 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.476 179.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -59.18 -42.69 91.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.555 -179.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -78.26 -37.17 45.72 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.088 -178.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 95.8 t -62.43 -36.87 77.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.083 0.468 . . . . 0.0 109.86 175.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.443 ' CD1' ' HD2' ' A' ' 41' ' ' PRO . 35.3 t90 -55.78 -44.09 77.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.701 176.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.543 ' HA ' ' HG3' ' A' ' 40' ' ' GLU . 67.3 mttm -73.02 -31.67 64.61 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.656 -0.247 . . . . 0.0 111.325 179.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 83.8 t80 -67.23 -40.65 86.37 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.951 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.517 HG23 ' HD3' ' A' ' 41' ' ' PRO . 35.0 m -79.04 4.12 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -177.086 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 102.64 4.11 49.35 Favored Glycine 0 C--N 1.33 0.231 0 C-N-CA 120.767 -0.73 . . . . 0.0 113.241 174.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.543 ' HG3' ' HA ' ' A' ' 36' ' ' LYS . 54.0 mt-10 57.59 78.29 0.37 Allowed Pre-proline 0 C--O 1.236 0.347 0 C-N-CA 122.925 0.49 . . . . 0.0 111.95 -179.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.517 ' HD3' HG23 ' A' ' 38' ' ' VAL . 4.9 Cg_exo -77.89 175.3 11.36 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.738 2.292 . . . . 0.0 110.659 173.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -81.46 133.72 35.44 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.18 0.514 . . . . 0.0 110.12 178.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 89.7 mt -73.17 120.94 19.48 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.774 -172.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -96.53 118.4 32.95 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.197 176.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 24.2 p -109.47 143.12 39.52 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.052 -176.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 17.9 p90 -126.27 133.53 51.41 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.728 177.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.408 HG22 ' HB2' ' A' ' 74' ' ' LYS . 60.5 t -93.63 125.95 46.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.717 -179.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.518 HD11 ' HE3' ' A' ' 75' ' ' LYS . 13.7 pt -125.7 131.0 72.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.576 174.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 . . . . . 0 C--N 1.315 -0.919 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.136 -179.211 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 60.9 mttm . . . . . 0 N--CA 1.452 -0.348 0 N-CA-C 110.328 -0.249 . . . . 0.0 110.328 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 15.1 tt -109.89 129.81 64.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.546 0.688 . . . . 0.0 110.66 178.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.491 ' O ' ' HB3' ' A' ' 90' ' ' TYR . 36.4 ttpt -108.86 115.71 30.59 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.075 -177.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.518 ' HE3' HD11 ' A' ' 48' ' ' ILE . 81.4 mttt -104.13 167.01 10.04 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.35 -0.386 . . . . 0.0 109.975 -179.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 14.6 p -122.51 146.79 27.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 120.925 0.393 . . . . 0.0 111.303 -173.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.463 ' HB3' HG22 ' A' ' 87' ' ' VAL . 48.1 p90 -149.85 164.82 34.34 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.132 175.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -134.23 149.25 50.96 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 169.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.569 ' HG2' ' HG2' ' A' ' 85' ' ' ARG . 41.6 mt-10 -102.5 138.21 39.72 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.681 -176.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 38.4 p -83.25 178.55 8.03 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.123 175.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.8 mp -62.73 -27.01 68.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.194 0.521 . . . . 0.0 110.726 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -99.98 15.04 28.48 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.715 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 10.0 m120 64.1 34.59 11.06 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 171.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.409 ' HB ' ' HB3' ' A' ' 3' ' ' SER . 58.6 t -90.69 129.56 41.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 169.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.569 ' HG2' ' HG2' ' A' ' 79' ' ' GLU . 41.7 mtm-85 -98.88 114.91 27.73 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.976 0.417 . . . . 0.0 111.389 -172.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 45.6 t -89.7 113.09 25.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 174.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.463 HG22 ' HB3' ' A' ' 77' ' ' TYR . 19.3 t -113.28 148.2 16.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.937 -171.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 6.2 t -152.13 171.52 17.78 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.065 174.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -73.02 111.71 8.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.188 0.518 . . . . 0.0 110.368 177.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.491 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 15.3 t80 -72.14 -20.94 61.53 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.595 -177.099 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.4 m -62.64 -58.22 8.29 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-O 121.184 0.516 . . . . 0.0 110.068 178.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.402 ' O ' HG13 ' A' ' 96' ' ' ILE . 28.4 tt0 -67.53 -35.28 78.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.406 178.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.403 ' O ' HD23 ' A' ' 97' ' ' LEU . 55.2 t80 -59.78 -46.77 88.17 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.48 179.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.446 ' O ' ' HG3' ' A' ' 98' ' ' LYS . 69.5 mt-30 -58.61 -40.02 82.11 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.612 0.244 . . . . 0.0 110.906 176.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -63.22 -39.82 95.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.528 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.402 HG13 ' O ' ' A' ' 92' ' ' GLU . 80.1 mt -63.58 -42.27 95.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.743 177.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.403 HD23 ' O ' ' A' ' 93' ' ' PHE . 4.1 mm? -57.84 -43.31 85.78 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.681 176.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.446 ' HG3' ' O ' ' A' ' 94' ' ' GLN . 94.0 mttt -70.05 -41.83 73.67 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.693 178.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 60.5 tttm -60.3 -48.68 80.69 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.649 -178.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 62.4 ttt180 -78.38 -30.48 47.91 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.041 0.448 . . . . 0.0 110.523 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.674 0 C-N-CA 120.681 -0.771 . . . . 0.0 111.869 -179.871 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 . . . . . 0 C--O 1.234 0.286 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 36.6 p -61.28 -27.9 68.8 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.931 -177.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -57.59 -45.59 85.09 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.98 0.419 . . . . 0.0 110.38 178.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.1 t -62.85 -39.31 84.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.261 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.405 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 58.9 mt -62.45 -45.75 98.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.181 177.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 49.3 mttm -57.07 -48.73 77.86 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.091 177.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -59.45 -47.34 85.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.927 179.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -63.62 -47.71 80.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.354 -177.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.472 HD13 HD21 ' A' ' 26' ' ' LEU . 95.5 mt -62.31 -46.98 86.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.195 -177.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -79.01 -6.1 55.54 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.734 0.302 . . . . 0.0 111.497 -177.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -82.42 -45.97 14.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.126 0.489 . . . . 0.0 109.792 173.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 34.9 pt -77.48 -12.21 13.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.941 179.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.46 28.48 10.45 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.771 -0.728 . . . . 0.0 113.06 174.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.513 ' OE2' HG21 ' A' ' 30' ' ' VAL . 3.9 tp10 -88.05 137.23 32.51 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.153 0.501 . . . . 0.0 111.058 -179.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -104.3 110.54 22.8 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.301 175.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.414 ' CD1' ' HB2' ' A' ' 19' ' ' GLU . 27.1 p90 -102.79 154.73 18.89 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.152 -177.022 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 58.1 mt -97.34 102.06 12.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 175.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.414 ' HB2' ' CD1' ' A' ' 17' ' ' TYR . 35.9 tt0 -105.84 116.71 32.41 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.491 0.662 . . . . 0.0 111.822 -172.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -94.24 -168.17 1.81 Allowed 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 172.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -68.21 99.79 0.95 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.003 0.43 . . . . 0.0 110.304 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 62.53 32.86 16.35 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.498 -178.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.453 ' HG2' ' HB2' ' A' ' 85' ' ' ARG . 23.2 mt-10 -138.56 113.77 9.44 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.097 174.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.534 ' HB ' HG22 ' A' ' 86' ' ' VAL . 64.3 mt -99.8 104.5 16.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 178.127 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 31.1 m-70 -90.85 112.12 23.82 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.981 0.419 . . . . 0.0 110.032 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.472 HD21 HD13 ' A' ' 10' ' ' LEU . 56.5 mt -101.37 -175.62 2.91 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.525 -0.762 . . . . 0.0 111.524 -176.067 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -95.35 144.16 27.34 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.389 176.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.545 ' HA ' HG21 ' A' ' 88' ' ' THR . 5.9 Cg_exo -41.59 -49.79 5.06 Favored 'Trans proline' 0 CA--C 1.534 0.486 0 C-N-CA 124.033 3.155 . . . . 0.0 114.391 -175.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -72.33 -40.69 67.22 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.845 0.355 . . . . 0.0 111.142 -175.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.513 HG21 ' OE2' ' A' ' 15' ' ' GLU . 58.3 t -67.01 -40.5 85.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.636 -178.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -59.19 -40.33 85.35 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.453 177.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.596 ' HA ' ' HE1' ' A' ' 93' ' ' PHE . 20.6 t80 -61.12 -33.12 72.88 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.024 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -80.11 -43.59 21.45 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.889 -179.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.451 ' O ' HG13 ' A' ' 38' ' ' VAL . 59.5 t -65.58 -33.11 61.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.848 0.356 . . . . 0.0 110.507 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.469 ' O ' HG22 ' A' ' 38' ' ' VAL . 27.6 t90 -53.05 -40.05 63.68 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.09 176.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 78.2 mttt -70.15 -36.97 75.11 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.271 0.558 . . . . 0.0 110.292 178.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 23.0 t80 -73.07 -30.57 63.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.548 -174.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.504 HG23 ' HD3' ' A' ' 41' ' ' PRO . 18.4 m -75.27 -2.17 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-O 120.916 0.389 . . . . 0.0 111.335 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 116.84 -9.45 16.17 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.883 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.413 ' N ' ' HD3' ' A' ' 41' ' ' PRO . 33.4 tt0 58.85 64.73 3.18 Favored Pre-proline 0 CA--C 1.538 0.487 0 CA-C-O 121.044 0.45 . . . . 0.0 111.131 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.504 ' HD3' HG23 ' A' ' 38' ' ' VAL . 92.3 Cg_endo -98.06 -173.24 0.17 Allowed 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 123.331 2.687 . . . . 0.0 112.193 179.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -79.25 116.51 19.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.073 0.463 . . . . 0.0 109.814 176.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.6 mt -75.24 156.72 35.43 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.2 -176.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 57.5 tttm -109.96 129.31 55.68 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.817 -177.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.0 p -109.17 149.52 29.25 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.617 -175.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.536 ' OH ' ' HD2' ' A' ' 75' ' ' LYS . 28.2 p90 -134.85 159.85 40.09 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 176.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 50.6 t -111.98 120.37 62.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 120.948 0.404 . . . . 0.0 110.911 -177.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 8.4 tt -110.48 115.5 49.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.262 0.553 . . . . 0.0 109.561 174.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.484 ' HG2' ' HG2' ' A' ' 72' ' ' LYS . 43.4 mt-10 . . . . . 0 C--N 1.321 -0.643 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.265 -177.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.484 ' HG2' ' HG2' ' A' ' 49' ' ' GLU . 43.8 mttp . . . . . 0 N--CA 1.452 -0.325 0 CA-C-O 120.93 0.395 . . . . 0.0 110.059 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 51.4 mm -92.03 110.26 22.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.27 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 41.0 ttpt -93.63 115.02 27.48 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.051 177.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.536 ' HD2' ' OH ' ' A' ' 46' ' ' TYR . 62.4 mttm -102.62 166.3 10.59 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 177.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 12.6 p -122.35 144.18 32.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.347 -176.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.452 ' HB3' HG22 ' A' ' 87' ' ' VAL . 36.8 p90 -149.8 165.94 30.98 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.02 0.438 . . . . 0.0 111.412 179.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.477 ' CE2' HG11 ' A' ' 38' ' ' VAL . 50.1 p90 -124.36 134.59 53.1 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.196 166.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.443 ' OE1' ' HD2' ' A' ' 85' ' ' ARG . 34.5 tt0 -103.87 118.11 35.93 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.164 -176.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 72.7 p -79.07 179.64 7.23 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.549 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 7.7 mp -66.6 -14.22 62.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.029 0.443 . . . . 0.0 110.658 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.514 ' HB2' HG23 ' A' ' 84' ' ' VAL . 1.9 m-20 -85.54 -1.73 57.41 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.621 -178.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 55.3 m-80 70.35 18.39 6.75 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 123.766 0.666 . . . . 0.0 110.423 -175.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.514 HG23 ' HB2' ' A' ' 82' ' ' ASP . 93.1 t -87.97 123.55 40.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.041 177.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.453 ' HB2' ' HG2' ' A' ' 23' ' ' GLU . 0.2 OUTLIER -100.01 108.87 21.17 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.905 -178.964 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.534 HG22 ' HB ' ' A' ' 24' ' ' ILE . 59.6 t -82.92 106.17 13.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 174.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.452 HG22 ' HB3' ' A' ' 77' ' ' TYR . 41.4 t -107.0 142.58 19.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.798 -169.131 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.545 HG21 ' HA ' ' A' ' 28' ' ' PRO . 96.0 m -152.07 153.81 34.69 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.309 174.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -64.41 119.02 9.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.288 0.566 . . . . 0.0 111.922 -178.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.43 ' H ' ' HA ' ' A' ' 75' ' ' LYS . 83.2 t80 -63.18 -37.48 87.4 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.806 -179.032 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.6 m -60.2 -45.41 93.26 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.751 178.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.449 ' HA ' ' HB3' ' A' ' 95' ' ' LYS . 22.0 mm-40 -77.93 -30.67 50.64 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.112 -179.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.596 ' HE1' ' HA ' ' A' ' 32' ' ' TYR . 75.7 t80 -61.03 -50.61 72.63 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.966 0.413 . . . . 0.0 110.405 177.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.649 ' HG2' HD12 ' A' ' 97' ' ' LEU . 45.4 mt-30 -77.31 -17.17 58.53 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.991 179.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.449 ' HB3' ' HA ' ' A' ' 92' ' ' GLU . 0.8 OUTLIER -69.35 -32.42 71.48 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 173.298 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.46 HD11 ' HB2' ' A' ' 28' ' ' PRO . 56.1 mt -79.03 -33.68 16.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.268 174.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.649 HD12 ' HG2' ' A' ' 94' ' ' GLN . 90.5 mt -59.94 -41.71 92.39 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 171.004 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 7.3 tmtt? -64.36 -40.36 95.69 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.805 176.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 56.7 tttm -62.11 -43.69 98.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.845 178.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 78.2 ttt180 -71.56 -45.44 62.29 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.967 0.413 . . . . 0.0 110.64 177.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.42 0 C-N-CA 120.846 -0.692 . . . . 0.0 111.811 -177.329 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 . . . . . 0 N--CA 1.453 -0.28 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.478 ' O ' ' HG3' ' A' ' 7' ' ' LYS . 19.1 p -56.67 -33.02 65.97 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.947 0.404 . . . . 0.0 110.803 177.074 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -51.59 -51.52 54.84 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.801 178.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.9 t -61.38 -48.65 87.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.928 -177.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.456 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 60.4 mt -54.4 -43.12 61.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.02 177.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.478 ' HG3' ' O ' ' A' ' 3' ' ' SER . 98.9 mttt -56.88 -49.24 76.13 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.163 178.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -61.01 -41.24 96.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.073 0.463 . . . . 0.0 110.529 -179.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.485 ' O ' HG13 ' A' ' 13' ' ' ILE . 74.5 t80 -62.22 -48.0 81.94 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.705 178.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.522 HD13 ' HB3' ' A' ' 17' ' ' TYR . 87.9 mt -69.45 -33.34 72.78 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.379 -177.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -65.66 -41.32 92.66 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.894 0.378 . . . . 0.0 110.137 176.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -64.05 -37.82 88.83 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.523 177.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.485 HG13 ' O ' ' A' ' 9' ' ' PHE . 59.6 mt -66.68 -41.05 87.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 121.432 0.634 . . . . 0.0 109.756 173.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.01 23.26 25.61 Favored Glycine 0 N--CA 1.446 -0.657 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.791 -179.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 47.8 mm-40 -98.02 158.92 15.26 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.152 0.501 . . . . 0.0 111.322 -178.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.403 ' HB2' ' HE3' ' A' ' 27' ' ' LYS . 9.3 m-20 -77.72 114.36 16.49 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.981 -177.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.522 ' HB3' HD13 ' A' ' 10' ' ' LEU . 39.3 p90 -111.13 112.15 23.75 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 170.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.553 ' HB ' ' HB2' ' A' ' 25' ' ' HIS . 51.6 mt -84.91 95.17 4.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.473 -175.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -76.05 114.03 14.24 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.095 176.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.551 ' HB2' ' HB2' ' A' ' 23' ' ' GLU . 93.6 mt -114.84 169.22 9.24 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 172.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.434 ' O ' ' HB2' ' A' ' 22' ' ' ASN . 40.6 mt-10 -64.39 107.35 1.32 Allowed 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.474 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.434 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 88.2 m-20 80.48 2.95 1.84 Allowed 'General case' 0 N--CA 1.47 0.575 0 O-C-N 124.593 1.183 . . . . 0.0 112.031 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.551 ' HB2' ' HB2' ' A' ' 20' ' ' LEU . 54.6 mt-10 -134.3 150.98 51.01 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.442 0.639 . . . . 0.0 112.424 -177.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 59.1 mt -130.95 109.78 17.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 166.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.553 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 11.7 m170 -89.96 125.09 35.25 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 39.8 mt -120.81 175.29 6.11 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.236 0.541 . . . . 0.0 111.388 -177.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.403 ' HE3' ' HB2' ' A' ' 16' ' ' ASP . 87.2 mttt -93.54 153.66 41.27 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.481 178.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_exo -48.45 -53.08 7.35 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 123.143 2.562 . . . . 0.0 113.571 -176.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -72.02 -37.13 69.83 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.851 0.357 . . . . 0.0 110.88 -176.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.462 ' O ' HG23 ' A' ' 34' ' ' VAL . 47.4 t -63.69 -40.46 89.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.28 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -61.92 -39.22 91.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.431 177.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -60.63 -43.31 97.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.596 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -64.62 -44.56 90.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.062 178.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 30' ' ' VAL . 91.2 t -65.74 -40.95 89.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.99 -179.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.433 ' CD1' ' HD2' ' A' ' 41' ' ' PRO . 28.1 t90 -55.04 -48.09 73.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.623 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.414 ' HA ' ' HG3' ' A' ' 40' ' ' GLU . 62.9 mttm -72.4 -31.02 65.18 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.266 179.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -63.0 -43.71 98.03 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.231 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.493 HG23 ' HD3' ' A' ' 41' ' ' PRO . 34.9 m -80.54 -5.87 8.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -177.011 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 108.53 12.56 20.98 Favored Glycine 0 C--N 1.331 0.263 0 C-N-CA 120.575 -0.822 . . . . 0.0 113.728 174.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.414 ' HG3' ' HA ' ' A' ' 36' ' ' LYS . 54.2 mt-10 55.25 78.39 0.39 Allowed Pre-proline 0 N--CA 1.466 0.359 0 C-N-CA 122.838 0.455 . . . . 0.0 111.856 178.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.493 ' HD3' HG23 ' A' ' 38' ' ' VAL . 95.1 Cg_endo -91.64 179.42 1.5 Allowed 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.852 2.368 . . . . 0.0 112.031 175.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -62.75 122.98 17.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.898 176.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 81.3 mt -92.2 132.16 36.87 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.669 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -97.57 137.62 36.21 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 31.6 p -122.41 135.48 54.7 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 120.825 0.345 . . . . 0.0 110.773 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.493 ' CE1' ' HB2' ' A' ' 75' ' ' LYS . 17.3 p90 -122.92 136.6 54.92 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.977 0.418 . . . . 0.0 110.294 179.127 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 50.3 t -96.89 105.0 16.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.981 178.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.469 HG23 ' HB ' ' A' ' 73' ' ' ILE . 8.4 tt -100.8 112.15 32.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 121.153 0.502 . . . . 0.0 110.189 178.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 . . . . . 0 C--N 1.322 -0.617 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 178.034 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 58.6 mttp . . . . . 0 N--CA 1.456 -0.152 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.469 ' HB ' HG23 ' A' ' 48' ' ' ILE . 55.1 mt -98.54 108.98 23.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.681 -178.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 57.4 tttp -87.12 103.03 15.01 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 176.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.493 ' HB2' ' CE1' ' A' ' 46' ' ' TYR . 97.5 mttt -104.91 163.73 12.31 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.337 178.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.9 p -116.84 141.11 36.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.946 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.473 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 33.8 p90 -149.01 152.4 36.22 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.612 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -131.28 144.43 51.28 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 170.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -102.03 130.4 48.57 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.305 -175.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 32.9 p -76.13 178.99 5.95 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.152 174.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 8.2 mp -70.46 -23.96 62.8 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.71 0.29 . . . . 0.0 110.822 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -90.06 8.92 30.22 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.337 0.589 . . . . 0.0 109.608 175.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 13.5 m120 65.77 30.39 10.16 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 114.711 -1.131 . . . . 0.0 112.906 171.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 43.3 t -87.89 127.28 41.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 171.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 34.2 mtt180 -93.25 108.38 20.02 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.214 -172.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 57.4 t -82.27 110.89 17.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 174.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 39.8 t -113.26 137.24 46.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.436 -171.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 59.1 m -148.27 154.74 40.44 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 174.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -66.61 126.27 28.4 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.95 0.405 . . . . 0.0 110.688 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -75.59 -26.19 57.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.68 -174.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.474 ' O ' ' HG3' ' A' ' 95' ' ' LYS . 28.1 t -69.74 -43.67 71.8 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -64.31 -39.16 93.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.102 0.477 . . . . 0.0 110.21 176.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -64.24 -42.32 96.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.372 178.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 26.3 mm-40 -60.58 -37.91 82.88 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.235 176.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.474 ' HG3' ' O ' ' A' ' 91' ' ' SER . 99.3 mttt -55.55 -49.68 72.03 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.862 0.363 . . . . 0.0 110.282 176.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 66.9 mt -64.05 -40.8 90.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.047 -178.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 97.4 mt -58.71 -46.65 86.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.1 0.476 . . . . 0.0 110.713 177.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 9.0 mtpm? -73.65 -34.51 64.99 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.064 -179.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -64.39 -44.84 90.05 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.996 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.43 HH11 ' HD3' ' A' ' 100' ' ' ARG . 52.1 mtt180 -84.99 -18.65 33.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.795 0.331 . . . . 0.0 111.194 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.417 0 C-N-CA 120.834 -0.698 . . . . 0.0 111.773 -179.047 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 18.0 m120 . . . . . 0 CA--C 1.517 -0.311 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 35.3 p -64.08 -29.96 71.06 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.15 0.5 . . . . 0.0 110.146 175.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -64.75 -38.1 89.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.012 176.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 95.9 t -62.64 -41.66 93.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.879 175.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 73.8 mt -62.42 -43.72 98.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.36 176.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 53.5 mttp -52.27 -53.71 40.54 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.744 175.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -70.63 -25.81 63.19 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.915 -175.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -67.46 -43.51 80.89 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.353 0.596 . . . . 0.0 109.905 174.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.489 HD13 ' HB3' ' A' ' 17' ' ' TYR . 69.8 mt -72.29 -34.31 68.06 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.392 178.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -64.0 -32.31 73.81 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.385 177.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -63.74 -58.88 5.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.614 179.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.8 pt -76.89 -17.36 14.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.797 -176.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 79.42 46.9 7.74 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.806 -179.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -97.78 169.18 9.85 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.929 0.395 . . . . 0.0 110.985 -178.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -96.94 137.25 36.33 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.112 -177.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.489 ' HB3' HD13 ' A' ' 10' ' ' LEU . 24.6 p90 -133.32 115.89 15.46 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.224 0.535 . . . . 0.0 110.223 173.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.461 ' HB ' ' HB2' ' A' ' 25' ' ' HIS . 57.4 mt -85.48 92.11 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 175.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.521 ' HG3' HG12 ' A' ' 24' ' ' ILE . 33.2 tt0 -103.51 104.46 14.53 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.247 -171.034 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 85.5 mt -79.61 -174.32 4.23 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 173.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -69.47 100.44 1.4 Allowed 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.042 0.448 . . . . 0.0 109.875 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 71.17 29.42 2.87 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.517 -177.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.565 ' HA ' ' O ' ' A' ' 85' ' ' ARG . 5.1 mt-10 -144.61 113.51 6.81 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 177.04 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.521 HG12 ' HG3' ' A' ' 19' ' ' GLU . 51.2 mt -101.2 108.21 22.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 110.175 -0.306 . . . . 0.0 110.175 179.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.54 ' HA ' ' O ' ' A' ' 87' ' ' VAL . 24.4 m-70 -96.18 119.12 34.1 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.77 0.319 . . . . 0.0 110.263 178.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 98.3 mt -116.33 173.58 6.52 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.166 -176.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.403 ' HB2' HG23 ' A' ' 30' ' ' VAL . 61.5 mttp -73.8 147.1 86.24 Favored Pre-proline 0 C--N 1.329 -0.318 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 172.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.472 ' HA ' HG21 ' A' ' 88' ' ' THR . 82.5 Cg_exo -47.07 -51.28 9.61 Favored 'Trans proline' 0 CA--C 1.53 0.284 0 C-N-CA 123.137 2.558 . . . . 0.0 113.606 -178.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -71.22 -34.33 70.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.748 0.309 . . . . 0.0 111.196 -177.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.453 ' O ' HG23 ' A' ' 34' ' ' VAL . 58.1 t -67.41 -45.96 84.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.939 0.399 . . . . 0.0 110.187 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -61.15 -38.58 86.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.079 175.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.509 ' HA ' ' HE1' ' A' ' 93' ' ' PHE . 19.1 t80 -56.74 -38.56 72.56 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.274 178.053 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -76.17 -36.68 58.59 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 121.139 -0.224 . . . . 0.0 111.182 177.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 30' ' ' VAL . 77.3 t -66.17 -33.12 61.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.093 0.473 . . . . 0.0 110.225 177.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.551 ' CZ2' ' HG3' ' A' ' 40' ' ' GLU . 45.9 t90 -56.98 -40.01 75.72 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.797 176.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 80.8 mttt -70.42 -42.67 71.29 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.195 0.522 . . . . 0.0 109.679 175.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -58.64 -38.9 79.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.086 -176.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.478 HG23 ' HD3' ' A' ' 41' ' ' PRO . 34.6 m -82.53 3.89 2.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.958 -178.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 100.57 14.68 31.66 Favored Glycine 0 C--N 1.329 0.193 0 C-N-CA 120.665 -0.779 . . . . 0.0 114.489 170.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.551 ' HG3' ' CZ2' ' A' ' 35' ' ' TRP . 35.7 tt0 57.09 72.78 0.88 Allowed Pre-proline 0 N--CA 1.468 0.456 0 CA-C-O 120.965 0.412 . . . . 0.0 111.359 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.478 ' HD3' HG23 ' A' ' 38' ' ' VAL . 78.4 Cg_endo -98.26 173.15 0.56 Allowed 'Trans proline' 0 N--CA 1.449 -1.1 0 C-N-CA 123.091 2.527 . . . . 0.0 112.135 175.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -75.02 146.58 41.47 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 173.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 82.3 mt -112.34 153.85 26.62 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.913 0.387 . . . . 0.0 111.426 -173.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.512 ' HE3' ' OE1' ' A' ' 79' ' ' GLU . 64.4 mttm -101.46 145.43 28.98 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.6 178.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 24.4 p -127.83 138.58 52.76 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.906 0.384 . . . . 0.0 111.278 -178.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -134.28 146.79 50.36 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.862 179.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.403 ' HA ' ' HA ' ' A' ' 74' ' ' LYS . 41.3 t -107.93 116.0 50.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 120.739 0.304 . . . . 0.0 110.659 -179.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 10.2 pt -107.12 139.92 27.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.377 175.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 . . . . . 0 C--N 1.323 -0.565 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.238 -177.518 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 63.0 mttm . . . . . 0 N--CA 1.452 -0.326 0 CA-C-O 121.227 0.536 . . . . 0.0 110.927 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 69.2 mt -102.96 109.23 26.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.075 177.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.526 ' O ' ' HB3' ' A' ' 90' ' ' TYR . 82.8 tttt -88.88 127.79 35.65 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.78 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.449 ' HA ' ' H ' ' A' ' 90' ' ' TYR . 72.5 mttt -124.59 165.25 18.19 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.657 0.265 . . . . 0.0 110.58 179.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 8.4 p -125.91 141.86 44.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.839 -173.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 14.0 p90 -155.34 168.36 27.34 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.83 0.348 . . . . 0.0 111.014 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -135.09 157.61 46.49 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.435 -0.579 . . . . 0.0 109.435 171.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.512 ' OE1' ' HE3' ' A' ' 44' ' ' LYS . 39.3 mt-10 -106.49 132.59 52.32 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.378 -176.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 69.7 p -84.66 166.97 16.64 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 175.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.469 ' H ' HD23 ' A' ' 81' ' ' LEU . 0.7 OUTLIER -67.7 -21.36 65.33 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.911 0.386 . . . . 0.0 110.496 178.022 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -90.81 16.9 8.44 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.103 178.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 66.6 t30 70.33 20.72 6.02 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 115.604 -0.725 . . . . 0.0 112.269 170.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 96.0 t -99.68 133.36 42.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.228 0.537 . . . . 0.0 110.208 176.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.565 ' O ' ' HA ' ' A' ' 23' ' ' GLU . 66.3 mtm180 -101.99 115.4 30.46 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.429 -176.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 43.1 t -91.84 108.57 20.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 177.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.54 ' O ' ' HA ' ' A' ' 25' ' ' HIS . 16.8 t -111.89 143.16 22.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.527 -170.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.472 HG21 ' HA ' ' A' ' 28' ' ' PRO . 91.4 m -150.66 154.46 37.51 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.887 176.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.63 120.44 13.45 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.827 0.822 . . . . 0.0 111.972 -177.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.526 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 82.4 t80 -65.65 -38.39 89.22 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.343 -1.298 . . . . 0.0 111.774 -173.193 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.503 ' O ' ' HG3' ' A' ' 95' ' ' LYS . 42.9 t -54.73 -56.62 17.25 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.634 -177.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 20.5 tp10 -71.39 -34.55 70.5 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.777 -175.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.509 ' HE1' ' HA ' ' A' ' 32' ' ' TYR . 83.8 t80 -64.01 -42.58 97.11 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.777 178.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 53.4 mm-40 -65.73 -31.63 72.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.304 178.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.535 ' O ' ' HG3' ' A' ' 99' ' ' LYS . 91.3 mttt -59.53 -44.76 93.11 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 174.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 65.1 mt -56.04 -50.06 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.772 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 87.5 mt -63.82 -36.4 83.77 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.597 179.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 59.1 tttm -66.57 -41.96 87.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.653 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.535 ' HG3' ' O ' ' A' ' 95' ' ' LYS . 90.9 mttt -64.29 -37.17 86.53 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.755 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 33.1 mtp180 -67.43 -32.52 73.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.351 176.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.469 0 C-N-CA 120.375 -0.917 . . . . 0.0 110.858 -175.119 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 13.7 m120 . . . . . 0 CA--C 1.516 -0.361 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.8 m -62.88 -34.34 77.18 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.307 0.575 . . . . 0.0 110.166 178.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -67.7 -35.38 78.69 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.899 176.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 89.8 t -64.59 -34.76 71.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.066 0.46 . . . . 0.0 110.131 178.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 74.7 mt -63.54 -44.82 98.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.91 -0.587 . . . . 0.0 109.948 174.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -59.84 -46.41 89.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.407 177.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -51.07 -49.59 60.34 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.173 176.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -62.4 -43.58 98.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.011 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.482 HD13 ' HB3' ' A' ' 17' ' ' TYR . 96.7 mt -69.61 -35.94 75.73 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.58 -177.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -70.24 -33.39 71.57 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 121.071 -0.252 . . . . 0.0 110.607 176.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -62.8 -53.77 49.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.584 178.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 30.1 pt -72.42 -24.49 22.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.121 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.54 47.43 4.59 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.022 178.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -111.37 -179.8 3.82 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.125 0.488 . . . . 0.0 111.387 -178.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -122.03 130.84 53.63 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.009 -173.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.482 ' HB3' HD13 ' A' ' 10' ' ' LEU . 51.5 p90 -123.04 144.56 49.2 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.565 177.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.573 ' HB ' ' HB2' ' A' ' 25' ' ' HIS . 75.5 mt -90.08 99.72 9.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 177.06 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.446 ' HB2' ' CE1' ' A' ' 17' ' ' TYR . 37.8 tt0 -92.56 106.98 18.86 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.089 -175.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 70.5 mt -112.58 166.31 11.45 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 172.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -60.39 106.03 0.49 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.043 0.449 . . . . 0.0 110.723 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 68.78 14.88 8.99 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 114.87 -1.059 . . . . 0.0 112.187 -179.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -138.46 113.71 9.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.873 0.368 . . . . 0.0 111.153 178.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.494 ' HB ' HG22 ' A' ' 86' ' ' VAL . 66.5 mt -105.28 104.76 17.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 174.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.573 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 20.0 m-70 -91.65 115.79 28.34 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -179.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 73.4 mt -105.16 153.76 21.11 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.953 -177.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.5 mtmm -77.22 133.76 68.08 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 173.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.488 ' HB2' HD11 ' A' ' 96' ' ' ILE . 7.0 Cg_endo -48.52 -43.97 31.62 Favored 'Trans proline' 0 CA--C 1.529 0.257 0 C-N-CA 123.685 2.923 . . . . 0.0 113.145 -175.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -57.4 -34.54 68.98 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 121.104 0.478 . . . . 0.0 111.504 -178.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 47.1 t -94.43 -32.17 4.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.733 -176.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.488 ' HE1' ' HE1' ' A' ' 78' ' ' PHE . 81.8 t80 -56.72 -35.23 68.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.187 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -58.98 -33.72 71.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.366 -178.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -77.94 -44.37 27.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.819 0.343 . . . . 0.0 110.594 179.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 46.3 t -63.67 -36.52 76.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.76 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.434 ' CD1' ' HD2' ' A' ' 41' ' ' PRO . 27.2 t90 -55.25 -45.38 76.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.941 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.417 ' HG2' ' HG2' ' A' ' 40' ' ' GLU . 74.8 mttt -78.2 -33.17 50.14 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.969 -0.293 . . . . 0.0 111.082 -179.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 91.1 t80 -58.11 -37.37 74.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.879 178.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.424 HG23 ' HD3' ' A' ' 41' ' ' PRO . 33.6 m -89.73 7.83 3.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.757 -177.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 99.7 15.57 31.28 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.718 -0.753 . . . . 0.0 113.967 172.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.417 ' HG2' ' HG2' ' A' ' 36' ' ' LYS . 49.2 mt-10 54.54 67.7 3.17 Favored Pre-proline 0 N--CA 1.469 0.52 0 C-N-CA 122.693 0.397 . . . . 0.0 111.424 179.105 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.434 ' HD2' ' CD1' ' A' ' 35' ' ' TRP . 5.7 Cg_exo -78.05 162.86 28.68 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 122.884 2.39 . . . . 0.0 111.958 -179.307 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -69.24 139.01 54.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.628 176.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.565 ' HB3' ' CG2' ' A' ' 76' ' ' VAL . 94.8 mt -111.05 134.29 52.77 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.216 -173.287 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -104.59 139.05 40.02 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.269 -0.423 . . . . 0.0 109.918 177.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 19.4 p -106.33 140.97 38.42 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.186 -178.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 6.5 p90 -124.84 153.71 42.15 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 175.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 66.5 t -111.91 113.51 44.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-O 121.024 0.44 . . . . 0.0 111.183 -174.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.451 HG23 ' HB ' ' A' ' 73' ' ' ILE . 8.2 tt -104.69 105.51 18.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 173.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.522 ' HB2' ' HG2' ' A' ' 72' ' ' LYS . 39.1 tt0 . . . . . 0 C--N 1.322 -0.619 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.606 -178.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.522 ' HG2' ' HB2' ' A' ' 49' ' ' GLU . 60.5 mttp . . . . . 0 C--O 1.234 0.274 0 CA-C-O 120.793 0.33 . . . . 0.0 110.934 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.451 ' HB ' HG23 ' A' ' 48' ' ' ILE . 60.9 mt -95.17 110.58 24.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.934 177.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -90.02 115.4 27.27 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.464 -178.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.451 ' HA ' ' H ' ' A' ' 90' ' ' TYR . 68.6 mttm -118.22 167.11 11.82 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.299 178.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.565 ' CG2' ' HB3' ' A' ' 43' ' ' LEU . 12.0 p -126.19 150.09 31.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.636 -0.256 . . . . 0.0 110.616 -174.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -155.09 164.68 38.53 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.798 0.332 . . . . 0.0 110.77 179.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.488 ' HE1' ' HE1' ' A' ' 31' ' ' PHE . 50.7 p90 -134.69 152.67 51.94 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 170.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.543 ' HG2' ' HG2' ' A' ' 85' ' ' ARG . 33.7 mt-10 -102.31 127.07 49.46 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.162 -175.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 81.1 p -83.97 174.88 9.97 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.742 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.9 mp -71.2 -12.08 61.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.113 0.482 . . . . 0.0 110.613 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -92.22 4.76 52.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.491 -179.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 66.8 t30 70.88 21.26 5.13 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.728 0.775 . . . . 0.0 109.884 -178.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 99.2 t -100.05 136.46 31.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.643 178.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.543 ' HG2' ' HG2' ' A' ' 79' ' ' GLU . 69.0 mtt180 -107.5 119.22 38.8 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.148 0.499 . . . . 0.0 111.243 -176.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.494 HG22 ' HB ' ' A' ' 24' ' ' ILE . 87.1 t -89.63 111.06 22.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.675 177.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.412 ' O ' ' HA ' ' A' ' 25' ' ' HIS . 40.9 t -105.62 140.42 23.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.18 -173.233 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 58.9 m -147.91 152.45 37.58 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 176.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -67.87 126.92 30.96 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.782 0.325 . . . . 0.0 110.724 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.451 ' H ' ' HA ' ' A' ' 75' ' ' LYS . 49.9 t80 -77.97 -30.23 50.14 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.045 -174.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 9.4 t -71.96 -40.63 68.52 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 -179.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.423 ' O ' HG13 ' A' ' 96' ' ' ILE . 35.8 mt-10 -69.49 -37.55 77.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.635 176.122 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -61.75 -47.22 86.18 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.931 0.396 . . . . 0.0 110.479 177.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 68.4 mm-40 -65.65 -31.33 72.28 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.016 178.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 57.9 tptt -66.19 -36.13 82.27 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 176.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.488 HD11 ' HB2' ' A' ' 28' ' ' PRO . 64.7 mt -67.12 -38.8 81.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.054 0.454 . . . . 0.0 110.501 176.013 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 73.1 mt -63.13 -25.97 68.6 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.166 176.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -79.37 -26.68 41.98 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.064 176.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.445 ' HG3' ' HA ' ' A' ' 96' ' ' ILE . 33.5 mttp -61.92 -51.62 67.38 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-O 121.239 0.542 . . . . 0.0 109.875 175.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -86.19 -30.03 22.75 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.035 -173.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.658 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.266 -175.655 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 . . . . . 0 CA--C 1.519 -0.249 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.7 p -63.83 -28.29 69.75 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.089 0.471 . . . . 0.0 110.102 175.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -62.33 -43.47 98.75 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.031 175.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 99.5 t -61.26 -39.63 83.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.033 176.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.555 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 63.5 mt -63.44 -41.48 92.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.3 177.386 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -54.95 -49.56 71.08 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.768 177.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -60.3 -36.9 78.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.898 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.464 ' O ' HG12 ' A' ' 13' ' ' ILE . 90.5 t80 -67.95 -44.43 76.78 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.299 177.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.555 ' HG ' ' O ' ' A' ' 6' ' ' ILE . 86.2 mt -66.73 -43.37 84.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.261 -178.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -65.57 -30.07 70.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.954 0.406 . . . . 0.0 110.938 179.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -75.23 -47.3 28.81 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.26 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.464 HG12 ' O ' ' A' ' 9' ' ' PHE . 40.3 pt -77.85 -37.92 24.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 121.041 -0.264 . . . . 0.0 111.504 -178.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 114.36 75.76 0.67 Allowed Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.904 178.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.571 ' HG2' HD22 ' A' ' 26' ' ' LEU . 3.8 tp10 -132.83 133.59 43.55 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 174.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -102.09 106.9 17.84 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 176.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.572 ' HB3' HD23 ' A' ' 26' ' ' LEU . 11.0 p90 -111.08 153.02 26.26 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.199 0.524 . . . . 0.0 112.241 -171.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.532 ' HB ' ' HB2' ' A' ' 25' ' ' HIS . 64.5 mt -89.35 107.18 17.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.355 174.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -94.29 97.74 10.44 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.38 0.61 . . . . 0.0 110.789 -179.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 91.9 mt -101.4 162.04 13.19 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 171.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -64.66 116.32 6.11 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 119.954 -0.699 . . . . 0.0 109.931 -178.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.445 ' O ' ' HG2' ' A' ' 85' ' ' ARG . 72.5 m-20 75.65 7.32 3.87 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 114.977 -1.011 . . . . 0.0 111.765 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -140.03 113.83 8.77 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-O 121.083 0.468 . . . . 0.0 112.191 -179.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 70.8 mt -109.4 116.36 51.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 173.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.532 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 23.6 m-70 -98.44 121.77 40.79 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.644 0.259 . . . . 0.0 111.073 -177.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.572 HD23 ' HB3' ' A' ' 17' ' ' TYR . 91.8 mt -117.25 161.81 18.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.633 -179.191 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 34.1 mttp -72.63 144.98 86.75 Favored Pre-proline 0 C--N 1.328 -0.356 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 172.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_exo -52.01 -33.75 54.05 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.25 1.966 . . . . 0.0 111.391 174.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -53.28 -57.31 10.98 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.168 175.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.4 ' O ' HG23 ' A' ' 34' ' ' VAL . 45.1 t -79.57 -36.35 17.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.048 -175.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -55.21 -38.85 68.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.411 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.584 ' HA ' ' HE1' ' A' ' 93' ' ' PHE . 23.8 t80 -55.56 -44.82 77.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.426 177.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -78.89 -32.52 45.87 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.176 -177.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 30' ' ' VAL . 84.7 t -65.22 -38.59 83.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 175.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 29.6 t90 -57.89 -42.33 84.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.117 176.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -63.02 -47.09 84.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.643 174.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 88.9 t80 -59.06 -43.88 91.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.044 -177.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.532 HG23 ' HD3' ' A' ' 41' ' ' PRO . 34.1 m -75.23 -8.46 11.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -175.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 108.21 5.02 32.93 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.442 -0.885 . . . . 0.0 113.107 175.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 57.02 76.03 0.52 Allowed Pre-proline 0 C--N 1.329 -0.307 0 C-N-CA 122.862 0.465 . . . . 0.0 112.014 178.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.532 ' HD3' HG23 ' A' ' 38' ' ' VAL . 57.7 Cg_endo -93.5 -172.63 0.33 Allowed 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 123.218 2.612 . . . . 0.0 111.22 175.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -72.02 148.15 46.15 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.085 0.469 . . . . 0.0 110.557 176.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.406 ' HB3' ' CG2' ' A' ' 76' ' ' VAL . 83.7 mt -111.95 132.76 54.56 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.225 -179.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -96.37 140.23 31.33 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 177.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 43.7 p -119.87 140.77 50.32 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 120.695 0.283 . . . . 0.0 110.527 178.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.401 ' CE1' ' HB2' ' A' ' 75' ' ' LYS . 10.4 p90 -122.68 141.8 51.36 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 177.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 48.2 t -97.37 108.57 21.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.786 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 10.1 tt -113.17 137.64 45.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.207 -179.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 . . . . . 0 N--CA 1.446 -0.629 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.26 177.097 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 51.8 mttm . . . . . 0 C--O 1.236 0.364 0 CA-C-O 120.813 0.34 . . . . 0.0 110.304 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.586 HG22 ' HG3' ' A' ' 75' ' ' LYS . 44.3 mm -97.46 120.23 46.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.174 0.511 . . . . 0.0 110.55 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.539 ' O ' ' HB3' ' A' ' 90' ' ' TYR . 57.2 tttp -85.58 101.87 13.06 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.283 178.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.586 ' HG3' HG22 ' A' ' 73' ' ' ILE . 74.6 mttt -102.43 154.96 18.58 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.171 -177.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.406 ' CG2' ' HB3' ' A' ' 43' ' ' LEU . 14.9 p -116.84 147.79 19.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.639 0.256 . . . . 0.0 111.258 -172.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.477 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 50.6 p90 -153.79 154.04 33.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.935 178.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -123.76 149.54 45.49 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 171.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -102.77 135.71 43.92 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.709 -174.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 59.7 p -89.85 -176.3 4.89 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.617 179.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.525 ' O ' HD13 ' A' ' 81' ' ' LEU . 2.1 tm? -63.89 -24.64 67.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.28 0.562 . . . . 0.0 109.803 178.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.426 ' O ' ' HB2' ' A' ' 83' ' ' ASN . 0.8 OUTLIER -81.75 1.33 34.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.841 -177.237 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.426 ' HB2' ' O ' ' A' ' 82' ' ' ASP . 47.1 m-80 71.46 6.62 5.8 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 123.572 0.545 . . . . 0.0 110.776 -176.114 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 85.1 t -83.55 132.54 31.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.731 178.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.445 ' HG2' ' O ' ' A' ' 22' ' ' ASN . 40.9 ptt180 -101.4 131.35 47.54 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.398 0.618 . . . . 0.0 111.109 -177.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.477 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 59.5 t -94.17 111.26 24.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.384 177.092 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.473 HG22 ' HB3' ' A' ' 77' ' ' TYR . 16.1 t -104.92 142.91 17.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.285 -171.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 8.1 t -151.42 -173.21 4.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.646 175.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -84.83 119.51 25.4 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.899 0.381 . . . . 0.0 110.56 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.539 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 76.3 t80 -70.28 -40.85 74.08 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.484 -176.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.587 ' O ' ' HG3' ' A' ' 95' ' ' LYS . 18.0 m -58.75 -56.94 15.72 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.36 -174.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.47 ' O ' HG13 ' A' ' 96' ' ' ILE . 33.1 mt-10 -75.29 -27.35 59.32 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 -176.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.584 ' HE1' ' HA ' ' A' ' 32' ' ' TYR . 65.7 t80 -61.78 -47.86 83.24 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 175.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 81.5 mm-40 -65.33 -28.84 69.58 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.946 178.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.587 ' HG3' ' O ' ' A' ' 91' ' ' SER . 65.9 mttm -68.49 -25.01 64.76 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.495 176.185 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.47 HG13 ' O ' ' A' ' 92' ' ' GLU . 77.0 mt -72.93 -39.4 58.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 174.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -63.11 -39.43 94.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.167 0.508 . . . . 0.0 109.822 173.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 62.6 mmtt -65.19 -37.34 87.04 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.114 174.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -63.11 -47.63 82.02 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.69 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 55.2 ttt180 -72.15 -34.31 68.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.747 177.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.73 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.871 -178.291 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 13.0 m120 . . . . . 0 CA--C 1.516 -0.333 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.423 ' O ' ' HG3' ' A' ' 7' ' ' LYS . 7.1 m -61.97 -36.03 80.25 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.861 0.363 . . . . 0.0 110.282 179.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -62.44 -42.5 99.5 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.152 175.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 67.3 t -60.06 -42.21 89.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.696 178.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.477 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 67.3 mt -62.18 -42.13 94.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.396 178.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.423 ' HG3' ' O ' ' A' ' 3' ' ' SER . 95.5 mttt -57.43 -51.23 70.26 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.839 178.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -60.28 -48.18 82.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.475 178.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.491 ' CE2' HD11 ' A' ' 13' ' ' ILE . 72.5 t80 -55.41 -41.73 73.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.99 -178.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 6' ' ' ILE . 93.0 mt -64.64 -42.67 95.3 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.094 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -70.81 -34.45 71.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.776 0.322 . . . . 0.0 110.606 178.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -60.49 -37.46 81.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.568 175.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.491 HD11 ' CE2' ' A' ' 9' ' ' PHE . 64.2 mt -74.19 -41.87 51.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.157 0.503 . . . . 0.0 109.949 174.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 109.17 24.5 5.95 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.485 -175.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 82.5 mm-40 -102.3 -179.73 4.07 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.74 0.305 . . . . 0.0 110.584 -179.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -128.13 173.27 10.24 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 -179.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.476 ' HB3' HD13 ' A' ' 10' ' ' LEU . 30.0 p90 -158.51 141.32 14.57 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.765 0.317 . . . . 0.0 110.371 -178.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.551 ' HB ' ' HB2' ' A' ' 25' ' ' HIS . 69.7 mt -97.76 103.22 14.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 120.937 0.399 . . . . 0.0 110.2 179.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -89.49 118.21 28.97 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.55 -179.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 83.4 mt -116.07 -166.4 1.14 Allowed 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 175.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -67.15 101.79 0.94 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.888 0.375 . . . . 0.0 111.067 -179.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 48.6 m-80 64.88 15.98 10.22 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.601 177.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -132.44 128.25 37.08 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.301 -179.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.439 ' HB ' HG22 ' A' ' 86' ' ' VAL . 65.1 mt -109.55 106.65 21.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 172.208 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.551 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 20.4 m170 -87.41 115.49 24.86 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -178.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.42 HD21 HD11 ' A' ' 10' ' ' LEU . 0.3 OUTLIER -98.18 161.01 13.93 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.391 -173.806 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -74.63 131.25 80.08 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.139 174.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.495 ' HA ' HG21 ' A' ' 88' ' ' THR . 89.8 Cg_exo -43.01 -50.23 6.41 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 123.825 3.017 . . . . 0.0 114.29 -174.07 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -75.15 -33.01 61.47 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.703 0.287 . . . . 0.0 111.655 -175.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.436 ' O ' HG23 ' A' ' 34' ' ' VAL . 21.8 t -74.12 -35.49 41.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.842 0.353 . . . . 0.0 110.305 -178.271 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -54.93 -38.49 67.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.877 179.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 73.8 t80 -59.14 -42.22 90.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.154 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -78.03 -31.16 50.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.985 -178.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 30' ' ' VAL . 92.8 t -65.38 -38.66 83.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.013 0.435 . . . . 0.0 109.838 175.25 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 26.9 t90 -57.34 -44.87 84.64 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.785 176.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.413 ' NZ ' ' HB3' ' A' ' 36' ' ' LYS . 8.3 mtpm? -80.02 -0.09 33.95 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.78 0.324 . . . . 0.0 111.24 -179.191 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -96.19 -39.58 9.61 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.012 0.434 . . . . 0.0 110.619 175.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 29.3 m -82.13 19.66 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.055 -0.52 . . . . 0.0 112.303 -173.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 91.02 19.48 42.79 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.97 176.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 37.17 65.82 2.33 Favored Pre-proline 0 N--CA 1.473 0.722 0 C-N-CA 123.884 0.874 . . . . 0.0 112.941 179.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -83.11 175.51 8.36 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 122.482 2.122 . . . . 0.0 111.953 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -71.55 110.4 6.11 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.844 175.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.509 ' HB3' ' CG2' ' A' ' 76' ' ' VAL . 81.0 mt -73.7 129.14 37.33 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.795 -178.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 25.6 tptp -92.54 121.98 34.52 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.959 -178.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.403 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 41.7 p -103.24 156.19 17.9 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.805 -178.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 30.6 p90 -132.83 146.5 51.88 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 173.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 57.9 t -99.28 116.55 42.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.45 -179.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.659 HG23 ' HB ' ' A' ' 73' ' ' ILE . 6.2 tt -102.95 101.29 11.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 174.189 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 . . . . . 0 C--N 1.319 -0.722 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.172 -175.963 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 67.3 mttm . . . . . 0 N--CA 1.454 -0.236 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.659 ' HB ' HG23 ' A' ' 48' ' ' ILE . 57.9 mt -91.1 132.96 34.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -117.7 126.75 53.06 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 120.885 0.374 . . . . 0.0 110.81 -174.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.437 ' HA ' ' H ' ' A' ' 90' ' ' TYR . 97.7 mttt -123.07 159.01 29.37 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.22 176.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.509 ' CG2' ' HB3' ' A' ' 43' ' ' LEU . 9.9 p -122.71 145.36 29.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.638 -175.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.405 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 53.2 p90 -152.51 165.29 35.57 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.964 0.412 . . . . 0.0 110.365 178.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -137.69 144.97 42.05 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 169.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.566 ' HG2' ' HG3' ' A' ' 85' ' ' ARG . 43.7 mt-10 -101.93 122.51 44.16 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.183 -177.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 49.6 p -73.17 178.25 4.55 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.044 -178.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 8.0 mp -64.06 -24.3 67.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.06 0.457 . . . . 0.0 109.851 176.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -83.26 -2.19 55.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.982 179.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 15.5 m120 71.03 24.57 3.92 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.35 178.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 62.0 t -90.33 134.71 28.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.779 176.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.566 ' HG3' ' HG2' ' A' ' 79' ' ' GLU . 4.3 mpt_? -92.3 110.3 21.69 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.035 -176.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.439 HG22 ' HB ' ' A' ' 24' ' ' ILE . 49.4 t -89.22 103.36 13.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 173.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.8 t -107.09 141.41 22.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.683 -170.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.495 HG21 ' HA ' ' A' ' 28' ' ' PRO . 73.0 m -149.56 153.73 37.59 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.583 175.308 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -64.43 127.96 33.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.931 0.396 . . . . 0.0 111.047 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.437 ' H ' ' HA ' ' A' ' 75' ' ' LYS . 83.7 t80 -80.69 -26.68 37.37 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.034 -174.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 47.3 t -62.94 -44.15 96.85 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.441 ' O ' ' HB3' ' A' ' 95' ' ' LYS . 39.8 mt-10 -80.05 -20.2 45.8 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.068 177.294 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -70.38 -49.53 48.14 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.406 173.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.472 ' HA ' HD12 ' A' ' 97' ' ' LEU . 19.6 pt20 -68.05 -22.6 64.94 Favored 'General case' 0 C--N 1.334 -0.074 0 CA-C-O 121.034 0.445 . . . . 0.0 110.05 177.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.441 ' HB3' ' O ' ' A' ' 92' ' ' GLU . 86.7 tttt -61.43 -45.05 95.91 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.726 173.284 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.43 HG13 ' O ' ' A' ' 92' ' ' GLU . 66.3 mt -68.49 -34.93 68.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.166 176.079 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.472 HD12 ' HA ' ' A' ' 94' ' ' GLN . 75.7 mt -60.83 -41.65 96.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.641 176.196 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.442 ' HG2' ' O ' ' A' ' 94' ' ' GLN . 34.4 mmtp -67.25 -38.77 85.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.177 0.513 . . . . 0.0 110.225 176.301 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -60.92 -50.22 74.3 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.31 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 73.9 mtp85 -95.44 1.17 53.99 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.641 -174.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.229 -0.203 0 C-N-CA 121.171 -0.538 . . . . 0.0 113.191 175.248 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 15.8 m120 . . . . . 0 C--O 1.234 0.287 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.5 p -57.48 -32.37 66.92 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.068 0.461 . . . . 0.0 111.078 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.475 ' HA ' ' HD2' ' A' ' 7' ' ' LYS . 35.3 tt0 -61.0 -42.3 98.18 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.697 178.071 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.3 t -68.01 -35.21 71.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.373 179.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.509 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 59.7 mt -62.73 -39.77 86.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.138 176.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.475 ' HD2' ' HA ' ' A' ' 4' ' ' GLU . 61.8 mttm -56.78 -44.66 82.07 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.488 176.097 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -57.67 -44.1 85.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.022 178.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -66.9 -43.54 83.13 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.878 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.513 HD13 ' HB3' ' A' ' 17' ' ' TYR . 87.3 mt -66.57 -40.03 88.76 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.371 -177.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -67.44 -39.46 85.4 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.922 0.391 . . . . 0.0 110.17 176.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -58.24 -51.04 71.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.183 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 33.7 pt -72.38 -26.26 24.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.405 -178.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.32 44.16 4.75 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.723 177.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -123.19 149.66 44.35 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.009 0.433 . . . . 0.0 110.813 178.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -93.99 131.96 38.93 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.294 -177.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.513 ' HB3' HD13 ' A' ' 10' ' ' LEU . 27.9 p90 -115.23 136.28 53.28 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.051 179.048 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 57.1 mt -87.45 97.81 6.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 120.848 0.356 . . . . 0.0 110.107 -179.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -91.12 106.63 18.65 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.352 0.596 . . . . 0.0 110.459 -179.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.516 ' HB2' ' HB2' ' A' ' 23' ' ' GLU . 88.1 mt -93.95 -164.84 1.22 Allowed 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.222 -0.899 . . . . 0.0 108.803 174.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -69.56 92.73 0.65 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.635 0.255 . . . . 0.0 110.52 179.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 10.0 m120 69.54 18.55 7.72 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.643 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.516 ' HB2' ' HB2' ' A' ' 20' ' ' LEU . 41.6 mt-10 -130.18 113.71 14.8 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.937 178.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 59.5 mt -96.04 102.55 13.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 173.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.507 ' HA ' ' O ' ' A' ' 87' ' ' VAL . 13.6 m-70 -90.35 117.74 29.31 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.016 0.436 . . . . 0.0 109.949 -179.076 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 70.6 mt -107.56 168.96 8.88 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.519 0.676 . . . . 0.0 111.562 -176.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -82.57 140.27 44.43 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 115.011 -0.995 . . . . 0.0 108.364 171.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.496 ' HA ' HG21 ' A' ' 88' ' ' THR . 3.2 Cg_endo -47.06 -43.69 24.53 Favored 'Trans proline' 0 CA--C 1.534 0.495 0 C-N-CA 123.195 2.597 . . . . 0.0 113.298 -176.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -61.15 -41.19 96.31 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.998 0.428 . . . . 0.0 111.197 179.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 47.9 t -73.82 -37.78 49.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.852 -178.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -60.62 -40.59 92.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.632 179.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 85.1 t80 -60.49 -39.69 88.6 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.576 178.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 38.2 mm-40 -59.6 -50.84 72.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.842 177.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 41.4 t -65.62 -40.33 87.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.996 -177.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.712 ' CD1' ' HD2' ' A' ' 41' ' ' PRO . 32.5 t90 -57.02 -44.62 83.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.708 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.423 ' HE2' ' HB3' ' A' ' 36' ' ' LYS . 51.1 mtpt -89.5 3.7 51.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.881 0.372 . . . . 0.0 111.108 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -83.6 -38.6 21.4 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -96.84 9.29 6.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.915 177.194 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 79.04 50.4 5.87 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.739 -0.744 . . . . 0.0 113.763 173.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 58.24 78.33 0.36 Allowed Pre-proline 0 N--CA 1.467 0.41 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 172.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.712 ' HD2' ' CD1' ' A' ' 35' ' ' TRP . 5.4 Cg_exo -78.76 173.73 13.22 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.374 2.049 . . . . 0.0 111.39 172.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -76.99 123.58 26.54 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.046 177.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.453 ' HB3' ' CG2' ' A' ' 76' ' ' VAL . 87.6 mt -94.36 132.03 39.41 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.809 -177.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -107.44 141.81 38.25 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.768 178.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 24.1 p -120.76 146.09 46.85 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.775 0.321 . . . . 0.0 111.487 -176.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 17.8 p90 -133.09 154.98 50.06 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 177.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.5 t -106.01 114.61 45.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.274 178.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 8.6 tt -110.53 118.03 56.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.267 0.556 . . . . 0.0 109.95 177.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.489 ' HG2' ' HG2' ' A' ' 72' ' ' LYS . 50.2 mt-10 . . . . . 0 C--N 1.322 -0.621 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.917 -178.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.489 ' HG2' ' HG2' ' A' ' 49' ' ' GLU . 61.5 mttm . . . . . 0 N--CA 1.453 -0.288 0 CA-C-O 120.749 0.309 . . . . 0.0 110.389 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 65.4 mt -97.77 118.91 45.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.131 0.491 . . . . 0.0 110.553 -178.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.427 ' O ' ' HB3' ' A' ' 90' ' ' TYR . 87.8 tttt -89.58 128.43 36.03 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.958 178.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.458 ' HG2' ' HA ' ' A' ' 89' ' ' ASP . 68.3 mttm -129.73 164.17 24.57 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 177.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.453 ' CG2' ' HB3' ' A' ' 43' ' ' LEU . 11.1 p -119.82 148.03 23.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.513 -174.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -154.79 162.35 41.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.058 0.456 . . . . 0.0 111.108 -179.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -132.45 142.21 49.15 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 168.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -102.16 132.43 48.07 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.633 -173.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 72.4 p -82.31 179.53 7.77 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.926 0.394 . . . . 0.0 109.994 176.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.407 ' N ' HD12 ' A' ' 81' ' ' LEU . 5.9 mp -77.11 -6.45 52.87 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.85 0.357 . . . . 0.0 110.7 -178.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.524 ' HB2' HG23 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -97.89 8.85 44.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.203 -179.384 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 63.4 t30 67.14 28.42 8.22 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.865 0.84 . . . . 0.0 110.133 -176.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.524 HG23 ' HB2' ' A' ' 82' ' ' ASP . 59.2 t -98.72 113.72 34.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 175.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 85.6 mtt180 -94.69 110.51 22.35 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.567 -176.09 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 58.0 t -81.63 104.62 10.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.724 179.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.507 ' O ' ' HA ' ' A' ' 25' ' ' HIS . 41.4 t -103.53 140.97 20.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.236 -172.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.496 HG21 ' HA ' ' A' ' 28' ' ' PRO . 98.6 m -147.58 151.43 36.25 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.33 174.359 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.458 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 20.3 t70 -59.97 134.8 57.38 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.063 0.458 . . . . 0.0 111.563 -177.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.427 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 88.1 t80 -76.64 -41.04 47.29 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.62 -175.26 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 11.0 p -68.65 -37.57 79.78 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.911 -0.316 . . . . 0.0 111.058 -176.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 43.1 mm-40 -72.65 -31.75 65.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.594 0.235 . . . . 0.0 110.992 176.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -69.34 -49.77 52.56 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 121.078 -0.249 . . . . 0.0 111.078 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.469 ' HA ' HD12 ' A' ' 97' ' ' LEU . 11.0 pt20 -63.86 -28.66 70.0 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.146 0.498 . . . . 0.0 110.094 178.511 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 53.7 tttt -60.59 -45.55 93.55 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.414 173.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.541 ' HA ' ' HB3' ' A' ' 99' ' ' LYS . 21.7 mt -71.07 -33.1 50.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.458 -179.536 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.469 HD12 ' HA ' ' A' ' 94' ' ' GLN . 98.4 mt -56.62 -40.92 76.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.031 0.443 . . . . 0.0 110.197 175.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -81.06 -31.92 34.25 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.624 177.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.541 ' HB3' ' HA ' ' A' ' 96' ' ' ILE . 46.9 tttm -56.59 -46.69 80.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.11 178.404 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 68.6 mtp85 -95.03 -14.47 24.29 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.576 179.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.442 0 C-N-CA 120.673 -0.775 . . . . 0.0 111.779 -179.997 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 17.3 m120 . . . . . 0 C--O 1.234 0.239 0 CA-C-O 120.848 0.356 . . . . 0.0 110.642 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.0 t -67.78 -25.99 65.87 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 175.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.422 ' O ' ' HG3' ' A' ' 8' ' ' GLU . 35.5 tt0 -51.94 -45.77 64.47 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.012 175.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.3 t -61.01 -41.38 88.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.854 -178.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 56.6 mt -65.14 -41.91 92.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.284 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 55.9 mttm -56.18 -44.44 79.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.24 177.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.422 ' HG3' ' O ' ' A' ' 4' ' ' GLU . 39.0 mt-10 -63.05 -41.65 99.53 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.595 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -66.02 -46.28 78.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.849 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 96.3 mt -68.16 -34.17 75.82 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.227 -177.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -67.15 -33.69 75.97 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.292 179.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -63.73 -55.06 26.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.844 178.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.415 HG13 ' H ' ' A' ' 15' ' ' GLU . 19.6 pt -69.56 -39.55 78.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.688 -177.334 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 95.36 21.73 23.9 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.815 177.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.415 ' H ' HG13 ' A' ' 13' ' ' ILE . 23.5 mm-40 -85.94 130.05 34.66 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 175.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -69.16 122.59 19.1 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.732 -176.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 43.8 p90 -112.95 133.91 54.7 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 171.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.556 ' HB ' ' HB2' ' A' ' 25' ' ' HIS . 57.8 mt -90.08 94.74 5.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 120.938 0.399 . . . . 0.0 110.081 -178.278 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -84.95 109.48 18.2 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.306 0.574 . . . . 0.0 110.598 179.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.4 mt -101.32 -161.86 0.89 Allowed 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.1 -0.954 . . . . 0.0 108.706 174.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -66.37 96.09 0.34 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.772 0.32 . . . . 0.0 110.61 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 65.25 20.14 11.84 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.65 179.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -134.24 114.22 12.82 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.801 0.334 . . . . 0.0 111.623 -178.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.446 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 54.3 mt -94.36 101.21 12.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 173.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.556 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 18.8 m-70 -84.87 107.07 16.84 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 177.605 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.9 mt -95.2 169.72 9.89 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.424 0.631 . . . . 0.0 111.752 -175.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.403 ' HB2' HG23 ' A' ' 30' ' ' VAL . 44.8 mtpt -87.11 136.02 34.3 Favored Pre-proline 0 C--N 1.319 -0.728 0 CA-C-N 114.904 -1.044 . . . . 0.0 108.688 175.217 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.412 ' HA ' HG21 ' A' ' 88' ' ' THR . 82.9 Cg_exo -47.0 -43.53 24.46 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 123.305 2.67 . . . . 0.0 113.245 -177.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -56.86 -44.56 82.3 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.29 0.567 . . . . 0.0 110.86 178.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.403 HG23 ' HB2' ' A' ' 27' ' ' LYS . 17.1 t -76.68 -46.83 30.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.73 -175.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -56.4 -37.97 70.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.524 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.652 ' OH ' ' HD2' ' A' ' 100' ' ' ARG . 6.6 t80 -58.27 -32.14 68.12 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.701 178.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 50.7 mm-40 -95.21 -37.17 11.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.546 0.212 . . . . 0.0 111.555 179.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.507 ' O ' HG22 ' A' ' 38' ' ' VAL . 93.4 t -62.67 -35.86 72.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.69 0.281 . . . . 0.0 110.789 179.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.675 ' CD1' ' HD2' ' A' ' 41' ' ' PRO . 46.2 t90 -55.56 -36.94 67.36 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.665 176.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.45 ' HA ' ' OE2' ' A' ' 40' ' ' GLU . 93.1 mttt -74.85 -40.98 60.71 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.483 179.14 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -58.02 -41.62 83.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.657 -178.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.577 HG23 ' HD3' ' A' ' 41' ' ' PRO . 15.5 m -85.54 1.46 5.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.753 -178.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 90.89 41.07 5.42 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.97 -0.633 . . . . 0.0 114.289 169.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.45 ' OE2' ' HA ' ' A' ' 36' ' ' LYS . 21.3 mp0 51.25 67.18 4.48 Favored Pre-proline 0 N--CA 1.467 0.416 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 176.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.675 ' HD2' ' CD1' ' A' ' 35' ' ' TRP . 72.5 Cg_endo -77.41 -179.58 5.57 Favored 'Trans proline' 0 C--O 1.24 0.598 0 C-N-CA 122.461 2.108 . . . . 0.0 112.119 178.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -68.47 132.13 46.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.683 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.459 ' HB3' ' CG2' ' A' ' 76' ' ' VAL . 77.8 mt -106.31 107.73 18.88 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.212 178.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.545 ' HE2' ' HG3' ' A' ' 79' ' ' GLU . 31.1 mttm -88.51 118.11 27.92 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 -179.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 41.8 p -95.62 119.42 34.08 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.33 177.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 14.6 p90 -118.56 152.88 35.16 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 60.3 t -104.17 112.6 38.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.18 178.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.496 HG23 ' HB ' ' A' ' 73' ' ' ILE . 11.6 tt -102.09 123.9 55.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 176.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 . . . . . 0 C--N 1.319 -0.757 0 CA-C-O 121.154 0.502 . . . . 0.0 110.731 -176.169 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 65.0 mttm . . . . . 0 N--CA 1.455 -0.217 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.496 ' HB ' HG23 ' A' ' 48' ' ' ILE . 49.0 mt -91.25 128.9 42.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.647 -176.007 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -101.32 113.11 25.88 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.009 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.449 ' HA ' ' H ' ' A' ' 90' ' ' TYR . 68.4 mttm -122.17 167.1 13.59 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.358 -179.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.459 ' CG2' ' HB3' ' A' ' 43' ' ' LEU . 14.8 p -126.31 147.39 31.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.819 -175.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 44.1 p90 -152.65 155.8 37.99 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.695 0.283 . . . . 0.0 110.782 175.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -124.71 157.73 34.93 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 171.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.545 ' HG2' ' HG2' ' A' ' 85' ' ' ARG . 29.4 mt-10 -109.07 146.34 34.16 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.908 0.385 . . . . 0.0 111.191 -174.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 32.5 p -102.6 179.46 4.29 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.995 175.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 11.2 mp -67.49 -18.16 64.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.066 0.46 . . . . 0.0 110.907 178.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -94.28 9.61 37.38 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.599 -177.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 14.7 t30 69.64 1.98 3.6 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.427 0.632 . . . . 0.0 110.808 -179.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 52.6 t -72.49 115.63 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 178.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.545 ' HG2' ' HG2' ' A' ' 79' ' ' GLU . 91.8 mtt180 -94.23 118.59 31.8 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.786 -176.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.446 ' HA ' ' O ' ' A' ' 24' ' ' ILE . 59.7 t -87.12 104.96 14.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 178.09 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 23.9 t -102.07 141.19 18.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.061 -173.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.412 HG21 ' HA ' ' A' ' 28' ' ' PRO . 97.9 m -150.99 150.02 30.27 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.363 175.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -64.88 125.83 26.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.943 0.401 . . . . 0.0 110.349 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.449 ' H ' ' HA ' ' A' ' 75' ' ' LYS . 18.3 t80 -75.85 -25.28 56.07 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.512 -173.109 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 10.9 t -74.31 -44.72 51.44 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 -70.36 -29.95 66.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.806 176.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.511 ' HE1' ' HA ' ' A' ' 32' ' ' TYR . 72.4 t80 -65.34 -52.17 55.66 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.365 -0.38 . . . . 0.0 109.985 174.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -63.16 -27.87 69.67 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.004 177.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -58.44 -51.3 70.41 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.013 176.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.446 ' HA ' ' HB3' ' A' ' 99' ' ' LYS . 62.3 mt -72.99 -32.57 40.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.22 0.533 . . . . 0.0 110.436 179.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.41 ' HA ' HD22 ' A' ' 97' ' ' LEU . 0.2 OUTLIER -59.2 -50.2 74.95 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.509 -0.768 . . . . 0.0 110.033 176.853 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -65.96 -36.13 82.5 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.576 176.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.446 ' HB3' ' HA ' ' A' ' 96' ' ' ILE . 47.8 tttp -57.37 -42.39 82.01 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.29 -179.174 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.652 ' HD2' ' OH ' ' A' ' 32' ' ' TYR . 63.5 ttt180 -73.1 -40.59 64.86 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.079 0.466 . . . . 0.0 110.924 179.26 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.562 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.962 -176.984 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . 0.513 ' HB3' ' OD2' ' A' ' 82' ' ' ASP . 2.0 m-20 . . . . . 0 N--CA 1.455 -0.225 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.427 ' O ' ' HG3' ' A' ' 7' ' ' LYS . 14.8 p -62.27 -29.36 70.36 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.081 0.467 . . . . 0.0 110.374 178.465 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -57.08 -46.76 82.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.984 176.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.8 t -63.0 -38.9 83.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.266 -178.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.491 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 61.5 mt -63.58 -43.56 98.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.209 178.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.427 ' HG3' ' O ' ' A' ' 3' ' ' SER . 99.0 mttt -58.51 -45.13 89.45 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.817 178.255 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -57.43 -47.28 82.19 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.108 179.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -61.04 -46.05 92.27 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.768 178.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.491 ' HG ' ' O ' ' A' ' 6' ' ' ILE . 95.7 mt -64.69 -37.12 86.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.454 -177.398 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -74.5 -36.02 63.23 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.785 0.326 . . . . 0.0 110.842 177.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -67.88 -35.06 77.86 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.848 0.356 . . . . 0.0 110.861 -179.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 39.0 pt -82.34 -17.2 11.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.854 0.359 . . . . 0.0 110.576 175.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 77.09 48.45 8.35 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 121.119 -0.562 . . . . 0.0 113.045 174.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.03 158.55 26.56 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.871 0.367 . . . . 0.0 110.431 179.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -95.99 120.41 36.22 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.822 -178.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 42.1 p90 -116.25 145.92 42.76 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.09 179.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.491 ' HB ' ' HB2' ' A' ' 25' ' ' HIS . 51.1 mt -96.39 97.97 7.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 120.76 0.314 . . . . 0.0 110.859 -177.222 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 47.2 tt0 -90.58 125.51 35.65 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.072 0.463 . . . . 0.0 110.171 176.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.585 ' HB2' ' HB2' ' A' ' 23' ' ' GLU . 90.4 mt -120.39 -161.65 0.9 Allowed 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 174.447 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -78.67 101.16 7.36 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.796 0.331 . . . . 0.0 110.407 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 58.7 m-80 69.43 10.07 7.55 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.724 -178.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.585 ' HB2' ' HB2' ' A' ' 20' ' ' LEU . 46.9 mt-10 -123.48 132.98 54.08 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.71 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.53 ' HB ' HG22 ' A' ' 86' ' ' VAL . 69.5 mt -120.98 111.59 32.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 170.582 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.491 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 66.3 m-70 -100.97 127.17 47.58 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 110.132 -0.322 . . . . 0.0 110.132 -178.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 69.9 mt -118.01 177.08 4.92 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.413 -176.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 58.7 mttp -92.61 154.9 42.4 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.118 175.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.26 -48.52 21.58 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.795 2.33 . . . . 0.0 113.07 -174.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -64.08 -47.61 79.43 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.841 0.353 . . . . 0.0 110.773 -177.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.404 ' O ' HG23 ' A' ' 34' ' ' VAL . 42.0 t -62.48 -45.86 97.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.775 -178.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -57.1 -44.76 83.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.842 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -59.48 -42.29 91.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.324 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -75.72 -44.37 42.32 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.91 -177.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 30' ' ' VAL . 97.5 t -61.83 -36.52 74.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-O 120.744 0.307 . . . . 0.0 110.571 178.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 28.3 t90 -53.77 -53.83 46.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.816 177.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.468 ' HA ' ' HG3' ' A' ' 40' ' ' GLU . 65.4 mttm -71.38 -29.9 65.5 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.039 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 86.4 t80 -60.91 -42.09 97.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.458 179.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.498 HG23 ' HD3' ' A' ' 41' ' ' PRO . 30.3 m -86.29 -0.37 6.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 -176.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 109.36 11.01 22.72 Favored Glycine 0 C--N 1.329 0.187 0 C-N-CA 120.437 -0.887 . . . . 0.0 113.427 175.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.468 ' HG3' ' HA ' ' A' ' 36' ' ' LYS . 46.3 mt-10 57.77 72.17 0.95 Allowed Pre-proline 0 C--O 1.234 0.287 0 C-N-CA 122.936 0.494 . . . . 0.0 111.938 179.321 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.498 ' HD3' HG23 ' A' ' 38' ' ' VAL . 5.0 Cg_exo -74.74 173.25 14.72 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.764 2.309 . . . . 0.0 111.475 176.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -64.63 123.39 19.18 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.014 0.435 . . . . 0.0 110.849 179.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.485 ' HB3' ' CG2' ' A' ' 76' ' ' VAL . 86.4 mt -90.84 102.25 15.01 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.136 176.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -82.74 143.66 30.73 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 176.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 31.5 p -121.51 138.88 54.11 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.95 0.405 . . . . 0.0 111.195 -176.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 15.0 p90 -127.16 141.22 51.8 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 176.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.464 ' HA ' ' HA ' ' A' ' 74' ' ' LYS . 5.3 p -98.8 105.24 17.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-O 121.655 0.74 . . . . 0.0 110.28 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 14.7 tt -93.99 125.66 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 CA-C-N 115.679 -0.692 . . . . 0.0 109.599 179.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 . . . . . 0 C--N 1.314 -0.965 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.259 -176.616 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 66.3 mttm . . . . . 0 N--CA 1.452 -0.37 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 62.8 mt -101.69 114.24 40.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.539 0.685 . . . . 0.0 111.004 -177.083 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.56 ' O ' ' HB3' ' A' ' 90' ' ' TYR . 88.1 tttt -80.7 124.25 28.87 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.197 -179.414 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -120.15 163.81 17.15 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.639 -0.255 . . . . 0.0 110.367 178.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.485 ' CG2' ' HB3' ' A' ' 43' ' ' LEU . 10.9 p -122.92 148.35 26.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.904 -174.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.422 ' CE2' ' HD3' ' A' ' 85' ' ' ARG . 55.5 p90 -152.95 153.24 32.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.71 0.291 . . . . 0.0 111.144 178.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.464 ' HB3' HD23 ' A' ' 43' ' ' LEU . 47.8 p90 -122.41 156.94 32.95 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 172.204 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.512 ' HG2' ' HG2' ' A' ' 85' ' ' ARG . 29.3 mt-10 -103.86 149.91 24.64 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.626 -171.504 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 73.9 p -108.77 176.69 5.02 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.966 175.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.41 HD23 HD21 ' A' ' 2' ' ' ASN . 47.2 tp -66.84 -26.47 66.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.724 0.297 . . . . 0.0 111.069 179.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.513 ' OD2' ' HB3' ' A' ' 2' ' ' ASN . 1.4 m-20 -82.77 3.64 28.52 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.776 -176.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.447 ' HB2' ' O ' ' A' ' 82' ' ' ASP . 0.9 OUTLIER 71.51 10.52 6.52 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 123.55 0.532 . . . . 0.0 110.917 -175.875 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.47 HG23 ' HB2' ' A' ' 82' ' ' ASP . 62.5 t -84.3 128.08 39.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 176.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.512 ' HG2' ' HG2' ' A' ' 79' ' ' GLU . 82.9 mtt180 -107.38 129.12 54.96 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.469 0.652 . . . . 0.0 111.673 -173.121 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.53 HG22 ' HB ' ' A' ' 24' ' ' ILE . 58.3 t -91.38 112.62 25.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.946 -179.306 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 41.4 t -105.51 140.79 22.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.129 -173.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 93.0 m -151.63 148.89 28.51 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.321 174.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -58.45 129.23 41.07 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.537 0.684 . . . . 0.0 111.982 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.56 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 93.9 t80 -76.49 -23.99 53.79 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.008 -0.997 . . . . 0.0 110.603 -177.272 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.2 m -65.14 -54.21 33.22 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.437 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -71.38 -28.05 63.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.413 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -63.43 -49.22 74.6 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.951 0.405 . . . . 0.0 109.937 175.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.475 ' O ' ' HG3' ' A' ' 98' ' ' LYS . 68.2 mm-40 -65.2 -33.86 76.99 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.656 176.02 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -57.84 -44.25 86.39 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.739 177.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 40.6 mt -68.64 -34.26 64.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.076 178.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 74.9 mt -62.04 -37.09 83.63 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.951 0.405 . . . . 0.0 110.189 176.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.475 ' HG3' ' O ' ' A' ' 94' ' ' GLN . 86.0 mttt -73.05 -39.47 65.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.031 176.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 55.7 tptt -64.85 -46.33 82.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.374 -178.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 84.5 mtt-85 -89.67 -8.49 52.32 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.451 -177.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.278 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.42 177.315 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . 0.548 ' HA ' ' HB ' ' A' ' 80' ' ' THR . 95.0 m-20 . . . . . 0 N--CA 1.451 -0.387 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.453 ' HB3' HG21 ' A' ' 84' ' ' VAL . 35.3 p -62.36 -34.79 77.35 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.017 0.437 . . . . 0.0 110.824 -179.493 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -57.05 -54.37 47.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.852 -177.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.3 t -59.22 -41.37 83.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.849 0.357 . . . . 0.0 110.915 -178.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 50.7 mt -66.03 -39.99 86.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.463 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 51.3 mttm -58.77 -47.52 84.42 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.984 175.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -62.19 -41.09 98.03 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.759 179.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -62.11 -51.18 68.97 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.643 179.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 93.3 mt -62.44 -38.15 88.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.943 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -66.26 -40.74 90.34 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.452 178.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -70.67 -35.04 72.62 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.472 -176.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 39.2 pt -87.15 -8.38 11.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.798 0.332 . . . . 0.0 110.919 178.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 65.45 52.37 40.31 Favored Glycine 0 N--CA 1.452 -0.258 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.433 176.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -112.37 148.88 33.36 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.9 0.381 . . . . 0.0 110.724 -178.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -86.37 133.17 33.81 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.818 177.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 47.5 p90 -135.24 142.5 45.99 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.768 0.318 . . . . 0.0 110.455 179.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.56 ' HB ' ' HB2' ' A' ' 25' ' ' HIS . 66.5 mt -90.79 100.99 11.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.993 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -91.18 116.69 29.02 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.026 -178.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.538 ' HB2' ' HB2' ' A' ' 23' ' ' GLU . 89.9 mt -115.19 173.64 6.4 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 173.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -60.3 105.03 0.37 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.918 0.39 . . . . 0.0 111.118 -178.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 17.1 m120 68.0 16.75 9.56 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.633 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.538 ' HB2' ' HB2' ' A' ' 20' ' ' LEU . 91.1 mt-10 -133.95 113.97 12.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.959 0.409 . . . . 0.0 111.275 179.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 64.5 mt -97.39 103.4 14.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 172.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.56 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 35.6 m-70 -89.94 110.77 21.71 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 -179.076 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 63.9 mt -106.11 169.67 8.36 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.486 -175.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 51.5 mtpt -81.31 138.47 48.52 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.168 175.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.539 ' HA ' HG21 ' A' ' 88' ' ' THR . 3.4 Cg_exo -41.35 -51.91 3.86 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 124.117 3.211 . . . . 0.0 114.427 -173.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -70.31 -37.96 74.84 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.733 0.301 . . . . 0.0 111.076 -175.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 46.7 t -65.11 -42.13 93.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.222 0.534 . . . . 0.0 109.811 177.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -57.66 -41.29 81.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.816 178.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -59.29 -45.62 90.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.51 -178.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -64.29 -35.81 82.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.273 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 60.4 t -72.13 -38.22 62.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.198 0.523 . . . . 0.0 110.45 178.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.646 ' CZ2' ' HG3' ' A' ' 40' ' ' GLU . 30.0 t90 -57.12 -46.87 82.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.33 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 55.8 mttm -86.46 -2.2 58.25 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.895 0.379 . . . . 0.0 111.384 179.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -78.72 -35.47 44.81 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 176.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.526 HG23 ' HD3' ' A' ' 41' ' ' PRO . 3.2 m -85.9 3.85 3.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.603 177.228 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 97.21 17.72 31.03 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.696 -0.764 . . . . 0.0 113.444 174.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.646 ' HG3' ' CZ2' ' A' ' 35' ' ' TRP . 36.1 tt0 61.7 84.59 0.19 Allowed Pre-proline 0 N--CA 1.466 0.336 0 CA-C-O 121.06 0.457 . . . . 0.0 111.498 178.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.565 ' HD2' ' CD1' ' A' ' 35' ' ' TRP . 94.3 Cg_endo -90.64 162.92 4.25 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.745 2.297 . . . . 0.0 111.7 173.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -71.45 125.42 26.97 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 175.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.459 ' CD2' ' HB3' ' A' ' 78' ' ' PHE . 90.4 mt -90.53 150.09 21.91 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.348 0.594 . . . . 0.0 112.292 -170.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -97.2 164.67 12.39 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.236 172.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.662 HG21 ' HE3' ' A' ' 74' ' ' LYS . 19.0 p -119.59 144.8 46.9 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.136 0.493 . . . . 0.0 111.22 177.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.586 ' HB2' ' CD2' ' A' ' 77' ' ' TYR . 32.4 t80 -118.69 114.49 22.81 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.044 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 95.6 t -100.23 121.43 50.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.972 -177.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.468 ' CG1' ' HB ' ' A' ' 73' ' ' ILE . 42.0 pt -105.59 132.16 53.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.732 174.24 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 . . . . . 0 C--N 1.32 -0.685 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.865 -178.65 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 58.4 mttp . . . . . 0 N--CA 1.45 -0.437 0 CA-C-O 120.928 0.394 . . . . 0.0 110.625 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.468 ' HB ' ' CG1' ' A' ' 48' ' ' ILE . 65.3 mt -91.15 113.67 27.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.659 178.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.662 ' HE3' HG21 ' A' ' 45' ' ' THR . 48.1 tttp -94.93 101.94 13.74 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.779 -173.119 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -96.62 167.54 11.07 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.427 176.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 12.5 p -116.64 148.66 19.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 110.4 -0.222 . . . . 0.0 110.4 -177.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.586 ' CD2' ' HB2' ' A' ' 46' ' ' TYR . 39.7 p90 -155.09 154.01 31.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.873 0.368 . . . . 0.0 111.242 177.309 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.459 ' HB3' ' CD2' ' A' ' 43' ' ' LEU . 48.8 p90 -119.09 160.68 21.61 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 171.304 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -111.8 138.86 47.83 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.961 0.41 . . . . 0.0 111.23 -173.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.548 ' HB ' ' HA ' ' A' ' 2' ' ' ASN . 40.2 p -93.82 169.63 10.16 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.587 173.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.446 ' HB2' ' OD1' ' A' ' 2' ' ' ASN . 6.9 mp -74.5 -10.15 59.27 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.247 0.546 . . . . 0.0 110.026 178.14 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -92.35 10.98 27.54 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.619 -179.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 68.93 20.83 7.76 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.483 176.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.453 HG21 ' HB3' ' A' ' 3' ' ' SER . 48.3 t -101.82 126.08 55.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.241 177.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . 0.457 ' O ' ' HA ' ' A' ' 23' ' ' GLU . 40.5 mtm180 -95.08 124.52 39.17 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.46 -179.238 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 59.4 t -95.16 107.61 19.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 176.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 28.6 t -105.09 138.67 28.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.605 -170.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.539 HG21 ' HA ' ' A' ' 28' ' ' PRO . 86.5 m -152.61 157.06 40.46 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.288 176.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -68.8 124.66 24.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.324 0.583 . . . . 0.0 112.248 -178.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -68.46 -32.63 72.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.302 -178.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 6.5 m -56.73 -41.46 77.55 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.964 0.411 . . . . 0.0 110.966 177.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.431 ' O ' HG13 ' A' ' 96' ' ' ILE . 43.6 mt-10 -83.6 -30.63 26.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.796 -179.141 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -62.68 -47.82 81.98 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.116 0.484 . . . . 0.0 109.875 175.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -58.15 -40.93 82.62 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.245 174.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.418 ' HB3' ' O ' ' A' ' 92' ' ' GLU . 64.4 tttp -56.95 -44.84 82.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.11 178.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.565 ' O ' ' HG2' ' A' ' 99' ' ' LYS . 75.7 mt -64.84 -47.06 89.97 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-O 121.024 0.44 . . . . 0.0 111.182 -179.444 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 87.4 mt -60.13 -51.17 70.73 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.859 -179.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -72.72 -28.31 62.57 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -174.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.565 ' HG2' ' O ' ' A' ' 96' ' ' ILE . 19.8 pttp -70.76 -29.93 66.29 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.33 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 22.6 mtm105 -78.53 -43.22 27.31 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 173.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.502 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.193 -178.766 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . 0.43 ' OD1' ' HB2' ' A' ' 81' ' ' LEU . 47.5 m-80 . . . . . 0 CA--C 1.52 -0.194 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 52.2 p -65.85 -20.71 66.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.428 0.632 . . . . 0.0 109.611 177.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . 0.535 ' O ' ' HG3' ' A' ' 8' ' ' GLU . 20.9 tp10 -61.2 -36.6 80.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.424 177.049 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.3 t -63.95 -35.92 75.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-O 121.236 0.541 . . . . 0.0 110.182 179.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 61.6 mt -66.86 -40.35 85.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.025 177.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -58.24 -45.31 88.01 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.286 177.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . 0.535 ' HG3' ' O ' ' A' ' 4' ' ' GLU . 41.5 mt-10 -60.0 -44.54 94.48 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.754 179.302 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.447 ' O ' HG12 ' A' ' 13' ' ' ILE . 79.5 t80 -61.51 -47.72 84.34 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.312 -179.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 91.3 mt -63.5 -37.7 88.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.881 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -59.44 -50.94 72.0 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.558 177.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -68.09 -37.87 81.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.878 -175.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.447 HG12 ' O ' ' A' ' 9' ' ' PHE . 35.4 pt -81.68 -14.67 12.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.235 -179.421 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 81.16 45.75 7.37 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.785 177.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -119.45 166.07 13.55 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.8 0.334 . . . . 0.0 110.71 178.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -117.35 161.1 20.08 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.949 179.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 28.5 p90 -130.7 146.54 52.21 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.683 179.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.46 ' HB ' ' HB2' ' A' ' 25' ' ' HIS . 54.6 mt -91.43 97.03 6.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 178.058 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.439 ' HA ' ' O ' ' A' ' 23' ' ' GLU . 1.9 tm-20 -99.35 107.27 19.49 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -176.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 89.9 mt -116.01 86.66 2.52 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.862 -177.259 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.438 ' O ' ' HB2' ' A' ' 22' ' ' ASN . 34.4 tt0 59.29 60.25 2.41 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.058 176.228 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.438 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 0.9 OUTLIER 75.07 14.01 3.18 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.293 177.454 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.439 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 35.1 mt-10 -111.16 113.74 26.48 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.8 170.62 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 62.0 mt -96.33 97.5 6.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 177.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.586 ' HA ' ' O ' ' A' ' 87' ' ' VAL . 14.1 m-70 -86.14 107.9 18.07 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.475 178.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 62.3 mt -95.13 164.45 12.86 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.254 -175.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -82.16 132.24 53.98 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.238 177.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -49.49 -40.3 45.18 Favored 'Trans proline' 0 N--CA 1.471 0.197 0 C-N-CA 123.1 2.533 . . . . 0.0 112.977 -177.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -60.54 -47.07 87.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.08 179.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 41.3 t -77.08 -40.2 29.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.768 -177.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.785 ' HE1' ' HE1' ' A' ' 78' ' ' PHE . 85.6 t80 -58.53 -37.17 75.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.883 -179.143 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.645 ' HA ' ' HE1' ' A' ' 93' ' ' PHE . 24.8 t80 -53.25 -39.4 63.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.291 177.34 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -84.0 -39.25 19.91 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.985 -178.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 62.6 t -62.53 -36.88 77.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-O 120.744 0.307 . . . . 0.0 110.841 179.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.428 ' CE2' ' HB2' ' A' ' 40' ' ' GLU . 22.1 t90 -53.13 -59.23 4.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.732 -179.336 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -74.0 -20.72 60.24 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.664 0.269 . . . . 0.0 111.403 -179.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -64.74 -28.8 69.83 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.806 178.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.411 HG23 ' HD3' ' A' ' 41' ' ' PRO . 29.0 m -103.34 11.22 8.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.36 -179.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.48 9.25 56.82 Favored Glycine 0 CA--C 1.517 0.186 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.877 177.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.428 ' HB2' ' CE2' ' A' ' 35' ' ' TRP . 15.5 pt-20 44.67 87.09 0.12 Allowed Pre-proline 0 N--CA 1.471 0.61 0 C-N-CA 124.527 1.131 . . . . 0.0 113.246 -179.394 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.411 ' HD3' HG23 ' A' ' 38' ' ' VAL . 74.5 Cg_endo -76.08 165.76 29.1 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.456 2.104 . . . . 0.0 111.486 175.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -63.15 137.11 58.12 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.033 0.444 . . . . 0.0 110.325 177.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.443 ' HB3' ' CG2' ' A' ' 76' ' ' VAL . 95.6 mt -87.29 144.29 26.87 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.491 -174.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -118.83 118.18 30.88 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 177.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 24.9 p -107.54 137.55 45.36 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 120.92 0.39 . . . . 0.0 111.843 -173.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 19.0 p90 -120.87 140.66 51.48 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 176.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.508 HG11 ' HE3' ' A' ' 72' ' ' LYS . 55.4 t -103.73 117.45 49.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.273 178.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 1.011 HG23 HG13 ' A' ' 73' ' ' ILE . 2.9 tt -98.88 122.37 50.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-O 121.522 0.677 . . . . 0.0 110.167 177.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.461 ' OE1' ' HG3' ' A' ' 72' ' ' LYS . 4.4 mm-40 . . . . . 0 C--N 1.325 -0.472 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.952 -176.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.508 ' HE3' HG11 ' A' ' 47' ' ' VAL . 39.0 tttp . . . . . 0 N--CA 1.452 -0.36 0 CA-C-O 120.749 0.309 . . . . 0.0 110.178 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 1.011 HG13 HG23 ' A' ' 48' ' ' ILE . 4.6 pt -109.04 125.26 66.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.616 0.722 . . . . 0.0 111.143 -177.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -106.78 131.58 53.73 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.966 -177.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -130.16 166.2 20.73 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.163 178.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.443 ' CG2' ' HB3' ' A' ' 43' ' ' LEU . 9.0 p -122.92 145.15 30.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.72 0.295 . . . . 0.0 111.112 -174.421 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 44.9 p90 -146.27 164.72 31.42 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.536 178.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.785 ' HE1' ' HE1' ' A' ' 31' ' ' PHE . 52.3 p90 -141.64 148.29 38.94 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 169.436 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -102.14 128.56 48.58 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.429 -176.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 72.7 p -88.08 -179.3 6.16 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.88 176.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.43 ' HB2' ' OD1' ' A' ' 2' ' ' ASN . 7.1 mp -70.12 -18.31 63.23 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.08 0.466 . . . . 0.0 110.207 178.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -71.18 -13.29 61.88 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.717 179.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 66.4 t30 77.68 10.12 2.3 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 124.079 0.862 . . . . 0.0 109.33 -171.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 77.8 t -81.74 129.12 38.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.278 178.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 56.1 mtm180 -92.94 105.46 17.57 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.343 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.3 t -84.28 106.74 14.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 177.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.586 ' O ' ' HA ' ' A' ' 25' ' ' HIS . 30.5 t -108.51 141.08 24.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.954 -173.432 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 34.3 m -144.44 150.57 37.88 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 176.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -62.92 126.11 26.24 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.182 0.515 . . . . 0.0 111.358 179.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -70.22 -38.06 75.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.14 -176.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 24.9 m -60.25 -57.75 11.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.354 -177.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.494 ' O ' ' HB3' ' A' ' 95' ' ' LYS . 36.3 mm-40 -68.22 -29.86 68.79 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.731 -177.502 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.645 ' HE1' ' HA ' ' A' ' 32' ' ' TYR . 53.0 t80 -67.87 -49.27 62.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.955 0.407 . . . . 0.0 110.404 177.41 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.52 ' O ' ' HG3' ' A' ' 98' ' ' LYS . 79.2 mm-40 -66.85 -24.46 66.14 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.568 178.193 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.494 ' HB3' ' O ' ' A' ' 92' ' ' GLU . 44.6 tttp -59.69 -49.57 77.24 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.366 174.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.453 ' O ' ' HB3' ' A' ' 99' ' ' LYS . 58.4 mt -67.93 -33.17 59.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.815 -179.29 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 69.8 mt -64.75 -39.82 94.26 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.563 177.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.52 ' HG3' ' O ' ' A' ' 94' ' ' GLN . 57.1 mttp -70.42 -33.81 71.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.033 0.444 . . . . 0.0 109.924 175.306 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.453 ' HB3' ' O ' ' A' ' 96' ' ' ILE . 61.9 tttp -56.65 -57.9 10.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.283 -0.872 . . . . 0.0 110.925 179.377 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -74.9 -23.78 58.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.587 0.232 . . . . 0.0 111.274 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.506 0 N-CA-C 111.339 -0.704 . . . . 0.0 111.339 -175.859 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 . . . . . 0 N--CA 1.452 -0.365 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.8 m -62.55 -23.26 66.89 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.009 0.433 . . . . 0.0 111.242 -177.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -61.59 -37.56 84.36 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.972 179.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 62.1 t -68.62 -34.32 64.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.023 0.439 . . . . 0.0 110.348 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.409 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 50.8 mt -62.39 -43.12 97.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.71 176.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 57.1 mttm -60.33 -38.33 83.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.049 177.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -57.6 -48.71 78.65 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.862 0.363 . . . . 0.0 110.777 178.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -66.17 -44.22 84.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.895 -179.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 6' ' ' ILE . 97.0 mt -66.66 -43.95 83.16 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.408 -177.287 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -69.3 -32.44 71.59 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.737 0.303 . . . . 0.0 110.37 -179.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -61.82 -48.68 79.51 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.12 178.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 38.3 pt -80.93 -12.55 12.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.165 -178.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 81.47 38.31 14.94 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.348 179.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -91.76 118.56 30.79 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.95 0.405 . . . . 0.0 110.197 178.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -97.8 102.78 14.63 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.964 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.467 ' CD2' HG23 ' A' ' 24' ' ' ILE . 29.0 p90 -97.97 170.59 8.84 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.469 -174.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.525 ' HB ' ' HB2' ' A' ' 25' ' ' HIS . 64.1 mt -94.25 100.33 10.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.99 177.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -90.54 135.53 33.64 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.245 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.673 ' HG ' ' H ' ' A' ' 21' ' ' GLU . 21.8 tp -133.28 177.22 7.85 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 175.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.673 ' H ' ' HG ' ' A' ' 20' ' ' LEU . 43.2 mt-10 -61.76 102.46 0.26 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.633 0.254 . . . . 0.0 110.902 -178.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.408 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 11.8 m120 71.68 16.25 5.78 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.999 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.56 ' HB2' ' HB3' ' A' ' 20' ' ' LEU . 41.4 mt-10 -131.63 134.96 46.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.056 0.455 . . . . 0.0 111.421 178.173 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.467 HG23 ' CD2' ' A' ' 17' ' ' TYR . 74.1 mt -118.69 107.53 21.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 171.54 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.525 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 73.0 m-70 -94.29 109.85 21.65 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.049 0.452 . . . . 0.0 110.491 -178.157 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.463 HD23 ' HB3' ' A' ' 17' ' ' TYR . 40.5 mt -109.25 150.54 27.8 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.936 -178.426 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 49.5 mtmt -64.38 135.61 96.42 Favored Pre-proline 0 C--N 1.326 -0.427 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 171.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.5 ' HB2' HD12 ' A' ' 96' ' ' ILE . 51.8 Cg_exo -54.27 -28.93 54.9 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.684 2.256 . . . . 0.0 112.075 -177.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -61.62 -56.38 20.51 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.49 177.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 49.2 t -68.14 -38.69 80.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.242 179.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -51.54 -46.86 63.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.238 -179.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 93.0 t80 -60.19 -43.38 95.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.137 -179.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.556 ' O ' ' HB2' ' A' ' 37' ' ' TYR . 43.6 mt-10 -76.96 -8.74 57.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.774 -175.448 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 62.5 t -93.07 -42.62 13.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.251 0.548 . . . . 0.0 109.522 171.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.553 ' CD1' ' HD2' ' A' ' 41' ' ' PRO . 44.2 t90 -55.82 -52.0 65.52 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.046 177.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 53.7 tttm -78.82 -14.35 59.3 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.015 0.436 . . . . 0.0 110.738 -177.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.556 ' HB2' ' O ' ' A' ' 33' ' ' GLU . 87.0 t80 -71.28 -44.77 64.59 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.814 -179.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 33.3 m -94.31 -3.66 10.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.338 -177.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 136.68 -85.28 0.24 Allowed Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.077 177.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 170.98 61.06 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.371 0 C-N-CA 122.969 0.508 . . . . 0.0 110.73 -175.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.553 ' HD2' ' CD1' ' A' ' 35' ' ' TRP . 71.1 Cg_exo -50.69 128.69 24.74 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.127 1.884 . . . . 0.0 111.584 177.126 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -61.16 116.07 4.28 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.318 0.58 . . . . 0.0 110.298 -177.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.576 ' HB3' ' CG2' ' A' ' 76' ' ' VAL . 93.3 mt -82.6 126.12 31.94 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.184 -0.917 . . . . 0.0 111.983 -170.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -92.06 139.21 30.86 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 175.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 69.5 p -118.68 145.85 45.17 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 121.148 -0.221 . . . . 0.0 110.599 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 25.7 p90 -133.46 143.49 48.87 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 176.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 48.4 t -94.98 110.72 24.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.24 -178.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 8.9 tt -118.9 111.17 32.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 121.425 0.631 . . . . 0.0 110.18 178.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.453 ' HG2' ' HG2' ' A' ' 72' ' ' LYS . 47.7 mt-10 . . . . . 0 C--N 1.321 -0.64 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 176.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.453 ' HG2' ' HG2' ' A' ' 49' ' ' GLU . 49.7 mttp . . . . . 0 C--O 1.234 0.253 0 CA-C-O 120.829 0.347 . . . . 0.0 110.537 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 49.3 mm -100.27 118.84 47.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.227 0.537 . . . . 0.0 110.572 -179.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.626 ' O ' ' HB3' ' A' ' 90' ' ' TYR . 49.5 tttp -92.8 118.55 31.22 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 176.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -118.44 159.61 23.18 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 179.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.576 ' CG2' ' HB3' ' A' ' 43' ' ' LEU . 14.2 p -131.03 147.94 33.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.978 -171.266 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 46.2 p90 -154.94 156.49 36.15 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.641 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -115.97 140.15 49.54 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 169.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -109.01 127.22 53.9 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.498 -170.019 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 44.5 p -88.89 -179.67 6.01 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.849 -175.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.9 mp -70.73 -22.84 62.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.229 178.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.445 ' HB2' HG23 ' A' ' 84' ' ' VAL . 2.9 m-20 -75.07 -10.02 59.08 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.344 179.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.438 ' HB2' ' O ' ' A' ' 82' ' ' ASP . 9.0 m120 68.72 28.76 5.49 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.156 -171.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.445 HG23 ' HB2' ' A' ' 82' ' ' ASP . 68.9 t -98.66 126.18 51.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.265 -0.88 . . . . 0.0 108.847 173.158 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 65.8 mtt180 -100.95 114.79 29.01 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.05 0.452 . . . . 0.0 111.176 -173.218 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 46.9 t -83.88 99.85 6.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 175.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 22.1 t -102.72 140.02 22.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.274 -171.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.9 t -143.65 -178.57 5.96 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 174.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -93.25 123.3 36.43 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.601 -177.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.626 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 61.8 t80 -69.26 -34.55 74.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.176 -176.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 12.7 t -65.83 -49.5 67.99 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 -178.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.479 ' HA ' ' HD3' ' A' ' 95' ' ' LYS . 28.9 mm-40 -66.12 -39.2 89.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.944 177.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.45 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 58.1 t80 -60.93 -45.98 92.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.756 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.526 ' O ' ' HG2' ' A' ' 98' ' ' LYS . 48.5 mm-40 -58.92 -39.45 81.58 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.145 177.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.479 ' HD3' ' HA ' ' A' ' 92' ' ' GLU . 50.1 mtpt -62.78 -43.68 98.15 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.87 177.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.5 HD12 ' HB2' ' A' ' 28' ' ' PRO . 67.4 mt -68.6 -33.29 59.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.879 179.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 93' ' ' PHE . 86.5 mt -58.17 -37.18 74.21 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.979 0.418 . . . . 0.0 110.323 174.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.526 ' HG2' ' O ' ' A' ' 94' ' ' GLN . 38.6 mmtm -74.35 -34.78 63.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.253 178.065 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.466 ' HD2' ' HA ' ' A' ' 96' ' ' ILE . 68.7 mttm -63.45 -46.76 84.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.785 176.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.597 ' HA ' ' HE ' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -73.87 -20.84 60.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.294 179.517 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.351 0 CA-C-N 115.945 -0.571 . . . . 0.0 112.266 178.727 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 11.7 m120 . . . . . 0 N--CA 1.454 -0.253 0 CA-C-O 120.794 0.33 . . . . 0.0 110.553 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.483 ' O ' ' HG3' ' A' ' 7' ' ' LYS . 34.2 t -61.48 -29.79 70.2 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.569 174.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -52.76 -43.13 65.57 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.759 176.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.7 t -62.9 -38.91 83.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.67 -178.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.522 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 60.5 mt -66.42 -44.86 90.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.315 179.335 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.483 ' HG3' ' O ' ' A' ' 3' ' ' SER . 85.6 mttt -63.63 -36.45 83.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.467 -179.187 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -55.86 -49.58 72.97 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.738 175.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -60.13 -43.14 95.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.066 179.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.531 HD13 ' HB3' ' A' ' 17' ' ' TYR . 74.4 mt -63.25 -48.27 78.92 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.325 -177.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -74.59 -19.62 60.25 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.96 -179.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -72.32 -45.34 60.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.837 177.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 38.1 pt -73.56 -17.78 17.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.979 0.419 . . . . 0.0 110.31 177.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.11 30.44 14.35 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.677 173.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -115.25 168.08 10.28 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 177.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -113.18 155.06 25.68 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.956 0.408 . . . . 0.0 110.96 -175.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.531 ' HB3' HD13 ' A' ' 10' ' ' LEU . 14.8 p90 -125.7 147.56 49.32 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.117 -173.219 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 52.5 mt -89.09 93.96 4.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 177.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -98.63 116.25 30.44 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.24 -176.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 77.4 mt -111.43 -176.53 2.97 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 171.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.491 ' HA ' ' OE1' ' A' ' 21' ' ' GLU . 6.3 tp10 -72.23 109.57 6.08 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 120.427 -0.509 . . . . 0.0 109.936 179.347 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 66.49 15.12 10.01 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.733 179.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -138.41 113.92 9.65 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.843 0.354 . . . . 0.0 111.277 179.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.453 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 63.9 mt -110.09 112.1 39.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 172.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 53.5 m-70 -98.44 117.21 32.35 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 80.4 mt -114.92 173.37 6.52 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.192 -175.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 75.6 mttt -84.5 149.65 55.16 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.492 178.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_exo -51.52 -41.68 59.28 Favored 'Trans proline' 0 C--O 1.233 0.241 0 C-N-CA 122.907 2.405 . . . . 0.0 112.855 -179.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -65.6 -44.71 85.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.76 0.314 . . . . 0.0 110.541 -179.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 61.4 t -64.91 -45.09 95.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.131 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -58.1 -40.12 80.35 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.033 -179.021 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -57.49 -42.54 82.9 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.338 179.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -76.43 -40.81 49.61 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.921 -177.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 79.0 t -65.56 -32.37 57.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.536 178.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.532 ' CD1' ' HD2' ' A' ' 41' ' ' PRO . 25.8 t90 -52.97 -52.27 58.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.027 178.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -76.07 -26.82 56.87 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.756 0.312 . . . . 0.0 110.762 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -65.82 -34.7 78.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.053 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.428 HG23 ' HD3' ' A' ' 41' ' ' PRO . 35.9 m -89.73 9.94 2.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.788 0.327 . . . . 0.0 111.579 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 100.7 14.7 31.26 Favored Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 120.604 -0.807 . . . . 0.0 113.604 174.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 48.75 73.09 1.06 Allowed Pre-proline 0 N--CA 1.466 0.357 0 CA-C-O 121.279 0.562 . . . . 0.0 111.409 177.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.532 ' HD2' ' CD1' ' A' ' 35' ' ' TRP . 95.4 Cg_endo -90.4 163.8 4.47 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 122.679 2.253 . . . . 0.0 112.48 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -71.32 107.12 4.13 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 172.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 70.5 mt -73.43 146.42 45.04 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.812 -172.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -87.95 138.45 31.44 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.776 176.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 19.3 p -127.94 132.3 49.25 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 120.825 0.345 . . . . 0.0 110.218 176.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.406 ' CE2' ' HB ' ' A' ' 48' ' ' ILE . 14.7 p90 -119.21 144.64 46.61 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.758 -178.557 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 43.7 t -93.72 105.14 16.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.279 -0.419 . . . . 0.0 109.951 179.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.406 ' HB ' ' CE2' ' A' ' 46' ' ' TYR . 12.1 tt -105.77 130.6 56.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.061 179.06 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.414 ' HG2' ' HG2' ' A' ' 72' ' ' LYS . 45.4 mt-10 . . . . . 0 C--N 1.32 -0.711 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 177.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.414 ' HG2' ' HG2' ' A' ' 49' ' ' GLU . 68.3 mttm . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.801 0.334 . . . . 0.0 110.556 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 56.8 mt -110.08 117.06 53.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.426 179.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.422 ' O ' ' HB3' ' A' ' 90' ' ' TYR . 52.9 tttm -87.44 91.77 8.85 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.554 179.06 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -92.04 160.96 14.98 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.08 -176.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 13.5 p -114.9 144.19 23.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.209 -173.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.413 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 37.6 p90 -154.99 162.7 41.01 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.729 176.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -137.1 150.18 47.84 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 170.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 54.9 tt0 -120.49 135.67 55.0 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.479 -173.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 73.0 p -94.8 -176.97 4.03 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.338 177.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.8 mp -65.05 -13.73 58.69 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.279 0.561 . . . . 0.0 110.727 179.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.426 ' O ' ' HB2' ' A' ' 83' ' ' ASN . 4.8 m-20 -79.22 -8.82 59.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.59 -179.548 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . 0.426 ' HB2' ' O ' ' A' ' 82' ' ' ASP . 14.3 m120 69.58 16.73 8.04 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.4 0.619 . . . . 0.0 110.252 -174.357 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 66.1 t -89.57 122.03 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.383 176.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -100.33 116.51 32.47 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.719 -176.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.453 ' HA ' ' O ' ' A' ' 24' ' ' ILE . 59.1 t -86.31 104.72 14.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.552 176.482 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 22.0 t -101.65 142.65 15.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.607 -174.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 58.2 m -151.15 157.09 42.26 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 177.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -71.09 121.02 17.51 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.093 0.473 . . . . 0.0 110.409 -178.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.422 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 12.2 t80 -75.72 -27.5 58.19 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.981 -174.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 33.0 t -70.02 -43.66 70.87 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -64.25 -42.32 96.57 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.357 175.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -62.79 -46.6 87.23 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.856 -179.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -65.7 -29.61 70.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.011 178.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -63.83 -33.47 75.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.076 0.465 . . . . 0.0 110.302 176.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.493 ' HA ' ' HD2' ' A' ' 99' ' ' LYS . 68.0 mt -75.02 -39.89 44.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.381 176.405 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 84.2 mt -65.07 -30.52 71.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.172 0.51 . . . . 0.0 110.138 176.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 44.9 tttm -67.41 -37.29 82.85 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.421 175.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.493 ' HD2' ' HA ' ' A' ' 96' ' ' ILE . 60.3 mttm -64.44 -47.54 78.68 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.356 175.449 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 52.8 ttt-85 -68.64 -38.39 80.46 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.963 -177.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.686 0 N-CA-C 111.251 -0.74 . . . . 0.0 111.251 -176.456 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 . . . . . 0 C--O 1.233 0.191 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 36.9 t -68.68 -27.7 66.2 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 175.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -58.05 -36.94 73.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.165 173.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 98.3 t -68.54 -42.85 83.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.458 178.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 62.9 mt -60.81 -45.31 98.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.981 177.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 45.9 mttp -56.51 -52.61 64.09 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.575 175.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -58.12 -45.16 87.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.105 -178.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -63.67 -45.66 89.1 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.34 -178.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 83.9 mt -71.04 -34.6 71.43 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.636 -0.256 . . . . 0.0 111.282 -177.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 43.1 mm-40 -69.74 -33.55 72.61 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.046 0.451 . . . . 0.0 110.418 175.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -63.37 -52.33 62.16 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.556 178.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 39.5 pt -77.97 -17.46 13.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.55 -177.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 76.99 60.43 2.91 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.074 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -112.5 158.87 19.38 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 -178.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -71.15 117.61 12.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.08 0.467 . . . . 0.0 110.82 179.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -116.09 121.07 41.08 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.269 -176.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 61.1 mt -120.82 107.24 20.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.758 0.313 . . . . 0.0 110.776 -179.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -125.8 125.04 42.28 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.04 0.448 . . . . 0.0 110.064 175.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 97.3 mt -95.16 46.49 1.12 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.875 178.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 66.62 94.79 0.06 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.569 -177.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 13.6 m120 73.18 -8.25 1.35 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.844 179.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 32.2 tp10 -112.76 113.78 26.04 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 175.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.583 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 55.0 mt -107.19 133.48 51.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 110.335 -0.246 . . . . 0.0 110.335 -177.144 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -125.27 105.45 9.13 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 173.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 37.1 mt -95.26 -179.81 4.92 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.774 0.797 . . . . 0.0 113.026 -168.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -87.53 132.83 39.63 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 114.389 -1.278 . . . . 0.0 109.942 -179.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 99.8 Cg_exo -42.56 -70.42 0.07 OUTLIER 'Trans proline' 0 CA--C 1.532 0.421 0 C-N-CA 123.948 3.099 . . . . 0.0 114.811 -172.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.41 ' HA ' HD13 ' A' ' 96' ' ' ILE . 41.4 mt-10 -75.64 -3.15 32.86 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -172.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 98.5 t -90.02 -44.64 15.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 175.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -58.98 -34.66 72.07 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.609 177.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 67.5 t80 -54.14 -40.97 67.9 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.397 178.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -83.36 -29.02 28.55 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.116 -178.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 66.9 t -66.42 -36.79 78.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.375 0.607 . . . . 0.0 109.486 174.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 33.5 t90 -56.46 -52.97 62.69 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.557 175.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.791 ' HA ' ' HB3' ' A' ' 40' ' ' GLU . 53.5 mttm -66.84 -30.39 70.56 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.631 -0.258 . . . . 0.0 111.201 178.113 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -59.58 -40.71 88.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.367 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 19.4 m -88.32 7.67 3.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.924 -175.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.417 ' O ' ' HG2' ' A' ' 40' ' ' GLU . . . 109.33 0.31 31.18 Favored Glycine 0 N--CA 1.453 -0.197 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.977 176.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.791 ' HB3' ' HA ' ' A' ' 36' ' ' LYS . 10.8 pt-20 44.8 69.46 2.5 Favored Pre-proline 0 N--CA 1.473 0.69 0 C-N-CA 124.267 1.027 . . . . 0.0 113.009 -179.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -94.04 -179.19 0.74 Allowed 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 123.096 2.53 . . . . 0.0 112.095 176.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -71.29 114.76 9.69 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.046 0.451 . . . . 0.0 110.691 176.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 68.5 mt -77.82 164.29 25.33 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.62 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 52.4 tttp -106.67 122.83 47.13 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.07 -176.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . 0.413 ' OG1' ' HE2' ' A' ' 74' ' ' LYS . 39.9 p -102.66 148.67 25.28 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.673 -0.24 . . . . 0.0 111.489 -177.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -130.63 145.29 51.87 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 176.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 60.1 t -104.85 113.64 42.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 120.832 0.348 . . . . 0.0 110.572 -179.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 10.8 tt -111.05 112.75 41.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.371 0.605 . . . . 0.0 110.398 177.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.877 ' HG2' ' HG2' ' A' ' 72' ' ' LYS . 50.4 mt-10 . . . . . 0 C--N 1.322 -0.599 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.258 179.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.877 ' HG2' ' HG2' ' A' ' 49' ' ' GLU . 79.4 mttt . . . . . 0 N--CA 1.453 -0.289 0 CA-C-O 120.987 0.423 . . . . 0.0 110.352 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 57.0 mt -92.71 115.09 30.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.054 -179.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.594 ' O ' ' HB3' ' A' ' 90' ' ' TYR . 82.2 tttt -98.9 114.71 27.44 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.247 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -111.83 166.99 10.72 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 13.9 p -125.83 143.48 39.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 120.733 0.301 . . . . 0.0 111.074 -172.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 28.9 p90 -155.0 173.8 16.06 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.934 0.397 . . . . 0.0 110.941 178.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -145.1 151.44 38.51 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 170.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -102.07 128.97 48.3 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.843 0.354 . . . . 0.0 110.23 -176.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.4 p -84.09 173.59 10.98 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.201 179.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.412 HD12 ' N ' ' A' ' 81' ' ' LEU . 7.0 mp -68.33 -17.74 64.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.068 0.461 . . . . 0.0 111.36 -176.213 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -95.62 14.95 21.29 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.213 -179.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 70.44 23.68 4.82 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.143 173.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 59.3 t -100.14 141.93 16.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 120.962 0.41 . . . . 0.0 110.562 178.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 8.2 mtp180 -98.0 117.08 31.54 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.229 -178.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.583 ' HA ' ' HB ' ' A' ' 24' ' ' ILE . 20.5 t -96.89 97.1 5.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 176.627 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 31.8 t -103.7 144.4 14.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.079 0.466 . . . . 0.0 111.656 -172.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 51.1 m -151.98 159.6 43.71 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 175.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -73.04 131.86 42.65 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 121.734 -0.604 . . . . 0.0 110.986 -176.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.594 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 88.9 t80 -73.93 -30.34 62.5 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.389 -176.725 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.25 -44.77 71.26 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.528 ' O ' ' HB3' ' A' ' 95' ' ' LYS . 5.3 tp10 -70.43 -34.66 72.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.233 179.301 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.414 ' O ' HD23 ' A' ' 97' ' ' LEU . 83.4 t80 -62.34 -51.5 67.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.325 176.588 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 72.5 mm-40 -64.31 -29.73 70.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.825 179.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.528 ' HB3' ' O ' ' A' ' 92' ' ' GLU . 23.4 tptm -55.72 -46.99 77.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.321 174.621 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.41 HD13 ' HA ' ' A' ' 29' ' ' GLU . 57.7 mt -68.84 -39.5 80.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.112 -179.052 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.414 HD23 ' O ' ' A' ' 93' ' ' PHE . 4.3 mm? -58.59 -45.25 89.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.788 178.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -74.27 -30.38 62.09 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.507 178.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -59.33 -45.35 91.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.908 -176.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 100' ' ' ARG . 21.3 ttp85 -104.35 -8.13 19.45 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.107 -179.127 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.261 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.111 179.046 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 . . . . . 0 C--O 1.235 0.327 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.579 ' O ' ' HG3' ' A' ' 7' ' ' LYS . 30.1 p -56.89 -31.69 65.12 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.764 0.316 . . . . 0.0 110.693 177.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -56.7 -52.62 64.24 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.975 175.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.1 t -60.42 -43.25 93.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.683 -179.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.45 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 67.1 mt -53.12 -45.33 53.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.88 174.68 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.579 ' HG3' ' O ' ' A' ' 3' ' ' SER . 91.6 mttt -62.48 -41.6 98.9 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.97 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -58.7 -42.69 89.21 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.993 0.425 . . . . 0.0 110.62 177.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -65.28 -43.83 89.97 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.412 179.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.509 HD13 ' HB3' ' A' ' 17' ' ' TYR . 85.4 mt -65.26 -39.3 92.46 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.996 179.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -67.26 -40.53 86.25 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.428 178.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -60.04 -43.38 95.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.795 177.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 62.5 mt -70.29 -41.35 78.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.544 177.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.74 35.76 5.02 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.99 -0.624 . . . . 0.0 111.784 -178.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -104.53 177.27 4.89 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.071 0.463 . . . . 0.0 111.245 -178.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -109.65 149.97 28.93 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.966 -178.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.509 ' HB3' HD13 ' A' ' 10' ' ' LEU . 34.1 p90 -144.84 144.52 31.17 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 176.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 67.3 mt -113.01 102.86 14.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 120.895 0.378 . . . . 0.0 110.103 178.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -92.2 133.22 36.0 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.275 0.559 . . . . 0.0 110.861 -178.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 88.9 mt -121.44 -162.24 0.96 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.788 177.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -71.62 102.06 2.66 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.892 -0.323 . . . . 0.0 110.399 177.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 67.3 20.48 10.04 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.33 177.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -136.77 138.86 41.35 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.287 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.44 HD11 ' HB2' ' A' ' 3' ' ' SER . 60.2 mt -122.86 113.01 36.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 170.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.51 ' HA ' ' O ' ' A' ' 87' ' ' VAL . 16.3 m-70 -95.87 123.72 39.57 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.251 -179.355 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 92.5 mt -114.98 177.55 4.61 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.345 -175.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.436 ' HB2' HG23 ' A' ' 30' ' ' VAL . 86.8 mttt -86.95 137.9 33.13 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 115.364 -0.835 . . . . 0.0 108.934 174.242 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.453 ' HA ' HG21 ' A' ' 88' ' ' THR . 57.6 Cg_exo -52.4 -38.05 73.12 Favored 'Trans proline' 0 CA--C 1.529 0.26 0 C-N-CA 122.92 2.414 . . . . 0.0 113.113 -177.218 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -73.6 -29.67 62.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.04 -177.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.436 HG23 ' HB2' ' A' ' 27' ' ' LYS . 27.0 t -84.54 -38.37 13.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.233 0.54 . . . . 0.0 110.134 179.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -57.63 -30.43 65.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.826 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -54.35 -45.95 72.85 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.271 178.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -82.05 -29.4 31.93 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.274 -177.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 79.5 t -67.8 -41.31 85.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.21 0.529 . . . . 0.0 109.977 176.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.483 ' CD1' ' HD2' ' A' ' 41' ' ' PRO . 29.2 t90 -57.14 -45.29 83.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.342 176.121 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 56.8 mttm -76.23 -21.53 56.27 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.461 179.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -65.97 -35.64 81.15 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.998 0.428 . . . . 0.0 110.381 178.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.535 HG23 ' HD3' ' A' ' 41' ' ' PRO . 26.9 m -93.68 12.39 3.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.316 179.559 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 87.01 29.33 23.34 Favored Glycine 0 C--N 1.33 0.237 0 C-N-CA 121.055 -0.593 . . . . 0.0 113.481 174.183 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 36.42 75.21 0.53 Allowed Pre-proline 0 N--CA 1.473 0.701 0 C-N-CA 124.07 0.948 . . . . 0.0 113.218 179.082 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.535 ' HD3' HG23 ' A' ' 38' ' ' VAL . 82.1 Cg_endo -89.01 -159.32 0.09 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 123.307 2.671 . . . . 0.0 112.617 -178.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -70.18 123.74 22.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.684 -178.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 74.7 mt -89.07 117.54 28.15 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.239 175.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -95.66 119.47 34.23 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.227 -178.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.6 p -107.2 134.73 49.87 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.614 179.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' TYR . . . . . 0.518 ' CE1' ' HB2' ' A' ' 75' ' ' LYS . 15.1 p90 -128.29 140.45 51.87 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.329 -0.396 . . . . 0.0 109.975 178.492 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 61.7 t -99.18 110.55 26.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.584 -179.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.446 HG23 ' HB ' ' A' ' 73' ' ' ILE . 7.4 tt -106.86 106.68 21.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.645 175.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.436 ' HA ' ' HA ' ' A' ' 72' ' ' LYS . 39.6 tt0 . . . . . 0 C--N 1.322 -0.593 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.121 -179.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.436 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 61.6 mttp . . . . . 0 C--O 1.232 0.155 0 CA-C-O 120.768 0.318 . . . . 0.0 110.31 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.446 ' HB ' HG23 ' A' ' 48' ' ' ILE . 40.3 mt -91.19 108.59 20.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.254 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 54.1 tttp -91.57 106.18 18.3 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.56 178.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . 0.518 ' HB2' ' CE1' ' A' ' 46' ' ' TYR . 89.9 mttt -105.49 162.23 13.65 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.158 -178.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 10.7 p -124.19 142.42 41.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.605 0.24 . . . . 0.0 110.574 -178.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.445 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 43.5 p90 -153.6 167.8 28.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.095 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 44.1 p90 -136.49 151.11 49.1 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 168.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -102.48 131.6 49.07 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.01 0.433 . . . . 0.0 111.466 -174.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 75.0 p -83.97 -172.66 4.28 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.003 179.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 8.5 mp -73.81 -33.61 64.25 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.949 0.404 . . . . 0.0 110.424 178.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -92.16 24.57 3.26 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.369 -177.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 20.8 m120 69.81 20.76 6.67 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 169.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 86.1 t -94.41 124.42 46.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.595 179.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 51.9 mtt-85 -89.52 110.93 21.72 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.707 179.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 45.9 t -81.35 99.5 4.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 175.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.51 ' O ' ' HA ' ' A' ' 25' ' ' HIS . 22.2 t -102.57 138.88 25.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.879 -172.297 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' THR . . . . . 0.453 HG21 ' HA ' ' A' ' 28' ' ' PRO . 42.8 m -144.76 157.59 44.12 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 177.022 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ASP . . . . . 0.47 ' OD2' ' HG2' ' A' ' 92' ' ' GLU . 9.5 t70 -66.88 122.46 17.76 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.155 0.503 . . . . 0.0 111.57 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -69.28 -30.23 68.28 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.845 -177.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 35.1 t -62.84 -66.38 0.55 Allowed 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.077 -176.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLU . . . . . 0.47 ' HG2' ' OD2' ' A' ' 89' ' ' ASP . 12.3 mm-40 -68.66 -28.96 67.34 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 121.042 -0.263 . . . . 0.0 111.323 -175.48 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' PHE . . . . . 0.432 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 53.0 t80 -62.09 -47.4 84.82 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 121.079 -0.248 . . . . 0.0 110.872 178.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -64.14 -35.52 81.06 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.779 0.323 . . . . 0.0 110.838 179.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -61.39 -43.72 98.38 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.515 177.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.407 HG13 ' O ' ' A' ' 92' ' ' GLU . 78.9 mt -66.79 -36.77 78.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.033 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 93' ' ' PHE . 97.8 mt -59.42 -49.95 75.85 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.943 0.401 . . . . 0.0 110.117 175.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 7.6 mtpm? -63.89 -42.61 97.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.602 177.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 7.6 tmtm? -59.76 -54.17 49.41 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.953 -177.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 100' ' ' ARG . 49.4 mtt180 -82.65 -6.41 59.35 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.349 -175.285 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 0.173 0 C-N-CA 120.967 -0.635 . . . . 0.0 113.409 172.322 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.965 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -91.72 166.13 12.94 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.006 174.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.6 m -63.93 -28.01 69.53 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.239 0.542 . . . . 0.0 110.36 178.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -62.71 -33.1 74.41 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.263 -0.881 . . . . 0.0 110.192 178.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 88.7 t -66.9 -39.42 83.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.164 177.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.472 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 64.0 mt -63.43 -39.9 87.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.422 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -64.2 -40.24 95.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.755 179.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 28.4 mm-40 -68.1 -36.85 80.45 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.7 177.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -62.14 -43.52 98.65 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.255 176.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' A' ' 6' ' ' ILE . 94.0 mt -65.26 -32.4 74.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.662 177.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -62.92 -47.35 83.64 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.36 177.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -64.02 -52.37 59.82 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.16 -178.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 40.1 pt -67.5 -27.46 38.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.243 -177.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 91.62 58.21 1.45 Allowed Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.503 178.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.452 ' HG2' HG21 ' A' ' 30' ' ' VAL . 8.4 tp10 -136.36 148.22 47.75 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 110.249 -0.278 . . . . 0.0 110.249 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -95.92 139.93 31.42 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.682 -179.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.464 ' HB3' HD13 ' A' ' 10' ' ' LEU . 52.6 p90 -112.34 142.39 44.91 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.863 0.363 . . . . 0.0 110.49 176.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 62.1 mt -101.65 96.59 4.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 176.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.406 ' HA ' ' O ' ' A' ' 23' ' ' GLU . 39.9 tt0 -97.28 121.88 39.67 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.374 0.607 . . . . 0.0 110.813 -178.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 96.3 mt -109.22 34.01 3.98 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.334 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 69.8 101.12 0.06 Allowed 'General case' 0 C--O 1.233 0.226 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.268 -177.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 7.7 m120 68.74 3.64 4.01 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.659 -0.701 . . . . 0.0 112.019 -177.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.406 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 12.9 mt-10 -129.32 113.9 15.55 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 110.406 -0.22 . . . . 0.0 110.406 172.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.405 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 67.6 mt -105.95 102.65 14.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 175.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 42.7 m-70 -87.81 120.99 29.68 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 59.9 mt -117.89 172.14 7.59 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.483 0.659 . . . . 0.0 111.634 -175.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 89.8 mttt -80.19 136.17 53.73 Favored Pre-proline 0 C--N 1.321 -0.657 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.402 176.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.83 ' HG2' ' HG2' ' A' ' 92' ' ' GLU . 88.2 Cg_exo -49.01 -43.81 34.66 Favored 'Trans proline' 0 N--CA 1.474 0.367 0 C-N-CA 123.536 2.824 . . . . 0.0 114.073 -175.146 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -67.71 -36.66 81.02 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.784 0.326 . . . . 0.0 110.988 -179.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.452 HG21 ' HG2' ' A' ' 15' ' ' GLU . 41.2 t -68.96 -43.86 81.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.087 0.47 . . . . 0.0 109.881 176.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -55.87 -45.62 78.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.082 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 78.4 t80 -57.7 -39.45 77.2 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.28 -178.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -76.78 -42.29 41.31 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.032 -178.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 89.4 t -65.6 -37.16 79.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.791 0.329 . . . . 0.0 110.516 178.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 26.1 t90 -54.19 -53.92 46.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.665 177.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.507 ' HA ' ' HB3' ' A' ' 40' ' ' GLU . 65.9 mttm -71.88 -26.46 62.35 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 121.158 -0.217 . . . . 0.0 111.246 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 77.1 t80 -63.36 -38.59 91.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.733 0.301 . . . . 0.0 110.975 179.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 29.0 m -88.39 10.42 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.827 0.346 . . . . 0.0 111.755 -177.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 99.86 8.18 51.83 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.934 176.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.507 ' HB3' ' HA ' ' A' ' 36' ' ' LYS . 19.1 pt-20 40.69 81.36 0.25 Allowed Pre-proline 0 N--CA 1.473 0.708 0 C-N-CA 124.335 1.054 . . . . 0.0 113.315 178.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -88.08 -168.68 0.39 Allowed 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.008 2.472 . . . . 0.0 111.842 175.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -75.85 136.4 40.17 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.008 0.432 . . . . 0.0 110.717 179.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 97.2 mt -97.08 146.66 24.81 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.71 -179.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 61.1 tttm -111.5 118.39 35.62 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.009 -0.541 . . . . 0.0 109.62 -179.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 37.2 p -105.19 141.94 35.84 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.178 -176.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 21.2 p90 -130.05 151.37 50.67 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.77 0.319 . . . . 0.0 110.273 177.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.544 HG22 ' HG3' ' A' ' 74' ' ' LYS . 42.5 t -107.23 129.86 60.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.632 177.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 6.4 tt -125.92 111.88 28.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 121.239 0.542 . . . . 0.0 110.543 177.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.593 ' HA ' ' HA ' ' A' ' 72' ' ' LYS . 1.6 mp0 -81.37 97.67 7.83 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.021 177.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -106.68 115.8 30.82 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.796 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.7 ' HG2' ' HA ' ' A' ' 70' ' ' LYS . 36.7 mt-10 -88.99 131.99 34.93 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.014 0.435 . . . . 0.0 110.921 -176.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 9.6 tt -86.46 125.55 40.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.498 175.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.62 ' HA ' HG12 ' A' ' 68' ' ' VAL . 9.1 p -90.75 164.28 2.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.602 -175.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -87.35 133.49 38.38 Favored Pre-proline 0 N--CA 1.449 -0.482 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.24 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -69.24 -67.39 0.03 OUTLIER 'Trans proline' 0 CA--C 1.531 0.359 0 C-N-CA 122.426 2.084 . . . . 0.0 112.472 178.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 164.4 43.56 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.436 0 N-CA-C 111.086 -0.805 . . . . 0.0 111.086 -178.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -61.08 112.61 2.16 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -173.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 47.2 m-85 -94.82 84.84 4.27 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.385 0.612 . . . . 0.0 110.051 174.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.676 ' H ' ' HD2' ' A' ' 60' ' ' PRO . 25.2 t70 -141.12 -52.89 0.02 OUTLIER Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 114.945 -1.025 . . . . 0.0 109.778 178.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.676 ' HD2' ' H ' ' A' ' 59' ' ' ASP . 73.5 Cg_endo -78.16 140.02 17.4 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 121.541 1.494 . . . . 0.0 111.292 171.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 60' ' ' PRO . 32.4 Cg_exo -58.79 147.94 85.91 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 122.492 2.128 . . . . 0.0 111.925 178.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -69.61 87.43 0.49 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.359 0.6 . . . . 0.0 110.89 -179.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 55.9 ttm -164.24 -45.6 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 178.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 36.7 mttp -79.22 154.02 29.54 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.321 168.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -120.72 115.3 23.06 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 121.051 -0.259 . . . . 0.0 110.46 -172.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.01 151.36 26.56 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.585 177.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 27.6 p-10 -123.31 144.74 49.23 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.078 0.466 . . . . 0.0 111.362 -176.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.62 HG12 ' HA ' ' A' ' 53' ' ' VAL . 27.4 m -80.56 152.7 4.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 173.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -116.66 132.9 56.57 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.222 0.534 . . . . 0.0 111.099 -177.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.7 ' HA ' ' HG2' ' A' ' 51' ' ' GLU . 85.4 tttt -90.51 102.28 15.02 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.344 -0.844 . . . . 0.0 110.656 -174.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 39.2 t -92.5 100.07 10.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.544 -179.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.593 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 20.5 pttp -88.27 99.03 11.92 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 176.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 13.9 tt -105.79 137.12 37.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-O 121.276 0.56 . . . . 0.0 110.945 -175.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.592 ' O ' ' HB3' ' A' ' 90' ' ' TYR . 28.7 tttm -95.52 125.82 40.38 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.07 178.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -125.03 158.66 33.17 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.701 0.286 . . . . 0.0 110.281 178.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 11.1 p -121.94 146.75 26.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.617 -175.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.409 ' CE1' ' HD2' ' A' ' 85' ' ' ARG . 48.7 p90 -152.67 164.53 37.55 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.81 0.338 . . . . 0.0 110.393 175.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -132.54 147.9 52.37 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 170.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.529 ' HG2' ' HG2' ' A' ' 85' ' ' ARG . 45.3 mt-10 -104.27 132.14 50.84 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.947 0.403 . . . . 0.0 110.91 -176.289 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 49.5 p -85.14 -175.65 5.83 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.164 -179.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 7.9 mp -66.86 -20.79 65.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.388 177.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.44 ' HB2' HG23 ' A' ' 84' ' ' VAL . 9.3 m-20 -92.08 6.58 45.92 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.287 -178.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 36.7 m-80 64.94 23.15 12.56 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.957 -177.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.44 HG23 ' HB2' ' A' ' 82' ' ' ASP . 79.3 t -87.87 126.51 41.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 176.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.529 ' HG2' ' HG2' ' A' ' 79' ' ' GLU . 31.1 mtm180 -96.74 111.09 23.4 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.446 -175.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 24' ' ' ILE . 59.7 t -83.43 103.33 10.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 175.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.4 t -99.21 144.08 12.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.002 -172.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.519 HG21 ' HA ' ' A' ' 28' ' ' PRO . 51.5 m -151.39 148.94 28.72 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.735 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -57.56 112.44 1.43 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.055 178.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.592 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 70.9 t80 -71.96 -30.12 64.97 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.09 0.471 . . . . 0.0 110.25 -179.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.3 p -60.95 -47.28 87.15 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.574 175.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.83 ' HG2' ' HG2' ' A' ' 28' ' ' PRO . 15.1 tp10 -72.17 -36.03 69.17 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.147 178.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.46 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 58.3 t80 -60.49 -52.59 64.54 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.068 -179.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 47.8 mt-30 -64.84 -31.71 73.07 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.777 0.322 . . . . 0.0 110.876 177.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.45 ' HB3' ' O ' ' A' ' 92' ' ' GLU . 76.8 tttt -59.42 -41.71 90.14 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.504 175.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.43 HG13 ' O ' ' A' ' 92' ' ' GLU . 73.1 mt -72.2 -37.11 58.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.499 176.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' A' ' 93' ' ' PHE . 86.5 mt -59.14 -48.96 79.7 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.62 177.016 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -65.3 -29.4 70.15 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.788 178.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 65.7 tttm -68.58 -52.05 35.92 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.795 -178.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 100' ' ' ARG . 56.8 mtt180 -82.64 -10.36 58.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.224 -179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 74.3 33.65 56.21 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.021 -179.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 38.8 m -78.16 101.29 6.97 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.854 -0.425 . . . . 0.0 109.854 177.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 53.2 tttm -83.94 122.12 28.31 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.256 -178.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 88.2 mt -85.05 113.16 21.26 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.929 0.395 . . . . 0.0 110.579 -179.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -66.08 154.99 38.09 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.765 178.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 20.3 m170 -74.57 -28.86 61.12 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.674 179.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 4.0 t60 -124.44 112.32 16.77 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 171.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 25.8 m170 -77.75 146.61 35.8 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.546 -177.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 34.9 m170 -81.07 38.19 0.46 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.857 -178.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -138.11 16.64 2.81 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.042 0.449 . . . . 0.0 110.183 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 19.4 t60 . . . . . 0 C--O 1.251 1.162 0 CA-C-N 115.921 -0.582 . . . . 0.0 109.972 -177.428 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.961 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -125.83 -179.92 4.89 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 173.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.2 m -60.06 -37.13 78.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.0 0.429 . . . . 0.0 111.241 -176.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -64.51 -35.99 82.74 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.577 -178.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 77.5 t -64.36 -40.57 89.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.347 177.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.554 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 65.9 mt -62.49 -46.4 96.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.216 177.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.409 ' O ' ' HG3' ' A' ' 11' ' ' GLU . 98.9 mttt -56.4 -49.23 75.11 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.622 178.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -57.92 -45.79 85.99 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.274 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 93.0 t80 -58.76 -40.67 84.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.352 178.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.554 ' HG ' ' O ' ' A' ' 6' ' ' ILE . 77.0 mt -66.48 -43.41 85.48 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.891 179.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.409 ' HG3' ' O ' ' A' ' 7' ' ' LYS . 52.4 mt-10 -62.46 -34.62 77.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.923 0.392 . . . . 0.0 110.624 178.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -66.16 -50.52 63.64 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.353 178.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 38.4 pt -75.98 -6.65 9.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.66 -177.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 86.73 24.19 39.58 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.614 175.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -89.91 154.16 20.07 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.837 0.351 . . . . 0.0 110.503 -177.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -103.36 122.87 45.72 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.136 177.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.539 ' HB3' HD13 ' A' ' 10' ' ' LEU . 39.8 p90 -115.25 133.24 56.22 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.029 176.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.551 ' HB ' ' HB2' ' A' ' 25' ' ' HIS . 44.0 mt -106.95 91.91 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 176.706 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.686 ' HA ' ' O ' ' A' ' 23' ' ' GLU . 1.0 OUTLIER -98.12 106.84 19.2 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.626 -179.081 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 97.0 mt -125.54 122.4 36.44 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.858 -178.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.47 ' O ' ' HB2' ' A' ' 22' ' ' ASN . 36.6 mt-10 58.43 36.64 25.51 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 123.577 0.548 . . . . 0.0 111.173 175.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.47 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 0.9 OUTLIER 73.92 25.71 1.87 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.08 -179.833 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.686 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 55.8 mt-10 -115.07 113.73 24.43 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.17 171.317 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.49 HG22 ' HG ' ' A' ' 26' ' ' LEU . 60.2 mt -91.55 101.62 12.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 177.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.551 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 12.3 m170 -87.29 121.95 30.41 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 179.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.49 ' HG ' HG22 ' A' ' 24' ' ' ILE . 63.6 mt -130.03 -174.83 3.43 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.243 0.544 . . . . 0.0 111.955 -175.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -92.02 144.7 29.59 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.091 177.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.523 ' HA ' HG21 ' A' ' 88' ' ' THR . 78.0 Cg_exo -50.19 -46.8 26.8 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 123.479 2.786 . . . . 0.0 113.911 -176.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -67.39 -36.52 81.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.791 0.329 . . . . 0.0 110.837 -177.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.407 ' O ' HG23 ' A' ' 34' ' ' VAL . 48.4 t -68.46 -41.56 83.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.09 179.046 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -56.01 -42.07 75.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.373 177.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 79.7 t80 -60.78 -44.99 96.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.351 179.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -68.64 -42.37 78.12 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.177 -179.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 30' ' ' VAL . 93.5 t -64.9 -36.99 79.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.814 0.34 . . . . 0.0 110.16 177.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.52 ' CD1' ' HD2' ' A' ' 41' ' ' PRO . 27.6 t90 -52.8 -50.88 62.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.563 176.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -70.71 -34.84 72.36 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.322 178.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -57.97 -43.59 86.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.731 0.3 . . . . 0.0 111.29 179.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.534 HG23 ' HD3' ' A' ' 41' ' ' PRO . 27.6 m -82.35 14.43 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -175.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 101.89 1.96 52.19 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.743 175.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 57.22 70.45 1.35 Allowed Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.19 0.519 . . . . 0.0 110.869 179.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.534 ' HD3' HG23 ' A' ' 38' ' ' VAL . 87.4 Cg_endo -88.28 -162.74 0.14 Allowed 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.967 2.445 . . . . 0.0 112.215 -179.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -88.11 145.12 26.11 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.247 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 96.0 mt -93.7 157.24 16.26 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.573 -175.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -125.3 148.3 48.76 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.184 176.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 11.6 p -141.15 153.13 45.22 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.797 0.332 . . . . 0.0 111.557 -175.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 16.8 p90 -145.04 148.86 34.17 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.203 -0.453 . . . . 0.0 109.839 176.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.43 ' HA ' ' HA ' ' A' ' 74' ' ' LYS . 45.7 t -102.03 122.28 54.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 179.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 17.5 tt -109.61 150.32 12.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.394 -178.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -87.74 96.19 10.35 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.359 -175.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -92.93 104.22 16.47 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.666 0.746 . . . . 0.0 109.241 173.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.533 ' HG2' ' HD3' ' A' ' 70' ' ' LYS . 22.9 mt-10 -96.16 113.64 25.27 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.405 -0.816 . . . . 0.0 112.07 -168.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.468 ' HB ' ' O ' ' A' ' 69' ' ' LYS . 51.7 mt -85.71 83.58 2.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 172.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.448 ' O ' ' HD3' ' A' ' 55' ' ' PRO . 19.8 m -91.14 170.36 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.21 179.159 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -87.44 108.83 21.67 Favored Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.448 ' HD3' ' O ' ' A' ' 53' ' ' VAL . 58.9 Cg_endo -90.94 82.48 0.39 Allowed 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 123.17 2.58 . . . . 0.0 112.543 -177.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 164.57 28.84 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.012 179.072 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -125.72 140.64 52.53 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.861 0.362 . . . . 0.0 110.461 -176.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 79.1 t80 -87.29 -30.54 20.79 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 175.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -94.87 139.74 22.26 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.213 178.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -58.0 116.63 3.37 Favored 'Trans proline' 0 C--O 1.236 0.379 0 C-N-CA 122.877 2.385 . . . . 0.0 112.568 -177.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_exo -62.11 -18.92 64.52 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 123.09 2.526 . . . . 0.0 112.07 179.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -53.04 -45.61 68.09 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.714 177.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 63.5 mtt -77.52 -16.4 58.71 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.11 0.481 . . . . 0.0 111.009 -176.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -90.38 -42.49 10.89 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.954 178.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 29.1 t80 52.07 68.89 0.74 Allowed 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.112 178.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 12.8 p -123.54 -61.08 1.42 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.602 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -109.34 11.75 25.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.576 0.227 . . . . 0.0 111.377 -179.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.4 t -75.26 94.18 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.854 0.359 . . . . 0.0 110.266 -178.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.468 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 29.5 tptp -116.7 107.79 15.11 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.201 -176.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.533 ' HD3' ' HG2' ' A' ' 51' ' ' GLU . 83.8 mttt -98.45 123.62 42.7 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.987 0.422 . . . . 0.0 110.688 -178.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 48.3 t -110.49 106.87 21.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.94 -179.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 51.3 mttm -78.03 112.76 15.29 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.021 -177.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 61.5 mt -98.63 125.6 51.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.238 0.542 . . . . 0.0 110.814 -176.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.517 ' O ' ' HB3' ' A' ' 90' ' ' TYR . 86.8 tttt -87.48 122.89 31.79 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.71 177.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -113.01 161.49 16.99 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.425 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.484 ' HB ' ' CD1' ' A' ' 90' ' ' TYR . 13.1 p -118.11 145.39 24.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.521 -0.308 . . . . 0.0 110.962 -175.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.413 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 38.8 p90 -154.94 159.55 40.5 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.909 178.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -133.4 152.29 51.9 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 170.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.548 ' HG2' ' HG2' ' A' ' 85' ' ' ARG . 24.9 mt-10 -104.61 138.82 40.37 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.987 0.423 . . . . 0.0 110.93 -173.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 73.0 p -97.54 -169.28 1.81 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.848 -175.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -69.9 -28.28 65.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.039 -179.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -95.71 19.5 11.14 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.086 -172.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 65.8 17.1 10.75 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.529 -179.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 85.2 t -88.34 137.9 20.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.108 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.548 ' HG2' ' HG2' ' A' ' 79' ' ' GLU . 90.5 mtt180 -107.84 113.87 27.41 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.453 -177.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.413 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 53.2 t -83.54 102.67 9.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 177.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 25' ' ' HIS . 32.5 t -100.38 136.29 32.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.778 -174.098 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.523 HG21 ' HA ' ' A' ' 28' ' ' PRO . 52.3 m -146.98 157.62 43.68 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.07 178.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -67.11 122.88 18.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.337 0.589 . . . . 0.0 111.617 -179.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.517 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 49.2 t80 -78.38 -20.1 51.97 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.691 -178.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.543 ' O ' ' HG3' ' A' ' 95' ' ' LYS . 4.1 m -62.22 -61.1 2.7 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.867 0.365 . . . . 0.0 110.253 179.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -71.17 -29.28 64.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.125 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.524 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 62.9 t80 -58.24 -45.18 88.24 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.875 0.369 . . . . 0.0 110.07 176.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.461 ' NE2' HD12 ' A' ' 97' ' ' LEU . 20.7 mm-40 -61.67 -40.38 94.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.049 176.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.543 ' HG3' ' O ' ' A' ' 91' ' ' SER . 90.3 mttt -65.18 -40.75 94.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.832 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.473 HD12 ' HB2' ' A' ' 28' ' ' PRO . 66.6 mt -71.5 -31.12 41.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.239 -179.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.524 ' HG ' ' O ' ' A' ' 93' ' ' PHE . 53.8 mt -61.7 -42.44 98.94 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.939 0.4 . . . . 0.0 110.419 175.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -73.94 -20.74 60.28 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.17 0.509 . . . . 0.0 110.521 177.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -74.38 -42.74 58.79 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.205 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 67.2 mtt180 -98.75 -4.12 34.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.843 0.354 . . . . 0.0 111.443 -177.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 76.95 60.31 2.95 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.588 177.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 38.6 m -120.58 115.58 23.69 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.874 0.368 . . . . 0.0 110.426 177.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -84.04 168.35 16.01 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.419 178.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 97.6 mt -83.23 -19.49 36.33 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.283 0.563 . . . . 0.0 109.811 176.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -83.6 120.55 26.1 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.575 -0.739 . . . . 0.0 110.936 176.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 74.6 m-70 -83.97 155.27 22.87 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.355 176.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 -72.51 -27.03 62.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.079 0.466 . . . . 0.0 110.436 -179.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 16.7 m-70 -128.53 124.37 35.85 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.346 173.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 46.0 m80 -93.88 159.12 15.32 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.84 179.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 -94.3 9.01 39.81 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.45 0.643 . . . . 0.0 109.73 175.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 35.7 m80 . . . . . 0 C--O 1.246 0.89 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.51 176.689 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.556 ' HA ' HG21 ' A' ' 5' ' ' VAL . 14.9 tmm? . . . . . 0 N--CA 1.479 0.982 0 CA-C-O 121.046 0.45 . . . . 0.0 110.441 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.508 HD22 HD23 ' A' ' 81' ' ' LEU . 0.8 OUTLIER -119.64 -178.52 3.64 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 174.156 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 64.8 p -58.76 -31.2 68.15 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.953 0.406 . . . . 0.0 110.409 176.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.598 ' HA ' ' HD2' ' A' ' 7' ' ' LYS . 35.5 tt0 -62.32 -38.39 89.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.8 178.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.556 HG21 ' HA ' ' A' ' 1' ' ' MET . 93.0 t -65.55 -45.8 91.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.041 0.448 . . . . 0.0 110.046 178.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 59.6 mt -59.62 -41.72 85.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.657 174.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.598 ' HD2' ' HA ' ' A' ' 4' ' ' GLU . 62.9 mttm -50.9 -57.79 7.62 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 120.811 0.339 . . . . 0.0 110.614 175.109 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -56.39 -43.17 78.99 Favored 'General case' 0 C--O 1.223 -0.323 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.963 -179.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.467 ' O ' HG12 ' A' ' 13' ' ' ILE . 70.1 t80 -60.81 -48.96 79.44 Favored 'General case' 0 C--N 1.328 -0.358 0 O-C-N 123.123 0.265 . . . . 0.0 110.935 -178.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 96.7 mt -62.48 -47.85 82.2 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.986 0.422 . . . . 0.0 111.085 -178.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -73.73 -21.74 60.12 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.013 -177.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -75.61 -38.53 58.92 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.858 0.361 . . . . 0.0 110.7 177.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.467 HG12 ' O ' ' A' ' 9' ' ' PHE . 32.1 pt -87.33 -4.82 9.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.875 0.369 . . . . 0.0 110.711 177.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 74.53 43.14 31.03 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.104 -0.569 . . . . 0.0 112.655 175.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 46.7 mm-40 -109.94 151.12 27.5 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.395 0.617 . . . . 0.0 111.742 -179.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -89.26 150.89 22.41 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.006 -178.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 33.0 p90 -145.54 143.3 29.86 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.906 0.384 . . . . 0.0 111.091 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.561 ' HB ' ' HB2' ' A' ' 25' ' ' HIS . 48.9 mm -97.82 92.76 3.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 174.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.405 ' HG3' HG12 ' A' ' 24' ' ' ILE . 33.8 tt0 -91.52 109.49 20.79 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.875 -175.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 69.7 mt -105.04 -170.79 1.81 Allowed 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 175.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -79.69 109.67 14.3 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.089 -0.644 . . . . 0.0 110.258 178.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 60.0 m-80 70.27 18.51 6.81 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 114.946 -1.025 . . . . 0.0 111.41 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.502 ' HG2' ' HB2' ' A' ' 85' ' ' ARG . 37.7 mt-10 -144.55 131.43 20.27 Favored 'General case' 0 C--O 1.222 -0.36 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.07 177.132 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.405 HG12 ' HG3' ' A' ' 19' ' ' GLU . 76.2 mt -125.91 107.84 18.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 173.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.561 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 19.6 m-70 -92.08 127.24 37.48 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 -178.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 87.2 mt -118.34 169.34 9.81 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.453 -174.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 84.9 mttt -70.42 140.43 87.42 Favored Pre-proline 0 C--N 1.327 -0.4 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 173.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_exo -47.6 -48.42 15.66 Favored 'Trans proline' 0 CA--C 1.531 0.342 0 C-N-CA 123.15 2.567 . . . . 0.0 113.592 -176.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -73.81 -31.09 63.08 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.788 0.327 . . . . 0.0 111.051 -175.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.44 ' O ' HG23 ' A' ' 34' ' ' VAL . 56.3 t -73.23 -41.44 58.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 178.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -56.53 -39.63 73.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.265 176.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.554 ' OH ' ' HD3' ' A' ' 100' ' ' ARG . 47.2 t80 -53.97 -44.36 70.71 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.513 178.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 7.6 mm-40 -76.6 -36.26 57.61 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.291 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 30' ' ' VAL . 76.8 t -67.13 -40.02 84.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.006 0.432 . . . . 0.0 110.475 178.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.611 ' CD1' ' HD2' ' A' ' 41' ' ' PRO . 27.8 t90 -56.68 -45.76 81.53 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.259 176.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 25.0 mttm -71.67 -34.75 69.96 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.243 178.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 90.6 t80 -58.26 -43.26 87.79 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.143 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.477 HG23 ' HD3' ' A' ' 41' ' ' PRO . 35.8 m -81.49 13.74 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -177.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 103.75 -0.37 45.53 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.971 174.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 59.99 70.11 1.1 Allowed Pre-proline 0 CA--C 1.536 0.427 0 CA-C-O 121.147 0.498 . . . . 0.0 110.457 -179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.611 ' HD2' ' CD1' ' A' ' 35' ' ' TRP . 66.2 Cg_endo -92.68 -162.47 0.1 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 123.282 2.655 . . . . 0.0 113.259 -177.089 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -58.06 144.75 38.86 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 115.502 -0.772 . . . . 0.0 112.176 -179.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 68.5 mt -105.29 112.01 24.96 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.066 173.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 60.6 mttm -107.72 140.5 40.68 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.5 p -127.87 157.37 40.67 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.706 0.289 . . . . 0.0 111.756 -174.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 38.7 p90 -138.55 136.73 36.35 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 172.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 58.3 t -98.96 122.03 50.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.312 -179.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 13.0 tt -104.3 128.88 57.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 121.191 0.519 . . . . 0.0 110.415 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -85.2 116.88 23.81 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.506 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -114.7 120.68 40.92 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.974 0.416 . . . . 0.0 110.358 -177.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -92.79 118.79 31.47 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.326 -173.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 74.4 mt -78.77 102.09 4.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.578 -0.526 . . . . 0.0 109.578 174.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.516 ' O ' ' HD3' ' A' ' 55' ' ' PRO . 9.3 p -115.11 161.34 13.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 178.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -87.63 107.66 16.47 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-O 120.752 0.311 . . . . 0.0 110.748 -179.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.516 ' HD3' ' O ' ' A' ' 53' ' ' VAL . 73.3 Cg_endo -100.16 70.18 0.05 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.18 0 C-N-CA 123.823 3.015 . . . . 0.0 112.357 178.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -134.94 -36.23 0.23 Allowed Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.317 -179.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -85.58 135.69 33.7 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 175.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -66.07 -36.26 82.73 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.012 -179.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -84.4 112.03 38.61 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.02 178.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.41 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 71.7 Cg_endo -85.64 120.3 2.04 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 122.718 2.279 . . . . 0.0 112.586 -177.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 60' ' ' PRO . 12.1 Cg_exo -70.78 121.16 7.65 Favored 'Trans proline' 0 N--CA 1.459 -0.543 0 C-N-CA 122.641 2.227 . . . . 0.0 111.429 176.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -72.57 -42.88 64.12 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.27 0.557 . . . . 0.0 109.726 179.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 62.6 mtt -75.02 126.56 31.28 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.582 -0.736 . . . . 0.0 109.131 175.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -75.44 88.23 2.62 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.249 0.547 . . . . 0.0 110.377 -177.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 40.0 t80 -57.8 -62.84 1.51 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 114.854 -1.066 . . . . 0.0 110.326 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.2 t -87.98 153.41 21.31 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 175.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -77.66 102.21 6.97 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.87 0.367 . . . . 0.0 110.376 -178.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 21.1 m -62.74 135.71 26.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.772 179.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -97.31 116.7 30.01 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.906 -0.588 . . . . 0.0 109.833 -178.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 99.8 mttt -98.46 126.82 44.15 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 120.866 0.365 . . . . 0.0 110.713 -178.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 23.1 m -102.29 148.44 7.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.773 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 58.2 mttm -113.76 99.94 8.08 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-O 121.156 0.503 . . . . 0.0 110.204 -174.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 71.2 mt -93.77 134.64 30.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.066 -177.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 36.2 ttpt -116.1 107.76 15.33 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.415 0.626 . . . . 0.0 110.961 -174.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 35.9 mmtp -96.4 149.15 22.04 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.982 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.474 ' HB ' ' HB2' ' A' ' 90' ' ' TYR . 9.7 p -114.07 142.84 25.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 109.943 -0.392 . . . . 0.0 109.943 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.546 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 37.5 p90 -151.36 159.03 44.48 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.152 0.501 . . . . 0.0 111.212 -177.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -132.27 147.84 52.42 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 168.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -102.21 137.78 40.02 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.944 0.402 . . . . 0.0 111.02 -174.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 82.8 p -91.48 -175.35 4.19 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.855 178.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.508 HD23 HD22 ' A' ' 2' ' ' ASN . 66.3 tp -60.92 -31.21 70.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.181 0.515 . . . . 0.0 110.356 176.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.618 ' HB2' HG23 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -79.84 -2.03 41.64 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.419 -0.81 . . . . 0.0 110.648 -178.142 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 59.3 m-80 70.87 23.11 4.48 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 123.346 0.658 . . . . 0.0 110.568 -176.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.618 HG23 ' HB2' ' A' ' 82' ' ' ASP . 70.7 t -86.24 126.49 40.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.438 178.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.502 ' HB2' ' HG2' ' A' ' 23' ' ' GLU . 63.4 mtt85 -86.03 110.02 19.21 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.666 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.546 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 49.1 t -82.66 109.05 16.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 171.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.468 HG22 ' HB3' ' A' ' 77' ' ' TYR . 9.6 t -116.79 147.59 20.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.22 0.533 . . . . 0.0 112.418 -167.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 6.0 t -155.76 -176.66 6.07 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 169.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -84.59 128.26 34.5 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 117.971 0.351 . . . . 0.0 110.561 -179.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.474 ' HB2' ' HB ' ' A' ' 76' ' ' VAL . 11.2 t80 -77.46 -22.17 51.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.523 -174.066 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.3 -47.1 52.54 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.919 -0.401 . . . . 0.0 109.919 178.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.422 ' O ' ' HB3' ' A' ' 95' ' ' LYS . 54.8 mm-40 -70.21 -29.65 66.54 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.707 176.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.528 ' HE1' ' HA ' ' A' ' 32' ' ' TYR . 43.0 t80 -69.08 -47.65 64.68 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.662 0.267 . . . . 0.0 110.473 178.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.555 ' O ' ' HG3' ' A' ' 98' ' ' LYS . 43.1 mt-30 -60.95 -34.58 74.97 Favored 'General case' 0 CA--C 1.519 -0.217 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.275 175.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.422 ' HB3' ' O ' ' A' ' 92' ' ' GLU . 42.4 tttt -52.98 -47.09 68.46 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.018 176.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.637 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 78.8 mt -68.94 -37.47 77.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.763 178.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 83.3 mt -65.34 -32.16 73.67 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.67 178.448 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.555 ' HG3' ' O ' ' A' ' 94' ' ' GLN . 96.8 mttt -65.35 -38.78 91.12 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 174.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.637 ' HE3' ' HA ' ' A' ' 96' ' ' ILE . 9.1 mtmp? -69.21 -33.24 73.02 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.716 178.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.554 ' HD3' ' OH ' ' A' ' 32' ' ' TYR . 13.0 ttp180 -71.16 -38.6 72.19 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 120.969 0.414 . . . . 0.0 110.365 175.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 100.56 36.16 4.13 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.937 -0.649 . . . . 0.0 111.742 -178.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 23.5 m -66.9 -28.04 67.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.099 0.476 . . . . 0.0 111.481 -178.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -105.65 26.59 9.35 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.284 0.564 . . . . 0.0 110.339 -178.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 49.3 tp -138.92 86.09 2.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.678 176.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 63.23 -175.51 0.15 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.956 -177.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 40.8 m80 -100.64 79.93 2.14 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.226 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 75.6 t60 -86.08 117.79 25.14 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.133 0.492 . . . . 0.0 110.396 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 11.9 m-70 -90.44 -171.17 2.99 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.369 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 19.0 t-80 -88.22 -9.41 53.08 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 171.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 79.4 m-70 -100.5 -63.07 1.16 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.221 -0.9 . . . . 0.0 109.321 175.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 85.4 t60 . . . . . 0 C--O 1.244 0.807 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.371 177.511 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.482 1.163 0 CA-C-O 120.717 0.294 . . . . 0.0 110.38 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.4 HD22 ' HB2' ' A' ' 82' ' ' ASP . 13.0 m120 -102.29 167.87 9.7 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 173.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.556 ' OG ' ' HB3' ' A' ' 82' ' ' ASP . 3.3 m -65.32 -35.06 79.85 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.797 0.332 . . . . 0.0 110.915 -177.246 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.458 ' O ' ' HG2' ' A' ' 8' ' ' GLU . 34.2 tt0 -58.51 -41.53 85.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.503 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 94.0 t -55.64 -45.2 78.92 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.825 177.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.521 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 64.4 mt -63.0 -43.59 99.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.554 -179.155 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.429 ' HE2' ' OE1' ' A' ' 19' ' ' GLU . 92.5 mttt -61.36 -46.62 89.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.784 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.458 ' HG2' ' O ' ' A' ' 4' ' ' GLU . 52.5 mm-40 -60.58 -48.01 83.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.271 177.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -59.69 -38.18 80.84 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.349 -178.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.521 ' HG ' ' O ' ' A' ' 6' ' ' ILE . 93.5 mt -65.26 -37.9 88.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.842 0.353 . . . . 0.0 110.488 178.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -69.97 -34.01 72.82 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.188 176.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -59.74 -43.61 94.17 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.052 175.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 35.1 pt -85.67 -7.51 10.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.841 0.353 . . . . 0.0 111.33 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 81.38 26.58 51.16 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 121.026 -0.606 . . . . 0.0 113.211 174.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -106.64 143.54 34.59 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.875 0.369 . . . . 0.0 110.408 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -102.29 147.92 26.08 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.885 -179.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 13.0 p90 -120.52 154.39 35.38 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.981 0.42 . . . . 0.0 111.672 -174.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 51.6 mt -101.51 96.84 5.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 174.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.429 ' OE1' ' HE2' ' A' ' 7' ' ' LYS . 61.1 tt0 -108.51 137.42 46.5 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.495 0.664 . . . . 0.0 112.02 -173.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 89.7 mt -116.73 -173.56 2.41 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 170.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -61.7 103.5 0.34 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.817 0.342 . . . . 0.0 110.831 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.462 ' HA ' HG22 ' A' ' 84' ' ' VAL . 4.2 m-20 66.94 23.0 9.98 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.725 178.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -134.81 113.95 12.12 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.681 0.277 . . . . 0.0 111.209 176.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.42 ' HB ' HG22 ' A' ' 86' ' ' VAL . 66.0 mt -103.33 109.68 27.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 175.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -92.55 120.31 32.88 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.415 ' HG ' HG22 ' A' ' 24' ' ' ILE . 64.8 mt -124.75 155.47 39.27 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.241 0.543 . . . . 0.0 111.691 -176.269 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 82.1 mttt -65.96 136.47 95.61 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.491 176.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -56.2 -33.46 90.72 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 122.319 2.013 . . . . 0.0 111.588 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -62.09 -43.91 97.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.956 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 45.9 t -81.36 -34.33 13.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 121.187 0.517 . . . . 0.0 110.244 179.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 62.0 t80 -55.64 -39.08 70.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.712 -176.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -58.46 -38.37 77.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.764 0.316 . . . . 0.0 111.113 -178.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -79.67 -34.53 40.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.838 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 95.9 t -64.53 -42.82 96.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.012 0.434 . . . . 0.0 110.024 176.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.518 ' CD1' ' HD2' ' A' ' 41' ' ' PRO . 29.6 t90 -57.6 -41.1 80.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.423 177.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -69.09 -43.61 74.19 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.884 176.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -60.92 -41.0 95.3 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.956 -178.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.516 HG23 ' HD3' ' A' ' 41' ' ' PRO . 35.1 m -76.9 4.42 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 112.308 0.485 . . . . 0.0 112.308 -175.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 105.82 -0.48 39.04 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.543 -0.837 . . . . 0.0 113.089 175.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 59.49 75.12 0.52 Allowed Pre-proline 0 CA--C 1.535 0.382 0 CA-C-O 120.987 0.422 . . . . 0.0 111.228 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.518 ' HD2' ' CD1' ' A' ' 35' ' ' TRP . 90.6 Cg_endo -91.58 -176.68 0.87 Allowed 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.791 2.327 . . . . 0.0 112.109 176.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 57.8 mm-40 -72.29 135.82 46.09 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.014 0.435 . . . . 0.0 110.765 178.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.465 ' HB3' ' CG2' ' A' ' 76' ' ' VAL . 95.2 mt -98.44 138.02 36.27 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.48 179.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -117.23 138.58 51.62 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.951 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 16.2 p -105.2 147.52 27.92 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-O 120.79 0.328 . . . . 0.0 111.443 -176.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.492 ' CE2' ' HB ' ' A' ' 48' ' ' ILE . 10.0 p90 -129.1 156.1 44.4 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 175.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 33.1 t -103.28 105.11 17.69 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.028 0.442 . . . . 0.0 110.945 -176.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.625 HG23 ' HB ' ' A' ' 73' ' ' ILE . 5.8 tt -95.83 101.33 12.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 121.672 0.749 . . . . 0.0 109.443 175.113 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -85.69 93.83 8.94 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.913 -177.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -103.11 135.75 44.19 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.883 -175.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.637 ' HG2' ' HG2' ' A' ' 70' ' ' LYS . 40.3 mt-10 -82.32 110.03 17.11 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.64 -0.254 . . . . 0.0 110.561 -176.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.658 HG23 ' HB3' ' A' ' 69' ' ' LYS . 8.1 pt 36.49 -104.31 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 O-C-N 124.437 1.086 . . . . 0.0 112.688 -174.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.53 ' H ' HG13 ' A' ' 52' ' ' ILE . 2.9 m -148.03 118.35 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 177.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -95.24 102.56 9.84 Favored Pre-proline 0 C--N 1.323 -0.576 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 174.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.505 ' HD3' ' O ' ' A' ' 53' ' ' VAL . 89.0 Cg_endo -92.7 155.48 2.86 Favored 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 122.88 2.387 . . . . 0.0 113.219 -175.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -135.22 3.01 3.99 Favored Glycine 0 N--CA 1.449 -0.454 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 173.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -78.86 -20.81 48.64 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.383 0.611 . . . . 0.0 109.841 176.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -130.32 146.58 51.93 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.481 -0.782 . . . . 0.0 109.317 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.466 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 44.7 m-20 -80.66 114.05 44.82 Favored Pre-proline 0 C--N 1.324 -0.529 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 173.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 59' ' ' ASP . 23.6 Cg_exo -63.56 117.69 4.65 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 122.997 2.465 . . . . 0.0 113.34 -172.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_exo -72.08 103.03 1.43 Allowed 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 122.792 2.328 . . . . 0.0 110.129 172.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -67.24 138.11 56.67 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.556 0.693 . . . . 0.0 112.859 -170.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 59.2 mtt -123.38 152.34 41.64 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 166.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -81.01 2.32 27.5 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 111.959 0.355 . . . . 0.0 111.959 -171.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -134.5 59.15 1.74 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.097 0.475 . . . . 0.0 110.626 176.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 25.7 m -74.81 126.58 31.24 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.653 176.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.423 HD22 ' HA ' ' A' ' 67' ' ' ASN . 11.0 m120 -81.17 117.51 21.78 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.011 0.434 . . . . 0.0 111.596 -174.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.0 m -83.96 76.76 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.904 0.859 . . . . 0.0 110.34 176.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.658 ' HB3' HG23 ' A' ' 52' ' ' ILE . 89.2 tttt -92.27 107.61 19.34 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.872 -177.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.637 ' HG2' ' HG2' ' A' ' 51' ' ' GLU . 54.4 mttm -87.41 120.67 28.94 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.589 -175.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 31.2 t -104.4 115.57 46.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.441 -179.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 57.0 mttm -76.86 93.65 3.78 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 177.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.625 ' HB ' HG23 ' A' ' 48' ' ' ILE . 58.8 mt -91.03 129.44 41.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.301 -178.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -103.32 111.46 23.87 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.237 -178.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.413 ' HB3' ' O ' ' A' ' 88' ' ' THR . 65.6 mttm -114.96 167.15 11.05 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.235 -0.439 . . . . 0.0 109.832 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.465 ' CG2' ' HB3' ' A' ' 43' ' ' LEU . 14.4 p -123.48 147.98 27.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 120.794 0.331 . . . . 0.0 111.241 -172.022 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 51.6 p90 -145.66 163.81 33.72 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.137 178.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.462 ' HB3' HD23 ' A' ' 43' ' ' LEU . 43.1 p90 -128.14 155.42 44.47 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 169.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -102.22 137.07 40.97 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.323 -175.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 69.8 p -90.31 169.08 11.41 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 175.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.3 mp -82.91 18.95 1.47 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.344 0.592 . . . . 0.0 109.638 174.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.556 ' HB3' ' OG ' ' A' ' 3' ' ' SER . 38.9 t70 -126.59 10.55 7.23 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.853 -177.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 66.3 t30 74.14 19.49 2.93 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 115.188 -0.915 . . . . 0.0 112.112 173.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.462 HG22 ' HA ' ' A' ' 22' ' ' ASN . 82.7 t -109.7 137.16 43.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 120.931 0.396 . . . . 0.0 110.413 177.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 84.0 mtt-85 -102.19 126.84 49.28 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.46 -178.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.42 HG22 ' HB ' ' A' ' 24' ' ' ILE . 61.0 t -98.67 113.93 34.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 174.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.8 t -111.02 147.13 15.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.146 -170.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.413 ' O ' ' HB3' ' A' ' 75' ' ' LYS . 4.9 t -152.74 -178.67 7.03 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.233 -0.439 . . . . 0.0 109.854 176.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -86.39 122.05 29.81 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.969 0.414 . . . . 0.0 110.885 -178.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 17.1 t80 -73.65 -23.87 59.91 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.28 -176.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 27.0 m -71.99 -52.34 17.52 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.848 0.356 . . . . 0.0 110.582 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.425 ' O ' ' HB3' ' A' ' 95' ' ' LYS . 10.0 mm-40 -71.26 -27.75 63.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.467 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.441 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 69.1 t80 -65.92 -42.82 89.65 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 175.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -63.3 -35.3 79.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.674 175.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.425 ' HB3' ' O ' ' A' ' 92' ' ' GLU . 3.7 ttmp? -56.49 -44.59 80.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.279 175.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 76.2 mt -69.27 -40.09 79.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.908 179.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 93' ' ' PHE . 99.5 mt -58.73 -50.95 72.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.412 177.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 9.6 mtpm? -70.25 -25.43 63.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.198 -178.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -59.57 -53.3 59.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.569 174.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 39.8 ttt85 -77.41 -38.01 50.64 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.985 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 111.5 17.04 8.93 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.738 -0.744 . . . . 0.0 111.643 -176.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 38.8 m -70.97 134.29 47.07 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.794 0.331 . . . . 0.0 110.394 179.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -126.91 169.87 12.84 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.099 178.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 50.9 tp -79.49 -19.37 49.9 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.231 0.539 . . . . 0.0 110.29 -178.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -73.29 131.26 41.72 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.935 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 81.3 m-70 -110.7 103.94 12.55 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 172.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 64.1 m170 -97.0 134.44 40.37 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.961 0.41 . . . . 0.0 111.635 -172.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 60.1 m80 -139.64 100.99 4.1 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.124 177.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 17.5 m-70 -102.69 148.92 24.99 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.054 177.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 69.0 m80 -112.25 168.18 9.83 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.901 -177.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 33.9 t60 . . . . . 0 C--O 1.247 0.94 0 CA-C-O 118.497 -0.764 . . . . 0.0 109.592 176.659 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.026 0 CA-C-O 120.926 0.393 . . . . 0.0 110.481 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -94.21 178.06 5.76 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 172.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.492 ' O ' ' HG3' ' A' ' 7' ' ' LYS . 89.3 p -62.95 -32.93 74.35 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.73 0.3 . . . . 0.0 111.118 -177.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.452 ' HA ' ' HD2' ' A' ' 7' ' ' LYS . 9.3 tp10 -56.81 -36.36 69.84 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.997 -178.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 66.5 t -64.38 -42.04 94.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.479 178.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.51 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 63.9 mt -63.95 -41.43 92.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.339 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.492 ' HG3' ' O ' ' A' ' 3' ' ' SER . 88.6 mttt -57.16 -52.45 65.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.426 178.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -69.27 -28.1 66.01 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.365 -178.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -64.92 -44.56 89.13 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.125 0.488 . . . . 0.0 109.892 175.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.51 ' HG ' ' O ' ' A' ' 6' ' ' ILE . 51.9 mt -64.52 -42.7 95.62 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.283 177.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -63.49 -38.0 89.47 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.504 178.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -62.82 -50.32 71.45 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.097 179.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 37.9 pt -78.44 -7.0 9.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.763 0.316 . . . . 0.0 111.382 -178.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 76.07 36.41 40.94 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 121.119 -0.562 . . . . 0.0 112.619 177.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 12.5 tp10 -95.69 157.48 15.88 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 179.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -73.68 122.99 23.2 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.187 0.518 . . . . 0.0 111.093 -177.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 93.2 t80 -105.64 120.01 40.58 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.987 179.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 15.3 tt -131.34 121.39 48.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 121.314 0.578 . . . . 0.0 110.576 175.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -108.38 108.27 19.17 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.046 178.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 24.7 tp -93.39 75.46 4.51 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 178.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 59.3 71.5 0.58 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.43 -0.805 . . . . 0.0 110.537 -177.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 12.5 m120 68.38 11.64 8.43 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.172 -0.922 . . . . 0.0 112.004 178.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 79.3 mt-10 -115.13 113.99 24.72 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 174.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 40.7 mt -86.77 109.35 18.94 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 177.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.452 ' HA ' ' O ' ' A' ' 87' ' ' VAL . 24.8 m-70 -95.98 111.13 23.22 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -178.364 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.476 HD21 HD13 ' A' ' 10' ' ' LEU . 67.4 mt -113.32 163.3 15.01 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.44 0.638 . . . . 0.0 112.679 -170.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 33.7 tttp -62.63 129.61 92.94 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 114.46 -1.245 . . . . 0.0 109.681 173.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -51.12 -41.28 58.03 Favored 'Trans proline' 0 N--CA 1.473 0.308 0 C-N-CA 122.884 2.389 . . . . 0.0 112.518 -179.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -53.78 -54.92 31.52 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.168 175.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 50.9 t -69.5 -41.12 80.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.712 -177.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 53.3 t80 -53.87 -42.01 68.15 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.476 179.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 81.8 t80 -59.18 -42.69 91.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.555 -179.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -78.26 -37.17 45.72 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.088 -178.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 95.8 t -62.43 -36.87 77.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.083 0.468 . . . . 0.0 109.86 175.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.443 ' CD1' ' HD2' ' A' ' 41' ' ' PRO . 35.3 t90 -55.78 -44.09 77.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.701 176.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.543 ' HA ' ' HG3' ' A' ' 40' ' ' GLU . 67.3 mttm -73.02 -31.67 64.61 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.656 -0.247 . . . . 0.0 111.325 179.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 83.8 t80 -67.23 -40.65 86.37 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.951 179.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.517 HG23 ' HD3' ' A' ' 41' ' ' PRO . 35.0 m -79.04 4.12 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 111.934 0.346 . . . . 0.0 111.934 -177.086 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 102.64 4.11 49.35 Favored Glycine 0 C--N 1.33 0.231 0 C-N-CA 120.767 -0.73 . . . . 0.0 113.241 174.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.543 ' HG3' ' HA ' ' A' ' 36' ' ' LYS . 54.0 mt-10 57.59 78.29 0.37 Allowed Pre-proline 0 C--O 1.236 0.347 0 C-N-CA 122.925 0.49 . . . . 0.0 111.95 -179.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.517 ' HD3' HG23 ' A' ' 38' ' ' VAL . 4.9 Cg_exo -77.89 175.3 11.36 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.738 2.292 . . . . 0.0 110.659 173.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -81.46 133.72 35.44 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.18 0.514 . . . . 0.0 110.12 178.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 89.7 mt -73.17 120.94 19.48 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.774 -172.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -96.53 118.4 32.95 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.197 176.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 24.2 p -109.47 143.12 39.52 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.052 -176.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 17.9 p90 -126.27 133.53 51.41 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.728 177.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.408 HG22 ' HB2' ' A' ' 74' ' ' LYS . 60.5 t -93.63 125.95 46.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.717 -179.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.518 HD11 ' HE3' ' A' ' 75' ' ' LYS . 13.7 pt -125.7 131.0 72.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.576 174.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.581 ' HB3' ' HG2' ' A' ' 70' ' ' LYS . 45.9 mt-10 -102.41 98.38 8.49 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.136 -179.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -93.08 154.73 17.93 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.239 -0.437 . . . . 0.0 109.964 -178.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.607 ' HB3' ' CG1' ' A' ' 68' ' ' VAL . 43.3 mt-10 -105.41 111.04 23.61 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.338 -172.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 44.0 pt -110.28 139.19 34.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.113 0.482 . . . . 0.0 110.811 177.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 6.5 m -107.05 97.57 5.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-O 121.275 0.56 . . . . 0.0 110.569 175.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.46 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 13.0 pt-20 -87.62 143.92 34.58 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 116.156 -0.474 . . . . 0.0 109.739 178.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 54' ' ' GLU . 35.7 Cg_exo -62.4 177.93 1.05 Allowed 'Trans proline' 0 C--O 1.237 0.438 0 C-N-CA 122.788 2.325 . . . . 0.0 112.867 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -135.26 43.66 1.24 Allowed Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.605 -177.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -63.85 -39.17 93.59 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.729 0.776 . . . . 0.0 108.914 175.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -121.17 135.06 55.22 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.629 -1.169 . . . . 0.0 108.55 175.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.41 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 10.9 p-10 -73.46 123.02 89.03 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-O 121.211 0.529 . . . . 0.0 111.556 -174.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.892 ' HD2' ' HE1' ' A' ' 65' ' ' TYR . 17.1 Cg_exo -68.08 153.45 74.93 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 122.951 2.434 . . . . 0.0 111.851 174.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 60' ' ' PRO . 22.4 Cg_exo -65.89 -16.23 51.99 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 123.162 2.574 . . . . 0.0 112.751 -179.104 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -78.75 116.37 19.05 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 177.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 66.0 mtt -84.1 -15.8 46.0 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.661 -177.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -86.63 72.69 10.18 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 172.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . 0.892 ' HE1' ' HD2' ' A' ' 60' ' ' PRO . 92.4 m-85 -64.83 121.38 14.45 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.633 -174.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 38.5 p -103.07 132.96 48.95 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.493 178.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -53.25 -51.98 60.47 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.219 0.533 . . . . 0.0 110.585 176.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.607 ' CG1' ' HB3' ' A' ' 51' ' ' GLU . 28.3 t -116.12 132.23 66.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.348 176.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 46.9 tptt -100.27 107.75 19.65 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.084 0.469 . . . . 0.0 110.264 -178.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.581 ' HG2' ' HB3' ' A' ' 49' ' ' GLU . 26.5 ttpp -85.41 116.51 23.78 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.759 178.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.478 ' O ' ' HA ' ' A' ' 49' ' ' GLU . 65.2 t -102.56 133.92 44.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.956 -174.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 60.9 mttm -86.06 96.96 10.03 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.328 179.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 15.1 tt -109.89 129.81 64.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 121.546 0.688 . . . . 0.0 110.66 178.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.491 ' O ' ' HB3' ' A' ' 90' ' ' TYR . 36.4 ttpt -108.86 115.71 30.59 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.075 -177.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.518 ' HE3' HD11 ' A' ' 48' ' ' ILE . 81.4 mttt -104.13 167.01 10.04 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.35 -0.386 . . . . 0.0 109.975 -179.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 14.6 p -122.51 146.79 27.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 120.925 0.393 . . . . 0.0 111.303 -173.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.463 ' HB3' HG22 ' A' ' 87' ' ' VAL . 48.1 p90 -149.85 164.82 34.34 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.132 175.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -134.23 149.25 50.96 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 169.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.569 ' HG2' ' HG2' ' A' ' 85' ' ' ARG . 41.6 mt-10 -102.5 138.21 39.72 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.681 -176.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 38.4 p -83.25 178.55 8.03 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.123 175.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.8 mp -62.73 -27.01 68.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.194 0.521 . . . . 0.0 110.726 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -99.98 15.04 28.48 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.715 179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 10.0 m120 64.1 34.59 11.06 Favored 'General case' 0 N--CA 1.47 0.543 0 N-CA-C 113.415 0.894 . . . . 0.0 113.415 171.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.409 ' HB ' ' HB3' ' A' ' 3' ' ' SER . 58.6 t -90.69 129.56 41.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 169.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.569 ' HG2' ' HG2' ' A' ' 79' ' ' GLU . 41.7 mtm-85 -98.88 114.91 27.73 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.976 0.417 . . . . 0.0 111.389 -172.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 45.6 t -89.7 113.09 25.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 174.557 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.463 HG22 ' HB3' ' A' ' 77' ' ' TYR . 19.3 t -113.28 148.2 16.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.937 -171.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 6.2 t -152.13 171.52 17.78 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.065 174.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -73.02 111.71 8.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.188 0.518 . . . . 0.0 110.368 177.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.491 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 15.3 t80 -72.14 -20.94 61.53 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.595 -177.099 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.4 m -62.64 -58.22 8.29 Favored 'General case' 0 C--O 1.238 0.467 0 CA-C-O 121.184 0.516 . . . . 0.0 110.068 178.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.402 ' O ' HG13 ' A' ' 96' ' ' ILE . 28.4 tt0 -67.53 -35.28 78.78 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.406 178.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.403 ' O ' HD23 ' A' ' 97' ' ' LEU . 55.2 t80 -59.78 -46.77 88.17 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.48 179.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.446 ' O ' ' HG3' ' A' ' 98' ' ' LYS . 69.5 mt-30 -58.61 -40.02 82.11 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.612 0.244 . . . . 0.0 110.906 176.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 62.1 tttp -63.22 -39.82 95.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.528 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.402 HG13 ' O ' ' A' ' 92' ' ' GLU . 80.1 mt -63.58 -42.27 95.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.743 177.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.403 HD23 ' O ' ' A' ' 93' ' ' PHE . 4.1 mm? -57.84 -43.31 85.78 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.681 176.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.446 ' HG3' ' O ' ' A' ' 94' ' ' GLN . 94.0 mttt -70.05 -41.83 73.67 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.693 178.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 60.5 tttm -60.3 -48.68 80.69 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.649 -178.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 62.4 ttt180 -78.38 -30.48 47.91 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.041 0.448 . . . . 0.0 110.523 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.72 45.35 6.83 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.681 -0.771 . . . . 0.0 111.869 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 23.1 m -72.24 -32.9 67.11 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.082 0.467 . . . . 0.0 110.267 178.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -107.5 149.99 27.33 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.9 -0.591 . . . . 0.0 109.715 176.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 86.5 mt -70.35 144.77 51.53 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.013 -175.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -68.85 -52.79 26.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.485 178.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 63.5 m80 -104.71 142.81 34.02 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.591 -176.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 56.8 m170 -100.62 134.07 44.13 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.622 -177.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 79.7 m80 -76.5 -29.7 56.92 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.473 178.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 72.3 t60 -128.65 133.5 48.27 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 173.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 33.3 m80 -81.6 138.59 35.34 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.788 0.328 . . . . 0.0 110.411 -176.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 89.6 m-70 . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.233 -0.889 . . . . 0.0 109.641 176.605 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.611 ' HE2' HG12 ' A' ' 38' ' ' VAL . 26.0 mtm . . . . . 0 N--CA 1.476 0.866 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -98.01 153.89 18.08 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.795 175.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 36.6 p -61.28 -27.9 68.8 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.931 -177.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -57.59 -45.59 85.09 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.98 0.419 . . . . 0.0 110.38 178.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 46.1 t -62.85 -39.31 84.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.261 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.405 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 58.9 mt -62.45 -45.75 98.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.181 177.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 49.3 mttm -57.07 -48.73 77.86 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.091 177.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -59.45 -47.34 85.87 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.927 179.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 90.8 t80 -63.62 -47.71 80.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.354 -177.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.472 HD13 HD21 ' A' ' 26' ' ' LEU . 95.5 mt -62.31 -46.98 86.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.195 -177.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -79.01 -6.1 55.54 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.734 0.302 . . . . 0.0 111.497 -177.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -82.42 -45.97 14.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.126 0.489 . . . . 0.0 109.792 173.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 34.9 pt -77.48 -12.21 13.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.941 179.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 94.46 28.48 10.45 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.771 -0.728 . . . . 0.0 113.06 174.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.513 ' OE2' HG21 ' A' ' 30' ' ' VAL . 3.9 tp10 -88.05 137.23 32.51 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.153 0.501 . . . . 0.0 111.058 -179.037 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -104.3 110.54 22.8 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.301 175.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.414 ' CD1' ' HB2' ' A' ' 19' ' ' GLU . 27.1 p90 -102.79 154.73 18.89 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.152 -177.022 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 58.1 mt -97.34 102.06 12.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 175.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.414 ' HB2' ' CD1' ' A' ' 17' ' ' TYR . 35.9 tt0 -105.84 116.71 32.41 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.491 0.662 . . . . 0.0 111.822 -172.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -94.24 -168.17 1.81 Allowed 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 172.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -68.21 99.79 0.95 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.003 0.43 . . . . 0.0 110.304 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 62.53 32.86 16.35 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.498 -178.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.453 ' HG2' ' HB2' ' A' ' 85' ' ' ARG . 23.2 mt-10 -138.56 113.77 9.44 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.097 174.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.534 ' HB ' HG22 ' A' ' 86' ' ' VAL . 64.3 mt -99.8 104.5 16.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 178.127 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 31.1 m-70 -90.85 112.12 23.82 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.981 0.419 . . . . 0.0 110.032 179.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.472 HD21 HD13 ' A' ' 10' ' ' LEU . 56.5 mt -101.37 -175.62 2.91 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.525 -0.762 . . . . 0.0 111.524 -176.067 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 61.2 mttp -95.35 144.16 27.34 Favored Pre-proline 0 C--N 1.321 -0.654 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.389 176.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.545 ' HA ' HG21 ' A' ' 88' ' ' THR . 5.9 Cg_exo -41.59 -49.79 5.06 Favored 'Trans proline' 0 CA--C 1.534 0.486 0 C-N-CA 124.033 3.155 . . . . 0.0 114.391 -175.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -72.33 -40.69 67.22 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.845 0.355 . . . . 0.0 111.142 -175.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.513 HG21 ' OE2' ' A' ' 15' ' ' GLU . 58.3 t -67.01 -40.5 85.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.636 -178.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -59.19 -40.33 85.35 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.453 177.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.596 ' HA ' ' HE1' ' A' ' 93' ' ' PHE . 20.6 t80 -61.12 -33.12 72.88 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.024 -179.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -80.11 -43.59 21.45 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.889 -179.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.451 ' O ' HG13 ' A' ' 38' ' ' VAL . 59.5 t -65.58 -33.11 61.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-O 120.848 0.356 . . . . 0.0 110.507 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.469 ' O ' HG22 ' A' ' 38' ' ' VAL . 27.6 t90 -53.05 -40.05 63.68 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.09 176.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 78.2 mttt -70.15 -36.97 75.11 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.271 0.558 . . . . 0.0 110.292 178.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 23.0 t80 -73.07 -30.57 63.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.548 -174.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.611 HG12 ' HE2' ' A' ' 1' ' ' MET . 18.4 m -75.27 -2.17 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.278 0 CA-C-O 120.916 0.389 . . . . 0.0 111.335 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 116.84 -9.45 16.17 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.835 -0.698 . . . . 0.0 111.883 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.413 ' N ' ' HD3' ' A' ' 41' ' ' PRO . 33.4 tt0 58.85 64.73 3.18 Favored Pre-proline 0 CA--C 1.538 0.487 0 CA-C-O 121.044 0.45 . . . . 0.0 111.131 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.504 ' HD3' HG23 ' A' ' 38' ' ' VAL . 92.3 Cg_endo -98.06 -173.24 0.17 Allowed 'Trans proline' 0 N--CA 1.452 -0.962 0 C-N-CA 123.331 2.687 . . . . 0.0 112.193 179.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -79.25 116.51 19.56 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.073 0.463 . . . . 0.0 109.814 176.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.6 mt -75.24 156.72 35.43 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.2 -176.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 57.5 tttm -109.96 129.31 55.68 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.817 -177.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.0 p -109.17 149.52 29.25 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.617 -175.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.536 ' OH ' ' HD2' ' A' ' 75' ' ' LYS . 28.2 p90 -134.85 159.85 40.09 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 176.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 50.6 t -111.98 120.37 62.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 120.948 0.404 . . . . 0.0 110.911 -177.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 8.4 tt -110.48 115.5 49.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.262 0.553 . . . . 0.0 109.561 174.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.484 ' HG2' ' HG2' ' A' ' 72' ' ' LYS . 43.4 mt-10 -95.48 118.91 33.07 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.265 -177.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.4 ' O ' HG22 ' A' ' 71' ' ' VAL . 36.1 t70 -121.15 144.37 48.61 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 176.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.685 ' HG2' ' HG2' ' A' ' 70' ' ' LYS . 44.7 mt-10 -103.01 118.51 36.98 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.594 0.235 . . . . 0.0 110.62 -178.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 13.8 tt -74.35 138.73 20.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 176.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 15.8 m -90.46 131.31 37.99 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.362 0.601 . . . . 0.0 111.035 -175.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -87.28 162.61 42.59 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.024 -178.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.77 119.39 6.38 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.467 2.111 . . . . 0.0 112.071 175.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -135.39 44.17 1.19 Allowed Glycine 0 N--CA 1.448 -0.516 0 N-CA-C 110.669 -0.972 . . . . 0.0 110.669 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -70.12 -172.79 0.59 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.724 -0.738 . . . . 0.0 111.635 -174.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 23.2 t80 -65.54 -27.44 68.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.125 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -147.55 106.79 3.78 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.264 177.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -85.31 138.62 6.59 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.682 2.255 . . . . 0.0 112.506 178.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -70.62 -22.4 28.18 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.52 2.146 . . . . 0.0 111.505 174.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 46.8 mm-40 -93.7 -159.41 0.69 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.476 175.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 65.2 mtm -69.03 166.14 18.7 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 174.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -76.3 -8.78 57.83 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.289 0.566 . . . . 0.0 110.552 178.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -135.74 135.28 39.86 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 173.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 11.4 t -138.4 -175.38 4.1 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.669 0.271 . . . . 0.0 110.658 -176.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -90.15 102.51 15.23 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.807 0.337 . . . . 0.0 111.825 -171.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 50.9 t -70.85 136.14 26.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.438 173.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 47.4 mttp -110.47 119.26 38.61 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.119 0.485 . . . . 0.0 111.762 -172.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.685 ' HG2' ' HG2' ' A' ' 51' ' ' GLU . 58.4 mttm -87.11 116.91 25.5 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.083 174.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.4 HG22 ' O ' ' A' ' 50' ' ' ASP . 30.8 m -99.13 118.34 45.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.362 0.601 . . . . 0.0 110.681 178.511 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.484 ' HG2' ' HG2' ' A' ' 49' ' ' GLU . 43.8 mttp -83.37 93.59 7.78 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.059 178.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 51.4 mm -92.03 110.26 22.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.27 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 41.0 ttpt -93.63 115.02 27.48 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.051 177.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.536 ' HD2' ' OH ' ' A' ' 46' ' ' TYR . 62.4 mttm -102.62 166.3 10.59 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 177.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 12.6 p -122.35 144.18 32.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.347 -176.076 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.452 ' HB3' HG22 ' A' ' 87' ' ' VAL . 36.8 p90 -149.8 165.94 30.98 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.02 0.438 . . . . 0.0 111.412 179.192 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.477 ' CE2' HG11 ' A' ' 38' ' ' VAL . 50.1 p90 -124.36 134.59 53.1 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.196 166.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.443 ' OE1' ' HD2' ' A' ' 85' ' ' ARG . 34.5 tt0 -103.87 118.11 35.93 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.164 -176.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 72.7 p -79.07 179.64 7.23 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.549 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 7.7 mp -66.6 -14.22 62.12 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.029 0.443 . . . . 0.0 110.658 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.514 ' HB2' HG23 ' A' ' 84' ' ' VAL . 1.9 m-20 -85.54 -1.73 57.41 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.621 -178.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 55.3 m-80 70.35 18.39 6.75 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 123.766 0.666 . . . . 0.0 110.423 -175.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.514 HG23 ' HB2' ' A' ' 82' ' ' ASP . 93.1 t -87.97 123.55 40.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.041 177.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.453 ' HB2' ' HG2' ' A' ' 23' ' ' GLU . 0.2 OUTLIER -100.01 108.87 21.17 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.905 -178.964 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.534 HG22 ' HB ' ' A' ' 24' ' ' ILE . 59.6 t -82.92 106.17 13.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 174.138 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.452 HG22 ' HB3' ' A' ' 77' ' ' TYR . 41.4 t -107.0 142.58 19.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.798 -169.131 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.545 HG21 ' HA ' ' A' ' 28' ' ' PRO . 96.0 m -152.07 153.81 34.69 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.309 174.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -64.41 119.02 9.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.288 0.566 . . . . 0.0 111.922 -178.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.43 ' H ' ' HA ' ' A' ' 75' ' ' LYS . 83.2 t80 -63.18 -37.48 87.4 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.806 -179.032 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.6 m -60.2 -45.41 93.26 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.751 178.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.449 ' HA ' ' HB3' ' A' ' 95' ' ' LYS . 22.0 mm-40 -77.93 -30.67 50.64 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.112 -179.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.596 ' HE1' ' HA ' ' A' ' 32' ' ' TYR . 75.7 t80 -61.03 -50.61 72.63 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.966 0.413 . . . . 0.0 110.405 177.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.649 ' HG2' HD12 ' A' ' 97' ' ' LEU . 45.4 mt-30 -77.31 -17.17 58.53 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.991 179.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.449 ' HB3' ' HA ' ' A' ' 92' ' ' GLU . 0.8 OUTLIER -69.35 -32.42 71.48 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 173.298 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.46 HD11 ' HB2' ' A' ' 28' ' ' PRO . 56.1 mt -79.03 -33.68 16.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.268 174.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.649 HD12 ' HG2' ' A' ' 94' ' ' GLN . 90.5 mt -59.94 -41.71 92.39 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 171.004 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 7.3 tmtt? -64.36 -40.36 95.69 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.96 -1.018 . . . . 0.0 109.805 176.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 56.7 tttm -62.11 -43.69 98.28 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.845 178.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 78.2 ttt180 -71.56 -45.44 62.29 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.967 0.413 . . . . 0.0 110.64 177.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 112.5 25.97 4.42 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.846 -0.692 . . . . 0.0 111.811 -177.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 42.6 m -85.18 113.77 21.8 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.952 0.406 . . . . 0.0 110.572 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 45.6 tttm -101.95 111.64 23.98 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.607 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 36.8 tp -98.31 71.21 2.05 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.119 179.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.491 ' HB2' ' CD2' ' A' ' 107' ' ' HIS . 37.8 mt-10 58.27 -165.58 0.17 Allowed 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.134 178.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 17.4 t-80 -105.39 65.87 0.73 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 174.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.491 ' CD2' ' HB2' ' A' ' 105' ' ' GLU . 14.2 m170 -65.49 127.4 31.68 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 176.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -49.13 -49.25 43.0 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 113.893 1.072 . . . . 0.0 113.893 -160.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 10.4 m-70 -77.68 76.64 4.21 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.455 0.645 . . . . 0.0 111.734 -177.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 45.8 m80 -156.5 -47.08 0.07 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 114.581 -1.19 . . . . 0.0 107.833 175.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 6.2 t60 . . . . . 0 C--O 1.248 0.988 0 CA-C-N 114.462 -1.245 . . . . 0.0 108.421 172.817 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.501 ' HG2' ' HB ' ' A' ' 5' ' ' VAL . 15.0 tmm? . . . . . 0 N--CA 1.479 1.012 0 CA-C-O 121.098 0.475 . . . . 0.0 110.368 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -112.6 -172.66 2.09 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 174.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.478 ' O ' ' HG3' ' A' ' 7' ' ' LYS . 19.1 p -56.67 -33.02 65.97 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.947 0.404 . . . . 0.0 110.803 177.074 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -51.59 -51.52 54.84 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.801 178.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.501 ' HB ' ' HG2' ' A' ' 1' ' ' MET . 59.9 t -61.38 -48.65 87.89 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.928 -177.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.456 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 60.4 mt -54.4 -43.12 61.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.02 177.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.478 ' HG3' ' O ' ' A' ' 3' ' ' SER . 98.9 mttt -56.88 -49.24 76.13 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.163 178.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -61.01 -41.24 96.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.073 0.463 . . . . 0.0 110.529 -179.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.485 ' O ' HG13 ' A' ' 13' ' ' ILE . 74.5 t80 -62.22 -48.0 81.94 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.705 178.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.522 HD13 ' HB3' ' A' ' 17' ' ' TYR . 87.9 mt -69.45 -33.34 72.78 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.379 -177.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -65.66 -41.32 92.66 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.894 0.378 . . . . 0.0 110.137 176.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 36.5 t70 -64.05 -37.82 88.83 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.523 177.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.485 HG13 ' O ' ' A' ' 9' ' ' PHE . 59.6 mt -66.68 -41.05 87.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 121.432 0.634 . . . . 0.0 109.756 173.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.01 23.26 25.61 Favored Glycine 0 N--CA 1.446 -0.657 0 CA-C-N 115.332 -0.849 . . . . 0.0 111.791 -179.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 47.8 mm-40 -98.02 158.92 15.26 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.152 0.501 . . . . 0.0 111.322 -178.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.403 ' HB2' ' HE3' ' A' ' 27' ' ' LYS . 9.3 m-20 -77.72 114.36 16.49 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.981 -177.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.522 ' HB3' HD13 ' A' ' 10' ' ' LEU . 39.3 p90 -111.13 112.15 23.75 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 170.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.553 ' HB ' ' HB2' ' A' ' 25' ' ' HIS . 51.6 mt -84.91 95.17 4.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.473 -175.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -76.05 114.03 14.24 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.095 176.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.551 ' HB2' ' HB2' ' A' ' 23' ' ' GLU . 93.6 mt -114.84 169.22 9.24 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 172.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.434 ' O ' ' HB2' ' A' ' 22' ' ' ASN . 40.6 mt-10 -64.39 107.35 1.32 Allowed 'General case' 0 C--N 1.317 -0.82 0 C-N-CA 120.588 -0.445 . . . . 0.0 110.474 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.434 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 88.2 m-20 80.48 2.95 1.84 Allowed 'General case' 0 N--CA 1.47 0.575 0 O-C-N 124.593 1.183 . . . . 0.0 112.031 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.551 ' HB2' ' HB2' ' A' ' 20' ' ' LEU . 54.6 mt-10 -134.3 150.98 51.01 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 121.442 0.639 . . . . 0.0 112.424 -177.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 59.1 mt -130.95 109.78 17.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 166.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.553 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 11.7 m170 -89.96 125.09 35.25 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 39.8 mt -120.81 175.29 6.11 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.236 0.541 . . . . 0.0 111.388 -177.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.403 ' HE3' ' HB2' ' A' ' 16' ' ' ASP . 87.2 mttt -93.54 153.66 41.27 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.481 178.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_exo -48.45 -53.08 7.35 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 123.143 2.562 . . . . 0.0 113.571 -176.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -72.02 -37.13 69.83 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.851 0.357 . . . . 0.0 110.88 -176.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.462 ' O ' HG23 ' A' ' 34' ' ' VAL . 47.4 t -63.69 -40.46 89.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.28 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 72.2 t80 -61.92 -39.22 91.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.431 177.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 66.3 t80 -60.63 -43.31 97.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.596 179.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -64.62 -44.56 90.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.062 178.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 30' ' ' VAL . 91.2 t -65.74 -40.95 89.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.99 -179.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.433 ' CD1' ' HD2' ' A' ' 41' ' ' PRO . 28.1 t90 -55.04 -48.09 73.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.623 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.414 ' HA ' ' HG3' ' A' ' 40' ' ' GLU . 62.9 mttm -72.4 -31.02 65.18 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.266 179.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -63.0 -43.71 98.03 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.464 -0.334 . . . . 0.0 111.231 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.493 HG23 ' HD3' ' A' ' 41' ' ' PRO . 34.9 m -80.54 -5.87 8.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 N-CA-C 111.854 0.316 . . . . 0.0 111.854 -177.011 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 108.53 12.56 20.98 Favored Glycine 0 C--N 1.331 0.263 0 C-N-CA 120.575 -0.822 . . . . 0.0 113.728 174.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.414 ' HG3' ' HA ' ' A' ' 36' ' ' LYS . 54.2 mt-10 55.25 78.39 0.39 Allowed Pre-proline 0 N--CA 1.466 0.359 0 C-N-CA 122.838 0.455 . . . . 0.0 111.856 178.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.493 ' HD3' HG23 ' A' ' 38' ' ' VAL . 95.1 Cg_endo -91.64 179.42 1.5 Allowed 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 122.852 2.368 . . . . 0.0 112.031 175.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -62.75 122.98 17.24 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.898 176.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 81.3 mt -92.2 132.16 36.87 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.669 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -97.57 137.62 36.21 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 178.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 31.6 p -122.41 135.48 54.7 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-O 120.825 0.345 . . . . 0.0 110.773 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.493 ' CE1' ' HB2' ' A' ' 75' ' ' LYS . 17.3 p90 -122.92 136.6 54.92 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.977 0.418 . . . . 0.0 110.294 179.127 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 50.3 t -96.89 105.0 16.53 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.904 -0.589 . . . . 0.0 109.981 178.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.469 HG23 ' HB ' ' A' ' 73' ' ' ILE . 8.4 tt -100.8 112.15 32.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 121.153 0.502 . . . . 0.0 110.189 178.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.492 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 45.4 tt0 -93.62 111.01 22.6 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 178.034 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -116.35 155.04 29.16 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.956 -0.566 . . . . 0.0 109.584 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.481 ' HG2' ' HG2' ' A' ' 70' ' ' LYS . 45.5 mt-10 -103.1 130.95 50.42 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.527 -177.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 60.2 mt 68.19 91.61 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.871 177.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 58.1 t -108.59 96.08 4.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.031 179.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.455 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 20.3 mt-10 -93.98 139.65 22.68 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.248 -178.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 54' ' ' GLU . 53.0 Cg_exo -55.2 -51.36 10.31 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 123.253 2.635 . . . . 0.0 113.199 -174.186 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -166.75 -36.11 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.661 -0.781 . . . . 0.0 111.812 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -98.46 136.83 38.03 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 172.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -84.03 152.71 24.25 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.696 -177.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.411 ' HA ' ' HD2' ' A' ' 60' ' ' PRO . 34.6 t70 -59.28 129.7 86.74 Favored Pre-proline 0 C--N 1.325 -0.481 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 172.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 59' ' ' ASP . 2.2 Cg_endo -40.95 111.86 0.17 Allowed 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 124.07 3.18 . . . . 0.0 112.969 -175.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.409 ' HD2' ' HA ' ' A' ' 60' ' ' PRO . 33.9 Cg_endo -65.07 94.5 0.23 Allowed 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 123.076 2.517 . . . . 0.0 112.001 -178.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 54.7 mm-40 -127.33 177.24 6.84 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.431 -178.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 54.6 ttp -80.93 83.17 6.71 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 172.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -158.06 145.39 18.14 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.652 -171.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 85.5 t80 -96.85 94.19 7.09 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.82 0.343 . . . . 0.0 110.347 178.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 26.1 m -77.94 140.76 39.28 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.769 177.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -62.12 124.46 20.91 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.937 0.399 . . . . 0.0 111.304 -175.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 46.2 t -88.79 110.83 21.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.008 178.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 9.4 tmtm? -107.31 127.75 53.83 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.092 -179.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.481 ' HG2' ' HG2' ' A' ' 51' ' ' GLU . 67.3 mttm -87.22 128.34 35.15 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.822 -0.626 . . . . 0.0 109.858 179.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.492 ' O ' ' HA ' ' A' ' 49' ' ' GLU . 41.0 t -117.85 115.36 48.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 C-N-CA 121.199 -0.2 . . . . 0.0 110.744 -179.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -81.77 103.26 11.33 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 174.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.469 ' HB ' HG23 ' A' ' 48' ' ' ILE . 55.1 mt -98.54 108.98 23.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 116.405 -0.362 . . . . 0.0 110.681 -178.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 57.4 tttp -87.12 103.03 15.01 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 176.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.493 ' HB2' ' CE1' ' A' ' 46' ' ' TYR . 97.5 mttt -104.91 163.73 12.31 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.337 178.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 7.9 p -116.84 141.11 36.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.946 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.473 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 33.8 p90 -149.01 152.4 36.22 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.612 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 51.0 p90 -131.28 144.43 51.28 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 170.477 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -102.03 130.4 48.57 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.305 -175.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 32.9 p -76.13 178.99 5.95 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.152 174.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 8.2 mp -70.46 -23.96 62.8 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.71 0.29 . . . . 0.0 110.822 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -90.06 8.92 30.22 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.337 0.589 . . . . 0.0 109.608 175.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 13.5 m120 65.77 30.39 10.16 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 114.711 -1.131 . . . . 0.0 112.906 171.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 43.3 t -87.89 127.28 41.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 171.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 34.2 mtt180 -93.25 108.38 20.02 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.214 -172.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 57.4 t -82.27 110.89 17.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 174.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 39.8 t -113.26 137.24 46.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.436 -171.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 59.1 m -148.27 154.74 40.44 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 174.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -66.61 126.27 28.4 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.95 0.405 . . . . 0.0 110.688 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -75.59 -26.19 57.66 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.68 -174.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.474 ' O ' ' HG3' ' A' ' 95' ' ' LYS . 28.1 t -69.74 -43.67 71.8 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -64.31 -39.16 93.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.102 0.477 . . . . 0.0 110.21 176.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -64.24 -42.32 96.58 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.372 178.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 26.3 mm-40 -60.58 -37.91 82.88 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.235 176.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.474 ' HG3' ' O ' ' A' ' 91' ' ' SER . 99.3 mttt -55.55 -49.68 72.03 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.862 0.363 . . . . 0.0 110.282 176.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 66.9 mt -64.05 -40.8 90.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.047 -178.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 97.4 mt -58.71 -46.65 86.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.1 0.476 . . . . 0.0 110.713 177.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 9.0 mtpm? -73.65 -34.51 64.99 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.064 -179.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -64.39 -44.84 90.05 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.996 179.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.43 HH11 ' HD3' ' A' ' 100' ' ' ARG . 52.1 mtt180 -84.99 -18.65 33.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.795 0.331 . . . . 0.0 111.194 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 78.02 33.81 39.87 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.834 -0.698 . . . . 0.0 111.773 -179.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 27.2 m -62.95 128.11 34.36 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.886 0.374 . . . . 0.0 110.341 -179.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -80.61 109.44 15.14 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.071 0.462 . . . . 0.0 110.755 -176.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 89.4 mt -86.29 154.47 21.23 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.44 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -70.33 100.73 1.78 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.103 -178.134 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -78.54 103.85 8.76 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.071 177.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -101.8 139.9 36.81 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.121 179.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 12.8 t-80 -82.68 -29.03 30.23 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 -179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 12.7 m80 -134.75 111.54 10.03 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.349 174.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 53.1 p-80 -64.49 -47.54 78.58 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 175.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 . . . . . 0 C--O 1.247 0.944 0 C-N-CA 123.9 0.88 . . . . 0.0 109.464 175.819 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.457 ' HA ' HG21 ' A' ' 5' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.988 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -143.9 178.08 8.09 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 179.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 35.3 p -64.08 -29.96 71.06 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.15 0.5 . . . . 0.0 110.146 175.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -64.75 -38.1 89.84 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.012 176.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.457 HG21 ' HA ' ' A' ' 1' ' ' MET . 95.9 t -62.64 -41.66 93.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.879 175.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 73.8 mt -62.42 -43.72 98.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.736 -0.666 . . . . 0.0 110.36 176.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 53.5 mttp -52.27 -53.71 40.54 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.744 175.264 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -70.63 -25.81 63.19 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.915 -175.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -67.46 -43.51 80.89 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.353 0.596 . . . . 0.0 109.905 174.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.489 HD13 ' HB3' ' A' ' 17' ' ' TYR . 69.8 mt -72.29 -34.31 68.06 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.392 178.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -64.0 -32.31 73.81 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.385 177.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -63.74 -58.88 5.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.614 179.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 20.8 pt -76.89 -17.36 14.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.797 -176.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 79.42 46.9 7.74 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.806 -179.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -97.78 169.18 9.85 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.929 0.395 . . . . 0.0 110.985 -178.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -96.94 137.25 36.33 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.112 -177.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.489 ' HB3' HD13 ' A' ' 10' ' ' LEU . 24.6 p90 -133.32 115.89 15.46 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.224 0.535 . . . . 0.0 110.223 173.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.461 ' HB ' ' HB2' ' A' ' 25' ' ' HIS . 57.4 mt -85.48 92.11 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 175.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.521 ' HG3' HG12 ' A' ' 24' ' ' ILE . 33.2 tt0 -103.51 104.46 14.53 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.247 -171.034 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 85.5 mt -79.61 -174.32 4.23 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 108.415 -0.958 . . . . 0.0 108.415 173.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -69.47 100.44 1.4 Allowed 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.042 0.448 . . . . 0.0 109.875 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 71.17 29.42 2.87 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.517 -177.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.565 ' HA ' ' O ' ' A' ' 85' ' ' ARG . 5.1 mt-10 -144.61 113.51 6.81 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 177.04 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.521 HG12 ' HG3' ' A' ' 19' ' ' GLU . 51.2 mt -101.2 108.21 22.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 110.175 -0.306 . . . . 0.0 110.175 179.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.54 ' HA ' ' O ' ' A' ' 87' ' ' VAL . 24.4 m-70 -96.18 119.12 34.1 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.77 0.319 . . . . 0.0 110.263 178.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 98.3 mt -116.33 173.58 6.52 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.166 -176.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.403 ' HB2' HG23 ' A' ' 30' ' ' VAL . 61.5 mttp -73.8 147.1 86.24 Favored Pre-proline 0 C--N 1.329 -0.318 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 172.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.472 ' HA ' HG21 ' A' ' 88' ' ' THR . 82.5 Cg_exo -47.07 -51.28 9.61 Favored 'Trans proline' 0 CA--C 1.53 0.284 0 C-N-CA 123.137 2.558 . . . . 0.0 113.606 -178.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -71.22 -34.33 70.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.748 0.309 . . . . 0.0 111.196 -177.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.453 ' O ' HG23 ' A' ' 34' ' ' VAL . 58.1 t -67.41 -45.96 84.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.939 0.399 . . . . 0.0 110.187 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 86.0 t80 -61.15 -38.58 86.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.079 175.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.509 ' HA ' ' HE1' ' A' ' 93' ' ' PHE . 19.1 t80 -56.74 -38.56 72.56 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.274 178.053 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -76.17 -36.68 58.59 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 121.139 -0.224 . . . . 0.0 111.182 177.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 30' ' ' VAL . 77.3 t -66.17 -33.12 61.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.093 0.473 . . . . 0.0 110.225 177.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.551 ' CZ2' ' HG3' ' A' ' 40' ' ' GLU . 45.9 t90 -56.98 -40.01 75.72 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.797 176.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 80.8 mttt -70.42 -42.67 71.29 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.195 0.522 . . . . 0.0 109.679 175.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -58.64 -38.9 79.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.106 -0.952 . . . . 0.0 111.086 -176.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.478 HG23 ' HD3' ' A' ' 41' ' ' PRO . 34.6 m -82.53 3.89 2.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.958 -178.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 100.57 14.68 31.66 Favored Glycine 0 C--N 1.329 0.193 0 C-N-CA 120.665 -0.779 . . . . 0.0 114.489 170.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.551 ' HG3' ' CZ2' ' A' ' 35' ' ' TRP . 35.7 tt0 57.09 72.78 0.88 Allowed Pre-proline 0 N--CA 1.468 0.456 0 CA-C-O 120.965 0.412 . . . . 0.0 111.359 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.478 ' HD3' HG23 ' A' ' 38' ' ' VAL . 78.4 Cg_endo -98.26 173.15 0.56 Allowed 'Trans proline' 0 N--CA 1.449 -1.1 0 C-N-CA 123.091 2.527 . . . . 0.0 112.135 175.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -75.02 146.58 41.47 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 173.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 82.3 mt -112.34 153.85 26.62 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.913 0.387 . . . . 0.0 111.426 -173.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.512 ' HE3' ' OE1' ' A' ' 79' ' ' GLU . 64.4 mttm -101.46 145.43 28.98 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.6 178.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 24.4 p -127.83 138.58 52.76 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.906 0.384 . . . . 0.0 111.278 -178.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -134.28 146.79 50.36 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.862 179.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.403 ' HA ' ' HA ' ' A' ' 74' ' ' LYS . 41.3 t -107.93 116.0 50.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 120.739 0.304 . . . . 0.0 110.659 -179.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 10.2 pt -107.12 139.92 27.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.377 175.655 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.595 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 25.7 mt-10 -116.89 87.89 2.79 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.238 -177.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -118.96 103.37 9.52 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.193 0.521 . . . . 0.0 111.533 -177.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.585 ' HB2' HG12 ' A' ' 71' ' ' VAL . 35.5 tt0 -140.87 -62.99 0.48 Allowed 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 170.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.591 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 11.3 tt -159.82 109.02 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.318 0.58 . . . . 0.0 110.589 173.052 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.2 m -105.48 154.96 6.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.0 176.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.477 ' HB3' HG11 ' A' ' 68' ' ' VAL . 15.8 pt-20 -92.81 138.66 23.43 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-O 120.803 0.335 . . . . 0.0 111.058 -176.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -83.83 -167.67 0.47 Allowed 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 122.913 2.409 . . . . 0.0 111.408 173.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -135.55 33.01 2.47 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.546 -0.835 . . . . 0.0 111.686 179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 51.6 tt0 -61.16 -39.85 91.65 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.135 0.493 . . . . 0.0 110.059 179.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 18.0 m-85 -119.0 93.03 3.95 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 174.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -69.14 109.54 4.57 Favored Pre-proline 0 C--N 1.323 -0.568 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 -178.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.431 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 97.5 Cg_endo -84.12 159.98 13.45 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 122.97 2.447 . . . . 0.0 113.468 -169.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 60' ' ' PRO . 36.4 Cg_exo -62.75 165.41 16.11 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.782 2.321 . . . . 0.0 111.702 174.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -72.82 -5.8 40.6 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.424 -174.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 86.5 mtp -94.3 -10.71 31.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.938 178.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -121.08 136.53 54.96 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.444 -0.343 . . . . 0.0 110.76 -175.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 47.5 p90 -138.42 171.16 14.79 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.235 -0.439 . . . . 0.0 109.927 178.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 12.1 m -121.37 126.22 48.88 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.19 -177.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -80.81 100.91 9.05 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.141 0.495 . . . . 0.0 110.391 -177.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.591 ' HB ' ' O ' ' A' ' 52' ' ' ILE . 15.2 m -113.92 173.61 3.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.895 177.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.487 ' HE2' ' HB3' ' A' ' 69' ' ' LYS . 40.6 mtpt -130.33 135.96 48.61 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 121.369 0.604 . . . . 0.0 112.437 -172.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 49.4 mttm -113.96 114.1 25.72 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.324 175.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.595 ' O ' ' HA ' ' A' ' 49' ' ' GLU . 7.6 p -99.27 115.15 39.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 172.443 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -81.36 97.75 7.86 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.227 0.536 . . . . 0.0 110.927 -173.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 69.2 mt -102.96 109.23 26.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.075 177.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.526 ' O ' ' HB3' ' A' ' 90' ' ' TYR . 82.8 tttt -88.88 127.79 35.65 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.78 -179.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.449 ' HA ' ' H ' ' A' ' 90' ' ' TYR . 72.5 mttt -124.59 165.25 18.19 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.657 0.265 . . . . 0.0 110.58 179.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 8.4 p -125.91 141.86 44.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.839 -173.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 14.0 p90 -155.34 168.36 27.34 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.83 0.348 . . . . 0.0 111.014 179.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -135.09 157.61 46.49 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.435 -0.579 . . . . 0.0 109.435 171.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.512 ' OE1' ' HE3' ' A' ' 44' ' ' LYS . 39.3 mt-10 -106.49 132.59 52.32 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.378 -176.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 69.7 p -84.66 166.97 16.64 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 175.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.469 ' H ' HD23 ' A' ' 81' ' ' LEU . 0.7 OUTLIER -67.7 -21.36 65.33 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.911 0.386 . . . . 0.0 110.496 178.022 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -90.81 16.9 8.44 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.103 178.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 66.6 t30 70.33 20.72 6.02 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 115.604 -0.725 . . . . 0.0 112.269 170.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 96.0 t -99.68 133.36 42.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.228 0.537 . . . . 0.0 110.208 176.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.565 ' O ' ' HA ' ' A' ' 23' ' ' GLU . 66.3 mtm180 -101.99 115.4 30.46 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.429 -176.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 43.1 t -91.84 108.57 20.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 177.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.54 ' O ' ' HA ' ' A' ' 25' ' ' HIS . 16.8 t -111.89 143.16 22.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.527 -170.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.472 HG21 ' HA ' ' A' ' 28' ' ' PRO . 91.4 m -150.66 154.46 37.51 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.887 176.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.63 120.44 13.45 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.827 0.822 . . . . 0.0 111.972 -177.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.526 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 82.4 t80 -65.65 -38.39 89.22 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.343 -1.298 . . . . 0.0 111.774 -173.193 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.503 ' O ' ' HG3' ' A' ' 95' ' ' LYS . 42.9 t -54.73 -56.62 17.25 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.634 -177.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 20.5 tp10 -71.39 -34.55 70.5 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.777 -175.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.509 ' HE1' ' HA ' ' A' ' 32' ' ' TYR . 83.8 t80 -64.01 -42.58 97.11 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.777 178.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 53.4 mm-40 -65.73 -31.63 72.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.304 178.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.535 ' O ' ' HG3' ' A' ' 99' ' ' LYS . 91.3 mttt -59.53 -44.76 93.11 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 174.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 65.1 mt -56.04 -50.06 72.0 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.22 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.772 -179.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 87.5 mt -63.82 -36.4 83.77 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.597 179.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 59.1 tttm -66.57 -41.96 87.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.653 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.535 ' HG3' ' O ' ' A' ' 95' ' ' LYS . 90.9 mttt -64.29 -37.17 86.53 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.755 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 33.1 mtp180 -67.43 -32.52 73.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.351 176.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 79.19 36.13 28.33 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.375 -0.917 . . . . 0.0 110.858 -175.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 21.6 m -71.37 129.22 38.28 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.304 -0.448 . . . . 0.0 110.873 -177.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -91.43 129.73 37.37 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.35 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 92.3 mt -80.78 4.47 18.93 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.5 0.667 . . . . 0.0 109.787 176.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -95.62 109.28 21.55 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.409 179.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 34.2 m170 -90.7 90.15 7.82 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 173.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 80.6 m-70 -83.36 125.66 31.89 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.988 0.423 . . . . 0.0 111.411 -176.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 14.6 t-80 -86.09 107.86 18.02 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.785 174.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 44.7 m-70 -91.54 169.84 10.42 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 55.1 t-80 -79.44 -49.24 12.62 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 85.9 t60 . . . . . 0 C--O 1.248 0.995 0 CA-C-O 118.223 -0.894 . . . . 0.0 110.769 178.375 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.0 ppp? . . . . . 0 N--CA 1.478 0.926 0 CA-C-O 121.114 0.483 . . . . 0.0 110.66 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -136.89 172.34 13.15 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.404 178.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.8 m -62.88 -34.34 77.18 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.307 0.575 . . . . 0.0 110.166 178.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -67.7 -35.38 78.69 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.899 176.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 89.8 t -64.59 -34.76 71.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.066 0.46 . . . . 0.0 110.131 178.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 74.7 mt -63.54 -44.82 98.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.91 -0.587 . . . . 0.0 109.948 174.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -59.84 -46.41 89.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.407 177.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -51.07 -49.59 60.34 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.173 176.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 86.3 t80 -62.4 -43.58 98.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.011 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.482 HD13 ' HB3' ' A' ' 17' ' ' TYR . 96.7 mt -69.61 -35.94 75.73 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.58 -177.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -70.24 -33.39 71.57 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 121.071 -0.252 . . . . 0.0 110.607 176.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -62.8 -53.77 49.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.584 178.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 30.1 pt -72.42 -24.49 22.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.121 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.54 47.43 4.59 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.022 178.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -111.37 -179.8 3.82 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.125 0.488 . . . . 0.0 111.387 -178.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -122.03 130.84 53.63 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.009 -173.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.482 ' HB3' HD13 ' A' ' 10' ' ' LEU . 51.5 p90 -123.04 144.56 49.2 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.565 177.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.573 ' HB ' ' HB2' ' A' ' 25' ' ' HIS . 75.5 mt -90.08 99.72 9.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 177.06 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.446 ' HB2' ' CE1' ' A' ' 17' ' ' TYR . 37.8 tt0 -92.56 106.98 18.86 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.089 -175.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 70.5 mt -112.58 166.31 11.45 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 172.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -60.39 106.03 0.49 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.043 0.449 . . . . 0.0 110.723 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 68.78 14.88 8.99 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 114.87 -1.059 . . . . 0.0 112.187 -179.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -138.46 113.71 9.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.873 0.368 . . . . 0.0 111.153 178.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.494 ' HB ' HG22 ' A' ' 86' ' ' VAL . 66.5 mt -105.28 104.76 17.46 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 174.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.573 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 20.0 m-70 -91.65 115.79 28.34 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -179.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 73.4 mt -105.16 153.76 21.11 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.953 -177.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.5 mtmm -77.22 133.76 68.08 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 173.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.488 ' HB2' HD11 ' A' ' 96' ' ' ILE . 7.0 Cg_endo -48.52 -43.97 31.62 Favored 'Trans proline' 0 CA--C 1.529 0.257 0 C-N-CA 123.685 2.923 . . . . 0.0 113.145 -175.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -57.4 -34.54 68.98 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 121.104 0.478 . . . . 0.0 111.504 -178.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 47.1 t -94.43 -32.17 4.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.733 -176.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.488 ' HE1' ' HE1' ' A' ' 78' ' ' PHE . 81.8 t80 -56.72 -35.23 68.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.668 -0.697 . . . . 0.0 111.187 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -58.98 -33.72 71.0 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.366 -178.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -77.94 -44.37 27.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.819 0.343 . . . . 0.0 110.594 179.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 46.3 t -63.67 -36.52 76.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.76 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.434 ' CD1' ' HD2' ' A' ' 41' ' ' PRO . 27.2 t90 -55.25 -45.38 76.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.941 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.417 ' HG2' ' HG2' ' A' ' 40' ' ' GLU . 74.8 mttt -78.2 -33.17 50.14 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.969 -0.293 . . . . 0.0 111.082 -179.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 91.1 t80 -58.11 -37.37 74.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.879 178.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.424 HG23 ' HD3' ' A' ' 41' ' ' PRO . 33.6 m -89.73 7.83 3.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.757 -177.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 99.7 15.57 31.28 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.718 -0.753 . . . . 0.0 113.967 172.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.417 ' HG2' ' HG2' ' A' ' 36' ' ' LYS . 49.2 mt-10 54.54 67.7 3.17 Favored Pre-proline 0 N--CA 1.469 0.52 0 C-N-CA 122.693 0.397 . . . . 0.0 111.424 179.105 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.434 ' HD2' ' CD1' ' A' ' 35' ' ' TRP . 5.7 Cg_exo -78.05 162.86 28.68 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 122.884 2.39 . . . . 0.0 111.958 -179.307 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -69.24 139.01 54.43 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.066 -0.515 . . . . 0.0 109.628 176.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.565 ' HB3' ' CG2' ' A' ' 76' ' ' VAL . 94.8 mt -111.05 134.29 52.77 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.216 -173.287 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 58.6 tttm -104.59 139.05 40.02 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.269 -0.423 . . . . 0.0 109.918 177.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 19.4 p -106.33 140.97 38.42 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.186 -178.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 6.5 p90 -124.84 153.71 42.15 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 175.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 66.5 t -111.91 113.51 44.41 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.861 0 CA-C-O 121.024 0.44 . . . . 0.0 111.183 -174.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.451 HG23 ' HB ' ' A' ' 73' ' ' ILE . 8.2 tt -104.69 105.51 18.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 173.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.522 ' HB2' ' HG2' ' A' ' 72' ' ' LYS . 39.1 tt0 -85.49 116.56 23.87 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.606 -178.281 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -109.22 147.23 32.9 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.278 178.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.719 ' HG2' ' HG2' ' A' ' 70' ' ' LYS . 49.4 mt-10 -103.21 117.57 34.83 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.114 0.483 . . . . 0.0 111.252 -178.267 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 6.4 tp -89.71 132.13 35.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.762 178.203 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 47.1 t -90.59 141.95 13.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.173 -177.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -87.41 139.0 31.81 Favored Pre-proline 0 C--N 1.321 -0.654 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_exo -31.93 110.24 0.04 OUTLIER 'Trans proline' 0 C--N 1.354 0.824 0 C-N-CA 124.345 3.364 . . . . 0.0 114.065 -178.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -135.5 38.39 1.8 Allowed Glycine 0 N--CA 1.445 -0.703 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.044 178.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -68.82 -30.56 69.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.629 0.728 . . . . 0.0 109.324 179.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -124.8 -175.62 3.33 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.13 174.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.472 ' HA ' ' HD3' ' A' ' 60' ' ' PRO . 9.5 m-20 -101.73 146.29 31.99 Favored Pre-proline 0 C--N 1.321 -0.672 0 CA-C-O 120.78 0.324 . . . . 0.0 111.022 -177.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' A' ' 59' ' ' ASP . 12.1 Cg_exo -71.02 160.92 47.81 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 123.013 2.476 . . . . 0.0 111.699 177.145 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_exo -65.94 -24.15 53.59 Favored 'Trans proline' 0 C--O 1.235 0.352 0 C-N-CA 122.725 2.284 . . . . 0.0 112.318 178.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -93.12 167.82 11.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.482 177.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 91.2 mmm -97.79 21.41 10.53 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.038 -175.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 52.0 mttp -120.93 144.56 48.38 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.806 0.336 . . . . 0.0 110.725 -178.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -111.39 144.18 41.01 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.548 176.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 16.4 p -92.48 -179.3 5.16 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.895 0.379 . . . . 0.0 111.905 -176.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 34.1 m-80 -93.13 166.23 12.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.124 -178.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.518 ' CG1' ' HB3' ' A' ' 51' ' ' GLU . 3.8 t -79.43 153.85 4.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 -179.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 17.1 tttp -100.06 116.47 32.17 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.712 0.291 . . . . 0.0 110.28 -176.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.719 ' HG2' ' HG2' ' A' ' 51' ' ' GLU . 58.5 mttp -84.99 130.88 34.55 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.805 0.336 . . . . 0.0 111.689 -177.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 15.3 m -127.97 120.23 53.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.46 0.648 . . . . 0.0 110.464 173.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.522 ' HG2' ' HB2' ' A' ' 49' ' ' GLU . 60.5 mttp -81.57 115.26 20.77 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.934 -179.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.451 ' HB ' HG23 ' A' ' 48' ' ' ILE . 60.9 mt -95.17 110.58 24.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.934 177.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -90.02 115.4 27.27 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.464 -178.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.451 ' HA ' ' H ' ' A' ' 90' ' ' TYR . 68.6 mttm -118.22 167.11 11.82 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.299 178.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.565 ' CG2' ' HB3' ' A' ' 43' ' ' LEU . 12.0 p -126.19 150.09 31.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.636 -0.256 . . . . 0.0 110.616 -174.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -155.09 164.68 38.53 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.798 0.332 . . . . 0.0 110.77 179.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.488 ' HE1' ' HE1' ' A' ' 31' ' ' PHE . 50.7 p90 -134.69 152.67 51.94 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 170.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.543 ' HG2' ' HG2' ' A' ' 85' ' ' ARG . 33.7 mt-10 -102.31 127.07 49.46 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.162 -175.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 81.1 p -83.97 174.88 9.97 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.742 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.9 mp -71.2 -12.08 61.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.113 0.482 . . . . 0.0 110.613 179.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -92.22 4.76 52.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.491 -179.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 66.8 t30 70.88 21.26 5.13 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.728 0.775 . . . . 0.0 109.884 -178.092 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 99.2 t -100.05 136.46 31.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.643 178.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.543 ' HG2' ' HG2' ' A' ' 79' ' ' GLU . 69.0 mtt180 -107.5 119.22 38.8 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.148 0.499 . . . . 0.0 111.243 -176.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.494 HG22 ' HB ' ' A' ' 24' ' ' ILE . 87.1 t -89.63 111.06 22.52 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.675 177.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.412 ' O ' ' HA ' ' A' ' 25' ' ' HIS . 40.9 t -105.62 140.42 23.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.18 -173.233 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 58.9 m -147.91 152.45 37.58 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 176.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -67.87 126.92 30.96 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.782 0.325 . . . . 0.0 110.724 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.451 ' H ' ' HA ' ' A' ' 75' ' ' LYS . 49.9 t80 -77.97 -30.23 50.14 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.045 -174.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 9.4 t -71.96 -40.63 68.52 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 -179.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.423 ' O ' HG13 ' A' ' 96' ' ' ILE . 35.8 mt-10 -69.49 -37.55 77.29 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.635 176.122 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -61.75 -47.22 86.18 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.931 0.396 . . . . 0.0 110.479 177.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 68.4 mm-40 -65.65 -31.33 72.28 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.016 178.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 57.9 tptt -66.19 -36.13 82.27 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 176.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.488 HD11 ' HB2' ' A' ' 28' ' ' PRO . 64.7 mt -67.12 -38.8 81.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.054 0.454 . . . . 0.0 110.501 176.013 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 73.1 mt -63.13 -25.97 68.6 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.166 176.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -79.37 -26.68 41.98 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.064 176.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.445 ' HG3' ' HA ' ' A' ' 96' ' ' ILE . 33.5 mttp -61.92 -51.62 67.38 Favored 'General case' 0 CA--C 1.521 -0.161 0 CA-C-O 121.239 0.542 . . . . 0.0 109.875 175.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 21.5 mtp180 -86.19 -30.03 22.75 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.035 -173.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.15 50.58 4.78 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.716 -0.754 . . . . 0.0 111.266 -175.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.43 HG22 ' H ' ' A' ' 104' ' ' LEU . 35.9 m -64.68 115.01 4.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.983 0.42 . . . . 0.0 110.882 -178.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -80.37 6.32 12.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.055 -173.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.43 ' H ' HG22 ' A' ' 102' ' ' THR . 72.3 mt -72.22 -23.54 61.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.886 0.374 . . . . 0.0 110.667 178.35 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -132.74 157.88 43.81 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.769 175.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 67.1 m-70 57.77 87.35 0.07 Allowed 'General case' 0 N--CA 1.466 0.358 0 O-C-N 123.851 0.719 . . . . 0.0 111.179 174.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -95.11 -16.92 22.26 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.34 -175.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 48.5 m-70 -107.89 137.8 45.27 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.29 176.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 59.9 m80 -88.9 87.85 7.38 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.465 0.65 . . . . 0.0 110.676 -178.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -91.22 134.4 34.59 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.047 -178.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 46.0 m80 . . . . . 0 C--O 1.248 0.992 0 CA-C-O 118.369 -0.824 . . . . 0.0 110.163 179.52 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.067 0 CA-C-O 120.821 0.343 . . . . 0.0 110.119 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -120.42 172.14 8.03 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 176.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.7 p -63.83 -28.29 69.75 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.089 0.471 . . . . 0.0 110.102 175.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -62.33 -43.47 98.75 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.031 175.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 99.5 t -61.26 -39.63 83.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.033 176.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.555 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 63.5 mt -63.44 -41.48 92.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.3 177.386 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -54.95 -49.56 71.08 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.768 177.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -60.3 -36.9 78.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.898 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.464 ' O ' HG12 ' A' ' 13' ' ' ILE . 90.5 t80 -67.95 -44.43 76.78 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.299 177.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.555 ' HG ' ' O ' ' A' ' 6' ' ' ILE . 86.2 mt -66.73 -43.37 84.41 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.261 -178.467 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -65.57 -30.07 70.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.954 0.406 . . . . 0.0 110.938 179.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -75.23 -47.3 28.81 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.26 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.464 HG12 ' O ' ' A' ' 9' ' ' PHE . 40.3 pt -77.85 -37.92 24.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 121.041 -0.264 . . . . 0.0 111.504 -178.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 114.36 75.76 0.67 Allowed Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.904 178.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.571 ' HG2' HD22 ' A' ' 26' ' ' LEU . 3.8 tp10 -132.83 133.59 43.55 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 174.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -102.09 106.9 17.84 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 176.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.572 ' HB3' HD23 ' A' ' 26' ' ' LEU . 11.0 p90 -111.08 153.02 26.26 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.199 0.524 . . . . 0.0 112.241 -171.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.532 ' HB ' ' HB2' ' A' ' 25' ' ' HIS . 64.5 mt -89.35 107.18 17.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.355 174.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 78.4 tt0 -94.29 97.74 10.44 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.38 0.61 . . . . 0.0 110.789 -179.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 91.9 mt -101.4 162.04 13.19 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 171.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -64.66 116.32 6.11 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 119.954 -0.699 . . . . 0.0 109.931 -178.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.445 ' O ' ' HG2' ' A' ' 85' ' ' ARG . 72.5 m-20 75.65 7.32 3.87 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 114.977 -1.011 . . . . 0.0 111.765 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -140.03 113.83 8.77 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-O 121.083 0.468 . . . . 0.0 112.191 -179.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 70.8 mt -109.4 116.36 51.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 173.495 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.532 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 23.6 m-70 -98.44 121.77 40.79 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.644 0.259 . . . . 0.0 111.073 -177.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.572 HD23 ' HB3' ' A' ' 17' ' ' TYR . 91.8 mt -117.25 161.81 18.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.633 -179.191 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 34.1 mttp -72.63 144.98 86.75 Favored Pre-proline 0 C--N 1.328 -0.356 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 172.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_exo -52.01 -33.75 54.05 Favored 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.25 1.966 . . . . 0.0 111.391 174.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -53.28 -57.31 10.98 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.168 175.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.4 ' O ' HG23 ' A' ' 34' ' ' VAL . 45.1 t -79.57 -36.35 17.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.048 -175.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -55.21 -38.85 68.94 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.411 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.584 ' HA ' ' HE1' ' A' ' 93' ' ' PHE . 23.8 t80 -55.56 -44.82 77.19 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.426 177.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -78.89 -32.52 45.87 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.176 -177.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.4 HG23 ' O ' ' A' ' 30' ' ' VAL . 84.7 t -65.22 -38.59 83.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 175.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 29.6 t90 -57.89 -42.33 84.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.117 176.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -63.02 -47.09 84.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.643 174.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 88.9 t80 -59.06 -43.88 91.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.044 -177.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.532 HG23 ' HD3' ' A' ' 41' ' ' PRO . 34.1 m -75.23 -8.46 11.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 112.04 0.385 . . . . 0.0 112.04 -175.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 108.21 5.02 32.93 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.442 -0.885 . . . . 0.0 113.107 175.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 57.02 76.03 0.52 Allowed Pre-proline 0 C--N 1.329 -0.307 0 C-N-CA 122.862 0.465 . . . . 0.0 112.014 178.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.532 ' HD3' HG23 ' A' ' 38' ' ' VAL . 57.7 Cg_endo -93.5 -172.63 0.33 Allowed 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 123.218 2.612 . . . . 0.0 111.22 175.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -72.02 148.15 46.15 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.085 0.469 . . . . 0.0 110.557 176.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.406 ' HB3' ' CG2' ' A' ' 76' ' ' VAL . 83.7 mt -111.95 132.76 54.56 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.225 -179.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 59.5 mttp -96.37 140.23 31.33 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 177.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 43.7 p -119.87 140.77 50.32 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 120.695 0.283 . . . . 0.0 110.527 178.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.401 ' CE1' ' HB2' ' A' ' 75' ' ' LYS . 10.4 p90 -122.68 141.8 51.36 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 177.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 48.2 t -97.37 108.57 21.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.786 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 10.1 tt -113.17 137.64 45.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.207 -179.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -96.1 87.85 4.67 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.26 177.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -94.12 100.26 12.39 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 167.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.735 ' HG2' ' HA ' ' A' ' 70' ' ' LYS . 30.8 mt-10 -77.87 147.02 35.31 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 114.574 -1.194 . . . . 0.0 111.438 -168.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 51.3 mm -110.86 88.61 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.365 0.602 . . . . 0.0 109.495 176.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.598 HG22 ' HA ' ' A' ' 68' ' ' VAL . 46.1 t -94.63 95.41 5.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.677 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.698 179.155 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.417 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 10.9 pt-20 -99.36 125.58 40.69 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-O 121.124 0.488 . . . . 0.0 110.175 179.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 54' ' ' GLU . 19.6 Cg_exo -67.03 169.13 15.62 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.705 2.27 . . . . 0.0 112.383 178.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -135.35 44.03 1.2 Allowed Glycine 0 N--CA 1.447 -0.592 0 N-CA-C 110.661 -0.976 . . . . 0.0 110.661 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 25.0 mm-40 -65.32 76.44 0.06 Allowed 'General case' 0 C--O 1.234 0.274 0 N-CA-C 112.454 0.538 . . . . 0.0 112.454 -173.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.413 ' HB2' ' H ' ' A' ' 59' ' ' ASP . 37.3 m-85 -145.84 -80.18 0.16 Allowed 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 173.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.413 ' H ' ' HB2' ' A' ' 58' ' ' TYR . 34.3 t70 172.37 101.27 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 114.051 -1.431 . . . . 0.0 107.805 172.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -53.31 111.73 0.75 Allowed 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 123.302 2.668 . . . . 0.0 113.428 -173.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -86.67 -20.81 2.4 Favored 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 122.937 2.425 . . . . 0.0 111.957 176.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -119.26 148.37 43.22 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.752 -178.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 95.6 mmm -102.62 -167.79 1.44 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.661 -179.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 62.1 mttp 63.2 26.69 15.33 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.542 0.687 . . . . 0.0 109.287 -171.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 22.6 t80 -91.52 128.51 37.38 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.224 -175.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 10.2 m -130.48 113.0 13.74 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.445 -179.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.509 ' O ' ' HA ' ' A' ' 53' ' ' VAL . 6.0 m-20 -70.69 -44.06 67.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.937 0.399 . . . . 0.0 110.817 178.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.598 ' HA ' HG22 ' A' ' 53' ' ' VAL . 40.1 t -78.79 88.04 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 121.099 0.476 . . . . 0.0 110.548 -177.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 60.4 tttm -100.24 107.82 19.74 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.013 -0.54 . . . . 0.0 109.723 176.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.735 ' HA ' ' HG2' ' A' ' 51' ' ' GLU . 66.2 mttm -80.3 111.49 16.74 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.262 -178.182 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.8 t -103.47 102.94 14.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.766 -175.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 51.8 mttm -81.88 99.04 8.82 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.304 176.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.586 HG22 ' HG3' ' A' ' 75' ' ' LYS . 44.3 mm -97.46 120.23 46.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.174 0.511 . . . . 0.0 110.55 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.539 ' O ' ' HB3' ' A' ' 90' ' ' TYR . 57.2 tttp -85.58 101.87 13.06 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.283 178.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.586 ' HG3' HG22 ' A' ' 73' ' ' ILE . 74.6 mttt -102.43 154.96 18.58 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.171 -177.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.406 ' CG2' ' HB3' ' A' ' 43' ' ' LEU . 14.9 p -116.84 147.79 19.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.639 0.256 . . . . 0.0 111.258 -172.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.477 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 50.6 p90 -153.79 154.04 33.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.935 178.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -123.76 149.54 45.49 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 171.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -102.77 135.71 43.92 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.709 -174.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 59.7 p -89.85 -176.3 4.89 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.617 179.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.525 ' O ' HD13 ' A' ' 81' ' ' LEU . 2.1 tm? -63.89 -24.64 67.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.28 0.562 . . . . 0.0 109.803 178.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.426 ' O ' ' HB2' ' A' ' 83' ' ' ASN . 0.8 OUTLIER -81.75 1.33 34.98 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.841 -177.237 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.426 ' HB2' ' O ' ' A' ' 82' ' ' ASP . 47.1 m-80 71.46 6.62 5.8 Favored 'General case' 0 N--CA 1.47 0.566 0 O-C-N 123.572 0.545 . . . . 0.0 110.776 -176.114 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 85.1 t -83.55 132.54 31.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.914 -0.584 . . . . 0.0 109.731 178.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.445 ' HG2' ' O ' ' A' ' 22' ' ' ASN . 40.9 ptt180 -101.4 131.35 47.54 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.398 0.618 . . . . 0.0 111.109 -177.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.477 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 59.5 t -94.17 111.26 24.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.384 177.092 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.473 HG22 ' HB3' ' A' ' 77' ' ' TYR . 16.1 t -104.92 142.91 17.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.285 -171.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 8.1 t -151.42 -173.21 4.44 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.646 175.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -84.83 119.51 25.4 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.899 0.381 . . . . 0.0 110.56 -179.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.539 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 76.3 t80 -70.28 -40.85 74.08 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.484 -176.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.587 ' O ' ' HG3' ' A' ' 95' ' ' LYS . 18.0 m -58.75 -56.94 15.72 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.36 -174.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.47 ' O ' HG13 ' A' ' 96' ' ' ILE . 33.1 mt-10 -75.29 -27.35 59.32 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 111.847 0.314 . . . . 0.0 111.847 -176.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.584 ' HE1' ' HA ' ' A' ' 32' ' ' TYR . 65.7 t80 -61.78 -47.86 83.24 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 175.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 81.5 mm-40 -65.33 -28.84 69.58 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.946 178.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.587 ' HG3' ' O ' ' A' ' 91' ' ' SER . 65.9 mttm -68.49 -25.01 64.76 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.495 176.185 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.47 HG13 ' O ' ' A' ' 92' ' ' GLU . 77.0 mt -72.93 -39.4 58.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 174.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -63.11 -39.43 94.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.167 0.508 . . . . 0.0 109.822 173.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 62.6 mmtt -65.19 -37.34 87.04 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.114 174.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 60.9 tttp -63.11 -47.63 82.02 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.69 179.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 55.2 ttt180 -72.15 -34.31 68.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.747 177.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 94.22 41.03 4.38 Favored Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.813 -0.708 . . . . 0.0 111.871 -178.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 20.1 m -84.2 -24.09 30.25 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.406 0.622 . . . . 0.0 110.212 177.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -116.04 103.63 10.76 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.144 174.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 91.7 mt -85.53 139.73 31.22 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.598 -172.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 24.0 mp0 -92.74 -176.87 4.38 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.791 175.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 73.9 t60 -77.86 -14.71 59.47 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.376 0.608 . . . . 0.0 110.335 177.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 21.4 t-160 -82.95 42.33 0.79 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.398 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 63.7 m-70 -130.4 -40.58 1.26 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.811 176.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 16.8 t60 -71.65 -28.88 64.06 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 177.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 -116.29 131.74 56.86 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.348 173.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 45.1 t-80 . . . . . 0 C--O 1.246 0.89 0 CA-C-O 118.568 -0.73 . . . . 0.0 109.974 -179.814 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.414 ' O ' HD13 ' A' ' 81' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.045 0 CA-C-O 120.734 0.302 . . . . 0.0 110.627 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -136.86 171.05 15.07 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 176.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.423 ' O ' ' HG3' ' A' ' 7' ' ' LYS . 7.1 m -61.97 -36.03 80.25 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.861 0.363 . . . . 0.0 110.282 179.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -62.44 -42.5 99.5 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.152 175.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 67.3 t -60.06 -42.21 89.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.696 178.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.477 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 67.3 mt -62.18 -42.13 94.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.396 178.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.423 ' HG3' ' O ' ' A' ' 3' ' ' SER . 95.5 mttt -57.43 -51.23 70.26 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.839 178.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -60.28 -48.18 82.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.475 178.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.491 ' CE2' HD11 ' A' ' 13' ' ' ILE . 72.5 t80 -55.41 -41.73 73.12 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.99 -178.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 6' ' ' ILE . 93.0 mt -64.64 -42.67 95.3 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.094 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -70.81 -34.45 71.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.776 0.322 . . . . 0.0 110.606 178.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -60.49 -37.46 81.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.568 175.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.491 HD11 ' CE2' ' A' ' 9' ' ' PHE . 64.2 mt -74.19 -41.87 51.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.157 0.503 . . . . 0.0 109.949 174.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 109.17 24.5 5.95 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.485 -175.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 82.5 mm-40 -102.3 -179.73 4.07 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.74 0.305 . . . . 0.0 110.584 -179.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -128.13 173.27 10.24 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 -179.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.476 ' HB3' HD13 ' A' ' 10' ' ' LEU . 30.0 p90 -158.51 141.32 14.57 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.765 0.317 . . . . 0.0 110.371 -178.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.551 ' HB ' ' HB2' ' A' ' 25' ' ' HIS . 69.7 mt -97.76 103.22 14.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 120.937 0.399 . . . . 0.0 110.2 179.549 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -89.49 118.21 28.97 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.55 -179.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 83.4 mt -116.07 -166.4 1.14 Allowed 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 175.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -67.15 101.79 0.94 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.888 0.375 . . . . 0.0 111.067 -179.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 48.6 m-80 64.88 15.98 10.22 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.359 -0.837 . . . . 0.0 111.601 177.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -132.44 128.25 37.08 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.301 -179.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.439 ' HB ' HG22 ' A' ' 86' ' ' VAL . 65.1 mt -109.55 106.65 21.11 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 172.208 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.551 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 20.4 m170 -87.41 115.49 24.86 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -178.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.42 HD21 HD11 ' A' ' 10' ' ' LEU . 0.3 OUTLIER -98.18 161.01 13.93 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.391 -173.806 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 57.3 mtpt -74.63 131.25 80.08 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.139 174.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.495 ' HA ' HG21 ' A' ' 88' ' ' THR . 89.8 Cg_exo -43.01 -50.23 6.41 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 123.825 3.017 . . . . 0.0 114.29 -174.07 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -75.15 -33.01 61.47 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.703 0.287 . . . . 0.0 111.655 -175.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.436 ' O ' HG23 ' A' ' 34' ' ' VAL . 21.8 t -74.12 -35.49 41.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.842 0.353 . . . . 0.0 110.305 -178.271 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 90.4 t80 -54.93 -38.49 67.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.877 179.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 73.8 t80 -59.14 -42.22 90.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.154 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -78.03 -31.16 50.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.985 -178.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 30' ' ' VAL . 92.8 t -65.38 -38.66 83.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.013 0.435 . . . . 0.0 109.838 175.25 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 26.9 t90 -57.34 -44.87 84.64 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.785 176.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.413 ' NZ ' ' HB3' ' A' ' 36' ' ' LYS . 8.3 mtpm? -80.02 -0.09 33.95 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.78 0.324 . . . . 0.0 111.24 -179.191 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -96.19 -39.58 9.61 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.012 0.434 . . . . 0.0 110.619 175.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 29.3 m -82.13 19.66 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.055 -0.52 . . . . 0.0 112.303 -173.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 91.02 19.48 42.79 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.97 176.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 37.17 65.82 2.33 Favored Pre-proline 0 N--CA 1.473 0.722 0 C-N-CA 123.884 0.874 . . . . 0.0 112.941 179.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -83.11 175.51 8.36 Favored 'Trans proline' 0 N--CA 1.458 -0.594 0 C-N-CA 122.482 2.122 . . . . 0.0 111.953 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -71.55 110.4 6.11 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.844 175.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.509 ' HB3' ' CG2' ' A' ' 76' ' ' VAL . 81.0 mt -73.7 129.14 37.33 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.795 -178.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 25.6 tptp -92.54 121.98 34.52 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.959 -178.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.403 ' HA ' ' HA ' ' A' ' 76' ' ' VAL . 41.7 p -103.24 156.19 17.9 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.805 -178.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 30.6 p90 -132.83 146.5 51.88 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 173.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 57.9 t -99.28 116.55 42.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.45 -179.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.659 HG23 ' HB ' ' A' ' 73' ' ' ILE . 6.2 tt -102.95 101.29 11.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 174.189 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -85.25 105.27 15.81 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.172 -175.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -94.67 154.33 17.38 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.895 -174.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.414 ' O ' ' HB ' ' A' ' 52' ' ' ILE . 40.6 mt-10 60.46 -133.62 0.76 Allowed 'General case' 0 C--O 1.236 0.356 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.132 179.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.608 HG12 ' HG3' ' A' ' 70' ' ' LYS . 42.2 mt 72.25 -63.8 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 C-N-CA 123.711 0.805 . . . . 0.0 110.307 -169.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.526 HG13 HG22 ' A' ' 52' ' ' ILE . 16.0 m -141.53 158.37 21.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.11 178.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -87.44 120.9 71.36 Favored Pre-proline 0 C--N 1.321 -0.647 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 173.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -59.99 -40.02 65.46 Favored 'Trans proline' 0 C--O 1.234 0.284 0 C-N-CA 122.822 2.348 . . . . 0.0 113.054 -172.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 164.48 -33.53 0.27 Allowed Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.487 -0.863 . . . . 0.0 112.214 -178.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -52.51 -35.25 52.7 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.878 0.371 . . . . 0.0 111.001 177.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -113.34 94.35 4.83 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 170.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -107.88 110.04 62.28 Favored Pre-proline 0 C--N 1.318 -0.761 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 174.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -64.07 107.62 0.82 Allowed 'Trans proline' 0 C--O 1.235 0.326 0 C-N-CA 122.698 2.265 . . . . 0.0 113.066 -174.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -80.54 -5.79 13.41 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 123.182 2.588 . . . . 0.0 110.624 178.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -95.61 -2.13 48.91 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.468 178.354 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 86.3 mtp 57.78 31.02 19.87 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.353 -176.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -99.87 115.15 28.93 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.224 -0.898 . . . . 0.0 109.99 -177.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -97.62 128.18 44.14 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.935 -178.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 22.4 p -99.12 175.54 5.86 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.449 -175.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -83.94 97.29 9.17 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.089 0.471 . . . . 0.0 110.025 178.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.413 HG12 ' HB3' ' A' ' 51' ' ' GLU . 16.9 t -97.81 138.8 21.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.967 -179.107 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 65.2 mttm -91.67 162.2 14.59 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.721 0.296 . . . . 0.0 110.991 -176.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.608 ' HG3' HG12 ' A' ' 52' ' ' ILE . 86.0 tttt -129.26 95.79 4.13 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.342 -0.39 . . . . 0.0 109.997 -178.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 18.8 m -139.26 146.35 25.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.186 -177.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -101.41 111.77 24.1 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.74 175.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.659 ' HB ' HG23 ' A' ' 48' ' ' ILE . 57.9 mt -91.1 132.96 34.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 179.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -117.7 126.75 53.06 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 120.885 0.374 . . . . 0.0 110.81 -174.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.437 ' HA ' ' H ' ' A' ' 90' ' ' TYR . 97.7 mttt -123.07 159.01 29.37 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.22 176.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.509 ' CG2' ' HB3' ' A' ' 43' ' ' LEU . 9.9 p -122.71 145.36 29.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.638 -175.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.405 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 53.2 p90 -152.51 165.29 35.57 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.964 0.412 . . . . 0.0 110.365 178.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -137.69 144.97 42.05 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 169.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.566 ' HG2' ' HG3' ' A' ' 85' ' ' ARG . 43.7 mt-10 -101.93 122.51 44.16 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.183 -177.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 49.6 p -73.17 178.25 4.55 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.044 -178.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.414 HD13 ' O ' ' A' ' 1' ' ' MET . 8.0 mp -64.06 -24.3 67.65 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.06 0.457 . . . . 0.0 109.851 176.131 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -83.26 -2.19 55.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.668 -0.696 . . . . 0.0 109.982 179.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 15.5 m120 71.03 24.57 3.92 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.35 178.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 62.0 t -90.33 134.71 28.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.15 -0.477 . . . . 0.0 109.779 176.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.566 ' HG3' ' HG2' ' A' ' 79' ' ' GLU . 4.3 mpt_? -92.3 110.3 21.69 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.035 -176.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.439 HG22 ' HB ' ' A' ' 24' ' ' ILE . 49.4 t -89.22 103.36 13.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 173.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.8 t -107.09 141.41 22.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.683 -170.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.495 HG21 ' HA ' ' A' ' 28' ' ' PRO . 73.0 m -149.56 153.73 37.59 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.583 175.308 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -64.43 127.96 33.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.931 0.396 . . . . 0.0 111.047 -179.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.437 ' H ' ' HA ' ' A' ' 75' ' ' LYS . 83.7 t80 -80.69 -26.68 37.37 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.034 -174.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 47.3 t -62.94 -44.15 96.85 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.441 ' O ' ' HB3' ' A' ' 95' ' ' LYS . 39.8 mt-10 -80.05 -20.2 45.8 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.068 177.294 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -70.38 -49.53 48.14 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.915 -0.314 . . . . 0.0 110.406 173.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.472 ' HA ' HD12 ' A' ' 97' ' ' LEU . 19.6 pt20 -68.05 -22.6 64.94 Favored 'General case' 0 C--N 1.334 -0.074 0 CA-C-O 121.034 0.445 . . . . 0.0 110.05 177.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.441 ' HB3' ' O ' ' A' ' 92' ' ' GLU . 86.7 tttt -61.43 -45.05 95.91 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.726 173.284 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.43 HG13 ' O ' ' A' ' 92' ' ' GLU . 66.3 mt -68.49 -34.93 68.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.166 176.079 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.472 HD12 ' HA ' ' A' ' 94' ' ' GLN . 75.7 mt -60.83 -41.65 96.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.641 176.196 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.442 ' HG2' ' O ' ' A' ' 94' ' ' GLN . 34.4 mmtp -67.25 -38.77 85.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.177 0.513 . . . . 0.0 110.225 176.301 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -60.92 -50.22 74.3 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.31 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 73.9 mtp85 -95.44 1.17 53.99 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.641 -174.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 69.92 29.88 70.56 Favored Glycine 0 C--O 1.229 -0.203 0 C-N-CA 121.171 -0.538 . . . . 0.0 113.191 175.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.479 ' HA ' ' HE1' ' A' ' 108' ' ' HIS . 5.0 m -111.94 155.74 23.22 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 -178.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -128.58 156.87 42.66 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.834 0.349 . . . . 0.0 110.585 178.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 51.9 tp -76.44 -33.18 58.78 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 176.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -74.03 -46.52 42.9 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.085 178.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 79.9 m-70 -112.63 107.7 16.49 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.702 -172.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 11.1 m170 -88.7 144.76 26.06 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 172.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . 0.479 ' HE1' ' HA ' ' A' ' 102' ' ' THR . 46.4 m80 -101.22 160.13 14.66 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 110.185 -0.302 . . . . 0.0 110.185 -174.334 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 29.9 m80 -78.92 41.5 0.43 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.279 0.561 . . . . 0.0 110.614 177.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 20.1 t-160 -170.32 -39.81 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -179.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 3.6 p80 . . . . . 0 C--O 1.245 0.828 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.621 174.879 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.51 ' HE3' HG12 ' A' ' 6' ' ' ILE . 48.5 mtm . . . . . 0 N--CA 1.481 1.081 0 CA-C-O 120.999 0.428 . . . . 0.0 111.006 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -86.47 162.4 18.11 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 167.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 11.5 p -57.48 -32.37 66.92 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.068 0.461 . . . . 0.0 111.078 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.475 ' HA ' ' HD2' ' A' ' 7' ' ' LYS . 35.3 tt0 -61.0 -42.3 98.18 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.697 178.071 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.3 t -68.01 -35.21 71.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.373 179.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.51 HG12 ' HE3' ' A' ' 1' ' ' MET . 59.7 mt -62.73 -39.77 86.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.138 176.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.475 ' HD2' ' HA ' ' A' ' 4' ' ' GLU . 61.8 mttm -56.78 -44.66 82.07 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.488 176.097 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -57.67 -44.1 85.51 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.022 178.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 85.3 t80 -66.9 -43.54 83.13 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.878 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.513 HD13 ' HB3' ' A' ' 17' ' ' TYR . 87.3 mt -66.57 -40.03 88.76 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.371 -177.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -67.44 -39.46 85.4 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.922 0.391 . . . . 0.0 110.17 176.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -58.24 -51.04 71.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.183 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 33.7 pt -72.38 -26.26 24.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.405 -178.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.32 44.16 4.75 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.723 177.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -123.19 149.66 44.35 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.009 0.433 . . . . 0.0 110.813 178.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -93.99 131.96 38.93 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.294 -177.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.513 ' HB3' HD13 ' A' ' 10' ' ' LEU . 27.9 p90 -115.23 136.28 53.28 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.051 179.048 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 57.1 mt -87.45 97.81 6.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 120.848 0.356 . . . . 0.0 110.107 -179.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -91.12 106.63 18.65 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.352 0.596 . . . . 0.0 110.459 -179.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.516 ' HB2' ' HB2' ' A' ' 23' ' ' GLU . 88.1 mt -93.95 -164.84 1.22 Allowed 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.222 -0.899 . . . . 0.0 108.803 174.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -69.56 92.73 0.65 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.635 0.255 . . . . 0.0 110.52 179.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 10.0 m120 69.54 18.55 7.72 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.643 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.516 ' HB2' ' HB2' ' A' ' 20' ' ' LEU . 41.6 mt-10 -130.18 113.71 14.8 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.937 178.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 59.5 mt -96.04 102.55 13.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 173.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.507 ' HA ' ' O ' ' A' ' 87' ' ' VAL . 13.6 m-70 -90.35 117.74 29.31 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.016 0.436 . . . . 0.0 109.949 -179.076 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 70.6 mt -107.56 168.96 8.88 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.519 0.676 . . . . 0.0 111.562 -176.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -82.57 140.27 44.43 Favored Pre-proline 0 C--N 1.322 -0.622 0 CA-C-N 115.011 -0.995 . . . . 0.0 108.364 171.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.496 ' HA ' HG21 ' A' ' 88' ' ' THR . 3.2 Cg_endo -47.06 -43.69 24.53 Favored 'Trans proline' 0 CA--C 1.534 0.495 0 C-N-CA 123.195 2.597 . . . . 0.0 113.298 -176.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 23.3 mm-40 -61.15 -41.19 96.31 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.998 0.428 . . . . 0.0 111.197 179.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 47.9 t -73.82 -37.78 49.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.852 -178.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -60.62 -40.59 92.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.632 179.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 85.1 t80 -60.49 -39.69 88.6 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.576 178.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 38.2 mm-40 -59.6 -50.84 72.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.842 177.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 41.4 t -65.62 -40.33 87.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.482 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.996 -177.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.712 ' CD1' ' HD2' ' A' ' 41' ' ' PRO . 32.5 t90 -57.02 -44.62 83.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.708 -179.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.423 ' HE2' ' HB3' ' A' ' 36' ' ' LYS . 51.1 mtpt -89.5 3.7 51.57 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.881 0.372 . . . . 0.0 111.108 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 39.8 t80 -83.6 -38.6 21.4 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 178.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -96.84 9.29 6.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.915 177.194 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 79.04 50.4 5.87 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.739 -0.744 . . . . 0.0 113.763 173.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 58.24 78.33 0.36 Allowed Pre-proline 0 N--CA 1.467 0.41 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 172.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.712 ' HD2' ' CD1' ' A' ' 35' ' ' TRP . 5.4 Cg_exo -78.76 173.73 13.22 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.374 2.049 . . . . 0.0 111.39 172.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -76.99 123.58 26.54 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.046 177.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.453 ' HB3' ' CG2' ' A' ' 76' ' ' VAL . 87.6 mt -94.36 132.03 39.41 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.809 -177.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -107.44 141.81 38.25 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.768 178.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 24.1 p -120.76 146.09 46.85 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.775 0.321 . . . . 0.0 111.487 -176.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 17.8 p90 -133.09 154.98 50.06 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 177.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.5 t -106.01 114.61 45.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.274 178.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 8.6 tt -110.53 118.03 56.22 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.267 0.556 . . . . 0.0 109.95 177.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.489 ' HG2' ' HG2' ' A' ' 72' ' ' LYS . 50.2 mt-10 -84.56 118.78 24.55 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.917 -178.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -96.13 103.13 15.0 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 174.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.486 ' HG2' ' HD3' ' A' ' 70' ' ' LYS . 56.2 mt-10 -77.23 122.69 25.41 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.792 -178.162 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.574 ' HB ' ' HB3' ' A' ' 69' ' ' LYS . 68.5 mt -87.05 108.94 18.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.855 177.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 48.5 t -126.46 100.02 6.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.346 179.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.605 ' HB2' ' HD2' ' A' ' 55' ' ' PRO . 10.1 pt-20 -137.11 165.71 32.7 Favored Pre-proline 0 C--N 1.32 -0.69 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.193 -177.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.605 ' HD2' ' HB2' ' A' ' 54' ' ' GLU . 9.7 Cg_endo -51.21 138.69 45.06 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 123.146 2.564 . . . . 0.0 112.976 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -135.11 23.73 3.47 Favored Glycine 0 N--CA 1.447 -0.606 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.313 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 -79.55 -19.46 49.42 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.147 0.498 . . . . 0.0 110.284 177.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 94.2 m-85 -80.29 -22.4 41.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.391 178.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -134.44 97.07 14.82 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.753 178.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.42 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 51.1 Cg_exo -53.63 133.92 55.96 Favored 'Trans proline' 0 C--O 1.236 0.41 0 C-N-CA 123.288 2.659 . . . . 0.0 113.008 -174.459 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 60' ' ' PRO . 39.6 Cg_exo -61.0 116.12 3.15 Favored 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 123.042 2.494 . . . . 0.0 111.979 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.507 ' CD ' ' H ' ' A' ' 63' ' ' MET . 0.4 OUTLIER -90.23 -158.06 0.51 Allowed 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 178.156 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . 0.507 ' H ' ' CD ' ' A' ' 62' ' ' GLU . 80.7 mtp -62.36 -18.21 60.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.112 0.482 . . . . 0.0 109.808 171.147 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -86.13 101.64 13.17 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 169.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -85.01 97.92 10.1 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.002 -175.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.5 p -76.49 45.1 0.38 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.981 176.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -75.32 -49.1 20.19 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.716 -176.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.4 p -148.09 120.42 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.272 0.558 . . . . 0.0 110.635 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.574 ' HB3' ' HB ' ' A' ' 52' ' ' ILE . 27.0 tptp -101.06 110.46 22.49 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.24 177.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.486 ' HD3' ' HG2' ' A' ' 51' ' ' GLU . 71.3 mmtt -84.26 105.38 15.06 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.686 177.304 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' A' ' 49' ' ' GLU . 48.0 t -101.53 100.28 10.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 176.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.489 ' HG2' ' HG2' ' A' ' 49' ' ' GLU . 61.5 mttm -78.85 98.36 6.31 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.389 -177.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 65.4 mt -97.77 118.91 45.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.131 0.491 . . . . 0.0 110.553 -178.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.427 ' O ' ' HB3' ' A' ' 90' ' ' TYR . 87.8 tttt -89.58 128.43 36.03 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.951 -0.568 . . . . 0.0 109.958 178.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.458 ' HG2' ' HA ' ' A' ' 89' ' ' ASP . 68.3 mttm -129.73 164.17 24.57 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 110.123 -0.325 . . . . 0.0 110.123 177.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.453 ' CG2' ' HB3' ' A' ' 43' ' ' LEU . 11.1 p -119.82 148.03 23.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.513 -174.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 39.0 p90 -154.79 162.35 41.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.058 0.456 . . . . 0.0 111.108 -179.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -132.45 142.21 49.15 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 168.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -102.16 132.43 48.07 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.633 -173.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 72.4 p -82.31 179.53 7.77 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.926 0.394 . . . . 0.0 109.994 176.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.407 ' N ' HD12 ' A' ' 81' ' ' LEU . 5.9 mp -77.11 -6.45 52.87 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.85 0.357 . . . . 0.0 110.7 -178.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.524 ' HB2' HG23 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -97.89 8.85 44.05 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.203 -179.384 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 63.4 t30 67.14 28.42 8.22 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.865 0.84 . . . . 0.0 110.133 -176.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.524 HG23 ' HB2' ' A' ' 82' ' ' ASP . 59.2 t -98.72 113.72 34.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 175.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 85.6 mtt180 -94.69 110.51 22.35 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.567 -176.09 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 58.0 t -81.63 104.62 10.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.724 179.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.507 ' O ' ' HA ' ' A' ' 25' ' ' HIS . 41.4 t -103.53 140.97 20.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.236 -172.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.496 HG21 ' HA ' ' A' ' 28' ' ' PRO . 98.6 m -147.58 151.43 36.25 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.33 174.359 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.458 ' HA ' ' HG2' ' A' ' 75' ' ' LYS . 20.3 t70 -59.97 134.8 57.38 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.063 0.458 . . . . 0.0 111.563 -177.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.427 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 88.1 t80 -76.64 -41.04 47.29 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.62 -175.26 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 11.0 p -68.65 -37.57 79.78 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.911 -0.316 . . . . 0.0 111.058 -176.699 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 43.1 mm-40 -72.65 -31.75 65.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.594 0.235 . . . . 0.0 110.992 176.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 57.1 t80 -69.34 -49.77 52.56 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 121.078 -0.249 . . . . 0.0 111.078 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.469 ' HA ' HD12 ' A' ' 97' ' ' LEU . 11.0 pt20 -63.86 -28.66 70.0 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 121.146 0.498 . . . . 0.0 110.094 178.511 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 53.7 tttt -60.59 -45.55 93.55 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.414 173.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.541 ' HA ' ' HB3' ' A' ' 99' ' ' LYS . 21.7 mt -71.07 -33.1 50.22 Favored 'Isoleucine or valine' 0 C--O 1.236 0.394 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.458 -179.536 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.469 HD12 ' HA ' ' A' ' 94' ' ' GLN . 98.4 mt -56.62 -40.92 76.21 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.031 0.443 . . . . 0.0 110.197 175.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -81.06 -31.92 34.25 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.624 177.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.541 ' HB3' ' HA ' ' A' ' 96' ' ' ILE . 46.9 tttm -56.59 -46.69 80.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.11 178.404 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 68.6 mtp85 -95.03 -14.47 24.29 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.576 179.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.43 ' HA2' HD21 ' A' ' 104' ' ' LEU . . . 73.65 67.19 1.83 Allowed Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.673 -0.775 . . . . 0.0 111.779 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 12.8 m -92.5 97.72 11.01 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.619 0.247 . . . . 0.0 111.026 -176.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.856 ' HG2' ' HB2' ' A' ' 111' ' ' HIS . 95.1 mttt 57.62 70.07 0.68 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.079 175.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.43 HD21 ' HA2' ' A' ' 101' ' ' GLY . 98.6 mt -73.81 166.42 23.36 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.554 -0.748 . . . . 0.0 112.483 -171.44 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -78.48 -21.49 48.9 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 114.989 -1.005 . . . . 0.0 112.238 -174.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 32.9 m170 -85.47 17.44 3.19 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.263 0.554 . . . . 0.0 111.159 -173.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.411 ' C ' ' H ' ' A' ' 109' ' ' HIS . 83.8 m-70 -121.43 130.55 53.65 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 172.45 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 19.3 m170 -77.34 42.08 0.33 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.481 0.658 . . . . 0.0 110.814 -178.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.411 ' H ' ' C ' ' A' ' 107' ' ' HIS . 31.4 t-80 -172.39 -7.29 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.902 -1.045 . . . . 0.0 109.295 -179.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.776 ' HB3' ' HB3' ' A' ' 103' ' ' LYS . 59.8 m-70 68.3 -62.68 0.36 Allowed 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.639 0.776 . . . . 0.0 111.344 -174.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.856 ' HB2' ' HG2' ' A' ' 103' ' ' LYS . 29.6 t-80 . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.203 -0.903 . . . . 0.0 109.327 178.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.1 0 CA-C-O 120.84 0.352 . . . . 0.0 110.424 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -88.11 163.9 15.98 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.642 175.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 21.0 t -67.78 -25.99 65.87 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 175.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.422 ' O ' ' HG3' ' A' ' 8' ' ' GLU . 35.5 tt0 -51.94 -45.77 64.47 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.012 175.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 42.3 t -61.01 -41.38 88.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.854 -178.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 56.6 mt -65.14 -41.91 92.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.284 179.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 55.9 mttm -56.18 -44.44 79.38 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.24 177.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.422 ' HG3' ' O ' ' A' ' 4' ' ' GLU . 39.0 mt-10 -63.05 -41.65 99.53 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.595 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -66.02 -46.28 78.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.849 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 96.3 mt -68.16 -34.17 75.82 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.227 -177.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -67.15 -33.69 75.97 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.292 179.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -63.73 -55.06 26.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.844 178.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.415 HG13 ' H ' ' A' ' 15' ' ' GLU . 19.6 pt -69.56 -39.55 78.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.688 -177.334 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 95.36 21.73 23.9 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.815 177.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.415 ' H ' HG13 ' A' ' 13' ' ' ILE . 23.5 mm-40 -85.94 130.05 34.66 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 175.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -69.16 122.59 19.1 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.732 -176.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 43.8 p90 -112.95 133.91 54.7 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.087 -0.708 . . . . 0.0 109.087 171.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.556 ' HB ' ' HB2' ' A' ' 25' ' ' HIS . 57.8 mt -90.08 94.74 5.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 120.938 0.399 . . . . 0.0 110.081 -178.278 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -84.95 109.48 18.2 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.306 0.574 . . . . 0.0 110.598 179.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 87.4 mt -101.32 -161.86 0.89 Allowed 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.1 -0.954 . . . . 0.0 108.706 174.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -66.37 96.09 0.34 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.772 0.32 . . . . 0.0 110.61 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 65.25 20.14 11.84 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.65 179.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -134.24 114.22 12.82 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.801 0.334 . . . . 0.0 111.623 -178.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.446 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 54.3 mt -94.36 101.21 12.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 173.503 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.556 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 18.8 m-70 -84.87 107.07 16.84 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 177.605 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.9 mt -95.2 169.72 9.89 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.424 0.631 . . . . 0.0 111.752 -175.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.403 ' HB2' HG23 ' A' ' 30' ' ' VAL . 44.8 mtpt -87.11 136.02 34.3 Favored Pre-proline 0 C--N 1.319 -0.728 0 CA-C-N 114.904 -1.044 . . . . 0.0 108.688 175.217 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.412 ' HA ' HG21 ' A' ' 88' ' ' THR . 82.9 Cg_exo -47.0 -43.53 24.46 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 123.305 2.67 . . . . 0.0 113.245 -177.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -56.86 -44.56 82.3 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.29 0.567 . . . . 0.0 110.86 178.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.403 HG23 ' HB2' ' A' ' 27' ' ' LYS . 17.1 t -76.68 -46.83 30.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.73 -175.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 83.9 t80 -56.4 -37.97 70.87 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.524 -179.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.652 ' OH ' ' HD2' ' A' ' 100' ' ' ARG . 6.6 t80 -58.27 -32.14 68.12 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.701 178.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 50.7 mm-40 -95.21 -37.17 11.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.546 0.212 . . . . 0.0 111.555 179.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.507 ' O ' HG22 ' A' ' 38' ' ' VAL . 93.4 t -62.67 -35.86 72.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.69 0.281 . . . . 0.0 110.789 179.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.675 ' CD1' ' HD2' ' A' ' 41' ' ' PRO . 46.2 t90 -55.56 -36.94 67.36 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.665 176.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.45 ' HA ' ' OE2' ' A' ' 40' ' ' GLU . 93.1 mttt -74.85 -40.98 60.71 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.483 179.14 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -58.02 -41.62 83.53 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.657 -178.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.577 HG23 ' HD3' ' A' ' 41' ' ' PRO . 15.5 m -85.54 1.46 5.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.753 -178.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 90.89 41.07 5.42 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.97 -0.633 . . . . 0.0 114.289 169.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.45 ' OE2' ' HA ' ' A' ' 36' ' ' LYS . 21.3 mp0 51.25 67.18 4.48 Favored Pre-proline 0 N--CA 1.467 0.416 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 176.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.675 ' HD2' ' CD1' ' A' ' 35' ' ' TRP . 72.5 Cg_endo -77.41 -179.58 5.57 Favored 'Trans proline' 0 C--O 1.24 0.598 0 C-N-CA 122.461 2.108 . . . . 0.0 112.119 178.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -68.47 132.13 46.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.683 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.459 ' HB3' ' CG2' ' A' ' 76' ' ' VAL . 77.8 mt -106.31 107.73 18.88 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.212 178.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.545 ' HE2' ' HG3' ' A' ' 79' ' ' GLU . 31.1 mttm -88.51 118.11 27.92 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 -179.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 41.8 p -95.62 119.42 34.08 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.33 177.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 14.6 p90 -118.56 152.88 35.16 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -179.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 60.3 t -104.17 112.6 38.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.18 178.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.496 HG23 ' HB ' ' A' ' 73' ' ' ILE . 11.6 tt -102.09 123.9 55.62 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 176.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -103.73 113.11 26.38 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.154 0.502 . . . . 0.0 110.731 -176.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -116.91 172.17 7.43 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.167 -179.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -73.06 162.45 29.46 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 110.248 -0.278 . . . . 0.0 110.248 179.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.2 tt -65.6 100.01 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-O 121.651 0.739 . . . . 0.0 110.56 178.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 20.3 m -90.55 137.59 21.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.597 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.422 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 2.3 pp20? -92.92 145.7 30.67 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.48 -175.11 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 54' ' ' GLU . 73.1 Cg_endo -98.86 8.42 0.92 Allowed 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 123.455 2.77 . . . . 0.0 113.07 176.189 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 172.67 35.97 0.03 OUTLIER Glycine 0 CA--C 1.518 0.262 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.725 -177.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -137.22 46.18 2.18 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 179.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 72.3 t80 -57.19 -35.5 69.67 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-N 115.002 -0.999 . . . . 0.0 111.245 -176.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -109.47 98.1 30.49 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-N 116.295 -0.411 . . . . 0.0 109.981 175.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -89.12 155.78 5.71 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 122.661 2.24 . . . . 0.0 112.472 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -74.34 113.02 3.69 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 122.112 1.875 . . . . 0.0 110.669 171.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -65.35 110.61 2.69 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.151 0.5 . . . . 0.0 111.054 -175.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 62.0 mtm -105.24 167.57 9.64 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.147 179.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -89.94 -49.98 6.29 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.984 0.421 . . . . 0.0 111.252 -175.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 51.8 m-85 -104.72 56.73 0.7 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.157 0.503 . . . . 0.0 110.34 -175.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.5 p -61.41 125.29 23.23 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.473 -175.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -75.1 115.18 14.45 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.92 174.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 60.1 t -88.17 118.74 34.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 120.904 0.383 . . . . 0.0 110.39 -179.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 54.8 tttp -113.44 142.57 45.75 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.287 -179.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -110.78 148.17 32.92 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.279 176.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 18.2 m -110.74 124.11 67.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 121.345 0.593 . . . . 0.0 110.61 177.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -88.55 95.24 10.16 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.893 178.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.496 ' HB ' HG23 ' A' ' 48' ' ' ILE . 49.0 mt -91.25 128.9 42.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.647 -176.007 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 84.1 tttt -101.32 113.11 25.88 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.009 -179.423 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.449 ' HA ' ' H ' ' A' ' 90' ' ' TYR . 68.4 mttm -122.17 167.1 13.59 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.358 -179.199 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.459 ' CG2' ' HB3' ' A' ' 43' ' ' LEU . 14.8 p -126.31 147.39 31.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.819 -175.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 44.1 p90 -152.65 155.8 37.99 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.695 0.283 . . . . 0.0 110.782 175.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -124.71 157.73 34.93 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 171.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.545 ' HG3' ' HE2' ' A' ' 44' ' ' LYS . 29.4 mt-10 -109.07 146.34 34.16 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.908 0.385 . . . . 0.0 111.191 -174.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 32.5 p -102.6 179.46 4.29 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.995 175.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 11.2 mp -67.49 -18.16 64.95 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.066 0.46 . . . . 0.0 110.907 178.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -94.28 9.61 37.38 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.599 -177.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 14.7 t30 69.64 1.98 3.6 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 121.427 0.632 . . . . 0.0 110.808 -179.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 52.6 t -72.49 115.63 13.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 178.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.545 ' HG2' ' HG2' ' A' ' 79' ' ' GLU . 91.8 mtt180 -94.23 118.59 31.8 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.786 -176.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.446 ' HA ' ' O ' ' A' ' 24' ' ' ILE . 59.7 t -87.12 104.96 14.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 178.09 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 23.9 t -102.07 141.19 18.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.061 -173.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.412 HG21 ' HA ' ' A' ' 28' ' ' PRO . 97.9 m -150.99 150.02 30.27 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.859 -0.609 . . . . 0.0 109.363 175.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -64.88 125.83 26.08 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.943 0.401 . . . . 0.0 110.349 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.449 ' H ' ' HA ' ' A' ' 75' ' ' LYS . 18.3 t80 -75.85 -25.28 56.07 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.945 -0.571 . . . . 0.0 111.512 -173.109 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 10.9 t -74.31 -44.72 51.44 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 -70.36 -29.95 66.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.806 176.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.511 ' HE1' ' HA ' ' A' ' 32' ' ' TYR . 72.4 t80 -65.34 -52.17 55.66 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.365 -0.38 . . . . 0.0 109.985 174.942 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 64.2 mt-30 -63.16 -27.87 69.67 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.004 177.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -58.44 -51.3 70.41 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.013 176.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.446 ' HA ' ' HB3' ' A' ' 99' ' ' LYS . 62.3 mt -72.99 -32.57 40.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.22 0.533 . . . . 0.0 110.436 179.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.726 HD13 ' HB ' ' A' ' 102' ' ' THR . 0.2 OUTLIER -59.2 -50.2 74.95 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.509 -0.768 . . . . 0.0 110.033 176.853 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -65.96 -36.13 82.5 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.576 176.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.446 ' HB3' ' HA ' ' A' ' 96' ' ' ILE . 47.8 tttp -57.37 -42.39 82.01 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.29 -179.174 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.652 ' HD2' ' OH ' ' A' ' 32' ' ' TYR . 63.5 ttt180 -73.1 -40.59 64.86 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.079 0.466 . . . . 0.0 110.924 179.26 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 110.7 16.1 10.39 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.75 -0.738 . . . . 0.0 111.962 -176.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.726 ' HB ' HD13 ' A' ' 97' ' ' LEU . 18.8 m -82.47 139.62 33.85 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 176.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -112.73 125.42 54.29 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.847 0.356 . . . . 0.0 110.222 178.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 93.9 mt -72.5 129.36 38.14 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.46 -179.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.17 -34.05 71.65 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.9 -177.048 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 30.8 t60 -69.92 -5.22 24.54 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-O 120.959 0.409 . . . . 0.0 111.318 -177.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 29.2 t60 -91.23 -16.19 28.02 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.508 0.671 . . . . 0.0 109.296 175.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 45.3 t60 -115.42 4.63 14.37 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.079 -0.964 . . . . 0.0 108.591 179.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 4.8 t-160 -142.24 109.7 5.68 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.368 -1.287 . . . . 0.0 107.912 -177.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 44.2 m170 -56.25 -48.49 76.43 Favored 'General case' 0 N--CA 1.467 0.407 0 O-C-N 123.2 0.313 . . . . 0.0 111.708 -171.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 33.5 m80 . . . . . 0 C--O 1.246 0.879 0 CA-C-O 118.692 -0.67 . . . . 0.0 109.816 175.716 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.999 0 CA-C-O 120.847 0.356 . . . . 0.0 110.599 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.513 ' HB3' ' OD2' ' A' ' 82' ' ' ASP . 2.0 m-20 -118.13 176.58 5.15 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.394 -0.595 . . . . 0.0 109.394 176.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.427 ' O ' ' HG3' ' A' ' 7' ' ' LYS . 14.8 p -62.27 -29.36 70.36 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.081 0.467 . . . . 0.0 110.374 178.465 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -57.08 -46.76 82.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.984 176.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 39.8 t -63.0 -38.9 83.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.266 -178.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.491 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 61.5 mt -63.58 -43.56 98.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.209 178.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.427 ' HG3' ' O ' ' A' ' 3' ' ' SER . 99.0 mttt -58.51 -45.13 89.45 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.817 178.255 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -57.43 -47.28 82.19 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.108 179.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -61.04 -46.05 92.27 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.768 178.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.491 ' HG ' ' O ' ' A' ' 6' ' ' ILE . 95.7 mt -64.69 -37.12 86.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.454 -177.398 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -74.5 -36.02 63.23 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.785 0.326 . . . . 0.0 110.842 177.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -67.88 -35.06 77.86 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.848 0.356 . . . . 0.0 110.861 -179.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 39.0 pt -82.34 -17.2 11.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.854 0.359 . . . . 0.0 110.576 175.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 77.09 48.45 8.35 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 121.119 -0.562 . . . . 0.0 113.045 174.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.03 158.55 26.56 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.871 0.367 . . . . 0.0 110.431 179.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -95.99 120.41 36.22 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.822 -178.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 42.1 p90 -116.25 145.92 42.76 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.09 179.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.491 ' HB ' ' HB2' ' A' ' 25' ' ' HIS . 51.1 mt -96.39 97.97 7.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 120.76 0.314 . . . . 0.0 110.859 -177.222 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 47.2 tt0 -90.58 125.51 35.65 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.072 0.463 . . . . 0.0 110.171 176.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.585 ' HB2' ' HB2' ' A' ' 23' ' ' GLU . 90.4 mt -120.39 -161.65 0.9 Allowed 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 174.447 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -78.67 101.16 7.36 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.796 0.331 . . . . 0.0 110.407 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 58.7 m-80 69.43 10.07 7.55 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.724 -178.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.585 ' HB2' ' HB2' ' A' ' 20' ' ' LEU . 46.9 mt-10 -123.48 132.98 54.08 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.71 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.53 ' HB ' HG22 ' A' ' 86' ' ' VAL . 69.5 mt -120.98 111.59 32.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 170.582 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.491 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 66.3 m-70 -100.97 127.17 47.58 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 110.132 -0.322 . . . . 0.0 110.132 -178.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 69.9 mt -118.01 177.08 4.92 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.413 -176.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 58.7 mttp -92.61 154.9 42.4 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.118 175.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -53.26 -48.52 21.58 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.795 2.33 . . . . 0.0 113.07 -174.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -64.08 -47.61 79.43 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.841 0.353 . . . . 0.0 110.773 -177.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.404 ' O ' HG23 ' A' ' 34' ' ' VAL . 42.0 t -62.48 -45.86 97.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.775 -178.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -57.1 -44.76 83.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.842 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 89.4 t80 -59.48 -42.29 91.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.324 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -75.72 -44.37 42.32 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.91 -177.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 30' ' ' VAL . 97.5 t -61.83 -36.52 74.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-O 120.744 0.307 . . . . 0.0 110.571 178.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 28.3 t90 -53.77 -53.83 46.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.816 177.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.468 ' HA ' ' HG3' ' A' ' 40' ' ' GLU . 65.4 mttm -71.38 -29.9 65.5 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.039 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 86.4 t80 -60.91 -42.09 97.4 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.458 179.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.498 HG23 ' HD3' ' A' ' 41' ' ' PRO . 30.3 m -86.29 -0.37 6.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 -176.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 109.36 11.01 22.72 Favored Glycine 0 C--N 1.329 0.187 0 C-N-CA 120.437 -0.887 . . . . 0.0 113.427 175.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.468 ' HG3' ' HA ' ' A' ' 36' ' ' LYS . 46.3 mt-10 57.77 72.17 0.95 Allowed Pre-proline 0 C--O 1.234 0.287 0 C-N-CA 122.936 0.494 . . . . 0.0 111.938 179.321 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.498 ' HD3' HG23 ' A' ' 38' ' ' VAL . 5.0 Cg_exo -74.74 173.25 14.72 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.764 2.309 . . . . 0.0 111.475 176.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -64.63 123.39 19.18 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.014 0.435 . . . . 0.0 110.849 179.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.485 ' HB3' ' CG2' ' A' ' 76' ' ' VAL . 86.4 mt -90.84 102.25 15.01 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.136 176.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 64.9 mttp -82.74 143.66 30.73 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 176.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 31.5 p -121.51 138.88 54.11 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.95 0.405 . . . . 0.0 111.195 -176.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 15.0 p90 -127.16 141.22 51.8 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 176.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.464 ' HA ' ' HA ' ' A' ' 74' ' ' LYS . 5.3 p -98.8 105.24 17.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-O 121.655 0.74 . . . . 0.0 110.28 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 14.7 tt -93.99 125.66 46.55 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 CA-C-N 115.679 -0.692 . . . . 0.0 109.599 179.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -92.21 105.71 17.87 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.259 -176.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 50.8 m-20 -92.92 123.71 36.38 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.756 -0.657 . . . . 0.0 109.663 -178.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.429 ' HG2' ' HG2' ' A' ' 70' ' ' LYS . 38.1 mt-10 -95.33 98.11 10.34 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.115 0.483 . . . . 0.0 110.342 -179.546 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.57 HG23 ' HB2' ' A' ' 69' ' ' LYS . 8.5 tt -93.07 120.69 42.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.749 -177.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.486 HG22 HG11 ' A' ' 68' ' ' VAL . 34.1 t -90.67 132.15 35.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.508 177.232 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.468 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 36.4 mt-10 -87.73 121.98 70.6 Favored Pre-proline 0 C--N 1.323 -0.583 0 CA-C-O 120.959 0.409 . . . . 0.0 109.957 -178.297 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 54' ' ' GLU . 27.4 Cg_exo -62.86 113.01 1.81 Allowed 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 123.185 2.59 . . . . 0.0 112.872 -176.191 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -135.42 35.7 2.14 Favored Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 175.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -98.25 9.94 41.81 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.376 0.608 . . . . 0.0 109.881 -175.267 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -87.72 -10.61 50.65 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.035 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -145.16 139.72 15.36 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.364 -177.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -47.57 113.78 0.86 Allowed 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.863 2.375 . . . . 0.0 112.26 176.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -58.63 127.93 26.37 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 123.264 2.642 . . . . 0.0 113.265 -172.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 29.9 mt-10 -63.08 -45.4 92.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.842 175.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 92.8 mmm -123.42 125.95 45.9 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.241 176.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -62.72 -37.91 88.41 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.318 0.58 . . . . 0.0 110.758 -178.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -100.89 112.56 25.01 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.273 -175.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 87.3 m -129.08 134.28 48.02 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.211 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -72.71 131.67 42.67 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 121.02 0.438 . . . . 0.0 110.944 -177.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.486 HG11 HG22 ' A' ' 53' ' ' VAL . 19.7 m -86.86 168.83 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.35 178.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.57 ' HB2' HG23 ' A' ' 52' ' ' ILE . 56.3 mttm -96.3 107.7 20.09 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.014 0.435 . . . . 0.0 110.907 -179.218 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.429 ' HG2' ' HG2' ' A' ' 51' ' ' GLU . 26.0 mtpp -89.78 98.72 11.93 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.287 -0.634 . . . . 0.0 109.287 175.399 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 27.4 m -99.47 128.55 51.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.337 0.589 . . . . 0.0 111.072 -176.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -87.69 99.44 12.07 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.828 -0.623 . . . . 0.0 109.749 179.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 62.8 mt -101.69 114.24 40.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 121.539 0.685 . . . . 0.0 111.004 -177.083 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.56 ' O ' ' HB3' ' A' ' 90' ' ' TYR . 88.1 tttt -80.7 124.25 28.87 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.197 -179.414 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -120.15 163.81 17.15 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.639 -0.255 . . . . 0.0 110.367 178.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.485 ' CG2' ' HB3' ' A' ' 43' ' ' LEU . 10.9 p -122.92 148.35 26.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.904 -174.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.422 ' CE2' ' HD3' ' A' ' 85' ' ' ARG . 55.5 p90 -152.95 153.24 32.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.71 0.291 . . . . 0.0 111.144 178.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.464 ' HB3' HD23 ' A' ' 43' ' ' LEU . 47.8 p90 -122.41 156.94 32.95 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 172.204 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.512 ' HG2' ' HG2' ' A' ' 85' ' ' ARG . 29.3 mt-10 -103.86 149.91 24.64 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.626 -171.504 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 73.9 p -108.77 176.69 5.02 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.966 175.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.41 HD23 HD21 ' A' ' 2' ' ' ASN . 47.2 tp -66.84 -26.47 66.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.724 0.297 . . . . 0.0 111.069 179.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.513 ' OD2' ' HB3' ' A' ' 2' ' ' ASN . 1.4 m-20 -82.77 3.64 28.52 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.602 -0.272 . . . . 0.0 110.776 -176.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.447 ' HB2' ' O ' ' A' ' 82' ' ' ASP . 0.9 OUTLIER 71.51 10.52 6.52 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 123.55 0.532 . . . . 0.0 110.917 -175.875 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.47 HG23 ' HB2' ' A' ' 82' ' ' ASP . 62.5 t -84.3 128.08 39.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 176.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.512 ' HG2' ' HG2' ' A' ' 79' ' ' GLU . 82.9 mtt180 -107.38 129.12 54.96 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.469 0.652 . . . . 0.0 111.673 -173.121 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.53 HG22 ' HB ' ' A' ' 24' ' ' ILE . 58.3 t -91.38 112.62 25.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.946 -179.306 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 41.4 t -105.51 140.79 22.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.129 -173.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 93.0 m -151.63 148.89 28.51 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.321 174.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -58.45 129.23 41.07 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.537 0.684 . . . . 0.0 111.982 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.56 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 93.9 t80 -76.49 -23.99 53.79 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.008 -0.997 . . . . 0.0 110.603 -177.272 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 2.2 m -65.14 -54.21 33.22 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.437 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -71.38 -28.05 63.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.413 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -63.43 -49.22 74.6 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.951 0.405 . . . . 0.0 109.937 175.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.475 ' O ' ' HG3' ' A' ' 98' ' ' LYS . 68.2 mm-40 -65.2 -33.86 76.99 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.656 176.02 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -57.84 -44.25 86.39 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.739 177.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 40.6 mt -68.64 -34.26 64.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.076 178.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.43 ' HB3' ' HB2' ' A' ' 103' ' ' LYS . 74.9 mt -62.04 -37.09 83.63 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.951 0.405 . . . . 0.0 110.189 176.498 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.475 ' HG3' ' O ' ' A' ' 94' ' ' GLN . 86.0 mttt -73.05 -39.47 65.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.031 176.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 55.7 tptt -64.85 -46.33 82.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.461 -0.79 . . . . 0.0 111.374 -178.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 84.5 mtt-85 -89.67 -8.49 52.32 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.451 -177.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.5 27.47 63.35 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.42 177.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 23.1 m -78.77 -24.23 44.83 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.193 0.52 . . . . 0.0 110.387 179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.43 ' HB2' ' HB3' ' A' ' 97' ' ' LEU . 54.6 tttm -96.35 93.45 6.87 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.169 -0.469 . . . . 0.0 109.956 179.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -75.81 146.3 40.02 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.63 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.61 -32.85 11.57 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.859 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 53.9 m80 -118.76 116.98 27.68 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.482 176.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 10.9 t-160 -85.81 -14.56 44.7 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.025 -178.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -119.07 132.97 56.06 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.705 179.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 34.0 m-70 -128.7 175.85 8.27 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.376 178.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.449 ' O ' ' HB2' ' A' ' 111' ' ' HIS . 22.3 p-80 -68.86 -38.09 79.53 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 176.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . 0.449 ' HB2' ' O ' ' A' ' 110' ' ' HIS . 72.2 t60 . . . . . 0 C--O 1.245 0.858 0 CA-C-O 118.163 -0.922 . . . . 0.0 108.796 177.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.646 ' HE3' HG12 ' A' ' 6' ' ' ILE . 43.4 mtm . . . . . 0 N--CA 1.483 1.22 0 CA-C-O 120.916 0.388 . . . . 0.0 110.883 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.548 ' HA ' ' HB ' ' A' ' 80' ' ' THR . 95.0 m-20 -114.37 -175.74 2.75 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.369 170.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.453 ' HB3' HG21 ' A' ' 84' ' ' VAL . 35.3 p -62.36 -34.79 77.35 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.017 0.437 . . . . 0.0 110.824 -179.493 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -57.05 -54.37 47.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.852 -177.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 61.3 t -59.22 -41.37 83.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.849 0.357 . . . . 0.0 110.915 -178.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.646 HG12 ' HE3' ' A' ' 1' ' ' MET . 50.7 mt -66.03 -39.99 86.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.463 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 51.3 mttm -58.77 -47.52 84.42 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.984 175.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -62.19 -41.09 98.03 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.759 179.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -62.11 -51.18 68.97 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.643 179.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 93.3 mt -62.44 -38.15 88.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.943 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -66.26 -40.74 90.34 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.452 178.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -70.67 -35.04 72.62 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.472 -176.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 39.2 pt -87.15 -8.38 11.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.798 0.332 . . . . 0.0 110.919 178.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 65.45 52.37 40.31 Favored Glycine 0 N--CA 1.452 -0.258 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.433 176.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -112.37 148.88 33.36 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.9 0.381 . . . . 0.0 110.724 -178.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -86.37 133.17 33.81 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.818 177.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 47.5 p90 -135.24 142.5 45.99 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.768 0.318 . . . . 0.0 110.455 179.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.56 ' HB ' ' HB2' ' A' ' 25' ' ' HIS . 66.5 mt -90.79 100.99 11.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.993 -179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -91.18 116.69 29.02 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.026 -178.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.538 ' HB2' ' HB2' ' A' ' 23' ' ' GLU . 89.9 mt -115.19 173.64 6.4 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 173.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -60.3 105.03 0.37 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.918 0.39 . . . . 0.0 111.118 -178.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 17.1 m120 68.0 16.75 9.56 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.633 179.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.538 ' HB2' ' HB2' ' A' ' 20' ' ' LEU . 91.1 mt-10 -133.95 113.97 12.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.959 0.409 . . . . 0.0 111.275 179.456 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 64.5 mt -97.39 103.4 14.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 172.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.56 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 35.6 m-70 -89.94 110.77 21.71 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 -179.076 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 63.9 mt -106.11 169.67 8.36 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.486 -175.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 51.5 mtpt -81.31 138.47 48.52 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.168 175.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.539 ' HA ' HG21 ' A' ' 88' ' ' THR . 3.4 Cg_exo -41.35 -51.91 3.86 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 124.117 3.211 . . . . 0.0 114.427 -173.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -70.31 -37.96 74.84 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.733 0.301 . . . . 0.0 111.076 -175.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 46.7 t -65.11 -42.13 93.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.222 0.534 . . . . 0.0 109.811 177.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 90.1 t80 -57.66 -41.29 81.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.816 178.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -59.29 -45.62 90.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.51 -178.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -64.29 -35.81 82.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.273 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 60.4 t -72.13 -38.22 62.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.198 0.523 . . . . 0.0 110.45 178.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.646 ' CZ2' ' HG3' ' A' ' 40' ' ' GLU . 30.0 t90 -57.12 -46.87 82.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.33 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 55.8 mttm -86.46 -2.2 58.25 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.895 0.379 . . . . 0.0 111.384 179.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -78.72 -35.47 44.81 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 176.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.526 HG23 ' HD3' ' A' ' 41' ' ' PRO . 3.2 m -85.9 3.85 3.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.603 177.228 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 97.21 17.72 31.03 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.696 -0.764 . . . . 0.0 113.444 174.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.646 ' HG3' ' CZ2' ' A' ' 35' ' ' TRP . 36.1 tt0 61.7 84.59 0.19 Allowed Pre-proline 0 N--CA 1.466 0.336 0 CA-C-O 121.06 0.457 . . . . 0.0 111.498 178.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.565 ' HD2' ' CD1' ' A' ' 35' ' ' TRP . 94.3 Cg_endo -90.64 162.92 4.25 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.745 2.297 . . . . 0.0 111.7 173.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -71.45 125.42 26.97 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 175.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.459 ' CD2' ' HB3' ' A' ' 78' ' ' PHE . 90.4 mt -90.53 150.09 21.91 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.348 0.594 . . . . 0.0 112.292 -170.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -97.2 164.67 12.39 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.198 -0.91 . . . . 0.0 109.236 172.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.662 HG21 ' HE3' ' A' ' 74' ' ' LYS . 19.0 p -119.59 144.8 46.9 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.136 0.493 . . . . 0.0 111.22 177.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.586 ' HB2' ' CD2' ' A' ' 77' ' ' TYR . 32.4 t80 -118.69 114.49 22.81 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.044 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 95.6 t -100.23 121.43 50.95 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.792 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.972 -177.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.468 ' CG1' ' HB ' ' A' ' 73' ' ' ILE . 42.0 pt -105.59 132.16 53.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.732 174.24 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.504 ' HA ' ' O ' ' A' ' 71' ' ' VAL . 37.8 tt0 -115.55 103.6 10.9 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.206 -0.452 . . . . 0.0 109.865 -178.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -153.29 123.73 7.14 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 112.049 0.388 . . . . 0.0 112.049 -176.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.547 ' HG2' HG13 ' A' ' 52' ' ' ILE . 31.5 tt0 -179.51 -81.65 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.113 168.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.578 ' HB ' ' H ' ' A' ' 69' ' ' LYS . 64.3 mt -117.85 101.02 11.29 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 109.71 -0.478 . . . . 0.0 109.71 178.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.462 ' HA ' HG13 ' A' ' 68' ' ' VAL . 4.3 m -134.76 104.22 5.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 121.198 0.523 . . . . 0.0 111.774 -176.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 64.1 mt-10 -89.61 114.29 60.02 Favored Pre-proline 0 C--N 1.324 -0.515 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 172.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -54.45 118.18 4.77 Favored 'Trans proline' 0 C--O 1.234 0.284 0 C-N-CA 122.892 2.394 . . . . 0.0 112.391 -176.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.633 ' HA2' ' HB3' ' A' ' 59' ' ' ASP . . . -149.29 23.54 1.23 Allowed Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.875 -0.678 . . . . 0.0 111.846 -178.734 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -70.33 -37.19 74.66 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.741 0.305 . . . . 0.0 110.675 -178.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 42.7 p90 -122.11 1.81 9.79 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.168 0.509 . . . . 0.0 110.008 177.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.633 ' HB3' ' HA2' ' A' ' 56' ' ' GLY . 23.4 t70 -95.66 132.72 26.83 Favored Pre-proline 0 C--N 1.322 -0.596 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.357 -176.02 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 59' ' ' ASP . 34.3 Cg_exo -60.21 125.96 18.9 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 123.134 2.556 . . . . 0.0 113.089 -177.094 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -74.51 125.12 9.36 Favored 'Trans proline' 0 CA--C 1.529 0.235 0 C-N-CA 122.799 2.332 . . . . 0.0 112.399 179.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -105.6 -165.07 1.08 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.294 179.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 67.0 mtt -76.91 -19.7 57.09 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.692 -175.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -82.44 92.18 6.99 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.028 0.442 . . . . 0.0 110.269 179.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -93.66 100.02 12.34 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.172 178.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.2 m -81.39 150.94 28.16 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.501 178.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -74.46 81.86 1.94 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.524 0.678 . . . . 0.0 110.546 177.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.462 HG13 ' HA ' ' A' ' 53' ' ' VAL . 71.2 t -71.87 110.15 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.719 179.088 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.578 ' H ' ' HB ' ' A' ' 52' ' ' ILE . 95.9 mttt -91.98 107.54 19.28 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.176 0.512 . . . . 0.0 110.589 -179.504 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -97.14 95.74 7.97 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 174.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.504 ' O ' ' HA ' ' A' ' 49' ' ' GLU . 59.8 t -92.56 108.37 20.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.945 -176.329 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -90.5 100.87 13.64 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.625 -178.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.468 ' HB ' ' CG1' ' A' ' 48' ' ' ILE . 65.3 mt -91.15 113.67 27.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.975 -0.557 . . . . 0.0 109.659 178.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.662 ' HE3' HG21 ' A' ' 45' ' ' THR . 48.1 tttp -94.93 101.94 13.74 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.779 -173.119 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -96.62 167.54 11.07 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.427 176.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 12.5 p -116.64 148.66 19.22 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 110.4 -0.222 . . . . 0.0 110.4 -177.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.586 ' CD2' ' HB2' ' A' ' 46' ' ' TYR . 39.7 p90 -155.09 154.01 31.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.873 0.368 . . . . 0.0 111.242 177.309 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.459 ' HB3' ' CD2' ' A' ' 43' ' ' LEU . 48.8 p90 -119.09 160.68 21.61 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 171.304 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -111.8 138.86 47.83 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.961 0.41 . . . . 0.0 111.23 -173.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.548 ' HB ' ' HA ' ' A' ' 2' ' ' ASN . 40.2 p -93.82 169.63 10.16 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.587 173.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.446 ' HB2' ' OD1' ' A' ' 2' ' ' ASN . 6.9 mp -74.5 -10.15 59.27 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.247 0.546 . . . . 0.0 110.026 178.14 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -92.35 10.98 27.54 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.619 -179.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 68.93 20.83 7.76 Favored 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.767 -0.652 . . . . 0.0 111.483 176.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.453 HG21 ' HB3' ' A' ' 3' ' ' SER . 48.3 t -101.82 126.08 55.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.241 177.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . 0.457 ' O ' ' HA ' ' A' ' 23' ' ' GLU . 40.5 mtm180 -95.08 124.52 39.17 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.46 -179.238 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 59.4 t -95.16 107.61 19.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 176.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 28.6 t -105.09 138.67 28.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.605 -170.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.539 HG21 ' HA ' ' A' ' 28' ' ' PRO . 86.5 m -152.61 157.06 40.46 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.288 176.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -68.8 124.66 24.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.324 0.583 . . . . 0.0 112.248 -178.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -68.46 -32.63 72.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.302 -178.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 6.5 m -56.73 -41.46 77.55 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.964 0.411 . . . . 0.0 110.966 177.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.431 ' O ' HG13 ' A' ' 96' ' ' ILE . 43.6 mt-10 -83.6 -30.63 26.82 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.796 -179.141 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 82.3 t80 -62.68 -47.82 81.98 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.116 0.484 . . . . 0.0 109.875 175.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -58.15 -40.93 82.62 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.245 174.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.418 ' HB3' ' O ' ' A' ' 92' ' ' GLU . 64.4 tttp -56.95 -44.84 82.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.11 178.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.565 ' O ' ' HG2' ' A' ' 99' ' ' LYS . 75.7 mt -64.84 -47.06 89.97 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-O 121.024 0.44 . . . . 0.0 111.182 -179.444 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 87.4 mt -60.13 -51.17 70.73 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.859 -179.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 86.3 mttt -72.72 -28.31 62.57 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -174.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.565 ' HG2' ' O ' ' A' ' 96' ' ' ILE . 19.8 pttp -70.76 -29.93 66.29 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.33 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 22.6 mtm105 -78.53 -43.22 27.31 Favored 'General case' 0 C--N 1.332 -0.171 0 N-CA-C 109.778 -0.453 . . . . 0.0 109.778 173.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 125.18 26.88 1.28 Allowed Glycine 0 N--CA 1.448 -0.502 0 CA-C-N 115.683 -0.69 . . . . 0.0 112.193 -178.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 21.2 m -97.14 139.06 33.69 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.692 0.282 . . . . 0.0 110.443 -179.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -98.53 163.58 12.61 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.352 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 91.4 mt -89.57 -20.43 23.78 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.861 0.363 . . . . 0.0 111.235 -175.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 23.2 mt-10 -101.51 124.47 47.23 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.961 -178.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 70.6 m80 -83.46 83.4 7.9 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.661 178.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 18.1 m170 -92.65 125.12 37.13 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.164 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 8.1 t-160 -100.25 -18.7 16.72 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 173.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 9.1 m170 -114.05 -176.29 2.87 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.15 -0.932 . . . . 0.0 109.937 173.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 34.7 m-70 -105.88 -71.93 0.73 Allowed 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 171.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 67.7 m-70 . . . . . 0 C--O 1.243 0.757 0 CA-C-N 115.022 -0.99 . . . . 0.0 108.746 169.114 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 ppp? . . . . . 0 N--CA 1.477 0.876 0 CA-C-O 121.032 0.444 . . . . 0.0 110.828 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.43 ' OD1' ' HB2' ' A' ' 81' ' ' LEU . 47.5 m-80 -128.38 178.5 6.23 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 176.328 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 52.2 p -65.85 -20.71 66.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.428 0.632 . . . . 0.0 109.611 177.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.535 ' O ' ' HG3' ' A' ' 8' ' ' GLU . 20.9 tp10 -61.2 -36.6 80.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.052 -0.976 . . . . 0.0 110.424 177.049 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 60.3 t -63.95 -35.92 75.04 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 CA-C-O 121.236 0.541 . . . . 0.0 110.182 179.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 61.6 mt -66.86 -40.35 85.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.025 177.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -58.24 -45.31 88.01 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.286 177.362 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . 0.535 ' HG3' ' O ' ' A' ' 4' ' ' GLU . 41.5 mt-10 -60.0 -44.54 94.48 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.754 179.302 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.447 ' O ' HG12 ' A' ' 13' ' ' ILE . 79.5 t80 -61.51 -47.72 84.34 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.736 -0.665 . . . . 0.0 110.312 -179.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 91.3 mt -63.5 -37.7 88.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.881 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -59.44 -50.94 72.0 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.558 177.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -68.09 -37.87 81.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.878 -175.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.447 HG12 ' O ' ' A' ' 9' ' ' PHE . 35.4 pt -81.68 -14.67 12.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.235 -179.421 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 81.16 45.75 7.37 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.785 177.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -119.45 166.07 13.55 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.8 0.334 . . . . 0.0 110.71 178.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -117.35 161.1 20.08 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.949 179.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 28.5 p90 -130.7 146.54 52.21 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.683 179.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.46 ' HB ' ' HB2' ' A' ' 25' ' ' HIS . 54.6 mt -91.43 97.03 6.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 178.058 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.439 ' HA ' ' O ' ' A' ' 23' ' ' GLU . 1.9 tm-20 -99.35 107.27 19.49 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -176.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 89.9 mt -116.01 86.66 2.52 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.862 -177.259 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.438 ' O ' ' HB2' ' A' ' 22' ' ' ASN . 34.4 tt0 59.29 60.25 2.41 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.058 176.228 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.438 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 0.9 OUTLIER 75.07 14.01 3.18 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.293 177.454 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.439 ' O ' ' HA ' ' A' ' 19' ' ' GLU . 35.1 mt-10 -111.16 113.74 26.48 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.8 170.62 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 62.0 mt -96.33 97.5 6.58 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 177.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.586 ' HA ' ' O ' ' A' ' 87' ' ' VAL . 14.1 m-70 -86.14 107.9 18.07 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.475 178.562 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 62.3 mt -95.13 164.45 12.86 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.254 -175.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -82.16 132.24 53.98 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.238 177.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -49.49 -40.3 45.18 Favored 'Trans proline' 0 N--CA 1.471 0.197 0 C-N-CA 123.1 2.533 . . . . 0.0 112.977 -177.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -60.54 -47.07 87.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.08 179.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 41.3 t -77.08 -40.2 29.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.768 -177.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.785 ' HE1' ' HE1' ' A' ' 78' ' ' PHE . 85.6 t80 -58.53 -37.17 75.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.883 -179.143 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.645 ' HA ' ' HE1' ' A' ' 93' ' ' PHE . 24.8 t80 -53.25 -39.4 63.82 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.291 177.34 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -84.0 -39.25 19.91 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.985 -178.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 62.6 t -62.53 -36.88 77.18 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-O 120.744 0.307 . . . . 0.0 110.841 179.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.428 ' CE2' ' HB2' ' A' ' 40' ' ' GLU . 22.1 t90 -53.13 -59.23 4.81 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.732 -179.336 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -74.0 -20.72 60.24 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.664 0.269 . . . . 0.0 111.403 -179.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 85.3 t80 -64.74 -28.8 69.83 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.806 178.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.411 HG23 ' HD3' ' A' ' 41' ' ' PRO . 29.0 m -103.34 11.22 8.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.36 -179.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.48 9.25 56.82 Favored Glycine 0 CA--C 1.517 0.186 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.877 177.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.428 ' HB2' ' CE2' ' A' ' 35' ' ' TRP . 15.5 pt-20 44.67 87.09 0.12 Allowed Pre-proline 0 N--CA 1.471 0.61 0 C-N-CA 124.527 1.131 . . . . 0.0 113.246 -179.394 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.411 ' HD3' HG23 ' A' ' 38' ' ' VAL . 74.5 Cg_endo -76.08 165.76 29.1 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 122.456 2.104 . . . . 0.0 111.486 175.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 23.6 mm-40 -63.15 137.11 58.12 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.033 0.444 . . . . 0.0 110.325 177.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.443 ' HB3' ' CG2' ' A' ' 76' ' ' VAL . 95.6 mt -87.29 144.29 26.87 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.491 -174.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -118.83 118.18 30.88 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 177.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 24.9 p -107.54 137.55 45.36 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 120.92 0.39 . . . . 0.0 111.843 -173.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 19.0 p90 -120.87 140.66 51.48 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 176.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.508 HG11 ' HE3' ' A' ' 72' ' ' LYS . 55.4 t -103.73 117.45 49.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.273 178.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 1.011 HG23 HG13 ' A' ' 73' ' ' ILE . 2.9 tt -98.88 122.37 50.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-O 121.522 0.677 . . . . 0.0 110.167 177.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.461 ' OE1' ' HG3' ' A' ' 72' ' ' LYS . 4.4 mm-40 -90.14 94.49 9.8 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.952 -176.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -101.61 126.62 48.46 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.639 0.257 . . . . 0.0 110.31 -178.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.977 ' HG2' ' HG2' ' A' ' 70' ' ' LYS . 28.8 mt-10 -101.09 108.11 19.72 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.837 0.351 . . . . 0.0 110.376 178.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 47.5 pt -79.95 137.83 20.92 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.166 0.508 . . . . 0.0 110.899 -177.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.9 p -102.13 113.47 38.66 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.856 176.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.442 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 41.0 mt-10 -87.61 115.26 62.34 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 116.11 -0.495 . . . . 0.0 109.818 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 54' ' ' GLU . 22.7 Cg_exo -65.09 154.42 73.56 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 123.157 2.571 . . . . 0.0 112.995 -174.531 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -135.35 44.06 1.2 Allowed Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 110.313 -1.115 . . . . 0.0 110.313 178.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -57.94 -30.91 66.35 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 123.347 0.659 . . . . 0.0 112.302 -172.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 93.0 t80 -70.75 -14.31 62.39 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.929 0.395 . . . . 0.0 110.333 178.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 39.0 t70 60.32 81.82 0.24 Allowed Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 115.459 -0.791 . . . . 0.0 110.232 -174.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.48 151.91 48.26 Favored 'Trans proline' 0 N--CA 1.461 -0.41 0 C-N-CA 122.56 2.174 . . . . 0.0 112.456 -176.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -69.49 -11.02 30.28 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.801 2.334 . . . . 0.0 111.525 175.77 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -66.6 149.95 49.74 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.362 -0.835 . . . . 0.0 109.638 176.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 32.9 mtt -59.95 120.9 10.52 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.234 0.54 . . . . 0.0 110.527 177.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 33.6 mttm -75.45 104.94 6.23 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.24 -174.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -78.69 131.24 36.56 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.142 -176.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -87.26 -16.91 33.82 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.261 178.208 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.4 p-10 -91.29 139.27 30.89 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.003 176.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.453 HG23 ' HB3' ' A' ' 51' ' ' GLU . 22.9 m -102.11 177.65 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.342 -179.145 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 51.6 tttm -111.77 138.45 48.35 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.417 -176.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.977 ' HG2' ' HG2' ' A' ' 51' ' ' GLU . 62.4 mttp -87.45 137.46 32.32 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.118 0.485 . . . . 0.0 111.421 -177.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.45 HG12 HG23 ' A' ' 73' ' ' ILE . 79.8 t -110.17 100.66 11.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 170.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.508 ' HE3' HG11 ' A' ' 47' ' ' VAL . 39.0 tttp -75.59 101.03 4.78 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.178 -175.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 1.011 HG13 HG23 ' A' ' 48' ' ' ILE . 4.6 pt -109.04 125.26 66.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.616 0.722 . . . . 0.0 111.143 -177.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -106.78 131.58 53.73 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.966 -177.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -130.16 166.2 20.73 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.163 178.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.443 ' CG2' ' HB3' ' A' ' 43' ' ' LEU . 9.0 p -122.92 145.15 30.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.72 0.295 . . . . 0.0 111.112 -174.421 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 44.9 p90 -146.27 164.72 31.42 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.536 178.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.785 ' HE1' ' HE1' ' A' ' 31' ' ' PHE . 52.3 p90 -141.64 148.29 38.94 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 169.436 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -102.14 128.56 48.58 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.429 -176.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 72.7 p -88.08 -179.3 6.16 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.25 -0.432 . . . . 0.0 109.88 176.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.43 ' HB2' ' OD1' ' A' ' 2' ' ' ASN . 7.1 mp -70.12 -18.31 63.23 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.08 0.466 . . . . 0.0 110.207 178.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -71.18 -13.29 61.88 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.717 179.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 66.4 t30 77.68 10.12 2.3 Favored 'General case' 0 N--CA 1.472 0.67 0 O-C-N 124.079 0.862 . . . . 0.0 109.33 -171.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 77.8 t -81.74 129.12 38.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.278 178.418 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 56.1 mtm180 -92.94 105.46 17.57 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.343 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 48.3 t -84.28 106.74 14.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 177.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.586 ' O ' ' HA ' ' A' ' 25' ' ' HIS . 30.5 t -108.51 141.08 24.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.954 -173.432 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 34.3 m -144.44 150.57 37.88 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 176.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 36.8 t70 -62.92 126.11 26.24 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.182 0.515 . . . . 0.0 111.358 179.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -70.22 -38.06 75.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.14 -176.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 24.9 m -60.25 -57.75 11.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.354 -177.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.494 ' O ' ' HB3' ' A' ' 95' ' ' LYS . 36.3 mm-40 -68.22 -29.86 68.79 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.731 -177.502 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.645 ' HE1' ' HA ' ' A' ' 32' ' ' TYR . 53.0 t80 -67.87 -49.27 62.98 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.955 0.407 . . . . 0.0 110.404 177.41 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.52 ' O ' ' HG3' ' A' ' 98' ' ' LYS . 79.2 mm-40 -66.85 -24.46 66.14 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.568 178.193 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.494 ' HB3' ' O ' ' A' ' 92' ' ' GLU . 44.6 tttp -59.69 -49.57 77.24 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.366 174.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.453 ' O ' ' HB3' ' A' ' 99' ' ' LYS . 58.4 mt -67.93 -33.17 59.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.815 -179.29 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 69.8 mt -64.75 -39.82 94.26 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.563 177.344 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.52 ' HG3' ' O ' ' A' ' 94' ' ' GLN . 57.1 mttp -70.42 -33.81 71.78 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.033 0.444 . . . . 0.0 109.924 175.306 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.453 ' HB3' ' O ' ' A' ' 96' ' ' ILE . 61.9 tttp -56.65 -57.9 10.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.283 -0.872 . . . . 0.0 110.925 179.377 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 3.2 ptm180 -74.9 -23.78 58.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.587 0.232 . . . . 0.0 111.274 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 93.37 95.1 1.5 Allowed Glycine 0 N--CA 1.448 -0.506 0 N-CA-C 111.339 -0.704 . . . . 0.0 111.339 -175.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.7 m -127.06 -38.43 2.01 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.165 0.507 . . . . 0.0 110.592 -177.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -109.5 115.49 30.02 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 177.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 88.3 mt -91.8 163.98 13.86 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.19 -176.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -72.35 164.79 25.73 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.507 -0.77 . . . . 0.0 111.262 -178.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 41.5 m80 -127.47 126.72 42.82 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 174.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 10.9 t-160 -61.52 -40.14 93.54 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.614 -0.513 . . . . 0.0 109.614 -179.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -102.67 124.03 47.46 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 170.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -71.87 -18.28 62.06 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.955 0.407 . . . . 0.0 110.212 -175.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 18.9 t60 -127.44 127.42 44.08 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 174.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 47.8 t60 . . . . . 0 C--O 1.247 0.925 0 CA-C-O 118.509 -0.758 . . . . 0.0 110.068 179.402 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.563 ' SD ' HG11 ' A' ' 38' ' ' VAL . 21.0 ptt? . . . . . 0 N--CA 1.478 0.971 0 CA-C-O 120.98 0.419 . . . . 0.0 110.26 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -94.15 174.79 6.97 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.56 174.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.8 m -62.55 -23.26 66.89 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.009 0.433 . . . . 0.0 111.242 -177.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -61.59 -37.56 84.36 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.972 179.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 62.1 t -68.62 -34.32 64.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 121.023 0.439 . . . . 0.0 110.348 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.409 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 50.8 mt -62.39 -43.12 97.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.71 176.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 57.1 mttm -60.33 -38.33 83.43 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.049 177.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -57.6 -48.71 78.65 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.862 0.363 . . . . 0.0 110.777 178.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -66.17 -44.22 84.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.895 -179.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.409 ' HG ' ' O ' ' A' ' 6' ' ' ILE . 97.0 mt -66.66 -43.95 83.16 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.408 -177.287 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -69.3 -32.44 71.59 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.737 0.303 . . . . 0.0 110.37 -179.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -61.82 -48.68 79.51 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.12 178.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 38.3 pt -80.93 -12.55 12.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.165 -178.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 81.47 38.31 14.94 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.348 179.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 16.8 tp10 -91.76 118.56 30.79 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.95 0.405 . . . . 0.0 110.197 178.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -97.8 102.78 14.63 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.964 179.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.467 ' CD2' HG23 ' A' ' 24' ' ' ILE . 29.0 p90 -97.97 170.59 8.84 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.469 -174.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.525 ' HB ' ' HB2' ' A' ' 25' ' ' HIS . 64.1 mt -94.25 100.33 10.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.99 177.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -90.54 135.53 33.64 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.245 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.673 ' HG ' ' H ' ' A' ' 21' ' ' GLU . 21.8 tp -133.28 177.22 7.85 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 175.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.673 ' H ' ' HG ' ' A' ' 20' ' ' LEU . 43.2 mt-10 -61.76 102.46 0.26 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.633 0.254 . . . . 0.0 110.902 -178.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.408 ' HB2' ' O ' ' A' ' 21' ' ' GLU . 11.8 m120 71.68 16.25 5.78 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.999 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.56 ' HB2' ' HB3' ' A' ' 20' ' ' LEU . 41.4 mt-10 -131.63 134.96 46.55 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.056 0.455 . . . . 0.0 111.421 178.173 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.467 HG23 ' CD2' ' A' ' 17' ' ' TYR . 74.1 mt -118.69 107.53 21.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 108.906 -0.776 . . . . 0.0 108.906 171.54 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.525 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 73.0 m-70 -94.29 109.85 21.65 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.049 0.452 . . . . 0.0 110.491 -178.157 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.463 HD23 ' HB3' ' A' ' 17' ' ' TYR . 40.5 mt -109.25 150.54 27.8 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.382 -0.826 . . . . 0.0 110.936 -178.426 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 49.5 mtmt -64.38 135.61 96.42 Favored Pre-proline 0 C--N 1.326 -0.427 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 171.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.5 ' HB2' HD12 ' A' ' 96' ' ' ILE . 51.8 Cg_exo -54.27 -28.93 54.9 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.684 2.256 . . . . 0.0 112.075 -177.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -61.62 -56.38 20.51 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.49 177.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 49.2 t -68.14 -38.69 80.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.242 179.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -51.54 -46.86 63.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.238 -179.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 93.0 t80 -60.19 -43.38 95.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.137 -179.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.556 ' O ' ' HB2' ' A' ' 37' ' ' TYR . 43.6 mt-10 -76.96 -8.74 57.93 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.774 -175.448 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 62.5 t -93.07 -42.62 13.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.251 0.548 . . . . 0.0 109.522 171.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.553 ' CD1' ' HD2' ' A' ' 41' ' ' PRO . 44.2 t90 -55.82 -52.0 65.52 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.046 177.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 53.7 tttm -78.82 -14.35 59.3 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.015 0.436 . . . . 0.0 110.738 -177.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.556 ' HB2' ' O ' ' A' ' 33' ' ' GLU . 87.0 t80 -71.28 -44.77 64.59 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.814 -179.693 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.563 HG11 ' SD ' ' A' ' 1' ' ' MET . 33.3 m -94.31 -3.66 10.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.338 -177.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 136.68 -85.28 0.24 Allowed Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.077 177.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 170.98 61.06 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.371 0 C-N-CA 122.969 0.508 . . . . 0.0 110.73 -175.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.553 ' HD2' ' CD1' ' A' ' 35' ' ' TRP . 71.1 Cg_exo -50.69 128.69 24.74 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 122.127 1.884 . . . . 0.0 111.584 177.126 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -61.16 116.07 4.28 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.318 0.58 . . . . 0.0 110.298 -177.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.576 ' HB3' ' CG2' ' A' ' 76' ' ' VAL . 93.3 mt -82.6 126.12 31.94 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.184 -0.917 . . . . 0.0 111.983 -170.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -92.06 139.21 30.86 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 175.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 69.5 p -118.68 145.85 45.17 Favored 'General case' 0 C--N 1.318 -0.795 0 C-N-CA 121.148 -0.221 . . . . 0.0 110.599 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 25.7 p90 -133.46 143.49 48.87 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 176.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 48.4 t -94.98 110.72 24.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.24 -178.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 8.9 tt -118.9 111.17 32.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-O 121.425 0.631 . . . . 0.0 110.18 178.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.453 ' HG2' ' HG2' ' A' ' 72' ' ' LYS . 47.7 mt-10 -76.95 125.18 28.88 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 176.161 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -92.97 118.68 31.43 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 -176.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -103.6 125.12 49.92 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.895 -174.165 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 65.9 mt 69.02 94.4 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.652 178.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.474 ' O ' ' HD3' ' A' ' 55' ' ' PRO . 42.7 t -90.96 138.1 20.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.45 -0.795 . . . . 0.0 108.89 178.339 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -87.57 111.82 44.32 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-O 121.235 0.541 . . . . 0.0 111.521 -174.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.474 ' HD3' ' O ' ' A' ' 53' ' ' VAL . 86.1 Cg_endo -92.69 145.47 2.56 Favored 'Trans proline' 0 N--CA 1.449 -1.108 0 C-N-CA 123.321 2.681 . . . . 0.0 112.12 176.487 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -135.89 1.44 3.51 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.836 -0.697 . . . . 0.0 111.759 178.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -82.87 -43.2 16.86 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.922 0.391 . . . . 0.0 110.449 -178.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -130.21 174.68 9.59 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.256 -178.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -137.39 149.69 66.3 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.022 178.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.54 138.84 19.85 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.504 2.136 . . . . 0.0 111.986 178.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -49.81 -48.13 20.55 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.973 2.449 . . . . 0.0 112.088 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.418 ' C ' ' H ' ' A' ' 64' ' ' LYS . 43.1 mt-10 -108.21 118.18 36.08 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.595 174.293 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 60.8 mtm -72.4 9.26 1.08 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.267 -177.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.418 ' H ' ' C ' ' A' ' 62' ' ' GLU . 68.8 mttt -85.07 -14.86 45.91 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.262 -179.129 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -113.01 147.83 36.36 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.954 -176.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 36.4 m -139.91 107.15 5.49 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.708 -0.678 . . . . 0.0 109.857 177.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -64.41 113.42 3.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.065 0.459 . . . . 0.0 110.67 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 48.7 t -83.06 105.41 12.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.553 -178.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -95.92 128.01 42.45 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.017 -0.538 . . . . 0.0 109.595 175.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -127.06 101.42 6.53 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 178.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 30.6 t -109.97 131.89 59.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.869 -174.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.453 ' HG2' ' HG2' ' A' ' 49' ' ' GLU . 49.7 mttp -73.56 101.09 3.48 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.537 177.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 49.3 mm -100.27 118.84 47.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.227 0.537 . . . . 0.0 110.572 -179.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.626 ' O ' ' HB3' ' A' ' 90' ' ' TYR . 49.5 tttp -92.8 118.55 31.22 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 176.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -118.44 159.61 23.18 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 179.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.576 ' CG2' ' HB3' ' A' ' 43' ' ' LEU . 14.2 p -131.03 147.94 33.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.978 -171.266 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 46.2 p90 -154.94 156.49 36.15 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.641 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -115.97 140.15 49.54 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 169.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -109.01 127.22 53.9 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.498 -170.019 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 44.5 p -88.89 -179.67 6.01 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.849 -175.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.9 mp -70.73 -22.84 62.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.229 178.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.445 ' HB2' HG23 ' A' ' 84' ' ' VAL . 2.9 m-20 -75.07 -10.02 59.08 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.344 179.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.438 ' HB2' ' O ' ' A' ' 82' ' ' ASP . 9.0 m120 68.72 28.76 5.49 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.156 -171.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.445 HG23 ' HB2' ' A' ' 82' ' ' ASP . 68.9 t -98.66 126.18 51.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.265 -0.88 . . . . 0.0 108.847 173.158 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 65.8 mtt180 -100.95 114.79 29.01 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.05 0.452 . . . . 0.0 111.176 -173.218 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 46.9 t -83.88 99.85 6.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 175.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 22.1 t -102.72 140.02 22.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.274 -171.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 5.9 t -143.65 -178.57 5.96 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 174.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -93.25 123.3 36.43 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.601 -177.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.626 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 61.8 t80 -69.26 -34.55 74.95 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.176 -176.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 12.7 t -65.83 -49.5 67.99 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 -178.237 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.479 ' HA ' ' HD3' ' A' ' 95' ' ' LYS . 28.9 mm-40 -66.12 -39.2 89.73 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.944 177.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.45 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 58.1 t80 -60.93 -45.98 92.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.756 -179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.526 ' O ' ' HG2' ' A' ' 98' ' ' LYS . 48.5 mm-40 -58.92 -39.45 81.58 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.145 177.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.479 ' HD3' ' HA ' ' A' ' 92' ' ' GLU . 50.1 mtpt -62.78 -43.68 98.15 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.87 177.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.5 HD12 ' HB2' ' A' ' 28' ' ' PRO . 67.4 mt -68.6 -33.29 59.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.879 179.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 93' ' ' PHE . 86.5 mt -58.17 -37.18 74.21 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.979 0.418 . . . . 0.0 110.323 174.705 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.526 ' HG2' ' O ' ' A' ' 94' ' ' GLN . 38.6 mmtm -74.35 -34.78 63.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.253 178.065 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.466 ' HD2' ' HA ' ' A' ' 96' ' ' ILE . 68.7 mttm -63.45 -46.76 84.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.785 176.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.597 ' HA ' ' HE ' ' A' ' 100' ' ' ARG . 0.0 OUTLIER -73.87 -20.84 60.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.294 179.517 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 77.42 35.28 37.64 Favored Glycine 0 N--CA 1.451 -0.351 0 CA-C-N 115.945 -0.571 . . . . 0.0 112.266 178.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.7 m -87.02 65.13 8.82 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.402 0.62 . . . . 0.0 110.385 -179.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 59.7 tttm -178.13 142.19 0.27 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.199 -0.909 . . . . 0.0 109.859 176.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.464 HD13 ' HA ' ' A' ' 110' ' ' HIS . 88.4 mt -88.92 150.8 22.68 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 174.671 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -77.45 -50.24 13.11 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.249 0.547 . . . . 0.0 110.026 178.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -92.48 -177.66 4.67 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.015 -178.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 71.3 t60 -135.54 -25.45 1.3 Allowed 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.887 -0.325 . . . . 0.0 111.525 -178.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 6.0 t-80 -92.12 -10.26 39.57 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 177.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 2.0 m-70 -132.32 140.12 48.44 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.878 -1.055 . . . . 0.0 108.888 175.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . 0.464 ' HA ' HD13 ' A' ' 104' ' ' LEU . 11.8 p-80 -77.48 78.67 3.99 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.862 0.839 . . . . 0.0 111.104 179.13 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 36.2 t60 . . . . . 0 C--O 1.244 0.764 0 CA-C-N 114.814 -1.084 . . . . 0.0 108.84 176.495 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.445 ' CE ' ' HB ' ' A' ' 38' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.938 0 CA-C-O 120.954 0.407 . . . . 0.0 110.552 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -93.92 170.95 9.17 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.553 175.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.483 ' O ' ' HG3' ' A' ' 7' ' ' LYS . 34.2 t -61.48 -29.79 70.2 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.569 174.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -52.76 -43.13 65.57 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.759 176.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.7 t -62.9 -38.91 83.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.67 -178.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.522 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 60.5 mt -66.42 -44.86 90.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.315 179.335 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.483 ' HG3' ' O ' ' A' ' 3' ' ' SER . 85.6 mttt -63.63 -36.45 83.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.743 -0.662 . . . . 0.0 110.467 -179.187 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -55.86 -49.58 72.97 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.738 175.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -60.13 -43.14 95.91 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.066 179.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.531 HD13 ' HB3' ' A' ' 17' ' ' TYR . 74.4 mt -63.25 -48.27 78.92 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.325 -177.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -74.59 -19.62 60.25 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.96 -179.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -72.32 -45.34 60.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.837 177.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 38.1 pt -73.56 -17.78 17.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.979 0.419 . . . . 0.0 110.31 177.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.11 30.44 14.35 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.677 173.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -115.25 168.08 10.28 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 177.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -113.18 155.06 25.68 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.956 0.408 . . . . 0.0 110.96 -175.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.531 ' HB3' HD13 ' A' ' 10' ' ' LEU . 14.8 p90 -125.7 147.56 49.32 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.117 -173.219 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 52.5 mt -89.09 93.96 4.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 177.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -98.63 116.25 30.44 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.24 -176.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 77.4 mt -111.43 -176.53 2.97 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 171.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.491 ' HA ' ' OE1' ' A' ' 21' ' ' GLU . 6.3 tp10 -72.23 109.57 6.08 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 120.427 -0.509 . . . . 0.0 109.936 179.347 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 66.49 15.12 10.01 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.733 179.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 29.0 mt-10 -138.41 113.92 9.65 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.843 0.354 . . . . 0.0 111.277 179.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.453 ' O ' ' HA ' ' A' ' 86' ' ' VAL . 63.9 mt -110.09 112.1 39.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 172.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 53.5 m-70 -98.44 117.21 32.35 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -179.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 80.4 mt -114.92 173.37 6.52 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.192 -175.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 75.6 mttt -84.5 149.65 55.16 Favored Pre-proline 0 C--N 1.321 -0.634 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.492 178.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_exo -51.52 -41.68 59.28 Favored 'Trans proline' 0 C--O 1.233 0.241 0 C-N-CA 122.907 2.405 . . . . 0.0 112.855 -179.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -65.6 -44.71 85.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.76 0.314 . . . . 0.0 110.541 -179.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 61.4 t -64.91 -45.09 95.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.131 179.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -58.1 -40.12 80.35 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.627 -0.715 . . . . 0.0 111.033 -179.021 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -57.49 -42.54 82.9 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.338 179.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -76.43 -40.81 49.61 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.921 -177.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 79.0 t -65.56 -32.37 57.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.536 178.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.532 ' CD1' ' HD2' ' A' ' 41' ' ' PRO . 25.8 t90 -52.97 -52.27 58.74 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.027 178.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -76.07 -26.82 56.87 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.756 0.312 . . . . 0.0 110.762 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 88.7 t80 -65.82 -34.7 78.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.053 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.445 ' HB ' ' CE ' ' A' ' 1' ' ' MET . 35.9 m -89.73 9.94 2.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.788 0.327 . . . . 0.0 111.579 -179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 100.7 14.7 31.26 Favored Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 120.604 -0.807 . . . . 0.0 113.604 174.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 48.75 73.09 1.06 Allowed Pre-proline 0 N--CA 1.466 0.357 0 CA-C-O 121.279 0.562 . . . . 0.0 111.409 177.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.532 ' HD2' ' CD1' ' A' ' 35' ' ' TRP . 95.4 Cg_endo -90.4 163.8 4.47 Favored 'Trans proline' 0 N--CA 1.454 -0.827 0 C-N-CA 122.679 2.253 . . . . 0.0 112.48 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -71.32 107.12 4.13 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 172.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 70.5 mt -73.43 146.42 45.04 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.812 -172.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -87.95 138.45 31.44 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.776 176.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 19.3 p -127.94 132.3 49.25 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 120.825 0.345 . . . . 0.0 110.218 176.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.406 ' CE2' ' HB ' ' A' ' 48' ' ' ILE . 14.7 p90 -119.21 144.64 46.61 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.758 -178.557 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 43.7 t -93.72 105.14 16.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.279 -0.419 . . . . 0.0 109.951 179.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.406 ' HB ' ' CE2' ' A' ' 46' ' ' TYR . 12.1 tt -105.77 130.6 56.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.061 179.06 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.709 ' HB3' ' HB3' ' A' ' 70' ' ' LYS . 45.4 mt-10 -88.83 106.66 18.53 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 177.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.535 ' O ' HG22 ' A' ' 71' ' ' VAL . 10.6 t70 -92.9 111.2 22.74 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.802 -0.635 . . . . 0.0 109.453 -174.753 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.48 ' HG2' ' HG2' ' A' ' 70' ' ' LYS . 41.8 mt-10 -81.39 93.49 6.6 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.372 0.606 . . . . 0.0 109.764 -179.15 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.1 tp -63.55 -25.85 39.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.043 -0.981 . . . . 0.0 111.882 -171.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 7.2 p -125.85 123.54 64.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 120.972 0.415 . . . . 0.0 110.596 -179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -132.03 101.56 15.08 Favored Pre-proline 0 C--N 1.325 -0.467 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.4 177.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 21.8 Cg_exo -65.53 120.19 7.34 Favored 'Trans proline' 0 N--CA 1.463 -0.268 0 C-N-CA 122.835 2.357 . . . . 0.0 111.685 177.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -135.65 -35.89 0.22 Allowed Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.343 -0.932 . . . . 0.0 111.899 -179.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -71.46 -63.02 1.2 Allowed 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 174.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -134.26 170.33 15.87 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.71 -1.132 . . . . 0.0 108.408 170.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.496 ' OD2' ' HB2' ' A' ' 62' ' ' GLU . 15.0 t0 -125.18 81.15 63.7 Favored Pre-proline 0 C--N 1.319 -0.735 0 CA-C-O 121.247 0.546 . . . . 0.0 111.299 -176.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_exo -58.95 -42.75 49.03 Favored 'Trans proline' 0 CA--C 1.542 0.918 0 C-N-CA 123.07 2.513 . . . . 0.0 113.966 172.511 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.723 ' HB2' ' HA ' ' A' ' 67' ' ' ASN . 31.4 Cg_exo -61.74 -2.8 3.0 Favored 'Trans proline' 0 C--N 1.365 1.421 0 C-N-CA 122.348 2.032 . . . . 0.0 113.772 -179.229 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.496 ' HB2' ' OD2' ' A' ' 59' ' ' ASP . 33.4 tt0 -60.42 -26.43 66.7 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 121.054 0.454 . . . . 0.0 109.935 173.233 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 85.8 mtp -67.07 -18.16 65.22 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.536 177.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -120.66 -162.22 0.94 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.284 -177.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -113.03 4.86 16.9 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.074 0.464 . . . . 0.0 111.004 -173.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 41.4 m -137.45 105.18 5.58 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.813 -178.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.723 ' HA ' ' HB2' ' A' ' 61' ' ' PRO . 13.2 m120 -83.63 -41.63 17.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.652 -178.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 30.6 m -118.64 145.21 24.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.328 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.478 ' O ' ' HA ' ' A' ' 51' ' ' GLU . 53.8 tttm -113.84 108.9 17.69 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.856 0.36 . . . . 0.0 110.252 178.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.709 ' HB3' ' HB3' ' A' ' 49' ' ' GLU . 59.5 mttm -85.2 109.0 17.99 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.584 -0.734 . . . . 0.0 110.309 179.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.535 HG22 ' O ' ' A' ' 50' ' ' ASP . 35.7 m -97.84 122.64 49.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.161 0.505 . . . . 0.0 110.164 175.092 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.414 ' HG2' ' HG2' ' A' ' 49' ' ' GLU . 68.3 mttm -76.45 104.13 6.81 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.556 -177.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 56.8 mt -110.08 117.06 53.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.426 179.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.422 ' O ' ' HB3' ' A' ' 90' ' ' TYR . 52.9 tttm -87.44 91.77 8.85 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.554 179.06 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -92.04 160.96 14.98 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.08 -176.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 13.5 p -114.9 144.19 23.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.209 -173.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.413 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 37.6 p90 -154.99 162.7 41.01 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.729 176.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -137.1 150.18 47.84 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 170.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 54.9 tt0 -120.49 135.67 55.0 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.479 -173.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 73.0 p -94.8 -176.97 4.03 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.338 177.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.8 mp -65.05 -13.73 58.69 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.279 0.561 . . . . 0.0 110.727 179.004 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.426 ' O ' ' HB2' ' A' ' 83' ' ' ASN . 4.8 m-20 -79.22 -8.82 59.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.59 -179.548 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . 0.426 ' HB2' ' O ' ' A' ' 82' ' ' ASP . 14.3 m120 69.58 16.73 8.04 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 121.4 0.619 . . . . 0.0 110.252 -174.357 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 66.1 t -89.57 122.03 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.383 176.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -100.33 116.51 32.47 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.719 -176.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.453 ' HA ' ' O ' ' A' ' 24' ' ' ILE . 59.1 t -86.31 104.72 14.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.552 176.482 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 22.0 t -101.65 142.65 15.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.607 -174.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 58.2 m -151.15 157.09 42.26 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 177.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -71.09 121.02 17.51 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.093 0.473 . . . . 0.0 110.409 -178.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.422 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 12.2 t80 -75.72 -27.5 58.19 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.981 -174.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 33.0 t -70.02 -43.66 70.87 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -64.25 -42.32 96.57 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.357 175.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 51.0 t80 -62.79 -46.6 87.23 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.856 -179.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 43.9 mt-30 -65.7 -29.61 70.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.011 178.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -63.83 -33.47 75.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.076 0.465 . . . . 0.0 110.302 176.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.493 ' HA ' ' HD2' ' A' ' 99' ' ' LYS . 68.0 mt -75.02 -39.89 44.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.381 176.405 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 84.2 mt -65.07 -30.52 71.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.172 0.51 . . . . 0.0 110.138 176.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 44.9 tttm -67.41 -37.29 82.85 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.43 -0.804 . . . . 0.0 110.421 175.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.493 ' HD2' ' HA ' ' A' ' 96' ' ' ILE . 60.3 mttm -64.44 -47.54 78.68 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.356 175.449 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 52.8 ttt-85 -68.64 -38.39 80.46 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.301 -0.863 . . . . 0.0 110.963 -177.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 87.43 40.12 6.99 Favored Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 111.251 -0.74 . . . . 0.0 111.251 -176.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.517 HG22 ' H ' ' A' ' 104' ' ' LEU . 20.7 m -63.26 130.16 43.35 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.012 0.434 . . . . 0.0 111.354 -177.448 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.46 ' HA ' ' O ' ' A' ' 106' ' ' HIS . 85.6 tttt -63.83 -17.16 62.85 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 115.408 -0.814 . . . . 0.0 112.099 -175.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.517 ' H ' HG22 ' A' ' 102' ' ' THR . 91.2 mt -57.2 -39.21 74.97 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.852 0.358 . . . . 0.0 111.002 179.612 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -91.83 -63.17 1.28 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.139 0.495 . . . . 0.0 109.885 175.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . 0.46 ' O ' ' HA ' ' A' ' 103' ' ' LYS . 42.6 m170 -84.13 92.94 8.03 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.677 178.168 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 40.4 m80 -65.92 -35.97 82.09 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.938 -177.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 23.2 m-70 -103.04 113.86 27.67 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 170.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 8.7 t-80 -57.73 -71.79 0.1 Allowed 'General case' 0 C--N 1.329 -0.305 0 O-C-N 123.531 0.519 . . . . 0.0 111.372 -172.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 2.1 m170 174.0 -68.22 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 124.053 0.941 . . . . 0.0 108.748 178.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 53.5 t60 . . . . . 0 C--O 1.244 0.771 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 173.081 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.511 ' HG2' HG12 ' A' ' 38' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.029 0 CA-C-O 120.744 0.307 . . . . 0.0 110.767 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -140.04 173.9 11.06 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 176.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 36.9 t -68.68 -27.7 66.2 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 175.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -58.05 -36.94 73.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.971 -1.013 . . . . 0.0 110.165 173.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 98.3 t -68.54 -42.85 83.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.458 178.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 62.9 mt -60.81 -45.31 98.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.981 177.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 45.9 mttp -56.51 -52.61 64.09 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.575 175.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -58.12 -45.16 87.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.105 -178.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -63.67 -45.66 89.1 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.34 -178.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 83.9 mt -71.04 -34.6 71.43 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.636 -0.256 . . . . 0.0 111.282 -177.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 43.1 mm-40 -69.74 -33.55 72.61 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.046 0.451 . . . . 0.0 110.418 175.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -63.37 -52.33 62.16 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.556 178.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 39.5 pt -77.97 -17.46 13.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.55 -177.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 76.99 60.43 2.91 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.074 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -112.5 158.87 19.38 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 -178.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -71.15 117.61 12.89 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.08 0.467 . . . . 0.0 110.82 179.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -116.09 121.07 41.08 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.269 -176.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 61.1 mt -120.82 107.24 20.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-O 120.758 0.313 . . . . 0.0 110.776 -179.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -125.8 125.04 42.28 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.04 0.448 . . . . 0.0 110.064 175.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 97.3 mt -95.16 46.49 1.12 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.703 -0.68 . . . . 0.0 109.875 178.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 66.62 94.79 0.06 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.569 -177.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 13.6 m120 73.18 -8.25 1.35 Allowed 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 115.243 -0.89 . . . . 0.0 111.844 179.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 32.2 tp10 -112.76 113.78 26.04 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 175.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.583 ' HB ' ' HA ' ' A' ' 86' ' ' VAL . 55.0 mt -107.19 133.48 51.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 110.335 -0.246 . . . . 0.0 110.335 -177.144 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -125.27 105.45 9.13 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 173.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 37.1 mt -95.26 -179.81 4.92 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.774 0.797 . . . . 0.0 113.026 -168.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -87.53 132.83 39.63 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 114.389 -1.278 . . . . 0.0 109.942 -179.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 99.8 Cg_exo -42.56 -70.42 0.07 OUTLIER 'Trans proline' 0 CA--C 1.532 0.421 0 C-N-CA 123.948 3.099 . . . . 0.0 114.811 -172.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.41 ' HA ' HD13 ' A' ' 96' ' ' ILE . 41.4 mt-10 -75.64 -3.15 32.86 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 112.143 0.423 . . . . 0.0 112.143 -172.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 98.5 t -90.02 -44.64 15.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 175.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -58.98 -34.66 72.07 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.609 177.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 67.5 t80 -54.14 -40.97 67.9 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.397 178.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -83.36 -29.02 28.55 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.116 -178.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 66.9 t -66.42 -36.79 78.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.375 0.607 . . . . 0.0 109.486 174.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 33.5 t90 -56.46 -52.97 62.69 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.557 175.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.791 ' HA ' ' HB3' ' A' ' 40' ' ' GLU . 53.5 mttm -66.84 -30.39 70.56 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.631 -0.258 . . . . 0.0 111.201 178.113 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -59.58 -40.71 88.28 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.367 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.511 HG12 ' HG2' ' A' ' 1' ' ' MET . 19.4 m -88.32 7.67 3.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.924 -175.468 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.417 ' O ' ' HG2' ' A' ' 40' ' ' GLU . . . 109.33 0.31 31.18 Favored Glycine 0 N--CA 1.453 -0.197 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.977 176.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.791 ' HB3' ' HA ' ' A' ' 36' ' ' LYS . 10.8 pt-20 44.8 69.46 2.5 Favored Pre-proline 0 N--CA 1.473 0.69 0 C-N-CA 124.267 1.027 . . . . 0.0 113.009 -179.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -94.04 -179.19 0.74 Allowed 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 123.096 2.53 . . . . 0.0 112.095 176.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -71.29 114.76 9.69 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.046 0.451 . . . . 0.0 110.691 176.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 68.5 mt -77.82 164.29 25.33 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.62 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 52.4 tttp -106.67 122.83 47.13 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.07 -176.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.413 ' OG1' ' HE2' ' A' ' 74' ' ' LYS . 39.9 p -102.66 148.67 25.28 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.673 -0.24 . . . . 0.0 111.489 -177.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -130.63 145.29 51.87 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 176.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 60.1 t -104.85 113.64 42.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 120.832 0.348 . . . . 0.0 110.572 -179.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 10.8 tt -111.05 112.75 41.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.371 0.605 . . . . 0.0 110.398 177.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.877 ' HG2' ' HG2' ' A' ' 72' ' ' LYS . 50.4 mt-10 -77.48 107.01 9.62 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.258 179.097 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -93.13 126.18 38.1 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 -179.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.402 ' HG2' HG13 ' A' ' 53' ' ' VAL . 40.2 tt0 -94.03 104.82 16.85 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 120.997 0.427 . . . . 0.0 111.199 -174.429 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 67.1 mt -87.19 110.71 20.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.098 178.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.45 HG12 ' HA ' ' A' ' 68' ' ' VAL . 21.2 m -132.23 144.9 35.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.685 178.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -97.75 117.95 64.64 Favored Pre-proline 0 C--N 1.321 -0.663 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 172.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -70.32 -175.96 1.47 Allowed 'Trans proline' 0 C--O 1.234 0.288 0 C-N-CA 122.836 2.357 . . . . 0.0 113.205 -174.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -135.27 43.99 1.21 Allowed Glycine 0 N--CA 1.444 -0.796 0 CA-C-N 115.329 -0.85 . . . . 0.0 110.981 -177.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -46.28 -43.9 16.06 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 123.296 0.639 . . . . 0.0 111.567 -177.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -123.22 94.59 4.31 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.226 179.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -95.68 115.22 65.34 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.105 -179.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.48 ' HG2' ' HE2' ' A' ' 64' ' ' LYS . 8.3 Cg_exo -73.47 165.06 33.44 Favored 'Trans proline' 0 C--O 1.234 0.305 0 C-N-CA 122.933 2.422 . . . . 0.0 111.099 173.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.44 43.67 0.65 Allowed 'Trans proline' 0 CA--C 1.534 0.507 0 C-N-CA 122.864 2.376 . . . . 0.0 112.719 179.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -123.47 -176.23 3.4 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.783 -179.108 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 68.3 mtm -113.34 83.39 1.83 Allowed 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 174.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.48 ' HE2' ' HG2' ' A' ' 60' ' ' PRO . 68.0 mttm -93.59 132.73 37.64 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 177.225 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 97.8 m-85 -107.9 147.18 31.34 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.293 0.568 . . . . 0.0 111.757 -172.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.2 t -163.43 153.32 15.33 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.18 -0.918 . . . . 0.0 108.558 178.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 29.2 p-10 -134.85 161.18 35.94 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.223 0.535 . . . . 0.0 112.06 -174.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.45 ' HA ' HG12 ' A' ' 53' ' ' VAL . 3.3 p -83.23 133.18 29.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.165 179.238 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -128.95 107.86 9.96 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.075 0.464 . . . . 0.0 110.303 176.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 48.7 mttm -92.14 132.92 36.24 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.146 -177.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 18.9 m -115.8 128.26 73.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-O 121.115 0.483 . . . . 0.0 110.524 176.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.877 ' HG2' ' HG2' ' A' ' 49' ' ' GLU . 79.4 mttt -86.74 100.06 12.22 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.987 0.423 . . . . 0.0 110.352 -178.483 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 57.0 mt -92.71 115.09 30.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.054 -179.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.594 ' O ' ' HB3' ' A' ' 90' ' ' TYR . 82.2 tttt -98.9 114.71 27.44 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.247 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -111.83 166.99 10.72 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 13.9 p -125.83 143.48 39.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 120.733 0.301 . . . . 0.0 111.074 -172.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 28.9 p90 -155.0 173.8 16.06 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.934 0.397 . . . . 0.0 110.941 178.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -145.1 151.44 38.51 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 170.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -102.07 128.97 48.3 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.843 0.354 . . . . 0.0 110.23 -176.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.4 p -84.09 173.59 10.98 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.201 179.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.412 HD12 ' N ' ' A' ' 81' ' ' LEU . 7.0 mp -68.33 -17.74 64.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.068 0.461 . . . . 0.0 111.36 -176.213 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -95.62 14.95 21.29 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.213 -179.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 70.44 23.68 4.82 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.143 173.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 59.3 t -100.14 141.93 16.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 120.962 0.41 . . . . 0.0 110.562 178.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 8.2 mtp180 -98.0 117.08 31.54 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.229 -178.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.583 ' HA ' ' HB ' ' A' ' 24' ' ' ILE . 20.5 t -96.89 97.1 5.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 176.627 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 31.8 t -103.7 144.4 14.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 121.079 0.466 . . . . 0.0 111.656 -172.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . . . . . . . . . 51.1 m -151.98 159.6 43.71 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 175.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -73.04 131.86 42.65 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 121.734 -0.604 . . . . 0.0 110.986 -176.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.594 ' HB3' ' O ' ' A' ' 74' ' ' LYS . 88.9 t80 -73.93 -30.34 62.5 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.389 -176.725 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.25 -44.77 71.26 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.528 ' O ' ' HB3' ' A' ' 95' ' ' LYS . 5.3 tp10 -70.43 -34.66 72.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.375 -0.83 . . . . 0.0 110.233 179.301 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.414 ' O ' HD23 ' A' ' 97' ' ' LEU . 83.4 t80 -62.34 -51.5 67.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.325 176.588 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 72.5 mm-40 -64.31 -29.73 70.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.825 179.138 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.528 ' HB3' ' O ' ' A' ' 92' ' ' GLU . 23.4 tptm -55.72 -46.99 77.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.321 174.621 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.41 HD13 ' HA ' ' A' ' 29' ' ' GLU . 57.7 mt -68.84 -39.5 80.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.112 -179.052 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.575 HD12 ' HG3' ' A' ' 103' ' ' LYS . 4.3 mm? -58.59 -45.25 89.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.788 178.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -74.27 -30.38 62.09 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.507 178.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -59.33 -45.35 91.59 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.908 -176.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.413 HH11 ' HD2' ' A' ' 100' ' ' ARG . 21.3 ttp85 -104.35 -8.13 19.45 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.107 -179.127 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 72.04 46.59 35.3 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.626 -0.797 . . . . 0.0 112.111 179.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.515 ' HB ' HD13 ' A' ' 97' ' ' LEU . 15.1 m -72.7 -24.92 61.07 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.166 0.508 . . . . 0.0 111.1 -177.225 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.575 ' HG3' HD12 ' A' ' 97' ' ' LEU . 55.7 mtmt -106.27 69.89 0.81 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.303 0.573 . . . . 0.0 109.829 175.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 8.1 tt -159.43 123.54 3.86 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.086 -179.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -113.92 113.1 24.38 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 12.4 t-80 -57.96 -30.44 65.99 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.794 -174.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -118.3 128.26 54.49 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 28.3 m80 -111.42 131.87 54.88 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.719 0.295 . . . . 0.0 110.679 177.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 15.6 m-70 -83.59 135.62 34.55 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 176.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 61.2 t60 67.51 -81.62 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.355 0 O-C-N 123.857 0.723 . . . . 0.0 109.579 -174.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 16.1 t-80 . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.085 -0.96 . . . . 0.0 109.805 175.578 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.0 tmm? . . . . . 0 N--CA 1.479 1.024 0 CA-C-O 120.969 0.414 . . . . 0.0 110.723 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . . . . . . . . . 51.3 m-80 -127.16 -178.11 4.31 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 173.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.579 ' O ' ' HG3' ' A' ' 7' ' ' LYS . 30.1 p -56.89 -31.69 65.12 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.764 0.316 . . . . 0.0 110.693 177.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -56.7 -52.62 64.24 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.975 175.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 59.1 t -60.42 -43.25 93.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.683 -179.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.45 ' O ' ' HG ' ' A' ' 10' ' ' LEU . 67.1 mt -53.12 -45.33 53.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.88 174.68 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.579 ' HG3' ' O ' ' A' ' 3' ' ' SER . 91.6 mttt -62.48 -41.6 98.9 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.97 -179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -58.7 -42.69 89.21 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.993 0.425 . . . . 0.0 110.62 177.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -65.28 -43.83 89.97 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.412 179.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.509 HD13 ' HB3' ' A' ' 17' ' ' TYR . 85.4 mt -65.26 -39.3 92.46 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.996 179.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -67.26 -40.53 86.25 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.428 178.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -60.04 -43.38 95.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.795 177.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 62.5 mt -70.29 -41.35 78.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.544 177.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 97.74 35.76 5.02 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.99 -0.624 . . . . 0.0 111.784 -178.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -104.53 177.27 4.89 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.071 0.463 . . . . 0.0 111.245 -178.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -109.65 149.97 28.93 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.663 -0.699 . . . . 0.0 109.966 -178.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.509 ' HB3' HD13 ' A' ' 10' ' ' LEU . 34.1 p90 -144.84 144.52 31.17 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.976 -0.379 . . . . 0.0 109.976 176.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 67.3 mt -113.01 102.86 14.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 120.895 0.378 . . . . 0.0 110.103 178.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -92.2 133.22 36.0 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.275 0.559 . . . . 0.0 110.861 -178.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 88.9 mt -121.44 -162.24 0.96 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.051 -0.977 . . . . 0.0 108.788 177.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -71.62 102.06 2.66 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.892 -0.323 . . . . 0.0 110.399 177.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 67.3 20.48 10.04 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.33 177.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -136.77 138.86 41.35 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.287 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.44 HD11 ' HB2' ' A' ' 3' ' ' SER . 60.2 mt -122.86 113.01 36.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 170.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.51 ' HA ' ' O ' ' A' ' 87' ' ' VAL . 16.3 m-70 -95.87 123.72 39.57 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.251 -179.355 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 92.5 mt -114.98 177.55 4.61 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.345 -175.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.436 ' HB2' HG23 ' A' ' 30' ' ' VAL . 86.8 mttt -86.95 137.9 33.13 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 115.364 -0.835 . . . . 0.0 108.934 174.242 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.453 ' HA ' HG21 ' A' ' 88' ' ' THR . 57.6 Cg_exo -52.4 -38.05 73.12 Favored 'Trans proline' 0 CA--C 1.529 0.26 0 C-N-CA 122.92 2.414 . . . . 0.0 113.113 -177.218 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -73.6 -29.67 62.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.04 -177.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.436 HG23 ' HB2' ' A' ' 27' ' ' LYS . 27.0 t -84.54 -38.37 13.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-O 121.233 0.54 . . . . 0.0 110.134 179.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -57.63 -30.43 65.36 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.826 179.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -54.35 -45.95 72.85 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.271 178.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -82.05 -29.4 31.93 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.274 -177.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 79.5 t -67.8 -41.31 85.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.21 0.529 . . . . 0.0 109.977 176.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.483 ' CD1' ' HD2' ' A' ' 41' ' ' PRO . 29.2 t90 -57.14 -45.29 83.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.342 176.121 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 56.8 mttm -76.23 -21.53 56.27 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.461 179.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -65.97 -35.64 81.15 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.998 0.428 . . . . 0.0 110.381 178.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.535 HG23 ' HD3' ' A' ' 41' ' ' PRO . 26.9 m -93.68 12.39 3.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.316 179.559 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 87.01 29.33 23.34 Favored Glycine 0 C--N 1.33 0.237 0 C-N-CA 121.055 -0.593 . . . . 0.0 113.481 174.183 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 36.42 75.21 0.53 Allowed Pre-proline 0 N--CA 1.473 0.701 0 C-N-CA 124.07 0.948 . . . . 0.0 113.218 179.082 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.535 ' HD3' HG23 ' A' ' 38' ' ' VAL . 82.1 Cg_endo -89.01 -159.32 0.09 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.712 0 C-N-CA 123.307 2.671 . . . . 0.0 112.617 -178.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -70.18 123.74 22.39 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.684 -178.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 74.7 mt -89.07 117.54 28.15 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.239 175.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -95.66 119.47 34.23 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.227 -178.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 40.6 p -107.2 134.73 49.87 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.614 179.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' TYR . . . . . 0.518 ' CE1' ' HB2' ' A' ' 75' ' ' LYS . 15.1 p90 -128.29 140.45 51.87 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.329 -0.396 . . . . 0.0 109.975 178.492 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 61.7 t -99.18 110.55 26.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.584 -179.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.446 HG23 ' HB ' ' A' ' 73' ' ' ILE . 7.4 tt -106.86 106.68 21.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.645 175.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.482 ' OE1' ' HD3' ' A' ' 70' ' ' LYS . 39.6 tt0 -81.94 104.05 12.03 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.121 -179.014 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -102.36 146.72 27.65 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 179.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -99.09 125.16 44.55 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 120.778 0.323 . . . . 0.0 111.074 -174.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 53.2 mt 63.72 85.63 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.788 -177.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.472 HG21 HD11 ' A' ' 73' ' ' ILE . 48.1 t -110.04 96.86 5.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.992 178.224 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -96.38 159.38 32.06 Favored Pre-proline 0 C--N 1.323 -0.575 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.497 -178.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -54.9 -32.94 80.22 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 123.124 2.55 . . . . 0.0 113.189 179.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 176.12 -35.32 0.09 OUTLIER Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.259 -0.972 . . . . 0.0 113.263 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -114.12 145.12 42.07 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.813 0.307 . . . . 0.0 111.008 -177.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -104.86 174.3 5.94 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 176.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -83.01 156.21 67.2 Favored Pre-proline 0 C--N 1.327 -0.4 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 177.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.539 ' HA ' ' HD3' ' A' ' 61' ' ' PRO . 88.5 Cg_exo -42.65 124.9 3.54 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 123.8 3.0 . . . . 0.0 113.872 -175.383 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.539 ' HD3' ' HA ' ' A' ' 60' ' ' PRO . 10.2 Cg_exo -70.42 87.3 0.64 Allowed 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 123.289 2.659 . . . . 0.0 112.517 -178.527 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -122.14 -177.53 3.62 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.766 178.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' MET . . . . . . . . . . . . . 46.8 ttp -75.03 82.07 2.23 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 173.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 72.7 tttt -153.78 138.29 16.82 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.803 -1.09 . . . . 0.0 109.464 -172.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 77.9 t80 -87.6 99.95 12.43 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.875 0.369 . . . . 0.0 110.811 178.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 32.9 m -71.04 119.4 15.11 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 169.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 -52.34 112.7 0.85 Allowed 'General case' 0 C--N 1.329 -0.313 0 O-C-N 123.372 0.42 . . . . 0.0 111.627 -175.082 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 45.4 t -75.63 86.67 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.827 178.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 32.4 tttm -96.66 127.22 42.43 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.665 -178.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.482 ' HD3' ' OE1' ' A' ' 49' ' ' GLU . 62.8 mttm -79.91 129.96 34.91 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.979 -175.392 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 53.8 t -116.75 109.94 29.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.452 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.436 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . 61.6 mttp -76.06 100.34 4.91 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.31 177.471 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.472 HD11 HG21 ' A' ' 53' ' ' VAL . 40.3 mt -91.19 108.59 20.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.254 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 54.1 tttp -91.57 106.18 18.3 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.56 178.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.518 ' HB2' ' CE1' ' A' ' 46' ' ' TYR . 89.9 mttt -105.49 162.23 13.65 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.158 -178.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 10.7 p -124.19 142.42 41.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.605 0.24 . . . . 0.0 110.574 -178.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.445 ' HA ' ' O ' ' A' ' 86' ' ' VAL . 43.5 p90 -153.6 167.8 28.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.095 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 44.1 p90 -136.49 151.11 49.1 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 168.073 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -102.48 131.6 49.07 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.01 0.433 . . . . 0.0 111.466 -174.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 75.0 p -83.97 -172.66 4.28 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.003 179.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 8.5 mp -73.81 -33.61 64.25 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.949 0.404 . . . . 0.0 110.424 178.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -92.16 24.57 3.26 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.938 -0.573 . . . . 0.0 111.369 -177.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 20.8 m120 69.81 20.76 6.67 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 169.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 86.1 t -94.41 124.42 46.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 C-N-CA 120.443 -0.503 . . . . 0.0 110.595 179.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ARG . . . . . . . . . . . . . 51.9 mtt-85 -89.52 110.93 21.72 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.707 179.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 77' ' ' TYR . 45.9 t -81.35 99.5 4.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 175.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.51 ' O ' ' HA ' ' A' ' 25' ' ' HIS . 22.2 t -102.57 138.88 25.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.879 -172.297 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' THR . . . . . 0.453 HG21 ' HA ' ' A' ' 28' ' ' PRO . 42.8 m -144.76 157.59 44.12 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 177.022 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ASP . . . . . 0.47 ' OD2' ' HG2' ' A' ' 92' ' ' GLU . 9.5 t70 -66.88 122.46 17.76 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.155 0.503 . . . . 0.0 111.57 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 79.5 t80 -69.28 -30.23 68.28 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.845 -177.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 35.1 t -62.84 -66.38 0.55 Allowed 'General case' 0 C--O 1.235 0.297 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.077 -176.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLU . . . . . 0.47 ' HG2' ' OD2' ' A' ' 89' ' ' ASP . 12.3 mm-40 -68.66 -28.96 67.34 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 121.042 -0.263 . . . . 0.0 111.323 -175.48 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.432 ' O ' ' HG ' ' A' ' 97' ' ' LEU . 53.0 t80 -62.09 -47.4 84.82 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 121.079 -0.248 . . . . 0.0 110.872 178.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 81.7 mm-40 -64.14 -35.52 81.06 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.779 0.323 . . . . 0.0 110.838 179.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -61.39 -43.72 98.38 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.515 177.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.407 HG13 ' O ' ' A' ' 92' ' ' GLU . 78.9 mt -66.79 -36.77 78.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.033 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 93' ' ' PHE . 97.8 mt -59.42 -49.95 75.85 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-O 120.943 0.401 . . . . 0.0 110.117 175.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 7.6 mtpm? -63.89 -42.61 97.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.602 177.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 7.6 tmtm? -59.76 -54.17 49.41 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.953 -177.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.404 HH11 ' HD3' ' A' ' 100' ' ' ARG . 49.4 mtt180 -82.65 -6.41 59.35 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.349 -175.285 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 81.22 40.62 11.12 Favored Glycine 0 C--N 1.329 0.173 0 C-N-CA 120.967 -0.635 . . . . 0.0 113.409 172.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 37.1 m -78.77 133.49 37.1 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.702 0.287 . . . . 0.0 110.345 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 42.8 mmtm -95.44 119.19 33.51 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.911 0.386 . . . . 0.0 111.029 -176.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 87.1 mt -105.69 164.83 11.61 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.959 177.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -70.44 138.36 51.15 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.359 0.6 . . . . 0.0 112.294 -176.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' HIS . . . . . . . . . . . . . 17.9 m-70 -127.07 102.39 6.95 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.17 172.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 10.7 m170 -99.92 164.19 12.12 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.061 -175.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -87.37 -11.35 49.59 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.526 0.679 . . . . 0.0 109.262 177.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 32.3 m80 -134.96 130.04 35.17 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.985 -1.007 . . . . 0.0 108.934 173.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' HIS . . . . . . . . . . . . . 53.8 p-80 -65.27 -36.77 85.13 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 174.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' HIS . . . . . . . . . . . . . 1.9 m80 . . . . . 0 C--O 1.246 0.884 0 CA-C-N 115.347 -0.842 . . . . 0.0 108.963 175.742 . . . . . . . . 0 0 . 1 stop_ save_